Datasets:

RevKen

/

chat_formatted_seo_without_title

like 0

edtsum820

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN FRANCISCO, April 28, 2020 /PRNewswire/ --Databricks, the Data and AI company, today released a commissioned global study conducted by Forrester Consulting, which reveals that an enterprise cohort of Databricks customers realizednearly $29 million in total value, driven by revenue, productivity and cost savings. Additionally, these same customers experienced a 417 percent return on investment (ROI) over three years and a payback in under six months when they deployed Databricks' Unified Data Analytics Platform. This value is driven by a combination of revenue acceleration, data team productivity and cost savings associated with retiring legacy infrastructure. The Total Economic Impact study provides companies with a tool to identify the potential financial impact the platform can have on their business. The study analyzed the cost, benefit, flexibility, and risk factors associated with Databricks' Unified Data Analytics Platform. The full study "The Total Economic Impact of the Databricks Unified Data Analytics Platform" is available at: https://databricks.com/p/whitepaper/forrester-tei-study According to Forrester, enterprises view AI and machine learning (ML) as both the biggest threat and the biggest opportunity for the future success of their businesses. To support data teams' ability to innovate faster, organizations must democratize data, restructure teams to bring data science and business expertise closer together, and re-architect technology stacks to benefit from the scale of the cloud. The Total Economic Impact study uncovers how companies can do this faster and more effectively with the Databricks Unified Data Analytics Platform. Using Databricks, customers can tap innovations like AI-powered personalized product recommendations, supply chain forecasting, manufacturing defect detection, and fraud prevention that help maximize top-line growth and reduce operating costs. Data teams interviewed for the study experienced the following key benefits of Databricks' Unified Data Analytics Platform: Increased Profits by Accelerating Data Science Outcomes:Customers reported an increase in revenues by 5%. By realizing the combination of more and better machine learning models with Databricks, data scientists were able to spend more time iterating on new innovations. According to a Vice President of Data Science at a global media company, "Before, we had to wait two weeks for a process to finish before we could analyze and iterate on a ML model. Now, the same job takes an hour. We can iterate over it multiple times a day, allowing us to really understand the outcomes of our research, tweak it, and make a new model without interruption." Improved Productivity of Data Teams: Databricks improved customer productivity of data scientists and data engineers by 25% and 20%, respectively. Customers shared that the improved data management capabilities enabled data teams to spend less time searching for and cleaning data, less time creating and maintaining ETL pipelines, and more time building analytics and ML models to drive meaningful business outcomes. Databricks also helped remove technical barriers that limited collaboration between analysts, data scientists, and data engineers, enabling data teams to work together more efficiently. Infrastructure Savings:By migrating to Databricks, organizations experienced a lower total cost of ownership and cost savings of millions of dollars from retiring legacy on-premise infrastructure. "Our customers have proven the business value that can be generated when an organization combines data and AI on one platform," said Ali Ghodsi, cofounder and CEO at Databricks. "We believe the Total Economic Impact study is validation that this unified approach enables data teams to innovate faster and delivers meaningful business value to our customers." For more information on Databricks' Unified Data Analytics Platform, visitwww.databricks.com. About DatabricksDatabricks is the data and AI company. Thousands of organizations worldwide including Comcast, Cond Nast, Nationwide and H&M rely on Databricks' open and unified platform for data engineering, machine learning and analytics. Databricks is venture-backed and headquartered in San Francisco, with offices around the globe. Founded by the original creators of Apache Spark, Delta Lake and MLflow, Databricks is on a mission to help data teams solve the world's toughest problems. To learn more, follow Databricks on Twitter, LinkedInand Facebook. Apache, Apache Spark and Spark are trademarks of theApache Software Foundation. MEDIA CONTACT: Kristalle Cooks P: 650-346-7810 [emailprotected] SOURCE Databricks Related Links http://www.databricks.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Databricks' Unified Data Analytics Platform Can Generate 417 Percent Return on Investment, According to Total Economic Impact Study. Independent Study Confirms that Databricks Customers Realize nearly $29 Million in Total Benefits.

SAN FRANCISCO, April 28, 2020 /PRNewswire/ --Databricks, the Data and AI company, today released a commissioned global study conducted by Forrester Consulting, which reveals that an enterprise cohort of Databricks customers realizednearly $29 million in total value, driven by revenue, productivity and cost savings. Additionally, these same customers experienced a 417 percent return on investment (ROI) over three years and a payback in under six months when they deployed Databricks' Unified Data Analytics Platform. This value is driven by a combination of revenue acceleration, data team productivity and cost savings associated with retiring legacy infrastructure. The Total Economic Impact study provides companies with a tool to identify the potential financial impact the platform can have on their business. The study analyzed the cost, benefit, flexibility, and risk factors associated with Databricks' Unified Data Analytics Platform. The full study "The Total Economic Impact of the Databricks Unified Data Analytics Platform" is available at: https://databricks.com/p/whitepaper/forrester-tei-study According to Forrester, enterprises view AI and machine learning (ML) as both the biggest threat and the biggest opportunity for the future success of their businesses. To support data teams' ability to innovate faster, organizations must democratize data, restructure teams to bring data science and business expertise closer together, and re-architect technology stacks to benefit from the scale of the cloud. The Total Economic Impact study uncovers how companies can do this faster and more effectively with the Databricks Unified Data Analytics Platform. Using Databricks, customers can tap innovations like AI-powered personalized product recommendations, supply chain forecasting, manufacturing defect detection, and fraud prevention that help maximize top-line growth and reduce operating costs. Data teams interviewed for the study experienced the following key benefits of Databricks' Unified Data Analytics Platform: Increased Profits by Accelerating Data Science Outcomes:Customers reported an increase in revenues by 5%. By realizing the combination of more and better machine learning models with Databricks, data scientists were able to spend more time iterating on new innovations. According to a Vice President of Data Science at a global media company, "Before, we had to wait two weeks for a process to finish before we could analyze and iterate on a ML model. Now, the same job takes an hour. We can iterate over it multiple times a day, allowing us to really understand the outcomes of our research, tweak it, and make a new model without interruption." Improved Productivity of Data Teams: Databricks improved customer productivity of data scientists and data engineers by 25% and 20%, respectively. Customers shared that the improved data management capabilities enabled data teams to spend less time searching for and cleaning data, less time creating and maintaining ETL pipelines, and more time building analytics and ML models to drive meaningful business outcomes. Databricks also helped remove technical barriers that limited collaboration between analysts, data scientists, and data engineers, enabling data teams to work together more efficiently. Infrastructure Savings:By migrating to Databricks, organizations experienced a lower total cost of ownership and cost savings of millions of dollars from retiring legacy on-premise infrastructure. "Our customers have proven the business value that can be generated when an organization combines data and AI on one platform," said Ali Ghodsi, cofounder and CEO at Databricks. "We believe the Total Economic Impact study is validation that this unified approach enables data teams to innovate faster and delivers meaningful business value to our customers." For more information on Databricks' Unified Data Analytics Platform, visitwww.databricks.com. About DatabricksDatabricks is the data and AI company. Thousands of organizations worldwide including Comcast, Cond Nast, Nationwide and H&M rely on Databricks' open and unified platform for data engineering, machine learning and analytics. Databricks is venture-backed and headquartered in San Francisco, with offices around the globe. Founded by the original creators of Apache Spark, Delta Lake and MLflow, Databricks is on a mission to help data teams solve the world's toughest problems. To learn more, follow Databricks on Twitter, LinkedInand Facebook. Apache, Apache Spark and Spark are trademarks of theApache Software Foundation. MEDIA CONTACT: Kristalle Cooks P: 650-346-7810 [emailprotected] SOURCE Databricks Related Links http://www.databricks.com

Databricks' Unified Data Analytics Platform Can Generate 417 Percent Return on Investment According to Total Economic Impact Study Independent Study Confirms that Databricks Customers Realize nearly $29 Million in Total Benefits

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN FRANCISCO, April 28, 2020 /PRNewswire/ --Databricks, the Data and AI company, today released a commissioned global study conducted by Forrester Consulting, which reveals that an enterprise cohort of Databricks customers realizednearly $29 million in total value, driven by revenue, productivity and cost savings. Additionally, these same customers experienced a 417 percent return on investment (ROI) over three years and a payback in under six months when they deployed Databricks' Unified Data Analytics Platform. This value is driven by a combination of revenue acceleration, data team productivity and cost savings associated with retiring legacy infrastructure. The Total Economic Impact study provides companies with a tool to identify the potential financial impact the platform can have on their business. The study analyzed the cost, benefit, flexibility, and risk factors associated with Databricks' Unified Data Analytics Platform. The full study "The Total Economic Impact of the Databricks Unified Data Analytics Platform" is available at: https://databricks.com/p/whitepaper/forrester-tei-study According to Forrester, enterprises view AI and machine learning (ML) as both the biggest threat and the biggest opportunity for the future success of their businesses. To support data teams' ability to innovate faster, organizations must democratize data, restructure teams to bring data science and business expertise closer together, and re-architect technology stacks to benefit from the scale of the cloud. The Total Economic Impact study uncovers how companies can do this faster and more effectively with the Databricks Unified Data Analytics Platform. Using Databricks, customers can tap innovations like AI-powered personalized product recommendations, supply chain forecasting, manufacturing defect detection, and fraud prevention that help maximize top-line growth and reduce operating costs. Data teams interviewed for the study experienced the following key benefits of Databricks' Unified Data Analytics Platform: Increased Profits by Accelerating Data Science Outcomes:Customers reported an increase in revenues by 5%. By realizing the combination of more and better machine learning models with Databricks, data scientists were able to spend more time iterating on new innovations. According to a Vice President of Data Science at a global media company, "Before, we had to wait two weeks for a process to finish before we could analyze and iterate on a ML model. Now, the same job takes an hour. We can iterate over it multiple times a day, allowing us to really understand the outcomes of our research, tweak it, and make a new model without interruption." Improved Productivity of Data Teams: Databricks improved customer productivity of data scientists and data engineers by 25% and 20%, respectively. Customers shared that the improved data management capabilities enabled data teams to spend less time searching for and cleaning data, less time creating and maintaining ETL pipelines, and more time building analytics and ML models to drive meaningful business outcomes. Databricks also helped remove technical barriers that limited collaboration between analysts, data scientists, and data engineers, enabling data teams to work together more efficiently. Infrastructure Savings:By migrating to Databricks, organizations experienced a lower total cost of ownership and cost savings of millions of dollars from retiring legacy on-premise infrastructure. "Our customers have proven the business value that can be generated when an organization combines data and AI on one platform," said Ali Ghodsi, cofounder and CEO at Databricks. "We believe the Total Economic Impact study is validation that this unified approach enables data teams to innovate faster and delivers meaningful business value to our customers." For more information on Databricks' Unified Data Analytics Platform, visitwww.databricks.com. About DatabricksDatabricks is the data and AI company. Thousands of organizations worldwide including Comcast, Cond Nast, Nationwide and H&M rely on Databricks' open and unified platform for data engineering, machine learning and analytics. Databricks is venture-backed and headquartered in San Francisco, with offices around the globe. Founded by the original creators of Apache Spark, Delta Lake and MLflow, Databricks is on a mission to help data teams solve the world's toughest problems. To learn more, follow Databricks on Twitter, LinkedInand Facebook. Apache, Apache Spark and Spark are trademarks of theApache Software Foundation. MEDIA CONTACT: Kristalle Cooks P: 650-346-7810 [emailprotected] SOURCE Databricks Related Links http://www.databricks.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Databricks' Unified Data Analytics Platform Can Generate 417 Percent Return on Investment, According to Total Economic Impact Study. Independent Study Confirms that Databricks Customers Realize nearly $29 Million in Total Benefits.<|eot_id|>

edtsum821

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SEATTLE, April 2, 2020 /PRNewswire/ --JennyLife, a no-health-exam-required life insurance provider for women and moms seeking to protect their family's financial stability, today announced it has secured $3.5 million in Series A funding for a total raise of $5 million, from CMFG Ventures (venture arm of CUNA Mutual Group) and undisclosed luminaries from within the insurance industry. JennyLife will use the funds to accelerate its ability to protect the 28.5 million families who have no mortality protection by focusing on technology development and growing its marketing to best attract and serve this audience. JennyLife, a no-health-exam-required life insurance provider for women and moms seeking to protect their familys financial stability,& today announced it has secured $3.5 million in Series A funding for a total raise of $5 million, from CMFG Ventures (venture arm of CUNA Mutual Group)& and& undisclosed luminaries from within the insurance industry. For more facts about JennyLife and free resources visit www.jennylife.com and download the app, available on iOS and Google Play. Brian Kaas, President CMFG Ventures and JennyLife board member, commented, "JennyLife has made tremendous progress since its launch and is poised to become the most trusted source for helping families maintain financial stability should they endure life's darkest moments. We are impressed with JennyLife's talented team of industry veterans and their category-leading technology that makes them well positioned to take advantage of the considerable market opportunity in the insuretech space." JennyLife is co-founded by veteran insurance executives, Chirag Pancholi and Lief Larson - two kick-ass husbands who said "no more!" to the old ways of getting life insurance. They witnessed firsthand the deep frustrations experienced by their wives as they followed the tedious steps of the traditional life insurance buying process. Health exams. Blood tests. Urine samples. Lengthy phone and paper applications that took weeks. So much time and energy, and still the risk of getting denied? This system was broken and it was time for a serious upgrade. The entrepreneurs gave this industry the makeover it needed and made it their mission to change how women enroll in life insurance. They developed a new life insurance technology and created the JennyLife native apps, Web app, and text (SMS) capabilities to modernize this process. "JennyLife is transforming the way people think about life insurance," said Chirag Pancholi, co-founder and chief executive officer of JennyLife. "In the face of these tough economic times, this additional financing allows us to continue to grow JennyLife and advance our product and business around the nation." He continued, "In this business climate, people are hungrier than ever for information about their financial security. We're improving the breadth, depth, and quality of our offerings to support the growing interest we're seeing from families." Women have typically had less access to tools that promote financial stability. Only one in three women own individual life insurance policies, according to LIMRA's 'Life Insurance Ownership in Focus, U.S. Personal Trends: 2016.' Women are also 80 percent more likely to be impoverished in retirement (National Institute on Retirement Security 2016). Companies like JennyLife are building financial products that help women and families gain equal access to tools promoting financial stability. For more facts and free resources visit www.jennylife.com and download the app iOS andGoogle Play.About JennyLifeJennyLife is a life insurance innovation company that uses new technology to upgrade the way you buy life insurance. Within minutes (we know you are time-starved) you can easily apply for life insurance from your smartphone or laptop using our native apps, web app, text messaging (SMS) or by calling 855-88-JENNY. No health exams. No blood draws. Just fast and easy life insurance from an A-rated insurance carrier. Plans start at $7/month. We help you find the option that fits your goals, family and budget. To keep up with the latest visithttp://www.jennylife.com. SOURCE JennyLife Related Links https://www.jennylife.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

JennyLife Secures $3.5 Million Series A Funding In Effort to Close the "Life Insurance Gap" for Women and Families.

SEATTLE, April 2, 2020 /PRNewswire/ --JennyLife, a no-health-exam-required life insurance provider for women and moms seeking to protect their family's financial stability, today announced it has secured $3.5 million in Series A funding for a total raise of $5 million, from CMFG Ventures (venture arm of CUNA Mutual Group) and undisclosed luminaries from within the insurance industry. JennyLife will use the funds to accelerate its ability to protect the 28.5 million families who have no mortality protection by focusing on technology development and growing its marketing to best attract and serve this audience. JennyLife, a no-health-exam-required life insurance provider for women and moms seeking to protect their familys financial stability,& today announced it has secured $3.5 million in Series A funding for a total raise of $5 million, from CMFG Ventures (venture arm of CUNA Mutual Group)& and& undisclosed luminaries from within the insurance industry. For more facts about JennyLife and free resources visit www.jennylife.com and download the app, available on iOS and Google Play. Brian Kaas, President CMFG Ventures and JennyLife board member, commented, "JennyLife has made tremendous progress since its launch and is poised to become the most trusted source for helping families maintain financial stability should they endure life's darkest moments. We are impressed with JennyLife's talented team of industry veterans and their category-leading technology that makes them well positioned to take advantage of the considerable market opportunity in the insuretech space." JennyLife is co-founded by veteran insurance executives, Chirag Pancholi and Lief Larson - two kick-ass husbands who said "no more!" to the old ways of getting life insurance. They witnessed firsthand the deep frustrations experienced by their wives as they followed the tedious steps of the traditional life insurance buying process. Health exams. Blood tests. Urine samples. Lengthy phone and paper applications that took weeks. So much time and energy, and still the risk of getting denied? This system was broken and it was time for a serious upgrade. The entrepreneurs gave this industry the makeover it needed and made it their mission to change how women enroll in life insurance. They developed a new life insurance technology and created the JennyLife native apps, Web app, and text (SMS) capabilities to modernize this process. "JennyLife is transforming the way people think about life insurance," said Chirag Pancholi, co-founder and chief executive officer of JennyLife. "In the face of these tough economic times, this additional financing allows us to continue to grow JennyLife and advance our product and business around the nation." He continued, "In this business climate, people are hungrier than ever for information about their financial security. We're improving the breadth, depth, and quality of our offerings to support the growing interest we're seeing from families." Women have typically had less access to tools that promote financial stability. Only one in three women own individual life insurance policies, according to LIMRA's 'Life Insurance Ownership in Focus, U.S. Personal Trends: 2016.' Women are also 80 percent more likely to be impoverished in retirement (National Institute on Retirement Security 2016). Companies like JennyLife are building financial products that help women and families gain equal access to tools promoting financial stability. For more facts and free resources visit www.jennylife.com and download the app iOS andGoogle Play.About JennyLifeJennyLife is a life insurance innovation company that uses new technology to upgrade the way you buy life insurance. Within minutes (we know you are time-starved) you can easily apply for life insurance from your smartphone or laptop using our native apps, web app, text messaging (SMS) or by calling 855-88-JENNY. No health exams. No blood draws. Just fast and easy life insurance from an A-rated insurance carrier. Plans start at $7/month. We help you find the option that fits your goals, family and budget. To keep up with the latest visithttp://www.jennylife.com. SOURCE JennyLife Related Links https://www.jennylife.com

JennyLife Secures $3.5 Million Series A Funding In Effort to Close the "Life Insurance Gap" for Women and Families

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SEATTLE, April 2, 2020 /PRNewswire/ --JennyLife, a no-health-exam-required life insurance provider for women and moms seeking to protect their family's financial stability, today announced it has secured $3.5 million in Series A funding for a total raise of $5 million, from CMFG Ventures (venture arm of CUNA Mutual Group) and undisclosed luminaries from within the insurance industry. JennyLife will use the funds to accelerate its ability to protect the 28.5 million families who have no mortality protection by focusing on technology development and growing its marketing to best attract and serve this audience. JennyLife, a no-health-exam-required life insurance provider for women and moms seeking to protect their familys financial stability,& today announced it has secured $3.5 million in Series A funding for a total raise of $5 million, from CMFG Ventures (venture arm of CUNA Mutual Group)& and& undisclosed luminaries from within the insurance industry. For more facts about JennyLife and free resources visit www.jennylife.com and download the app, available on iOS and Google Play. Brian Kaas, President CMFG Ventures and JennyLife board member, commented, "JennyLife has made tremendous progress since its launch and is poised to become the most trusted source for helping families maintain financial stability should they endure life's darkest moments. We are impressed with JennyLife's talented team of industry veterans and their category-leading technology that makes them well positioned to take advantage of the considerable market opportunity in the insuretech space." JennyLife is co-founded by veteran insurance executives, Chirag Pancholi and Lief Larson - two kick-ass husbands who said "no more!" to the old ways of getting life insurance. They witnessed firsthand the deep frustrations experienced by their wives as they followed the tedious steps of the traditional life insurance buying process. Health exams. Blood tests. Urine samples. Lengthy phone and paper applications that took weeks. So much time and energy, and still the risk of getting denied? This system was broken and it was time for a serious upgrade. The entrepreneurs gave this industry the makeover it needed and made it their mission to change how women enroll in life insurance. They developed a new life insurance technology and created the JennyLife native apps, Web app, and text (SMS) capabilities to modernize this process. "JennyLife is transforming the way people think about life insurance," said Chirag Pancholi, co-founder and chief executive officer of JennyLife. "In the face of these tough economic times, this additional financing allows us to continue to grow JennyLife and advance our product and business around the nation." He continued, "In this business climate, people are hungrier than ever for information about their financial security. We're improving the breadth, depth, and quality of our offerings to support the growing interest we're seeing from families." Women have typically had less access to tools that promote financial stability. Only one in three women own individual life insurance policies, according to LIMRA's 'Life Insurance Ownership in Focus, U.S. Personal Trends: 2016.' Women are also 80 percent more likely to be impoverished in retirement (National Institute on Retirement Security 2016). Companies like JennyLife are building financial products that help women and families gain equal access to tools promoting financial stability. For more facts and free resources visit www.jennylife.com and download the app iOS andGoogle Play.About JennyLifeJennyLife is a life insurance innovation company that uses new technology to upgrade the way you buy life insurance. Within minutes (we know you are time-starved) you can easily apply for life insurance from your smartphone or laptop using our native apps, web app, text messaging (SMS) or by calling 855-88-JENNY. No health exams. No blood draws. Just fast and easy life insurance from an A-rated insurance carrier. Plans start at $7/month. We help you find the option that fits your goals, family and budget. To keep up with the latest visithttp://www.jennylife.com. SOURCE JennyLife Related Links https://www.jennylife.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> JennyLife Secures $3.5 Million Series A Funding In Effort to Close the "Life Insurance Gap" for Women and Families.<|eot_id|>

edtsum822

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: VANCOUVER, BC and ATLANTA, March 25, 2021 /PRNewswire/ -Liberty Defense Holdings Ltd. ("Liberty" or the "Company") (TSXV: SCAN) (OTCQB: LDDFF) (FRANKFURT: LD2), a leading concealed threat detection solutions company, is pleased to announce that it has achieved a key product milestone, and as a result of having recently completed its merger with DrawDown Detection, is now accelerating its HEXWAVE platform development timeline. Leveraging its exclusively licensed video-rate Ultra-Wideband imaging capability out of MIT Lincoln Laboratory, the Company's first generation AI detection algorithm was recently developed and successfully demonstrated finding threats on people in motion. This milestone is significant as the Company progresses toward its target of fielding Beta units in the first half of 2022. Mike Lanzaro, CTO of Liberty Defense, comments: "Achieving high levels of security threat screening performance for people while they are in motion is a technology challenge that has yet to be solved for the marketplace. Aman Bhardwaj, our COO, and the core group of engineers at Liberty have made great progress towards this goal over the past twelve months. We are now able to demonstrate not only 3D video-rate imaging but also the real-time automated detection of concealed metallic and non-metallic threats that may be carried into a public venue or other hi-traffic application. Unfortunately, we continue to see a rise in gun violence in the United States, so it is becoming even more important to commercialize products like HEXWAVE." The Liberty Defense HEXWAVE platform is a next generation security screening solution that can be used anywhere that crowds gather, including stadiums, schools, hospitals, places of worship, government buildings, warehouses, etc. HEXWAVE offers key advantages over existing technology: Automated detection of concealed metallic and non-metallic threats, including explosives and IED's Generates 3D imaging data for Automatic Threat Detection (AI/Deep Learning), reducing the number of "false alarms" leading to pat-downs and delays. Achieves 1,000+ people / hour throughput Indoor and outdoor use, while enabling a stand-off and layered security capability Contactless and harmless Preserves privacy (no personally identifiable information is collected, stored, or shown) Multiple configuration options: stand-alone, networked, relocatable / mobile Smart IOT functionality and capability to interact / integrate with existing security systems On Behalf of Liberty Defense Bill FrainCEO & Director About Liberty Defense Liberty provides security solutions for concealed weapon detection in high volume foot traffic areas and has secured an exclusive license from Massachusetts Institute of Technology (MIT), as well as a technology transfer agreement, for patents related to active 3D radar imaging technology that are packaged into the HEXWAVE product. The system is designed to provide discrete, modular, and scalable protection to provide layered, stand-off detection capability. This is intended to provide a means to counter evolving urban threats proactively. The sensors with active 3D radar imaging and Artificial Intelligence (AI)-enhanced automatic detection are designed to detect metal and non-metal firearms, knives, explosives and other threats. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions. Learn more: LibertyDefense.com FORWARD-LOOKING STATEMENTS When used in this press release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although Liberty believes, in light of the experience of their respective officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this press release are reasonable, undue reliance should not be placed on them because the parties can give no assurance that such statements will prove to be correct. Such statements and information reflect the current view of Liberty. There are risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. There are a number of important factors that could cause Liberty's actual results to differ materially from those indicated or implied by forward-looking statements and information. Such factors include, among others: currency fluctuations; limited business history of the parties; disruptions or changes in the credit or security markets; results of operation activities and development of projects; project cost overruns or unanticipated costs and expenses; and general development, market and industry conditions. The parties undertake no obligation to comment on analyses, expectations or statements made by third parties in respect of their securities or their respective financial or operating results (as applicable). Liberty cautions that the foregoing list of material factors is not exhaustive. When relying on Liberty's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Liberty has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking information contained in this press release represents the expectations of Liberty as of the date of this press release and, accordingly, are subject to change after such date. Liberty does not undertake to update this information at any particular time except as required in accordance with applicable laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. SOURCE Liberty Defense Holdings Ltd. Related Links www.libertydefense.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Liberty Defense Achieves Key Milestones and Accelerates Development Plans.

VANCOUVER, BC and ATLANTA, March 25, 2021 /PRNewswire/ -Liberty Defense Holdings Ltd. ("Liberty" or the "Company") (TSXV: SCAN) (OTCQB: LDDFF) (FRANKFURT: LD2), a leading concealed threat detection solutions company, is pleased to announce that it has achieved a key product milestone, and as a result of having recently completed its merger with DrawDown Detection, is now accelerating its HEXWAVE platform development timeline. Leveraging its exclusively licensed video-rate Ultra-Wideband imaging capability out of MIT Lincoln Laboratory, the Company's first generation AI detection algorithm was recently developed and successfully demonstrated finding threats on people in motion. This milestone is significant as the Company progresses toward its target of fielding Beta units in the first half of 2022. Mike Lanzaro, CTO of Liberty Defense, comments: "Achieving high levels of security threat screening performance for people while they are in motion is a technology challenge that has yet to be solved for the marketplace. Aman Bhardwaj, our COO, and the core group of engineers at Liberty have made great progress towards this goal over the past twelve months. We are now able to demonstrate not only 3D video-rate imaging but also the real-time automated detection of concealed metallic and non-metallic threats that may be carried into a public venue or other hi-traffic application. Unfortunately, we continue to see a rise in gun violence in the United States, so it is becoming even more important to commercialize products like HEXWAVE." The Liberty Defense HEXWAVE platform is a next generation security screening solution that can be used anywhere that crowds gather, including stadiums, schools, hospitals, places of worship, government buildings, warehouses, etc. HEXWAVE offers key advantages over existing technology: Automated detection of concealed metallic and non-metallic threats, including explosives and IED's Generates 3D imaging data for Automatic Threat Detection (AI/Deep Learning), reducing the number of "false alarms" leading to pat-downs and delays. Achieves 1,000+ people / hour throughput Indoor and outdoor use, while enabling a stand-off and layered security capability Contactless and harmless Preserves privacy (no personally identifiable information is collected, stored, or shown) Multiple configuration options: stand-alone, networked, relocatable / mobile Smart IOT functionality and capability to interact / integrate with existing security systems On Behalf of Liberty Defense Bill FrainCEO & Director About Liberty Defense Liberty provides security solutions for concealed weapon detection in high volume foot traffic areas and has secured an exclusive license from Massachusetts Institute of Technology (MIT), as well as a technology transfer agreement, for patents related to active 3D radar imaging technology that are packaged into the HEXWAVE product. The system is designed to provide discrete, modular, and scalable protection to provide layered, stand-off detection capability. This is intended to provide a means to counter evolving urban threats proactively. The sensors with active 3D radar imaging and Artificial Intelligence (AI)-enhanced automatic detection are designed to detect metal and non-metal firearms, knives, explosives and other threats. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions. Learn more: LibertyDefense.com FORWARD-LOOKING STATEMENTS When used in this press release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although Liberty believes, in light of the experience of their respective officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this press release are reasonable, undue reliance should not be placed on them because the parties can give no assurance that such statements will prove to be correct. Such statements and information reflect the current view of Liberty. There are risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. There are a number of important factors that could cause Liberty's actual results to differ materially from those indicated or implied by forward-looking statements and information. Such factors include, among others: currency fluctuations; limited business history of the parties; disruptions or changes in the credit or security markets; results of operation activities and development of projects; project cost overruns or unanticipated costs and expenses; and general development, market and industry conditions. The parties undertake no obligation to comment on analyses, expectations or statements made by third parties in respect of their securities or their respective financial or operating results (as applicable). Liberty cautions that the foregoing list of material factors is not exhaustive. When relying on Liberty's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Liberty has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking information contained in this press release represents the expectations of Liberty as of the date of this press release and, accordingly, are subject to change after such date. Liberty does not undertake to update this information at any particular time except as required in accordance with applicable laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. SOURCE Liberty Defense Holdings Ltd. Related Links www.libertydefense.com

Liberty Defense Achieves Key Milestones and Accelerates Development Plans

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: VANCOUVER, BC and ATLANTA, March 25, 2021 /PRNewswire/ -Liberty Defense Holdings Ltd. ("Liberty" or the "Company") (TSXV: SCAN) (OTCQB: LDDFF) (FRANKFURT: LD2), a leading concealed threat detection solutions company, is pleased to announce that it has achieved a key product milestone, and as a result of having recently completed its merger with DrawDown Detection, is now accelerating its HEXWAVE platform development timeline. Leveraging its exclusively licensed video-rate Ultra-Wideband imaging capability out of MIT Lincoln Laboratory, the Company's first generation AI detection algorithm was recently developed and successfully demonstrated finding threats on people in motion. This milestone is significant as the Company progresses toward its target of fielding Beta units in the first half of 2022. Mike Lanzaro, CTO of Liberty Defense, comments: "Achieving high levels of security threat screening performance for people while they are in motion is a technology challenge that has yet to be solved for the marketplace. Aman Bhardwaj, our COO, and the core group of engineers at Liberty have made great progress towards this goal over the past twelve months. We are now able to demonstrate not only 3D video-rate imaging but also the real-time automated detection of concealed metallic and non-metallic threats that may be carried into a public venue or other hi-traffic application. Unfortunately, we continue to see a rise in gun violence in the United States, so it is becoming even more important to commercialize products like HEXWAVE." The Liberty Defense HEXWAVE platform is a next generation security screening solution that can be used anywhere that crowds gather, including stadiums, schools, hospitals, places of worship, government buildings, warehouses, etc. HEXWAVE offers key advantages over existing technology: Automated detection of concealed metallic and non-metallic threats, including explosives and IED's Generates 3D imaging data for Automatic Threat Detection (AI/Deep Learning), reducing the number of "false alarms" leading to pat-downs and delays. Achieves 1,000+ people / hour throughput Indoor and outdoor use, while enabling a stand-off and layered security capability Contactless and harmless Preserves privacy (no personally identifiable information is collected, stored, or shown) Multiple configuration options: stand-alone, networked, relocatable / mobile Smart IOT functionality and capability to interact / integrate with existing security systems On Behalf of Liberty Defense Bill FrainCEO & Director About Liberty Defense Liberty provides security solutions for concealed weapon detection in high volume foot traffic areas and has secured an exclusive license from Massachusetts Institute of Technology (MIT), as well as a technology transfer agreement, for patents related to active 3D radar imaging technology that are packaged into the HEXWAVE product. The system is designed to provide discrete, modular, and scalable protection to provide layered, stand-off detection capability. This is intended to provide a means to counter evolving urban threats proactively. The sensors with active 3D radar imaging and Artificial Intelligence (AI)-enhanced automatic detection are designed to detect metal and non-metal firearms, knives, explosives and other threats. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions. Learn more: LibertyDefense.com FORWARD-LOOKING STATEMENTS When used in this press release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although Liberty believes, in light of the experience of their respective officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this press release are reasonable, undue reliance should not be placed on them because the parties can give no assurance that such statements will prove to be correct. Such statements and information reflect the current view of Liberty. There are risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. There are a number of important factors that could cause Liberty's actual results to differ materially from those indicated or implied by forward-looking statements and information. Such factors include, among others: currency fluctuations; limited business history of the parties; disruptions or changes in the credit or security markets; results of operation activities and development of projects; project cost overruns or unanticipated costs and expenses; and general development, market and industry conditions. The parties undertake no obligation to comment on analyses, expectations or statements made by third parties in respect of their securities or their respective financial or operating results (as applicable). Liberty cautions that the foregoing list of material factors is not exhaustive. When relying on Liberty's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Liberty has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking information contained in this press release represents the expectations of Liberty as of the date of this press release and, accordingly, are subject to change after such date. Liberty does not undertake to update this information at any particular time except as required in accordance with applicable laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. SOURCE Liberty Defense Holdings Ltd. Related Links www.libertydefense.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Liberty Defense Achieves Key Milestones and Accelerates Development Plans.<|eot_id|>

edtsum823

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 21,639,851 shares of common stock of the Company at a price to the public of $1.50 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about April 12, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company also has granted to the underwriter a 30-day option to purchase up to an additional 3,245,977 shares of common stock at the public offering price, less underwriting discounts and commission. The gross proceeds of the offering are expected to be approximately $32.5 million, before deducting underwriting discounts and commissions and offering expenses payable by Astrotech and assuming no exercise of the option to purchase additional shares. Astrotech intends to use the net proceeds of the offering for general corporate purposes, working capital, and capital expenditures. The securities described above are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-253835) filed with the Securities and Exchange Commission (SEC) and declared effective on March 15, 2021 and the accompanying prospectus contained therein. The offering of the securities is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A preliminary prospectus supplement and the accompanying prospectus relating to this offering were filed with the SEC and are available on the SECs website at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus relating to this offering, when filed, may be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by e-mail at placements@hcwco.com or by calling (212) 856-5711. This announcement is neither an offer to sell, nor a solicitation of an offer to buy, any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer, solicitation, or sale is unlawful. Any offer, if at all, will be made only by means of the prospectus forming a part of the effective registration statement. About Astrotech Corporation Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com. This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including regarding the anticipated closing of the offering. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the public offering, the Companys ability to obtain additional financing, the severity and duration of the COVID-19 pandemic and its impact on the U.S. and worldwide economy, the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, and whether the market will accept our products and services, market and other conditions, as well as other risk factors and business considerations described in the Companys Securities and Exchange Commission filings including our annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent the Companys views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to update these forward-looking statements. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Astrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million.

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 21,639,851 shares of common stock of the Company at a price to the public of $1.50 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about April 12, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company also has granted to the underwriter a 30-day option to purchase up to an additional 3,245,977 shares of common stock at the public offering price, less underwriting discounts and commission. The gross proceeds of the offering are expected to be approximately $32.5 million, before deducting underwriting discounts and commissions and offering expenses payable by Astrotech and assuming no exercise of the option to purchase additional shares. Astrotech intends to use the net proceeds of the offering for general corporate purposes, working capital, and capital expenditures. The securities described above are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-253835) filed with the Securities and Exchange Commission (SEC) and declared effective on March 15, 2021 and the accompanying prospectus contained therein. The offering of the securities is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A preliminary prospectus supplement and the accompanying prospectus relating to this offering were filed with the SEC and are available on the SECs website at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus relating to this offering, when filed, may be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by e-mail at placements@hcwco.com or by calling (212) 856-5711. This announcement is neither an offer to sell, nor a solicitation of an offer to buy, any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer, solicitation, or sale is unlawful. Any offer, if at all, will be made only by means of the prospectus forming a part of the effective registration statement. About Astrotech Corporation Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com. This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including regarding the anticipated closing of the offering. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the public offering, the Companys ability to obtain additional financing, the severity and duration of the COVID-19 pandemic and its impact on the U.S. and worldwide economy, the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, and whether the market will accept our products and services, market and other conditions, as well as other risk factors and business considerations described in the Companys Securities and Exchange Commission filings including our annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent the Companys views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to update these forward-looking statements.

Astrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 21,639,851 shares of common stock of the Company at a price to the public of $1.50 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about April 12, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company also has granted to the underwriter a 30-day option to purchase up to an additional 3,245,977 shares of common stock at the public offering price, less underwriting discounts and commission. The gross proceeds of the offering are expected to be approximately $32.5 million, before deducting underwriting discounts and commissions and offering expenses payable by Astrotech and assuming no exercise of the option to purchase additional shares. Astrotech intends to use the net proceeds of the offering for general corporate purposes, working capital, and capital expenditures. The securities described above are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-253835) filed with the Securities and Exchange Commission (SEC) and declared effective on March 15, 2021 and the accompanying prospectus contained therein. The offering of the securities is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A preliminary prospectus supplement and the accompanying prospectus relating to this offering were filed with the SEC and are available on the SECs website at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus relating to this offering, when filed, may be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by e-mail at placements@hcwco.com or by calling (212) 856-5711. This announcement is neither an offer to sell, nor a solicitation of an offer to buy, any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer, solicitation, or sale is unlawful. Any offer, if at all, will be made only by means of the prospectus forming a part of the effective registration statement. About Astrotech Corporation Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com. This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including regarding the anticipated closing of the offering. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the public offering, the Companys ability to obtain additional financing, the severity and duration of the COVID-19 pandemic and its impact on the U.S. and worldwide economy, the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, and whether the market will accept our products and services, market and other conditions, as well as other risk factors and business considerations described in the Companys Securities and Exchange Commission filings including our annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent the Companys views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to update these forward-looking statements. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Astrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million.<|eot_id|>

edtsum824

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LAS VEGAS, Jan. 15, 2021 /PRNewswire/ --ROC Title, a full-service title and escrow company with six locations serving Nevada and Arizona, celebrated its fifth anniversary this year with over 48% growth and was also named the fastest growing title company in America by Inc. 500/5000. "Despite the uncertainty and challenges of 2020, it was our best year ever," said Tara Johnson, ROC Title President. "Our team of ROCstars have no intention of slowing down in the new year." In just five short years, ROC Title is now one of the top ten title companies in Las Vegas, NV, and was named a 'Best of Las Vegas' winner by the Las Vegas Review-Journal. The company is projecting 40% growth in business in the new year, attracting more top talent while expanding to new locations to support its 'Ready, Open, Close,' hassle-free experience. Additionally, the company is also committed to its communities and is a proud sponsor of the Women's Council of REALTORS. The ROC Title team gives back through local volunteerism and fundraisers and is a VAREP (Veterans Association of Real Estate Professionals) sponsor. ROC Title sets itself apart with a commitment to closing escrows on time and providing excellent customer service. The awesome culture, modern marketing and branding, and dynamic offices have helped ROC Title achieve number one market share in three of the largest real estate offices in Las Vegas. ABOUT ROC TITLE ROC Title was founded in 2015 and now operates six full-service offices across Nevada and Arizona. Besides the awesome culture, modern marketing and branding, and dynamic offices, their talented and caring ROCSTARS are committed to closing escrows on time while providing lower costs versus the competition with the clear understanding that everyone loves value. To learn more, visit ROCTitle.com. SOURCE ROC Title Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

ROC Title Breaks Growth Records In 2020. The company celebrates five-year anniversary smashing its own records while being named the fastest growing Title Company in America.

LAS VEGAS, Jan. 15, 2021 /PRNewswire/ --ROC Title, a full-service title and escrow company with six locations serving Nevada and Arizona, celebrated its fifth anniversary this year with over 48% growth and was also named the fastest growing title company in America by Inc. 500/5000. "Despite the uncertainty and challenges of 2020, it was our best year ever," said Tara Johnson, ROC Title President. "Our team of ROCstars have no intention of slowing down in the new year." In just five short years, ROC Title is now one of the top ten title companies in Las Vegas, NV, and was named a 'Best of Las Vegas' winner by the Las Vegas Review-Journal. The company is projecting 40% growth in business in the new year, attracting more top talent while expanding to new locations to support its 'Ready, Open, Close,' hassle-free experience. Additionally, the company is also committed to its communities and is a proud sponsor of the Women's Council of REALTORS. The ROC Title team gives back through local volunteerism and fundraisers and is a VAREP (Veterans Association of Real Estate Professionals) sponsor. ROC Title sets itself apart with a commitment to closing escrows on time and providing excellent customer service. The awesome culture, modern marketing and branding, and dynamic offices have helped ROC Title achieve number one market share in three of the largest real estate offices in Las Vegas. ABOUT ROC TITLE ROC Title was founded in 2015 and now operates six full-service offices across Nevada and Arizona. Besides the awesome culture, modern marketing and branding, and dynamic offices, their talented and caring ROCSTARS are committed to closing escrows on time while providing lower costs versus the competition with the clear understanding that everyone loves value. To learn more, visit ROCTitle.com. SOURCE ROC Title

ROC Title Breaks Growth Records In 2020 The company celebrates five-year anniversary smashing its own records while being named the fastest growing Title Company in America

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LAS VEGAS, Jan. 15, 2021 /PRNewswire/ --ROC Title, a full-service title and escrow company with six locations serving Nevada and Arizona, celebrated its fifth anniversary this year with over 48% growth and was also named the fastest growing title company in America by Inc. 500/5000. "Despite the uncertainty and challenges of 2020, it was our best year ever," said Tara Johnson, ROC Title President. "Our team of ROCstars have no intention of slowing down in the new year." In just five short years, ROC Title is now one of the top ten title companies in Las Vegas, NV, and was named a 'Best of Las Vegas' winner by the Las Vegas Review-Journal. The company is projecting 40% growth in business in the new year, attracting more top talent while expanding to new locations to support its 'Ready, Open, Close,' hassle-free experience. Additionally, the company is also committed to its communities and is a proud sponsor of the Women's Council of REALTORS. The ROC Title team gives back through local volunteerism and fundraisers and is a VAREP (Veterans Association of Real Estate Professionals) sponsor. ROC Title sets itself apart with a commitment to closing escrows on time and providing excellent customer service. The awesome culture, modern marketing and branding, and dynamic offices have helped ROC Title achieve number one market share in three of the largest real estate offices in Las Vegas. ABOUT ROC TITLE ROC Title was founded in 2015 and now operates six full-service offices across Nevada and Arizona. Besides the awesome culture, modern marketing and branding, and dynamic offices, their talented and caring ROCSTARS are committed to closing escrows on time while providing lower costs versus the competition with the clear understanding that everyone loves value. To learn more, visit ROCTitle.com. SOURCE ROC Title Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> ROC Title Breaks Growth Records In 2020. The company celebrates five-year anniversary smashing its own records while being named the fastest growing Title Company in America.<|eot_id|>

edtsum825

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CAPE COD, Mass., Oct. 12, 2020 /PRNewswire/ --Casabella Interiors was recently honored with four design awards from three different organizations. Luxe Interiors Magazine awarded Casabella the "Best of the Rest, Landscape Design/Outdoor Rooms" award for 2020. The Eastern Massachusetts Chapter of the National Association of the Remodeling Industry (EM NARI) awarded Casabella the 2020 EM NARI Contractor of the Year (CotY) Gold Award for Residential Exterior, andAmerica's Property Awards selected Casabella for both Bathroom Designand Residential Interior Private Residence Design awards. These awards reflect Founder and Principal Designer, Michele Holbrook's continuous pursuit of design excellence for her clients. Says Holbrook, ""Our top priority is to provide an ultra-premium design experience for our clients.Each client's interior reflects a completely distinctive approach no two homes are alike.I am always thrilled to see the efforts of me and my team be professionally recognized." The LUXE Interiors Magazine RED Award honors excellence, innovation and the best residential architecture, interior design and landscape architecture projects across the country. Casabella's winning entry features extraordinary work on an outdoor living space in Dennis, Massachusetts complete with custom-designed poolside sectionals precisely placed for best ocean views, a stone fireplace, and state-of-the art outdoor kitchen. For the CotY Award there were 80 projects submitted across eighteen categories. A panel of eleven independent reviewers judged the project entries in a blind evaluation. Casabella's outdoor space took top honors for the combined mixture of poolside relaxation and luxury. A stunning, fully reimagined bathroom overlooking the ocean took the top prize with America's Property Awards as did Casabella's captivating residential interior featuring a fetching queen size rope bed, custom kitchen cabinetry, and bespoke furnishings to lend the home a chic seaside feel. About Casabella Interiors Casabella Interiors is a nationally recognized design firm specializing in distinctive and inviting home interiors. They source from a globally curated selection of custom furnishings, artwork, fixtures, and textiles and work with best-in-class artisans to deliver a five star design experience to their clients. The firm also has a Cape Cod boutique featuring a selection of their custom offerings and a 2,500 square foot off-site showroom. www.casabellainteriors.com SOURCE Casabella Interiors Related Links https://www.casabellainteriors.com/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Cape Cod-Based Interior Design Firm Wins Four Top Awards.

CAPE COD, Mass., Oct. 12, 2020 /PRNewswire/ --Casabella Interiors was recently honored with four design awards from three different organizations. Luxe Interiors Magazine awarded Casabella the "Best of the Rest, Landscape Design/Outdoor Rooms" award for 2020. The Eastern Massachusetts Chapter of the National Association of the Remodeling Industry (EM NARI) awarded Casabella the 2020 EM NARI Contractor of the Year (CotY) Gold Award for Residential Exterior, andAmerica's Property Awards selected Casabella for both Bathroom Designand Residential Interior Private Residence Design awards. These awards reflect Founder and Principal Designer, Michele Holbrook's continuous pursuit of design excellence for her clients. Says Holbrook, ""Our top priority is to provide an ultra-premium design experience for our clients.Each client's interior reflects a completely distinctive approach no two homes are alike.I am always thrilled to see the efforts of me and my team be professionally recognized." The LUXE Interiors Magazine RED Award honors excellence, innovation and the best residential architecture, interior design and landscape architecture projects across the country. Casabella's winning entry features extraordinary work on an outdoor living space in Dennis, Massachusetts complete with custom-designed poolside sectionals precisely placed for best ocean views, a stone fireplace, and state-of-the art outdoor kitchen. For the CotY Award there were 80 projects submitted across eighteen categories. A panel of eleven independent reviewers judged the project entries in a blind evaluation. Casabella's outdoor space took top honors for the combined mixture of poolside relaxation and luxury. A stunning, fully reimagined bathroom overlooking the ocean took the top prize with America's Property Awards as did Casabella's captivating residential interior featuring a fetching queen size rope bed, custom kitchen cabinetry, and bespoke furnishings to lend the home a chic seaside feel. About Casabella Interiors Casabella Interiors is a nationally recognized design firm specializing in distinctive and inviting home interiors. They source from a globally curated selection of custom furnishings, artwork, fixtures, and textiles and work with best-in-class artisans to deliver a five star design experience to their clients. The firm also has a Cape Cod boutique featuring a selection of their custom offerings and a 2,500 square foot off-site showroom. www.casabellainteriors.com SOURCE Casabella Interiors Related Links https://www.casabellainteriors.com/

Cape Cod-Based Interior Design Firm Wins Four Top Awards

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CAPE COD, Mass., Oct. 12, 2020 /PRNewswire/ --Casabella Interiors was recently honored with four design awards from three different organizations. Luxe Interiors Magazine awarded Casabella the "Best of the Rest, Landscape Design/Outdoor Rooms" award for 2020. The Eastern Massachusetts Chapter of the National Association of the Remodeling Industry (EM NARI) awarded Casabella the 2020 EM NARI Contractor of the Year (CotY) Gold Award for Residential Exterior, andAmerica's Property Awards selected Casabella for both Bathroom Designand Residential Interior Private Residence Design awards. These awards reflect Founder and Principal Designer, Michele Holbrook's continuous pursuit of design excellence for her clients. Says Holbrook, ""Our top priority is to provide an ultra-premium design experience for our clients.Each client's interior reflects a completely distinctive approach no two homes are alike.I am always thrilled to see the efforts of me and my team be professionally recognized." The LUXE Interiors Magazine RED Award honors excellence, innovation and the best residential architecture, interior design and landscape architecture projects across the country. Casabella's winning entry features extraordinary work on an outdoor living space in Dennis, Massachusetts complete with custom-designed poolside sectionals precisely placed for best ocean views, a stone fireplace, and state-of-the art outdoor kitchen. For the CotY Award there were 80 projects submitted across eighteen categories. A panel of eleven independent reviewers judged the project entries in a blind evaluation. Casabella's outdoor space took top honors for the combined mixture of poolside relaxation and luxury. A stunning, fully reimagined bathroom overlooking the ocean took the top prize with America's Property Awards as did Casabella's captivating residential interior featuring a fetching queen size rope bed, custom kitchen cabinetry, and bespoke furnishings to lend the home a chic seaside feel. About Casabella Interiors Casabella Interiors is a nationally recognized design firm specializing in distinctive and inviting home interiors. They source from a globally curated selection of custom furnishings, artwork, fixtures, and textiles and work with best-in-class artisans to deliver a five star design experience to their clients. The firm also has a Cape Cod boutique featuring a selection of their custom offerings and a 2,500 square foot off-site showroom. www.casabellainteriors.com SOURCE Casabella Interiors Related Links https://www.casabellainteriors.com/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Cape Cod-Based Interior Design Firm Wins Four Top Awards.<|eot_id|>

edtsum826

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CHICAGO, April 22, 2020 /PRNewswire/ -- Post COVID-19, the report"COVID-19 Impact on Internet of Things (IoT) Marketby Components (Software Solutions, Platforms, Services), Vertical (BFSI, Healthcare, Manufacturing, Retail, Transportation, Utilities, Government & Defense) and Region - Global Forecast 2021", size is expected to grow from USD 150 billion in 2019 to USD 243 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period. Over the years, organizations have enhanced the level of innovation, and with the outbreak of COVID-19, a majority of operations have been compromised. This has forced organizations to function in a non-optimized manner, as a result of which they are looking for innovative areas that can improve their revenue by a small percentage. Request for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=212332561 Banking Financial Services and Insurance to witness growth during the forecast period The IoT technology assists in getting payments streamlined as these online transactions can be monitored and managed electronically. Decisions that are driven by data help in saving time. Therefore, electronic payments are already benefitting from long-standing trends where physical cash is quickly becoming a thing of the past, and the COVID-19 outbreak is expected to accelerate the use of electronic payment methods. In the short-term, most shops across the globe are now only accepting digital payments, even though the total number of transactions is decreasing. Although cash is quickly becoming a thing of the past, some traditional generations still resist the use of digital currency. Digital payments continue to evolve, with the inclusion of payment-enabled IoT devices augmenting the browser and mobile payment experience. Consumers can pay using a range of newly connected devices, including connected cars, household appliances, and, most recently, wearables. In parallel, the IoT is also changing the retail Point of Sale (PoS) to include several new touchpoints, including parking meters, fitting room mirrors, and vending machines. IoT devices range from small wearable devices and shopping carts to home appliances and cars. IoT devices use a connectivity channel to trigger a payment transaction, with technology depending on the environment. Manufacturing vertical is expected to see less growth during the forecast period With the ongoing COVID-19 pandemic, the manufacturing industry is badly hit. The manufacturing slowdown in China has affected the manufacturing business in more than 15 countries, due to country-wide lockdowns, strict international border controls, social distancing measures for workers, and supply chain issues from China. According to The Economic Times, the government ordered manufacturing sectors in India, such as automakers, smartphone makers, consumer electronic firms, appliance makers, and many others, to shut down their operations till the end of March 2020. Factory shutdowns will further lead to incalculable damages to the production of key products. The Economic Times also stated that in this extreme scenario of a complete shutdown of all factories for one month, it is estimated that the real manufacturing Gross Value Added (GVA) would fall by 5% in FY 2020/21. These factory shutdowns would delay the immediate implementation of IoT solutions, thus, adversely affecting the Indian manufacturing market. Browsein-depth TOC on"Covid-19 Impact on Internet of Things (IoT) Market"12 Tables31 Figures73 Pages Request more details on:https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=212332561 Europe to witness the higher impact of COVID-19 during the forecast period The most affected region across the globe is Europe. As Italy struggles to deal with its rising numbers of deaths, countries across Europe have brought in increasingly strict measures to ensure their citizens stay at home. Many countries, including Italy, went into a full lockdown, shutting down businesses and banning public gatherings nationwide since 12 March 2020. It has now stopped all movement inside the country and closed all non-essential businesses. The spread of the virus is resulting in countries across Europe entering into lockdowns with economic activity and daily life on hold for millions of people. This is clearly having an extremely disruptive impact on the banking sector, although the authorities are taking steps to mitigate the worst effects. European Union (EU) banks have implemented measures to ensure business continuity and adequate services to their customers, but are facing operational challenges; hence, the need to focus on their core operations and critical functions. The major Internet of Things market vendors includes IBM (US), Royal Phillips (Netherlands), Stanley Healthcare (US), Microsfot (US), Oracle (US), Bosch (Germany), CloudMinds (US), XAG (China), CBT (US), PTC PTC (US), Rockwell Automation (US), Honeywell (US), GE Digital (US), Intel (US), Siemens (Germany), Ericsson (Sweden), Hitachi Vantara (US), ABB (Switzerkland), NEC Corporation (Japan), Telit (UK), Sierra Wireless (Canada), Itron (US), Arad Group (Israel), Cisco (US), Medtronic (Ireland), SAP (Germany), Software AG (Germany) AWS (US), Softweb Solutions (US), Google (US), hIOTron (India), Sony(Japan), Capgemini (France), Adobe (US), NTT Communications (Japan), Happiest Minds (India), Vodafone (UK), TCS (India), DXC (US), Infosys (India), Verizon (US), Service Group (US), Cognizant (US), and Accenture (Ireland). Related Reports: Internet of Things (IoT) Professional Services Marketby Service Type (Consulting, Infrastructure, System Designing and Integration, Support and Maintenance, and Education and Training), Application, and Region - Global Forecast to 2023 https://www.marketsandmarkets.com/Market-Reports/iot-professional-service-market-93273117.html IoT in Utilities Marketby Component (Platform, Solutions (Asset Monitoring and Management and CIS and Billing), Services), Application (Electricity Grid Management Water and Wastewater Management), Region - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/iot-utility-market-116054824.html About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Sanjay Gupta MarketsandMarkets INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email:[emailprotected] Research Insight:https://www.marketsandmarkets.com/ResearchInsight/covid-19-impact-on-iot-market.asp Content Source:https://www.marketsandmarkets.com/PressReleases/covid-19-impact-on-iot.asp SOURCE MarketsandMarkets Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

COVID-19 Impact on Internet of Things (IoT) Market - Exclusive Report by MarketsandMarkets.

CHICAGO, April 22, 2020 /PRNewswire/ -- Post COVID-19, the report"COVID-19 Impact on Internet of Things (IoT) Marketby Components (Software Solutions, Platforms, Services), Vertical (BFSI, Healthcare, Manufacturing, Retail, Transportation, Utilities, Government & Defense) and Region - Global Forecast 2021", size is expected to grow from USD 150 billion in 2019 to USD 243 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period. Over the years, organizations have enhanced the level of innovation, and with the outbreak of COVID-19, a majority of operations have been compromised. This has forced organizations to function in a non-optimized manner, as a result of which they are looking for innovative areas that can improve their revenue by a small percentage. Request for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=212332561 Banking Financial Services and Insurance to witness growth during the forecast period The IoT technology assists in getting payments streamlined as these online transactions can be monitored and managed electronically. Decisions that are driven by data help in saving time. Therefore, electronic payments are already benefitting from long-standing trends where physical cash is quickly becoming a thing of the past, and the COVID-19 outbreak is expected to accelerate the use of electronic payment methods. In the short-term, most shops across the globe are now only accepting digital payments, even though the total number of transactions is decreasing. Although cash is quickly becoming a thing of the past, some traditional generations still resist the use of digital currency. Digital payments continue to evolve, with the inclusion of payment-enabled IoT devices augmenting the browser and mobile payment experience. Consumers can pay using a range of newly connected devices, including connected cars, household appliances, and, most recently, wearables. In parallel, the IoT is also changing the retail Point of Sale (PoS) to include several new touchpoints, including parking meters, fitting room mirrors, and vending machines. IoT devices range from small wearable devices and shopping carts to home appliances and cars. IoT devices use a connectivity channel to trigger a payment transaction, with technology depending on the environment. Manufacturing vertical is expected to see less growth during the forecast period With the ongoing COVID-19 pandemic, the manufacturing industry is badly hit. The manufacturing slowdown in China has affected the manufacturing business in more than 15 countries, due to country-wide lockdowns, strict international border controls, social distancing measures for workers, and supply chain issues from China. According to The Economic Times, the government ordered manufacturing sectors in India, such as automakers, smartphone makers, consumer electronic firms, appliance makers, and many others, to shut down their operations till the end of March 2020. Factory shutdowns will further lead to incalculable damages to the production of key products. The Economic Times also stated that in this extreme scenario of a complete shutdown of all factories for one month, it is estimated that the real manufacturing Gross Value Added (GVA) would fall by 5% in FY 2020/21. These factory shutdowns would delay the immediate implementation of IoT solutions, thus, adversely affecting the Indian manufacturing market. Browsein-depth TOC on"Covid-19 Impact on Internet of Things (IoT) Market"12 Tables31 Figures73 Pages Request more details on:https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=212332561 Europe to witness the higher impact of COVID-19 during the forecast period The most affected region across the globe is Europe. As Italy struggles to deal with its rising numbers of deaths, countries across Europe have brought in increasingly strict measures to ensure their citizens stay at home. Many countries, including Italy, went into a full lockdown, shutting down businesses and banning public gatherings nationwide since 12 March 2020. It has now stopped all movement inside the country and closed all non-essential businesses. The spread of the virus is resulting in countries across Europe entering into lockdowns with economic activity and daily life on hold for millions of people. This is clearly having an extremely disruptive impact on the banking sector, although the authorities are taking steps to mitigate the worst effects. European Union (EU) banks have implemented measures to ensure business continuity and adequate services to their customers, but are facing operational challenges; hence, the need to focus on their core operations and critical functions. The major Internet of Things market vendors includes IBM (US), Royal Phillips (Netherlands), Stanley Healthcare (US), Microsfot (US), Oracle (US), Bosch (Germany), CloudMinds (US), XAG (China), CBT (US), PTC PTC (US), Rockwell Automation (US), Honeywell (US), GE Digital (US), Intel (US), Siemens (Germany), Ericsson (Sweden), Hitachi Vantara (US), ABB (Switzerkland), NEC Corporation (Japan), Telit (UK), Sierra Wireless (Canada), Itron (US), Arad Group (Israel), Cisco (US), Medtronic (Ireland), SAP (Germany), Software AG (Germany) AWS (US), Softweb Solutions (US), Google (US), hIOTron (India), Sony(Japan), Capgemini (France), Adobe (US), NTT Communications (Japan), Happiest Minds (India), Vodafone (UK), TCS (India), DXC (US), Infosys (India), Verizon (US), Service Group (US), Cognizant (US), and Accenture (Ireland). Related Reports: Internet of Things (IoT) Professional Services Marketby Service Type (Consulting, Infrastructure, System Designing and Integration, Support and Maintenance, and Education and Training), Application, and Region - Global Forecast to 2023 https://www.marketsandmarkets.com/Market-Reports/iot-professional-service-market-93273117.html IoT in Utilities Marketby Component (Platform, Solutions (Asset Monitoring and Management and CIS and Billing), Services), Application (Electricity Grid Management Water and Wastewater Management), Region - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/iot-utility-market-116054824.html About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Sanjay Gupta MarketsandMarkets INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email:[emailprotected] Research Insight:https://www.marketsandmarkets.com/ResearchInsight/covid-19-impact-on-iot-market.asp Content Source:https://www.marketsandmarkets.com/PressReleases/covid-19-impact-on-iot.asp SOURCE MarketsandMarkets

COVID-19 Impact on Internet of Things (IoT) Market - Exclusive Report by MarketsandMarkets

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CHICAGO, April 22, 2020 /PRNewswire/ -- Post COVID-19, the report"COVID-19 Impact on Internet of Things (IoT) Marketby Components (Software Solutions, Platforms, Services), Vertical (BFSI, Healthcare, Manufacturing, Retail, Transportation, Utilities, Government & Defense) and Region - Global Forecast 2021", size is expected to grow from USD 150 billion in 2019 to USD 243 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period. Over the years, organizations have enhanced the level of innovation, and with the outbreak of COVID-19, a majority of operations have been compromised. This has forced organizations to function in a non-optimized manner, as a result of which they are looking for innovative areas that can improve their revenue by a small percentage. Request for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=212332561 Banking Financial Services and Insurance to witness growth during the forecast period The IoT technology assists in getting payments streamlined as these online transactions can be monitored and managed electronically. Decisions that are driven by data help in saving time. Therefore, electronic payments are already benefitting from long-standing trends where physical cash is quickly becoming a thing of the past, and the COVID-19 outbreak is expected to accelerate the use of electronic payment methods. In the short-term, most shops across the globe are now only accepting digital payments, even though the total number of transactions is decreasing. Although cash is quickly becoming a thing of the past, some traditional generations still resist the use of digital currency. Digital payments continue to evolve, with the inclusion of payment-enabled IoT devices augmenting the browser and mobile payment experience. Consumers can pay using a range of newly connected devices, including connected cars, household appliances, and, most recently, wearables. In parallel, the IoT is also changing the retail Point of Sale (PoS) to include several new touchpoints, including parking meters, fitting room mirrors, and vending machines. IoT devices range from small wearable devices and shopping carts to home appliances and cars. IoT devices use a connectivity channel to trigger a payment transaction, with technology depending on the environment. Manufacturing vertical is expected to see less growth during the forecast period With the ongoing COVID-19 pandemic, the manufacturing industry is badly hit. The manufacturing slowdown in China has affected the manufacturing business in more than 15 countries, due to country-wide lockdowns, strict international border controls, social distancing measures for workers, and supply chain issues from China. According to The Economic Times, the government ordered manufacturing sectors in India, such as automakers, smartphone makers, consumer electronic firms, appliance makers, and many others, to shut down their operations till the end of March 2020. Factory shutdowns will further lead to incalculable damages to the production of key products. The Economic Times also stated that in this extreme scenario of a complete shutdown of all factories for one month, it is estimated that the real manufacturing Gross Value Added (GVA) would fall by 5% in FY 2020/21. These factory shutdowns would delay the immediate implementation of IoT solutions, thus, adversely affecting the Indian manufacturing market. Browsein-depth TOC on"Covid-19 Impact on Internet of Things (IoT) Market"12 Tables31 Figures73 Pages Request more details on:https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=212332561 Europe to witness the higher impact of COVID-19 during the forecast period The most affected region across the globe is Europe. As Italy struggles to deal with its rising numbers of deaths, countries across Europe have brought in increasingly strict measures to ensure their citizens stay at home. Many countries, including Italy, went into a full lockdown, shutting down businesses and banning public gatherings nationwide since 12 March 2020. It has now stopped all movement inside the country and closed all non-essential businesses. The spread of the virus is resulting in countries across Europe entering into lockdowns with economic activity and daily life on hold for millions of people. This is clearly having an extremely disruptive impact on the banking sector, although the authorities are taking steps to mitigate the worst effects. European Union (EU) banks have implemented measures to ensure business continuity and adequate services to their customers, but are facing operational challenges; hence, the need to focus on their core operations and critical functions. The major Internet of Things market vendors includes IBM (US), Royal Phillips (Netherlands), Stanley Healthcare (US), Microsfot (US), Oracle (US), Bosch (Germany), CloudMinds (US), XAG (China), CBT (US), PTC PTC (US), Rockwell Automation (US), Honeywell (US), GE Digital (US), Intel (US), Siemens (Germany), Ericsson (Sweden), Hitachi Vantara (US), ABB (Switzerkland), NEC Corporation (Japan), Telit (UK), Sierra Wireless (Canada), Itron (US), Arad Group (Israel), Cisco (US), Medtronic (Ireland), SAP (Germany), Software AG (Germany) AWS (US), Softweb Solutions (US), Google (US), hIOTron (India), Sony(Japan), Capgemini (France), Adobe (US), NTT Communications (Japan), Happiest Minds (India), Vodafone (UK), TCS (India), DXC (US), Infosys (India), Verizon (US), Service Group (US), Cognizant (US), and Accenture (Ireland). Related Reports: Internet of Things (IoT) Professional Services Marketby Service Type (Consulting, Infrastructure, System Designing and Integration, Support and Maintenance, and Education and Training), Application, and Region - Global Forecast to 2023 https://www.marketsandmarkets.com/Market-Reports/iot-professional-service-market-93273117.html IoT in Utilities Marketby Component (Platform, Solutions (Asset Monitoring and Management and CIS and Billing), Services), Application (Electricity Grid Management Water and Wastewater Management), Region - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/iot-utility-market-116054824.html About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Sanjay Gupta MarketsandMarkets INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email:[emailprotected] Research Insight:https://www.marketsandmarkets.com/ResearchInsight/covid-19-impact-on-iot-market.asp Content Source:https://www.marketsandmarkets.com/PressReleases/covid-19-impact-on-iot.asp SOURCE MarketsandMarkets Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> COVID-19 Impact on Internet of Things (IoT) Market - Exclusive Report by MarketsandMarkets.<|eot_id|>

edtsum827

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: HOLLYWOOD, Calif., Oct. 22, 2020 /PRNewswire/ --Infinity Festival Hollywood kicks off year three celebrating "Story Enabled by Technology," with a virtual event to be held on a new proprietary platform developed by the live event pros at FNTECH. Beginning October 28, 2020 and continuing through January 7, 2021, each Wednesday and Thursday, the Festival (IF), will include innovative programming, bringing together creators, directors, producers and writers, as well as senior executives and technologists from Hollywood and Silicon Valley. All eight weeks will be streamed free of charge. Since its inception, the festival has brought together blue-chip attendees representing companies and studios with 2020 revenues greater than $4 Trillion and representing more than $40 Billion in IT and Production spend. View the official IF trailer HERE. To attract a broader international audience and position itself as a hybrid event in 2021, Infinity Festival has transitioned its programming to be exclusively online for 2020. IF is pleased to announce its partnership with powerhouse Capitol Music Group and Tech event "Capitol Royale," and welcome Z by HP and Microsoft as Presenting Sponsors. Unity will serve as Co-Presenting Sponsor. Intel, Phase Two, and Essentia Water will serve as Producer Sponsors and FNTECH will serve as Official Production Partner. Hanno Basse, Chief Technology Officer, Microsoft Azure Media and Entertainment serves as Chairman, and Television Academy Board of Governors member and StoryTech CEO, Lori H. Schwartz, oversees programming in her role as the festival's Chief Curator. Adam Newman, who previously served as IF Fine Art Curator, has been named the Festival's Creative Director. Infinity Festival Hollywood and Capitol Royale celebrate entertainment& tech with 8-week virtual event starting Oct. 28 Tweet this This year's festival will include 8 weeks of original programing, and over 60 pieces of premium content. IF includes high-profile tech exhibitions and screenings, industry-leading speakers, panel discussions, innovation labs, and a fine art exhibition, each with an emerging-tech focus. New technologies and trends will be spotlighted, including: Remote Collaboration/Cloud, Artificial Intelligence, 3D/Visual Effects, Virtual Production, Wellness Tech, Immersive Experiences, Real Time Storytelling and Entertainment Content. Programming advisors include over 150 members from leading studios, talent agencies and technology companies. This year, Capitol Royalewill bring a unique slate ofmusic-related programming to the table including weekly music content drops/premieres, newannouncements, thought leadership conversations, an Innovation Challenge, andStartup programming. For the first time ever, Capitol Royale will be hosted in Neon XP'svirtual Capitol Records Tower experience, where guests will be able to explore 360navigable versions of the iconic Hollywood landmark's lobby, rooftop, and surrounding lot. In each area, guests will beable to watch exclusive content live and on-demand. View a teaser for the virtual Capitol Records Tower experience HERE. On November 12in partnership with gener8tor and OnRamp Entertainment, andas part of Capitol Royale's Startup TrackInfinity Festival will be hosting a Startup Demo Day, as well as one-on-one pitch meetings between the entertainment industry's leading corporations, investors, and startups. Programming will address the cutting-edge technology advances in storytelling today, with panel discussions on global analytics, industry trends, professional insights and consumer research."Capitol Royale was founded with the vision to expand on the legacy of Capitol Tower, and all the music greats that have walked its halls, by transforming it into a hub for musicians and technologists to connect in the heart of Hollywood," said Ching-Ching Chen, Vice President, Content Partnerships & Strategy, Capitol Records. "We are thrilled to be partnering with Infinity Festival to connect the dots between all aspects of Entertainment, Music & Technology." In addition, Chen will be joining forces with IF as it's newest executive board member.This marks the second year of IF's partnership with FNTECH, a groundbreaking full-service event production company headquartered in Northern and Southern California. FNTECH has successfully partnered with scores of top-tier companies such as Apple, Facebook, HP, Vans and Volcom to create multi-faceted, high-profile, newsworthy events. FNTECH is excited about the new frontiers in virtual events and looking forward to bringing tech and storytelling to life in a compellingway with their new proprietary virtual event platform. Jeremy Muir, CEO of FNTECH, expounded on this thought: "We are thrilled to use this expansiveand cutting-edgetool. The next horizon is hybrid events, which will be more broad-reaching and inclusive than anything seen to date."The Chairman of the Infinity Festival Hanno Basse was equally thrilled about this year's content. "We are excited to once again bring you top-notch original content on our virtual platform as we enter year three, with support from the industry's leading studios, tech companies and business leaders." "With the current state of events and programming so fluid and shifting towards all things virtual in 2020, we are fortunate to have the technology and infrastructure to bring our festival online," said Mark Lieber, Infinity Festival Founder."We are excited to showcase some of the best digital and entertainment programming and are confident that this will be one of the best immersive events of the year."About Infinity Festival HollywoodInfinity Festival Hollywood, guided by more than 150 Advisors from the leading studios, talent agencies and technology companies, celebrates "Story Enabled by Technology" by bringing together Silicon Valley innovators with Hollywood's leading storytellers. IF Programming has an emerging-technology focus, and includes high-profile screenings, tech exhibitions, thought-leading speakers, panel discussions, innovation labs, VIP networking opportunities and a fine art exhibition. The festival is inspired by the seemingly infinite possibilities being realized in content creation for evolving technologies and platforms.The Festival is free this year and attendees can register atinfinityfestival.comto obtain ticketsand additional information.About Capitol Music GroupCapitol Music Group (CMG) is comprised of Capitol Records, Virgin Records, Motown Records, Blue Note Records, Astralwerks, Harvest Records and Capitol Christian Music Group, as well as Capitol Studios and the company's independent distribution and label services arm, Caroline. Capitol Music Group is based in Hollywood, California within the iconic Capitol Tower.Artists that record for CMG labels include: Erykah Badu, The Beach Boys, The Beatles, Beck, Bee Gees, Jon Bellion, Rosanne Cash, Christine and the Queens, City Girls, Fletcher, Neil Diamond, Halsey, Don Henley, Hillsong United, Niall Horan, Tori Kelly, KEM, Lil Baby, Lil Yachty, Charles Lloyd, tobyMac, Paul McCartney, Migos, NE-YO, NF, Norah Jones, Queen Naija, Katy Perry, Gregory Porter, Maggie Rogers, Calum Scott, Bob Seger, Tiana Major9, Troye Sivan and Chris Tomlin. For the U.S.: Disclosure, Empire Of The Sun, MNEK and Sam Smith.Capitol Music Group is a division of Universal Music Group, which is a fully owned subsidiary of Vivendi.Please click here for promo reel:IF 2020 Official TrailerPlease click here for media assets:IF 2020 Poster* Terms and conditions apply.SOURCE Capitol Music Group; Infinity Festival Hollywood Related Links http://www.umusic.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Infinity Festival Hollywood Expands For Year Three. Announcing New Partnership With Capitol Music Group's Event 'Capitol Royale'.

HOLLYWOOD, Calif., Oct. 22, 2020 /PRNewswire/ --Infinity Festival Hollywood kicks off year three celebrating "Story Enabled by Technology," with a virtual event to be held on a new proprietary platform developed by the live event pros at FNTECH. Beginning October 28, 2020 and continuing through January 7, 2021, each Wednesday and Thursday, the Festival (IF), will include innovative programming, bringing together creators, directors, producers and writers, as well as senior executives and technologists from Hollywood and Silicon Valley. All eight weeks will be streamed free of charge. Since its inception, the festival has brought together blue-chip attendees representing companies and studios with 2020 revenues greater than $4 Trillion and representing more than $40 Billion in IT and Production spend. View the official IF trailer HERE. To attract a broader international audience and position itself as a hybrid event in 2021, Infinity Festival has transitioned its programming to be exclusively online for 2020. IF is pleased to announce its partnership with powerhouse Capitol Music Group and Tech event "Capitol Royale," and welcome Z by HP and Microsoft as Presenting Sponsors. Unity will serve as Co-Presenting Sponsor. Intel, Phase Two, and Essentia Water will serve as Producer Sponsors and FNTECH will serve as Official Production Partner. Hanno Basse, Chief Technology Officer, Microsoft Azure Media and Entertainment serves as Chairman, and Television Academy Board of Governors member and StoryTech CEO, Lori H. Schwartz, oversees programming in her role as the festival's Chief Curator. Adam Newman, who previously served as IF Fine Art Curator, has been named the Festival's Creative Director. Infinity Festival Hollywood and Capitol Royale celebrate entertainment& tech with 8-week virtual event starting Oct. 28 Tweet this This year's festival will include 8 weeks of original programing, and over 60 pieces of premium content. IF includes high-profile tech exhibitions and screenings, industry-leading speakers, panel discussions, innovation labs, and a fine art exhibition, each with an emerging-tech focus. New technologies and trends will be spotlighted, including: Remote Collaboration/Cloud, Artificial Intelligence, 3D/Visual Effects, Virtual Production, Wellness Tech, Immersive Experiences, Real Time Storytelling and Entertainment Content. Programming advisors include over 150 members from leading studios, talent agencies and technology companies. This year, Capitol Royalewill bring a unique slate ofmusic-related programming to the table including weekly music content drops/premieres, newannouncements, thought leadership conversations, an Innovation Challenge, andStartup programming. For the first time ever, Capitol Royale will be hosted in Neon XP'svirtual Capitol Records Tower experience, where guests will be able to explore 360navigable versions of the iconic Hollywood landmark's lobby, rooftop, and surrounding lot. In each area, guests will beable to watch exclusive content live and on-demand. View a teaser for the virtual Capitol Records Tower experience HERE. On November 12in partnership with gener8tor and OnRamp Entertainment, andas part of Capitol Royale's Startup TrackInfinity Festival will be hosting a Startup Demo Day, as well as one-on-one pitch meetings between the entertainment industry's leading corporations, investors, and startups. Programming will address the cutting-edge technology advances in storytelling today, with panel discussions on global analytics, industry trends, professional insights and consumer research."Capitol Royale was founded with the vision to expand on the legacy of Capitol Tower, and all the music greats that have walked its halls, by transforming it into a hub for musicians and technologists to connect in the heart of Hollywood," said Ching-Ching Chen, Vice President, Content Partnerships & Strategy, Capitol Records. "We are thrilled to be partnering with Infinity Festival to connect the dots between all aspects of Entertainment, Music & Technology." In addition, Chen will be joining forces with IF as it's newest executive board member.This marks the second year of IF's partnership with FNTECH, a groundbreaking full-service event production company headquartered in Northern and Southern California. FNTECH has successfully partnered with scores of top-tier companies such as Apple, Facebook, HP, Vans and Volcom to create multi-faceted, high-profile, newsworthy events. FNTECH is excited about the new frontiers in virtual events and looking forward to bringing tech and storytelling to life in a compellingway with their new proprietary virtual event platform. Jeremy Muir, CEO of FNTECH, expounded on this thought: "We are thrilled to use this expansiveand cutting-edgetool. The next horizon is hybrid events, which will be more broad-reaching and inclusive than anything seen to date."The Chairman of the Infinity Festival Hanno Basse was equally thrilled about this year's content. "We are excited to once again bring you top-notch original content on our virtual platform as we enter year three, with support from the industry's leading studios, tech companies and business leaders." "With the current state of events and programming so fluid and shifting towards all things virtual in 2020, we are fortunate to have the technology and infrastructure to bring our festival online," said Mark Lieber, Infinity Festival Founder."We are excited to showcase some of the best digital and entertainment programming and are confident that this will be one of the best immersive events of the year."About Infinity Festival HollywoodInfinity Festival Hollywood, guided by more than 150 Advisors from the leading studios, talent agencies and technology companies, celebrates "Story Enabled by Technology" by bringing together Silicon Valley innovators with Hollywood's leading storytellers. IF Programming has an emerging-technology focus, and includes high-profile screenings, tech exhibitions, thought-leading speakers, panel discussions, innovation labs, VIP networking opportunities and a fine art exhibition. The festival is inspired by the seemingly infinite possibilities being realized in content creation for evolving technologies and platforms.The Festival is free this year and attendees can register atinfinityfestival.comto obtain ticketsand additional information.About Capitol Music GroupCapitol Music Group (CMG) is comprised of Capitol Records, Virgin Records, Motown Records, Blue Note Records, Astralwerks, Harvest Records and Capitol Christian Music Group, as well as Capitol Studios and the company's independent distribution and label services arm, Caroline. Capitol Music Group is based in Hollywood, California within the iconic Capitol Tower.Artists that record for CMG labels include: Erykah Badu, The Beach Boys, The Beatles, Beck, Bee Gees, Jon Bellion, Rosanne Cash, Christine and the Queens, City Girls, Fletcher, Neil Diamond, Halsey, Don Henley, Hillsong United, Niall Horan, Tori Kelly, KEM, Lil Baby, Lil Yachty, Charles Lloyd, tobyMac, Paul McCartney, Migos, NE-YO, NF, Norah Jones, Queen Naija, Katy Perry, Gregory Porter, Maggie Rogers, Calum Scott, Bob Seger, Tiana Major9, Troye Sivan and Chris Tomlin. For the U.S.: Disclosure, Empire Of The Sun, MNEK and Sam Smith.Capitol Music Group is a division of Universal Music Group, which is a fully owned subsidiary of Vivendi.Please click here for promo reel:IF 2020 Official TrailerPlease click here for media assets:IF 2020 Poster* Terms and conditions apply.SOURCE Capitol Music Group; Infinity Festival Hollywood Related Links http://www.umusic.com

Infinity Festival Hollywood Expands For Year Three, Announcing New Partnership With Capitol Music Group's Event 'Capitol Royale'

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: HOLLYWOOD, Calif., Oct. 22, 2020 /PRNewswire/ --Infinity Festival Hollywood kicks off year three celebrating "Story Enabled by Technology," with a virtual event to be held on a new proprietary platform developed by the live event pros at FNTECH. Beginning October 28, 2020 and continuing through January 7, 2021, each Wednesday and Thursday, the Festival (IF), will include innovative programming, bringing together creators, directors, producers and writers, as well as senior executives and technologists from Hollywood and Silicon Valley. All eight weeks will be streamed free of charge. Since its inception, the festival has brought together blue-chip attendees representing companies and studios with 2020 revenues greater than $4 Trillion and representing more than $40 Billion in IT and Production spend. View the official IF trailer HERE. To attract a broader international audience and position itself as a hybrid event in 2021, Infinity Festival has transitioned its programming to be exclusively online for 2020. IF is pleased to announce its partnership with powerhouse Capitol Music Group and Tech event "Capitol Royale," and welcome Z by HP and Microsoft as Presenting Sponsors. Unity will serve as Co-Presenting Sponsor. Intel, Phase Two, and Essentia Water will serve as Producer Sponsors and FNTECH will serve as Official Production Partner. Hanno Basse, Chief Technology Officer, Microsoft Azure Media and Entertainment serves as Chairman, and Television Academy Board of Governors member and StoryTech CEO, Lori H. Schwartz, oversees programming in her role as the festival's Chief Curator. Adam Newman, who previously served as IF Fine Art Curator, has been named the Festival's Creative Director. Infinity Festival Hollywood and Capitol Royale celebrate entertainment& tech with 8-week virtual event starting Oct. 28 Tweet this This year's festival will include 8 weeks of original programing, and over 60 pieces of premium content. IF includes high-profile tech exhibitions and screenings, industry-leading speakers, panel discussions, innovation labs, and a fine art exhibition, each with an emerging-tech focus. New technologies and trends will be spotlighted, including: Remote Collaboration/Cloud, Artificial Intelligence, 3D/Visual Effects, Virtual Production, Wellness Tech, Immersive Experiences, Real Time Storytelling and Entertainment Content. Programming advisors include over 150 members from leading studios, talent agencies and technology companies. This year, Capitol Royalewill bring a unique slate ofmusic-related programming to the table including weekly music content drops/premieres, newannouncements, thought leadership conversations, an Innovation Challenge, andStartup programming. For the first time ever, Capitol Royale will be hosted in Neon XP'svirtual Capitol Records Tower experience, where guests will be able to explore 360navigable versions of the iconic Hollywood landmark's lobby, rooftop, and surrounding lot. In each area, guests will beable to watch exclusive content live and on-demand. View a teaser for the virtual Capitol Records Tower experience HERE. On November 12in partnership with gener8tor and OnRamp Entertainment, andas part of Capitol Royale's Startup TrackInfinity Festival will be hosting a Startup Demo Day, as well as one-on-one pitch meetings between the entertainment industry's leading corporations, investors, and startups. Programming will address the cutting-edge technology advances in storytelling today, with panel discussions on global analytics, industry trends, professional insights and consumer research."Capitol Royale was founded with the vision to expand on the legacy of Capitol Tower, and all the music greats that have walked its halls, by transforming it into a hub for musicians and technologists to connect in the heart of Hollywood," said Ching-Ching Chen, Vice President, Content Partnerships & Strategy, Capitol Records. "We are thrilled to be partnering with Infinity Festival to connect the dots between all aspects of Entertainment, Music & Technology." In addition, Chen will be joining forces with IF as it's newest executive board member.This marks the second year of IF's partnership with FNTECH, a groundbreaking full-service event production company headquartered in Northern and Southern California. FNTECH has successfully partnered with scores of top-tier companies such as Apple, Facebook, HP, Vans and Volcom to create multi-faceted, high-profile, newsworthy events. FNTECH is excited about the new frontiers in virtual events and looking forward to bringing tech and storytelling to life in a compellingway with their new proprietary virtual event platform. Jeremy Muir, CEO of FNTECH, expounded on this thought: "We are thrilled to use this expansiveand cutting-edgetool. The next horizon is hybrid events, which will be more broad-reaching and inclusive than anything seen to date."The Chairman of the Infinity Festival Hanno Basse was equally thrilled about this year's content. "We are excited to once again bring you top-notch original content on our virtual platform as we enter year three, with support from the industry's leading studios, tech companies and business leaders." "With the current state of events and programming so fluid and shifting towards all things virtual in 2020, we are fortunate to have the technology and infrastructure to bring our festival online," said Mark Lieber, Infinity Festival Founder."We are excited to showcase some of the best digital and entertainment programming and are confident that this will be one of the best immersive events of the year."About Infinity Festival HollywoodInfinity Festival Hollywood, guided by more than 150 Advisors from the leading studios, talent agencies and technology companies, celebrates "Story Enabled by Technology" by bringing together Silicon Valley innovators with Hollywood's leading storytellers. IF Programming has an emerging-technology focus, and includes high-profile screenings, tech exhibitions, thought-leading speakers, panel discussions, innovation labs, VIP networking opportunities and a fine art exhibition. The festival is inspired by the seemingly infinite possibilities being realized in content creation for evolving technologies and platforms.The Festival is free this year and attendees can register atinfinityfestival.comto obtain ticketsand additional information.About Capitol Music GroupCapitol Music Group (CMG) is comprised of Capitol Records, Virgin Records, Motown Records, Blue Note Records, Astralwerks, Harvest Records and Capitol Christian Music Group, as well as Capitol Studios and the company's independent distribution and label services arm, Caroline. Capitol Music Group is based in Hollywood, California within the iconic Capitol Tower.Artists that record for CMG labels include: Erykah Badu, The Beach Boys, The Beatles, Beck, Bee Gees, Jon Bellion, Rosanne Cash, Christine and the Queens, City Girls, Fletcher, Neil Diamond, Halsey, Don Henley, Hillsong United, Niall Horan, Tori Kelly, KEM, Lil Baby, Lil Yachty, Charles Lloyd, tobyMac, Paul McCartney, Migos, NE-YO, NF, Norah Jones, Queen Naija, Katy Perry, Gregory Porter, Maggie Rogers, Calum Scott, Bob Seger, Tiana Major9, Troye Sivan and Chris Tomlin. For the U.S.: Disclosure, Empire Of The Sun, MNEK and Sam Smith.Capitol Music Group is a division of Universal Music Group, which is a fully owned subsidiary of Vivendi.Please click here for promo reel:IF 2020 Official TrailerPlease click here for media assets:IF 2020 Poster* Terms and conditions apply.SOURCE Capitol Music Group; Infinity Festival Hollywood Related Links http://www.umusic.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Infinity Festival Hollywood Expands For Year Three. Announcing New Partnership With Capitol Music Group's Event 'Capitol Royale'.<|eot_id|>

edtsum828

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation ("HSAC", "Immunovant", or the "Company") (NASDAQ: IMVT; HSACU; HSAC; and HSACW) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-00918, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Immunovant securities between October 2, 2019 and February 1, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. If you are a shareholder who purchased Immunovant securities during the Class Period, you have until April 20, 2021to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com.To discuss this action, contact Robert S. Willoughby at [emailprotected]or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] Immunovant is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of autoimmune diseases. The Company is developing IMVT-1401, a novel fully human monoclonal antibody, which is in Phase II a clinical trials for the treatment of myasthenia gravis and thyroid eye disease ("TED"), also known as Graves' ophthalmopathy.The Company has also completed initiation of Phase II clinical trials of IMVT-1401 for the treatment of warm autoimmune hemolytic anemia ("WAIHA"). On September 29, 2019, HSAC, then a blank check company, also known as a special purpose acquisition company, entered into an agreement with Immunovant Sciences Ltd. ("Legacy Immunovant"), a private biopharmaceutical company, and shareholders of Legacy Immunovant, to effect a merger between the two entities (the "Merger").As a result of the Merger, HSAC acquired all of the issued and outstanding shares of Legacy Immunovant, and Legacy Immunovant became a wholly owned subsidiary of HSAC. Upon the closing of the Merger, HSAC changed its name to "Immunovant, Inc." Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) HSAC had performed inadequate due diligence into Legacy Immunovant prior to the Merger, and/or ignored or failed to disclose safety issues associated with IMVT-1401; (ii) IMVT-1401 was less safe than the Company had led investors to believe, particularly with respect to treating TED and WAIHA; (iii) the foregoing foreseeably diminished IMVT-1401's prospects for regulatory approval, commercial viability, and profitability; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times. On February 2, 2021, Immunovant issued a press release "announc[ing] a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401."Immunovant disclosed that it "has become aware of a physiological signal consisting of elevated total cholesterol and LDL [low-density lipoproteins] levels in IMVT-1401-treated patients" and "[o]ut of an abundance of caution, the Company has decided to voluntarily pause dosing in ongoing clinical studies in both TED and in [WAIHA], in order to inform patients, investigators, and regulators as well as to modify the monitoring program." On this news, Immunovant's stock price fell $18.22 per share, or 42.08%, to close at $25.08 per share on February 2, 2021. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com CONTACT:Robert S. WilloughbyPomerantz LLP[emailprotected] 888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc., f/k/a Health Sciences Acquisitions Corporation, of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW.

NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation ("HSAC", "Immunovant", or the "Company") (NASDAQ: IMVT; HSACU; HSAC; and HSACW) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-00918, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Immunovant securities between October 2, 2019 and February 1, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. If you are a shareholder who purchased Immunovant securities during the Class Period, you have until April 20, 2021to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com.To discuss this action, contact Robert S. Willoughby at [emailprotected]or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] Immunovant is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of autoimmune diseases. The Company is developing IMVT-1401, a novel fully human monoclonal antibody, which is in Phase II a clinical trials for the treatment of myasthenia gravis and thyroid eye disease ("TED"), also known as Graves' ophthalmopathy.The Company has also completed initiation of Phase II clinical trials of IMVT-1401 for the treatment of warm autoimmune hemolytic anemia ("WAIHA"). On September 29, 2019, HSAC, then a blank check company, also known as a special purpose acquisition company, entered into an agreement with Immunovant Sciences Ltd. ("Legacy Immunovant"), a private biopharmaceutical company, and shareholders of Legacy Immunovant, to effect a merger between the two entities (the "Merger").As a result of the Merger, HSAC acquired all of the issued and outstanding shares of Legacy Immunovant, and Legacy Immunovant became a wholly owned subsidiary of HSAC. Upon the closing of the Merger, HSAC changed its name to "Immunovant, Inc." Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) HSAC had performed inadequate due diligence into Legacy Immunovant prior to the Merger, and/or ignored or failed to disclose safety issues associated with IMVT-1401; (ii) IMVT-1401 was less safe than the Company had led investors to believe, particularly with respect to treating TED and WAIHA; (iii) the foregoing foreseeably diminished IMVT-1401's prospects for regulatory approval, commercial viability, and profitability; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times. On February 2, 2021, Immunovant issued a press release "announc[ing] a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401."Immunovant disclosed that it "has become aware of a physiological signal consisting of elevated total cholesterol and LDL [low-density lipoproteins] levels in IMVT-1401-treated patients" and "[o]ut of an abundance of caution, the Company has decided to voluntarily pause dosing in ongoing clinical studies in both TED and in [WAIHA], in order to inform patients, investigators, and regulators as well as to modify the monitoring program." On this news, Immunovant's stock price fell $18.22 per share, or 42.08%, to close at $25.08 per share on February 2, 2021. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com CONTACT:Robert S. WilloughbyPomerantz LLP[emailprotected] 888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation ("HSAC", "Immunovant", or the "Company") (NASDAQ: IMVT; HSACU; HSAC; and HSACW) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-00918, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Immunovant securities between October 2, 2019 and February 1, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. If you are a shareholder who purchased Immunovant securities during the Class Period, you have until April 20, 2021to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com.To discuss this action, contact Robert S. Willoughby at [emailprotected]or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] Immunovant is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of autoimmune diseases. The Company is developing IMVT-1401, a novel fully human monoclonal antibody, which is in Phase II a clinical trials for the treatment of myasthenia gravis and thyroid eye disease ("TED"), also known as Graves' ophthalmopathy.The Company has also completed initiation of Phase II clinical trials of IMVT-1401 for the treatment of warm autoimmune hemolytic anemia ("WAIHA"). On September 29, 2019, HSAC, then a blank check company, also known as a special purpose acquisition company, entered into an agreement with Immunovant Sciences Ltd. ("Legacy Immunovant"), a private biopharmaceutical company, and shareholders of Legacy Immunovant, to effect a merger between the two entities (the "Merger").As a result of the Merger, HSAC acquired all of the issued and outstanding shares of Legacy Immunovant, and Legacy Immunovant became a wholly owned subsidiary of HSAC. Upon the closing of the Merger, HSAC changed its name to "Immunovant, Inc." Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) HSAC had performed inadequate due diligence into Legacy Immunovant prior to the Merger, and/or ignored or failed to disclose safety issues associated with IMVT-1401; (ii) IMVT-1401 was less safe than the Company had led investors to believe, particularly with respect to treating TED and WAIHA; (iii) the foregoing foreseeably diminished IMVT-1401's prospects for regulatory approval, commercial viability, and profitability; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times. On February 2, 2021, Immunovant issued a press release "announc[ing] a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401."Immunovant disclosed that it "has become aware of a physiological signal consisting of elevated total cholesterol and LDL [low-density lipoproteins] levels in IMVT-1401-treated patients" and "[o]ut of an abundance of caution, the Company has decided to voluntarily pause dosing in ongoing clinical studies in both TED and in [WAIHA], in order to inform patients, investigators, and regulators as well as to modify the monitoring program." On this news, Immunovant's stock price fell $18.22 per share, or 42.08%, to close at $25.08 per share on February 2, 2021. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com CONTACT:Robert S. WilloughbyPomerantz LLP[emailprotected] 888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc., f/k/a Health Sciences Acquisitions Corporation, of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW.<|eot_id|>

edtsum829

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: FOUNTAIN VALLEY, Calif., May 1, 2020 /PRNewswire/ -- Hyundai Motor America reported total April sales of 33,968 units, a 39% decrease compared with April 2019. Retail sales declined 28%, while fleet sales were down 74% and represented 10% of total volume. Monthly sales results were better than early industry predictions that forecasted an 80% decline in April. Hyundai sold 30,468 retail units in April, up 6% compared with March 2020. Hyundai's SUVs represented 67% of the total retail mix. Tucson was the strongest performing Hyundai model with retail sales increasing 7% year-over-year. Tucson achieved a significant milestone in April, exceeding 1 million total sales in the U.S. First introduced in 2004, Tucson has gone on to be one of Hyundai's most popular vehicles and was the second highest selling model in 2019. Now in its third generation, Tucson continues to attract buyers with its refreshed designed and extensive comfort, safety and technology features. April Sales Summary Apr-20 Apr-19 2020 YTD 2019 YTD Hyundai 33,968 55,420 164,843 203,005 "The COVID-19 global pandemic significantly disrupted the U.S. auto industry in April, but Hyundai sales showed some resiliency thanks to the ingenuity of our dealers and being first to market with robust customer assistance programs," said Randy Parker, vice president, National Sales, Hyundai Motor America. "Sales varied significantly across regions. We focused on supporting sales in areas that transitioned from showroom retail to digital and contactless retail sales and service. We look forward to supporting our dealers and customers as cities, counties and states slowly re-open and we begin returning to work after this tragic pandemic." Hyundai Assurance Job Loss Protection Extension Hyundai is providing peace of mind by extending the Assurance Job Loss Protection program through May 17. The industry-first program covers up to six months of payments for Hyundai owners who purchased or leased a Hyundai vehicle between March 14 and May 17, 2020 if they lose their job due to COVID-19 this year. The program is executed in partnership with Insurianand for more details visit HyundaiUSA.com. Hyundai customers can also depend on other Assurance programs, including Hyundai Complimentary Maintenance and America's Best Warranty. Hyundai's Retail Operations and Safety Practices Hyundai dealers across the country enhanced their safety measures and adapted their businesses to comply with social distancing guidelines by leveraging Shopper Assuranceand Hyundai's Click to Buycapability. Hyundai dealers have implemented thorough cleaning and disinfection practices for all facilities and vehicles going to customers, while increasing digital communication between the customer and dealer staff. More than 95% of all Hyundai dealers offer digital retailing and most will deliver new vehicles to customers' homes. For service or repair, almost all of Hyundai dealers will pick up and drop off the customers' vehicles. Hyundai also salutes its dealers who have helped their hometowns and communities by providing complimentary maintenance for first responders, loaning service vehicles, and delivering critical supplies. April Product and Corporate Activities Coronavirus (COVID-19) Actions: In response to this global crisis, Hyundai has taken numerous actions to help employees, customers, dealers and healthcare providers, all of which can be found on HyundaiNews.comand HyundaiUSA.com Hyundai Hope On Wheels Donations: Hyundai's non-profit organization, Hyundai Hope On Wheels, donated$4.3 million and 65,000 COVID-19 tests to 22 children's hospitals and institutions across the country for drive thru testing centers Global Warranty Extension: Hyundai owners in the U.S. with a 5-year/60,000-mile new vehicle limited warranty or a 10-year/100,000-mile powertrain warranty that is expiring between March and June 2020, will have their warranty extended to June 30, 2020 New Vehicles: Hyundai pulled the virtual sheet off of the upcoming Veloster Nwith a new DCT transmission and previewed the all-new 2021 Elantra N Line Safety Awards: The 2020 Palisade, Sonataand Sonata Hybrid all received Five-Star Safety Ratings from NHTSA Product Awards: The Kona Electric was acknowledged as the Best Small Family Car in the inaugural TopGear Electric Awardsand was named Best Electric Vehicle by U.S. News & World Report, who also recognized Ioniq Hybrid with its Best Hybrid Car award Earth Day: For the 50th anniversary of Earth Day, Hyundai released a "How it Works" video for its NEXO fuel cell SUV and globally premiered a new filmwith the global K-pop group, BTS Model Sales Vehicle Apr-20 Apr-19 2020 YTD 2019 YTD Accent 736 2,834 5,543 9,615 Elantra 7,536 16,586 33,281 52,698 Ioniq 422 1,211 3,944 4,521 Kona 3,114 5,154 18,288 23,551 Nexo 3 19 54 79 Palisade 3,331 0 20,420 0 Santa Fe 5,602 10,746 25,504 39,429 Sonata 3,428 8,634 19,030 30,154 Tucson 8,438 8,682 32,173 37,513 Veloster 541 1,554 2,623 5,445 Venue 817 0 3,983 0 Hyundai Motor America At Hyundai Motor America, we believe everyone deserves better. From the way we design and build our cars to the way we treat the people who drive them, making things better is at the heart of everything we do. Hyundai's technology-rich product lineup of cars, SUVs and alternative-powered electric and fuel cell vehicles is backed by Hyundai Assuranceour promise to create a better experience for customers. Hyundai vehicles are sold and serviced through more than 820 dealerships nationwide and nearly half of those sold in the U.S. are built at Hyundai Motor Manufacturing Alabama. Hyundai Motor America is headquartered in Fountain Valley, California, and is a subsidiary of Hyundai Motor Company of Korea. Please visit our media website at www.HyundaiNews.com Hyundai Motor America on Twitter | YouTube | Facebook | Instagram SOURCE Hyundai Motor America Related Links https://www.hyundainews.com/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Hyundai Motor America Reports April 2020 Sales and Extends Consumer Benefits.

FOUNTAIN VALLEY, Calif., May 1, 2020 /PRNewswire/ -- Hyundai Motor America reported total April sales of 33,968 units, a 39% decrease compared with April 2019. Retail sales declined 28%, while fleet sales were down 74% and represented 10% of total volume. Monthly sales results were better than early industry predictions that forecasted an 80% decline in April. Hyundai sold 30,468 retail units in April, up 6% compared with March 2020. Hyundai's SUVs represented 67% of the total retail mix. Tucson was the strongest performing Hyundai model with retail sales increasing 7% year-over-year. Tucson achieved a significant milestone in April, exceeding 1 million total sales in the U.S. First introduced in 2004, Tucson has gone on to be one of Hyundai's most popular vehicles and was the second highest selling model in 2019. Now in its third generation, Tucson continues to attract buyers with its refreshed designed and extensive comfort, safety and technology features. April Sales Summary Apr-20 Apr-19 2020 YTD 2019 YTD Hyundai 33,968 55,420 164,843 203,005 "The COVID-19 global pandemic significantly disrupted the U.S. auto industry in April, but Hyundai sales showed some resiliency thanks to the ingenuity of our dealers and being first to market with robust customer assistance programs," said Randy Parker, vice president, National Sales, Hyundai Motor America. "Sales varied significantly across regions. We focused on supporting sales in areas that transitioned from showroom retail to digital and contactless retail sales and service. We look forward to supporting our dealers and customers as cities, counties and states slowly re-open and we begin returning to work after this tragic pandemic." Hyundai Assurance Job Loss Protection Extension Hyundai is providing peace of mind by extending the Assurance Job Loss Protection program through May 17. The industry-first program covers up to six months of payments for Hyundai owners who purchased or leased a Hyundai vehicle between March 14 and May 17, 2020 if they lose their job due to COVID-19 this year. The program is executed in partnership with Insurianand for more details visit HyundaiUSA.com. Hyundai customers can also depend on other Assurance programs, including Hyundai Complimentary Maintenance and America's Best Warranty. Hyundai's Retail Operations and Safety Practices Hyundai dealers across the country enhanced their safety measures and adapted their businesses to comply with social distancing guidelines by leveraging Shopper Assuranceand Hyundai's Click to Buycapability. Hyundai dealers have implemented thorough cleaning and disinfection practices for all facilities and vehicles going to customers, while increasing digital communication between the customer and dealer staff. More than 95% of all Hyundai dealers offer digital retailing and most will deliver new vehicles to customers' homes. For service or repair, almost all of Hyundai dealers will pick up and drop off the customers' vehicles. Hyundai also salutes its dealers who have helped their hometowns and communities by providing complimentary maintenance for first responders, loaning service vehicles, and delivering critical supplies. April Product and Corporate Activities Coronavirus (COVID-19) Actions: In response to this global crisis, Hyundai has taken numerous actions to help employees, customers, dealers and healthcare providers, all of which can be found on HyundaiNews.comand HyundaiUSA.com Hyundai Hope On Wheels Donations: Hyundai's non-profit organization, Hyundai Hope On Wheels, donated$4.3 million and 65,000 COVID-19 tests to 22 children's hospitals and institutions across the country for drive thru testing centers Global Warranty Extension: Hyundai owners in the U.S. with a 5-year/60,000-mile new vehicle limited warranty or a 10-year/100,000-mile powertrain warranty that is expiring between March and June 2020, will have their warranty extended to June 30, 2020 New Vehicles: Hyundai pulled the virtual sheet off of the upcoming Veloster Nwith a new DCT transmission and previewed the all-new 2021 Elantra N Line Safety Awards: The 2020 Palisade, Sonataand Sonata Hybrid all received Five-Star Safety Ratings from NHTSA Product Awards: The Kona Electric was acknowledged as the Best Small Family Car in the inaugural TopGear Electric Awardsand was named Best Electric Vehicle by U.S. News & World Report, who also recognized Ioniq Hybrid with its Best Hybrid Car award Earth Day: For the 50th anniversary of Earth Day, Hyundai released a "How it Works" video for its NEXO fuel cell SUV and globally premiered a new filmwith the global K-pop group, BTS Model Sales Vehicle Apr-20 Apr-19 2020 YTD 2019 YTD Accent 736 2,834 5,543 9,615 Elantra 7,536 16,586 33,281 52,698 Ioniq 422 1,211 3,944 4,521 Kona 3,114 5,154 18,288 23,551 Nexo 3 19 54 79 Palisade 3,331 0 20,420 0 Santa Fe 5,602 10,746 25,504 39,429 Sonata 3,428 8,634 19,030 30,154 Tucson 8,438 8,682 32,173 37,513 Veloster 541 1,554 2,623 5,445 Venue 817 0 3,983 0 Hyundai Motor America At Hyundai Motor America, we believe everyone deserves better. From the way we design and build our cars to the way we treat the people who drive them, making things better is at the heart of everything we do. Hyundai's technology-rich product lineup of cars, SUVs and alternative-powered electric and fuel cell vehicles is backed by Hyundai Assuranceour promise to create a better experience for customers. Hyundai vehicles are sold and serviced through more than 820 dealerships nationwide and nearly half of those sold in the U.S. are built at Hyundai Motor Manufacturing Alabama. Hyundai Motor America is headquartered in Fountain Valley, California, and is a subsidiary of Hyundai Motor Company of Korea. Please visit our media website at www.HyundaiNews.com Hyundai Motor America on Twitter | YouTube | Facebook | Instagram SOURCE Hyundai Motor America Related Links https://www.hyundainews.com/

Hyundai Motor America Reports April 2020 Sales and Extends Consumer Benefits

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: FOUNTAIN VALLEY, Calif., May 1, 2020 /PRNewswire/ -- Hyundai Motor America reported total April sales of 33,968 units, a 39% decrease compared with April 2019. Retail sales declined 28%, while fleet sales were down 74% and represented 10% of total volume. Monthly sales results were better than early industry predictions that forecasted an 80% decline in April. Hyundai sold 30,468 retail units in April, up 6% compared with March 2020. Hyundai's SUVs represented 67% of the total retail mix. Tucson was the strongest performing Hyundai model with retail sales increasing 7% year-over-year. Tucson achieved a significant milestone in April, exceeding 1 million total sales in the U.S. First introduced in 2004, Tucson has gone on to be one of Hyundai's most popular vehicles and was the second highest selling model in 2019. Now in its third generation, Tucson continues to attract buyers with its refreshed designed and extensive comfort, safety and technology features. April Sales Summary Apr-20 Apr-19 2020 YTD 2019 YTD Hyundai 33,968 55,420 164,843 203,005 "The COVID-19 global pandemic significantly disrupted the U.S. auto industry in April, but Hyundai sales showed some resiliency thanks to the ingenuity of our dealers and being first to market with robust customer assistance programs," said Randy Parker, vice president, National Sales, Hyundai Motor America. "Sales varied significantly across regions. We focused on supporting sales in areas that transitioned from showroom retail to digital and contactless retail sales and service. We look forward to supporting our dealers and customers as cities, counties and states slowly re-open and we begin returning to work after this tragic pandemic." Hyundai Assurance Job Loss Protection Extension Hyundai is providing peace of mind by extending the Assurance Job Loss Protection program through May 17. The industry-first program covers up to six months of payments for Hyundai owners who purchased or leased a Hyundai vehicle between March 14 and May 17, 2020 if they lose their job due to COVID-19 this year. The program is executed in partnership with Insurianand for more details visit HyundaiUSA.com. Hyundai customers can also depend on other Assurance programs, including Hyundai Complimentary Maintenance and America's Best Warranty. Hyundai's Retail Operations and Safety Practices Hyundai dealers across the country enhanced their safety measures and adapted their businesses to comply with social distancing guidelines by leveraging Shopper Assuranceand Hyundai's Click to Buycapability. Hyundai dealers have implemented thorough cleaning and disinfection practices for all facilities and vehicles going to customers, while increasing digital communication between the customer and dealer staff. More than 95% of all Hyundai dealers offer digital retailing and most will deliver new vehicles to customers' homes. For service or repair, almost all of Hyundai dealers will pick up and drop off the customers' vehicles. Hyundai also salutes its dealers who have helped their hometowns and communities by providing complimentary maintenance for first responders, loaning service vehicles, and delivering critical supplies. April Product and Corporate Activities Coronavirus (COVID-19) Actions: In response to this global crisis, Hyundai has taken numerous actions to help employees, customers, dealers and healthcare providers, all of which can be found on HyundaiNews.comand HyundaiUSA.com Hyundai Hope On Wheels Donations: Hyundai's non-profit organization, Hyundai Hope On Wheels, donated$4.3 million and 65,000 COVID-19 tests to 22 children's hospitals and institutions across the country for drive thru testing centers Global Warranty Extension: Hyundai owners in the U.S. with a 5-year/60,000-mile new vehicle limited warranty or a 10-year/100,000-mile powertrain warranty that is expiring between March and June 2020, will have their warranty extended to June 30, 2020 New Vehicles: Hyundai pulled the virtual sheet off of the upcoming Veloster Nwith a new DCT transmission and previewed the all-new 2021 Elantra N Line Safety Awards: The 2020 Palisade, Sonataand Sonata Hybrid all received Five-Star Safety Ratings from NHTSA Product Awards: The Kona Electric was acknowledged as the Best Small Family Car in the inaugural TopGear Electric Awardsand was named Best Electric Vehicle by U.S. News & World Report, who also recognized Ioniq Hybrid with its Best Hybrid Car award Earth Day: For the 50th anniversary of Earth Day, Hyundai released a "How it Works" video for its NEXO fuel cell SUV and globally premiered a new filmwith the global K-pop group, BTS Model Sales Vehicle Apr-20 Apr-19 2020 YTD 2019 YTD Accent 736 2,834 5,543 9,615 Elantra 7,536 16,586 33,281 52,698 Ioniq 422 1,211 3,944 4,521 Kona 3,114 5,154 18,288 23,551 Nexo 3 19 54 79 Palisade 3,331 0 20,420 0 Santa Fe 5,602 10,746 25,504 39,429 Sonata 3,428 8,634 19,030 30,154 Tucson 8,438 8,682 32,173 37,513 Veloster 541 1,554 2,623 5,445 Venue 817 0 3,983 0 Hyundai Motor America At Hyundai Motor America, we believe everyone deserves better. From the way we design and build our cars to the way we treat the people who drive them, making things better is at the heart of everything we do. Hyundai's technology-rich product lineup of cars, SUVs and alternative-powered electric and fuel cell vehicles is backed by Hyundai Assuranceour promise to create a better experience for customers. Hyundai vehicles are sold and serviced through more than 820 dealerships nationwide and nearly half of those sold in the U.S. are built at Hyundai Motor Manufacturing Alabama. Hyundai Motor America is headquartered in Fountain Valley, California, and is a subsidiary of Hyundai Motor Company of Korea. Please visit our media website at www.HyundaiNews.com Hyundai Motor America on Twitter | YouTube | Facebook | Instagram SOURCE Hyundai Motor America Related Links https://www.hyundainews.com/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Hyundai Motor America Reports April 2020 Sales and Extends Consumer Benefits.<|eot_id|>

edtsum830

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Jan. 19, 2021 /PRNewswire/ --Haven Life Insurance Agency (Haven Life), the customer-centric life insurance innovator backed and wholly owned by Massachusetts Mutual Life Insurance Company (MassMutual), is continuing its tradition of sharing its Annual Report to highlight meaningful growth from the previous year. Rather than focusing on charts and sales figures, though, Haven Life's Annual Report highlights the accomplishments of its remarkable customers. Even in 2020, a year unlike any other, Haven Life's customers highlighted moments of hope and inspiration that made the year one to remember for reasons other than the pandemic. To commemorate these achievements, the Haven Life Annual Report doubles as a cookbook, filled with the ingredients that made this past year - and our tummies - full despite the difficult realities we all faced. Each recipe comes directly from policyholders - food they made in their kitchens with the people they love and want to financially protect. As Haven Term policyholder, JC, put it: "This has been a difficult year for so many people around the world. To cope, I've relied on familiar comforts such as cooking, my pets, and really connecting heart to heart with loved ones I cannot physically be with." From opening a new bakery, to paying off one's student loans, these and many more achievements made 2020 a meaningful year for policyholders. In 2020, 84.2% of Haven Term policyholders chose to see the glass as half-full, with many proud of their accomplishments including: Finishing radiation and continuing to fight cancer Coming out to friends and family Giving birth after years of trying Standing up in support of people who are different from themselves Homeschooling their kids (a big salute to all the parents and teachers out there who did monumental work!) Additionally, 65% of customers achieved one of their dreams: "I got to watch the Lakers AND the Dodgers win championships!" "I launched a non-profit organization to help build up the community" "I lost 70 pounds" "We paid off my fiance's private student loan" "I coached my son's 14U baseball team to a championship" Meanwhile, 15.48% of Haven Term policyholders welcomed new pets into their families this year including new dogs, cats, chickens, rabbits, ferrets, guinea pigs and more. "The Haven Life community continues to inspire us," said Haven Life co-founder and CEO Yaron Ben-Zvi, who, along with his daughter, successfully baked Babka and Malawach - two of his favorite treats as a kid. "Last year was incredibly difficult and challenging for everyone, and yet our policyholders are still able to acknowledge some of the hope that 2020 brought with it." Haven Term policyholders are looking forward to appreciating all that life has to offer in 2021, with a renewed focus on taking care of themselves and looking out for others: "I'm going to hike more than I did in 2020 - and, trust me, there was a lot of hiking done in 2020" "I'm going to learn how to speak Korean" "I'm going to pursue my dream of rebuilding coral reefs" "I will not shy away from uncomfortable conversations that I can learn from" "I will savor every hug" Read the Haven Life Annual Reportto find recipes for all that policyholders cooked up in 2020, such as Vegan Spaghetti Squash Marinara, Japanese Milk Bread, Korean Braised Short Bread and lots more. About Haven LifeHaven Life Insurance Agency, LLC (Haven Life) is re-thinking how people financially protect the ones they love. Haven Life is committed to delivering exceptional products, delightful purchasing experiences, and meaningful moments of service to the modern life insurance customer. Haven Term is a Term Life Insurance Policy (DTC 042017 and ICC17DTC in certain states, including NC; DTC NY 1017 in NY and DTC CA 042017 in CA) issued by Massachusetts Mutual Life Insurance Company (MassMutual), Springfield, MA 01111-0001 and offered exclusively through Haven Life Insurance Agency, LLC. Our Agency license number in California is OK71922 and in Arkansas, 100139527. SOURCE Haven Life Related Links https://havenlife.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Haven Life Cooks Up Positivity, Even In 2020. The digital life insurance agency shares its annual report, focusing on the numbers that matter most.

NEW YORK, Jan. 19, 2021 /PRNewswire/ --Haven Life Insurance Agency (Haven Life), the customer-centric life insurance innovator backed and wholly owned by Massachusetts Mutual Life Insurance Company (MassMutual), is continuing its tradition of sharing its Annual Report to highlight meaningful growth from the previous year. Rather than focusing on charts and sales figures, though, Haven Life's Annual Report highlights the accomplishments of its remarkable customers. Even in 2020, a year unlike any other, Haven Life's customers highlighted moments of hope and inspiration that made the year one to remember for reasons other than the pandemic. To commemorate these achievements, the Haven Life Annual Report doubles as a cookbook, filled with the ingredients that made this past year - and our tummies - full despite the difficult realities we all faced. Each recipe comes directly from policyholders - food they made in their kitchens with the people they love and want to financially protect. As Haven Term policyholder, JC, put it: "This has been a difficult year for so many people around the world. To cope, I've relied on familiar comforts such as cooking, my pets, and really connecting heart to heart with loved ones I cannot physically be with." From opening a new bakery, to paying off one's student loans, these and many more achievements made 2020 a meaningful year for policyholders. In 2020, 84.2% of Haven Term policyholders chose to see the glass as half-full, with many proud of their accomplishments including: Finishing radiation and continuing to fight cancer Coming out to friends and family Giving birth after years of trying Standing up in support of people who are different from themselves Homeschooling their kids (a big salute to all the parents and teachers out there who did monumental work!) Additionally, 65% of customers achieved one of their dreams: "I got to watch the Lakers AND the Dodgers win championships!" "I launched a non-profit organization to help build up the community" "I lost 70 pounds" "We paid off my fiance's private student loan" "I coached my son's 14U baseball team to a championship" Meanwhile, 15.48% of Haven Term policyholders welcomed new pets into their families this year including new dogs, cats, chickens, rabbits, ferrets, guinea pigs and more. "The Haven Life community continues to inspire us," said Haven Life co-founder and CEO Yaron Ben-Zvi, who, along with his daughter, successfully baked Babka and Malawach - two of his favorite treats as a kid. "Last year was incredibly difficult and challenging for everyone, and yet our policyholders are still able to acknowledge some of the hope that 2020 brought with it." Haven Term policyholders are looking forward to appreciating all that life has to offer in 2021, with a renewed focus on taking care of themselves and looking out for others: "I'm going to hike more than I did in 2020 - and, trust me, there was a lot of hiking done in 2020" "I'm going to learn how to speak Korean" "I'm going to pursue my dream of rebuilding coral reefs" "I will not shy away from uncomfortable conversations that I can learn from" "I will savor every hug" Read the Haven Life Annual Reportto find recipes for all that policyholders cooked up in 2020, such as Vegan Spaghetti Squash Marinara, Japanese Milk Bread, Korean Braised Short Bread and lots more. About Haven LifeHaven Life Insurance Agency, LLC (Haven Life) is re-thinking how people financially protect the ones they love. Haven Life is committed to delivering exceptional products, delightful purchasing experiences, and meaningful moments of service to the modern life insurance customer. Haven Term is a Term Life Insurance Policy (DTC 042017 and ICC17DTC in certain states, including NC; DTC NY 1017 in NY and DTC CA 042017 in CA) issued by Massachusetts Mutual Life Insurance Company (MassMutual), Springfield, MA 01111-0001 and offered exclusively through Haven Life Insurance Agency, LLC. Our Agency license number in California is OK71922 and in Arkansas, 100139527. SOURCE Haven Life Related Links https://havenlife.com

Haven Life Cooks Up Positivity, Even In 2020 The digital life insurance agency shares its annual report, focusing on the numbers that matter most

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Jan. 19, 2021 /PRNewswire/ --Haven Life Insurance Agency (Haven Life), the customer-centric life insurance innovator backed and wholly owned by Massachusetts Mutual Life Insurance Company (MassMutual), is continuing its tradition of sharing its Annual Report to highlight meaningful growth from the previous year. Rather than focusing on charts and sales figures, though, Haven Life's Annual Report highlights the accomplishments of its remarkable customers. Even in 2020, a year unlike any other, Haven Life's customers highlighted moments of hope and inspiration that made the year one to remember for reasons other than the pandemic. To commemorate these achievements, the Haven Life Annual Report doubles as a cookbook, filled with the ingredients that made this past year - and our tummies - full despite the difficult realities we all faced. Each recipe comes directly from policyholders - food they made in their kitchens with the people they love and want to financially protect. As Haven Term policyholder, JC, put it: "This has been a difficult year for so many people around the world. To cope, I've relied on familiar comforts such as cooking, my pets, and really connecting heart to heart with loved ones I cannot physically be with." From opening a new bakery, to paying off one's student loans, these and many more achievements made 2020 a meaningful year for policyholders. In 2020, 84.2% of Haven Term policyholders chose to see the glass as half-full, with many proud of their accomplishments including: Finishing radiation and continuing to fight cancer Coming out to friends and family Giving birth after years of trying Standing up in support of people who are different from themselves Homeschooling their kids (a big salute to all the parents and teachers out there who did monumental work!) Additionally, 65% of customers achieved one of their dreams: "I got to watch the Lakers AND the Dodgers win championships!" "I launched a non-profit organization to help build up the community" "I lost 70 pounds" "We paid off my fiance's private student loan" "I coached my son's 14U baseball team to a championship" Meanwhile, 15.48% of Haven Term policyholders welcomed new pets into their families this year including new dogs, cats, chickens, rabbits, ferrets, guinea pigs and more. "The Haven Life community continues to inspire us," said Haven Life co-founder and CEO Yaron Ben-Zvi, who, along with his daughter, successfully baked Babka and Malawach - two of his favorite treats as a kid. "Last year was incredibly difficult and challenging for everyone, and yet our policyholders are still able to acknowledge some of the hope that 2020 brought with it." Haven Term policyholders are looking forward to appreciating all that life has to offer in 2021, with a renewed focus on taking care of themselves and looking out for others: "I'm going to hike more than I did in 2020 - and, trust me, there was a lot of hiking done in 2020" "I'm going to learn how to speak Korean" "I'm going to pursue my dream of rebuilding coral reefs" "I will not shy away from uncomfortable conversations that I can learn from" "I will savor every hug" Read the Haven Life Annual Reportto find recipes for all that policyholders cooked up in 2020, such as Vegan Spaghetti Squash Marinara, Japanese Milk Bread, Korean Braised Short Bread and lots more. About Haven LifeHaven Life Insurance Agency, LLC (Haven Life) is re-thinking how people financially protect the ones they love. Haven Life is committed to delivering exceptional products, delightful purchasing experiences, and meaningful moments of service to the modern life insurance customer. Haven Term is a Term Life Insurance Policy (DTC 042017 and ICC17DTC in certain states, including NC; DTC NY 1017 in NY and DTC CA 042017 in CA) issued by Massachusetts Mutual Life Insurance Company (MassMutual), Springfield, MA 01111-0001 and offered exclusively through Haven Life Insurance Agency, LLC. Our Agency license number in California is OK71922 and in Arkansas, 100139527. SOURCE Haven Life Related Links https://havenlife.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Haven Life Cooks Up Positivity, Even In 2020. The digital life insurance agency shares its annual report, focusing on the numbers that matter most.<|eot_id|>

edtsum831

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: Please take note that the timing of the conference call has changed MONTRAL, April 27, 2020 /PRNewswire/ -Boralex Inc. ("Boralex" or the "Corporation") announces that the release of the 2019 first quarter results will take place on Wednesday May 6, 2019 at 9 a.m. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time: Wednesday, May 6, 2020 at8 a.m. ET Dial-in numbers: 1-888-231-8191 or 647-427-7450 Media and other interested individuals are invited to listen to the conference and view a presentation which will be broadcasted live and on a deferred basis on the Boralex website at www.boralex.com. A full replay will also be available by dialing toll free at 1-855-859-2056 until May 13, 2020. The access code is 3387555, followed by the pound sign(#). The financial information will be released through a press release and on the Boralex's website on May 6, 2020 at 7 a.m. About Boralex Boralex develops, builds and operates renewable energy power facilities in Canada, France, the United Kingdom and the United States. A leader in the Canadian market and France's largest independent producer of onshore wind power, the Corporation is recognized for its solid experience in optimizing its asset base in four power generation types wind, hydroelectric, thermal and solar. Boralex ensures sustained growth by leveraging the expertise and diversification developed over the past 25 years. Boralex's shares are listed on the Toronto Stock Exchange under the ticker symbol BLX. More information is available at www.boralex.com or www.sedar.com. Follow us on Facebook, LinkedIn and Twitter. SOURCE Boralex Inc. Related Links www.boralex.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Update - Advisory - Boralex will release its 2020 first quarter financial results on May 6.

Please take note that the timing of the conference call has changed MONTRAL, April 27, 2020 /PRNewswire/ -Boralex Inc. ("Boralex" or the "Corporation") announces that the release of the 2019 first quarter results will take place on Wednesday May 6, 2019 at 9 a.m. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time: Wednesday, May 6, 2020 at8 a.m. ET Dial-in numbers: 1-888-231-8191 or 647-427-7450 Media and other interested individuals are invited to listen to the conference and view a presentation which will be broadcasted live and on a deferred basis on the Boralex website at www.boralex.com. A full replay will also be available by dialing toll free at 1-855-859-2056 until May 13, 2020. The access code is 3387555, followed by the pound sign(#). The financial information will be released through a press release and on the Boralex's website on May 6, 2020 at 7 a.m. About Boralex Boralex develops, builds and operates renewable energy power facilities in Canada, France, the United Kingdom and the United States. A leader in the Canadian market and France's largest independent producer of onshore wind power, the Corporation is recognized for its solid experience in optimizing its asset base in four power generation types wind, hydroelectric, thermal and solar. Boralex ensures sustained growth by leveraging the expertise and diversification developed over the past 25 years. Boralex's shares are listed on the Toronto Stock Exchange under the ticker symbol BLX. More information is available at www.boralex.com or www.sedar.com. Follow us on Facebook, LinkedIn and Twitter. SOURCE Boralex Inc. Related Links www.boralex.com

Update - Advisory - Boralex will Release its 2020 First Quarter Financial Results on May 6

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: Please take note that the timing of the conference call has changed MONTRAL, April 27, 2020 /PRNewswire/ -Boralex Inc. ("Boralex" or the "Corporation") announces that the release of the 2019 first quarter results will take place on Wednesday May 6, 2019 at 9 a.m. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time: Wednesday, May 6, 2020 at8 a.m. ET Dial-in numbers: 1-888-231-8191 or 647-427-7450 Media and other interested individuals are invited to listen to the conference and view a presentation which will be broadcasted live and on a deferred basis on the Boralex website at www.boralex.com. A full replay will also be available by dialing toll free at 1-855-859-2056 until May 13, 2020. The access code is 3387555, followed by the pound sign(#). The financial information will be released through a press release and on the Boralex's website on May 6, 2020 at 7 a.m. About Boralex Boralex develops, builds and operates renewable energy power facilities in Canada, France, the United Kingdom and the United States. A leader in the Canadian market and France's largest independent producer of onshore wind power, the Corporation is recognized for its solid experience in optimizing its asset base in four power generation types wind, hydroelectric, thermal and solar. Boralex ensures sustained growth by leveraging the expertise and diversification developed over the past 25 years. Boralex's shares are listed on the Toronto Stock Exchange under the ticker symbol BLX. More information is available at www.boralex.com or www.sedar.com. Follow us on Facebook, LinkedIn and Twitter. SOURCE Boralex Inc. Related Links www.boralex.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Update - Advisory - Boralex will release its 2020 first quarter financial results on May 6.<|eot_id|>

edtsum832

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BEDFORD, Mass., Feb. 10, 2021 /PRNewswire/ --iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the fourth quarter and full year ended January 2, 2021. "iRobot delivered a strong finish to 2020 with revenue, operating income and EPS that surpassed the plans that we outlined at the end of October," said Colin Angle, chairman and chief executive officer of iRobot. "Solid demand combined with excellent collaboration and execution among our sales, marketing and operations teams and our broader supply chain enabled us to grow fourth-quarter revenue in excess of 25% in each major geographic region. We converted this top-line performance into increased operating income and EPS." Angle continued, "Maintaining a clean home has taken on increasing importance while the pandemic forces people to stay at home. It is gratifying to see that our efforts to differentiate our floor cleaning robots with innovative features and functionality that support the fluid lifestyles of their owners are resonating in the marketplace. To that end, we generated significant growth with our premium floor cleaning robots throughout the year. We were also pleased with the substantial expansion of our connected customer base, which grew over 80% in 2020." Angle concluded, "Our outlook for 2021 reflects our confidence that the growth drivers for our business will remain largely intact over the coming quarters. We believe that our success in continuing to drive solid top-line expansion in 2021 will also enable us to fund investment into key areas of our business and help mitigate the impact of tariffs on our 2021 profitability. As we move forward, we believe that our success in scaling Malaysia volumes, advancing key R&D initiatives and building stronger, more enduring relationships with millions of connected customers will further strengthen our business, enhance our ability to drive overall top-line growth and accelerate our profitability over the long term. As we continue to execute on our plans, we are excited about our prospects to sustain solid top-line growth into 2022 and convert that expansion into 2022 profit margins and EPS that exceed 2020 levels." Financial Performance Highlights Revenue for the fourth quarter of 2020 grew 28% to $544.8 million over $426.8 million for the fourth quarter of 2019. Full-year 2020 revenue was $1,430.4 million, an increase of 18% over $1,214.0 million in 2019. Fourth-quarter 2020 revenue growth was highlighted by 28% growth in the U.S. and 27% international growth. Growth outside of the U.S. was led by 39% expansion in Japan and a 26% increase in EMEA. Full-year 2020 revenue grew 23% in the U.S., 20% in Japan and 8% in EMEA. We estimate that iRobot's fourth-quarter 2020 revenue to support e-commerce, which spans the company's own website and app, dedicated e-commerce websites and the online arms of traditional retailers, grew by over 70% over the fourth quarter of 2019, and represented approximately 60% of fourth-quarter 2020 revenue. For the full year 2020, we estimate that revenue to support e-commerce grew approximately 55% and represented 60% of annual revenue. Direct-to-consumer revenue of $68 million in the fourth quarter of 2020 grew 117% from the prior year's fourth quarter. 2020 direct-to-consumer revenue of $151 million grew 114% over 2019. The company enjoyed strong growth in its premium robots for both the quarter and full year. Premium robot revenue grew 55% in the fourth quarter of 2020 and nearly 50% for the full year. Premium robots are defined as floor cleaning robots with an MSRP of $500 and higher (the Roomba i3+, 900 Series, i7 Series and s9 Series, and the Braava Jet m Series). Fourth-quarter 2020 GAAP operating income was $15.3 million, compared with $16.6 million in the fourth quarter of 2019. Fourth-quarter 2020 non-GAAP operating income was $30.4 million versus $27.0 million in the same period last year. Full-year 2020 GAAP operating income was $146.3 million, compared with $86.6 million for the full year 2019. For 2020, non-GAAP operating income was $149.7 million versus $125.8 million for the full year 2019. GAAP net income per share for the fourth quarter of 2020 was $0.46, compared with $0.70 per share in the fourth quarter of 2019. Non-GAAP net income per share was $0.84 for the fourth quarter of 2020, compared with $0.69 in the fourth quarter of 2019. GAAP net income per share for 2020 was $5.14, compared with $2.97 per share in 2019. Full-year non-GAAP 2020 net income per share was $4.14, compared with $3.62 for full-year 2019. iRobot's 2020 financial results were achieved over a 53-week period while the company's 2019 performance reflected a 52-week period. As of January 2, 2021, the company's cash, cash equivalents and short-term investments were $483.7 million, up from $357.3 million as of September 26, 2020, and $256.4 million as of December 28, 2019. Q420 and Recent Business Highlights In late January, iRobot announced the filing of a new patent infringement action against SharkNinja Operating LLC and its related entities at the International Trade Commission. iRobot introduced the Roomba i3 Series across the EMEA region in January 2021. The company launched its Root rt1 coding robot in Japan in January 2021. The company surpassed the 35 million robots sold milestone. During the fourth quarter of 2020, iRobot launched the Roomba Combo, a new floor cleaning robot that combines vacuuming and mopping at an affordable price, in certain European countries. During the fourth quarter of 2020, iRobot commenced small-scale pilots for new commercial services. The company made substantial progress in expanding its community of engaged, connected customers who have opted-in to its digital communications. At the end of 2020, iRobot supported approximately 9.7 million connected customers, an increase of over 80% since the end of 2019. Roomba and Braava earned numerous accolades during the fourth quarter as best consumer robotic floor cleaning products, including citations and awards in The Wall Street Journal, Reviewed.com, Tech Hive, Homes and Gardens, Which?, El Pais, Kaden Hihyo and MONOQLO. Financial Expectations iRobot is providing GAAP and non-GAAP financial expectations for the fiscal year endingJanuary 1, 2022. A detailed reconciliation between the company's GAAP and non-GAAP expectations is included in the attached financial tables. Fiscal Year 2021: Metric GAAP Adjustments Non-GAAP Revenue $1.635 - $1.675 billion $1.635 - $1.675 billion Gross Profit $662 - $692 million ~$3 million $665 - $695 million Operating Income $69 - $79 million ~$41 million $110 - $120 million Earnings Per Share $1.85 - $2.10 ~$1.15 $3.00 - $3.25 Fourth-Quarter and Full-Year 2020 Results Conference Call iRobot will host a conference call tomorrow at 8:30 a.m. ET to discuss its fourth-quarter and full-year 2020 financial results, major business developments and its outlook for fiscal year 2021 financial performance. Pertinent conference call details include: Date: Thursday, February 11 Time: 8:30 a.m. ET Call-In Number: 213-358-0894 Conference ID: 8336358 A live webcast of the conference call, along with the conference call prepared remarks, will be accessible on the event section of the company's website at https://investor.irobot.com/events/event-details/q4-2020-irobot-corp-financial-results-conference-call. An archived version of the broadcast will be available on the same website shortly after the conclusion of the live event. A replay of the telephone conference call will be available through February 18, and can be accessed by dialing 404-537-3406, passcode 8336358. About iRobot Corp. iRobot, the leading global consumer robot company, designs and builds robots that empower people to do more both inside and outside of the home. iRobot created the home robot cleaning category with the introduction of its Roomba Robot Vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 30 million robots worldwide. iRobot's product line, including the Roomba and the Braava family of mopping robots, feature proprietary technologies and advanced concepts in cleaning, mapping and navigation. iRobot engineers are building an ecosystem of robots and technologies to enable the smart home. For more information about iRobot, please visit www.irobot.com. For iRobot Investors Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to, among other things, iRobot Corp.'s expectations regarding: future financial performance, including revenue growth in 2021 and 2022, increased incremental costs in 2021, and profit margin expansion and EPS growth in 2022; the impact of tariffs; the impact of our supply chain and R&D initiatives; and anticipated revenue, gross profit, operating income and earnings per share for the fiscal year ending January 1, 2022. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: our ability to operate in an emerging market; the financial strength of our customers and retailers; the impact of tariffs on goods imported into the United States; general economic conditions; market acceptance of and adoption of our products; and competition. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. iRobot Corp. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For additional disclosure regarding these and other risks faced by iRobot Corp., see the disclosure contained in our public filings with the Securities and Exchange Commission. iRobot Corporation Consolidated Statements of Income (in thousands, except per share amounts) (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 Revenue $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 Cost of revenue: Cost of product revenue 329,181 254,970 758,241 658,362 Amortization of acquired intangible assets 225 2,438 1,920 11,721 Total cost of revenue 329,406 257,408 760,161 670,083 Gross profit 215,421 169,370 670,229 543,927 Operating expenses: Research and development 44,741 37,287 156,670 141,607 Selling and marketing 129,331 94,046 265,475 231,548 General and administrative 25,851 21,232 100,770 83,103 Amortization of acquired intangible assets 228 255 992 1,051 Total operating expenses 200,151 152,820 523,907 457,309 Operating income 15,270 16,550 146,322 86,618 Other (expense) income, net (244) 8,502 41,593 12,215 Income before income taxes 15,026 25,052 187,915 98,833 Income tax expense 1,691 5,011 40,847 13,533 Net income $ 13,335 $ 20,041 $ 147,068 $ 85,300 Net income per share: Basic $ 0.47 $ 0.71 $ 5.23 $ 3.04 Diluted $ 0.46 $ 0.70 $ 5.14 $ 2.97 Number of shares used in per share calculations: Basic 28,148 28,300 28,101 28,097 Diluted 28,763 28,563 28,618 28,735 Stock-based compensation included in above figures: Cost of revenue $ 362 $ 366 $ 1,511 $ 1,486 Research and development 3,154 2,557 10,655 9,186 Selling and marketing 1,101 857 3,700 3,323 General and administrative 4,454 1,221 14,109 9,749 Total $ 9,071 $ 5,001 $ 29,975 $ 23,744 iRobot Corporation Condensed Consolidated Balance Sheets (unaudited, in thousands) January 2, 2021 December 28, 2019 Assets Cash and cash equivalents $ 432,635 $ 239,392 Short term investments 51,081 17,032 Accounts receivable, net 170,526 146,161 Inventory 181,756 157,347 Other current assets 45,223 34,285 Total current assets 881,221 594,217 Property and equipment, net 76,584 75,988 Operating lease right-of-use assets 43,682 47,478 Deferred tax assets 33,404 41,791 Goodwill 125,872 118,732 Intangible assets, net 9,902 12,352 Other assets 19,063 30,195 Total assets $ 1,189,728 $ 920,753 Liabilities and stockholders' equity Accounts payable $ 165,779 $ 116,185 Accrued expenses 131,388 81,768 Deferred revenue and customer advances 10,400 4,549 Total current liabilities 307,567 202,502 Operating lease liabilities 50,485 54,928 Deferred tax liabilities 705 912 Other long-term liabilities 26,537 10,342 Total long-term liabilities 77,727 66,182 Total liabilities 385,294 268,684 Stockholders' equity 804,434 652,069 Total liabilities and stockholders' equity $ 1,189,728 $ 920,753 iRobot Corporation Consolidated Statements of Cash Flows (unaudited, in thousands) For the twelve months ended January 2, 2021 December 28, 2019 Cash flows from operating activities: Net income $ 147,068 $ 85,300 Adjustments to reconcile net income to net cash provided by operating activities, net of the effects of acquisition: Depreciation and amortization 34,762 37,159 Gain on equity investment (43,817) (8,439) Stock-based compensation 29,975 23,744 Deferred income taxes, net 13,837 (11,118) Other 6,467 7,267 Changes in operating assets and liabilities (use) source Accounts receivable (21,893) 13,064 Inventory (24,535) 7,307 Other assets (15,804) (3,310) Accounts payable 48,699 (20,536) Accrued expenses and other liabilities 57,289 (386) Net cash provided by operating activities 232,048 130,052 Cash flows from investing activities: Additions of property and equipment (31,599) (35,337) Change in other assets (4,150) (5,436) Proceeds from sale of equity investment - 9,787 Cash paid for business acquisition, net of cash acquired - (2,817) Sales and maturities of investments 13,500 12,880 Net cash used in investing activities (22,249) (20,923) Cash flows from financing activities: Proceeds from employee stock plans 5,584 7,147 Income tax withholding payment associated with restricted stock vesting (1,845) (7,277) Stock repurchases (25,000) - Net cash used in financing activities (21,261) (130) Effect of exchange rate changes on cash and cash equivalents 4,705 20 Net increase in cash and cash equivalents 193,243 109,019 Cash and cash equivalents, at beginning of period 239,392 130,373 Cash and cash equivalents, at end of period $ 432,635 $ 239,392 iRobot Corporation Supplemental Information (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 Revenue by Geography: * Domestic $ 316,259 $ 247,152 $ 744,648 $ 603,618 International 228,568 179,626 685,742 610,392 Total $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 Units Shipped * Vacuum 1,952 1,730 4,859 4,403 Mopping 241 179 635 586 Total 2,193 1,909 5,494 4,989 Revenue by Product Category ** Vacuum*** $ 484 $ 388 $ 1,274 $ 1,103 Mopping*** 61 39 157 111 Total $ 545 $ 427 $ 1,430 $ 1,214 Average gross selling prices for robot units $ 327 $ 317 $ 318 $ 310 Section 301 tariff costs * $ - $ 21,896 $ - $ 37,862 Section 301 tariff impact on gross and operating margin - % (5.1)% - % (3.1)% Headcount 1,209 1,128 * in thousands ** in millions *** includes accessory revenue Certain numbers may not total due to rounding iRobot Corporation Explanation of Non-GAAP Measures In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures. Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated. Amortization of acquired intangible assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance. Tariff Refunds: iRobot was granted a Section 301 List 3 Tariff Exclusion in April 2020, which temporarily eliminates tariffs on the Company's products imported from China until December 31, 2020 and entitles the Company to a refund of all related tariffs previously paid since September 2018. We exclude the refunds for tariffs paid in 2018 and 2019 from our 2020 second-quarter and year-to-date non-GAAP measures because those tariff refunds associated with tariff costs incurred in the past have no impact to our current period earnings. Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures. It also includes business combination adjustments including adjustments after the measurement period has ended. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance. Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies. IP Litigation Expense, Net: IP litigation expense, net relates to legal costs incurred to litigate patent, trademark, copyright and false advertising infringements, or to oppose or defend against interparty actions related to intellectual property. Any settlement payment or proceeds resulting from these infringements are included or netted against the costs. We exclude these costs from our non-GAAP measures as we do not believe these costs have a direct correlation to the operations of our business and may vary in size depending on the timing and results of such litigations and settlements. Gain/Loss on Strategic Investments:Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance. Restructuring and Other: Restructuring charges are related to one-time actions associated with workforce reductions, including severance costs, certain professional fees and other costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude this item from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business. Income tax adjustments:Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We reassess the need for any valuation allowance recorded based on the non-GAAP profitability and have eliminated the effect of the valuation allowance recorded in the U.S. jurisdiction. We also exclude certain tax items that are not reflective of income tax expense incurred as a result of current period earnings. These certain tax items include, among other non-recurring tax items, impacts from the Tax Cuts and Jobs Act of 2017 and stock-based compensation windfalls/shortfalls. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors' consistent earnings comparison between periods. iRobot Corporation Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals (in thousands, except per share amounts) (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 GAAP Revenue $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 GAAP Gross Profit $ 215,421 $ 169,370 $ 670,229 $ 543,927 Amortization of acquired intangible assets 225 2,438 1,920 11,721 Stock-based compensation 362 366 1,511 1,486 Tariff refunds 3,531 - (36,486) - Non-GAAP Gross Profit $ 219,539 $ 172,174 $ 637,174 $ 557,134 Non-GAAP Gross Margin 40.3% 40.3% 44.5% 45.9% GAAP Operating Expenses $ 200,151 $ 152,820 $ 523,907 $ 457,309 Amortization of acquired intangible assets (228) (255) (992) (1,051) Stock-based compensation (8,709) (4,635) (28,464) (22,258) Net merger, acquisition and divestiture (expense) income - (138) 566 (466) IP litigation expense, net (2,084) (2,582) (5,444) (2,218) Restructuring and other (10) - (2,073) - Non-GAAP Operating Expenses $ 189,120 $ 145,210 $ 487,500 $ 431,316 Non-GAAP Operating Expenses as a % of Non-GAAP Revenue 34.7% 34.0% 34.1% 35.5% GAAP Operating Income $ 15,270 $ 16,550 $ 146,322 $ 86,618 Amortization of acquired intangible assets 453 2,693 2,912 12,772 Stock-based compensation 9,071 5,001 29,975 23,744 Tariff refunds 3,531 - (36,486) - Net merger, acquisition and divestiture expense (income) - 138 (566) 466 IP litigation expense, net 2,084 2,582 5,444 2,218 Restructuring and other 10 - 2,073 - Non-GAAP Operating Income $ 30,419 $ 26,964 $ 149,674 $ 125,818 Non-GAAP Operating Margin 5.6% 6.3% 10.5% 10.4% GAAP Income Tax Expense $ 1,691 $ 5,011 $ 40,847 $ 13,533 Tax effect of non-GAAP adjustments 3,826 1,159 (12,016) 4,648 Other tax adjustments 253 1,267 (635) 6,928 Non-GAAP Income Tax Expense $ 5,770 $ 7,437 $ 28,196 $ 25,109 GAAP Net Income $ 13,335 $ 20,041 $ 147,068 $ 85,300 Amortization of acquired intangible assets 453 2,693 2,912 12,772 Stock-based compensation 9,071 5,001 29,975 23,744 Tariff refunds 3,531 - (36,486) - Net merger, acquisition and divestiture expense (income) - 138 (1,241) 466 IP litigation expense, net 2,084 2,582 5,444 2,218 Restructuring and other 10 - 2,073 - Gain on strategic investments (250) (8,332) (43,817) (8,904) Income tax effect (4,079) (2,426) 12,651 (11,576) Non-GAAP Net Income $ 24,155 $ 19,697 $ 118,579 $ 104,020 GAAP Net Income Per Diluted Share $ 0.46 $ 0.70 $ 5.14 $ 2.97 Amortization of acquired intangible assets 0.02 0.09 0.10 0.44 Stock-based compensation 0.32 0.18 1.05 0.83 Tariff refunds 0.12 - (1.28) - Net merger, acquisition and divestiture expense (income) - - (0.04) 0.01 IP litigation expense, net 0.07 0.09 0.19 0.08 Restructuring and other - - 0.07 - Gain on strategic investments (0.01) (0.29) (1.53) (0.31) Income tax effect (0.14) (0.08) 0.44 (0.40) Non-GAAP Net Income Per Diluted Share $ 0.84 $ 0.69 $ 4.14 $ 3.62 Number of shares used in diluted per share calculation 28,763 28,563 28,618 28,735 Section 301 Tariff Costs Section 301 tariff costs $ - $ 21,896 $ - $ 37,862 Impact of Section 301 tariff costs to gross and operating margin (GAAP & non-GAAP) - % (5.1)% - % (3.1)% Impact of Section 301 tariff costs to net (loss) income per diluted share (GAAP & non-GAAP) $ - $ (0.77) $ - $ (1.32) Supplemental Information Days sales outstanding 31 31 Days in inventory 55 56 iRobot Corporation Supplemental Reconciliation of Fiscal Year 2021 GAAP to Non-GAAP Guidance (unaudited) FY-21 GAAP Gross Profit $662 - $692 million Amortization of acquired intangible assets ~$1 million Stock-based compensation ~$2 million Total adjustments ~$3 million Non-GAAP Gross Profit $665 - $695 million FY-21 GAAP Operating Income $69 - $79 million Amortization of acquired intangible assets ~$1 million Stock-based compensation ~$32 million IP litigation expense, net ~$8 million Total adjustments ~$41 million Non-GAAP Operating Income $110 - $120 million FY-21 GAAP Net Income Per Diluted Share $1.85 - $2.10 Amortization of acquired intangible assets ~$0.03 Stock-based compensation ~$1.10 IP litigation expense, net ~ $0.27 Income tax effect ~($0.25) Total adjustments ~$1.15 Non-GAAP Net Income Per Diluted Share $3.00 - $3.25 Number of shares used in diluted per share calculations ~29.1 million SOURCE iRobot Corporation Related Links http://www.irobot.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

iRobot Reports Fourth-Quarter and Full-Year 2020 Financial Results. 28% Revenue Growth Drives Better-than-Expected Operating Income and EPS.

BEDFORD, Mass., Feb. 10, 2021 /PRNewswire/ --iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the fourth quarter and full year ended January 2, 2021. "iRobot delivered a strong finish to 2020 with revenue, operating income and EPS that surpassed the plans that we outlined at the end of October," said Colin Angle, chairman and chief executive officer of iRobot. "Solid demand combined with excellent collaboration and execution among our sales, marketing and operations teams and our broader supply chain enabled us to grow fourth-quarter revenue in excess of 25% in each major geographic region. We converted this top-line performance into increased operating income and EPS." Angle continued, "Maintaining a clean home has taken on increasing importance while the pandemic forces people to stay at home. It is gratifying to see that our efforts to differentiate our floor cleaning robots with innovative features and functionality that support the fluid lifestyles of their owners are resonating in the marketplace. To that end, we generated significant growth with our premium floor cleaning robots throughout the year. We were also pleased with the substantial expansion of our connected customer base, which grew over 80% in 2020." Angle concluded, "Our outlook for 2021 reflects our confidence that the growth drivers for our business will remain largely intact over the coming quarters. We believe that our success in continuing to drive solid top-line expansion in 2021 will also enable us to fund investment into key areas of our business and help mitigate the impact of tariffs on our 2021 profitability. As we move forward, we believe that our success in scaling Malaysia volumes, advancing key R&D initiatives and building stronger, more enduring relationships with millions of connected customers will further strengthen our business, enhance our ability to drive overall top-line growth and accelerate our profitability over the long term. As we continue to execute on our plans, we are excited about our prospects to sustain solid top-line growth into 2022 and convert that expansion into 2022 profit margins and EPS that exceed 2020 levels." Financial Performance Highlights Revenue for the fourth quarter of 2020 grew 28% to $544.8 million over $426.8 million for the fourth quarter of 2019. Full-year 2020 revenue was $1,430.4 million, an increase of 18% over $1,214.0 million in 2019. Fourth-quarter 2020 revenue growth was highlighted by 28% growth in the U.S. and 27% international growth. Growth outside of the U.S. was led by 39% expansion in Japan and a 26% increase in EMEA. Full-year 2020 revenue grew 23% in the U.S., 20% in Japan and 8% in EMEA. We estimate that iRobot's fourth-quarter 2020 revenue to support e-commerce, which spans the company's own website and app, dedicated e-commerce websites and the online arms of traditional retailers, grew by over 70% over the fourth quarter of 2019, and represented approximately 60% of fourth-quarter 2020 revenue. For the full year 2020, we estimate that revenue to support e-commerce grew approximately 55% and represented 60% of annual revenue. Direct-to-consumer revenue of $68 million in the fourth quarter of 2020 grew 117% from the prior year's fourth quarter. 2020 direct-to-consumer revenue of $151 million grew 114% over 2019. The company enjoyed strong growth in its premium robots for both the quarter and full year. Premium robot revenue grew 55% in the fourth quarter of 2020 and nearly 50% for the full year. Premium robots are defined as floor cleaning robots with an MSRP of $500 and higher (the Roomba i3+, 900 Series, i7 Series and s9 Series, and the Braava Jet m Series). Fourth-quarter 2020 GAAP operating income was $15.3 million, compared with $16.6 million in the fourth quarter of 2019. Fourth-quarter 2020 non-GAAP operating income was $30.4 million versus $27.0 million in the same period last year. Full-year 2020 GAAP operating income was $146.3 million, compared with $86.6 million for the full year 2019. For 2020, non-GAAP operating income was $149.7 million versus $125.8 million for the full year 2019. GAAP net income per share for the fourth quarter of 2020 was $0.46, compared with $0.70 per share in the fourth quarter of 2019. Non-GAAP net income per share was $0.84 for the fourth quarter of 2020, compared with $0.69 in the fourth quarter of 2019. GAAP net income per share for 2020 was $5.14, compared with $2.97 per share in 2019. Full-year non-GAAP 2020 net income per share was $4.14, compared with $3.62 for full-year 2019. iRobot's 2020 financial results were achieved over a 53-week period while the company's 2019 performance reflected a 52-week period. As of January 2, 2021, the company's cash, cash equivalents and short-term investments were $483.7 million, up from $357.3 million as of September 26, 2020, and $256.4 million as of December 28, 2019. Q420 and Recent Business Highlights In late January, iRobot announced the filing of a new patent infringement action against SharkNinja Operating LLC and its related entities at the International Trade Commission. iRobot introduced the Roomba i3 Series across the EMEA region in January 2021. The company launched its Root rt1 coding robot in Japan in January 2021. The company surpassed the 35 million robots sold milestone. During the fourth quarter of 2020, iRobot launched the Roomba Combo, a new floor cleaning robot that combines vacuuming and mopping at an affordable price, in certain European countries. During the fourth quarter of 2020, iRobot commenced small-scale pilots for new commercial services. The company made substantial progress in expanding its community of engaged, connected customers who have opted-in to its digital communications. At the end of 2020, iRobot supported approximately 9.7 million connected customers, an increase of over 80% since the end of 2019. Roomba and Braava earned numerous accolades during the fourth quarter as best consumer robotic floor cleaning products, including citations and awards in The Wall Street Journal, Reviewed.com, Tech Hive, Homes and Gardens, Which?, El Pais, Kaden Hihyo and MONOQLO. Financial Expectations iRobot is providing GAAP and non-GAAP financial expectations for the fiscal year endingJanuary 1, 2022. A detailed reconciliation between the company's GAAP and non-GAAP expectations is included in the attached financial tables. Fiscal Year 2021: Metric GAAP Adjustments Non-GAAP Revenue $1.635 - $1.675 billion $1.635 - $1.675 billion Gross Profit $662 - $692 million ~$3 million $665 - $695 million Operating Income $69 - $79 million ~$41 million $110 - $120 million Earnings Per Share $1.85 - $2.10 ~$1.15 $3.00 - $3.25 Fourth-Quarter and Full-Year 2020 Results Conference Call iRobot will host a conference call tomorrow at 8:30 a.m. ET to discuss its fourth-quarter and full-year 2020 financial results, major business developments and its outlook for fiscal year 2021 financial performance. Pertinent conference call details include: Date: Thursday, February 11 Time: 8:30 a.m. ET Call-In Number: 213-358-0894 Conference ID: 8336358 A live webcast of the conference call, along with the conference call prepared remarks, will be accessible on the event section of the company's website at https://investor.irobot.com/events/event-details/q4-2020-irobot-corp-financial-results-conference-call. An archived version of the broadcast will be available on the same website shortly after the conclusion of the live event. A replay of the telephone conference call will be available through February 18, and can be accessed by dialing 404-537-3406, passcode 8336358. About iRobot Corp. iRobot, the leading global consumer robot company, designs and builds robots that empower people to do more both inside and outside of the home. iRobot created the home robot cleaning category with the introduction of its Roomba Robot Vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 30 million robots worldwide. iRobot's product line, including the Roomba and the Braava family of mopping robots, feature proprietary technologies and advanced concepts in cleaning, mapping and navigation. iRobot engineers are building an ecosystem of robots and technologies to enable the smart home. For more information about iRobot, please visit www.irobot.com. For iRobot Investors Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to, among other things, iRobot Corp.'s expectations regarding: future financial performance, including revenue growth in 2021 and 2022, increased incremental costs in 2021, and profit margin expansion and EPS growth in 2022; the impact of tariffs; the impact of our supply chain and R&D initiatives; and anticipated revenue, gross profit, operating income and earnings per share for the fiscal year ending January 1, 2022. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: our ability to operate in an emerging market; the financial strength of our customers and retailers; the impact of tariffs on goods imported into the United States; general economic conditions; market acceptance of and adoption of our products; and competition. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. iRobot Corp. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For additional disclosure regarding these and other risks faced by iRobot Corp., see the disclosure contained in our public filings with the Securities and Exchange Commission. iRobot Corporation Consolidated Statements of Income (in thousands, except per share amounts) (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 Revenue $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 Cost of revenue: Cost of product revenue 329,181 254,970 758,241 658,362 Amortization of acquired intangible assets 225 2,438 1,920 11,721 Total cost of revenue 329,406 257,408 760,161 670,083 Gross profit 215,421 169,370 670,229 543,927 Operating expenses: Research and development 44,741 37,287 156,670 141,607 Selling and marketing 129,331 94,046 265,475 231,548 General and administrative 25,851 21,232 100,770 83,103 Amortization of acquired intangible assets 228 255 992 1,051 Total operating expenses 200,151 152,820 523,907 457,309 Operating income 15,270 16,550 146,322 86,618 Other (expense) income, net (244) 8,502 41,593 12,215 Income before income taxes 15,026 25,052 187,915 98,833 Income tax expense 1,691 5,011 40,847 13,533 Net income $ 13,335 $ 20,041 $ 147,068 $ 85,300 Net income per share: Basic $ 0.47 $ 0.71 $ 5.23 $ 3.04 Diluted $ 0.46 $ 0.70 $ 5.14 $ 2.97 Number of shares used in per share calculations: Basic 28,148 28,300 28,101 28,097 Diluted 28,763 28,563 28,618 28,735 Stock-based compensation included in above figures: Cost of revenue $ 362 $ 366 $ 1,511 $ 1,486 Research and development 3,154 2,557 10,655 9,186 Selling and marketing 1,101 857 3,700 3,323 General and administrative 4,454 1,221 14,109 9,749 Total $ 9,071 $ 5,001 $ 29,975 $ 23,744 iRobot Corporation Condensed Consolidated Balance Sheets (unaudited, in thousands) January 2, 2021 December 28, 2019 Assets Cash and cash equivalents $ 432,635 $ 239,392 Short term investments 51,081 17,032 Accounts receivable, net 170,526 146,161 Inventory 181,756 157,347 Other current assets 45,223 34,285 Total current assets 881,221 594,217 Property and equipment, net 76,584 75,988 Operating lease right-of-use assets 43,682 47,478 Deferred tax assets 33,404 41,791 Goodwill 125,872 118,732 Intangible assets, net 9,902 12,352 Other assets 19,063 30,195 Total assets $ 1,189,728 $ 920,753 Liabilities and stockholders' equity Accounts payable $ 165,779 $ 116,185 Accrued expenses 131,388 81,768 Deferred revenue and customer advances 10,400 4,549 Total current liabilities 307,567 202,502 Operating lease liabilities 50,485 54,928 Deferred tax liabilities 705 912 Other long-term liabilities 26,537 10,342 Total long-term liabilities 77,727 66,182 Total liabilities 385,294 268,684 Stockholders' equity 804,434 652,069 Total liabilities and stockholders' equity $ 1,189,728 $ 920,753 iRobot Corporation Consolidated Statements of Cash Flows (unaudited, in thousands) For the twelve months ended January 2, 2021 December 28, 2019 Cash flows from operating activities: Net income $ 147,068 $ 85,300 Adjustments to reconcile net income to net cash provided by operating activities, net of the effects of acquisition: Depreciation and amortization 34,762 37,159 Gain on equity investment (43,817) (8,439) Stock-based compensation 29,975 23,744 Deferred income taxes, net 13,837 (11,118) Other 6,467 7,267 Changes in operating assets and liabilities (use) source Accounts receivable (21,893) 13,064 Inventory (24,535) 7,307 Other assets (15,804) (3,310) Accounts payable 48,699 (20,536) Accrued expenses and other liabilities 57,289 (386) Net cash provided by operating activities 232,048 130,052 Cash flows from investing activities: Additions of property and equipment (31,599) (35,337) Change in other assets (4,150) (5,436) Proceeds from sale of equity investment - 9,787 Cash paid for business acquisition, net of cash acquired - (2,817) Sales and maturities of investments 13,500 12,880 Net cash used in investing activities (22,249) (20,923) Cash flows from financing activities: Proceeds from employee stock plans 5,584 7,147 Income tax withholding payment associated with restricted stock vesting (1,845) (7,277) Stock repurchases (25,000) - Net cash used in financing activities (21,261) (130) Effect of exchange rate changes on cash and cash equivalents 4,705 20 Net increase in cash and cash equivalents 193,243 109,019 Cash and cash equivalents, at beginning of period 239,392 130,373 Cash and cash equivalents, at end of period $ 432,635 $ 239,392 iRobot Corporation Supplemental Information (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 Revenue by Geography: * Domestic $ 316,259 $ 247,152 $ 744,648 $ 603,618 International 228,568 179,626 685,742 610,392 Total $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 Units Shipped * Vacuum 1,952 1,730 4,859 4,403 Mopping 241 179 635 586 Total 2,193 1,909 5,494 4,989 Revenue by Product Category ** Vacuum*** $ 484 $ 388 $ 1,274 $ 1,103 Mopping*** 61 39 157 111 Total $ 545 $ 427 $ 1,430 $ 1,214 Average gross selling prices for robot units $ 327 $ 317 $ 318 $ 310 Section 301 tariff costs * $ - $ 21,896 $ - $ 37,862 Section 301 tariff impact on gross and operating margin - % (5.1)% - % (3.1)% Headcount 1,209 1,128 * in thousands ** in millions *** includes accessory revenue Certain numbers may not total due to rounding iRobot Corporation Explanation of Non-GAAP Measures In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures. Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated. Amortization of acquired intangible assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance. Tariff Refunds: iRobot was granted a Section 301 List 3 Tariff Exclusion in April 2020, which temporarily eliminates tariffs on the Company's products imported from China until December 31, 2020 and entitles the Company to a refund of all related tariffs previously paid since September 2018. We exclude the refunds for tariffs paid in 2018 and 2019 from our 2020 second-quarter and year-to-date non-GAAP measures because those tariff refunds associated with tariff costs incurred in the past have no impact to our current period earnings. Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures. It also includes business combination adjustments including adjustments after the measurement period has ended. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance. Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies. IP Litigation Expense, Net: IP litigation expense, net relates to legal costs incurred to litigate patent, trademark, copyright and false advertising infringements, or to oppose or defend against interparty actions related to intellectual property. Any settlement payment or proceeds resulting from these infringements are included or netted against the costs. We exclude these costs from our non-GAAP measures as we do not believe these costs have a direct correlation to the operations of our business and may vary in size depending on the timing and results of such litigations and settlements. Gain/Loss on Strategic Investments:Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance. Restructuring and Other: Restructuring charges are related to one-time actions associated with workforce reductions, including severance costs, certain professional fees and other costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude this item from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business. Income tax adjustments:Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We reassess the need for any valuation allowance recorded based on the non-GAAP profitability and have eliminated the effect of the valuation allowance recorded in the U.S. jurisdiction. We also exclude certain tax items that are not reflective of income tax expense incurred as a result of current period earnings. These certain tax items include, among other non-recurring tax items, impacts from the Tax Cuts and Jobs Act of 2017 and stock-based compensation windfalls/shortfalls. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors' consistent earnings comparison between periods. iRobot Corporation Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals (in thousands, except per share amounts) (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 GAAP Revenue $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 GAAP Gross Profit $ 215,421 $ 169,370 $ 670,229 $ 543,927 Amortization of acquired intangible assets 225 2,438 1,920 11,721 Stock-based compensation 362 366 1,511 1,486 Tariff refunds 3,531 - (36,486) - Non-GAAP Gross Profit $ 219,539 $ 172,174 $ 637,174 $ 557,134 Non-GAAP Gross Margin 40.3% 40.3% 44.5% 45.9% GAAP Operating Expenses $ 200,151 $ 152,820 $ 523,907 $ 457,309 Amortization of acquired intangible assets (228) (255) (992) (1,051) Stock-based compensation (8,709) (4,635) (28,464) (22,258) Net merger, acquisition and divestiture (expense) income - (138) 566 (466) IP litigation expense, net (2,084) (2,582) (5,444) (2,218) Restructuring and other (10) - (2,073) - Non-GAAP Operating Expenses $ 189,120 $ 145,210 $ 487,500 $ 431,316 Non-GAAP Operating Expenses as a % of Non-GAAP Revenue 34.7% 34.0% 34.1% 35.5% GAAP Operating Income $ 15,270 $ 16,550 $ 146,322 $ 86,618 Amortization of acquired intangible assets 453 2,693 2,912 12,772 Stock-based compensation 9,071 5,001 29,975 23,744 Tariff refunds 3,531 - (36,486) - Net merger, acquisition and divestiture expense (income) - 138 (566) 466 IP litigation expense, net 2,084 2,582 5,444 2,218 Restructuring and other 10 - 2,073 - Non-GAAP Operating Income $ 30,419 $ 26,964 $ 149,674 $ 125,818 Non-GAAP Operating Margin 5.6% 6.3% 10.5% 10.4% GAAP Income Tax Expense $ 1,691 $ 5,011 $ 40,847 $ 13,533 Tax effect of non-GAAP adjustments 3,826 1,159 (12,016) 4,648 Other tax adjustments 253 1,267 (635) 6,928 Non-GAAP Income Tax Expense $ 5,770 $ 7,437 $ 28,196 $ 25,109 GAAP Net Income $ 13,335 $ 20,041 $ 147,068 $ 85,300 Amortization of acquired intangible assets 453 2,693 2,912 12,772 Stock-based compensation 9,071 5,001 29,975 23,744 Tariff refunds 3,531 - (36,486) - Net merger, acquisition and divestiture expense (income) - 138 (1,241) 466 IP litigation expense, net 2,084 2,582 5,444 2,218 Restructuring and other 10 - 2,073 - Gain on strategic investments (250) (8,332) (43,817) (8,904) Income tax effect (4,079) (2,426) 12,651 (11,576) Non-GAAP Net Income $ 24,155 $ 19,697 $ 118,579 $ 104,020 GAAP Net Income Per Diluted Share $ 0.46 $ 0.70 $ 5.14 $ 2.97 Amortization of acquired intangible assets 0.02 0.09 0.10 0.44 Stock-based compensation 0.32 0.18 1.05 0.83 Tariff refunds 0.12 - (1.28) - Net merger, acquisition and divestiture expense (income) - - (0.04) 0.01 IP litigation expense, net 0.07 0.09 0.19 0.08 Restructuring and other - - 0.07 - Gain on strategic investments (0.01) (0.29) (1.53) (0.31) Income tax effect (0.14) (0.08) 0.44 (0.40) Non-GAAP Net Income Per Diluted Share $ 0.84 $ 0.69 $ 4.14 $ 3.62 Number of shares used in diluted per share calculation 28,763 28,563 28,618 28,735 Section 301 Tariff Costs Section 301 tariff costs $ - $ 21,896 $ - $ 37,862 Impact of Section 301 tariff costs to gross and operating margin (GAAP & non-GAAP) - % (5.1)% - % (3.1)% Impact of Section 301 tariff costs to net (loss) income per diluted share (GAAP & non-GAAP) $ - $ (0.77) $ - $ (1.32) Supplemental Information Days sales outstanding 31 31 Days in inventory 55 56 iRobot Corporation Supplemental Reconciliation of Fiscal Year 2021 GAAP to Non-GAAP Guidance (unaudited) FY-21 GAAP Gross Profit $662 - $692 million Amortization of acquired intangible assets ~$1 million Stock-based compensation ~$2 million Total adjustments ~$3 million Non-GAAP Gross Profit $665 - $695 million FY-21 GAAP Operating Income $69 - $79 million Amortization of acquired intangible assets ~$1 million Stock-based compensation ~$32 million IP litigation expense, net ~$8 million Total adjustments ~$41 million Non-GAAP Operating Income $110 - $120 million FY-21 GAAP Net Income Per Diluted Share $1.85 - $2.10 Amortization of acquired intangible assets ~$0.03 Stock-based compensation ~$1.10 IP litigation expense, net ~ $0.27 Income tax effect ~($0.25) Total adjustments ~$1.15 Non-GAAP Net Income Per Diluted Share $3.00 - $3.25 Number of shares used in diluted per share calculations ~29.1 million SOURCE iRobot Corporation Related Links http://www.irobot.com

iRobot Reports Fourth-Quarter and Full-Year 2020 Financial Results 28% Revenue Growth Drives Better-than-Expected Operating Income and EPS

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BEDFORD, Mass., Feb. 10, 2021 /PRNewswire/ --iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the fourth quarter and full year ended January 2, 2021. "iRobot delivered a strong finish to 2020 with revenue, operating income and EPS that surpassed the plans that we outlined at the end of October," said Colin Angle, chairman and chief executive officer of iRobot. "Solid demand combined with excellent collaboration and execution among our sales, marketing and operations teams and our broader supply chain enabled us to grow fourth-quarter revenue in excess of 25% in each major geographic region. We converted this top-line performance into increased operating income and EPS." Angle continued, "Maintaining a clean home has taken on increasing importance while the pandemic forces people to stay at home. It is gratifying to see that our efforts to differentiate our floor cleaning robots with innovative features and functionality that support the fluid lifestyles of their owners are resonating in the marketplace. To that end, we generated significant growth with our premium floor cleaning robots throughout the year. We were also pleased with the substantial expansion of our connected customer base, which grew over 80% in 2020." Angle concluded, "Our outlook for 2021 reflects our confidence that the growth drivers for our business will remain largely intact over the coming quarters. We believe that our success in continuing to drive solid top-line expansion in 2021 will also enable us to fund investment into key areas of our business and help mitigate the impact of tariffs on our 2021 profitability. As we move forward, we believe that our success in scaling Malaysia volumes, advancing key R&D initiatives and building stronger, more enduring relationships with millions of connected customers will further strengthen our business, enhance our ability to drive overall top-line growth and accelerate our profitability over the long term. As we continue to execute on our plans, we are excited about our prospects to sustain solid top-line growth into 2022 and convert that expansion into 2022 profit margins and EPS that exceed 2020 levels." Financial Performance Highlights Revenue for the fourth quarter of 2020 grew 28% to $544.8 million over $426.8 million for the fourth quarter of 2019. Full-year 2020 revenue was $1,430.4 million, an increase of 18% over $1,214.0 million in 2019. Fourth-quarter 2020 revenue growth was highlighted by 28% growth in the U.S. and 27% international growth. Growth outside of the U.S. was led by 39% expansion in Japan and a 26% increase in EMEA. Full-year 2020 revenue grew 23% in the U.S., 20% in Japan and 8% in EMEA. We estimate that iRobot's fourth-quarter 2020 revenue to support e-commerce, which spans the company's own website and app, dedicated e-commerce websites and the online arms of traditional retailers, grew by over 70% over the fourth quarter of 2019, and represented approximately 60% of fourth-quarter 2020 revenue. For the full year 2020, we estimate that revenue to support e-commerce grew approximately 55% and represented 60% of annual revenue. Direct-to-consumer revenue of $68 million in the fourth quarter of 2020 grew 117% from the prior year's fourth quarter. 2020 direct-to-consumer revenue of $151 million grew 114% over 2019. The company enjoyed strong growth in its premium robots for both the quarter and full year. Premium robot revenue grew 55% in the fourth quarter of 2020 and nearly 50% for the full year. Premium robots are defined as floor cleaning robots with an MSRP of $500 and higher (the Roomba i3+, 900 Series, i7 Series and s9 Series, and the Braava Jet m Series). Fourth-quarter 2020 GAAP operating income was $15.3 million, compared with $16.6 million in the fourth quarter of 2019. Fourth-quarter 2020 non-GAAP operating income was $30.4 million versus $27.0 million in the same period last year. Full-year 2020 GAAP operating income was $146.3 million, compared with $86.6 million for the full year 2019. For 2020, non-GAAP operating income was $149.7 million versus $125.8 million for the full year 2019. GAAP net income per share for the fourth quarter of 2020 was $0.46, compared with $0.70 per share in the fourth quarter of 2019. Non-GAAP net income per share was $0.84 for the fourth quarter of 2020, compared with $0.69 in the fourth quarter of 2019. GAAP net income per share for 2020 was $5.14, compared with $2.97 per share in 2019. Full-year non-GAAP 2020 net income per share was $4.14, compared with $3.62 for full-year 2019. iRobot's 2020 financial results were achieved over a 53-week period while the company's 2019 performance reflected a 52-week period. As of January 2, 2021, the company's cash, cash equivalents and short-term investments were $483.7 million, up from $357.3 million as of September 26, 2020, and $256.4 million as of December 28, 2019. Q420 and Recent Business Highlights In late January, iRobot announced the filing of a new patent infringement action against SharkNinja Operating LLC and its related entities at the International Trade Commission. iRobot introduced the Roomba i3 Series across the EMEA region in January 2021. The company launched its Root rt1 coding robot in Japan in January 2021. The company surpassed the 35 million robots sold milestone. During the fourth quarter of 2020, iRobot launched the Roomba Combo, a new floor cleaning robot that combines vacuuming and mopping at an affordable price, in certain European countries. During the fourth quarter of 2020, iRobot commenced small-scale pilots for new commercial services. The company made substantial progress in expanding its community of engaged, connected customers who have opted-in to its digital communications. At the end of 2020, iRobot supported approximately 9.7 million connected customers, an increase of over 80% since the end of 2019. Roomba and Braava earned numerous accolades during the fourth quarter as best consumer robotic floor cleaning products, including citations and awards in The Wall Street Journal, Reviewed.com, Tech Hive, Homes and Gardens, Which?, El Pais, Kaden Hihyo and MONOQLO. Financial Expectations iRobot is providing GAAP and non-GAAP financial expectations for the fiscal year endingJanuary 1, 2022. A detailed reconciliation between the company's GAAP and non-GAAP expectations is included in the attached financial tables. Fiscal Year 2021: Metric GAAP Adjustments Non-GAAP Revenue $1.635 - $1.675 billion $1.635 - $1.675 billion Gross Profit $662 - $692 million ~$3 million $665 - $695 million Operating Income $69 - $79 million ~$41 million $110 - $120 million Earnings Per Share $1.85 - $2.10 ~$1.15 $3.00 - $3.25 Fourth-Quarter and Full-Year 2020 Results Conference Call iRobot will host a conference call tomorrow at 8:30 a.m. ET to discuss its fourth-quarter and full-year 2020 financial results, major business developments and its outlook for fiscal year 2021 financial performance. Pertinent conference call details include: Date: Thursday, February 11 Time: 8:30 a.m. ET Call-In Number: 213-358-0894 Conference ID: 8336358 A live webcast of the conference call, along with the conference call prepared remarks, will be accessible on the event section of the company's website at https://investor.irobot.com/events/event-details/q4-2020-irobot-corp-financial-results-conference-call. An archived version of the broadcast will be available on the same website shortly after the conclusion of the live event. A replay of the telephone conference call will be available through February 18, and can be accessed by dialing 404-537-3406, passcode 8336358. About iRobot Corp. iRobot, the leading global consumer robot company, designs and builds robots that empower people to do more both inside and outside of the home. iRobot created the home robot cleaning category with the introduction of its Roomba Robot Vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 30 million robots worldwide. iRobot's product line, including the Roomba and the Braava family of mopping robots, feature proprietary technologies and advanced concepts in cleaning, mapping and navigation. iRobot engineers are building an ecosystem of robots and technologies to enable the smart home. For more information about iRobot, please visit www.irobot.com. For iRobot Investors Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to, among other things, iRobot Corp.'s expectations regarding: future financial performance, including revenue growth in 2021 and 2022, increased incremental costs in 2021, and profit margin expansion and EPS growth in 2022; the impact of tariffs; the impact of our supply chain and R&D initiatives; and anticipated revenue, gross profit, operating income and earnings per share for the fiscal year ending January 1, 2022. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: our ability to operate in an emerging market; the financial strength of our customers and retailers; the impact of tariffs on goods imported into the United States; general economic conditions; market acceptance of and adoption of our products; and competition. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. iRobot Corp. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For additional disclosure regarding these and other risks faced by iRobot Corp., see the disclosure contained in our public filings with the Securities and Exchange Commission. iRobot Corporation Consolidated Statements of Income (in thousands, except per share amounts) (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 Revenue $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 Cost of revenue: Cost of product revenue 329,181 254,970 758,241 658,362 Amortization of acquired intangible assets 225 2,438 1,920 11,721 Total cost of revenue 329,406 257,408 760,161 670,083 Gross profit 215,421 169,370 670,229 543,927 Operating expenses: Research and development 44,741 37,287 156,670 141,607 Selling and marketing 129,331 94,046 265,475 231,548 General and administrative 25,851 21,232 100,770 83,103 Amortization of acquired intangible assets 228 255 992 1,051 Total operating expenses 200,151 152,820 523,907 457,309 Operating income 15,270 16,550 146,322 86,618 Other (expense) income, net (244) 8,502 41,593 12,215 Income before income taxes 15,026 25,052 187,915 98,833 Income tax expense 1,691 5,011 40,847 13,533 Net income $ 13,335 $ 20,041 $ 147,068 $ 85,300 Net income per share: Basic $ 0.47 $ 0.71 $ 5.23 $ 3.04 Diluted $ 0.46 $ 0.70 $ 5.14 $ 2.97 Number of shares used in per share calculations: Basic 28,148 28,300 28,101 28,097 Diluted 28,763 28,563 28,618 28,735 Stock-based compensation included in above figures: Cost of revenue $ 362 $ 366 $ 1,511 $ 1,486 Research and development 3,154 2,557 10,655 9,186 Selling and marketing 1,101 857 3,700 3,323 General and administrative 4,454 1,221 14,109 9,749 Total $ 9,071 $ 5,001 $ 29,975 $ 23,744 iRobot Corporation Condensed Consolidated Balance Sheets (unaudited, in thousands) January 2, 2021 December 28, 2019 Assets Cash and cash equivalents $ 432,635 $ 239,392 Short term investments 51,081 17,032 Accounts receivable, net 170,526 146,161 Inventory 181,756 157,347 Other current assets 45,223 34,285 Total current assets 881,221 594,217 Property and equipment, net 76,584 75,988 Operating lease right-of-use assets 43,682 47,478 Deferred tax assets 33,404 41,791 Goodwill 125,872 118,732 Intangible assets, net 9,902 12,352 Other assets 19,063 30,195 Total assets $ 1,189,728 $ 920,753 Liabilities and stockholders' equity Accounts payable $ 165,779 $ 116,185 Accrued expenses 131,388 81,768 Deferred revenue and customer advances 10,400 4,549 Total current liabilities 307,567 202,502 Operating lease liabilities 50,485 54,928 Deferred tax liabilities 705 912 Other long-term liabilities 26,537 10,342 Total long-term liabilities 77,727 66,182 Total liabilities 385,294 268,684 Stockholders' equity 804,434 652,069 Total liabilities and stockholders' equity $ 1,189,728 $ 920,753 iRobot Corporation Consolidated Statements of Cash Flows (unaudited, in thousands) For the twelve months ended January 2, 2021 December 28, 2019 Cash flows from operating activities: Net income $ 147,068 $ 85,300 Adjustments to reconcile net income to net cash provided by operating activities, net of the effects of acquisition: Depreciation and amortization 34,762 37,159 Gain on equity investment (43,817) (8,439) Stock-based compensation 29,975 23,744 Deferred income taxes, net 13,837 (11,118) Other 6,467 7,267 Changes in operating assets and liabilities (use) source Accounts receivable (21,893) 13,064 Inventory (24,535) 7,307 Other assets (15,804) (3,310) Accounts payable 48,699 (20,536) Accrued expenses and other liabilities 57,289 (386) Net cash provided by operating activities 232,048 130,052 Cash flows from investing activities: Additions of property and equipment (31,599) (35,337) Change in other assets (4,150) (5,436) Proceeds from sale of equity investment - 9,787 Cash paid for business acquisition, net of cash acquired - (2,817) Sales and maturities of investments 13,500 12,880 Net cash used in investing activities (22,249) (20,923) Cash flows from financing activities: Proceeds from employee stock plans 5,584 7,147 Income tax withholding payment associated with restricted stock vesting (1,845) (7,277) Stock repurchases (25,000) - Net cash used in financing activities (21,261) (130) Effect of exchange rate changes on cash and cash equivalents 4,705 20 Net increase in cash and cash equivalents 193,243 109,019 Cash and cash equivalents, at beginning of period 239,392 130,373 Cash and cash equivalents, at end of period $ 432,635 $ 239,392 iRobot Corporation Supplemental Information (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 Revenue by Geography: * Domestic $ 316,259 $ 247,152 $ 744,648 $ 603,618 International 228,568 179,626 685,742 610,392 Total $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 Units Shipped * Vacuum 1,952 1,730 4,859 4,403 Mopping 241 179 635 586 Total 2,193 1,909 5,494 4,989 Revenue by Product Category ** Vacuum*** $ 484 $ 388 $ 1,274 $ 1,103 Mopping*** 61 39 157 111 Total $ 545 $ 427 $ 1,430 $ 1,214 Average gross selling prices for robot units $ 327 $ 317 $ 318 $ 310 Section 301 tariff costs * $ - $ 21,896 $ - $ 37,862 Section 301 tariff impact on gross and operating margin - % (5.1)% - % (3.1)% Headcount 1,209 1,128 * in thousands ** in millions *** includes accessory revenue Certain numbers may not total due to rounding iRobot Corporation Explanation of Non-GAAP Measures In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures. Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated. Amortization of acquired intangible assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance. Tariff Refunds: iRobot was granted a Section 301 List 3 Tariff Exclusion in April 2020, which temporarily eliminates tariffs on the Company's products imported from China until December 31, 2020 and entitles the Company to a refund of all related tariffs previously paid since September 2018. We exclude the refunds for tariffs paid in 2018 and 2019 from our 2020 second-quarter and year-to-date non-GAAP measures because those tariff refunds associated with tariff costs incurred in the past have no impact to our current period earnings. Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures. It also includes business combination adjustments including adjustments after the measurement period has ended. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance. Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies. IP Litigation Expense, Net: IP litigation expense, net relates to legal costs incurred to litigate patent, trademark, copyright and false advertising infringements, or to oppose or defend against interparty actions related to intellectual property. Any settlement payment or proceeds resulting from these infringements are included or netted against the costs. We exclude these costs from our non-GAAP measures as we do not believe these costs have a direct correlation to the operations of our business and may vary in size depending on the timing and results of such litigations and settlements. Gain/Loss on Strategic Investments:Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance. Restructuring and Other: Restructuring charges are related to one-time actions associated with workforce reductions, including severance costs, certain professional fees and other costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude this item from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business. Income tax adjustments:Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We reassess the need for any valuation allowance recorded based on the non-GAAP profitability and have eliminated the effect of the valuation allowance recorded in the U.S. jurisdiction. We also exclude certain tax items that are not reflective of income tax expense incurred as a result of current period earnings. These certain tax items include, among other non-recurring tax items, impacts from the Tax Cuts and Jobs Act of 2017 and stock-based compensation windfalls/shortfalls. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors' consistent earnings comparison between periods. iRobot Corporation Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals (in thousands, except per share amounts) (unaudited) For the three months ended For the twelve months ended January 2, 2021 December 28, 2019 January 2, 2021 December 28, 2019 GAAP Revenue $ 544,827 $ 426,778 $ 1,430,390 $ 1,214,010 GAAP Gross Profit $ 215,421 $ 169,370 $ 670,229 $ 543,927 Amortization of acquired intangible assets 225 2,438 1,920 11,721 Stock-based compensation 362 366 1,511 1,486 Tariff refunds 3,531 - (36,486) - Non-GAAP Gross Profit $ 219,539 $ 172,174 $ 637,174 $ 557,134 Non-GAAP Gross Margin 40.3% 40.3% 44.5% 45.9% GAAP Operating Expenses $ 200,151 $ 152,820 $ 523,907 $ 457,309 Amortization of acquired intangible assets (228) (255) (992) (1,051) Stock-based compensation (8,709) (4,635) (28,464) (22,258) Net merger, acquisition and divestiture (expense) income - (138) 566 (466) IP litigation expense, net (2,084) (2,582) (5,444) (2,218) Restructuring and other (10) - (2,073) - Non-GAAP Operating Expenses $ 189,120 $ 145,210 $ 487,500 $ 431,316 Non-GAAP Operating Expenses as a % of Non-GAAP Revenue 34.7% 34.0% 34.1% 35.5% GAAP Operating Income $ 15,270 $ 16,550 $ 146,322 $ 86,618 Amortization of acquired intangible assets 453 2,693 2,912 12,772 Stock-based compensation 9,071 5,001 29,975 23,744 Tariff refunds 3,531 - (36,486) - Net merger, acquisition and divestiture expense (income) - 138 (566) 466 IP litigation expense, net 2,084 2,582 5,444 2,218 Restructuring and other 10 - 2,073 - Non-GAAP Operating Income $ 30,419 $ 26,964 $ 149,674 $ 125,818 Non-GAAP Operating Margin 5.6% 6.3% 10.5% 10.4% GAAP Income Tax Expense $ 1,691 $ 5,011 $ 40,847 $ 13,533 Tax effect of non-GAAP adjustments 3,826 1,159 (12,016) 4,648 Other tax adjustments 253 1,267 (635) 6,928 Non-GAAP Income Tax Expense $ 5,770 $ 7,437 $ 28,196 $ 25,109 GAAP Net Income $ 13,335 $ 20,041 $ 147,068 $ 85,300 Amortization of acquired intangible assets 453 2,693 2,912 12,772 Stock-based compensation 9,071 5,001 29,975 23,744 Tariff refunds 3,531 - (36,486) - Net merger, acquisition and divestiture expense (income) - 138 (1,241) 466 IP litigation expense, net 2,084 2,582 5,444 2,218 Restructuring and other 10 - 2,073 - Gain on strategic investments (250) (8,332) (43,817) (8,904) Income tax effect (4,079) (2,426) 12,651 (11,576) Non-GAAP Net Income $ 24,155 $ 19,697 $ 118,579 $ 104,020 GAAP Net Income Per Diluted Share $ 0.46 $ 0.70 $ 5.14 $ 2.97 Amortization of acquired intangible assets 0.02 0.09 0.10 0.44 Stock-based compensation 0.32 0.18 1.05 0.83 Tariff refunds 0.12 - (1.28) - Net merger, acquisition and divestiture expense (income) - - (0.04) 0.01 IP litigation expense, net 0.07 0.09 0.19 0.08 Restructuring and other - - 0.07 - Gain on strategic investments (0.01) (0.29) (1.53) (0.31) Income tax effect (0.14) (0.08) 0.44 (0.40) Non-GAAP Net Income Per Diluted Share $ 0.84 $ 0.69 $ 4.14 $ 3.62 Number of shares used in diluted per share calculation 28,763 28,563 28,618 28,735 Section 301 Tariff Costs Section 301 tariff costs $ - $ 21,896 $ - $ 37,862 Impact of Section 301 tariff costs to gross and operating margin (GAAP & non-GAAP) - % (5.1)% - % (3.1)% Impact of Section 301 tariff costs to net (loss) income per diluted share (GAAP & non-GAAP) $ - $ (0.77) $ - $ (1.32) Supplemental Information Days sales outstanding 31 31 Days in inventory 55 56 iRobot Corporation Supplemental Reconciliation of Fiscal Year 2021 GAAP to Non-GAAP Guidance (unaudited) FY-21 GAAP Gross Profit $662 - $692 million Amortization of acquired intangible assets ~$1 million Stock-based compensation ~$2 million Total adjustments ~$3 million Non-GAAP Gross Profit $665 - $695 million FY-21 GAAP Operating Income $69 - $79 million Amortization of acquired intangible assets ~$1 million Stock-based compensation ~$32 million IP litigation expense, net ~$8 million Total adjustments ~$41 million Non-GAAP Operating Income $110 - $120 million FY-21 GAAP Net Income Per Diluted Share $1.85 - $2.10 Amortization of acquired intangible assets ~$0.03 Stock-based compensation ~$1.10 IP litigation expense, net ~ $0.27 Income tax effect ~($0.25) Total adjustments ~$1.15 Non-GAAP Net Income Per Diluted Share $3.00 - $3.25 Number of shares used in diluted per share calculations ~29.1 million SOURCE iRobot Corporation Related Links http://www.irobot.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> iRobot Reports Fourth-Quarter and Full-Year 2020 Financial Results. 28% Revenue Growth Drives Better-than-Expected Operating Income and EPS.<|eot_id|>

edtsum833

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: STOCKHOLM, May 26, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that seven members of the company's Board and management today have exercised options to purchase shares in the company in accordance with the existing option agreements with the principal owners of BioArctic AB. Seven members of BioArctic's Board of Directors and management, including the CEO of the company, Gunilla Osswald, have today exercised their options to purchase shares in the company in accordance with the option agreement previously concluded with the principal owners of BioArctic AB. The program comprised a total of 366,795 shares divided among twelve members of the BioArctic Board of Directors and management. Today, the remaining 159,390 shares were acquired at the exercise price of SEK 26.67 per share, meaning that all rights to purchase shares in the option agreement with the principal owners now have been redeemed (see earlier transaction concluded and described in the press release on May 9th 2019). The company's CEO Gunilla Osswald has exercised 66,270 stock options. To finance the purchase of the shares, Gunilla Osswald has invested an additional approx. SEK 500,000 in cash and made a sale of 25,000 shares to partly finance the purchase. The proceeds from the sale of shares have been fully utilized to acquire new shares in the share option program described above. After the transaction, the two founders and principal owners' holdings amount to: Lars Lannfelt: ownership via Demban AB of 35.51 percent of the shares and 50.09percent of the votes Pr Gellerfors: ownership via Ackelsta AB of 23.67 percent of the shares and 33.39 percent of the votes "It is gratifying to see that the Board of Directors and management of BioArctic are engaged and see the company's future positively. An increased share ownership strengthens commitment," says BioArctics chairman Wenche Rolfsen in a comment. For further information, please contact: Jan Mattsson, CFO, BioArctic ABE-post: [emailprotected]Phone: +46 8 695 69 30Mobile: +46 70352 27 72 This information was submitted for publication at 15:30 a.m. CET on May 26, 2020. About BioArctic AB BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. BioArctic focuses on innovative treatments in areas with high unmet medical needs. The company was founded in 2003 based on innovative research from Uppsala University, Sweden. Collaborations with universities are of great importance to the company together with its strategically important global partners in the Alzheimer (Eisai) and Parkinson (AbbVie) projects. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and outlicensing potential. BioArctic's Class B share is listed on Nasdaq Stockholm Mid Cap (ticker: BIOA B). For more information about BioArctic, please visitwww.bioarctic.com. This information was brought to you by Cision http://news.cision.com https://news.cision.com/bioarctic/r/members-of-bioarctic-s-board-of-directors-and-management-increase-their-shareholdings,c3120181 The following files are available for download: https://mb.cision.com/Main/9978/3120181/1253838.pdf Release SOURCE BioArctic Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Members of BioArctic's Board of Directors and Management Increase Their Shareholdings.

STOCKHOLM, May 26, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that seven members of the company's Board and management today have exercised options to purchase shares in the company in accordance with the existing option agreements with the principal owners of BioArctic AB. Seven members of BioArctic's Board of Directors and management, including the CEO of the company, Gunilla Osswald, have today exercised their options to purchase shares in the company in accordance with the option agreement previously concluded with the principal owners of BioArctic AB. The program comprised a total of 366,795 shares divided among twelve members of the BioArctic Board of Directors and management. Today, the remaining 159,390 shares were acquired at the exercise price of SEK 26.67 per share, meaning that all rights to purchase shares in the option agreement with the principal owners now have been redeemed (see earlier transaction concluded and described in the press release on May 9th 2019). The company's CEO Gunilla Osswald has exercised 66,270 stock options. To finance the purchase of the shares, Gunilla Osswald has invested an additional approx. SEK 500,000 in cash and made a sale of 25,000 shares to partly finance the purchase. The proceeds from the sale of shares have been fully utilized to acquire new shares in the share option program described above. After the transaction, the two founders and principal owners' holdings amount to: Lars Lannfelt: ownership via Demban AB of 35.51 percent of the shares and 50.09percent of the votes Pr Gellerfors: ownership via Ackelsta AB of 23.67 percent of the shares and 33.39 percent of the votes "It is gratifying to see that the Board of Directors and management of BioArctic are engaged and see the company's future positively. An increased share ownership strengthens commitment," says BioArctics chairman Wenche Rolfsen in a comment. For further information, please contact: Jan Mattsson, CFO, BioArctic ABE-post: [emailprotected]Phone: +46 8 695 69 30Mobile: +46 70352 27 72 This information was submitted for publication at 15:30 a.m. CET on May 26, 2020. About BioArctic AB BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. BioArctic focuses on innovative treatments in areas with high unmet medical needs. The company was founded in 2003 based on innovative research from Uppsala University, Sweden. Collaborations with universities are of great importance to the company together with its strategically important global partners in the Alzheimer (Eisai) and Parkinson (AbbVie) projects. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and outlicensing potential. BioArctic's Class B share is listed on Nasdaq Stockholm Mid Cap (ticker: BIOA B). For more information about BioArctic, please visitwww.bioarctic.com. This information was brought to you by Cision http://news.cision.com https://news.cision.com/bioarctic/r/members-of-bioarctic-s-board-of-directors-and-management-increase-their-shareholdings,c3120181 The following files are available for download: https://mb.cision.com/Main/9978/3120181/1253838.pdf Release SOURCE BioArctic

Members of BioArctic's Board of Directors and Management Increase Their Shareholdings

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: STOCKHOLM, May 26, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that seven members of the company's Board and management today have exercised options to purchase shares in the company in accordance with the existing option agreements with the principal owners of BioArctic AB. Seven members of BioArctic's Board of Directors and management, including the CEO of the company, Gunilla Osswald, have today exercised their options to purchase shares in the company in accordance with the option agreement previously concluded with the principal owners of BioArctic AB. The program comprised a total of 366,795 shares divided among twelve members of the BioArctic Board of Directors and management. Today, the remaining 159,390 shares were acquired at the exercise price of SEK 26.67 per share, meaning that all rights to purchase shares in the option agreement with the principal owners now have been redeemed (see earlier transaction concluded and described in the press release on May 9th 2019). The company's CEO Gunilla Osswald has exercised 66,270 stock options. To finance the purchase of the shares, Gunilla Osswald has invested an additional approx. SEK 500,000 in cash and made a sale of 25,000 shares to partly finance the purchase. The proceeds from the sale of shares have been fully utilized to acquire new shares in the share option program described above. After the transaction, the two founders and principal owners' holdings amount to: Lars Lannfelt: ownership via Demban AB of 35.51 percent of the shares and 50.09percent of the votes Pr Gellerfors: ownership via Ackelsta AB of 23.67 percent of the shares and 33.39 percent of the votes "It is gratifying to see that the Board of Directors and management of BioArctic are engaged and see the company's future positively. An increased share ownership strengthens commitment," says BioArctics chairman Wenche Rolfsen in a comment. For further information, please contact: Jan Mattsson, CFO, BioArctic ABE-post: [emailprotected]Phone: +46 8 695 69 30Mobile: +46 70352 27 72 This information was submitted for publication at 15:30 a.m. CET on May 26, 2020. About BioArctic AB BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. BioArctic focuses on innovative treatments in areas with high unmet medical needs. The company was founded in 2003 based on innovative research from Uppsala University, Sweden. Collaborations with universities are of great importance to the company together with its strategically important global partners in the Alzheimer (Eisai) and Parkinson (AbbVie) projects. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and outlicensing potential. BioArctic's Class B share is listed on Nasdaq Stockholm Mid Cap (ticker: BIOA B). For more information about BioArctic, please visitwww.bioarctic.com. This information was brought to you by Cision http://news.cision.com https://news.cision.com/bioarctic/r/members-of-bioarctic-s-board-of-directors-and-management-increase-their-shareholdings,c3120181 The following files are available for download: https://mb.cision.com/Main/9978/3120181/1253838.pdf Release SOURCE BioArctic Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Members of BioArctic's Board of Directors and Management Increase Their Shareholdings.<|eot_id|>

edtsum834

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN, Jan. 28, 2021 /PRNewswire/ -- The "Projector Screen Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type and End User" report has been added to ResearchAndMarkets.com's offering. North America to Dominate Global Projector Screen Market.The market was valued at US$ 6.94 billion in 2019 and is projected to reach US$ 13.50 billion by 2027; it is expected to grow at a CAGR of 9.6% from 2020 to 2027The global projector screen market has been analyzed based on historical, current, and future trends in the countries across the global region. Increasing adoption of digital technologies in developed as well as developing nations is the key factor propelling the market growth. Projector screens are continuously supporting virtual operations, analysis, and communication of businesses; thus, it has major adoption ratio in offices of each industry. There is an immense growth in the projector market; hence, each country would witness the launch of more enhanced projector screens technology offering high quality projection and advanced portable projectors.As residential customers are identifying the potential of projector screen, the market players are focused to develop short distance projection screen technologies. The COVID-19 further supplemented the market growth in residential sector as customers are demanding large screens to experience cinema and other shows at home. Besides, growing demand from commercial segment, such as restaurants, sport bars, and shopping malls is pressurizing projector screen manufacturers to improve offering suitable for particular location. Companies operating in the market adopt various marketing strategies, such as new product developments, partnerships, and acquisitions, to optimize their existing offerings and expand their portfolio to target a significant number of customers.For instance, in November 2020, 2019, Elite Screens, provider of advanced projector screens introduced new Elite Projector line, a combined package of portable devices. The package includes screen and projector to enhance customers experience for outdoor movies. To increase the customer base and market share, the company introduced a combined solution to enhance service such one stop solution. Thus, all the above factors are leading toward the growth of the market in global regions.Surge in demand from emerging countries to provide numerous business opportunities for market payers.Digital transformation is growing at a faster rate in North America, Europe, and Asia pacific with an advent of supporting digital devices. China, India, the US, Germany, and the UK are among the countries that are strongly adopting digital technologies. Further, rising growth in cinema industry in Asian region is accelerating the adoption of projector screens. For instance, in July, 2019, IMAX China in partnership with CGV, a South Korean cinema chain has announced a launch of new cinema projector screens in China. Around 40 new screens will be installed under the partnership to provide enhanced large screen movie experience for customers. Also, PVR, an Indian cinema chain also started to install Barco cinema projectors in India. Key Topics Covered: 1. Introduction2. Key Takeaways3. Research Methodology4. Projector Screen Market Landscape4.1 Market Overview4.2 PEST Analysis4.3 Ecosystem Analysis5. Projector Screen Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increasing Demand for Portable Projector Screens5.1.2 Rising Adoption from Home and Non-Traditional Users5.2 Market Restraints5.2.1 Advent of Alternative Solution: Large LED screens5.3 Market Opportunities5.3.1 Growing Demand for Cinema Projector Screens in Developing Nations5.4 Future Trends5.4.1 Advancement in Screen Size and Layers5.5 Impact Analysis of Drivers and Restraints6. Projector Screen Market - Global Analysis6.1 Projector Screen Market Global Overview6.2 Projector Screen Market - Revenue and Forecast to 2027 (US$ Million)6.3 Market Positioning - Global Market Players Ranking7. Projector Screen Market Revenue and Forecast to 2027 - Type7.1 Overview7.2 Projector Screen Market Breakdown, By Type, 2020 & 20277.3 Fixed Frame7.4 Tripod7.5 Folding Frame7.6 Floor Rising/Pull Up7.7 Electric7.8 Manual8. Projector Screen Market Revenue and Forecast to 2027 - End User8.1 OVERVIEW8.2 Projector Screen Market Breakdown, By End User, 2020 & 20278.3 Education8.4 Media and Entertainment8.5 Healthcare8.6 Government and Defense8.7 Commercial8.8 Personal9. Projector Screen Market - Geographic Analysis9.1 Overview10. Projector Screen Market - COVID-19 Impact Analysis10.1 Overview10.2 North America: Impact Assessment of COVID-19 Pandemic10.3 Europe: Impact Assessment of COVID-19 Pandemic10.4 Asia-Pacific: Impact Assessment of COVID-19 Pandemic10.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic10.6 South America: Impact Assessment of COVID-19 Pandemic11. Industry Landscape11.1 Overview11.2 Market Initiative11.3 New Product Development11.4 Merger and Acquisition12. Company Profiles Barco NV Custom Display Solutions, Inc. Draper, Inc. Elite Screens Inc. Glimm Display LEGRAND AV INC. Seiko Epson Corporation (Seiko Group) SnapAV Stewart Filmscreen Grandview Crystal Screen Co.,Ltd. For more information about this report visit https://www.researchandmarkets.com/r/6px59u Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Global $13.5 Billion Projector Screen Market to 2027: COVID-19 Further Supplemented the Market Growth in the Residential Sector.

DUBLIN, Jan. 28, 2021 /PRNewswire/ -- The "Projector Screen Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type and End User" report has been added to ResearchAndMarkets.com's offering. North America to Dominate Global Projector Screen Market.The market was valued at US$ 6.94 billion in 2019 and is projected to reach US$ 13.50 billion by 2027; it is expected to grow at a CAGR of 9.6% from 2020 to 2027The global projector screen market has been analyzed based on historical, current, and future trends in the countries across the global region. Increasing adoption of digital technologies in developed as well as developing nations is the key factor propelling the market growth. Projector screens are continuously supporting virtual operations, analysis, and communication of businesses; thus, it has major adoption ratio in offices of each industry. There is an immense growth in the projector market; hence, each country would witness the launch of more enhanced projector screens technology offering high quality projection and advanced portable projectors.As residential customers are identifying the potential of projector screen, the market players are focused to develop short distance projection screen technologies. The COVID-19 further supplemented the market growth in residential sector as customers are demanding large screens to experience cinema and other shows at home. Besides, growing demand from commercial segment, such as restaurants, sport bars, and shopping malls is pressurizing projector screen manufacturers to improve offering suitable for particular location. Companies operating in the market adopt various marketing strategies, such as new product developments, partnerships, and acquisitions, to optimize their existing offerings and expand their portfolio to target a significant number of customers.For instance, in November 2020, 2019, Elite Screens, provider of advanced projector screens introduced new Elite Projector line, a combined package of portable devices. The package includes screen and projector to enhance customers experience for outdoor movies. To increase the customer base and market share, the company introduced a combined solution to enhance service such one stop solution. Thus, all the above factors are leading toward the growth of the market in global regions.Surge in demand from emerging countries to provide numerous business opportunities for market payers.Digital transformation is growing at a faster rate in North America, Europe, and Asia pacific with an advent of supporting digital devices. China, India, the US, Germany, and the UK are among the countries that are strongly adopting digital technologies. Further, rising growth in cinema industry in Asian region is accelerating the adoption of projector screens. For instance, in July, 2019, IMAX China in partnership with CGV, a South Korean cinema chain has announced a launch of new cinema projector screens in China. Around 40 new screens will be installed under the partnership to provide enhanced large screen movie experience for customers. Also, PVR, an Indian cinema chain also started to install Barco cinema projectors in India. Key Topics Covered: 1. Introduction2. Key Takeaways3. Research Methodology4. Projector Screen Market Landscape4.1 Market Overview4.2 PEST Analysis4.3 Ecosystem Analysis5. Projector Screen Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increasing Demand for Portable Projector Screens5.1.2 Rising Adoption from Home and Non-Traditional Users5.2 Market Restraints5.2.1 Advent of Alternative Solution: Large LED screens5.3 Market Opportunities5.3.1 Growing Demand for Cinema Projector Screens in Developing Nations5.4 Future Trends5.4.1 Advancement in Screen Size and Layers5.5 Impact Analysis of Drivers and Restraints6. Projector Screen Market - Global Analysis6.1 Projector Screen Market Global Overview6.2 Projector Screen Market - Revenue and Forecast to 2027 (US$ Million)6.3 Market Positioning - Global Market Players Ranking7. Projector Screen Market Revenue and Forecast to 2027 - Type7.1 Overview7.2 Projector Screen Market Breakdown, By Type, 2020 & 20277.3 Fixed Frame7.4 Tripod7.5 Folding Frame7.6 Floor Rising/Pull Up7.7 Electric7.8 Manual8. Projector Screen Market Revenue and Forecast to 2027 - End User8.1 OVERVIEW8.2 Projector Screen Market Breakdown, By End User, 2020 & 20278.3 Education8.4 Media and Entertainment8.5 Healthcare8.6 Government and Defense8.7 Commercial8.8 Personal9. Projector Screen Market - Geographic Analysis9.1 Overview10. Projector Screen Market - COVID-19 Impact Analysis10.1 Overview10.2 North America: Impact Assessment of COVID-19 Pandemic10.3 Europe: Impact Assessment of COVID-19 Pandemic10.4 Asia-Pacific: Impact Assessment of COVID-19 Pandemic10.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic10.6 South America: Impact Assessment of COVID-19 Pandemic11. Industry Landscape11.1 Overview11.2 Market Initiative11.3 New Product Development11.4 Merger and Acquisition12. Company Profiles Barco NV Custom Display Solutions, Inc. Draper, Inc. Elite Screens Inc. Glimm Display LEGRAND AV INC. Seiko Epson Corporation (Seiko Group) SnapAV Stewart Filmscreen Grandview Crystal Screen Co.,Ltd. For more information about this report visit https://www.researchandmarkets.com/r/6px59u Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Global $13.5 Billion Projector Screen Market to 2027: COVID-19 Further Supplemented the Market Growth in the Residential Sector

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN, Jan. 28, 2021 /PRNewswire/ -- The "Projector Screen Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type and End User" report has been added to ResearchAndMarkets.com's offering. North America to Dominate Global Projector Screen Market.The market was valued at US$ 6.94 billion in 2019 and is projected to reach US$ 13.50 billion by 2027; it is expected to grow at a CAGR of 9.6% from 2020 to 2027The global projector screen market has been analyzed based on historical, current, and future trends in the countries across the global region. Increasing adoption of digital technologies in developed as well as developing nations is the key factor propelling the market growth. Projector screens are continuously supporting virtual operations, analysis, and communication of businesses; thus, it has major adoption ratio in offices of each industry. There is an immense growth in the projector market; hence, each country would witness the launch of more enhanced projector screens technology offering high quality projection and advanced portable projectors.As residential customers are identifying the potential of projector screen, the market players are focused to develop short distance projection screen technologies. The COVID-19 further supplemented the market growth in residential sector as customers are demanding large screens to experience cinema and other shows at home. Besides, growing demand from commercial segment, such as restaurants, sport bars, and shopping malls is pressurizing projector screen manufacturers to improve offering suitable for particular location. Companies operating in the market adopt various marketing strategies, such as new product developments, partnerships, and acquisitions, to optimize their existing offerings and expand their portfolio to target a significant number of customers.For instance, in November 2020, 2019, Elite Screens, provider of advanced projector screens introduced new Elite Projector line, a combined package of portable devices. The package includes screen and projector to enhance customers experience for outdoor movies. To increase the customer base and market share, the company introduced a combined solution to enhance service such one stop solution. Thus, all the above factors are leading toward the growth of the market in global regions.Surge in demand from emerging countries to provide numerous business opportunities for market payers.Digital transformation is growing at a faster rate in North America, Europe, and Asia pacific with an advent of supporting digital devices. China, India, the US, Germany, and the UK are among the countries that are strongly adopting digital technologies. Further, rising growth in cinema industry in Asian region is accelerating the adoption of projector screens. For instance, in July, 2019, IMAX China in partnership with CGV, a South Korean cinema chain has announced a launch of new cinema projector screens in China. Around 40 new screens will be installed under the partnership to provide enhanced large screen movie experience for customers. Also, PVR, an Indian cinema chain also started to install Barco cinema projectors in India. Key Topics Covered: 1. Introduction2. Key Takeaways3. Research Methodology4. Projector Screen Market Landscape4.1 Market Overview4.2 PEST Analysis4.3 Ecosystem Analysis5. Projector Screen Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increasing Demand for Portable Projector Screens5.1.2 Rising Adoption from Home and Non-Traditional Users5.2 Market Restraints5.2.1 Advent of Alternative Solution: Large LED screens5.3 Market Opportunities5.3.1 Growing Demand for Cinema Projector Screens in Developing Nations5.4 Future Trends5.4.1 Advancement in Screen Size and Layers5.5 Impact Analysis of Drivers and Restraints6. Projector Screen Market - Global Analysis6.1 Projector Screen Market Global Overview6.2 Projector Screen Market - Revenue and Forecast to 2027 (US$ Million)6.3 Market Positioning - Global Market Players Ranking7. Projector Screen Market Revenue and Forecast to 2027 - Type7.1 Overview7.2 Projector Screen Market Breakdown, By Type, 2020 & 20277.3 Fixed Frame7.4 Tripod7.5 Folding Frame7.6 Floor Rising/Pull Up7.7 Electric7.8 Manual8. Projector Screen Market Revenue and Forecast to 2027 - End User8.1 OVERVIEW8.2 Projector Screen Market Breakdown, By End User, 2020 & 20278.3 Education8.4 Media and Entertainment8.5 Healthcare8.6 Government and Defense8.7 Commercial8.8 Personal9. Projector Screen Market - Geographic Analysis9.1 Overview10. Projector Screen Market - COVID-19 Impact Analysis10.1 Overview10.2 North America: Impact Assessment of COVID-19 Pandemic10.3 Europe: Impact Assessment of COVID-19 Pandemic10.4 Asia-Pacific: Impact Assessment of COVID-19 Pandemic10.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic10.6 South America: Impact Assessment of COVID-19 Pandemic11. Industry Landscape11.1 Overview11.2 Market Initiative11.3 New Product Development11.4 Merger and Acquisition12. Company Profiles Barco NV Custom Display Solutions, Inc. Draper, Inc. Elite Screens Inc. Glimm Display LEGRAND AV INC. Seiko Epson Corporation (Seiko Group) SnapAV Stewart Filmscreen Grandview Crystal Screen Co.,Ltd. For more information about this report visit https://www.researchandmarkets.com/r/6px59u Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Global $13.5 Billion Projector Screen Market to 2027: COVID-19 Further Supplemented the Market Growth in the Residential Sector.<|eot_id|>

edtsum835

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LONDON--(BUSINESS WIRE)--The industrial adhesives market is expected to grow by USD 14.61 billion during 2020-2024. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. We expect the impact to be significant in the first quarter but gradually lessen in subsequent quarters with a limited impact on the full-year economic growth. Request challenges and opportunities influenced by COVID-19 pandemic - Request a Free Sample Report on COVID-19 Impacts Industrial adhesives are increasingly being used in various applications such as mechanical fastening, welding, and other joining methods. This has led to the replacement of mechanical fasteners with industrial adhesives across industries such as construction, consumer durables, electronics, aerospace, packaging, and other heavy industries. The high adoption of industrial adhesives can be attributed to their superior product performance and better operation compared to conventional methods. For example, the use of adhesives eliminates corrosion caused by the joining of dissimilar materials with different galvanic potential. They also eliminate the damage caused to products that occur while using rivets or screws. Many such advantages leading to the replacement of mechanical fasteners with industrial adhesives in various applications. These factors are fueling the growth of the global industrial adhesives market. To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44848 As per Technavio, the rise in the demand for lightweight and low carbon emission vehicles will have a positive impact on the market and contribute to its growth significantly over the forecast period. This research report also analyzes other significant trends and market drivers that will influence market growth over 2020-2024. Industrial Adhesives Market: Rise in Demand for Lightweight and Low Carbon Emission Vehicles Stringent regulatory norms and concerns regarding fuel efficiency are compelling automobile manufacturers to focus on reducing the overall weight of the vehicles. This is increasing the use of new materials such as composites, aluminum, and lightweight grades of steel. Automakers are also finding new ways for bonding vehicle parts other than welding and mechanical fasteners. This is increasing the use of enhanced adhesives with superior bonding capabilities. These adhesives help in reducing the overall weight of the vehicle as they eliminate the use of nuts, bolts, and other mechanical fasteners. Therefore, the rising demand for light-weight and low carbon emission vehicles is expected to fuel the growth of the global industrial adhesives market during the forecast period. The rising adoption of eco-friendly adhesives and the growing demand from the packaged food and beverage industry will further boost market growth during the forecast period, says a senior analyst at Technavio. Register for a free trial today and gain instant access to 17,000+ market research reports Technavio's SUBSCRIPTION platform Industrial Adhesives Market: Segmentation Analysis This market research report segments the industrial adhesives market by Technology (Water-based adhesives, Solvent-based adhesives, Hot melt adhesives, and Reactive adhesives), Geography (APAC, North America, Europe, MEA, and South America), and End-user (Building and woodworking, Packaging, Transportation, Pressure-sensitive products, and Others). The APAC region led the industrial adhesives market in 2019, followed by North America, Europe, MEA, and South America respectively. During the forecast period, APAC is expected to register the highest incremental growth due to the increasing investments in infrastructure development in the region. Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report Some of the key topics covered in the report include: Market Drivers Market Challenges Market Trends Vendor Landscape About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Industrial Adhesives Market - Post Pandemic Recovery Plan, Strategies and Processes. Industrial Adhesives Replacing Mechanical Fasteners to Boost Market Growth. Technavio.

LONDON--(BUSINESS WIRE)--The industrial adhesives market is expected to grow by USD 14.61 billion during 2020-2024. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. We expect the impact to be significant in the first quarter but gradually lessen in subsequent quarters with a limited impact on the full-year economic growth. Request challenges and opportunities influenced by COVID-19 pandemic - Request a Free Sample Report on COVID-19 Impacts Industrial adhesives are increasingly being used in various applications such as mechanical fastening, welding, and other joining methods. This has led to the replacement of mechanical fasteners with industrial adhesives across industries such as construction, consumer durables, electronics, aerospace, packaging, and other heavy industries. The high adoption of industrial adhesives can be attributed to their superior product performance and better operation compared to conventional methods. For example, the use of adhesives eliminates corrosion caused by the joining of dissimilar materials with different galvanic potential. They also eliminate the damage caused to products that occur while using rivets or screws. Many such advantages leading to the replacement of mechanical fasteners with industrial adhesives in various applications. These factors are fueling the growth of the global industrial adhesives market. To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44848 As per Technavio, the rise in the demand for lightweight and low carbon emission vehicles will have a positive impact on the market and contribute to its growth significantly over the forecast period. This research report also analyzes other significant trends and market drivers that will influence market growth over 2020-2024. Industrial Adhesives Market: Rise in Demand for Lightweight and Low Carbon Emission Vehicles Stringent regulatory norms and concerns regarding fuel efficiency are compelling automobile manufacturers to focus on reducing the overall weight of the vehicles. This is increasing the use of new materials such as composites, aluminum, and lightweight grades of steel. Automakers are also finding new ways for bonding vehicle parts other than welding and mechanical fasteners. This is increasing the use of enhanced adhesives with superior bonding capabilities. These adhesives help in reducing the overall weight of the vehicle as they eliminate the use of nuts, bolts, and other mechanical fasteners. Therefore, the rising demand for light-weight and low carbon emission vehicles is expected to fuel the growth of the global industrial adhesives market during the forecast period. The rising adoption of eco-friendly adhesives and the growing demand from the packaged food and beverage industry will further boost market growth during the forecast period, says a senior analyst at Technavio. Register for a free trial today and gain instant access to 17,000+ market research reports Technavio's SUBSCRIPTION platform Industrial Adhesives Market: Segmentation Analysis This market research report segments the industrial adhesives market by Technology (Water-based adhesives, Solvent-based adhesives, Hot melt adhesives, and Reactive adhesives), Geography (APAC, North America, Europe, MEA, and South America), and End-user (Building and woodworking, Packaging, Transportation, Pressure-sensitive products, and Others). The APAC region led the industrial adhesives market in 2019, followed by North America, Europe, MEA, and South America respectively. During the forecast period, APAC is expected to register the highest incremental growth due to the increasing investments in infrastructure development in the region. Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report Some of the key topics covered in the report include: Market Drivers Market Challenges Market Trends Vendor Landscape About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Industrial Adhesives Market - Post Pandemic Recovery Plan, Strategies and Processes | Industrial Adhesives Replacing Mechanical Fasteners to Boost Market Growth | Technavio

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LONDON--(BUSINESS WIRE)--The industrial adhesives market is expected to grow by USD 14.61 billion during 2020-2024. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. We expect the impact to be significant in the first quarter but gradually lessen in subsequent quarters with a limited impact on the full-year economic growth. Request challenges and opportunities influenced by COVID-19 pandemic - Request a Free Sample Report on COVID-19 Impacts Industrial adhesives are increasingly being used in various applications such as mechanical fastening, welding, and other joining methods. This has led to the replacement of mechanical fasteners with industrial adhesives across industries such as construction, consumer durables, electronics, aerospace, packaging, and other heavy industries. The high adoption of industrial adhesives can be attributed to their superior product performance and better operation compared to conventional methods. For example, the use of adhesives eliminates corrosion caused by the joining of dissimilar materials with different galvanic potential. They also eliminate the damage caused to products that occur while using rivets or screws. Many such advantages leading to the replacement of mechanical fasteners with industrial adhesives in various applications. These factors are fueling the growth of the global industrial adhesives market. To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44848 As per Technavio, the rise in the demand for lightweight and low carbon emission vehicles will have a positive impact on the market and contribute to its growth significantly over the forecast period. This research report also analyzes other significant trends and market drivers that will influence market growth over 2020-2024. Industrial Adhesives Market: Rise in Demand for Lightweight and Low Carbon Emission Vehicles Stringent regulatory norms and concerns regarding fuel efficiency are compelling automobile manufacturers to focus on reducing the overall weight of the vehicles. This is increasing the use of new materials such as composites, aluminum, and lightweight grades of steel. Automakers are also finding new ways for bonding vehicle parts other than welding and mechanical fasteners. This is increasing the use of enhanced adhesives with superior bonding capabilities. These adhesives help in reducing the overall weight of the vehicle as they eliminate the use of nuts, bolts, and other mechanical fasteners. Therefore, the rising demand for light-weight and low carbon emission vehicles is expected to fuel the growth of the global industrial adhesives market during the forecast period. The rising adoption of eco-friendly adhesives and the growing demand from the packaged food and beverage industry will further boost market growth during the forecast period, says a senior analyst at Technavio. Register for a free trial today and gain instant access to 17,000+ market research reports Technavio's SUBSCRIPTION platform Industrial Adhesives Market: Segmentation Analysis This market research report segments the industrial adhesives market by Technology (Water-based adhesives, Solvent-based adhesives, Hot melt adhesives, and Reactive adhesives), Geography (APAC, North America, Europe, MEA, and South America), and End-user (Building and woodworking, Packaging, Transportation, Pressure-sensitive products, and Others). The APAC region led the industrial adhesives market in 2019, followed by North America, Europe, MEA, and South America respectively. During the forecast period, APAC is expected to register the highest incremental growth due to the increasing investments in infrastructure development in the region. Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report Some of the key topics covered in the report include: Market Drivers Market Challenges Market Trends Vendor Landscape About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Industrial Adhesives Market - Post Pandemic Recovery Plan, Strategies and Processes. Industrial Adhesives Replacing Mechanical Fasteners to Boost Market Growth. Technavio.<|eot_id|>

edtsum836

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: RALEIGH, N.C., June 9, 2020 /PRNewswire/ --The American Foundation for Suicide Prevention(AFSP), the largest suicide prevention organization in the United States, applauds the North Carolina legislature and Governor Cooper for passing and signing Senate Bill 476 into law. This landmark legislation will ensure employees throughout the North Carolina school system are trained to recognize and respond when a young person indicates they are at risk of hurting themselves or may be struggling with other mental health issues. (PRNewsfoto/AFSP) In 2018, North Carolina lost 84 young people ages 10-19 to suicide, making it the 2nd leading cause of death for that age group. "Our educators and school staff need this training, now more than ever," said AFSP NC Chapter Board Co-Chair, Tiffany Hall, MSW, LCSW. "Several COVID-19 related issues, including social disconnection, anxiety, depression, loss, and grief, have known ways of worsening mental health and/or suicide risk for young people and adults alike. SB 476 will help create an environment within our schools where it is okay to have a real conversation about mental health and suicide." Sponsored by Senators Rick Horner, Jerry Tillman, and Deanna Ballard, and shepherded in the House of Representatives by Representative Craig Horn, SB 476 requires the NC State Board of Education to adopt a school-based mental health policy that includes a model mental health training program and suicide risk referral protocol for K-12 schools. Schools will be required to adopt a plan for promoting student mental health and well-being that includes, at a minimum, the models developed by the Board. Related mental health training will also be required annually for school employees.Youth suicide can be prevented through early detection of students who may be in crisis or struggling with their mental health and connecting those students to resources and treatment services.AFSP North Carolina Chapteradvocates are part of a larger national movement of AFSP volunteer advocates working with public officials across the United States in 2020 to bring best practices in suicide prevention to legislators and their staff. AFSP-NC thanks our partners at National Alliance on Mental Illness, North Carolina and Mental Health America of Central Carolinas for their continued advocacy and support of SB 476 over several legislative sessions. To learn more about AFSP's advocacy efforts, visit here: https://afsp.org/our-work/advocacy/.The American Foundation for Suicide Preventionis dedicated to saving lives and bringing hope to those affected by suicide. AFSP creates a culture that's smart about mental health through education and community programs, develops suicide prevention through research and advocacy, and provides support for those affected by suicide. Led by CEO Robert Gebbia and headquartered in New York, with a Public Policy Office in Washington, D.C. AFSP has local chapters in all 50 states and the District of Columbia with programs and events nationwide. Learn more about AFSP in its latest Annual Report, and join the conversation on suicide prevention by following AFSP on Facebook, Twitter, Instagram, and YouTube. SOURCE American Foundation for Suicide Prevention Related Links www.afsp.org Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

AFSP Applauds Passage of K-12 Suicide Prevention and Mental Health Legislation in NC.

RALEIGH, N.C., June 9, 2020 /PRNewswire/ --The American Foundation for Suicide Prevention(AFSP), the largest suicide prevention organization in the United States, applauds the North Carolina legislature and Governor Cooper for passing and signing Senate Bill 476 into law. This landmark legislation will ensure employees throughout the North Carolina school system are trained to recognize and respond when a young person indicates they are at risk of hurting themselves or may be struggling with other mental health issues. (PRNewsfoto/AFSP) In 2018, North Carolina lost 84 young people ages 10-19 to suicide, making it the 2nd leading cause of death for that age group. "Our educators and school staff need this training, now more than ever," said AFSP NC Chapter Board Co-Chair, Tiffany Hall, MSW, LCSW. "Several COVID-19 related issues, including social disconnection, anxiety, depression, loss, and grief, have known ways of worsening mental health and/or suicide risk for young people and adults alike. SB 476 will help create an environment within our schools where it is okay to have a real conversation about mental health and suicide." Sponsored by Senators Rick Horner, Jerry Tillman, and Deanna Ballard, and shepherded in the House of Representatives by Representative Craig Horn, SB 476 requires the NC State Board of Education to adopt a school-based mental health policy that includes a model mental health training program and suicide risk referral protocol for K-12 schools. Schools will be required to adopt a plan for promoting student mental health and well-being that includes, at a minimum, the models developed by the Board. Related mental health training will also be required annually for school employees.Youth suicide can be prevented through early detection of students who may be in crisis or struggling with their mental health and connecting those students to resources and treatment services.AFSP North Carolina Chapteradvocates are part of a larger national movement of AFSP volunteer advocates working with public officials across the United States in 2020 to bring best practices in suicide prevention to legislators and their staff. AFSP-NC thanks our partners at National Alliance on Mental Illness, North Carolina and Mental Health America of Central Carolinas for their continued advocacy and support of SB 476 over several legislative sessions. To learn more about AFSP's advocacy efforts, visit here: https://afsp.org/our-work/advocacy/.The American Foundation for Suicide Preventionis dedicated to saving lives and bringing hope to those affected by suicide. AFSP creates a culture that's smart about mental health through education and community programs, develops suicide prevention through research and advocacy, and provides support for those affected by suicide. Led by CEO Robert Gebbia and headquartered in New York, with a Public Policy Office in Washington, D.C. AFSP has local chapters in all 50 states and the District of Columbia with programs and events nationwide. Learn more about AFSP in its latest Annual Report, and join the conversation on suicide prevention by following AFSP on Facebook, Twitter, Instagram, and YouTube. SOURCE American Foundation for Suicide Prevention Related Links www.afsp.org

AFSP Applauds Passage of K-12 Suicide Prevention and Mental Health Legislation in NC

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: RALEIGH, N.C., June 9, 2020 /PRNewswire/ --The American Foundation for Suicide Prevention(AFSP), the largest suicide prevention organization in the United States, applauds the North Carolina legislature and Governor Cooper for passing and signing Senate Bill 476 into law. This landmark legislation will ensure employees throughout the North Carolina school system are trained to recognize and respond when a young person indicates they are at risk of hurting themselves or may be struggling with other mental health issues. (PRNewsfoto/AFSP) In 2018, North Carolina lost 84 young people ages 10-19 to suicide, making it the 2nd leading cause of death for that age group. "Our educators and school staff need this training, now more than ever," said AFSP NC Chapter Board Co-Chair, Tiffany Hall, MSW, LCSW. "Several COVID-19 related issues, including social disconnection, anxiety, depression, loss, and grief, have known ways of worsening mental health and/or suicide risk for young people and adults alike. SB 476 will help create an environment within our schools where it is okay to have a real conversation about mental health and suicide." Sponsored by Senators Rick Horner, Jerry Tillman, and Deanna Ballard, and shepherded in the House of Representatives by Representative Craig Horn, SB 476 requires the NC State Board of Education to adopt a school-based mental health policy that includes a model mental health training program and suicide risk referral protocol for K-12 schools. Schools will be required to adopt a plan for promoting student mental health and well-being that includes, at a minimum, the models developed by the Board. Related mental health training will also be required annually for school employees.Youth suicide can be prevented through early detection of students who may be in crisis or struggling with their mental health and connecting those students to resources and treatment services.AFSP North Carolina Chapteradvocates are part of a larger national movement of AFSP volunteer advocates working with public officials across the United States in 2020 to bring best practices in suicide prevention to legislators and their staff. AFSP-NC thanks our partners at National Alliance on Mental Illness, North Carolina and Mental Health America of Central Carolinas for their continued advocacy and support of SB 476 over several legislative sessions. To learn more about AFSP's advocacy efforts, visit here: https://afsp.org/our-work/advocacy/.The American Foundation for Suicide Preventionis dedicated to saving lives and bringing hope to those affected by suicide. AFSP creates a culture that's smart about mental health through education and community programs, develops suicide prevention through research and advocacy, and provides support for those affected by suicide. Led by CEO Robert Gebbia and headquartered in New York, with a Public Policy Office in Washington, D.C. AFSP has local chapters in all 50 states and the District of Columbia with programs and events nationwide. Learn more about AFSP in its latest Annual Report, and join the conversation on suicide prevention by following AFSP on Facebook, Twitter, Instagram, and YouTube. SOURCE American Foundation for Suicide Prevention Related Links www.afsp.org Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> AFSP Applauds Passage of K-12 Suicide Prevention and Mental Health Legislation in NC.<|eot_id|>

edtsum837

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P. (FTA) announced today that, subject to the satisfaction of certain customary closing conditions, the reorganization of First Trust Mega Cap AlphaDEX Fund (Nasdaq: FMK), an index based exchange-traded fund (ETF), managed by FTA, into First Trust Dow 30 Equal Weight ETF (NYSE Arca: EDOW), an index based ETF managed by FTA, is expected to become effective immediately before the opening of the NYSE Arca on December 14, 2020. As previously announced, the shareholders of FMK and EDOW approved the FMKs reorganization into EDOW at a Joint Special Meeting of Shareholders on November 9, 2020. The reorganization was approved by the Board of Trustees of each of FMK and EDOW on January 30, 2020. Upon the completion of the transaction, which is expected to be tax-free, the assets of FMK will be transferred to, and the liabilities of FMK will be assumed by, EDOW. The shareholders of FMK will receive shares of EDOW with a value equal to the aggregate net asset value of the shares of FMK held by them. EDOW is an index based ETF that seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the Dow Jones Industrial Average Equal Weight Index. EDOW pursues this investment objective by investing at least 90% of its net assets in the common stocks that comprise the index. The index is the equal weight version of and seeks to measure the performance of the Dow Jones Industrial AverageTM which is composed of 30 securities issued by blue-chip U.S. companies covering all industries, with the exception of transportation and utilities. FMK is an index based ETF that seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the NASDAQ AlphaDEX Mega Cap Index. FMK pursues this investment objective by investing at least 90% of its net assets in the common stocks that comprise the index. The index is designed to select mega cap stocks from the NASDAQ US 500 Large Cap Index that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX selection methodology. FTA is a federally registered investment advisor and serves as the investment advisor of FMK and EDOW. FTA and its affiliate First Trust Portfolios L.P. (FTP), a FINRA registered broker-dealer, are privately-held companies that provide a variety of investment services. FTA has collective assets under management or supervision of approximately $164 billion as of November 30, 2020 through unit investment trusts, exchange-traded funds, closed-end funds, mutual funds and separate managed accounts. FTA is the supervisor of the First Trust unit investment trusts, while FTP is the sponsor. FTP is also a distributor of mutual fund shares and exchange-traded fund creation units. FTA and FTP are based in Wheaton, Illinois. Additional Information / Forward-Looking Statements This press release is not intended to, and shall not, constitute an offer to purchase or sell shares of FMK or EDOW. Certain statements made in this news release that are not historical facts are referred to as forward-looking statements under the U.S. federal securities laws. Actual future results or occurrences may differ significantly from those anticipated in any forward- looking statements due to numerous factors. Generally, the words believe, expect, intend, estimate, anticipate, project, will and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ from the historical experience of FTA and the funds managed by FTA and its present expectations or projections. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. FTA, FMK and EDOW undertake no responsibility to update publicly or revise any forward-looking statements. An investor should carefully consider the investment objectives, risks, charges and expenses of FMK or EDOW, as applicable, before investing. The prospectuses for FMK and EDOW contain this and other important information and are available free of charge by calling toll-free at 1-800-621-1675 or writing FMK or EDOW at 120 East Liberty Drive, Suite 400, Wheaton, IL 60187. The prospectus should be read carefully before investing. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

First Trust Announces Expected Effective Date of First Trust Mega Cap AlphaDEX Fund's Reorganization into First Trust Dow 30 Equal Weight ETF.

WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P. (FTA) announced today that, subject to the satisfaction of certain customary closing conditions, the reorganization of First Trust Mega Cap AlphaDEX Fund (Nasdaq: FMK), an index based exchange-traded fund (ETF), managed by FTA, into First Trust Dow 30 Equal Weight ETF (NYSE Arca: EDOW), an index based ETF managed by FTA, is expected to become effective immediately before the opening of the NYSE Arca on December 14, 2020. As previously announced, the shareholders of FMK and EDOW approved the FMKs reorganization into EDOW at a Joint Special Meeting of Shareholders on November 9, 2020. The reorganization was approved by the Board of Trustees of each of FMK and EDOW on January 30, 2020. Upon the completion of the transaction, which is expected to be tax-free, the assets of FMK will be transferred to, and the liabilities of FMK will be assumed by, EDOW. The shareholders of FMK will receive shares of EDOW with a value equal to the aggregate net asset value of the shares of FMK held by them. EDOW is an index based ETF that seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the Dow Jones Industrial Average Equal Weight Index. EDOW pursues this investment objective by investing at least 90% of its net assets in the common stocks that comprise the index. The index is the equal weight version of and seeks to measure the performance of the Dow Jones Industrial AverageTM which is composed of 30 securities issued by blue-chip U.S. companies covering all industries, with the exception of transportation and utilities. FMK is an index based ETF that seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the NASDAQ AlphaDEX Mega Cap Index. FMK pursues this investment objective by investing at least 90% of its net assets in the common stocks that comprise the index. The index is designed to select mega cap stocks from the NASDAQ US 500 Large Cap Index that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX selection methodology. FTA is a federally registered investment advisor and serves as the investment advisor of FMK and EDOW. FTA and its affiliate First Trust Portfolios L.P. (FTP), a FINRA registered broker-dealer, are privately-held companies that provide a variety of investment services. FTA has collective assets under management or supervision of approximately $164 billion as of November 30, 2020 through unit investment trusts, exchange-traded funds, closed-end funds, mutual funds and separate managed accounts. FTA is the supervisor of the First Trust unit investment trusts, while FTP is the sponsor. FTP is also a distributor of mutual fund shares and exchange-traded fund creation units. FTA and FTP are based in Wheaton, Illinois. Additional Information / Forward-Looking Statements This press release is not intended to, and shall not, constitute an offer to purchase or sell shares of FMK or EDOW. Certain statements made in this news release that are not historical facts are referred to as forward-looking statements under the U.S. federal securities laws. Actual future results or occurrences may differ significantly from those anticipated in any forward- looking statements due to numerous factors. Generally, the words believe, expect, intend, estimate, anticipate, project, will and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ from the historical experience of FTA and the funds managed by FTA and its present expectations or projections. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. FTA, FMK and EDOW undertake no responsibility to update publicly or revise any forward-looking statements. An investor should carefully consider the investment objectives, risks, charges and expenses of FMK or EDOW, as applicable, before investing. The prospectuses for FMK and EDOW contain this and other important information and are available free of charge by calling toll-free at 1-800-621-1675 or writing FMK or EDOW at 120 East Liberty Drive, Suite 400, Wheaton, IL 60187. The prospectus should be read carefully before investing.

First Trust Announces Expected Effective Date of First Trust Mega Cap AlphaDEX Funds Reorganization into First Trust Dow 30 Equal Weight ETF

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P. (FTA) announced today that, subject to the satisfaction of certain customary closing conditions, the reorganization of First Trust Mega Cap AlphaDEX Fund (Nasdaq: FMK), an index based exchange-traded fund (ETF), managed by FTA, into First Trust Dow 30 Equal Weight ETF (NYSE Arca: EDOW), an index based ETF managed by FTA, is expected to become effective immediately before the opening of the NYSE Arca on December 14, 2020. As previously announced, the shareholders of FMK and EDOW approved the FMKs reorganization into EDOW at a Joint Special Meeting of Shareholders on November 9, 2020. The reorganization was approved by the Board of Trustees of each of FMK and EDOW on January 30, 2020. Upon the completion of the transaction, which is expected to be tax-free, the assets of FMK will be transferred to, and the liabilities of FMK will be assumed by, EDOW. The shareholders of FMK will receive shares of EDOW with a value equal to the aggregate net asset value of the shares of FMK held by them. EDOW is an index based ETF that seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the Dow Jones Industrial Average Equal Weight Index. EDOW pursues this investment objective by investing at least 90% of its net assets in the common stocks that comprise the index. The index is the equal weight version of and seeks to measure the performance of the Dow Jones Industrial AverageTM which is composed of 30 securities issued by blue-chip U.S. companies covering all industries, with the exception of transportation and utilities. FMK is an index based ETF that seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the NASDAQ AlphaDEX Mega Cap Index. FMK pursues this investment objective by investing at least 90% of its net assets in the common stocks that comprise the index. The index is designed to select mega cap stocks from the NASDAQ US 500 Large Cap Index that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX selection methodology. FTA is a federally registered investment advisor and serves as the investment advisor of FMK and EDOW. FTA and its affiliate First Trust Portfolios L.P. (FTP), a FINRA registered broker-dealer, are privately-held companies that provide a variety of investment services. FTA has collective assets under management or supervision of approximately $164 billion as of November 30, 2020 through unit investment trusts, exchange-traded funds, closed-end funds, mutual funds and separate managed accounts. FTA is the supervisor of the First Trust unit investment trusts, while FTP is the sponsor. FTP is also a distributor of mutual fund shares and exchange-traded fund creation units. FTA and FTP are based in Wheaton, Illinois. Additional Information / Forward-Looking Statements This press release is not intended to, and shall not, constitute an offer to purchase or sell shares of FMK or EDOW. Certain statements made in this news release that are not historical facts are referred to as forward-looking statements under the U.S. federal securities laws. Actual future results or occurrences may differ significantly from those anticipated in any forward- looking statements due to numerous factors. Generally, the words believe, expect, intend, estimate, anticipate, project, will and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ from the historical experience of FTA and the funds managed by FTA and its present expectations or projections. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. FTA, FMK and EDOW undertake no responsibility to update publicly or revise any forward-looking statements. An investor should carefully consider the investment objectives, risks, charges and expenses of FMK or EDOW, as applicable, before investing. The prospectuses for FMK and EDOW contain this and other important information and are available free of charge by calling toll-free at 1-800-621-1675 or writing FMK or EDOW at 120 East Liberty Drive, Suite 400, Wheaton, IL 60187. The prospectus should be read carefully before investing. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> First Trust Announces Expected Effective Date of First Trust Mega Cap AlphaDEX Fund's Reorganization into First Trust Dow 30 Equal Weight ETF.<|eot_id|>

edtsum838

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK--(BUSINESS WIRE)--Altice USA, Inc. (NYSE: ATUS) (Altice USA or the Company) announced today that it has commenced a modified Dutch auction tender offer to repurchase up to $2.5 billion of its Class A common stock at a price not greater than $36.00 per share nor less than $32.25 per share, less any applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase and Letter of Transmittal that are being distributed to stockholders (the Offer). If the Offer is fully subscribed, the number of shares to be purchased in the Offer represents approximately 19.6% to 21.9% of Altice USAs issued and outstanding shares of Class A common stock (or approximately 12.8% to 14.3% of Altice USAs total outstanding shares including both Class A and Class B common stock) as of November 19, 2020 depending on the purchase price payable for those shares pursuant to the Offer. The Offer represents a premium of approximately 0% to 12% to the NYSE closing price of the shares on November 20, 2020 of $32.27 per share. With this Offer, Altice USA is increasing its buyback target for full year 2020 from $2.0 billion to approximately $5.0 billion. From October 1, 2020 to November 20, 2020, the Company repurchased 22,677,812 Class A shares pursuant to its share repurchase program at an average cost of $29.10 per share for approximately $660 million (a total amount of approximately $2.5 billion year-to-date). As a result of the Offer, the Company now expects its 2020 year-end net leverage for the CSC Holdings, LLC debt silo to be between 5.0x to 5.5x Adjusted EBITDA (on a L2QA basis). The Company expects to return to its net leverage target for CSC Holdings, LLC of 4.5x to 5.0x over time. On November 20, 2020, the Altice USA Board of Directors increased the capacity under the Companys existing share repurchase program from $5.0 billion to $7.0 billion in the aggregate of Class A shares to facilitate the Offer and any subsequent additional share repurchases (commencing at least ten business days following the expiration or termination of the Offer). As of November 23, 2020, the capacity under the Companys upsized share repurchase program was approximately $4.3 billion, or approximately $1.8 billion after the assumed repurchase of $2.5 billion of Class A shares pursuant to the Offer. The Offer will expire at one (1) minute after 11:59 p.m., New York City time, on Monday, December 21, 2020, unless extended by Altice USA. Tenders of shares must be made prior to the expiration of the Offer and may be withdrawn at any time prior to the expiration of the Offer. The Offer will not be conditioned upon any minimum number of shares being tendered; however, the Offer is subject to a number of terms and conditions described in the Offer to Purchase, including the closing of the Companys sale of 49.99% of its Lightpath fiber enterprise business. Tendering stockholders may specify a price not greater than $36.00 per share nor less than $32.25 per share (in increments of $0.25) at which they are willing to sell their shares pursuant to the Offer. On the terms and subject to the conditions of the Offer, the Company will designate a single per share price that the Company will pay for shares properly tendered and not properly withdrawn from the Offer, taking into account the total number of shares tendered and the prices specified by tendering stockholders. The Company will select the lowest purchase price, not greater than $36.00 per share nor less than $32.25 per share, that will allow it to purchase shares having an aggregate purchase price of $2.5 billion, or a lower amount depending on the number of shares properly tendered and not properly withdrawn (such purchase price, the Final Purchase Price). Only shares validly tendered at prices at or below the Final Purchase Price, and not properly withdrawn, will be eligible for purchase in the Offer. All shares acquired in the Offer will be acquired at the Final Purchase Price, including those shares tendered at a price lower than the Final Purchase Price. However, due to the odd lot priority, proration and conditional tender offer provisions described in the Offer to Purchase, all of the shares tendered may not be purchased if the number of shares properly tendered at or below the Final Purchase Price and not properly withdrawn have an aggregate value in excess of $2.5 billion (based on the Final Purchase Price). The Company will purchase only those shares properly tendered and not properly withdrawn upon the terms and conditions of the Offer. All shares accepted for payment will be paid promptly after the expiration of the Offer period, to the seller in cash, less any applicable withholding taxes and without interest. At the maximum Final Purchase Price of $36.00 per share, the Company would purchase 69,444,444 shares if the Offer is fully subscribed, which would represent approximately 12.8% of the total issued and outstanding shares of Class A and Class B Common Stock as of November 19, 2020. At the minimum Final Purchase Price of $32.25 per share, the Company would purchase 77,519,379 shares if the Offer is fully subscribed, which would represent approximately 14.3% of the total issued and outstanding shares of Class A and Class B Common Stock as of November 19, 2020. Shares not purchased in the Offer will be returned at the Companys expense promptly following the expiration of the Offer. The Company reserves the right, in its sole discretion, to change the per share purchase price options and to increase or decrease the aggregate value of shares sought in the Offer, subject to applicable law. In accordance with the rules of the U.S. Securities and Exchange Commission (SEC), the Company may purchase in the Offer up to an additional 2% of its outstanding shares without amending or extending the Offer. The Company intends to pay for the purchase of the shares with cash on hand, cash from operations and, to the extent necessary, borrowings under its revolving credit facility. The Information Agent for the Offer is D.F. King & Co., Inc. The Depositary is American Stock Transfer & Trust Company, LLC. The Offer to Purchase, Letter of Transmittal and related documents are being mailed to stockholders of record and also will be made available for distribution to beneficial owners of shares. For questions and information, please call the Information Agent toll free at 1-866-745-0271. Goldman Sachs & Co. LLC is acting as Financial Advisor to the Company in connection with the Offer. Altice USAs Board of Directors has approved the Offer. However, none of Altice USA, its Board of Directors, the Information Agent, the Depositary or the Financial Advisor is making any recommendations to stockholders as to whether to tender or refrain from tendering their shares or as to the purchase price or the purchase prices at which shares may be tendered into the Offer. Stockholders must make their own decisions as to how many shares they will tender, if any, and at what price or prices to tender. In so doing, stockholders should read and evaluate carefully the information in the Offer to Purchase and in the related Letter of Transmittal. THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL SHARES OF CLASS A COMMON STOCK OF ALTICE USA, INC. THE OFFER IS BEING MADE ONLY PURSUANT TO THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS THAT ALTICE USA WILL SHORTLY BE DISTRIBUTING TO ITS STOCKHOLDERS AND FILING WITH THE SEC. STOCKHOLDERS SHOULD READ CAREFULLY THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING THE VARIOUS TERMS OF, AND CONDITIONS TO, THE OFFER. STOCKHOLDERS MAY OBTAIN A FREE COPY OF THE TENDER OFFER STATEMENT ON SCHEDULE TO, THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND OTHER DOCUMENTS THAT ALTICE USA WILL SHORTLY BE FILING WITH THE SEC AT THE SECS WEBSITE AT WWW.SEC.GOV OR BY CALLING D.F. KING & CO., INC., THE INFORMATION AGENT FOR THE OFFER, TOLL-FREE AT 1-866-745-0271. STOCKHOLDERS ARE URGED TO CAREFULLY READ THESE MATERIALS PRIOR TO MAKING ANY DECISION WITH RESPECT TO THE OFFER. About Altice USA Altice USA is one of the largest broadband communications and video services providers in the United States, delivering broadband, video, mobile, proprietary content and advertising services to more than 5 million residential and business customers across 21 states through its Optimum and Suddenlink brands. The company operates a4, an advanced advertising and data business, which provides audience-based, multiscreen advertising solutions to local, regional and national businesses and advertising clients. Altice USA also offers hyper-local, national, international and business news through its News 12, Cheddar and i24NEWS networks. FORWARD-LOOKING STATEMENTS Certain statements in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts contained in this release. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "anticipate", "believe", "could", "estimate", "expect", "forecast", "intend", "may", "plan", "project", "should" or "will" or, in each case, their negative, or other variations or comparable terminology. Where, in any forward-looking statement, we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. To the extent that statements in this release are not recitations of historical fact, such statements constitute forward-looking statements, which, by definition, involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements including risks referred to in our most recently filed Annual Report on Form 10-K and in our most recently filed Quarterly Report on Form 10-Q. You are cautioned to not place undue reliance on Altice USAs forward-looking statements. Any forward-looking statement speaks only as of the date on which it was made. Altice USA specifically disclaims any obligation to publicly update or revise any forward-looking statement, as of any future date. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Altice USA Announces Commencement of Tender Offer to Repurchase up to $2.5 Billion of Its Class A Common Stock.

NEW YORK--(BUSINESS WIRE)--Altice USA, Inc. (NYSE: ATUS) (Altice USA or the Company) announced today that it has commenced a modified Dutch auction tender offer to repurchase up to $2.5 billion of its Class A common stock at a price not greater than $36.00 per share nor less than $32.25 per share, less any applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase and Letter of Transmittal that are being distributed to stockholders (the Offer). If the Offer is fully subscribed, the number of shares to be purchased in the Offer represents approximately 19.6% to 21.9% of Altice USAs issued and outstanding shares of Class A common stock (or approximately 12.8% to 14.3% of Altice USAs total outstanding shares including both Class A and Class B common stock) as of November 19, 2020 depending on the purchase price payable for those shares pursuant to the Offer. The Offer represents a premium of approximately 0% to 12% to the NYSE closing price of the shares on November 20, 2020 of $32.27 per share. With this Offer, Altice USA is increasing its buyback target for full year 2020 from $2.0 billion to approximately $5.0 billion. From October 1, 2020 to November 20, 2020, the Company repurchased 22,677,812 Class A shares pursuant to its share repurchase program at an average cost of $29.10 per share for approximately $660 million (a total amount of approximately $2.5 billion year-to-date). As a result of the Offer, the Company now expects its 2020 year-end net leverage for the CSC Holdings, LLC debt silo to be between 5.0x to 5.5x Adjusted EBITDA (on a L2QA basis). The Company expects to return to its net leverage target for CSC Holdings, LLC of 4.5x to 5.0x over time. On November 20, 2020, the Altice USA Board of Directors increased the capacity under the Companys existing share repurchase program from $5.0 billion to $7.0 billion in the aggregate of Class A shares to facilitate the Offer and any subsequent additional share repurchases (commencing at least ten business days following the expiration or termination of the Offer). As of November 23, 2020, the capacity under the Companys upsized share repurchase program was approximately $4.3 billion, or approximately $1.8 billion after the assumed repurchase of $2.5 billion of Class A shares pursuant to the Offer. The Offer will expire at one (1) minute after 11:59 p.m., New York City time, on Monday, December 21, 2020, unless extended by Altice USA. Tenders of shares must be made prior to the expiration of the Offer and may be withdrawn at any time prior to the expiration of the Offer. The Offer will not be conditioned upon any minimum number of shares being tendered; however, the Offer is subject to a number of terms and conditions described in the Offer to Purchase, including the closing of the Companys sale of 49.99% of its Lightpath fiber enterprise business. Tendering stockholders may specify a price not greater than $36.00 per share nor less than $32.25 per share (in increments of $0.25) at which they are willing to sell their shares pursuant to the Offer. On the terms and subject to the conditions of the Offer, the Company will designate a single per share price that the Company will pay for shares properly tendered and not properly withdrawn from the Offer, taking into account the total number of shares tendered and the prices specified by tendering stockholders. The Company will select the lowest purchase price, not greater than $36.00 per share nor less than $32.25 per share, that will allow it to purchase shares having an aggregate purchase price of $2.5 billion, or a lower amount depending on the number of shares properly tendered and not properly withdrawn (such purchase price, the Final Purchase Price). Only shares validly tendered at prices at or below the Final Purchase Price, and not properly withdrawn, will be eligible for purchase in the Offer. All shares acquired in the Offer will be acquired at the Final Purchase Price, including those shares tendered at a price lower than the Final Purchase Price. However, due to the odd lot priority, proration and conditional tender offer provisions described in the Offer to Purchase, all of the shares tendered may not be purchased if the number of shares properly tendered at or below the Final Purchase Price and not properly withdrawn have an aggregate value in excess of $2.5 billion (based on the Final Purchase Price). The Company will purchase only those shares properly tendered and not properly withdrawn upon the terms and conditions of the Offer. All shares accepted for payment will be paid promptly after the expiration of the Offer period, to the seller in cash, less any applicable withholding taxes and without interest. At the maximum Final Purchase Price of $36.00 per share, the Company would purchase 69,444,444 shares if the Offer is fully subscribed, which would represent approximately 12.8% of the total issued and outstanding shares of Class A and Class B Common Stock as of November 19, 2020. At the minimum Final Purchase Price of $32.25 per share, the Company would purchase 77,519,379 shares if the Offer is fully subscribed, which would represent approximately 14.3% of the total issued and outstanding shares of Class A and Class B Common Stock as of November 19, 2020. Shares not purchased in the Offer will be returned at the Companys expense promptly following the expiration of the Offer. The Company reserves the right, in its sole discretion, to change the per share purchase price options and to increase or decrease the aggregate value of shares sought in the Offer, subject to applicable law. In accordance with the rules of the U.S. Securities and Exchange Commission (SEC), the Company may purchase in the Offer up to an additional 2% of its outstanding shares without amending or extending the Offer. The Company intends to pay for the purchase of the shares with cash on hand, cash from operations and, to the extent necessary, borrowings under its revolving credit facility. The Information Agent for the Offer is D.F. King & Co., Inc. The Depositary is American Stock Transfer & Trust Company, LLC. The Offer to Purchase, Letter of Transmittal and related documents are being mailed to stockholders of record and also will be made available for distribution to beneficial owners of shares. For questions and information, please call the Information Agent toll free at 1-866-745-0271. Goldman Sachs & Co. LLC is acting as Financial Advisor to the Company in connection with the Offer. Altice USAs Board of Directors has approved the Offer. However, none of Altice USA, its Board of Directors, the Information Agent, the Depositary or the Financial Advisor is making any recommendations to stockholders as to whether to tender or refrain from tendering their shares or as to the purchase price or the purchase prices at which shares may be tendered into the Offer. Stockholders must make their own decisions as to how many shares they will tender, if any, and at what price or prices to tender. In so doing, stockholders should read and evaluate carefully the information in the Offer to Purchase and in the related Letter of Transmittal. THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL SHARES OF CLASS A COMMON STOCK OF ALTICE USA, INC. THE OFFER IS BEING MADE ONLY PURSUANT TO THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS THAT ALTICE USA WILL SHORTLY BE DISTRIBUTING TO ITS STOCKHOLDERS AND FILING WITH THE SEC. STOCKHOLDERS SHOULD READ CAREFULLY THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING THE VARIOUS TERMS OF, AND CONDITIONS TO, THE OFFER. STOCKHOLDERS MAY OBTAIN A FREE COPY OF THE TENDER OFFER STATEMENT ON SCHEDULE TO, THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND OTHER DOCUMENTS THAT ALTICE USA WILL SHORTLY BE FILING WITH THE SEC AT THE SECS WEBSITE AT WWW.SEC.GOV OR BY CALLING D.F. KING & CO., INC., THE INFORMATION AGENT FOR THE OFFER, TOLL-FREE AT 1-866-745-0271. STOCKHOLDERS ARE URGED TO CAREFULLY READ THESE MATERIALS PRIOR TO MAKING ANY DECISION WITH RESPECT TO THE OFFER. About Altice USA Altice USA is one of the largest broadband communications and video services providers in the United States, delivering broadband, video, mobile, proprietary content and advertising services to more than 5 million residential and business customers across 21 states through its Optimum and Suddenlink brands. The company operates a4, an advanced advertising and data business, which provides audience-based, multiscreen advertising solutions to local, regional and national businesses and advertising clients. Altice USA also offers hyper-local, national, international and business news through its News 12, Cheddar and i24NEWS networks. FORWARD-LOOKING STATEMENTS Certain statements in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts contained in this release. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "anticipate", "believe", "could", "estimate", "expect", "forecast", "intend", "may", "plan", "project", "should" or "will" or, in each case, their negative, or other variations or comparable terminology. Where, in any forward-looking statement, we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. To the extent that statements in this release are not recitations of historical fact, such statements constitute forward-looking statements, which, by definition, involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements including risks referred to in our most recently filed Annual Report on Form 10-K and in our most recently filed Quarterly Report on Form 10-Q. You are cautioned to not place undue reliance on Altice USAs forward-looking statements. Any forward-looking statement speaks only as of the date on which it was made. Altice USA specifically disclaims any obligation to publicly update or revise any forward-looking statement, as of any future date.

Altice USA Announces Commencement of Tender Offer to Repurchase up to $2.5 Billion of Its Class A Common Stock

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK--(BUSINESS WIRE)--Altice USA, Inc. (NYSE: ATUS) (Altice USA or the Company) announced today that it has commenced a modified Dutch auction tender offer to repurchase up to $2.5 billion of its Class A common stock at a price not greater than $36.00 per share nor less than $32.25 per share, less any applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase and Letter of Transmittal that are being distributed to stockholders (the Offer). If the Offer is fully subscribed, the number of shares to be purchased in the Offer represents approximately 19.6% to 21.9% of Altice USAs issued and outstanding shares of Class A common stock (or approximately 12.8% to 14.3% of Altice USAs total outstanding shares including both Class A and Class B common stock) as of November 19, 2020 depending on the purchase price payable for those shares pursuant to the Offer. The Offer represents a premium of approximately 0% to 12% to the NYSE closing price of the shares on November 20, 2020 of $32.27 per share. With this Offer, Altice USA is increasing its buyback target for full year 2020 from $2.0 billion to approximately $5.0 billion. From October 1, 2020 to November 20, 2020, the Company repurchased 22,677,812 Class A shares pursuant to its share repurchase program at an average cost of $29.10 per share for approximately $660 million (a total amount of approximately $2.5 billion year-to-date). As a result of the Offer, the Company now expects its 2020 year-end net leverage for the CSC Holdings, LLC debt silo to be between 5.0x to 5.5x Adjusted EBITDA (on a L2QA basis). The Company expects to return to its net leverage target for CSC Holdings, LLC of 4.5x to 5.0x over time. On November 20, 2020, the Altice USA Board of Directors increased the capacity under the Companys existing share repurchase program from $5.0 billion to $7.0 billion in the aggregate of Class A shares to facilitate the Offer and any subsequent additional share repurchases (commencing at least ten business days following the expiration or termination of the Offer). As of November 23, 2020, the capacity under the Companys upsized share repurchase program was approximately $4.3 billion, or approximately $1.8 billion after the assumed repurchase of $2.5 billion of Class A shares pursuant to the Offer. The Offer will expire at one (1) minute after 11:59 p.m., New York City time, on Monday, December 21, 2020, unless extended by Altice USA. Tenders of shares must be made prior to the expiration of the Offer and may be withdrawn at any time prior to the expiration of the Offer. The Offer will not be conditioned upon any minimum number of shares being tendered; however, the Offer is subject to a number of terms and conditions described in the Offer to Purchase, including the closing of the Companys sale of 49.99% of its Lightpath fiber enterprise business. Tendering stockholders may specify a price not greater than $36.00 per share nor less than $32.25 per share (in increments of $0.25) at which they are willing to sell their shares pursuant to the Offer. On the terms and subject to the conditions of the Offer, the Company will designate a single per share price that the Company will pay for shares properly tendered and not properly withdrawn from the Offer, taking into account the total number of shares tendered and the prices specified by tendering stockholders. The Company will select the lowest purchase price, not greater than $36.00 per share nor less than $32.25 per share, that will allow it to purchase shares having an aggregate purchase price of $2.5 billion, or a lower amount depending on the number of shares properly tendered and not properly withdrawn (such purchase price, the Final Purchase Price). Only shares validly tendered at prices at or below the Final Purchase Price, and not properly withdrawn, will be eligible for purchase in the Offer. All shares acquired in the Offer will be acquired at the Final Purchase Price, including those shares tendered at a price lower than the Final Purchase Price. However, due to the odd lot priority, proration and conditional tender offer provisions described in the Offer to Purchase, all of the shares tendered may not be purchased if the number of shares properly tendered at or below the Final Purchase Price and not properly withdrawn have an aggregate value in excess of $2.5 billion (based on the Final Purchase Price). The Company will purchase only those shares properly tendered and not properly withdrawn upon the terms and conditions of the Offer. All shares accepted for payment will be paid promptly after the expiration of the Offer period, to the seller in cash, less any applicable withholding taxes and without interest. At the maximum Final Purchase Price of $36.00 per share, the Company would purchase 69,444,444 shares if the Offer is fully subscribed, which would represent approximately 12.8% of the total issued and outstanding shares of Class A and Class B Common Stock as of November 19, 2020. At the minimum Final Purchase Price of $32.25 per share, the Company would purchase 77,519,379 shares if the Offer is fully subscribed, which would represent approximately 14.3% of the total issued and outstanding shares of Class A and Class B Common Stock as of November 19, 2020. Shares not purchased in the Offer will be returned at the Companys expense promptly following the expiration of the Offer. The Company reserves the right, in its sole discretion, to change the per share purchase price options and to increase or decrease the aggregate value of shares sought in the Offer, subject to applicable law. In accordance with the rules of the U.S. Securities and Exchange Commission (SEC), the Company may purchase in the Offer up to an additional 2% of its outstanding shares without amending or extending the Offer. The Company intends to pay for the purchase of the shares with cash on hand, cash from operations and, to the extent necessary, borrowings under its revolving credit facility. The Information Agent for the Offer is D.F. King & Co., Inc. The Depositary is American Stock Transfer & Trust Company, LLC. The Offer to Purchase, Letter of Transmittal and related documents are being mailed to stockholders of record and also will be made available for distribution to beneficial owners of shares. For questions and information, please call the Information Agent toll free at 1-866-745-0271. Goldman Sachs & Co. LLC is acting as Financial Advisor to the Company in connection with the Offer. Altice USAs Board of Directors has approved the Offer. However, none of Altice USA, its Board of Directors, the Information Agent, the Depositary or the Financial Advisor is making any recommendations to stockholders as to whether to tender or refrain from tendering their shares or as to the purchase price or the purchase prices at which shares may be tendered into the Offer. Stockholders must make their own decisions as to how many shares they will tender, if any, and at what price or prices to tender. In so doing, stockholders should read and evaluate carefully the information in the Offer to Purchase and in the related Letter of Transmittal. THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL SHARES OF CLASS A COMMON STOCK OF ALTICE USA, INC. THE OFFER IS BEING MADE ONLY PURSUANT TO THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS THAT ALTICE USA WILL SHORTLY BE DISTRIBUTING TO ITS STOCKHOLDERS AND FILING WITH THE SEC. STOCKHOLDERS SHOULD READ CAREFULLY THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING THE VARIOUS TERMS OF, AND CONDITIONS TO, THE OFFER. STOCKHOLDERS MAY OBTAIN A FREE COPY OF THE TENDER OFFER STATEMENT ON SCHEDULE TO, THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND OTHER DOCUMENTS THAT ALTICE USA WILL SHORTLY BE FILING WITH THE SEC AT THE SECS WEBSITE AT WWW.SEC.GOV OR BY CALLING D.F. KING & CO., INC., THE INFORMATION AGENT FOR THE OFFER, TOLL-FREE AT 1-866-745-0271. STOCKHOLDERS ARE URGED TO CAREFULLY READ THESE MATERIALS PRIOR TO MAKING ANY DECISION WITH RESPECT TO THE OFFER. About Altice USA Altice USA is one of the largest broadband communications and video services providers in the United States, delivering broadband, video, mobile, proprietary content and advertising services to more than 5 million residential and business customers across 21 states through its Optimum and Suddenlink brands. The company operates a4, an advanced advertising and data business, which provides audience-based, multiscreen advertising solutions to local, regional and national businesses and advertising clients. Altice USA also offers hyper-local, national, international and business news through its News 12, Cheddar and i24NEWS networks. FORWARD-LOOKING STATEMENTS Certain statements in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts contained in this release. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "anticipate", "believe", "could", "estimate", "expect", "forecast", "intend", "may", "plan", "project", "should" or "will" or, in each case, their negative, or other variations or comparable terminology. Where, in any forward-looking statement, we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. To the extent that statements in this release are not recitations of historical fact, such statements constitute forward-looking statements, which, by definition, involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements including risks referred to in our most recently filed Annual Report on Form 10-K and in our most recently filed Quarterly Report on Form 10-Q. You are cautioned to not place undue reliance on Altice USAs forward-looking statements. Any forward-looking statement speaks only as of the date on which it was made. Altice USA specifically disclaims any obligation to publicly update or revise any forward-looking statement, as of any future date. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Altice USA Announces Commencement of Tender Offer to Repurchase up to $2.5 Billion of Its Class A Common Stock.<|eot_id|>

edtsum839

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BOCA RATON, Fla., June 1, 2020 /PRNewswire/ --AE Industrial Partners, LP ("AEI"), a private equity firm specializing in Aerospace, Defense & Government Services, Power Generation, and Specialty Industrial markets, announced today that it has acquired Deep Space Systems ("DSS" or the "Company"), a pioneer in the space industry providing mission-critical payloads, systems, and components. AEI will combine Deep Space Systems with Adcole Space to form Redwire, a next generation space technology platform focused on designing and developing mission critical systems and high reliability electronics in support of the next generation space architecture. AEI acquired Adcole Space in March 2020. Founded in 2001 and based in Littleton, Colorado, DSS supports the design, development, integration, testing, and operations of advanced space systems, components, and exploration spacecraft. The Company's products include integrated spacecraft, fully qualified payloads, spacecraft elements, data acquisition and recovery systems, ground support equipment, and embedded software. DSS professionals have worked on many of the most notable U.S. spacecraft and space system projects including the Space Shuttle, ISS, Orion, Dream Chaser, many planetary exploration missions, and several large classified programs. Adcole Space has been at the forefront of space exploration since its founding in 1957, providing satellite components that are integral to the mission success of hundreds of low-earth orbit (LEO), geosynchronous (GEO) and interplanetary spacecraft. Adcole Space has been an essential part of many space missions including voyages to Mercury, Mars, Jupiter, Saturn, and Pluto. Redwire will combine the capabilities of both DSS and Adcole Space to form a unique and exciting participant in the rapidly growing space industry. The additional scale and complementary capabilities will provide significant value to both companies' respective customer bases. "DSS and Adcole Space have been at the forefront of space exploration for decades and together, as part of a single space focused company in Redwire, have the unmatched flight heritage and demonstrated innovation to address the growing demand for the next generation of space systems and components," said Peter Cannito, an Operating Partner at AEI. "Combining DSS with Adcole Space to form Redwire will provide opportunities for current employees of DSS to contribute and build a truly one of a kind space company with unlimited potential," said Steve Bailey, President of DSS. "The combination of our businesses will enable us to offer our customers a one-stop shop for complex space exploration products and services." "When AEI acquired Adcole Space earlier this year, we saw an opportunity to build an innovative and unique space technology platform, and with the acquisition of DSS, we are pleased that we have been able to launch Redwire, an exciting and unparalleled new industry leader in space," said Kirk Konert, a Partner at AEI. BRG served as the financial advisor and Akerman LLP served as the legal advisor to AEI. Holland & Hart LLP served as the legal advisor to DSS. About Deep Space SystemsHeadquartered in Littleton, Colorado, Deep Space Systems ("DSS" or the "Company") is a leader in space systems engineering supporting the design, development, integration, testing, and operations of science, technology, and exploration spacecraft. The Company's products range from integrated spacecraft to fully qualified space components to ground support equipment and software. Its advanced engineering capabilities include design and analysis of space systems and subsystems including Structures, Mechanisms, Propulsion, Power, Thermal, Telecommunications, Avionics, Optical, and Instrumentation systems. For more information, please visit www.deepspacesystems.com. About Redwire Formed by the combination of Adcole Space and Deep Space Systems, Redwire is a new leader in mission critical space solutions and high reliability components for next generation space architecture. With decades of flight heritage combined with the agile and innovative culture of a new space platform, Redwire is uniquely positioned to assist its customers in solving the complex challenges of future space missions. For more information, please visit www.redwire.space. About AE Industrial PartnersAE Industrial Partners is a private equity firm specializing in Aerospace, Defense & Government Services, Power Generation, and Specialty Industrial markets. AE Industrial Partners invests in market-leading companies that can benefit from our deep industry knowledge, operating experience, and relationships throughout our target markets. Learn more at www.aeroequity.com. CONTACT: Lambert & Co.Jennifer Hurson(845) 507-0571[emailprotected] or Kristin Celauro(732) 433-5200[emailprotected] SOURCE AE Industrial Partners Related Links https://www.aeroequity.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

AE Industrial Partners acquires Deep Space Systems. Combines Deep Space Systems with Adcole Space to create Redwire, a next generation space technology platform.

BOCA RATON, Fla., June 1, 2020 /PRNewswire/ --AE Industrial Partners, LP ("AEI"), a private equity firm specializing in Aerospace, Defense & Government Services, Power Generation, and Specialty Industrial markets, announced today that it has acquired Deep Space Systems ("DSS" or the "Company"), a pioneer in the space industry providing mission-critical payloads, systems, and components. AEI will combine Deep Space Systems with Adcole Space to form Redwire, a next generation space technology platform focused on designing and developing mission critical systems and high reliability electronics in support of the next generation space architecture. AEI acquired Adcole Space in March 2020. Founded in 2001 and based in Littleton, Colorado, DSS supports the design, development, integration, testing, and operations of advanced space systems, components, and exploration spacecraft. The Company's products include integrated spacecraft, fully qualified payloads, spacecraft elements, data acquisition and recovery systems, ground support equipment, and embedded software. DSS professionals have worked on many of the most notable U.S. spacecraft and space system projects including the Space Shuttle, ISS, Orion, Dream Chaser, many planetary exploration missions, and several large classified programs. Adcole Space has been at the forefront of space exploration since its founding in 1957, providing satellite components that are integral to the mission success of hundreds of low-earth orbit (LEO), geosynchronous (GEO) and interplanetary spacecraft. Adcole Space has been an essential part of many space missions including voyages to Mercury, Mars, Jupiter, Saturn, and Pluto. Redwire will combine the capabilities of both DSS and Adcole Space to form a unique and exciting participant in the rapidly growing space industry. The additional scale and complementary capabilities will provide significant value to both companies' respective customer bases. "DSS and Adcole Space have been at the forefront of space exploration for decades and together, as part of a single space focused company in Redwire, have the unmatched flight heritage and demonstrated innovation to address the growing demand for the next generation of space systems and components," said Peter Cannito, an Operating Partner at AEI. "Combining DSS with Adcole Space to form Redwire will provide opportunities for current employees of DSS to contribute and build a truly one of a kind space company with unlimited potential," said Steve Bailey, President of DSS. "The combination of our businesses will enable us to offer our customers a one-stop shop for complex space exploration products and services." "When AEI acquired Adcole Space earlier this year, we saw an opportunity to build an innovative and unique space technology platform, and with the acquisition of DSS, we are pleased that we have been able to launch Redwire, an exciting and unparalleled new industry leader in space," said Kirk Konert, a Partner at AEI. BRG served as the financial advisor and Akerman LLP served as the legal advisor to AEI. Holland & Hart LLP served as the legal advisor to DSS. About Deep Space SystemsHeadquartered in Littleton, Colorado, Deep Space Systems ("DSS" or the "Company") is a leader in space systems engineering supporting the design, development, integration, testing, and operations of science, technology, and exploration spacecraft. The Company's products range from integrated spacecraft to fully qualified space components to ground support equipment and software. Its advanced engineering capabilities include design and analysis of space systems and subsystems including Structures, Mechanisms, Propulsion, Power, Thermal, Telecommunications, Avionics, Optical, and Instrumentation systems. For more information, please visit www.deepspacesystems.com. About Redwire Formed by the combination of Adcole Space and Deep Space Systems, Redwire is a new leader in mission critical space solutions and high reliability components for next generation space architecture. With decades of flight heritage combined with the agile and innovative culture of a new space platform, Redwire is uniquely positioned to assist its customers in solving the complex challenges of future space missions. For more information, please visit www.redwire.space. About AE Industrial PartnersAE Industrial Partners is a private equity firm specializing in Aerospace, Defense & Government Services, Power Generation, and Specialty Industrial markets. AE Industrial Partners invests in market-leading companies that can benefit from our deep industry knowledge, operating experience, and relationships throughout our target markets. Learn more at www.aeroequity.com. CONTACT: Lambert & Co.Jennifer Hurson(845) 507-0571[emailprotected] or Kristin Celauro(732) 433-5200[emailprotected] SOURCE AE Industrial Partners Related Links https://www.aeroequity.com

AE Industrial Partners Acquires Deep Space Systems Combines Deep Space Systems with Adcole Space to Create Redwire, a Next Generation Space Technology Platform

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BOCA RATON, Fla., June 1, 2020 /PRNewswire/ --AE Industrial Partners, LP ("AEI"), a private equity firm specializing in Aerospace, Defense & Government Services, Power Generation, and Specialty Industrial markets, announced today that it has acquired Deep Space Systems ("DSS" or the "Company"), a pioneer in the space industry providing mission-critical payloads, systems, and components. AEI will combine Deep Space Systems with Adcole Space to form Redwire, a next generation space technology platform focused on designing and developing mission critical systems and high reliability electronics in support of the next generation space architecture. AEI acquired Adcole Space in March 2020. Founded in 2001 and based in Littleton, Colorado, DSS supports the design, development, integration, testing, and operations of advanced space systems, components, and exploration spacecraft. The Company's products include integrated spacecraft, fully qualified payloads, spacecraft elements, data acquisition and recovery systems, ground support equipment, and embedded software. DSS professionals have worked on many of the most notable U.S. spacecraft and space system projects including the Space Shuttle, ISS, Orion, Dream Chaser, many planetary exploration missions, and several large classified programs. Adcole Space has been at the forefront of space exploration since its founding in 1957, providing satellite components that are integral to the mission success of hundreds of low-earth orbit (LEO), geosynchronous (GEO) and interplanetary spacecraft. Adcole Space has been an essential part of many space missions including voyages to Mercury, Mars, Jupiter, Saturn, and Pluto. Redwire will combine the capabilities of both DSS and Adcole Space to form a unique and exciting participant in the rapidly growing space industry. The additional scale and complementary capabilities will provide significant value to both companies' respective customer bases. "DSS and Adcole Space have been at the forefront of space exploration for decades and together, as part of a single space focused company in Redwire, have the unmatched flight heritage and demonstrated innovation to address the growing demand for the next generation of space systems and components," said Peter Cannito, an Operating Partner at AEI. "Combining DSS with Adcole Space to form Redwire will provide opportunities for current employees of DSS to contribute and build a truly one of a kind space company with unlimited potential," said Steve Bailey, President of DSS. "The combination of our businesses will enable us to offer our customers a one-stop shop for complex space exploration products and services." "When AEI acquired Adcole Space earlier this year, we saw an opportunity to build an innovative and unique space technology platform, and with the acquisition of DSS, we are pleased that we have been able to launch Redwire, an exciting and unparalleled new industry leader in space," said Kirk Konert, a Partner at AEI. BRG served as the financial advisor and Akerman LLP served as the legal advisor to AEI. Holland & Hart LLP served as the legal advisor to DSS. About Deep Space SystemsHeadquartered in Littleton, Colorado, Deep Space Systems ("DSS" or the "Company") is a leader in space systems engineering supporting the design, development, integration, testing, and operations of science, technology, and exploration spacecraft. The Company's products range from integrated spacecraft to fully qualified space components to ground support equipment and software. Its advanced engineering capabilities include design and analysis of space systems and subsystems including Structures, Mechanisms, Propulsion, Power, Thermal, Telecommunications, Avionics, Optical, and Instrumentation systems. For more information, please visit www.deepspacesystems.com. About Redwire Formed by the combination of Adcole Space and Deep Space Systems, Redwire is a new leader in mission critical space solutions and high reliability components for next generation space architecture. With decades of flight heritage combined with the agile and innovative culture of a new space platform, Redwire is uniquely positioned to assist its customers in solving the complex challenges of future space missions. For more information, please visit www.redwire.space. About AE Industrial PartnersAE Industrial Partners is a private equity firm specializing in Aerospace, Defense & Government Services, Power Generation, and Specialty Industrial markets. AE Industrial Partners invests in market-leading companies that can benefit from our deep industry knowledge, operating experience, and relationships throughout our target markets. Learn more at www.aeroequity.com. CONTACT: Lambert & Co.Jennifer Hurson(845) 507-0571[emailprotected] or Kristin Celauro(732) 433-5200[emailprotected] SOURCE AE Industrial Partners Related Links https://www.aeroequity.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> AE Industrial Partners acquires Deep Space Systems. Combines Deep Space Systems with Adcole Space to create Redwire, a next generation space technology platform.<|eot_id|>

edtsum840

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LAVAL, QC and CAMBRIDGE, England, June 30, 2020 /PRNewswire/ -Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, today announced that Prometic Plasma Resources, a subsidiary of Liminal BioSciences, has commenced the collection of convalescent plasma from donors who have recovered from COVID-19. "Recent published studies have indicated immune globulin and hyperimmune globulin therapy to have the potential to be one of the treatment options for patients with COVID-19. We are proud to be collecting COVID-19 convalescent plasma to be potentially used in the manufacture of hyperimmune immunoglobulins by third parties and be a part of this historic effort which aims to accelerate a reliable, scalable and sustainable option for patients suffering from the impact of COVID-19.", stated Kenneth Galbraith, Chief Executive Officer of Liminal BioSciences. "We expect that developing a hyperimmune will require third parties to collect plasma donations from many individuals who have fully recovered from COVID-19 and we encourage anyone who has recovered from COVID-19 without symptoms for 14 days to come forward and donate plasma to this worthy cause." Individuals interested in donating plasma can visit the nearest licensed plasma collection center to their location. For more information visit plasma.prometic.com. About Liminal BioSciences Inc.Liminal BioSciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis, including respiratory, liver and kidney diseases that have high unmet medical need. Liminal BioSciences has a deep understanding of certain biological targets and pathways that have been implicated in the fibrotic process, including fatty acid receptors such as FFAR1, or GPR40, G-protein-coupled receptor 84, or GPR84, and peroxisome proliferator-activated receptors, or PPARs. In preclinical studies, we observed that targeting these receptors promoted normal tissue regeneration and scar resolution, including preventing the progression of and reversing established fibrosis. We also have encouraging clinical data that we believe supports the translatability of our preclinical data observations to the clinic. We have leveraged this understanding, as well as our experience with generating small molecules, to build a pipeline of differentiated product candidates. Our lead small molecule product candidate, fezagepras (PBI-4050), is expected to enter an additional Phase 1 clinical trial in 2H-2020 to evaluate multiple ascending doses of fezagepras in healthy volunteers, at daily dose exposures higher than those previously evaluated in our completed Phase 1 and Phase 2 clinical trials. Liminal BioSciences has also leveraged its experience in bioseparation technologies through its subsidiary Prometic Bioproduction Inc. to isolate and purify biopharmaceuticals from human plasma. Our lead plasma-derived product candidate is Ryplazim(plasminogen), for which the Company expects to resubmit a BLA in Q3-2020 with the FDA seeking approval to treat patients with congenital plasminogen deficiency. Prometic Plasma Resources operates two plasma collection centers in North America managed by a team of qualified professionals with decades of experience in the field of plasma collection. Our Canadian center located in Winnipeg, Manitoba is licensed by the FDA and Health Canada, and is certified by the European Union and the Plasma Protein Therapeutics Association (PPTA). Our American center located in Amherst, New York is licensed by the State of New York and its' BLA submission is currently under review by the FDA. Liminal BioSciences has active business operations in Canada, the United Kingdom and the United States. Forward Looking StatementThis press release contains forward-looking statements about Liminal BioSciences' objectives, strategies and businesses that involve risks and uncertainties. Forwardlooking information includes statements concerning, among other things, statements with respect to the timing of any planned BLA resubmission, development of R&D programs, the timing of initiation of clinical trials, the exploration of alternatives for the future commercialization of Ryplazim, if approved, including through a third-party marketing collaboration, and the potential commercial launch of Ryplazim, if approved. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. At this stage, the product candidates of the Company have not been authorized for sale in any country. Among the factors that could cause actual results to differ materially from those described or projected herein include, but are not limited to, Liminal BioSciences' ability to develop, manufacture, and successfully commercialize product candidates if ever, the impact of the COVID-19 crisis on its business operations, clinical development, regulatory activities and financial and other corporate impacts, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical trials, the ability of Liminal BioSciences to take advantage of business opportunities in the pharmaceutical industry, uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals and general changes in economic conditions. You will find a more detailed assessment of these risks, uncertainties and other risks that could cause actual events or results to materially differ from our current expectations in the Company's U.S. Securities and Exchange Commission and Canadian Securities Commissions filings and reports filings and reports, including in the Annual Report on Form 20-F for the year ended December 31, 2019 and future filings and reports by the Company, from time to time. As a result, we cannot guarantee that any forward-looking statement will materialize. Such risks may be amplified by the COVID-19 pandemic and its potential impact on Liminal BioSciences' business and the global economy. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date hereof.We assume no obligation to update any forward-looking statement contained in this Press Release even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations. SOURCE Liminal BioSciences Inc. Related Links https://liminalbiosciences.com/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Liminal BioSciences Commences Collection of Convalescent Plasma from COVID-19 Recovered Donors.

LAVAL, QC and CAMBRIDGE, England, June 30, 2020 /PRNewswire/ -Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, today announced that Prometic Plasma Resources, a subsidiary of Liminal BioSciences, has commenced the collection of convalescent plasma from donors who have recovered from COVID-19. "Recent published studies have indicated immune globulin and hyperimmune globulin therapy to have the potential to be one of the treatment options for patients with COVID-19. We are proud to be collecting COVID-19 convalescent plasma to be potentially used in the manufacture of hyperimmune immunoglobulins by third parties and be a part of this historic effort which aims to accelerate a reliable, scalable and sustainable option for patients suffering from the impact of COVID-19.", stated Kenneth Galbraith, Chief Executive Officer of Liminal BioSciences. "We expect that developing a hyperimmune will require third parties to collect plasma donations from many individuals who have fully recovered from COVID-19 and we encourage anyone who has recovered from COVID-19 without symptoms for 14 days to come forward and donate plasma to this worthy cause." Individuals interested in donating plasma can visit the nearest licensed plasma collection center to their location. For more information visit plasma.prometic.com. About Liminal BioSciences Inc.Liminal BioSciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis, including respiratory, liver and kidney diseases that have high unmet medical need. Liminal BioSciences has a deep understanding of certain biological targets and pathways that have been implicated in the fibrotic process, including fatty acid receptors such as FFAR1, or GPR40, G-protein-coupled receptor 84, or GPR84, and peroxisome proliferator-activated receptors, or PPARs. In preclinical studies, we observed that targeting these receptors promoted normal tissue regeneration and scar resolution, including preventing the progression of and reversing established fibrosis. We also have encouraging clinical data that we believe supports the translatability of our preclinical data observations to the clinic. We have leveraged this understanding, as well as our experience with generating small molecules, to build a pipeline of differentiated product candidates. Our lead small molecule product candidate, fezagepras (PBI-4050), is expected to enter an additional Phase 1 clinical trial in 2H-2020 to evaluate multiple ascending doses of fezagepras in healthy volunteers, at daily dose exposures higher than those previously evaluated in our completed Phase 1 and Phase 2 clinical trials. Liminal BioSciences has also leveraged its experience in bioseparation technologies through its subsidiary Prometic Bioproduction Inc. to isolate and purify biopharmaceuticals from human plasma. Our lead plasma-derived product candidate is Ryplazim(plasminogen), for which the Company expects to resubmit a BLA in Q3-2020 with the FDA seeking approval to treat patients with congenital plasminogen deficiency. Prometic Plasma Resources operates two plasma collection centers in North America managed by a team of qualified professionals with decades of experience in the field of plasma collection. Our Canadian center located in Winnipeg, Manitoba is licensed by the FDA and Health Canada, and is certified by the European Union and the Plasma Protein Therapeutics Association (PPTA). Our American center located in Amherst, New York is licensed by the State of New York and its' BLA submission is currently under review by the FDA. Liminal BioSciences has active business operations in Canada, the United Kingdom and the United States. Forward Looking StatementThis press release contains forward-looking statements about Liminal BioSciences' objectives, strategies and businesses that involve risks and uncertainties. Forwardlooking information includes statements concerning, among other things, statements with respect to the timing of any planned BLA resubmission, development of R&D programs, the timing of initiation of clinical trials, the exploration of alternatives for the future commercialization of Ryplazim, if approved, including through a third-party marketing collaboration, and the potential commercial launch of Ryplazim, if approved. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. At this stage, the product candidates of the Company have not been authorized for sale in any country. Among the factors that could cause actual results to differ materially from those described or projected herein include, but are not limited to, Liminal BioSciences' ability to develop, manufacture, and successfully commercialize product candidates if ever, the impact of the COVID-19 crisis on its business operations, clinical development, regulatory activities and financial and other corporate impacts, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical trials, the ability of Liminal BioSciences to take advantage of business opportunities in the pharmaceutical industry, uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals and general changes in economic conditions. You will find a more detailed assessment of these risks, uncertainties and other risks that could cause actual events or results to materially differ from our current expectations in the Company's U.S. Securities and Exchange Commission and Canadian Securities Commissions filings and reports filings and reports, including in the Annual Report on Form 20-F for the year ended December 31, 2019 and future filings and reports by the Company, from time to time. As a result, we cannot guarantee that any forward-looking statement will materialize. Such risks may be amplified by the COVID-19 pandemic and its potential impact on Liminal BioSciences' business and the global economy. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date hereof.We assume no obligation to update any forward-looking statement contained in this Press Release even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations. SOURCE Liminal BioSciences Inc. Related Links https://liminalbiosciences.com/

Liminal BioSciences Commences Collection of Convalescent Plasma from COVID-19 Recovered Donors

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LAVAL, QC and CAMBRIDGE, England, June 30, 2020 /PRNewswire/ -Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, today announced that Prometic Plasma Resources, a subsidiary of Liminal BioSciences, has commenced the collection of convalescent plasma from donors who have recovered from COVID-19. "Recent published studies have indicated immune globulin and hyperimmune globulin therapy to have the potential to be one of the treatment options for patients with COVID-19. We are proud to be collecting COVID-19 convalescent plasma to be potentially used in the manufacture of hyperimmune immunoglobulins by third parties and be a part of this historic effort which aims to accelerate a reliable, scalable and sustainable option for patients suffering from the impact of COVID-19.", stated Kenneth Galbraith, Chief Executive Officer of Liminal BioSciences. "We expect that developing a hyperimmune will require third parties to collect plasma donations from many individuals who have fully recovered from COVID-19 and we encourage anyone who has recovered from COVID-19 without symptoms for 14 days to come forward and donate plasma to this worthy cause." Individuals interested in donating plasma can visit the nearest licensed plasma collection center to their location. For more information visit plasma.prometic.com. About Liminal BioSciences Inc.Liminal BioSciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis, including respiratory, liver and kidney diseases that have high unmet medical need. Liminal BioSciences has a deep understanding of certain biological targets and pathways that have been implicated in the fibrotic process, including fatty acid receptors such as FFAR1, or GPR40, G-protein-coupled receptor 84, or GPR84, and peroxisome proliferator-activated receptors, or PPARs. In preclinical studies, we observed that targeting these receptors promoted normal tissue regeneration and scar resolution, including preventing the progression of and reversing established fibrosis. We also have encouraging clinical data that we believe supports the translatability of our preclinical data observations to the clinic. We have leveraged this understanding, as well as our experience with generating small molecules, to build a pipeline of differentiated product candidates. Our lead small molecule product candidate, fezagepras (PBI-4050), is expected to enter an additional Phase 1 clinical trial in 2H-2020 to evaluate multiple ascending doses of fezagepras in healthy volunteers, at daily dose exposures higher than those previously evaluated in our completed Phase 1 and Phase 2 clinical trials. Liminal BioSciences has also leveraged its experience in bioseparation technologies through its subsidiary Prometic Bioproduction Inc. to isolate and purify biopharmaceuticals from human plasma. Our lead plasma-derived product candidate is Ryplazim(plasminogen), for which the Company expects to resubmit a BLA in Q3-2020 with the FDA seeking approval to treat patients with congenital plasminogen deficiency. Prometic Plasma Resources operates two plasma collection centers in North America managed by a team of qualified professionals with decades of experience in the field of plasma collection. Our Canadian center located in Winnipeg, Manitoba is licensed by the FDA and Health Canada, and is certified by the European Union and the Plasma Protein Therapeutics Association (PPTA). Our American center located in Amherst, New York is licensed by the State of New York and its' BLA submission is currently under review by the FDA. Liminal BioSciences has active business operations in Canada, the United Kingdom and the United States. Forward Looking StatementThis press release contains forward-looking statements about Liminal BioSciences' objectives, strategies and businesses that involve risks and uncertainties. Forwardlooking information includes statements concerning, among other things, statements with respect to the timing of any planned BLA resubmission, development of R&D programs, the timing of initiation of clinical trials, the exploration of alternatives for the future commercialization of Ryplazim, if approved, including through a third-party marketing collaboration, and the potential commercial launch of Ryplazim, if approved. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. At this stage, the product candidates of the Company have not been authorized for sale in any country. Among the factors that could cause actual results to differ materially from those described or projected herein include, but are not limited to, Liminal BioSciences' ability to develop, manufacture, and successfully commercialize product candidates if ever, the impact of the COVID-19 crisis on its business operations, clinical development, regulatory activities and financial and other corporate impacts, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical trials, the ability of Liminal BioSciences to take advantage of business opportunities in the pharmaceutical industry, uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals and general changes in economic conditions. You will find a more detailed assessment of these risks, uncertainties and other risks that could cause actual events or results to materially differ from our current expectations in the Company's U.S. Securities and Exchange Commission and Canadian Securities Commissions filings and reports filings and reports, including in the Annual Report on Form 20-F for the year ended December 31, 2019 and future filings and reports by the Company, from time to time. As a result, we cannot guarantee that any forward-looking statement will materialize. Such risks may be amplified by the COVID-19 pandemic and its potential impact on Liminal BioSciences' business and the global economy. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date hereof.We assume no obligation to update any forward-looking statement contained in this Press Release even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations. SOURCE Liminal BioSciences Inc. Related Links https://liminalbiosciences.com/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Liminal BioSciences Commences Collection of Convalescent Plasma from COVID-19 Recovered Donors.<|eot_id|>

edtsum841

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LOS ANGELES--(BUSINESS WIRE)--TriLinc Global Impact Fund, LLC (TriLinc Global Impact Fund or TGIF) announced today that it recently approved a $1,245,664 term loan transaction in Latin America. The transaction details are summarized below. TGIF is an impact investing company that provides growth-stage loans and trade finance to established small and medium enterprises (SMEs) primarily in developing economies where access to affordable capital is significantly limited. Impact investing is defined as investing with the specific objective of achieving a competitive financial return as well as creating positive, measurable impact in communities across the globe. TGIF recently approved a $1,245,664 transaction that meets TGIFs requirements for underwriting, economic development, and societal advancement, as described below: On December 3, 2020, TGIF funded $1,245,664 as part of a new five year term loan facility to a sustainable consumer lender in Colombia. Priced at 12%, the transaction is set to mature on September 3, 2025. The borrower has a network of over 20 branches throughout Colombia and a footprint of more than 4,500 clients, the majority of which are women seeking to further their purchasing power for household staple goods. By extending financing to the consumer lender in Colombia, TGIF is demonstrating its commitment to businesses that have positive environmental and social impact in Latin America, said Gloria Nelund, CEO of TGIF. More specifically, we are confident that this financing will support the daily consumer needs of segments of Colombias population - teachers and retirees - that are significantly affected by the realities of the COVID-19 pandemic, added Ms. Nelund. About TriLinc Global Impact Fund TGIF is a public non-traded, externally managed, limited liability company that makes impact investments in SMEs, primarily in developing economies, that provide the opportunity to achieve both competitive financial returns and positive measurable impact. TGIF invests in SMEs through experienced local market sub-advisors, and expects to create a diversified portfolio of financial assets consisting primarily of collateralized private debt instruments. In addition, TGIF aggregates and analyzes social, economic, and environmental impact data to track progress and measure success against stated objectives. Forward-Looking Statements This press release contains forward-looking statements (including, without limitation, statements concerning the use of financing provided to borrowers and the expected repayment of financing extended to the borrowers) that are based on TGIFs current expectations, plans, estimates, assumptions, and beliefs that involve numerous risks and uncertainties, including, without limitation, the future operating performance of the borrower and those risks set forth in the Risk Factors section of TGIFs most recent Annual Report on Form 10-K, as amended or supplemented by TGIFs other filings with the Securities and Exchange Commission. Although these forward-looking statements reflect managements belief as to future events, actual events or TGIFs investments and results of operations could differ materially from those expressed or implied in these forward-looking statements. To the extent that TGIFs assumptions differ from actual results, TGIFs ability to meet such forward-looking statements may be significantly hindered. You are cautioned not to place undue reliance on any forward-looking statements. TGIF cannot assure you that it will attain its investment objectives. Any forward-looking statements presented herein are made only as of the date of this press release, and TGIF does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

TriLinc Global Impact Fund Makes Impact Investment in Latin America. TriLinc Global Impact Fund announced today that it recently approved a $1,245,664 term loan transaction, bringing total financing commitments as of December 31, 2020, to $403 million for business expansion and socioeconomic development through its holdings in Sub-Saharan Africa, Latin America, Southeast Asia, and Emerging Europe.

LOS ANGELES--(BUSINESS WIRE)--TriLinc Global Impact Fund, LLC (TriLinc Global Impact Fund or TGIF) announced today that it recently approved a $1,245,664 term loan transaction in Latin America. The transaction details are summarized below. TGIF is an impact investing company that provides growth-stage loans and trade finance to established small and medium enterprises (SMEs) primarily in developing economies where access to affordable capital is significantly limited. Impact investing is defined as investing with the specific objective of achieving a competitive financial return as well as creating positive, measurable impact in communities across the globe. TGIF recently approved a $1,245,664 transaction that meets TGIFs requirements for underwriting, economic development, and societal advancement, as described below: On December 3, 2020, TGIF funded $1,245,664 as part of a new five year term loan facility to a sustainable consumer lender in Colombia. Priced at 12%, the transaction is set to mature on September 3, 2025. The borrower has a network of over 20 branches throughout Colombia and a footprint of more than 4,500 clients, the majority of which are women seeking to further their purchasing power for household staple goods. By extending financing to the consumer lender in Colombia, TGIF is demonstrating its commitment to businesses that have positive environmental and social impact in Latin America, said Gloria Nelund, CEO of TGIF. More specifically, we are confident that this financing will support the daily consumer needs of segments of Colombias population - teachers and retirees - that are significantly affected by the realities of the COVID-19 pandemic, added Ms. Nelund. About TriLinc Global Impact Fund TGIF is a public non-traded, externally managed, limited liability company that makes impact investments in SMEs, primarily in developing economies, that provide the opportunity to achieve both competitive financial returns and positive measurable impact. TGIF invests in SMEs through experienced local market sub-advisors, and expects to create a diversified portfolio of financial assets consisting primarily of collateralized private debt instruments. In addition, TGIF aggregates and analyzes social, economic, and environmental impact data to track progress and measure success against stated objectives. Forward-Looking Statements This press release contains forward-looking statements (including, without limitation, statements concerning the use of financing provided to borrowers and the expected repayment of financing extended to the borrowers) that are based on TGIFs current expectations, plans, estimates, assumptions, and beliefs that involve numerous risks and uncertainties, including, without limitation, the future operating performance of the borrower and those risks set forth in the Risk Factors section of TGIFs most recent Annual Report on Form 10-K, as amended or supplemented by TGIFs other filings with the Securities and Exchange Commission. Although these forward-looking statements reflect managements belief as to future events, actual events or TGIFs investments and results of operations could differ materially from those expressed or implied in these forward-looking statements. To the extent that TGIFs assumptions differ from actual results, TGIFs ability to meet such forward-looking statements may be significantly hindered. You are cautioned not to place undue reliance on any forward-looking statements. TGIF cannot assure you that it will attain its investment objectives. Any forward-looking statements presented herein are made only as of the date of this press release, and TGIF does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.

TriLinc Global Impact Fund Makes Impact Investment in Latin America TriLinc Global Impact Fund announced today that it recently approved a $1,245,664 term loan transaction, bringing total financing commitments as of December 31, 2020 to $403 million for business expansion and socioeconomic development through its holdings in Sub-Saharan Africa, Latin America, Southeast Asia, and Emerging Europe.

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LOS ANGELES--(BUSINESS WIRE)--TriLinc Global Impact Fund, LLC (TriLinc Global Impact Fund or TGIF) announced today that it recently approved a $1,245,664 term loan transaction in Latin America. The transaction details are summarized below. TGIF is an impact investing company that provides growth-stage loans and trade finance to established small and medium enterprises (SMEs) primarily in developing economies where access to affordable capital is significantly limited. Impact investing is defined as investing with the specific objective of achieving a competitive financial return as well as creating positive, measurable impact in communities across the globe. TGIF recently approved a $1,245,664 transaction that meets TGIFs requirements for underwriting, economic development, and societal advancement, as described below: On December 3, 2020, TGIF funded $1,245,664 as part of a new five year term loan facility to a sustainable consumer lender in Colombia. Priced at 12%, the transaction is set to mature on September 3, 2025. The borrower has a network of over 20 branches throughout Colombia and a footprint of more than 4,500 clients, the majority of which are women seeking to further their purchasing power for household staple goods. By extending financing to the consumer lender in Colombia, TGIF is demonstrating its commitment to businesses that have positive environmental and social impact in Latin America, said Gloria Nelund, CEO of TGIF. More specifically, we are confident that this financing will support the daily consumer needs of segments of Colombias population - teachers and retirees - that are significantly affected by the realities of the COVID-19 pandemic, added Ms. Nelund. About TriLinc Global Impact Fund TGIF is a public non-traded, externally managed, limited liability company that makes impact investments in SMEs, primarily in developing economies, that provide the opportunity to achieve both competitive financial returns and positive measurable impact. TGIF invests in SMEs through experienced local market sub-advisors, and expects to create a diversified portfolio of financial assets consisting primarily of collateralized private debt instruments. In addition, TGIF aggregates and analyzes social, economic, and environmental impact data to track progress and measure success against stated objectives. Forward-Looking Statements This press release contains forward-looking statements (including, without limitation, statements concerning the use of financing provided to borrowers and the expected repayment of financing extended to the borrowers) that are based on TGIFs current expectations, plans, estimates, assumptions, and beliefs that involve numerous risks and uncertainties, including, without limitation, the future operating performance of the borrower and those risks set forth in the Risk Factors section of TGIFs most recent Annual Report on Form 10-K, as amended or supplemented by TGIFs other filings with the Securities and Exchange Commission. Although these forward-looking statements reflect managements belief as to future events, actual events or TGIFs investments and results of operations could differ materially from those expressed or implied in these forward-looking statements. To the extent that TGIFs assumptions differ from actual results, TGIFs ability to meet such forward-looking statements may be significantly hindered. You are cautioned not to place undue reliance on any forward-looking statements. TGIF cannot assure you that it will attain its investment objectives. Any forward-looking statements presented herein are made only as of the date of this press release, and TGIF does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> TriLinc Global Impact Fund Makes Impact Investment in Latin America. TriLinc Global Impact Fund announced today that it recently approved a $1,245,664 term loan transaction, bringing total financing commitments as of December 31, 2020, to $403 million for business expansion and socioeconomic development through its holdings in Sub-Saharan Africa, Latin America, Southeast Asia, and Emerging Europe.<|eot_id|>

edtsum842

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN FRANCISCO, July 27, 2020 /PRNewswire/ --Hero Digital, a leading independent digital customer experience (CX) company, today announced Hank Summy will join the company as managing director of its Western region, reporting to Hero Digital President Patrick Frend. Summy brings over 25 years of experience advising leading brands on their marketing and digital transformations including The United States Postal Service, Subway, Godiva, and Jose Cuervo. Summy joins Hero Digital from Capgemini where he most recently served as Executive Vice President of the Consumer Products, Retail, and Wholesale market unit for North America. Prior to Capgemini, Summy held leadership roles at Interpublic Group, including President of MRM//McCann and President of McCann North America. Prior to McCann, he was Managing Director of Sapient, and led the company's Eastern United States region. "We have built a company that is indispensable to business leaders of today's most valuable brands," said David Kilimnik CEO of Hero Digital. "Hank's experience in bringing a full experience-driven growth proposition to the marketplace is second-to-none. We are thrilled to have Hank be our market leader in the West." Patrick Frend, President of Hero Digital, added: "Creating impactful customer experiences that delight and serve customers while delivering business results requires a rare combination of business consulting, brand strategy, design thinking, and technology prowess. Hank brings deep experience across the entire spectrum which will both accelerate the progress of our agency and bring great value to our clients." "Customer experience is core to today's leading brands and important to their performance as they define new ways to differentiate and grow," said Hank Summy, Managing Director of Hero Digital. "Hero Digital has been at the center of creating compelling digital experiences since it was formed, and I'm excited to join the company during this important time." About Hero Digital Hero Digital is a leading independent customer experience company founded in California at the intersection of business, design, and technology. Hero Digital works with the C-Suite of the Fortune 500 to drive transformational business growth through superior customer experiences that deliver brand and consumer value. A trusted advisor to the world's best brands like Comcast, U.S. Bank, Twitter, Salesforce, Sephora, and TD Ameritrade. For more information, visit http://www.herodigital.com. SOURCE Hero Digital, LLC Related Links www.herodigital.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Hero Digital LLC hires Hank Summy, former McCann and Capgemini executive, to lead Western Region.

SAN FRANCISCO, July 27, 2020 /PRNewswire/ --Hero Digital, a leading independent digital customer experience (CX) company, today announced Hank Summy will join the company as managing director of its Western region, reporting to Hero Digital President Patrick Frend. Summy brings over 25 years of experience advising leading brands on their marketing and digital transformations including The United States Postal Service, Subway, Godiva, and Jose Cuervo. Summy joins Hero Digital from Capgemini where he most recently served as Executive Vice President of the Consumer Products, Retail, and Wholesale market unit for North America. Prior to Capgemini, Summy held leadership roles at Interpublic Group, including President of MRM//McCann and President of McCann North America. Prior to McCann, he was Managing Director of Sapient, and led the company's Eastern United States region. "We have built a company that is indispensable to business leaders of today's most valuable brands," said David Kilimnik CEO of Hero Digital. "Hank's experience in bringing a full experience-driven growth proposition to the marketplace is second-to-none. We are thrilled to have Hank be our market leader in the West." Patrick Frend, President of Hero Digital, added: "Creating impactful customer experiences that delight and serve customers while delivering business results requires a rare combination of business consulting, brand strategy, design thinking, and technology prowess. Hank brings deep experience across the entire spectrum which will both accelerate the progress of our agency and bring great value to our clients." "Customer experience is core to today's leading brands and important to their performance as they define new ways to differentiate and grow," said Hank Summy, Managing Director of Hero Digital. "Hero Digital has been at the center of creating compelling digital experiences since it was formed, and I'm excited to join the company during this important time." About Hero Digital Hero Digital is a leading independent customer experience company founded in California at the intersection of business, design, and technology. Hero Digital works with the C-Suite of the Fortune 500 to drive transformational business growth through superior customer experiences that deliver brand and consumer value. A trusted advisor to the world's best brands like Comcast, U.S. Bank, Twitter, Salesforce, Sephora, and TD Ameritrade. For more information, visit http://www.herodigital.com. SOURCE Hero Digital, LLC Related Links www.herodigital.com

Hero Digital LLC hires Hank Summy, former McCann and Capgemini executive, to lead Western Region

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN FRANCISCO, July 27, 2020 /PRNewswire/ --Hero Digital, a leading independent digital customer experience (CX) company, today announced Hank Summy will join the company as managing director of its Western region, reporting to Hero Digital President Patrick Frend. Summy brings over 25 years of experience advising leading brands on their marketing and digital transformations including The United States Postal Service, Subway, Godiva, and Jose Cuervo. Summy joins Hero Digital from Capgemini where he most recently served as Executive Vice President of the Consumer Products, Retail, and Wholesale market unit for North America. Prior to Capgemini, Summy held leadership roles at Interpublic Group, including President of MRM//McCann and President of McCann North America. Prior to McCann, he was Managing Director of Sapient, and led the company's Eastern United States region. "We have built a company that is indispensable to business leaders of today's most valuable brands," said David Kilimnik CEO of Hero Digital. "Hank's experience in bringing a full experience-driven growth proposition to the marketplace is second-to-none. We are thrilled to have Hank be our market leader in the West." Patrick Frend, President of Hero Digital, added: "Creating impactful customer experiences that delight and serve customers while delivering business results requires a rare combination of business consulting, brand strategy, design thinking, and technology prowess. Hank brings deep experience across the entire spectrum which will both accelerate the progress of our agency and bring great value to our clients." "Customer experience is core to today's leading brands and important to their performance as they define new ways to differentiate and grow," said Hank Summy, Managing Director of Hero Digital. "Hero Digital has been at the center of creating compelling digital experiences since it was formed, and I'm excited to join the company during this important time." About Hero Digital Hero Digital is a leading independent customer experience company founded in California at the intersection of business, design, and technology. Hero Digital works with the C-Suite of the Fortune 500 to drive transformational business growth through superior customer experiences that deliver brand and consumer value. A trusted advisor to the world's best brands like Comcast, U.S. Bank, Twitter, Salesforce, Sephora, and TD Ameritrade. For more information, visit http://www.herodigital.com. SOURCE Hero Digital, LLC Related Links www.herodigital.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Hero Digital LLC hires Hank Summy, former McCann and Capgemini executive, to lead Western Region.<|eot_id|>

edtsum843

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "China Games Hardware and Infrastructure" report has been added to ResearchAndMarkets.com's offering. Understanding the hardware that gamers will use to access and play games, and the internet infrastructure available to gamers and game operators is critical for success in China. Rankings and revenue are only part of the story. To really understand a market you need to understand gamers and their behavior, the regulations that govern the market, and the available infrastructure and hardware on which gaming depends. This report delivers a detailed look at the internet infrastructure, hardware, devices, and components that enable gaming in China, how the landscape is changing and what this means for developers, publishers, hardware companies, service providers, investors, and others looking to understand the direction of the industry. What's included: The addressable market, hardware usage, and consumer demand for hardware and infrastructure including ownership, usage, and purchase intent, and purchase decision influences for PC, console, mobile device, GPU/CPU, and accessories; trends, connectivity, and bandwidth available to gamers, the impact of 5G, and more. Key takeaways from the analysis: Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/3smw8l Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

China Games Hardware and Infrastructure Market Report 2020 - ResearchAndMarkets.com.

DUBLIN--(BUSINESS WIRE)--The "China Games Hardware and Infrastructure" report has been added to ResearchAndMarkets.com's offering. Understanding the hardware that gamers will use to access and play games, and the internet infrastructure available to gamers and game operators is critical for success in China. Rankings and revenue are only part of the story. To really understand a market you need to understand gamers and their behavior, the regulations that govern the market, and the available infrastructure and hardware on which gaming depends. This report delivers a detailed look at the internet infrastructure, hardware, devices, and components that enable gaming in China, how the landscape is changing and what this means for developers, publishers, hardware companies, service providers, investors, and others looking to understand the direction of the industry. What's included: The addressable market, hardware usage, and consumer demand for hardware and infrastructure including ownership, usage, and purchase intent, and purchase decision influences for PC, console, mobile device, GPU/CPU, and accessories; trends, connectivity, and bandwidth available to gamers, the impact of 5G, and more. Key takeaways from the analysis: Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/3smw8l

China Games Hardware and Infrastructure Market Report 2020 - ResearchAndMarkets.com

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "China Games Hardware and Infrastructure" report has been added to ResearchAndMarkets.com's offering. Understanding the hardware that gamers will use to access and play games, and the internet infrastructure available to gamers and game operators is critical for success in China. Rankings and revenue are only part of the story. To really understand a market you need to understand gamers and their behavior, the regulations that govern the market, and the available infrastructure and hardware on which gaming depends. This report delivers a detailed look at the internet infrastructure, hardware, devices, and components that enable gaming in China, how the landscape is changing and what this means for developers, publishers, hardware companies, service providers, investors, and others looking to understand the direction of the industry. What's included: The addressable market, hardware usage, and consumer demand for hardware and infrastructure including ownership, usage, and purchase intent, and purchase decision influences for PC, console, mobile device, GPU/CPU, and accessories; trends, connectivity, and bandwidth available to gamers, the impact of 5G, and more. Key takeaways from the analysis: Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/3smw8l Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> China Games Hardware and Infrastructure Market Report 2020 - ResearchAndMarkets.com.<|eot_id|>

edtsum844

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: STOCKHOLM, July 27, 2020 /PRNewswire/ -- Sweden-based localization and software company LocalizeDirect announces an investment of SEK10,264,530 (USD1,130,802) from Entreprenrinvest, owned by The IKEA Family Foundation and a number of Swedish venture capital firms and private individuals, including Innovum Invest. Former investors also participated in the financing round. Jan Andersson, a founder and former CEO of ReadSoft (now Kofax), will join LocalizeDirect's Board of Directors. The funding will support the launch and development of Gridly - a collaborative headless CMS for multilingual game projects. Gridly is currently in beta and will be released in September 2020. "The trend we've seen for the last few years is a shift to a continuous development of games - games as a service. Instead of a one-time launch, developers now push out new content frequently, often on a weekly basis, in multiple languages. Managing game data (such as strings, IAP, gameplay variables) for agile multiplatform and multilanguage releases is time-consuming and can rapidly spiral out of control. Gridly facilitates this process, allowing the product teams to cooperate more efficiently time- and cost-wise," says LocalizeDirect's Managing Director Christoffer Nilsson. Gridly has an open API, spreadsheet UI and features version control, branching, granular user access control and localization support. LocalizeDirect offers development companies plans depending on their project's sizes, starting with a free tier. "The demand for agile, high-quality localization technology and services will continue to grow. It is already a key success factor in the game industry, but it is evident that the need for localization also grows fast in many other areas. LocalizeDirect is very well positioned to grow in this market and Gridly has the potential to become the preferred solution for many companies in many industries," Jan Andersson, the Board Member of Entreprenrinvest and Innovum Invest underlines. About LocalizeDirect:LocalizeDirect is a Swedish localization and technology company. Founded in 2009, it now provides game translation, LQA, and CMS services for the game development industry in over 65 language pairs. LocalizeDirect is based in Sweden and Vietnam with a number of sales, localization & QA managers working across the globe. Find out more about Gridly at www.gridly.com About Entreprenrinvest: Entreprenrinvest is wholly owned by The IKEA Family Foundation. It specializes in investments into small- and medium-sized enterprises outside metropolitan areas of Sweden. About Innovum Invest:Innovum Invest is based in Helsingborg and provides capital, networks and expertise for Southern Swedish companies. Contacts:Myroslava Zaiets[emailprotected]+46 (0)42 181962 This information was brought to you by Cision http://news.cision.com https://news.cision.com/localize-direct-ab/r/localizedirect-raises--1-1-million-for-gridly---a-headless-cms-tailor-made-for-game-developers,c3160091 The following files are available for download: https://mb.cision.com/Main/19671/3160091/1284120.pdf Release https://news.cision.com/localize-direct-ab/i/mattias-christoffer-founders-localizedirect,c2808306 Mattias Christoffer Founders LocalizeDirect https://news.cision.com/localize-direct-ab/i/gridly-logo-vertical-400,c2808305 gridly logo vertical 400 SOURCE Localize Direct AB Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

LocalizeDirect Raises $1.1 Million for Gridly - a Headless CMS Tailor-made for Game Developers. Gridly is the response to industry requirements as it shifts to games as a service model.

STOCKHOLM, July 27, 2020 /PRNewswire/ -- Sweden-based localization and software company LocalizeDirect announces an investment of SEK10,264,530 (USD1,130,802) from Entreprenrinvest, owned by The IKEA Family Foundation and a number of Swedish venture capital firms and private individuals, including Innovum Invest. Former investors also participated in the financing round. Jan Andersson, a founder and former CEO of ReadSoft (now Kofax), will join LocalizeDirect's Board of Directors. The funding will support the launch and development of Gridly - a collaborative headless CMS for multilingual game projects. Gridly is currently in beta and will be released in September 2020. "The trend we've seen for the last few years is a shift to a continuous development of games - games as a service. Instead of a one-time launch, developers now push out new content frequently, often on a weekly basis, in multiple languages. Managing game data (such as strings, IAP, gameplay variables) for agile multiplatform and multilanguage releases is time-consuming and can rapidly spiral out of control. Gridly facilitates this process, allowing the product teams to cooperate more efficiently time- and cost-wise," says LocalizeDirect's Managing Director Christoffer Nilsson. Gridly has an open API, spreadsheet UI and features version control, branching, granular user access control and localization support. LocalizeDirect offers development companies plans depending on their project's sizes, starting with a free tier. "The demand for agile, high-quality localization technology and services will continue to grow. It is already a key success factor in the game industry, but it is evident that the need for localization also grows fast in many other areas. LocalizeDirect is very well positioned to grow in this market and Gridly has the potential to become the preferred solution for many companies in many industries," Jan Andersson, the Board Member of Entreprenrinvest and Innovum Invest underlines. About LocalizeDirect:LocalizeDirect is a Swedish localization and technology company. Founded in 2009, it now provides game translation, LQA, and CMS services for the game development industry in over 65 language pairs. LocalizeDirect is based in Sweden and Vietnam with a number of sales, localization & QA managers working across the globe. Find out more about Gridly at www.gridly.com About Entreprenrinvest: Entreprenrinvest is wholly owned by The IKEA Family Foundation. It specializes in investments into small- and medium-sized enterprises outside metropolitan areas of Sweden. About Innovum Invest:Innovum Invest is based in Helsingborg and provides capital, networks and expertise for Southern Swedish companies. Contacts:Myroslava Zaiets[emailprotected]+46 (0)42 181962 This information was brought to you by Cision http://news.cision.com https://news.cision.com/localize-direct-ab/r/localizedirect-raises--1-1-million-for-gridly---a-headless-cms-tailor-made-for-game-developers,c3160091 The following files are available for download: https://mb.cision.com/Main/19671/3160091/1284120.pdf Release https://news.cision.com/localize-direct-ab/i/mattias-christoffer-founders-localizedirect,c2808306 Mattias Christoffer Founders LocalizeDirect https://news.cision.com/localize-direct-ab/i/gridly-logo-vertical-400,c2808305 gridly logo vertical 400 SOURCE Localize Direct AB

LocalizeDirect Raises $1.1 Million for Gridly - a Headless CMS Tailor-made for Game Developers Gridly is the response to industry requirements as it shifts to games as a service model

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: STOCKHOLM, July 27, 2020 /PRNewswire/ -- Sweden-based localization and software company LocalizeDirect announces an investment of SEK10,264,530 (USD1,130,802) from Entreprenrinvest, owned by The IKEA Family Foundation and a number of Swedish venture capital firms and private individuals, including Innovum Invest. Former investors also participated in the financing round. Jan Andersson, a founder and former CEO of ReadSoft (now Kofax), will join LocalizeDirect's Board of Directors. The funding will support the launch and development of Gridly - a collaborative headless CMS for multilingual game projects. Gridly is currently in beta and will be released in September 2020. "The trend we've seen for the last few years is a shift to a continuous development of games - games as a service. Instead of a one-time launch, developers now push out new content frequently, often on a weekly basis, in multiple languages. Managing game data (such as strings, IAP, gameplay variables) for agile multiplatform and multilanguage releases is time-consuming and can rapidly spiral out of control. Gridly facilitates this process, allowing the product teams to cooperate more efficiently time- and cost-wise," says LocalizeDirect's Managing Director Christoffer Nilsson. Gridly has an open API, spreadsheet UI and features version control, branching, granular user access control and localization support. LocalizeDirect offers development companies plans depending on their project's sizes, starting with a free tier. "The demand for agile, high-quality localization technology and services will continue to grow. It is already a key success factor in the game industry, but it is evident that the need for localization also grows fast in many other areas. LocalizeDirect is very well positioned to grow in this market and Gridly has the potential to become the preferred solution for many companies in many industries," Jan Andersson, the Board Member of Entreprenrinvest and Innovum Invest underlines. About LocalizeDirect:LocalizeDirect is a Swedish localization and technology company. Founded in 2009, it now provides game translation, LQA, and CMS services for the game development industry in over 65 language pairs. LocalizeDirect is based in Sweden and Vietnam with a number of sales, localization & QA managers working across the globe. Find out more about Gridly at www.gridly.com About Entreprenrinvest: Entreprenrinvest is wholly owned by The IKEA Family Foundation. It specializes in investments into small- and medium-sized enterprises outside metropolitan areas of Sweden. About Innovum Invest:Innovum Invest is based in Helsingborg and provides capital, networks and expertise for Southern Swedish companies. Contacts:Myroslava Zaiets[emailprotected]+46 (0)42 181962 This information was brought to you by Cision http://news.cision.com https://news.cision.com/localize-direct-ab/r/localizedirect-raises--1-1-million-for-gridly---a-headless-cms-tailor-made-for-game-developers,c3160091 The following files are available for download: https://mb.cision.com/Main/19671/3160091/1284120.pdf Release https://news.cision.com/localize-direct-ab/i/mattias-christoffer-founders-localizedirect,c2808306 Mattias Christoffer Founders LocalizeDirect https://news.cision.com/localize-direct-ab/i/gridly-logo-vertical-400,c2808305 gridly logo vertical 400 SOURCE Localize Direct AB Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> LocalizeDirect Raises $1.1 Million for Gridly - a Headless CMS Tailor-made for Game Developers. Gridly is the response to industry requirements as it shifts to games as a service model.<|eot_id|>

edtsum845

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: HAIFA, Israel, Nov. 24, 2020 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT)(the "Company" or "Elbit Systems"), the international high technology company, reported today its consolidated results for the quarter ended September30, 2020. In this release, the Company is providing US-GAAP results as well as additional non-GAAP financial data, which are intended to provide investors a more comprehensive understanding of the Company's business results and trends. Unless otherwise stated, all financial data presented is GAAP financial data. Management Comment: Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems, commented:"I am pleased with the third quarter results, particularly with the improved operating performance in this challenging COVID-19 environment and despite the pandemic's impact on our Commercial Aviation business, which resulted in a $60 million non-cash impairment of assets in the quarter. We are encouraged by our backlog of orders and the volume of opportunities we are facing around the world, which provides us with confidence in the Company's future prospects." Third Quarter 2020 Results: Revenues in the third quarter of 2020were $1,134.2 million, as compared to $1,101.2 million in the third quarter of 2019. Non-GAAP(*) gross profit amounted to $302.3 million (26.7% of revenues) in the third quarter of 2020, as compared to $290.0 million (26.3% of revenues) in the third quarter of 2019. GAAP gross profit in the third quarter of 2020 was $237.4 million (20.9% of revenues), as compared to $286.2 million (26.0% of revenues) in the third quarter of 2019. The decrease in GAAP gross profit in the third quarter of 2020 was a result of non-cash expenses related to impairment of assets and inventory write-offs due to the impact of COVID-19, in the amount of approximately $60 million. These expenses were eliminated in the non-GAAP results. Research and development expenses, netwere $91.3 million (8.0% of revenues) in the third quarter of 2020, as compared to $79.5 million (7.2% of revenues) in the third quarter of 2019. *see page 4 Marketing and selling expenses, net were $71.6 million (6.3% of revenues) in the third quarter of 2020, as compared to $75.5 million (6.9% of revenues) in the third quarter of 2019. General and administrative expenses, netwere $51.0 million (4.5% of revenues) in the third quarter of 2020, as compared to $57.5 million (5.2% of revenues) in the third quarter of 2019. Other operating income, netin the third quarter of 2019 was $28.0 million, resulting mainly from capital gains related to sale and lease back of buildings by a subsidiary in Israel. Non-GAAP(*) operating income was $93.1 million (8.2% of revenues) in the third quarter of 2020, as compared to $80.7 million (7.3% of revenues) in the third quarter of 2019.GAAP operating income in the third quarter of 2020 was $23.5 million (2.1% of revenues), as compared to $101.7 million (9.2% of revenues) in the third quarter of 2019. Financial expenses, netwere $9.7 million in the third quarter of 2020, as compared to $18.5 million in the third quarter of 2019. Financial expenses, net in the third quarter of 2019 included exchange rate differences of approximately $7 million related to lease liabilities. Other income, netin the third quarter of 2020 was $0.5 million , as compared to other expenses of $2.8 millionin the third quarter of 2019. Taxes on income were $2.2 million (effective tax rate of 15.4%) in the third quarter of 2020, as compared to $7.6 million (effective tax rate of 9.5%) in the third quarter of 2019. Equity in net earnings (losses)of affiliated companies and partnerships were earnings of $4.9 million in the third quarter of 2020, as compared to losses of $0.5 million in the third quarter of 2019. The loss in the third quarter of 2019 was a result of the write-off of a $2.3 million investment in an affiliated company in Israel. Net income attributable to non-controlling interestsin the third quarter of 2020 was $0.1 million, as compared to $0.3 million in the third quarter of 2019. Non-GAAP(*) net income attributable to the Company's shareholders in the third quarter of 2020 was $72.7 million (6.4% of revenues), as compared to $58.7 million (5.3% of revenues) in the third quarter of 2019. GAAP net income attributable to the Company's shareholders in the third quarter of 2020 was $17.0 million (1.5% of revenues), as compared to $72.1 million (6.5% of revenues) in the third quarter of 2019. Non-GAAP(*) diluted net earnings per share attributable to the Company'sshareholders were $1.64 for the third quarter of 2020, as compared to $1.33 for the third quarter of 2019. GAAP diluted earnings per share in the third quarter of 2020 were $0.38, as compared to $1.63 for the third quarter of 2019. The Company's backlog of ordersas of September30, 2020 totaled $10,858 million, as compared to $9,796 million as of September30, 2019. Approximately 65% of the current backlog is attributable to orders from outside Israel. Approximately 46% of the current backlog is scheduled to be performed during the last quarter of 2020 and during 2021. Operating cash flow in the nine months ended September30, 2020was a positive $106.7 million, as compared to a negative operating cash flow in the nine months ended September30, 2019 in the amount of $140.3 million. *see page 4 Impact of the COVID-19 Pandemic on the Company: The Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020. COVID-19 has had significant negative impacts on the worldwide economy, resulting in disruptions to supply chains and financial markets, significant travel restrictions, facility closures and shelter-in-place orders in various locations. Elbit Systems is closely monitoring the evolution of the COVID-19 pandemic and its impacts on the Company's employees, customers and suppliers, as well as on the global economy. As we last reported on August 13, 2020, we have been taking a number of actions to protect the safety of our employees as well as maintain business continuity and secure our supply chain. We also reported on a number of activities where we are leveraging our technological capabilities to assist hospital staffs and other first responders protecting our communities from the impact of the pandemic. All of these actions remain ongoing. We have implemented a series of cost control measures to help limit the financial impact of the pandemic on the Company, in parallel to the measures we are taking to maintain business continuity and deliveries to our customers. We also are working on efficiency initiatives with a number of our suppliers. We continue to evaluate our operations on an ongoing basis in order to adapt to the evolving business environment. During the first three quarters of 2020 our defense activities, which account for most of our business, were not materially impacted by the pandemic, although some of our businesses are experiencing certain disruptions due to government directed safety measures, travel restrictions and supply chain delays. The significant slowdown in commercial air traffic, and the expectation that a commercial air traffic recovery to 2019 levels will likely take a number of years, have reduced the demand for products and services for the commercial aviation markets. Additionally, manufacturers of aircrafts for these markets have announced plans to reduce production rates to adapt to the lower demand. Following a review of the economic impact on the Company's assets overall, and those assets impacted by the commercial aviation industry in particular, the Company recorded in the third quarter of 2020 non-cash expenses related to impairment of assets and inventory write-offs, due to COVID-19, in the amount of approximately $60 million. These expenses were recorded mainly in the 'Cost of Revenues' line item in the Consolidated Statement of Income and were eliminated in the non-GAAP results as a category of expenses that are not part of the Company's recurring business. We believe that as of September 30, 2020, Elbit Systems had a healthy balance sheet, adequate levels of cash and access to credit facilities that provide liquidity when necessary. We have given high priority to cash management and adequate cash reserves to run the business. The extent of the impact of COVID-19 on the Company's performance depends on future developments including the duration and spread of the pandemic, the measures adopted by governments to limit the spread of the pandemic and resulting actions that may be taken by our customers and our supply chain, all of which are uncertain. As noted in our annual report on Form 20-F, the preparation of financial reports such as our quarterly financial results requires us to make judgments, assumptions and estimates that affect the amounts reported. For our quarterly financial results for the quarter ended September 30, 2020, we considered the economic impact of the COVID-19 pandemic on our critical and significant accounting estimates. The expected impact of the COVID-19 pandemic did not have a material effect on our judgments, assumptions and estimates reflected in the results. However, our future results may differ materially from our estimates. As events continue to evolve in connection with the COVID-19 pandemic, the estimates we use in future periods may change materially. *Non-GAAP financial data: The following non-GAAP financial data is presented to enable investors to have additional information on the Company's business performance as well as a further basis for periodical comparisons and trends relating to the Company's financial results. The Company believes such data provides useful information to investors by facilitating more meaningful comparisons of the Company's financial results over time. Such non-GAAP information is used by the Company's management to make strategic decisions, forecast future results and evaluate the Company's current performance. However, investors are cautioned that, unlike financial measures prepared in accordance with GAAP, non-GAAP measures may not be comparable with the calculation of similar measures for other companies. The non-GAAP financial data includes reconciliation adjustments regarding non-GAAP gross profit, operating income, net income and diluted EPS. In arriving at non-GAAP presentations, companies generally factor out items such as those that have a non-recurring impact on the income statements, various non-cash items including significant exchange rate differences, significant effects of retroactive tax legislation, changes in accounting guidance, financial transactions and other items not considered to be part of regular ongoing business, which, in management's judgment, are items that are considered to be outside of the review of core operating results. In the Company's non-GAAP presentation, the Company made certain adjustments, as indicated in the table below. These non-GAAP measures are not based on any comprehensive set of accounting rules or principles. The Company believes that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company's results of operations, as determined in accordance with GAAP, and that these measures should only be used to evaluate the Company's results of operations in conjunction with the corresponding GAAP measures.Investors should consider non-GAAP financial measures in addition to, and not as replacements for or superior to, measures of financial performance prepared in accordance with GAAP. Reconciliation of GAAP to Non-GAAP (Unaudited) Supplemental Financial Data:(US Dollars in millions,except for share and per share amount) Nine Months EndedSeptember 30, Three Months Ended September 30, Year EndedDecember 31, 2020 2019 2020 2019 2019 GAAP gross profit $ 807.3 $ 852.2 $ 237.4 $ 286.2 $ 1,136.5 Adjustments: Amortization of purchased intangible assets 17.5 15.4 5.5 3.8 22.0 Non-recurring expenses(*) 56.0 56.0 55.0 Impairment of long-lived assets 3.4 3.4 Non-GAAP gross profit $ 884.2 $ 867.6 $ 302.3 $ 290.0 $ 1,213.5 Percent of revenues 26.9 % 27.2 % 26.7 % 26.3 % 26.9 % GAAP operating income $ 221.1 $ 258.0 $ 23.5 $ 101.7 $ 321.6 Adjustments: Amortization of purchased intangible assets 30.2 25.5 9.6 7.0 36.1 Non-recurring expenses(*) 56.6 56.6 55.0 Impairment of long-lived assets 3.4 3.4 Capital gain (35.0) (28.0) (28.0) (31.8) Gain from changes in holdings (1.2) (1.2) Non-GAAP operating income $ 276.3 $ 254.3 $ 93.1 $ 80.7 $ 379.7 Percent of revenues 8.4 % 8.0 % 8.2 % 7.3 % 8.4 % GAAP net income attributable to Elbit Systems' shareholders $ 169.8 $ 176.3 $ 17.0 $ 72.1 $ 227.9 Adjustments: Amortization of purchased intangible assets 30.2 25.5 9.6 7.0 36.1 Non-recurring expenses(*) 56.6 56.6 55.0 Capital gain (35.0) (28.0) (28.0) (31.8) Gain from changes in holdings (1.2) (1.2) Impairment of long-lived assets 7.8 3.4 3.7 Exchange rate differences 5.6 22.1 (1.2) 6.7 24.6 Capital gain and revaluation of investments (21.4) (4.6) (2.8) (8.3) Related tax (benefits) expenses, net (0.2) (1.5) (9.9) 0.9 (8.2) Non-GAAP net income attributable to Elbit Systems' shareholders $ 213.4 $ 188.6 $ 72.7 $ 58.7 $ 297.8 Percent of revenues 6.5 % 5.9 % 6.4 % 5.3 % 6.6 % GAAP diluted net EPS $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Adjustments, net 0.99 0.28 1.26 (0.30) 1.59 Non-GAAP diluted net EPS $ 4.83 $ 4.32 $ 1.64 $ 1.33 $ 6.79 (*) Non-recurring expenses in 2020 are related to COVID-19 write-offs. In 2019 the expenses are related to acquisition of a subsidiary in the U.S. Recent Events: On August 17, 2020, the Company announced that it was awarded a contract valued at approximately $27 million to supply air-to-air combat training systems for the Navy of a South Asian Country. The contract will be performed over a two-year period, to be followed by three years of availability-based maintenance. On August 31, 2020, the Company announced that its U.S. subsidiary, Elbit Systems of America, LLC ("Elbit Systems of America"), was awarded an Indefinite Delivery/Indefinite Quantity ("ID/IQ") contract by the Defense Logistics Agency Land to supply the U.S. Army with gunner hand stations, commander hand stations and circuit cards for the Bradley Infantry Fighting Vehicle. The contract, with a maximum value of up to approximately $79 million, will be performed over a five-year period. An initial purchase order of approximately $26 million under the ID/IQ contract followed by a second purchase order of approximately $12 million have been issued to be executed over a three-year period. On September 14, 2020, the Company announced that its wholly-owned subsidiary, Elbit Systems - Cyclone Ltd., was awarded a contract by Lockheed Martin (NYSE: LMT) for the manufacture of assemblies for Forward Equipment Bay assemblies for the F-35 fighter aircraft. The contract is in an amount that is not material to Elbit Systems and will be performed over a period of four years. On September 29, 2020, the Company announced that it filed a shelf prospectus with the Israel Securities Authority and the Tel Aviv Stock Exchange. On October 1, 2020, the Company announced that it was awarded a contract valued at approximately $33 million to supply tactical radio systems to a customer in Asia-Pacific. The contract will be performed over a twelve-month period. On October 5, 2020,the Company announced that Elbit Systems of America was awarded an approximately $35 million five-year firm-fixed-priced contract by the U.S. Naval Supply Systems Command for repair of line-replaceable units in support of the V-22 aircraft. The repairs will be performed in Fort Worth, Texas and Talladega, Alabama, and the contract will be performed until October 2025. On October 7, 2020,the Company announced that Elbit Systems of America was awarded an ID/IQ contract with a maximum value of approximately $50 million to produce spare parts in support of the Aviators' Night Vision Imaging System Head-Up Display system of the U.S. Army. The contract, that will be performed over a period of five years, was awarded on behalf of the United States Army, by the Defense Logistics Agency. An initial order for $17.9 million was recently placed under this contract, to be supplied until 2023. On October 22, 2020, the Company announced that Elbit Systems of America was awarded an Other Transaction Authority ("OTA") contract from the U.S. Army for Enhanced Night Vision Goggle Binocular systems. The potential contract value under the OTA contract could reach a maximum of approximately $442 million. The U.S. Army did not define an overall time-frame for performance of the OTA contract. An initial order in the amount of approximately $22.5 million for low-rate initial production of systems has been placed under the OTA contract, with a period of performance through December 2021, to be executed in Roanoke, Virginia. On October 26, 2020, the Company announced that, as a result of the impact of the COVID-19 pandemic, Elbit Systems experienced reduced demand for the products and services it supplies to the commercial aviation markets. The significant slowdown in commercial air traffic, and the expectation that a commercial air traffic recovery to 2019 levels will likely take a number of years, have reduced the demand for products and services for the commercial aviation markets. Additionally, manufacturers of aircraft for these markets have announced plans to reduce production rates to adapt to the lower demand. Following a review of the economic impact on the Company's assets overall, and those assets impacted by the commercial aviation industry in particular, the Company recorded in the third quarter of 2020 non-cash expenses related to impairment of assets and inventory write-offs, due to COVID-19, in the amount of approximately $60 million. These expenses were recorded mainly in the "Cost of Revenues" line item in the Consolidated Statement of Income and were eliminated in the non-GAAP results as a category of expenses that are not part of the Company's regular on-going business. Reorganization of Certain Business Activities: As part of the Company's ongoing review of its businesses and portfolio, and in view of the changing business environment and the need to better serve our customers as well as to leverage the synergy and inter-operable activities of our areas of operation, a decision has been made to reorganize some of our business activities. The major parts of this reorganization include: (1) integration of our unmanned aircraft systems business with our manned military aircraft business to leverage synergies across manned and unmanned military aircraft; (2) integration of our electro-optical and our electronic warfare and signal intelligence businesses to provide advanced solutions across the electro-magnetic spectrum; and (3) integration of the precision guided munitions activities, currently part of our military aircraft business, with the IMI munitions portfolio. This reorganization will begin in the coming months and be completed during 2021. Dividend: The Board of Directors declared a dividend of $0.44 per share for the third quarter of 2020. The dividend's record date is December 21, 2020. The dividend will be paid from income generated as Preferred Income (as defined under Israel tax laws), on January 4, 2021, net of taxes and levies, at the rate of 20%. Conference Call: The Company will be hosting a conference call on Tuesday, November 24, 2020 at 9:00 a.m. Eastern Time. On the call, the Company's management will review and discuss the results and will be available to answer questions. To participate, please call any of the teleconferencing numbers that follow. If you are unable to connect using the toll-free numbers, please try the international dial-in number. US Dial-in Number: 1-866-744-5399Canada Dial-in Number: 1-866-485-2399Israel Dial-in Number: 03-918-0610International Dial-in Number: +972-3-918-0610 at 9:00am Eastern Time; 6:00am Pacific Time; 4:00pm Israel Time The conference call will also be broadcast live on Elbit Systems' web-site at http://www.elbitsystems.com. An online replay will be available from 24 hours after the call ends. Alternatively, for two days following the call, investors will be able to dial a replay number to listen to the call. The dial-in numbers are: 1-888-782-4291 (US and Canada) or +972-3-925-5918 (Israel and International). About Elbit Systems Elbit Systems Ltd. is an international high technology company engaged in a wide range of defense, homeland security and commercial programs throughout the world. The Company, which includes Elbit Systems and its subsidiaries, operates in the areas of aerospace, land and naval systems, command, control, communications, computers, intelligence surveillance and reconnaissance ("C4ISR"), unmanned aircraft systems, advanced electro-optics, electro-optic space systems, EW suites, signal intelligence systems, data links and communications systems, radios, cyber-based systems and munitions. The Company also focuses on the upgrading of existing platforms, developing new technologies for defense, homeland security and commercial applications and providing a range of support services, including training and simulation systems. For additional information, visit: https://elbitsystems.com/, follow us on Twitteror visit our official Facebook, Youtube and LinkedInChannels. Company Contact: Joseph Gaspar, Executive VP & CFOTel: +972-77-2946663 [emailprotected] Rami Myerson, Director, Investor Relations Tel: +972-77-2948984 [emailprotected] David Vaaknin, VP, Brand & Corporate Communications Tel: +972-77-2946691 [emailprotected] IR Contact: Ehud HelftKenny Green GK Investor Relations Tel: 1-646-201-9246 [emailprotected] This press release may contain forwardlooking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Israeli Securities Law, 1968) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current facts. Forward-looking statements are based on management's current expectations, estimates, projections and assumptions about future events. Forwardlooking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions about the Company, which are difficult to predict, including projections of the Company's future financial results, its anticipated growth strategies and anticipated trends in its business. Therefore, actual future results, performance and trends may differ materially from these forwardlooking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States among others; changes in global health and macro-economic conditions; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; changes in the competitive environment; and the outcome of legal and/or regulatory proceedings. The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.'s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forwardlooking statements speak only as of the date of this release. Although the Company believes the expectations reflected in theforward-lookingstatements contained herein are reasonable, it cannot guarantee future results, level of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of any of theseforward-lookingstatements. The Company does not undertake to update its forward-looking statements. Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this Press Release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies. All other brand, product, service and process names appearing are the trademarks of their respective holders. Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of Elbit Systems Ltd. or any third party, except as expressly granted herein. ELBIT SYSTEMS LTD.CONSOLIDATED BALANCE SHEETS (In thousands of U.S. Dollars) September 30, 2020 December 31, 2019 Unaudited Audited Assets Cash and cash equivalents $ 287,151 $ 221,060 Short-term bank deposits 1,158 2,213 Trade receivables and contract assets, net 2,301,518 2,067,846 Other receivables and prepaid expenses 188,267 160,728 Inventories, net 1,325,800 1,219,920 Total current assets 4,103,894 3,671,767 Investments in affiliated companies and partnerships and other companies 183,510 201,574 Long-term trade receivables and contract assets 253,127 259,150 Long-term bank deposits and other receivables 54,894 58,076 Deferred income taxes, net 107,928 89,452 Severance pay fund 275,013 287,104 874,472 895,356 Operating lease right of use assets 423,126 365,763 Property, plant and equipment, net 760,088 766,532 Goodwill and other intangible assets, net 1,565,582 1,635,940 Total assets $ 7,727,162 $ 7,335,358 Liabilities and equity Short-term bank credit and loans $ 290,520 $ 208,399 Current maturities of long-term loans and Series A Notes 37,809 199,882 Operating lease liabilities 60,860 62,565 Trade payables 893,841 926,338 Other payables and accrued expenses 1,111,057 1,052,080 Contract liabilities 943,121 723,581 3,337,208 3,172,845 Long-term loans, net of current maturities 538,631 440,124 Employee benefit liabilities 812,324 836,535 Deferred income taxes and tax liabilities, net 122,534 114,419 Operating lease liabilities 380,767 323,287 Contract liabilities 98,138 62,830 Other long-term liabilities 180,949 225,478 2,133,343 2,002,673 Elbit Systems Ltd.'s equity 2,238,604 2,141,406 Non-controlling interests 18,007 18,434 Total equity 2,256,611 2,159,840 Total liabilities and equity $ 7,727,162 $ 7,335,358 ELBIT SYSTEMS LTD.CONSOLIDATED STATEMENTS OF INCOME(In thousands of U.S. Dollars, except for share and per share amount) Nine Months Ended September 30, Three Months Ended September 30, Year Ended December 31, 2020 2019 2020 2019 2019 Unaudited Unaudited Audited Revenues $ 3,284,840 $ 3,186,894 $ 1,134,169 $ 1,101,190 $ 4,508,400 Cost of revenues 2,477,567 2,334,720 896,780 815,032 3,371,933 Gross profit 807,273 852,174 237,389 286,158 1,136,467 Operating expenses: Research and development, net 250,683 234,126 91,282 79,468 331,757 Marketing and selling, net 209,477 220,917 71,557 75,512 301,400 General and administrative, net 161,015 168,385 51,020 57,520 214,749 Other operating income, net (34,963) (29,264) (28,030) (33,049) Total operating expenses 586,212 594,164 213,859 184,470 814,857 Operating income 221,061 258,010 23,530 101,688 321,610 Financial expenses, net (38,745) (52,715) (9,673) (18,461) (69,072) Other income (expenses), net 14,740 (4,618) 525 (2,811) (6,243) Income before income taxes 197,056 200,677 14,382 80,416 246,295 Taxes on income (34,565) (28,543) (2,215) (7,619) (19,414) 162,491 172,134 12,167 72,797 226,881 Equity in net earnings (losses) of affiliated companies and partnerships 7,579 5,272 4,880 (469) 1,774 Net income $ 170,070 $ 177,406 $ 17,047 $ 72,328 $ 228,655 Less: net income attributable to non-controlling interests (235) (1,063) (73) (263) (798) Net income attributable to Elbit Systems Ltd.'s shareholders $ 169,835 $ 176,343 $ 16,974 $ 72,065 $ 227,857 Earnings per share attributable to Elbit Systems Ltd.'sshareholders: Basic net earnings per share $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Diluted net earnings per share $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Weighted average number of shares (in thousands) Shares used in computation of basic earnings per share 44,198 43,653 44,198 44,201 43,787 Shares used in computation of diluted earnings per share 44,220 43,702 44,221 44,253 43,848 ELBIT SYSTEMS LTD.CONSOLIDATED STATEMENTS OF CASH FLOW(In thousands of U.S. dollars) Nine Months Ended September 30, Year Ended December 31, 2020 2019 2019 Unaudited Audited CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 170,070 $ 177,406 $ 228,655 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 109,040 98,280 137,146 Impairment of assets 7,771 3,692 Stock-based compensation 3,064 2,973 3,994 Amortization of Series A Notes premium and related issuance costs, net (46) (69) (93) Deferred income taxes and reserve, net (12,773) 12,567 (15,059) Gain on sale of property, plant and equipment (32,180) (28,509) (34,154) Gain on sale of investments and remeasurement of investment held under fair value method, net (23,652) (4,479) (7,928) Equity in net earnings of affiliated companies and partnerships, net of dividend received (*) (5,862) 1,780 8,526 Changes in operating assets and liabilities, net of amounts acquired: Increase in trade receivables and contract assets and prepaid expenses (242,994) (121,167) (267,924) Increase in inventories, net (78,874) (195,857) (55,841) Increase (decrease) in trade payables, other payables and accrued expenses (13,739) 6,710 115,621 Severance, pension and termination indemnities, net (3,874) 9,000 4,629 Increase (decrease) in contract liabilities 230,757 (98,892) (174,582) Net cash provided by (used in) operating activities 106,708 (140,257) (53,318) CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property, plant and equipment and other assets (92,945) (97,898) (137,604) Acquisition of subsidiaries and business operations (357,144) (357,144) Proceeds from premises evacuation grants receivables 344,913 344,913 Investments in affiliated companies and other companies (12,316) (3,350) (8,567) Proceeds from sale of property, plant and equipment 71,918 36,189 36,671 Proceeds from sale of investments 44,200 Investment in long-term deposits, net (161) 61 (38) Investment in short-term deposits (600) (15,913) (2,314) Proceeds from sale of short-term deposits 1,663 28,789 17,294 Net cash provided by (used in) investing activities 11,759 (64,353) (106,789) CASH FLOWS FROM FINANCING ACTIVITIES Issuance of treasury shares, net 184,840 184,840 Repayment of long-term loans (205,923) (242,440) (243,324) Proceeds from long-term loans 201,551 350,000 350,000 Repayment of Series A Notes (55,532) (55,532) (55,532) Dividends paid (74,308) (58,922) (62,578) Change in short-term bank credit and loans, net 81,836 (16,135) (718) Net cash provided by (used in) financing activities (52,376) 161,811 172,688 Net increase (decrease) in cash and cash equivalents 66,091 (42,799) 12,581 Cash and cash equivalents at the beginning of the year 221,060 208,479 208,479 Cash and cash equivalents at the end of the period $ 287,151 $ 165,680 $ 221,060 * Dividend received from affiliated companies and partnerships $ 6,117 $ 7,052 $ 10,300 ELBIT SYSTEMS LTD.DISTRIBUTION OF REVENUES Consolidated Revenues by Areas of Operation: Nine Months EndedSeptember 30, Three Months EndedSeptember 30, 2020 2019 2020 2019 $ millions % $ millions % $ millions % $ millions % Airborne systems 1,170.0 35.6 1,178.8 37.0 393.0 34.7 397.6 36.1 C4ISR systems 759.6 23.1 804.6 25.2 280.3 24.7 299.2 27.2 Land systems 916.8 27.9 860.7 27.0 323.9 28.6 295.2 26.8 Electro-optic systems 359.5 10.9 249.6 7.8 108.2 9.5 78.3 7.1 Other (mainly non-defenseengineering and production services) 78.9 2.5 93.2 3.0 28.7 2.5 30.9 2.8 Total 3,284.8 100.0 3,186.9 100.0 1,134.1 100.0 1,101.2 100.0 Consolidated Revenues by Geographical Regions: Nine Months EndedSeptember 30, Three Months EndedSeptember 30, 2020 2019 2020 2019 $ millions % $ millions % $ millions % $ millions % Israel 796.7 24.3 740.2 23.2 284.8 25.1 245.9 22.3 North America 1,077.1 32.8 908.6 28.5 343.8 30.3 333.4 30.3 Europe 557.1 17.0 583.3 18.3 209.5 18.5 195.3 17.7 Asia-Pacific 683.8 20.8 732.0 23.0 252.6 22.3 248.0 22.5 Latin America 99.5 3.0 122.0 3.8 25.5 2.2 49.5 4.5 Other countries 70.6 2.1 100.8 3.2 17.9 1.6 29.1 2.7 Total 3,284.8 100.0 3,186.9 100.0 1,134.1 100.0 1,101.2 100.0 SOURCE Elbit Systems Ltd. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Elbit Systems Reports Third Quarter 2020 Results. USA - English. USA - English. Backlog of orders at $10.9 billion; Revenues at $1.1 billion; Non-GAAP net income of $73 million; GAAP net income of $17 million; Non-GAAP net EPS of $1.64; GAAP net EPS of $0.38.

HAIFA, Israel, Nov. 24, 2020 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT)(the "Company" or "Elbit Systems"), the international high technology company, reported today its consolidated results for the quarter ended September30, 2020. In this release, the Company is providing US-GAAP results as well as additional non-GAAP financial data, which are intended to provide investors a more comprehensive understanding of the Company's business results and trends. Unless otherwise stated, all financial data presented is GAAP financial data. Management Comment: Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems, commented:"I am pleased with the third quarter results, particularly with the improved operating performance in this challenging COVID-19 environment and despite the pandemic's impact on our Commercial Aviation business, which resulted in a $60 million non-cash impairment of assets in the quarter. We are encouraged by our backlog of orders and the volume of opportunities we are facing around the world, which provides us with confidence in the Company's future prospects." Third Quarter 2020 Results: Revenues in the third quarter of 2020were $1,134.2 million, as compared to $1,101.2 million in the third quarter of 2019. Non-GAAP(*) gross profit amounted to $302.3 million (26.7% of revenues) in the third quarter of 2020, as compared to $290.0 million (26.3% of revenues) in the third quarter of 2019. GAAP gross profit in the third quarter of 2020 was $237.4 million (20.9% of revenues), as compared to $286.2 million (26.0% of revenues) in the third quarter of 2019. The decrease in GAAP gross profit in the third quarter of 2020 was a result of non-cash expenses related to impairment of assets and inventory write-offs due to the impact of COVID-19, in the amount of approximately $60 million. These expenses were eliminated in the non-GAAP results. Research and development expenses, netwere $91.3 million (8.0% of revenues) in the third quarter of 2020, as compared to $79.5 million (7.2% of revenues) in the third quarter of 2019. *see page 4 Marketing and selling expenses, net were $71.6 million (6.3% of revenues) in the third quarter of 2020, as compared to $75.5 million (6.9% of revenues) in the third quarter of 2019. General and administrative expenses, netwere $51.0 million (4.5% of revenues) in the third quarter of 2020, as compared to $57.5 million (5.2% of revenues) in the third quarter of 2019. Other operating income, netin the third quarter of 2019 was $28.0 million, resulting mainly from capital gains related to sale and lease back of buildings by a subsidiary in Israel. Non-GAAP(*) operating income was $93.1 million (8.2% of revenues) in the third quarter of 2020, as compared to $80.7 million (7.3% of revenues) in the third quarter of 2019.GAAP operating income in the third quarter of 2020 was $23.5 million (2.1% of revenues), as compared to $101.7 million (9.2% of revenues) in the third quarter of 2019. Financial expenses, netwere $9.7 million in the third quarter of 2020, as compared to $18.5 million in the third quarter of 2019. Financial expenses, net in the third quarter of 2019 included exchange rate differences of approximately $7 million related to lease liabilities. Other income, netin the third quarter of 2020 was $0.5 million , as compared to other expenses of $2.8 millionin the third quarter of 2019. Taxes on income were $2.2 million (effective tax rate of 15.4%) in the third quarter of 2020, as compared to $7.6 million (effective tax rate of 9.5%) in the third quarter of 2019. Equity in net earnings (losses)of affiliated companies and partnerships were earnings of $4.9 million in the third quarter of 2020, as compared to losses of $0.5 million in the third quarter of 2019. The loss in the third quarter of 2019 was a result of the write-off of a $2.3 million investment in an affiliated company in Israel. Net income attributable to non-controlling interestsin the third quarter of 2020 was $0.1 million, as compared to $0.3 million in the third quarter of 2019. Non-GAAP(*) net income attributable to the Company's shareholders in the third quarter of 2020 was $72.7 million (6.4% of revenues), as compared to $58.7 million (5.3% of revenues) in the third quarter of 2019. GAAP net income attributable to the Company's shareholders in the third quarter of 2020 was $17.0 million (1.5% of revenues), as compared to $72.1 million (6.5% of revenues) in the third quarter of 2019. Non-GAAP(*) diluted net earnings per share attributable to the Company'sshareholders were $1.64 for the third quarter of 2020, as compared to $1.33 for the third quarter of 2019. GAAP diluted earnings per share in the third quarter of 2020 were $0.38, as compared to $1.63 for the third quarter of 2019. The Company's backlog of ordersas of September30, 2020 totaled $10,858 million, as compared to $9,796 million as of September30, 2019. Approximately 65% of the current backlog is attributable to orders from outside Israel. Approximately 46% of the current backlog is scheduled to be performed during the last quarter of 2020 and during 2021. Operating cash flow in the nine months ended September30, 2020was a positive $106.7 million, as compared to a negative operating cash flow in the nine months ended September30, 2019 in the amount of $140.3 million. *see page 4 Impact of the COVID-19 Pandemic on the Company: The Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020. COVID-19 has had significant negative impacts on the worldwide economy, resulting in disruptions to supply chains and financial markets, significant travel restrictions, facility closures and shelter-in-place orders in various locations. Elbit Systems is closely monitoring the evolution of the COVID-19 pandemic and its impacts on the Company's employees, customers and suppliers, as well as on the global economy. As we last reported on August 13, 2020, we have been taking a number of actions to protect the safety of our employees as well as maintain business continuity and secure our supply chain. We also reported on a number of activities where we are leveraging our technological capabilities to assist hospital staffs and other first responders protecting our communities from the impact of the pandemic. All of these actions remain ongoing. We have implemented a series of cost control measures to help limit the financial impact of the pandemic on the Company, in parallel to the measures we are taking to maintain business continuity and deliveries to our customers. We also are working on efficiency initiatives with a number of our suppliers. We continue to evaluate our operations on an ongoing basis in order to adapt to the evolving business environment. During the first three quarters of 2020 our defense activities, which account for most of our business, were not materially impacted by the pandemic, although some of our businesses are experiencing certain disruptions due to government directed safety measures, travel restrictions and supply chain delays. The significant slowdown in commercial air traffic, and the expectation that a commercial air traffic recovery to 2019 levels will likely take a number of years, have reduced the demand for products and services for the commercial aviation markets. Additionally, manufacturers of aircrafts for these markets have announced plans to reduce production rates to adapt to the lower demand. Following a review of the economic impact on the Company's assets overall, and those assets impacted by the commercial aviation industry in particular, the Company recorded in the third quarter of 2020 non-cash expenses related to impairment of assets and inventory write-offs, due to COVID-19, in the amount of approximately $60 million. These expenses were recorded mainly in the 'Cost of Revenues' line item in the Consolidated Statement of Income and were eliminated in the non-GAAP results as a category of expenses that are not part of the Company's recurring business. We believe that as of September 30, 2020, Elbit Systems had a healthy balance sheet, adequate levels of cash and access to credit facilities that provide liquidity when necessary. We have given high priority to cash management and adequate cash reserves to run the business. The extent of the impact of COVID-19 on the Company's performance depends on future developments including the duration and spread of the pandemic, the measures adopted by governments to limit the spread of the pandemic and resulting actions that may be taken by our customers and our supply chain, all of which are uncertain. As noted in our annual report on Form 20-F, the preparation of financial reports such as our quarterly financial results requires us to make judgments, assumptions and estimates that affect the amounts reported. For our quarterly financial results for the quarter ended September 30, 2020, we considered the economic impact of the COVID-19 pandemic on our critical and significant accounting estimates. The expected impact of the COVID-19 pandemic did not have a material effect on our judgments, assumptions and estimates reflected in the results. However, our future results may differ materially from our estimates. As events continue to evolve in connection with the COVID-19 pandemic, the estimates we use in future periods may change materially. *Non-GAAP financial data: The following non-GAAP financial data is presented to enable investors to have additional information on the Company's business performance as well as a further basis for periodical comparisons and trends relating to the Company's financial results. The Company believes such data provides useful information to investors by facilitating more meaningful comparisons of the Company's financial results over time. Such non-GAAP information is used by the Company's management to make strategic decisions, forecast future results and evaluate the Company's current performance. However, investors are cautioned that, unlike financial measures prepared in accordance with GAAP, non-GAAP measures may not be comparable with the calculation of similar measures for other companies. The non-GAAP financial data includes reconciliation adjustments regarding non-GAAP gross profit, operating income, net income and diluted EPS. In arriving at non-GAAP presentations, companies generally factor out items such as those that have a non-recurring impact on the income statements, various non-cash items including significant exchange rate differences, significant effects of retroactive tax legislation, changes in accounting guidance, financial transactions and other items not considered to be part of regular ongoing business, which, in management's judgment, are items that are considered to be outside of the review of core operating results. In the Company's non-GAAP presentation, the Company made certain adjustments, as indicated in the table below. These non-GAAP measures are not based on any comprehensive set of accounting rules or principles. The Company believes that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company's results of operations, as determined in accordance with GAAP, and that these measures should only be used to evaluate the Company's results of operations in conjunction with the corresponding GAAP measures.Investors should consider non-GAAP financial measures in addition to, and not as replacements for or superior to, measures of financial performance prepared in accordance with GAAP. Reconciliation of GAAP to Non-GAAP (Unaudited) Supplemental Financial Data:(US Dollars in millions,except for share and per share amount) Nine Months EndedSeptember 30, Three Months Ended September 30, Year EndedDecember 31, 2020 2019 2020 2019 2019 GAAP gross profit $ 807.3 $ 852.2 $ 237.4 $ 286.2 $ 1,136.5 Adjustments: Amortization of purchased intangible assets 17.5 15.4 5.5 3.8 22.0 Non-recurring expenses(*) 56.0 56.0 55.0 Impairment of long-lived assets 3.4 3.4 Non-GAAP gross profit $ 884.2 $ 867.6 $ 302.3 $ 290.0 $ 1,213.5 Percent of revenues 26.9 % 27.2 % 26.7 % 26.3 % 26.9 % GAAP operating income $ 221.1 $ 258.0 $ 23.5 $ 101.7 $ 321.6 Adjustments: Amortization of purchased intangible assets 30.2 25.5 9.6 7.0 36.1 Non-recurring expenses(*) 56.6 56.6 55.0 Impairment of long-lived assets 3.4 3.4 Capital gain (35.0) (28.0) (28.0) (31.8) Gain from changes in holdings (1.2) (1.2) Non-GAAP operating income $ 276.3 $ 254.3 $ 93.1 $ 80.7 $ 379.7 Percent of revenues 8.4 % 8.0 % 8.2 % 7.3 % 8.4 % GAAP net income attributable to Elbit Systems' shareholders $ 169.8 $ 176.3 $ 17.0 $ 72.1 $ 227.9 Adjustments: Amortization of purchased intangible assets 30.2 25.5 9.6 7.0 36.1 Non-recurring expenses(*) 56.6 56.6 55.0 Capital gain (35.0) (28.0) (28.0) (31.8) Gain from changes in holdings (1.2) (1.2) Impairment of long-lived assets 7.8 3.4 3.7 Exchange rate differences 5.6 22.1 (1.2) 6.7 24.6 Capital gain and revaluation of investments (21.4) (4.6) (2.8) (8.3) Related tax (benefits) expenses, net (0.2) (1.5) (9.9) 0.9 (8.2) Non-GAAP net income attributable to Elbit Systems' shareholders $ 213.4 $ 188.6 $ 72.7 $ 58.7 $ 297.8 Percent of revenues 6.5 % 5.9 % 6.4 % 5.3 % 6.6 % GAAP diluted net EPS $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Adjustments, net 0.99 0.28 1.26 (0.30) 1.59 Non-GAAP diluted net EPS $ 4.83 $ 4.32 $ 1.64 $ 1.33 $ 6.79 (*) Non-recurring expenses in 2020 are related to COVID-19 write-offs. In 2019 the expenses are related to acquisition of a subsidiary in the U.S. Recent Events: On August 17, 2020, the Company announced that it was awarded a contract valued at approximately $27 million to supply air-to-air combat training systems for the Navy of a South Asian Country. The contract will be performed over a two-year period, to be followed by three years of availability-based maintenance. On August 31, 2020, the Company announced that its U.S. subsidiary, Elbit Systems of America, LLC ("Elbit Systems of America"), was awarded an Indefinite Delivery/Indefinite Quantity ("ID/IQ") contract by the Defense Logistics Agency Land to supply the U.S. Army with gunner hand stations, commander hand stations and circuit cards for the Bradley Infantry Fighting Vehicle. The contract, with a maximum value of up to approximately $79 million, will be performed over a five-year period. An initial purchase order of approximately $26 million under the ID/IQ contract followed by a second purchase order of approximately $12 million have been issued to be executed over a three-year period. On September 14, 2020, the Company announced that its wholly-owned subsidiary, Elbit Systems - Cyclone Ltd., was awarded a contract by Lockheed Martin (NYSE: LMT) for the manufacture of assemblies for Forward Equipment Bay assemblies for the F-35 fighter aircraft. The contract is in an amount that is not material to Elbit Systems and will be performed over a period of four years. On September 29, 2020, the Company announced that it filed a shelf prospectus with the Israel Securities Authority and the Tel Aviv Stock Exchange. On October 1, 2020, the Company announced that it was awarded a contract valued at approximately $33 million to supply tactical radio systems to a customer in Asia-Pacific. The contract will be performed over a twelve-month period. On October 5, 2020,the Company announced that Elbit Systems of America was awarded an approximately $35 million five-year firm-fixed-priced contract by the U.S. Naval Supply Systems Command for repair of line-replaceable units in support of the V-22 aircraft. The repairs will be performed in Fort Worth, Texas and Talladega, Alabama, and the contract will be performed until October 2025. On October 7, 2020,the Company announced that Elbit Systems of America was awarded an ID/IQ contract with a maximum value of approximately $50 million to produce spare parts in support of the Aviators' Night Vision Imaging System Head-Up Display system of the U.S. Army. The contract, that will be performed over a period of five years, was awarded on behalf of the United States Army, by the Defense Logistics Agency. An initial order for $17.9 million was recently placed under this contract, to be supplied until 2023. On October 22, 2020, the Company announced that Elbit Systems of America was awarded an Other Transaction Authority ("OTA") contract from the U.S. Army for Enhanced Night Vision Goggle Binocular systems. The potential contract value under the OTA contract could reach a maximum of approximately $442 million. The U.S. Army did not define an overall time-frame for performance of the OTA contract. An initial order in the amount of approximately $22.5 million for low-rate initial production of systems has been placed under the OTA contract, with a period of performance through December 2021, to be executed in Roanoke, Virginia. On October 26, 2020, the Company announced that, as a result of the impact of the COVID-19 pandemic, Elbit Systems experienced reduced demand for the products and services it supplies to the commercial aviation markets. The significant slowdown in commercial air traffic, and the expectation that a commercial air traffic recovery to 2019 levels will likely take a number of years, have reduced the demand for products and services for the commercial aviation markets. Additionally, manufacturers of aircraft for these markets have announced plans to reduce production rates to adapt to the lower demand. Following a review of the economic impact on the Company's assets overall, and those assets impacted by the commercial aviation industry in particular, the Company recorded in the third quarter of 2020 non-cash expenses related to impairment of assets and inventory write-offs, due to COVID-19, in the amount of approximately $60 million. These expenses were recorded mainly in the "Cost of Revenues" line item in the Consolidated Statement of Income and were eliminated in the non-GAAP results as a category of expenses that are not part of the Company's regular on-going business. Reorganization of Certain Business Activities: As part of the Company's ongoing review of its businesses and portfolio, and in view of the changing business environment and the need to better serve our customers as well as to leverage the synergy and inter-operable activities of our areas of operation, a decision has been made to reorganize some of our business activities. The major parts of this reorganization include: (1) integration of our unmanned aircraft systems business with our manned military aircraft business to leverage synergies across manned and unmanned military aircraft; (2) integration of our electro-optical and our electronic warfare and signal intelligence businesses to provide advanced solutions across the electro-magnetic spectrum; and (3) integration of the precision guided munitions activities, currently part of our military aircraft business, with the IMI munitions portfolio. This reorganization will begin in the coming months and be completed during 2021. Dividend: The Board of Directors declared a dividend of $0.44 per share for the third quarter of 2020. The dividend's record date is December 21, 2020. The dividend will be paid from income generated as Preferred Income (as defined under Israel tax laws), on January 4, 2021, net of taxes and levies, at the rate of 20%. Conference Call: The Company will be hosting a conference call on Tuesday, November 24, 2020 at 9:00 a.m. Eastern Time. On the call, the Company's management will review and discuss the results and will be available to answer questions. To participate, please call any of the teleconferencing numbers that follow. If you are unable to connect using the toll-free numbers, please try the international dial-in number. US Dial-in Number: 1-866-744-5399Canada Dial-in Number: 1-866-485-2399Israel Dial-in Number: 03-918-0610International Dial-in Number: +972-3-918-0610 at 9:00am Eastern Time; 6:00am Pacific Time; 4:00pm Israel Time The conference call will also be broadcast live on Elbit Systems' web-site at http://www.elbitsystems.com. An online replay will be available from 24 hours after the call ends. Alternatively, for two days following the call, investors will be able to dial a replay number to listen to the call. The dial-in numbers are: 1-888-782-4291 (US and Canada) or +972-3-925-5918 (Israel and International). About Elbit Systems Elbit Systems Ltd. is an international high technology company engaged in a wide range of defense, homeland security and commercial programs throughout the world. The Company, which includes Elbit Systems and its subsidiaries, operates in the areas of aerospace, land and naval systems, command, control, communications, computers, intelligence surveillance and reconnaissance ("C4ISR"), unmanned aircraft systems, advanced electro-optics, electro-optic space systems, EW suites, signal intelligence systems, data links and communications systems, radios, cyber-based systems and munitions. The Company also focuses on the upgrading of existing platforms, developing new technologies for defense, homeland security and commercial applications and providing a range of support services, including training and simulation systems. For additional information, visit: https://elbitsystems.com/, follow us on Twitteror visit our official Facebook, Youtube and LinkedInChannels. Company Contact: Joseph Gaspar, Executive VP & CFOTel: +972-77-2946663 [emailprotected] Rami Myerson, Director, Investor Relations Tel: +972-77-2948984 [emailprotected] David Vaaknin, VP, Brand & Corporate Communications Tel: +972-77-2946691 [emailprotected] IR Contact: Ehud HelftKenny Green GK Investor Relations Tel: 1-646-201-9246 [emailprotected] This press release may contain forwardlooking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Israeli Securities Law, 1968) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current facts. Forward-looking statements are based on management's current expectations, estimates, projections and assumptions about future events. Forwardlooking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions about the Company, which are difficult to predict, including projections of the Company's future financial results, its anticipated growth strategies and anticipated trends in its business. Therefore, actual future results, performance and trends may differ materially from these forwardlooking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States among others; changes in global health and macro-economic conditions; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; changes in the competitive environment; and the outcome of legal and/or regulatory proceedings. The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.'s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forwardlooking statements speak only as of the date of this release. Although the Company believes the expectations reflected in theforward-lookingstatements contained herein are reasonable, it cannot guarantee future results, level of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of any of theseforward-lookingstatements. The Company does not undertake to update its forward-looking statements. Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this Press Release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies. All other brand, product, service and process names appearing are the trademarks of their respective holders. Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of Elbit Systems Ltd. or any third party, except as expressly granted herein. ELBIT SYSTEMS LTD.CONSOLIDATED BALANCE SHEETS (In thousands of U.S. Dollars) September 30, 2020 December 31, 2019 Unaudited Audited Assets Cash and cash equivalents $ 287,151 $ 221,060 Short-term bank deposits 1,158 2,213 Trade receivables and contract assets, net 2,301,518 2,067,846 Other receivables and prepaid expenses 188,267 160,728 Inventories, net 1,325,800 1,219,920 Total current assets 4,103,894 3,671,767 Investments in affiliated companies and partnerships and other companies 183,510 201,574 Long-term trade receivables and contract assets 253,127 259,150 Long-term bank deposits and other receivables 54,894 58,076 Deferred income taxes, net 107,928 89,452 Severance pay fund 275,013 287,104 874,472 895,356 Operating lease right of use assets 423,126 365,763 Property, plant and equipment, net 760,088 766,532 Goodwill and other intangible assets, net 1,565,582 1,635,940 Total assets $ 7,727,162 $ 7,335,358 Liabilities and equity Short-term bank credit and loans $ 290,520 $ 208,399 Current maturities of long-term loans and Series A Notes 37,809 199,882 Operating lease liabilities 60,860 62,565 Trade payables 893,841 926,338 Other payables and accrued expenses 1,111,057 1,052,080 Contract liabilities 943,121 723,581 3,337,208 3,172,845 Long-term loans, net of current maturities 538,631 440,124 Employee benefit liabilities 812,324 836,535 Deferred income taxes and tax liabilities, net 122,534 114,419 Operating lease liabilities 380,767 323,287 Contract liabilities 98,138 62,830 Other long-term liabilities 180,949 225,478 2,133,343 2,002,673 Elbit Systems Ltd.'s equity 2,238,604 2,141,406 Non-controlling interests 18,007 18,434 Total equity 2,256,611 2,159,840 Total liabilities and equity $ 7,727,162 $ 7,335,358 ELBIT SYSTEMS LTD.CONSOLIDATED STATEMENTS OF INCOME(In thousands of U.S. Dollars, except for share and per share amount) Nine Months Ended September 30, Three Months Ended September 30, Year Ended December 31, 2020 2019 2020 2019 2019 Unaudited Unaudited Audited Revenues $ 3,284,840 $ 3,186,894 $ 1,134,169 $ 1,101,190 $ 4,508,400 Cost of revenues 2,477,567 2,334,720 896,780 815,032 3,371,933 Gross profit 807,273 852,174 237,389 286,158 1,136,467 Operating expenses: Research and development, net 250,683 234,126 91,282 79,468 331,757 Marketing and selling, net 209,477 220,917 71,557 75,512 301,400 General and administrative, net 161,015 168,385 51,020 57,520 214,749 Other operating income, net (34,963) (29,264) (28,030) (33,049) Total operating expenses 586,212 594,164 213,859 184,470 814,857 Operating income 221,061 258,010 23,530 101,688 321,610 Financial expenses, net (38,745) (52,715) (9,673) (18,461) (69,072) Other income (expenses), net 14,740 (4,618) 525 (2,811) (6,243) Income before income taxes 197,056 200,677 14,382 80,416 246,295 Taxes on income (34,565) (28,543) (2,215) (7,619) (19,414) 162,491 172,134 12,167 72,797 226,881 Equity in net earnings (losses) of affiliated companies and partnerships 7,579 5,272 4,880 (469) 1,774 Net income $ 170,070 $ 177,406 $ 17,047 $ 72,328 $ 228,655 Less: net income attributable to non-controlling interests (235) (1,063) (73) (263) (798) Net income attributable to Elbit Systems Ltd.'s shareholders $ 169,835 $ 176,343 $ 16,974 $ 72,065 $ 227,857 Earnings per share attributable to Elbit Systems Ltd.'sshareholders: Basic net earnings per share $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Diluted net earnings per share $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Weighted average number of shares (in thousands) Shares used in computation of basic earnings per share 44,198 43,653 44,198 44,201 43,787 Shares used in computation of diluted earnings per share 44,220 43,702 44,221 44,253 43,848 ELBIT SYSTEMS LTD.CONSOLIDATED STATEMENTS OF CASH FLOW(In thousands of U.S. dollars) Nine Months Ended September 30, Year Ended December 31, 2020 2019 2019 Unaudited Audited CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 170,070 $ 177,406 $ 228,655 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 109,040 98,280 137,146 Impairment of assets 7,771 3,692 Stock-based compensation 3,064 2,973 3,994 Amortization of Series A Notes premium and related issuance costs, net (46) (69) (93) Deferred income taxes and reserve, net (12,773) 12,567 (15,059) Gain on sale of property, plant and equipment (32,180) (28,509) (34,154) Gain on sale of investments and remeasurement of investment held under fair value method, net (23,652) (4,479) (7,928) Equity in net earnings of affiliated companies and partnerships, net of dividend received (*) (5,862) 1,780 8,526 Changes in operating assets and liabilities, net of amounts acquired: Increase in trade receivables and contract assets and prepaid expenses (242,994) (121,167) (267,924) Increase in inventories, net (78,874) (195,857) (55,841) Increase (decrease) in trade payables, other payables and accrued expenses (13,739) 6,710 115,621 Severance, pension and termination indemnities, net (3,874) 9,000 4,629 Increase (decrease) in contract liabilities 230,757 (98,892) (174,582) Net cash provided by (used in) operating activities 106,708 (140,257) (53,318) CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property, plant and equipment and other assets (92,945) (97,898) (137,604) Acquisition of subsidiaries and business operations (357,144) (357,144) Proceeds from premises evacuation grants receivables 344,913 344,913 Investments in affiliated companies and other companies (12,316) (3,350) (8,567) Proceeds from sale of property, plant and equipment 71,918 36,189 36,671 Proceeds from sale of investments 44,200 Investment in long-term deposits, net (161) 61 (38) Investment in short-term deposits (600) (15,913) (2,314) Proceeds from sale of short-term deposits 1,663 28,789 17,294 Net cash provided by (used in) investing activities 11,759 (64,353) (106,789) CASH FLOWS FROM FINANCING ACTIVITIES Issuance of treasury shares, net 184,840 184,840 Repayment of long-term loans (205,923) (242,440) (243,324) Proceeds from long-term loans 201,551 350,000 350,000 Repayment of Series A Notes (55,532) (55,532) (55,532) Dividends paid (74,308) (58,922) (62,578) Change in short-term bank credit and loans, net 81,836 (16,135) (718) Net cash provided by (used in) financing activities (52,376) 161,811 172,688 Net increase (decrease) in cash and cash equivalents 66,091 (42,799) 12,581 Cash and cash equivalents at the beginning of the year 221,060 208,479 208,479 Cash and cash equivalents at the end of the period $ 287,151 $ 165,680 $ 221,060 * Dividend received from affiliated companies and partnerships $ 6,117 $ 7,052 $ 10,300 ELBIT SYSTEMS LTD.DISTRIBUTION OF REVENUES Consolidated Revenues by Areas of Operation: Nine Months EndedSeptember 30, Three Months EndedSeptember 30, 2020 2019 2020 2019 $ millions % $ millions % $ millions % $ millions % Airborne systems 1,170.0 35.6 1,178.8 37.0 393.0 34.7 397.6 36.1 C4ISR systems 759.6 23.1 804.6 25.2 280.3 24.7 299.2 27.2 Land systems 916.8 27.9 860.7 27.0 323.9 28.6 295.2 26.8 Electro-optic systems 359.5 10.9 249.6 7.8 108.2 9.5 78.3 7.1 Other (mainly non-defenseengineering and production services) 78.9 2.5 93.2 3.0 28.7 2.5 30.9 2.8 Total 3,284.8 100.0 3,186.9 100.0 1,134.1 100.0 1,101.2 100.0 Consolidated Revenues by Geographical Regions: Nine Months EndedSeptember 30, Three Months EndedSeptember 30, 2020 2019 2020 2019 $ millions % $ millions % $ millions % $ millions % Israel 796.7 24.3 740.2 23.2 284.8 25.1 245.9 22.3 North America 1,077.1 32.8 908.6 28.5 343.8 30.3 333.4 30.3 Europe 557.1 17.0 583.3 18.3 209.5 18.5 195.3 17.7 Asia-Pacific 683.8 20.8 732.0 23.0 252.6 22.3 248.0 22.5 Latin America 99.5 3.0 122.0 3.8 25.5 2.2 49.5 4.5 Other countries 70.6 2.1 100.8 3.2 17.9 1.6 29.1 2.7 Total 3,284.8 100.0 3,186.9 100.0 1,134.1 100.0 1,101.2 100.0 SOURCE Elbit Systems Ltd.

Elbit Systems Reports Third Quarter 2020 Results USA - English USA - English Backlog of orders at $10.9 billion; Revenues at $1.1 billion; Non-GAAP net income of $73 million; GAAP net income of $17 million; Non-GAAP net EPS of $1.64; GAAP net EPS of $0.38

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: HAIFA, Israel, Nov. 24, 2020 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT)(the "Company" or "Elbit Systems"), the international high technology company, reported today its consolidated results for the quarter ended September30, 2020. In this release, the Company is providing US-GAAP results as well as additional non-GAAP financial data, which are intended to provide investors a more comprehensive understanding of the Company's business results and trends. Unless otherwise stated, all financial data presented is GAAP financial data. Management Comment: Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems, commented:"I am pleased with the third quarter results, particularly with the improved operating performance in this challenging COVID-19 environment and despite the pandemic's impact on our Commercial Aviation business, which resulted in a $60 million non-cash impairment of assets in the quarter. We are encouraged by our backlog of orders and the volume of opportunities we are facing around the world, which provides us with confidence in the Company's future prospects." Third Quarter 2020 Results: Revenues in the third quarter of 2020were $1,134.2 million, as compared to $1,101.2 million in the third quarter of 2019. Non-GAAP(*) gross profit amounted to $302.3 million (26.7% of revenues) in the third quarter of 2020, as compared to $290.0 million (26.3% of revenues) in the third quarter of 2019. GAAP gross profit in the third quarter of 2020 was $237.4 million (20.9% of revenues), as compared to $286.2 million (26.0% of revenues) in the third quarter of 2019. The decrease in GAAP gross profit in the third quarter of 2020 was a result of non-cash expenses related to impairment of assets and inventory write-offs due to the impact of COVID-19, in the amount of approximately $60 million. These expenses were eliminated in the non-GAAP results. Research and development expenses, netwere $91.3 million (8.0% of revenues) in the third quarter of 2020, as compared to $79.5 million (7.2% of revenues) in the third quarter of 2019. *see page 4 Marketing and selling expenses, net were $71.6 million (6.3% of revenues) in the third quarter of 2020, as compared to $75.5 million (6.9% of revenues) in the third quarter of 2019. General and administrative expenses, netwere $51.0 million (4.5% of revenues) in the third quarter of 2020, as compared to $57.5 million (5.2% of revenues) in the third quarter of 2019. Other operating income, netin the third quarter of 2019 was $28.0 million, resulting mainly from capital gains related to sale and lease back of buildings by a subsidiary in Israel. Non-GAAP(*) operating income was $93.1 million (8.2% of revenues) in the third quarter of 2020, as compared to $80.7 million (7.3% of revenues) in the third quarter of 2019.GAAP operating income in the third quarter of 2020 was $23.5 million (2.1% of revenues), as compared to $101.7 million (9.2% of revenues) in the third quarter of 2019. Financial expenses, netwere $9.7 million in the third quarter of 2020, as compared to $18.5 million in the third quarter of 2019. Financial expenses, net in the third quarter of 2019 included exchange rate differences of approximately $7 million related to lease liabilities. Other income, netin the third quarter of 2020 was $0.5 million , as compared to other expenses of $2.8 millionin the third quarter of 2019. Taxes on income were $2.2 million (effective tax rate of 15.4%) in the third quarter of 2020, as compared to $7.6 million (effective tax rate of 9.5%) in the third quarter of 2019. Equity in net earnings (losses)of affiliated companies and partnerships were earnings of $4.9 million in the third quarter of 2020, as compared to losses of $0.5 million in the third quarter of 2019. The loss in the third quarter of 2019 was a result of the write-off of a $2.3 million investment in an affiliated company in Israel. Net income attributable to non-controlling interestsin the third quarter of 2020 was $0.1 million, as compared to $0.3 million in the third quarter of 2019. Non-GAAP(*) net income attributable to the Company's shareholders in the third quarter of 2020 was $72.7 million (6.4% of revenues), as compared to $58.7 million (5.3% of revenues) in the third quarter of 2019. GAAP net income attributable to the Company's shareholders in the third quarter of 2020 was $17.0 million (1.5% of revenues), as compared to $72.1 million (6.5% of revenues) in the third quarter of 2019. Non-GAAP(*) diluted net earnings per share attributable to the Company'sshareholders were $1.64 for the third quarter of 2020, as compared to $1.33 for the third quarter of 2019. GAAP diluted earnings per share in the third quarter of 2020 were $0.38, as compared to $1.63 for the third quarter of 2019. The Company's backlog of ordersas of September30, 2020 totaled $10,858 million, as compared to $9,796 million as of September30, 2019. Approximately 65% of the current backlog is attributable to orders from outside Israel. Approximately 46% of the current backlog is scheduled to be performed during the last quarter of 2020 and during 2021. Operating cash flow in the nine months ended September30, 2020was a positive $106.7 million, as compared to a negative operating cash flow in the nine months ended September30, 2019 in the amount of $140.3 million. *see page 4 Impact of the COVID-19 Pandemic on the Company: The Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020. COVID-19 has had significant negative impacts on the worldwide economy, resulting in disruptions to supply chains and financial markets, significant travel restrictions, facility closures and shelter-in-place orders in various locations. Elbit Systems is closely monitoring the evolution of the COVID-19 pandemic and its impacts on the Company's employees, customers and suppliers, as well as on the global economy. As we last reported on August 13, 2020, we have been taking a number of actions to protect the safety of our employees as well as maintain business continuity and secure our supply chain. We also reported on a number of activities where we are leveraging our technological capabilities to assist hospital staffs and other first responders protecting our communities from the impact of the pandemic. All of these actions remain ongoing. We have implemented a series of cost control measures to help limit the financial impact of the pandemic on the Company, in parallel to the measures we are taking to maintain business continuity and deliveries to our customers. We also are working on efficiency initiatives with a number of our suppliers. We continue to evaluate our operations on an ongoing basis in order to adapt to the evolving business environment. During the first three quarters of 2020 our defense activities, which account for most of our business, were not materially impacted by the pandemic, although some of our businesses are experiencing certain disruptions due to government directed safety measures, travel restrictions and supply chain delays. The significant slowdown in commercial air traffic, and the expectation that a commercial air traffic recovery to 2019 levels will likely take a number of years, have reduced the demand for products and services for the commercial aviation markets. Additionally, manufacturers of aircrafts for these markets have announced plans to reduce production rates to adapt to the lower demand. Following a review of the economic impact on the Company's assets overall, and those assets impacted by the commercial aviation industry in particular, the Company recorded in the third quarter of 2020 non-cash expenses related to impairment of assets and inventory write-offs, due to COVID-19, in the amount of approximately $60 million. These expenses were recorded mainly in the 'Cost of Revenues' line item in the Consolidated Statement of Income and were eliminated in the non-GAAP results as a category of expenses that are not part of the Company's recurring business. We believe that as of September 30, 2020, Elbit Systems had a healthy balance sheet, adequate levels of cash and access to credit facilities that provide liquidity when necessary. We have given high priority to cash management and adequate cash reserves to run the business. The extent of the impact of COVID-19 on the Company's performance depends on future developments including the duration and spread of the pandemic, the measures adopted by governments to limit the spread of the pandemic and resulting actions that may be taken by our customers and our supply chain, all of which are uncertain. As noted in our annual report on Form 20-F, the preparation of financial reports such as our quarterly financial results requires us to make judgments, assumptions and estimates that affect the amounts reported. For our quarterly financial results for the quarter ended September 30, 2020, we considered the economic impact of the COVID-19 pandemic on our critical and significant accounting estimates. The expected impact of the COVID-19 pandemic did not have a material effect on our judgments, assumptions and estimates reflected in the results. However, our future results may differ materially from our estimates. As events continue to evolve in connection with the COVID-19 pandemic, the estimates we use in future periods may change materially. *Non-GAAP financial data: The following non-GAAP financial data is presented to enable investors to have additional information on the Company's business performance as well as a further basis for periodical comparisons and trends relating to the Company's financial results. The Company believes such data provides useful information to investors by facilitating more meaningful comparisons of the Company's financial results over time. Such non-GAAP information is used by the Company's management to make strategic decisions, forecast future results and evaluate the Company's current performance. However, investors are cautioned that, unlike financial measures prepared in accordance with GAAP, non-GAAP measures may not be comparable with the calculation of similar measures for other companies. The non-GAAP financial data includes reconciliation adjustments regarding non-GAAP gross profit, operating income, net income and diluted EPS. In arriving at non-GAAP presentations, companies generally factor out items such as those that have a non-recurring impact on the income statements, various non-cash items including significant exchange rate differences, significant effects of retroactive tax legislation, changes in accounting guidance, financial transactions and other items not considered to be part of regular ongoing business, which, in management's judgment, are items that are considered to be outside of the review of core operating results. In the Company's non-GAAP presentation, the Company made certain adjustments, as indicated in the table below. These non-GAAP measures are not based on any comprehensive set of accounting rules or principles. The Company believes that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company's results of operations, as determined in accordance with GAAP, and that these measures should only be used to evaluate the Company's results of operations in conjunction with the corresponding GAAP measures.Investors should consider non-GAAP financial measures in addition to, and not as replacements for or superior to, measures of financial performance prepared in accordance with GAAP. Reconciliation of GAAP to Non-GAAP (Unaudited) Supplemental Financial Data:(US Dollars in millions,except for share and per share amount) Nine Months EndedSeptember 30, Three Months Ended September 30, Year EndedDecember 31, 2020 2019 2020 2019 2019 GAAP gross profit $ 807.3 $ 852.2 $ 237.4 $ 286.2 $ 1,136.5 Adjustments: Amortization of purchased intangible assets 17.5 15.4 5.5 3.8 22.0 Non-recurring expenses(*) 56.0 56.0 55.0 Impairment of long-lived assets 3.4 3.4 Non-GAAP gross profit $ 884.2 $ 867.6 $ 302.3 $ 290.0 $ 1,213.5 Percent of revenues 26.9 % 27.2 % 26.7 % 26.3 % 26.9 % GAAP operating income $ 221.1 $ 258.0 $ 23.5 $ 101.7 $ 321.6 Adjustments: Amortization of purchased intangible assets 30.2 25.5 9.6 7.0 36.1 Non-recurring expenses(*) 56.6 56.6 55.0 Impairment of long-lived assets 3.4 3.4 Capital gain (35.0) (28.0) (28.0) (31.8) Gain from changes in holdings (1.2) (1.2) Non-GAAP operating income $ 276.3 $ 254.3 $ 93.1 $ 80.7 $ 379.7 Percent of revenues 8.4 % 8.0 % 8.2 % 7.3 % 8.4 % GAAP net income attributable to Elbit Systems' shareholders $ 169.8 $ 176.3 $ 17.0 $ 72.1 $ 227.9 Adjustments: Amortization of purchased intangible assets 30.2 25.5 9.6 7.0 36.1 Non-recurring expenses(*) 56.6 56.6 55.0 Capital gain (35.0) (28.0) (28.0) (31.8) Gain from changes in holdings (1.2) (1.2) Impairment of long-lived assets 7.8 3.4 3.7 Exchange rate differences 5.6 22.1 (1.2) 6.7 24.6 Capital gain and revaluation of investments (21.4) (4.6) (2.8) (8.3) Related tax (benefits) expenses, net (0.2) (1.5) (9.9) 0.9 (8.2) Non-GAAP net income attributable to Elbit Systems' shareholders $ 213.4 $ 188.6 $ 72.7 $ 58.7 $ 297.8 Percent of revenues 6.5 % 5.9 % 6.4 % 5.3 % 6.6 % GAAP diluted net EPS $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Adjustments, net 0.99 0.28 1.26 (0.30) 1.59 Non-GAAP diluted net EPS $ 4.83 $ 4.32 $ 1.64 $ 1.33 $ 6.79 (*) Non-recurring expenses in 2020 are related to COVID-19 write-offs. In 2019 the expenses are related to acquisition of a subsidiary in the U.S. Recent Events: On August 17, 2020, the Company announced that it was awarded a contract valued at approximately $27 million to supply air-to-air combat training systems for the Navy of a South Asian Country. The contract will be performed over a two-year period, to be followed by three years of availability-based maintenance. On August 31, 2020, the Company announced that its U.S. subsidiary, Elbit Systems of America, LLC ("Elbit Systems of America"), was awarded an Indefinite Delivery/Indefinite Quantity ("ID/IQ") contract by the Defense Logistics Agency Land to supply the U.S. Army with gunner hand stations, commander hand stations and circuit cards for the Bradley Infantry Fighting Vehicle. The contract, with a maximum value of up to approximately $79 million, will be performed over a five-year period. An initial purchase order of approximately $26 million under the ID/IQ contract followed by a second purchase order of approximately $12 million have been issued to be executed over a three-year period. On September 14, 2020, the Company announced that its wholly-owned subsidiary, Elbit Systems - Cyclone Ltd., was awarded a contract by Lockheed Martin (NYSE: LMT) for the manufacture of assemblies for Forward Equipment Bay assemblies for the F-35 fighter aircraft. The contract is in an amount that is not material to Elbit Systems and will be performed over a period of four years. On September 29, 2020, the Company announced that it filed a shelf prospectus with the Israel Securities Authority and the Tel Aviv Stock Exchange. On October 1, 2020, the Company announced that it was awarded a contract valued at approximately $33 million to supply tactical radio systems to a customer in Asia-Pacific. The contract will be performed over a twelve-month period. On October 5, 2020,the Company announced that Elbit Systems of America was awarded an approximately $35 million five-year firm-fixed-priced contract by the U.S. Naval Supply Systems Command for repair of line-replaceable units in support of the V-22 aircraft. The repairs will be performed in Fort Worth, Texas and Talladega, Alabama, and the contract will be performed until October 2025. On October 7, 2020,the Company announced that Elbit Systems of America was awarded an ID/IQ contract with a maximum value of approximately $50 million to produce spare parts in support of the Aviators' Night Vision Imaging System Head-Up Display system of the U.S. Army. The contract, that will be performed over a period of five years, was awarded on behalf of the United States Army, by the Defense Logistics Agency. An initial order for $17.9 million was recently placed under this contract, to be supplied until 2023. On October 22, 2020, the Company announced that Elbit Systems of America was awarded an Other Transaction Authority ("OTA") contract from the U.S. Army for Enhanced Night Vision Goggle Binocular systems. The potential contract value under the OTA contract could reach a maximum of approximately $442 million. The U.S. Army did not define an overall time-frame for performance of the OTA contract. An initial order in the amount of approximately $22.5 million for low-rate initial production of systems has been placed under the OTA contract, with a period of performance through December 2021, to be executed in Roanoke, Virginia. On October 26, 2020, the Company announced that, as a result of the impact of the COVID-19 pandemic, Elbit Systems experienced reduced demand for the products and services it supplies to the commercial aviation markets. The significant slowdown in commercial air traffic, and the expectation that a commercial air traffic recovery to 2019 levels will likely take a number of years, have reduced the demand for products and services for the commercial aviation markets. Additionally, manufacturers of aircraft for these markets have announced plans to reduce production rates to adapt to the lower demand. Following a review of the economic impact on the Company's assets overall, and those assets impacted by the commercial aviation industry in particular, the Company recorded in the third quarter of 2020 non-cash expenses related to impairment of assets and inventory write-offs, due to COVID-19, in the amount of approximately $60 million. These expenses were recorded mainly in the "Cost of Revenues" line item in the Consolidated Statement of Income and were eliminated in the non-GAAP results as a category of expenses that are not part of the Company's regular on-going business. Reorganization of Certain Business Activities: As part of the Company's ongoing review of its businesses and portfolio, and in view of the changing business environment and the need to better serve our customers as well as to leverage the synergy and inter-operable activities of our areas of operation, a decision has been made to reorganize some of our business activities. The major parts of this reorganization include: (1) integration of our unmanned aircraft systems business with our manned military aircraft business to leverage synergies across manned and unmanned military aircraft; (2) integration of our electro-optical and our electronic warfare and signal intelligence businesses to provide advanced solutions across the electro-magnetic spectrum; and (3) integration of the precision guided munitions activities, currently part of our military aircraft business, with the IMI munitions portfolio. This reorganization will begin in the coming months and be completed during 2021. Dividend: The Board of Directors declared a dividend of $0.44 per share for the third quarter of 2020. The dividend's record date is December 21, 2020. The dividend will be paid from income generated as Preferred Income (as defined under Israel tax laws), on January 4, 2021, net of taxes and levies, at the rate of 20%. Conference Call: The Company will be hosting a conference call on Tuesday, November 24, 2020 at 9:00 a.m. Eastern Time. On the call, the Company's management will review and discuss the results and will be available to answer questions. To participate, please call any of the teleconferencing numbers that follow. If you are unable to connect using the toll-free numbers, please try the international dial-in number. US Dial-in Number: 1-866-744-5399Canada Dial-in Number: 1-866-485-2399Israel Dial-in Number: 03-918-0610International Dial-in Number: +972-3-918-0610 at 9:00am Eastern Time; 6:00am Pacific Time; 4:00pm Israel Time The conference call will also be broadcast live on Elbit Systems' web-site at http://www.elbitsystems.com. An online replay will be available from 24 hours after the call ends. Alternatively, for two days following the call, investors will be able to dial a replay number to listen to the call. The dial-in numbers are: 1-888-782-4291 (US and Canada) or +972-3-925-5918 (Israel and International). About Elbit Systems Elbit Systems Ltd. is an international high technology company engaged in a wide range of defense, homeland security and commercial programs throughout the world. The Company, which includes Elbit Systems and its subsidiaries, operates in the areas of aerospace, land and naval systems, command, control, communications, computers, intelligence surveillance and reconnaissance ("C4ISR"), unmanned aircraft systems, advanced electro-optics, electro-optic space systems, EW suites, signal intelligence systems, data links and communications systems, radios, cyber-based systems and munitions. The Company also focuses on the upgrading of existing platforms, developing new technologies for defense, homeland security and commercial applications and providing a range of support services, including training and simulation systems. For additional information, visit: https://elbitsystems.com/, follow us on Twitteror visit our official Facebook, Youtube and LinkedInChannels. Company Contact: Joseph Gaspar, Executive VP & CFOTel: +972-77-2946663 [emailprotected] Rami Myerson, Director, Investor Relations Tel: +972-77-2948984 [emailprotected] David Vaaknin, VP, Brand & Corporate Communications Tel: +972-77-2946691 [emailprotected] IR Contact: Ehud HelftKenny Green GK Investor Relations Tel: 1-646-201-9246 [emailprotected] This press release may contain forwardlooking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Israeli Securities Law, 1968) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current facts. Forward-looking statements are based on management's current expectations, estimates, projections and assumptions about future events. Forwardlooking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions about the Company, which are difficult to predict, including projections of the Company's future financial results, its anticipated growth strategies and anticipated trends in its business. Therefore, actual future results, performance and trends may differ materially from these forwardlooking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States among others; changes in global health and macro-economic conditions; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; changes in the competitive environment; and the outcome of legal and/or regulatory proceedings. The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.'s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forwardlooking statements speak only as of the date of this release. Although the Company believes the expectations reflected in theforward-lookingstatements contained herein are reasonable, it cannot guarantee future results, level of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of any of theseforward-lookingstatements. The Company does not undertake to update its forward-looking statements. Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this Press Release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies. All other brand, product, service and process names appearing are the trademarks of their respective holders. Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of Elbit Systems Ltd. or any third party, except as expressly granted herein. ELBIT SYSTEMS LTD.CONSOLIDATED BALANCE SHEETS (In thousands of U.S. Dollars) September 30, 2020 December 31, 2019 Unaudited Audited Assets Cash and cash equivalents $ 287,151 $ 221,060 Short-term bank deposits 1,158 2,213 Trade receivables and contract assets, net 2,301,518 2,067,846 Other receivables and prepaid expenses 188,267 160,728 Inventories, net 1,325,800 1,219,920 Total current assets 4,103,894 3,671,767 Investments in affiliated companies and partnerships and other companies 183,510 201,574 Long-term trade receivables and contract assets 253,127 259,150 Long-term bank deposits and other receivables 54,894 58,076 Deferred income taxes, net 107,928 89,452 Severance pay fund 275,013 287,104 874,472 895,356 Operating lease right of use assets 423,126 365,763 Property, plant and equipment, net 760,088 766,532 Goodwill and other intangible assets, net 1,565,582 1,635,940 Total assets $ 7,727,162 $ 7,335,358 Liabilities and equity Short-term bank credit and loans $ 290,520 $ 208,399 Current maturities of long-term loans and Series A Notes 37,809 199,882 Operating lease liabilities 60,860 62,565 Trade payables 893,841 926,338 Other payables and accrued expenses 1,111,057 1,052,080 Contract liabilities 943,121 723,581 3,337,208 3,172,845 Long-term loans, net of current maturities 538,631 440,124 Employee benefit liabilities 812,324 836,535 Deferred income taxes and tax liabilities, net 122,534 114,419 Operating lease liabilities 380,767 323,287 Contract liabilities 98,138 62,830 Other long-term liabilities 180,949 225,478 2,133,343 2,002,673 Elbit Systems Ltd.'s equity 2,238,604 2,141,406 Non-controlling interests 18,007 18,434 Total equity 2,256,611 2,159,840 Total liabilities and equity $ 7,727,162 $ 7,335,358 ELBIT SYSTEMS LTD.CONSOLIDATED STATEMENTS OF INCOME(In thousands of U.S. Dollars, except for share and per share amount) Nine Months Ended September 30, Three Months Ended September 30, Year Ended December 31, 2020 2019 2020 2019 2019 Unaudited Unaudited Audited Revenues $ 3,284,840 $ 3,186,894 $ 1,134,169 $ 1,101,190 $ 4,508,400 Cost of revenues 2,477,567 2,334,720 896,780 815,032 3,371,933 Gross profit 807,273 852,174 237,389 286,158 1,136,467 Operating expenses: Research and development, net 250,683 234,126 91,282 79,468 331,757 Marketing and selling, net 209,477 220,917 71,557 75,512 301,400 General and administrative, net 161,015 168,385 51,020 57,520 214,749 Other operating income, net (34,963) (29,264) (28,030) (33,049) Total operating expenses 586,212 594,164 213,859 184,470 814,857 Operating income 221,061 258,010 23,530 101,688 321,610 Financial expenses, net (38,745) (52,715) (9,673) (18,461) (69,072) Other income (expenses), net 14,740 (4,618) 525 (2,811) (6,243) Income before income taxes 197,056 200,677 14,382 80,416 246,295 Taxes on income (34,565) (28,543) (2,215) (7,619) (19,414) 162,491 172,134 12,167 72,797 226,881 Equity in net earnings (losses) of affiliated companies and partnerships 7,579 5,272 4,880 (469) 1,774 Net income $ 170,070 $ 177,406 $ 17,047 $ 72,328 $ 228,655 Less: net income attributable to non-controlling interests (235) (1,063) (73) (263) (798) Net income attributable to Elbit Systems Ltd.'s shareholders $ 169,835 $ 176,343 $ 16,974 $ 72,065 $ 227,857 Earnings per share attributable to Elbit Systems Ltd.'sshareholders: Basic net earnings per share $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Diluted net earnings per share $ 3.84 $ 4.04 $ 0.38 $ 1.63 $ 5.20 Weighted average number of shares (in thousands) Shares used in computation of basic earnings per share 44,198 43,653 44,198 44,201 43,787 Shares used in computation of diluted earnings per share 44,220 43,702 44,221 44,253 43,848 ELBIT SYSTEMS LTD.CONSOLIDATED STATEMENTS OF CASH FLOW(In thousands of U.S. dollars) Nine Months Ended September 30, Year Ended December 31, 2020 2019 2019 Unaudited Audited CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 170,070 $ 177,406 $ 228,655 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 109,040 98,280 137,146 Impairment of assets 7,771 3,692 Stock-based compensation 3,064 2,973 3,994 Amortization of Series A Notes premium and related issuance costs, net (46) (69) (93) Deferred income taxes and reserve, net (12,773) 12,567 (15,059) Gain on sale of property, plant and equipment (32,180) (28,509) (34,154) Gain on sale of investments and remeasurement of investment held under fair value method, net (23,652) (4,479) (7,928) Equity in net earnings of affiliated companies and partnerships, net of dividend received (*) (5,862) 1,780 8,526 Changes in operating assets and liabilities, net of amounts acquired: Increase in trade receivables and contract assets and prepaid expenses (242,994) (121,167) (267,924) Increase in inventories, net (78,874) (195,857) (55,841) Increase (decrease) in trade payables, other payables and accrued expenses (13,739) 6,710 115,621 Severance, pension and termination indemnities, net (3,874) 9,000 4,629 Increase (decrease) in contract liabilities 230,757 (98,892) (174,582) Net cash provided by (used in) operating activities 106,708 (140,257) (53,318) CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property, plant and equipment and other assets (92,945) (97,898) (137,604) Acquisition of subsidiaries and business operations (357,144) (357,144) Proceeds from premises evacuation grants receivables 344,913 344,913 Investments in affiliated companies and other companies (12,316) (3,350) (8,567) Proceeds from sale of property, plant and equipment 71,918 36,189 36,671 Proceeds from sale of investments 44,200 Investment in long-term deposits, net (161) 61 (38) Investment in short-term deposits (600) (15,913) (2,314) Proceeds from sale of short-term deposits 1,663 28,789 17,294 Net cash provided by (used in) investing activities 11,759 (64,353) (106,789) CASH FLOWS FROM FINANCING ACTIVITIES Issuance of treasury shares, net 184,840 184,840 Repayment of long-term loans (205,923) (242,440) (243,324) Proceeds from long-term loans 201,551 350,000 350,000 Repayment of Series A Notes (55,532) (55,532) (55,532) Dividends paid (74,308) (58,922) (62,578) Change in short-term bank credit and loans, net 81,836 (16,135) (718) Net cash provided by (used in) financing activities (52,376) 161,811 172,688 Net increase (decrease) in cash and cash equivalents 66,091 (42,799) 12,581 Cash and cash equivalents at the beginning of the year 221,060 208,479 208,479 Cash and cash equivalents at the end of the period $ 287,151 $ 165,680 $ 221,060 * Dividend received from affiliated companies and partnerships $ 6,117 $ 7,052 $ 10,300 ELBIT SYSTEMS LTD.DISTRIBUTION OF REVENUES Consolidated Revenues by Areas of Operation: Nine Months EndedSeptember 30, Three Months EndedSeptember 30, 2020 2019 2020 2019 $ millions % $ millions % $ millions % $ millions % Airborne systems 1,170.0 35.6 1,178.8 37.0 393.0 34.7 397.6 36.1 C4ISR systems 759.6 23.1 804.6 25.2 280.3 24.7 299.2 27.2 Land systems 916.8 27.9 860.7 27.0 323.9 28.6 295.2 26.8 Electro-optic systems 359.5 10.9 249.6 7.8 108.2 9.5 78.3 7.1 Other (mainly non-defenseengineering and production services) 78.9 2.5 93.2 3.0 28.7 2.5 30.9 2.8 Total 3,284.8 100.0 3,186.9 100.0 1,134.1 100.0 1,101.2 100.0 Consolidated Revenues by Geographical Regions: Nine Months EndedSeptember 30, Three Months EndedSeptember 30, 2020 2019 2020 2019 $ millions % $ millions % $ millions % $ millions % Israel 796.7 24.3 740.2 23.2 284.8 25.1 245.9 22.3 North America 1,077.1 32.8 908.6 28.5 343.8 30.3 333.4 30.3 Europe 557.1 17.0 583.3 18.3 209.5 18.5 195.3 17.7 Asia-Pacific 683.8 20.8 732.0 23.0 252.6 22.3 248.0 22.5 Latin America 99.5 3.0 122.0 3.8 25.5 2.2 49.5 4.5 Other countries 70.6 2.1 100.8 3.2 17.9 1.6 29.1 2.7 Total 3,284.8 100.0 3,186.9 100.0 1,134.1 100.0 1,101.2 100.0 SOURCE Elbit Systems Ltd. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Elbit Systems Reports Third Quarter 2020 Results. USA - English. USA - English. Backlog of orders at $10.9 billion; Revenues at $1.1 billion; Non-GAAP net income of $73 million; GAAP net income of $17 million; Non-GAAP net EPS of $1.64; GAAP net EPS of $0.38.<|eot_id|>

edtsum846

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SEATTLE, Aug. 11, 2020 /PRNewswire/ --RealSelf, the go-to destination for making cosmetic treatment decisions and connecting with doctors, today introduces RealSelf INSIDER, a new membership program that offers cash back rewards for cosmetic treatments as well as exclusive perks, including free virtual consultations and medical-grade skin-care products. RealSelf is launching the program in Los Angeles and New York City, with plans to capture and incorporate feedback from early members before expanding to additional markets. RealSelf Launches RealSelf INSIDER, a New Cosmetic Treatment Membership Program Offering Cash Back Rewards, Medical-Grade Skin-Care Products and Free Virtual Consultations RealSelf INSIDER is the most flexible membership program in medical aesthetics. Members can earn cash back rewards on hundreds of different cosmetic treatments, including nonsurgical procedures like injectable fillers or microneedling, as well as surgical procedures like rhinoplasty. "A cosmetic treatment is a serious investment, and we want to encourage consumers to meet with a doctor and then choose a treatment based on what will be best for their unique needs," said RealSelf founder and CEO Tom Seery. An annual RealSelf INSIDER membership costs $149, and members gain access to benefits immediately after signing up. RealSelf INSIDER members can choose to receive a $125 cash back reward for a nonsurgical treatment twice annually ($250 total value) or one $250 cash back reward for a surgical procedure.How the RealSelf INSIDER membership program works: Sign up to become a RealSelf INSIDER.New members receive a welcome box worth $200 that features medical-grade skin-care products from brands like ZO Skin Health, Epionce, and Skinbetter Science. Book a consultation through RealSelf. Members can choose to consult virtually (for free) or in person with any RealSelf Verified doctor in Los Angeles or New York City who is participating in the INSIDER program. Get a treatment.When a member is ready to move forward, they can visit their RealSelf Verified doctor for the nonsurgical or surgical treatment of their choosing. Receive a cash reward.To redeem a cash back reward, members simply share their RealSelf INSIDER account email with their doctor. After the appointment, RealSelf will email members an electronic Visa prepaid gift card. More than 70 doctors in Los Angeles and New York City are already participating in the RealSelf INSIDER program. To be approved for the program, doctors must have earned RealSelf Verified status, which requires them to maintain specific standards of trust, transparency and patient satisfaction. In addition to having an active medical license and remaining in good standing with their local medical board, RealSelf Verified doctors must maintain an average patient satisfaction score of four stars or higher. They are also required to respond to RealSelf user requests within two business days and must provide specific information such as years of experience, hospital privileges and whether they carry malpractice insurance on their RealSelf profile. The status of a RealSelf Verified doctor's medical license is reviewed by RealSelf every three months."This program strengthens the one-on-one relationships we've built with our community members," said RealSelf founder and CEO Tom Seery. "Now more than ever, consumers are being mindful about their spending. With RealSelf INSIDER, we're offering cost savings and the peace of mind that comes with going to a RealSelf Verified doctor." Learn more about RealSelf INSIDER and sign up today at www.realself.com/insider. To find a participating doctor, visit www.realself.com/find and look for doctors with a RealSelf INSIDER badge. About RealSelfRealSelfis the go-to destination for making cosmetic treatment decisions and connecting with doctors. Millions of people from around the world count on RealSelf to find unbiased information, real patient reviews and photos, treatment costs and ratings, and Verified doctors. From medical-grade skin-care products to emerging noninvasive technologies to cosmetic surgeries, RealSelf makes it easy to get the trusted insights you need to make smart, confident decisions about modern beauty treatments and doctors. For more information, visitRealSelf News and follow us on Instagram, Facebook and Pinterest.SOURCE RealSelf Related Links http://www.realself.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

RealSelf Launches RealSelf INSIDER, a New Cosmetic Treatment Membership Program Offering Cash Back Rewards, Medical-Grade Skin-Care Products, and Free Virtual Consultations. RealSelf INSIDER is now available in Los Angeles and New York City and offers members more reward-eligible treatment options than any other membership program in medical aesthetics.

SEATTLE, Aug. 11, 2020 /PRNewswire/ --RealSelf, the go-to destination for making cosmetic treatment decisions and connecting with doctors, today introduces RealSelf INSIDER, a new membership program that offers cash back rewards for cosmetic treatments as well as exclusive perks, including free virtual consultations and medical-grade skin-care products. RealSelf is launching the program in Los Angeles and New York City, with plans to capture and incorporate feedback from early members before expanding to additional markets. RealSelf Launches RealSelf INSIDER, a New Cosmetic Treatment Membership Program Offering Cash Back Rewards, Medical-Grade Skin-Care Products and Free Virtual Consultations RealSelf INSIDER is the most flexible membership program in medical aesthetics. Members can earn cash back rewards on hundreds of different cosmetic treatments, including nonsurgical procedures like injectable fillers or microneedling, as well as surgical procedures like rhinoplasty. "A cosmetic treatment is a serious investment, and we want to encourage consumers to meet with a doctor and then choose a treatment based on what will be best for their unique needs," said RealSelf founder and CEO Tom Seery. An annual RealSelf INSIDER membership costs $149, and members gain access to benefits immediately after signing up. RealSelf INSIDER members can choose to receive a $125 cash back reward for a nonsurgical treatment twice annually ($250 total value) or one $250 cash back reward for a surgical procedure.How the RealSelf INSIDER membership program works: Sign up to become a RealSelf INSIDER.New members receive a welcome box worth $200 that features medical-grade skin-care products from brands like ZO Skin Health, Epionce, and Skinbetter Science. Book a consultation through RealSelf. Members can choose to consult virtually (for free) or in person with any RealSelf Verified doctor in Los Angeles or New York City who is participating in the INSIDER program. Get a treatment.When a member is ready to move forward, they can visit their RealSelf Verified doctor for the nonsurgical or surgical treatment of their choosing. Receive a cash reward.To redeem a cash back reward, members simply share their RealSelf INSIDER account email with their doctor. After the appointment, RealSelf will email members an electronic Visa prepaid gift card. More than 70 doctors in Los Angeles and New York City are already participating in the RealSelf INSIDER program. To be approved for the program, doctors must have earned RealSelf Verified status, which requires them to maintain specific standards of trust, transparency and patient satisfaction. In addition to having an active medical license and remaining in good standing with their local medical board, RealSelf Verified doctors must maintain an average patient satisfaction score of four stars or higher. They are also required to respond to RealSelf user requests within two business days and must provide specific information such as years of experience, hospital privileges and whether they carry malpractice insurance on their RealSelf profile. The status of a RealSelf Verified doctor's medical license is reviewed by RealSelf every three months."This program strengthens the one-on-one relationships we've built with our community members," said RealSelf founder and CEO Tom Seery. "Now more than ever, consumers are being mindful about their spending. With RealSelf INSIDER, we're offering cost savings and the peace of mind that comes with going to a RealSelf Verified doctor." Learn more about RealSelf INSIDER and sign up today at www.realself.com/insider. To find a participating doctor, visit www.realself.com/find and look for doctors with a RealSelf INSIDER badge. About RealSelfRealSelfis the go-to destination for making cosmetic treatment decisions and connecting with doctors. Millions of people from around the world count on RealSelf to find unbiased information, real patient reviews and photos, treatment costs and ratings, and Verified doctors. From medical-grade skin-care products to emerging noninvasive technologies to cosmetic surgeries, RealSelf makes it easy to get the trusted insights you need to make smart, confident decisions about modern beauty treatments and doctors. For more information, visitRealSelf News and follow us on Instagram, Facebook and Pinterest.SOURCE RealSelf Related Links http://www.realself.com

RealSelf Launches RealSelf INSIDER, a New Cosmetic Treatment Membership Program Offering Cash Back Rewards, Medical-Grade Skin-Care Products and Free Virtual Consultations RealSelf INSIDER is now available in Los Angeles and New York City and offers members more reward-eligible treatment options than any other membership program in medical aesthetics

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SEATTLE, Aug. 11, 2020 /PRNewswire/ --RealSelf, the go-to destination for making cosmetic treatment decisions and connecting with doctors, today introduces RealSelf INSIDER, a new membership program that offers cash back rewards for cosmetic treatments as well as exclusive perks, including free virtual consultations and medical-grade skin-care products. RealSelf is launching the program in Los Angeles and New York City, with plans to capture and incorporate feedback from early members before expanding to additional markets. RealSelf Launches RealSelf INSIDER, a New Cosmetic Treatment Membership Program Offering Cash Back Rewards, Medical-Grade Skin-Care Products and Free Virtual Consultations RealSelf INSIDER is the most flexible membership program in medical aesthetics. Members can earn cash back rewards on hundreds of different cosmetic treatments, including nonsurgical procedures like injectable fillers or microneedling, as well as surgical procedures like rhinoplasty. "A cosmetic treatment is a serious investment, and we want to encourage consumers to meet with a doctor and then choose a treatment based on what will be best for their unique needs," said RealSelf founder and CEO Tom Seery. An annual RealSelf INSIDER membership costs $149, and members gain access to benefits immediately after signing up. RealSelf INSIDER members can choose to receive a $125 cash back reward for a nonsurgical treatment twice annually ($250 total value) or one $250 cash back reward for a surgical procedure.How the RealSelf INSIDER membership program works: Sign up to become a RealSelf INSIDER.New members receive a welcome box worth $200 that features medical-grade skin-care products from brands like ZO Skin Health, Epionce, and Skinbetter Science. Book a consultation through RealSelf. Members can choose to consult virtually (for free) or in person with any RealSelf Verified doctor in Los Angeles or New York City who is participating in the INSIDER program. Get a treatment.When a member is ready to move forward, they can visit their RealSelf Verified doctor for the nonsurgical or surgical treatment of their choosing. Receive a cash reward.To redeem a cash back reward, members simply share their RealSelf INSIDER account email with their doctor. After the appointment, RealSelf will email members an electronic Visa prepaid gift card. More than 70 doctors in Los Angeles and New York City are already participating in the RealSelf INSIDER program. To be approved for the program, doctors must have earned RealSelf Verified status, which requires them to maintain specific standards of trust, transparency and patient satisfaction. In addition to having an active medical license and remaining in good standing with their local medical board, RealSelf Verified doctors must maintain an average patient satisfaction score of four stars or higher. They are also required to respond to RealSelf user requests within two business days and must provide specific information such as years of experience, hospital privileges and whether they carry malpractice insurance on their RealSelf profile. The status of a RealSelf Verified doctor's medical license is reviewed by RealSelf every three months."This program strengthens the one-on-one relationships we've built with our community members," said RealSelf founder and CEO Tom Seery. "Now more than ever, consumers are being mindful about their spending. With RealSelf INSIDER, we're offering cost savings and the peace of mind that comes with going to a RealSelf Verified doctor." Learn more about RealSelf INSIDER and sign up today at www.realself.com/insider. To find a participating doctor, visit www.realself.com/find and look for doctors with a RealSelf INSIDER badge. About RealSelfRealSelfis the go-to destination for making cosmetic treatment decisions and connecting with doctors. Millions of people from around the world count on RealSelf to find unbiased information, real patient reviews and photos, treatment costs and ratings, and Verified doctors. From medical-grade skin-care products to emerging noninvasive technologies to cosmetic surgeries, RealSelf makes it easy to get the trusted insights you need to make smart, confident decisions about modern beauty treatments and doctors. For more information, visitRealSelf News and follow us on Instagram, Facebook and Pinterest.SOURCE RealSelf Related Links http://www.realself.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> RealSelf Launches RealSelf INSIDER, a New Cosmetic Treatment Membership Program Offering Cash Back Rewards, Medical-Grade Skin-Care Products, and Free Virtual Consultations. RealSelf INSIDER is now available in Los Angeles and New York City and offers members more reward-eligible treatment options than any other membership program in medical aesthetics.<|eot_id|>

edtsum847

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Global Organic Fertilizers Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The organic fertilizers market is poised to grow by $9.09 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period. The report on the organic fertilizers market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the stringent regulations and policies and growing awareness about organic farming. In addition, stringent regulations and policies are anticipated to boost the growth of the market as well. This study identifies the increasing demand for food due to population growth as one of the prime reasons driving the organic fertilizers market growth during the next few years. The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading organic fertilizers market vendors that include BioStar Renewables LLC, Coromandel International Ltd., Fertikal NV, Israel Chemicals Ltd., Italpollina Spa, KRIBCHO, Midwestern BioAg Inc., Sustane Natural Fertilizer Inc., The Fertrell Co., and Walts Organic Fertilizer. Also, the organic fertilizers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer Landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix For more information about this report visit https://www.researchandmarkets.com/r/p9lltd Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Global Organic Fertilizers Market 2020-2024: Market is Poised to Grow by $9.09 Billion - ResearchAndMarkets.com.

DUBLIN--(BUSINESS WIRE)--The "Global Organic Fertilizers Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The organic fertilizers market is poised to grow by $9.09 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period. The report on the organic fertilizers market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the stringent regulations and policies and growing awareness about organic farming. In addition, stringent regulations and policies are anticipated to boost the growth of the market as well. This study identifies the increasing demand for food due to population growth as one of the prime reasons driving the organic fertilizers market growth during the next few years. The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading organic fertilizers market vendors that include BioStar Renewables LLC, Coromandel International Ltd., Fertikal NV, Israel Chemicals Ltd., Italpollina Spa, KRIBCHO, Midwestern BioAg Inc., Sustane Natural Fertilizer Inc., The Fertrell Co., and Walts Organic Fertilizer. Also, the organic fertilizers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer Landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix For more information about this report visit https://www.researchandmarkets.com/r/p9lltd

Global Organic Fertilizers Market 2020-2024: Market is Poised to Grow by $9.09 Billion - ResearchAndMarkets.com

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Global Organic Fertilizers Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The organic fertilizers market is poised to grow by $9.09 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period. The report on the organic fertilizers market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the stringent regulations and policies and growing awareness about organic farming. In addition, stringent regulations and policies are anticipated to boost the growth of the market as well. This study identifies the increasing demand for food due to population growth as one of the prime reasons driving the organic fertilizers market growth during the next few years. The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading organic fertilizers market vendors that include BioStar Renewables LLC, Coromandel International Ltd., Fertikal NV, Israel Chemicals Ltd., Italpollina Spa, KRIBCHO, Midwestern BioAg Inc., Sustane Natural Fertilizer Inc., The Fertrell Co., and Walts Organic Fertilizer. Also, the organic fertilizers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer Landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix For more information about this report visit https://www.researchandmarkets.com/r/p9lltd Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Global Organic Fertilizers Market 2020-2024: Market is Poised to Grow by $9.09 Billion - ResearchAndMarkets.com.<|eot_id|>

edtsum848

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: FORT LAUDERDALE, Fla/--(BUSINESS WIRE)--BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB) (BBX Capital or the Company) announced today that its Board of Directors has set a record date of September 22, 2020 for determining shareholders entitled to receive the distribution of shares in connection with the Companys proposed spin-off of its subsidiary, BBX Capital Florida LLC (New BBX Capital). If the spin-off is completed, the Companys shareholders will continue to own their shares of the Companys Common Stock and will also receive one share of New BBX Capitals Class A Common Stock for each share of the Companys Class A Common Stock held as of the close of business on September 22, 2020 and one share of New BBX Capitals Class B Common Stock for each share of the Companys Class B Common Stock held as of the close of business on September 22, 2020, in each case, subject to any trading of the Companys shares between the record date and distribution date with an entitlement to shares of New BBX Capital. The Company currently anticipates that the distribution of New BBX Capitals shares will occur on September 30, 2020. Information regarding any change in the distribution date for the spin-off will be disclosed in a subsequent press release by the Company. Trading of New BBX Capitals Class A Common Stock and Class B Common Stock will commence on the OTCQX upon approval and announcement by FINRA of the commencement of trading on the date established by FINRA. There is no assurance when trading of New BBX Capitals Class A Common Stock and Class B Common Stock will begin. The Company will provide a subsequent press release with updated information regarding the trading of New BBX Capitals Class A Common Stock and Class B Common Stock following the Companys receipt of such information from FINRA. Completion of the spin-off is subject to approval of the spin-off by the Companys shareholders. The Company has scheduled a special meeting of its shareholders, to be held in virtual format only on September 25, 2020, for the purpose of approving the spin-off and the Companys contemplated name change to Bluegreen Vacations Holding Corporation in connection with the spin-off. Additional information regarding the spin-off and the special meeting is set forth in the Companys definitive proxy statement for the special meeting, which was filed with the SEC on August 27, 2020 and has been mailed to the Companys shareholders. About BBX Capital Corporation: BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB) is a Florida-based diversified holding company whose principal investments include Bluegreen Vacations Corporation (NYSE: BXG), BBX Capital Real Estate, BBX Sweet Holdings, and Renin. For additional information, please visit www.BBXCapital.com. About Bluegreen Vacations Corporation: Bluegreen Vacations Corporation (NYSE: BXG) is a leading vacation ownership company that markets and sells vacation ownership interests and manages resorts in popular leisure and urban destinations. The Bluegreen Vacation Club is a flexible, points-based, deeded vacation ownership plan with approximately 219,000 owners, 68 Club and Club Associate Resorts, and access to almost 11,400 other hotels and resorts through partnerships and exchange networks as of June 30, 2020. Bluegreen Vacations also offers a portfolio of comprehensive, fee-based resort management, financial, and sales and marketing services to, or on behalf of, third parties. Bluegreen is approximately 93% owned by BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB), a diversified holding company. For further information, visit www.BluegreenVacations.com. Forward-Looking Statements This press release contains forward-looking statements based on current expectations that involve a number of risks and uncertainties. All opinions, forecasts, projections, future plans or other statements, other than statements of historical fact, are forward-looking statements. The forward-looking statements in this press release are also forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements involve risks, uncertainties, and other factors, many of which are beyond the Companys control, that may cause actual results or performance to differ from those set forth or implied in the forward-looking statements. These risks and uncertainties include, without limitation, risks associated with the proposed spin-off, including that actual plans, actions and results relating to the spin-off may differ materially from current expectations, that the spin-off may not be consummated on the contemplated terms, or at all; that the distribution may not occur on the date contemplated; uncertainties regarding the trading of New BBX Capitals Class A Common Stock and/or Class B Common Stock, including that it may not commence when or as currently anticipated; that the Companys Board of Directors may waive certain conditions to closing the spin-off and determine to consummate the spin-off notwithstanding the fact that such conditions were not satisfied; that the Company may, in the sole discretion of its Board of Directors, abandon the spin-off at any time prior to its consummation notwithstanding shareholder approval of the spin-off; that, if consummated, the spin-off may not result in the benefits anticipated; uncertainties related to the tax effects of the spin-off to the Companys shareholders; and, the other risks and uncertainties set forth in the proxy statement for the special meeting, including the Risk Factors section thereof. In addition, reference is also made to other risks and factors detailed in reports filed by the Company with the SEC, including the Companys Annual Report on Form 10-K for the year ended December 31, 2019 and the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, which may be viewed on the SEC's website at www.sec.gov or in the Investor Relations section of the Companys website at www.BBXCapital.com. The Company cautions that the foregoing factors are not exclusive. You should not place undue reliance on any forward-looking statement, which speaks only as of the date made. The Company does not undertake, and specifically disclaims any obligation, to update or supplement any forward-looking statements. Additional Information and Where to Find it On August 27, 2020, the Company filed with the SEC and mailed to its shareholders a definitive proxy statement for the special meeting. The Company has also filed with the SEC certain other documents that are incorporated by reference into the proxy statement. SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND THE INFORMATION INCORPORATED THEREIN BY REFERENCE CAREFULLY AND IN THEIR ENTIRETY BEFORE MAKING A VOTING DECISION BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED SPIN-OFF. Copies of all documents filed by the Company with the SEC, including the proxy statement and information incorporated therein by reference, are available, free of charge, on the SEC's website at www.sec.gov and in the Investor Relations section of the Companys website at www.bbxcapital.com. In addition, the Companys shareholders may obtain copies of the documents filed by the Company with the SEC at no charge by contacting the Companys Investor Relations Department by mail at BBX Capital Corporation, 401 East Las Olas Boulevard, Suite 800, Fort Lauderdale, Florida 33301, or by phone at 954-940-5300. Shareholders may also contact Laurel Hill Advisory Group, LLC, the Company proxy solicitor, toll-free at (888) 742-1305 for copies of the proxy statement and information incorporated therein by reference. Participant Information The Company and its directors and executive officers may, under the rules of the SEC, be deemed to be participants in the solicitation of proxies from the Companys shareholders in connection with the proposed spin-off. Information regarding the Company's directors and executive officers, including their names and interests in the Company, is set forth in Amendment No. 1 to the Companys Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the SEC on April 29, 2020. This document can be obtained free of charge from the sources indicated above. Additional information regarding the Companys directors and executive officers and their interests in the Company and the proposed spin-off is contained in the proxy statement filed by the Company with the SEC and mailed to the Companys shareholders. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

BBX Capital Corporation Announces Record Date for Proposed Spin-Off of BBX Capital Florida LLC.

FORT LAUDERDALE, Fla/--(BUSINESS WIRE)--BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB) (BBX Capital or the Company) announced today that its Board of Directors has set a record date of September 22, 2020 for determining shareholders entitled to receive the distribution of shares in connection with the Companys proposed spin-off of its subsidiary, BBX Capital Florida LLC (New BBX Capital). If the spin-off is completed, the Companys shareholders will continue to own their shares of the Companys Common Stock and will also receive one share of New BBX Capitals Class A Common Stock for each share of the Companys Class A Common Stock held as of the close of business on September 22, 2020 and one share of New BBX Capitals Class B Common Stock for each share of the Companys Class B Common Stock held as of the close of business on September 22, 2020, in each case, subject to any trading of the Companys shares between the record date and distribution date with an entitlement to shares of New BBX Capital. The Company currently anticipates that the distribution of New BBX Capitals shares will occur on September 30, 2020. Information regarding any change in the distribution date for the spin-off will be disclosed in a subsequent press release by the Company. Trading of New BBX Capitals Class A Common Stock and Class B Common Stock will commence on the OTCQX upon approval and announcement by FINRA of the commencement of trading on the date established by FINRA. There is no assurance when trading of New BBX Capitals Class A Common Stock and Class B Common Stock will begin. The Company will provide a subsequent press release with updated information regarding the trading of New BBX Capitals Class A Common Stock and Class B Common Stock following the Companys receipt of such information from FINRA. Completion of the spin-off is subject to approval of the spin-off by the Companys shareholders. The Company has scheduled a special meeting of its shareholders, to be held in virtual format only on September 25, 2020, for the purpose of approving the spin-off and the Companys contemplated name change to Bluegreen Vacations Holding Corporation in connection with the spin-off. Additional information regarding the spin-off and the special meeting is set forth in the Companys definitive proxy statement for the special meeting, which was filed with the SEC on August 27, 2020 and has been mailed to the Companys shareholders. About BBX Capital Corporation: BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB) is a Florida-based diversified holding company whose principal investments include Bluegreen Vacations Corporation (NYSE: BXG), BBX Capital Real Estate, BBX Sweet Holdings, and Renin. For additional information, please visit www.BBXCapital.com. About Bluegreen Vacations Corporation: Bluegreen Vacations Corporation (NYSE: BXG) is a leading vacation ownership company that markets and sells vacation ownership interests and manages resorts in popular leisure and urban destinations. The Bluegreen Vacation Club is a flexible, points-based, deeded vacation ownership plan with approximately 219,000 owners, 68 Club and Club Associate Resorts, and access to almost 11,400 other hotels and resorts through partnerships and exchange networks as of June 30, 2020. Bluegreen Vacations also offers a portfolio of comprehensive, fee-based resort management, financial, and sales and marketing services to, or on behalf of, third parties. Bluegreen is approximately 93% owned by BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB), a diversified holding company. For further information, visit www.BluegreenVacations.com. Forward-Looking Statements This press release contains forward-looking statements based on current expectations that involve a number of risks and uncertainties. All opinions, forecasts, projections, future plans or other statements, other than statements of historical fact, are forward-looking statements. The forward-looking statements in this press release are also forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements involve risks, uncertainties, and other factors, many of which are beyond the Companys control, that may cause actual results or performance to differ from those set forth or implied in the forward-looking statements. These risks and uncertainties include, without limitation, risks associated with the proposed spin-off, including that actual plans, actions and results relating to the spin-off may differ materially from current expectations, that the spin-off may not be consummated on the contemplated terms, or at all; that the distribution may not occur on the date contemplated; uncertainties regarding the trading of New BBX Capitals Class A Common Stock and/or Class B Common Stock, including that it may not commence when or as currently anticipated; that the Companys Board of Directors may waive certain conditions to closing the spin-off and determine to consummate the spin-off notwithstanding the fact that such conditions were not satisfied; that the Company may, in the sole discretion of its Board of Directors, abandon the spin-off at any time prior to its consummation notwithstanding shareholder approval of the spin-off; that, if consummated, the spin-off may not result in the benefits anticipated; uncertainties related to the tax effects of the spin-off to the Companys shareholders; and, the other risks and uncertainties set forth in the proxy statement for the special meeting, including the Risk Factors section thereof. In addition, reference is also made to other risks and factors detailed in reports filed by the Company with the SEC, including the Companys Annual Report on Form 10-K for the year ended December 31, 2019 and the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, which may be viewed on the SEC's website at www.sec.gov or in the Investor Relations section of the Companys website at www.BBXCapital.com. The Company cautions that the foregoing factors are not exclusive. You should not place undue reliance on any forward-looking statement, which speaks only as of the date made. The Company does not undertake, and specifically disclaims any obligation, to update or supplement any forward-looking statements. Additional Information and Where to Find it On August 27, 2020, the Company filed with the SEC and mailed to its shareholders a definitive proxy statement for the special meeting. The Company has also filed with the SEC certain other documents that are incorporated by reference into the proxy statement. SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND THE INFORMATION INCORPORATED THEREIN BY REFERENCE CAREFULLY AND IN THEIR ENTIRETY BEFORE MAKING A VOTING DECISION BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED SPIN-OFF. Copies of all documents filed by the Company with the SEC, including the proxy statement and information incorporated therein by reference, are available, free of charge, on the SEC's website at www.sec.gov and in the Investor Relations section of the Companys website at www.bbxcapital.com. In addition, the Companys shareholders may obtain copies of the documents filed by the Company with the SEC at no charge by contacting the Companys Investor Relations Department by mail at BBX Capital Corporation, 401 East Las Olas Boulevard, Suite 800, Fort Lauderdale, Florida 33301, or by phone at 954-940-5300. Shareholders may also contact Laurel Hill Advisory Group, LLC, the Company proxy solicitor, toll-free at (888) 742-1305 for copies of the proxy statement and information incorporated therein by reference. Participant Information The Company and its directors and executive officers may, under the rules of the SEC, be deemed to be participants in the solicitation of proxies from the Companys shareholders in connection with the proposed spin-off. Information regarding the Company's directors and executive officers, including their names and interests in the Company, is set forth in Amendment No. 1 to the Companys Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the SEC on April 29, 2020. This document can be obtained free of charge from the sources indicated above. Additional information regarding the Companys directors and executive officers and their interests in the Company and the proposed spin-off is contained in the proxy statement filed by the Company with the SEC and mailed to the Companys shareholders.

BBX Capital Corporation Announces Record Date for Proposed Spin-Off of BBX Capital Florida LLC

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: FORT LAUDERDALE, Fla/--(BUSINESS WIRE)--BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB) (BBX Capital or the Company) announced today that its Board of Directors has set a record date of September 22, 2020 for determining shareholders entitled to receive the distribution of shares in connection with the Companys proposed spin-off of its subsidiary, BBX Capital Florida LLC (New BBX Capital). If the spin-off is completed, the Companys shareholders will continue to own their shares of the Companys Common Stock and will also receive one share of New BBX Capitals Class A Common Stock for each share of the Companys Class A Common Stock held as of the close of business on September 22, 2020 and one share of New BBX Capitals Class B Common Stock for each share of the Companys Class B Common Stock held as of the close of business on September 22, 2020, in each case, subject to any trading of the Companys shares between the record date and distribution date with an entitlement to shares of New BBX Capital. The Company currently anticipates that the distribution of New BBX Capitals shares will occur on September 30, 2020. Information regarding any change in the distribution date for the spin-off will be disclosed in a subsequent press release by the Company. Trading of New BBX Capitals Class A Common Stock and Class B Common Stock will commence on the OTCQX upon approval and announcement by FINRA of the commencement of trading on the date established by FINRA. There is no assurance when trading of New BBX Capitals Class A Common Stock and Class B Common Stock will begin. The Company will provide a subsequent press release with updated information regarding the trading of New BBX Capitals Class A Common Stock and Class B Common Stock following the Companys receipt of such information from FINRA. Completion of the spin-off is subject to approval of the spin-off by the Companys shareholders. The Company has scheduled a special meeting of its shareholders, to be held in virtual format only on September 25, 2020, for the purpose of approving the spin-off and the Companys contemplated name change to Bluegreen Vacations Holding Corporation in connection with the spin-off. Additional information regarding the spin-off and the special meeting is set forth in the Companys definitive proxy statement for the special meeting, which was filed with the SEC on August 27, 2020 and has been mailed to the Companys shareholders. About BBX Capital Corporation: BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB) is a Florida-based diversified holding company whose principal investments include Bluegreen Vacations Corporation (NYSE: BXG), BBX Capital Real Estate, BBX Sweet Holdings, and Renin. For additional information, please visit www.BBXCapital.com. About Bluegreen Vacations Corporation: Bluegreen Vacations Corporation (NYSE: BXG) is a leading vacation ownership company that markets and sells vacation ownership interests and manages resorts in popular leisure and urban destinations. The Bluegreen Vacation Club is a flexible, points-based, deeded vacation ownership plan with approximately 219,000 owners, 68 Club and Club Associate Resorts, and access to almost 11,400 other hotels and resorts through partnerships and exchange networks as of June 30, 2020. Bluegreen Vacations also offers a portfolio of comprehensive, fee-based resort management, financial, and sales and marketing services to, or on behalf of, third parties. Bluegreen is approximately 93% owned by BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB), a diversified holding company. For further information, visit www.BluegreenVacations.com. Forward-Looking Statements This press release contains forward-looking statements based on current expectations that involve a number of risks and uncertainties. All opinions, forecasts, projections, future plans or other statements, other than statements of historical fact, are forward-looking statements. The forward-looking statements in this press release are also forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements involve risks, uncertainties, and other factors, many of which are beyond the Companys control, that may cause actual results or performance to differ from those set forth or implied in the forward-looking statements. These risks and uncertainties include, without limitation, risks associated with the proposed spin-off, including that actual plans, actions and results relating to the spin-off may differ materially from current expectations, that the spin-off may not be consummated on the contemplated terms, or at all; that the distribution may not occur on the date contemplated; uncertainties regarding the trading of New BBX Capitals Class A Common Stock and/or Class B Common Stock, including that it may not commence when or as currently anticipated; that the Companys Board of Directors may waive certain conditions to closing the spin-off and determine to consummate the spin-off notwithstanding the fact that such conditions were not satisfied; that the Company may, in the sole discretion of its Board of Directors, abandon the spin-off at any time prior to its consummation notwithstanding shareholder approval of the spin-off; that, if consummated, the spin-off may not result in the benefits anticipated; uncertainties related to the tax effects of the spin-off to the Companys shareholders; and, the other risks and uncertainties set forth in the proxy statement for the special meeting, including the Risk Factors section thereof. In addition, reference is also made to other risks and factors detailed in reports filed by the Company with the SEC, including the Companys Annual Report on Form 10-K for the year ended December 31, 2019 and the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, which may be viewed on the SEC's website at www.sec.gov or in the Investor Relations section of the Companys website at www.BBXCapital.com. The Company cautions that the foregoing factors are not exclusive. You should not place undue reliance on any forward-looking statement, which speaks only as of the date made. The Company does not undertake, and specifically disclaims any obligation, to update or supplement any forward-looking statements. Additional Information and Where to Find it On August 27, 2020, the Company filed with the SEC and mailed to its shareholders a definitive proxy statement for the special meeting. The Company has also filed with the SEC certain other documents that are incorporated by reference into the proxy statement. SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND THE INFORMATION INCORPORATED THEREIN BY REFERENCE CAREFULLY AND IN THEIR ENTIRETY BEFORE MAKING A VOTING DECISION BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED SPIN-OFF. Copies of all documents filed by the Company with the SEC, including the proxy statement and information incorporated therein by reference, are available, free of charge, on the SEC's website at www.sec.gov and in the Investor Relations section of the Companys website at www.bbxcapital.com. In addition, the Companys shareholders may obtain copies of the documents filed by the Company with the SEC at no charge by contacting the Companys Investor Relations Department by mail at BBX Capital Corporation, 401 East Las Olas Boulevard, Suite 800, Fort Lauderdale, Florida 33301, or by phone at 954-940-5300. Shareholders may also contact Laurel Hill Advisory Group, LLC, the Company proxy solicitor, toll-free at (888) 742-1305 for copies of the proxy statement and information incorporated therein by reference. Participant Information The Company and its directors and executive officers may, under the rules of the SEC, be deemed to be participants in the solicitation of proxies from the Companys shareholders in connection with the proposed spin-off. Information regarding the Company's directors and executive officers, including their names and interests in the Company, is set forth in Amendment No. 1 to the Companys Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the SEC on April 29, 2020. This document can be obtained free of charge from the sources indicated above. Additional information regarding the Companys directors and executive officers and their interests in the Company and the proposed spin-off is contained in the proxy statement filed by the Company with the SEC and mailed to the Companys shareholders. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> BBX Capital Corporation Announces Record Date for Proposed Spin-Off of BBX Capital Florida LLC.<|eot_id|>

edtsum849

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MIAMI, Oct. 20, 2020 /PRNewswire/ --La GranjaRestaurants just opened a new restaurant on South Dixie Hwy in South Miami just south of SW 72nd Street at 6144 S. Dixie Hwy South Miami, FL 33143.Buenprovecho!Dining is nowopen in Miami!Governor DeSantis recently signed an order on September 25allowing restaurants and bars to open after the pandemic.https://www.sun-sentinel.com/coronavirus/fl-ne-florida-coronavirus-deaths-cases-friday-september-25-20200925-bcc6ecjh3nfblfyrfakkj23gtu-story.html Continue Reading La Granja Restaurants LaJamaTV recentlyfeasted withIvan Tucker, Chief Chefat the new Miami LaGranjarestaurant. https://www.facebook.com/watch/?v=373082054063611.Theyenjoyed a buffet of amazing La Granjaplatters, includingJalea,whichismixed fried seafood with shrimp, calamari, octopus with some fried yucca, some fish, and lemon. La Granja's popular 1/4 chicken with rice and beansis the complete meal of choice for lunch and dinner.Come eat a1/4 chicken meal with rice and beans, starting at only $5.25. Order 1/4 chicken with black beans and rice or with fried plantains and soda, whichstartsat only $7.25.Feel like steak for lunch or dinner? Get a 1/2 lb grilled steakserved with twoside orders, starting at $11.25.During thepandemic, even though beef prices in the U.S. have also doubled, LaGranjahas kept their prices for beef very low,sacrificing profits for the well-being of its familiesand individualpatrons.Check out La Granja's menu, which includes chicken, pork, steak or seafood meals.La Granja'sMenu includesLomoSaltado,Chicken,Ceviche, Jalea, and Fried Whole Snapper.A favorite dish at La Granjais its traditional Rotisserie Peruvian Chicken called "polloa la brasa," slow-roasted for two hours on a rotisserie machine.Chef Ivan Tucker is a popular chef in Miami who has been named theRotisserie Chicken King of Miami.If people are in the mood for real Peruvian food, they can find the nearest La Granjarestaurant location.Type in a zip code here.LaGranjaRestaurants are located from Miami to Orlando. Please visitlagranjarestaurants.com, go to locations and pick the closest location to you. Delivery viaDoorDashandGrubHub.Call(786) 558-8702.La Granja Restaurantsare located throughout Florida from Orange County to Miami Dade County.La Granja owes their expansion to their delicious cuisine, outstanding customer service and affordable prices.Over the last 20 years, they have opened their doors in several locations including Kissimmee, Apopka, Palm Beach, Downtown Miami and Orlando.La Granjahas won awards such as "The Best Family Style Peruvian Restaurant".La Granja offers authentic Latin cuisine in an affordable and accessible way. Customers love theirgrilled steak, grilled chicken and fajitas. La Granja also offers family meals featuring a choice of meat, rice, beans and fries.For information about LaGranjaRestaurants, go towww.lagranjarestaurants.com.Related Imagesnew-la-granja-restaurant-opens-in.png New La Granja Restaurant Opens in Miami at 6144 S Dixie Hwy South Miami, FL 33143. Buen Provecho! SOURCE La Granja Restaurants Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

New La Granja Restaurant Opens in Miami at 6144 S Dixie Hwy, South Miami, for Lunch and Dinner. For homemade food served fast, visit the new La Granja in Miami at 6144 S. Dixie Hwy, Miami, FL 33143. Call ahead for curbside or delivery (786) 558-8702.

MIAMI, Oct. 20, 2020 /PRNewswire/ --La GranjaRestaurants just opened a new restaurant on South Dixie Hwy in South Miami just south of SW 72nd Street at 6144 S. Dixie Hwy South Miami, FL 33143.Buenprovecho!Dining is nowopen in Miami!Governor DeSantis recently signed an order on September 25allowing restaurants and bars to open after the pandemic.https://www.sun-sentinel.com/coronavirus/fl-ne-florida-coronavirus-deaths-cases-friday-september-25-20200925-bcc6ecjh3nfblfyrfakkj23gtu-story.html Continue Reading La Granja Restaurants LaJamaTV recentlyfeasted withIvan Tucker, Chief Chefat the new Miami LaGranjarestaurant. https://www.facebook.com/watch/?v=373082054063611.Theyenjoyed a buffet of amazing La Granjaplatters, includingJalea,whichismixed fried seafood with shrimp, calamari, octopus with some fried yucca, some fish, and lemon. La Granja's popular 1/4 chicken with rice and beansis the complete meal of choice for lunch and dinner.Come eat a1/4 chicken meal with rice and beans, starting at only $5.25. Order 1/4 chicken with black beans and rice or with fried plantains and soda, whichstartsat only $7.25.Feel like steak for lunch or dinner? Get a 1/2 lb grilled steakserved with twoside orders, starting at $11.25.During thepandemic, even though beef prices in the U.S. have also doubled, LaGranjahas kept their prices for beef very low,sacrificing profits for the well-being of its familiesand individualpatrons.Check out La Granja's menu, which includes chicken, pork, steak or seafood meals.La Granja'sMenu includesLomoSaltado,Chicken,Ceviche, Jalea, and Fried Whole Snapper.A favorite dish at La Granjais its traditional Rotisserie Peruvian Chicken called "polloa la brasa," slow-roasted for two hours on a rotisserie machine.Chef Ivan Tucker is a popular chef in Miami who has been named theRotisserie Chicken King of Miami.If people are in the mood for real Peruvian food, they can find the nearest La Granjarestaurant location.Type in a zip code here.LaGranjaRestaurants are located from Miami to Orlando. Please visitlagranjarestaurants.com, go to locations and pick the closest location to you. Delivery viaDoorDashandGrubHub.Call(786) 558-8702.La Granja Restaurantsare located throughout Florida from Orange County to Miami Dade County.La Granja owes their expansion to their delicious cuisine, outstanding customer service and affordable prices.Over the last 20 years, they have opened their doors in several locations including Kissimmee, Apopka, Palm Beach, Downtown Miami and Orlando.La Granjahas won awards such as "The Best Family Style Peruvian Restaurant".La Granja offers authentic Latin cuisine in an affordable and accessible way. Customers love theirgrilled steak, grilled chicken and fajitas. La Granja also offers family meals featuring a choice of meat, rice, beans and fries.For information about LaGranjaRestaurants, go towww.lagranjarestaurants.com.Related Imagesnew-la-granja-restaurant-opens-in.png New La Granja Restaurant Opens in Miami at 6144 S Dixie Hwy South Miami, FL 33143. Buen Provecho! SOURCE La Granja Restaurants

New La Granja Restaurant Opens in Miami at 6144 S Dixie Hwy South Miami for Lunch and Dinner For homemade food served fast, visit the new La Granja in Miami at 6144 S. Dixie Hwy, Miami Fl 33143. Call ahead for curbside or delivery (786) 558-8702.

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MIAMI, Oct. 20, 2020 /PRNewswire/ --La GranjaRestaurants just opened a new restaurant on South Dixie Hwy in South Miami just south of SW 72nd Street at 6144 S. Dixie Hwy South Miami, FL 33143.Buenprovecho!Dining is nowopen in Miami!Governor DeSantis recently signed an order on September 25allowing restaurants and bars to open after the pandemic.https://www.sun-sentinel.com/coronavirus/fl-ne-florida-coronavirus-deaths-cases-friday-september-25-20200925-bcc6ecjh3nfblfyrfakkj23gtu-story.html Continue Reading La Granja Restaurants LaJamaTV recentlyfeasted withIvan Tucker, Chief Chefat the new Miami LaGranjarestaurant. https://www.facebook.com/watch/?v=373082054063611.Theyenjoyed a buffet of amazing La Granjaplatters, includingJalea,whichismixed fried seafood with shrimp, calamari, octopus with some fried yucca, some fish, and lemon. La Granja's popular 1/4 chicken with rice and beansis the complete meal of choice for lunch and dinner.Come eat a1/4 chicken meal with rice and beans, starting at only $5.25. Order 1/4 chicken with black beans and rice or with fried plantains and soda, whichstartsat only $7.25.Feel like steak for lunch or dinner? Get a 1/2 lb grilled steakserved with twoside orders, starting at $11.25.During thepandemic, even though beef prices in the U.S. have also doubled, LaGranjahas kept their prices for beef very low,sacrificing profits for the well-being of its familiesand individualpatrons.Check out La Granja's menu, which includes chicken, pork, steak or seafood meals.La Granja'sMenu includesLomoSaltado,Chicken,Ceviche, Jalea, and Fried Whole Snapper.A favorite dish at La Granjais its traditional Rotisserie Peruvian Chicken called "polloa la brasa," slow-roasted for two hours on a rotisserie machine.Chef Ivan Tucker is a popular chef in Miami who has been named theRotisserie Chicken King of Miami.If people are in the mood for real Peruvian food, they can find the nearest La Granjarestaurant location.Type in a zip code here.LaGranjaRestaurants are located from Miami to Orlando. Please visitlagranjarestaurants.com, go to locations and pick the closest location to you. Delivery viaDoorDashandGrubHub.Call(786) 558-8702.La Granja Restaurantsare located throughout Florida from Orange County to Miami Dade County.La Granja owes their expansion to their delicious cuisine, outstanding customer service and affordable prices.Over the last 20 years, they have opened their doors in several locations including Kissimmee, Apopka, Palm Beach, Downtown Miami and Orlando.La Granjahas won awards such as "The Best Family Style Peruvian Restaurant".La Granja offers authentic Latin cuisine in an affordable and accessible way. Customers love theirgrilled steak, grilled chicken and fajitas. La Granja also offers family meals featuring a choice of meat, rice, beans and fries.For information about LaGranjaRestaurants, go towww.lagranjarestaurants.com.Related Imagesnew-la-granja-restaurant-opens-in.png New La Granja Restaurant Opens in Miami at 6144 S Dixie Hwy South Miami, FL 33143. Buen Provecho! SOURCE La Granja Restaurants Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> New La Granja Restaurant Opens in Miami at 6144 S Dixie Hwy, South Miami, for Lunch and Dinner. For homemade food served fast, visit the new La Granja in Miami at 6144 S. Dixie Hwy, Miami, FL 33143. Call ahead for curbside or delivery (786) 558-8702.<|eot_id|>

edtsum850

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BOISE, Idaho--(BUSINESS WIRE)--PlexTrac, a solution for cybersecurity professionals to identify and accomplish the right security work, today announced $10 million in Series A funding. Venture firms Noro-Moseley Partners and Madrona Venture Group led the round with participation from StageDotO Ventures. The company will use the funds to continue to build the team and grow the platform. PlexTrac founder and CEO Dan DeCloss developed the platform to solve the pain points he experienced over his 15+ year career in the cybersecurity industry, including roles with the Department of Defense and in penetration testing. PlexTrac saw incredible customer and revenue growth in 2020. PlexTrac enables offensive and defensive security teams to collaborate in real time on cyber-attack simulations, known as purple teaming. Security professionals in all types of organizations are faced with unprecedented threats, but how they work has not substantially changed. PlexTrac brings red and blue cybersecurity teams together in one workflow to build transparency and efficiency at remediating vulnerabilities and defending against increasingly sophisticated adversaries, said DeCloss. The growing traction we are seeing with Fortune 500 companies speaks to how PlexTrac resonates with security professionals as they focus on a proactive assessment mindset. We are excited to work with our new partners at Noro-Moseley and Madrona on our growth trajectory. The mission of the company is to keep every cybersecurity team focused on growing their assessment capabilities, automating their reporting process, and collaborating more effectively. PlexTrac addresses bottlenecks in getting security work done through: Never before have security professionals seen the level of pressure they are now facing to protect their assets and communicate with teams across the organization and outside of it. Dan brings personal experience and a clear vision to this challenge. We believe that PlexTrac is the solution that every security organization needs to succeed against current and future threats and are excited to support the team, said John Ale, Partner at Noro Moseley. PlexTracs holistic approach to security and penetration testing reflects a fresh approach to this growing discipline in enterprise IT. By uniting red and blue teams on one platform, and developing deep integrations with existing infrastructure and tools, PlexTrac is bringing a software enabled workflow to IT pros and security engineers who are looking for ways to work smarter and faster. We have been impressed with the traction Dan and his team have driven over the last 12 months and we look forward to working with the team in the coming years, commented S. Somasegar, Managing Director, Madrona Venture Group. Based in Boise, ID, the team is hiring for local and remote positions. Media Kit is here. About PlexTrac PlexTrac, Inc. (www.plextrac.com) is a fast-growing cybersecurity company driven by a mission to improve the security posture of organizations and security teams of all sizes. The PlexTrac solution is a software platform focused on streamlining the reporting and remediation of cybersecurity risks and aiding efficient collaboration within security teams. Supporting organizations using a purple teaming paradigm, PlexTrac serves as the central communication hub to aggregate all of the components of an organizations cybersecurity program. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

PlexTrac Closes $10 Million Round to Fuel Growth of Cybersecurity Workflow Platform. Company provides the essential platform to unite offensive and defensive security teams, keeping all security professionals focused on the right work.

BOISE, Idaho--(BUSINESS WIRE)--PlexTrac, a solution for cybersecurity professionals to identify and accomplish the right security work, today announced $10 million in Series A funding. Venture firms Noro-Moseley Partners and Madrona Venture Group led the round with participation from StageDotO Ventures. The company will use the funds to continue to build the team and grow the platform. PlexTrac founder and CEO Dan DeCloss developed the platform to solve the pain points he experienced over his 15+ year career in the cybersecurity industry, including roles with the Department of Defense and in penetration testing. PlexTrac saw incredible customer and revenue growth in 2020. PlexTrac enables offensive and defensive security teams to collaborate in real time on cyber-attack simulations, known as purple teaming. Security professionals in all types of organizations are faced with unprecedented threats, but how they work has not substantially changed. PlexTrac brings red and blue cybersecurity teams together in one workflow to build transparency and efficiency at remediating vulnerabilities and defending against increasingly sophisticated adversaries, said DeCloss. The growing traction we are seeing with Fortune 500 companies speaks to how PlexTrac resonates with security professionals as they focus on a proactive assessment mindset. We are excited to work with our new partners at Noro-Moseley and Madrona on our growth trajectory. The mission of the company is to keep every cybersecurity team focused on growing their assessment capabilities, automating their reporting process, and collaborating more effectively. PlexTrac addresses bottlenecks in getting security work done through: Never before have security professionals seen the level of pressure they are now facing to protect their assets and communicate with teams across the organization and outside of it. Dan brings personal experience and a clear vision to this challenge. We believe that PlexTrac is the solution that every security organization needs to succeed against current and future threats and are excited to support the team, said John Ale, Partner at Noro Moseley. PlexTracs holistic approach to security and penetration testing reflects a fresh approach to this growing discipline in enterprise IT. By uniting red and blue teams on one platform, and developing deep integrations with existing infrastructure and tools, PlexTrac is bringing a software enabled workflow to IT pros and security engineers who are looking for ways to work smarter and faster. We have been impressed with the traction Dan and his team have driven over the last 12 months and we look forward to working with the team in the coming years, commented S. Somasegar, Managing Director, Madrona Venture Group. Based in Boise, ID, the team is hiring for local and remote positions. Media Kit is here. About PlexTrac PlexTrac, Inc. (www.plextrac.com) is a fast-growing cybersecurity company driven by a mission to improve the security posture of organizations and security teams of all sizes. The PlexTrac solution is a software platform focused on streamlining the reporting and remediation of cybersecurity risks and aiding efficient collaboration within security teams. Supporting organizations using a purple teaming paradigm, PlexTrac serves as the central communication hub to aggregate all of the components of an organizations cybersecurity program.

PlexTrac Closes $10 Million Round to Fuel Growth of Cybersecurity Workflow Platform Company provides the essential platform to unite offensive and defensive security teams, keeping all security professionals focused on the right work

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BOISE, Idaho--(BUSINESS WIRE)--PlexTrac, a solution for cybersecurity professionals to identify and accomplish the right security work, today announced $10 million in Series A funding. Venture firms Noro-Moseley Partners and Madrona Venture Group led the round with participation from StageDotO Ventures. The company will use the funds to continue to build the team and grow the platform. PlexTrac founder and CEO Dan DeCloss developed the platform to solve the pain points he experienced over his 15+ year career in the cybersecurity industry, including roles with the Department of Defense and in penetration testing. PlexTrac saw incredible customer and revenue growth in 2020. PlexTrac enables offensive and defensive security teams to collaborate in real time on cyber-attack simulations, known as purple teaming. Security professionals in all types of organizations are faced with unprecedented threats, but how they work has not substantially changed. PlexTrac brings red and blue cybersecurity teams together in one workflow to build transparency and efficiency at remediating vulnerabilities and defending against increasingly sophisticated adversaries, said DeCloss. The growing traction we are seeing with Fortune 500 companies speaks to how PlexTrac resonates with security professionals as they focus on a proactive assessment mindset. We are excited to work with our new partners at Noro-Moseley and Madrona on our growth trajectory. The mission of the company is to keep every cybersecurity team focused on growing their assessment capabilities, automating their reporting process, and collaborating more effectively. PlexTrac addresses bottlenecks in getting security work done through: Never before have security professionals seen the level of pressure they are now facing to protect their assets and communicate with teams across the organization and outside of it. Dan brings personal experience and a clear vision to this challenge. We believe that PlexTrac is the solution that every security organization needs to succeed against current and future threats and are excited to support the team, said John Ale, Partner at Noro Moseley. PlexTracs holistic approach to security and penetration testing reflects a fresh approach to this growing discipline in enterprise IT. By uniting red and blue teams on one platform, and developing deep integrations with existing infrastructure and tools, PlexTrac is bringing a software enabled workflow to IT pros and security engineers who are looking for ways to work smarter and faster. We have been impressed with the traction Dan and his team have driven over the last 12 months and we look forward to working with the team in the coming years, commented S. Somasegar, Managing Director, Madrona Venture Group. Based in Boise, ID, the team is hiring for local and remote positions. Media Kit is here. About PlexTrac PlexTrac, Inc. (www.plextrac.com) is a fast-growing cybersecurity company driven by a mission to improve the security posture of organizations and security teams of all sizes. The PlexTrac solution is a software platform focused on streamlining the reporting and remediation of cybersecurity risks and aiding efficient collaboration within security teams. Supporting organizations using a purple teaming paradigm, PlexTrac serves as the central communication hub to aggregate all of the components of an organizations cybersecurity program. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> PlexTrac Closes $10 Million Round to Fuel Growth of Cybersecurity Workflow Platform. Company provides the essential platform to unite offensive and defensive security teams, keeping all security professionals focused on the right work.<|eot_id|>

edtsum852

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: FISHERS, Ind.--(BUSINESS WIRE)--The Board of Directors of First Internet Bancorp (the Company) (Nasdaq: INBK) has declared a quarterly cash dividend of $0.06 per common share. The dividend will be payable on April 15, 2021 to shareholders of record at the close of business on March 31, 2021. The declaration and amount of any future cash dividends will be subject to the sole discretion of the Board of Directors and will depend upon many factors, including the Companys results of operations, financial condition, capital requirements, regulatory and contractual restrictions, business strategy and other factors deemed relevant by the Board of Directors. About First Internet Bancorp First Internet Bancorp is a bank holding company with assets of $4.2 billion as of December 31, 2020. The Companys subsidiary, First Internet Bank, opened for business in 1999 as an industry pioneer in the branchless delivery of banking services. The Bank provides consumer and small business deposit, consumer loan, residential mortgage, and specialty finance services nationally as well as commercial real estate loans, commercial and industrial loans, SBA financing and treasury management services in select geographies. First Internet Bancorps common stock trades on the Nasdaq Global Select Market under the symbol INBK and is a component of the Russell 2000 Index. Additional information about the Company is available at www.firstinternetbancorp.com and additional information about the Bank, including its products and services, is available at www.firstib.com. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

First Internet Bancorp to Pay Cash Dividend.

FISHERS, Ind.--(BUSINESS WIRE)--The Board of Directors of First Internet Bancorp (the Company) (Nasdaq: INBK) has declared a quarterly cash dividend of $0.06 per common share. The dividend will be payable on April 15, 2021 to shareholders of record at the close of business on March 31, 2021. The declaration and amount of any future cash dividends will be subject to the sole discretion of the Board of Directors and will depend upon many factors, including the Companys results of operations, financial condition, capital requirements, regulatory and contractual restrictions, business strategy and other factors deemed relevant by the Board of Directors. About First Internet Bancorp First Internet Bancorp is a bank holding company with assets of $4.2 billion as of December 31, 2020. The Companys subsidiary, First Internet Bank, opened for business in 1999 as an industry pioneer in the branchless delivery of banking services. The Bank provides consumer and small business deposit, consumer loan, residential mortgage, and specialty finance services nationally as well as commercial real estate loans, commercial and industrial loans, SBA financing and treasury management services in select geographies. First Internet Bancorps common stock trades on the Nasdaq Global Select Market under the symbol INBK and is a component of the Russell 2000 Index. Additional information about the Company is available at www.firstinternetbancorp.com and additional information about the Bank, including its products and services, is available at www.firstib.com.

First Internet Bancorp to Pay Cash Dividend

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: FISHERS, Ind.--(BUSINESS WIRE)--The Board of Directors of First Internet Bancorp (the Company) (Nasdaq: INBK) has declared a quarterly cash dividend of $0.06 per common share. The dividend will be payable on April 15, 2021 to shareholders of record at the close of business on March 31, 2021. The declaration and amount of any future cash dividends will be subject to the sole discretion of the Board of Directors and will depend upon many factors, including the Companys results of operations, financial condition, capital requirements, regulatory and contractual restrictions, business strategy and other factors deemed relevant by the Board of Directors. About First Internet Bancorp First Internet Bancorp is a bank holding company with assets of $4.2 billion as of December 31, 2020. The Companys subsidiary, First Internet Bank, opened for business in 1999 as an industry pioneer in the branchless delivery of banking services. The Bank provides consumer and small business deposit, consumer loan, residential mortgage, and specialty finance services nationally as well as commercial real estate loans, commercial and industrial loans, SBA financing and treasury management services in select geographies. First Internet Bancorps common stock trades on the Nasdaq Global Select Market under the symbol INBK and is a component of the Russell 2000 Index. Additional information about the Company is available at www.firstinternetbancorp.com and additional information about the Bank, including its products and services, is available at www.firstib.com. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> First Internet Bancorp to Pay Cash Dividend.<|eot_id|>

edtsum853

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: OAKLAND, Calif., Jan. 7, 2021 /PRNewswire/ --Fast-growing San Francisco food business, Don Bugito, purveyor of planet-friendly protein snacks, is the latest high-growth small business tojointhe ICA investment portfolio. Founded by Monica Martinez, Don Bugito produces edible insect snacks inspired by Pre-Columbian Mexican cuisine.ICA just closed a $200K investment in Don Bugito, as part of our mission to accelerate great businesses to close the racial and gender wealth gaps. Continue Reading Don Bugito makes a variety of insects snacks. Monica Martinez pitches her company, Don Bugito, at the 2020 ICA Pitch Event. Don Bugito was born in 2010 after Monica Martinez, an industrial designer by training, saw an opportunity to address the growing demand for sustainable protein while celebrating her cultural heritage. Her company champions the use of "bugitos" like crickets and mealworms, combined with traditional spices found in Native American and Mexican cuisine. Today, Don Bugito's product line includes Chile Lime Crickets, Spicy Bugitos, Granola Bites powered with insect protein powder, and even baking flour made of insects. "ICA will offer Don Bugito the required fuel to propel us to the next stage. With this investment we will be able to grow our team, expand our farm operations, and increase our sales nationally," said Don Bugito founder, Monica Martinez. "2020 has been a hard year for everyone but we are thrilled to end the year with ICA's investment, and we are looking forward to growing and expanding in 2021," she added.ICA's investment is part of the San Francisco Entrepreneurs of Color Fund (EOCF), a collaborative investment fund that partners with local Community Development Financial Institutions to deploy capital to entrepreneurs of color, with an emphasis on underinvested Latinx- and Black-owned businesses. Don Bugito joins Red Bay Coffee and Onigilly, as EOCF-funded ICA investments. EOCF is supported by JPMorgan Chase, which provided a $3.1 million philanthropic investment to expand the EOCF model to San Francisco in 2018 and help local underserved entrepreneurs access to the capital they need to grow.If Monica looks familiar, that's because she pitched at ICA's 2020 Pitch Event after completing the Accelerator at ICA. Before working with ICA, she participated in La Cocina's food incubator program in San Francisco, and worked with Kitchentown, a Bay Area commissary kitchen that helps food entrepreneurs scale their products."ICA is thrilled to invest in founder and super-entrepreneur Monica Martinez with $200,000 of patient capital to fund Don Bugito's ongoing development and expansion," said ICA's Chief Investment Officer, John Gough. "When they receive the capital and coaching they need, small businesses like Monica's add new good jobs and create wealth for their owners and workers," he added.ICA's investment will allow Don Bugito to expand its farming operations and, eventually, to meet Monica's goal of complete vertical integration across the entire product portfolio. Under Monica's leadership Don Bugito was a first-mover in the fast-growing insect protein market. Vertical integration is the next step for Don Bugito, allowing the company to scale, while eliminating waste. The insect market is expanding rapidly due in large part to the sustainability of cultivating insect which can be grown with limited natural resources and a relatively small environmental footprint,Don Bugito's snacks are delicious, and healthy too the insects are rich in Omega-3 fatty acids, non-GMO, grain, oil and cholesterol-free, and have great taste and texture.Don Bugito is on track to double its workforce in 2021and currently employs a team that is majority people of color. Monica is committed to creating wealth-building opportunities in parallel with the company's growth."ICA's investment in Monica demonstrates our strategy to support under-capitalized entrepreneurs poised for growth," said John Gough. "As we raise a new investment fund, we're looking forward to continued growth for ICA and our portfolio of companies."You can find Don Bugito products in stores throughout the country, or shop online at donbugito.com. To read more about ICA, our investments, our programs, and our companies visit ica.fund.About Don BugitoDon Bugito, the Prehispanic Snackeria, is a San Francisco company focused on planet-friendly protein snacks, featuring delicious edible insects in savory and sweet flavors. Founded by Monica Martinez, Don Bugito focuses on treats inspired by Pre-Columbian Mexican cuisine and works toward re-inventing ancestral food for the modern health-conscious market.About ICAICAaccelerates great businesses through mentoring and investments to close the racial and gender wealth gaps. A 501(c)3 organization with a vision of creating an economy that works for all, ICA supports growth-stage small businesses, led by people of color and women in the Bay Area, by providing capital, coaching, and connections to help them grow the value of their businesses, add good jobs, and create wealth.Contact:John Gough, Chief Investment Officer[emailprotected](406) 607-0123SOURCE ICA Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

ICA invests $200,000 to Accelerate Insect Snack Maker. Oakland-based nonprofit venture capital fund, ICA, invests $200K of patient capital in sustainable insect snack maker, Don Bugito.

OAKLAND, Calif., Jan. 7, 2021 /PRNewswire/ --Fast-growing San Francisco food business, Don Bugito, purveyor of planet-friendly protein snacks, is the latest high-growth small business tojointhe ICA investment portfolio. Founded by Monica Martinez, Don Bugito produces edible insect snacks inspired by Pre-Columbian Mexican cuisine.ICA just closed a $200K investment in Don Bugito, as part of our mission to accelerate great businesses to close the racial and gender wealth gaps. Continue Reading Don Bugito makes a variety of insects snacks. Monica Martinez pitches her company, Don Bugito, at the 2020 ICA Pitch Event. Don Bugito was born in 2010 after Monica Martinez, an industrial designer by training, saw an opportunity to address the growing demand for sustainable protein while celebrating her cultural heritage. Her company champions the use of "bugitos" like crickets and mealworms, combined with traditional spices found in Native American and Mexican cuisine. Today, Don Bugito's product line includes Chile Lime Crickets, Spicy Bugitos, Granola Bites powered with insect protein powder, and even baking flour made of insects. "ICA will offer Don Bugito the required fuel to propel us to the next stage. With this investment we will be able to grow our team, expand our farm operations, and increase our sales nationally," said Don Bugito founder, Monica Martinez. "2020 has been a hard year for everyone but we are thrilled to end the year with ICA's investment, and we are looking forward to growing and expanding in 2021," she added.ICA's investment is part of the San Francisco Entrepreneurs of Color Fund (EOCF), a collaborative investment fund that partners with local Community Development Financial Institutions to deploy capital to entrepreneurs of color, with an emphasis on underinvested Latinx- and Black-owned businesses. Don Bugito joins Red Bay Coffee and Onigilly, as EOCF-funded ICA investments. EOCF is supported by JPMorgan Chase, which provided a $3.1 million philanthropic investment to expand the EOCF model to San Francisco in 2018 and help local underserved entrepreneurs access to the capital they need to grow.If Monica looks familiar, that's because she pitched at ICA's 2020 Pitch Event after completing the Accelerator at ICA. Before working with ICA, she participated in La Cocina's food incubator program in San Francisco, and worked with Kitchentown, a Bay Area commissary kitchen that helps food entrepreneurs scale their products."ICA is thrilled to invest in founder and super-entrepreneur Monica Martinez with $200,000 of patient capital to fund Don Bugito's ongoing development and expansion," said ICA's Chief Investment Officer, John Gough. "When they receive the capital and coaching they need, small businesses like Monica's add new good jobs and create wealth for their owners and workers," he added.ICA's investment will allow Don Bugito to expand its farming operations and, eventually, to meet Monica's goal of complete vertical integration across the entire product portfolio. Under Monica's leadership Don Bugito was a first-mover in the fast-growing insect protein market. Vertical integration is the next step for Don Bugito, allowing the company to scale, while eliminating waste. The insect market is expanding rapidly due in large part to the sustainability of cultivating insect which can be grown with limited natural resources and a relatively small environmental footprint,Don Bugito's snacks are delicious, and healthy too the insects are rich in Omega-3 fatty acids, non-GMO, grain, oil and cholesterol-free, and have great taste and texture.Don Bugito is on track to double its workforce in 2021and currently employs a team that is majority people of color. Monica is committed to creating wealth-building opportunities in parallel with the company's growth."ICA's investment in Monica demonstrates our strategy to support under-capitalized entrepreneurs poised for growth," said John Gough. "As we raise a new investment fund, we're looking forward to continued growth for ICA and our portfolio of companies."You can find Don Bugito products in stores throughout the country, or shop online at donbugito.com. To read more about ICA, our investments, our programs, and our companies visit ica.fund.About Don BugitoDon Bugito, the Prehispanic Snackeria, is a San Francisco company focused on planet-friendly protein snacks, featuring delicious edible insects in savory and sweet flavors. Founded by Monica Martinez, Don Bugito focuses on treats inspired by Pre-Columbian Mexican cuisine and works toward re-inventing ancestral food for the modern health-conscious market.About ICAICAaccelerates great businesses through mentoring and investments to close the racial and gender wealth gaps. A 501(c)3 organization with a vision of creating an economy that works for all, ICA supports growth-stage small businesses, led by people of color and women in the Bay Area, by providing capital, coaching, and connections to help them grow the value of their businesses, add good jobs, and create wealth.Contact:John Gough, Chief Investment Officer[emailprotected](406) 607-0123SOURCE ICA

ICA invests $200,000 to Accelerate Insect Snack Maker Oakland-based nonprofit venture capital fund, ICA, invests $200K of patient capital in sustainable insect snack maker, Don Bugito.

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: OAKLAND, Calif., Jan. 7, 2021 /PRNewswire/ --Fast-growing San Francisco food business, Don Bugito, purveyor of planet-friendly protein snacks, is the latest high-growth small business tojointhe ICA investment portfolio. Founded by Monica Martinez, Don Bugito produces edible insect snacks inspired by Pre-Columbian Mexican cuisine.ICA just closed a $200K investment in Don Bugito, as part of our mission to accelerate great businesses to close the racial and gender wealth gaps. Continue Reading Don Bugito makes a variety of insects snacks. Monica Martinez pitches her company, Don Bugito, at the 2020 ICA Pitch Event. Don Bugito was born in 2010 after Monica Martinez, an industrial designer by training, saw an opportunity to address the growing demand for sustainable protein while celebrating her cultural heritage. Her company champions the use of "bugitos" like crickets and mealworms, combined with traditional spices found in Native American and Mexican cuisine. Today, Don Bugito's product line includes Chile Lime Crickets, Spicy Bugitos, Granola Bites powered with insect protein powder, and even baking flour made of insects. "ICA will offer Don Bugito the required fuel to propel us to the next stage. With this investment we will be able to grow our team, expand our farm operations, and increase our sales nationally," said Don Bugito founder, Monica Martinez. "2020 has been a hard year for everyone but we are thrilled to end the year with ICA's investment, and we are looking forward to growing and expanding in 2021," she added.ICA's investment is part of the San Francisco Entrepreneurs of Color Fund (EOCF), a collaborative investment fund that partners with local Community Development Financial Institutions to deploy capital to entrepreneurs of color, with an emphasis on underinvested Latinx- and Black-owned businesses. Don Bugito joins Red Bay Coffee and Onigilly, as EOCF-funded ICA investments. EOCF is supported by JPMorgan Chase, which provided a $3.1 million philanthropic investment to expand the EOCF model to San Francisco in 2018 and help local underserved entrepreneurs access to the capital they need to grow.If Monica looks familiar, that's because she pitched at ICA's 2020 Pitch Event after completing the Accelerator at ICA. Before working with ICA, she participated in La Cocina's food incubator program in San Francisco, and worked with Kitchentown, a Bay Area commissary kitchen that helps food entrepreneurs scale their products."ICA is thrilled to invest in founder and super-entrepreneur Monica Martinez with $200,000 of patient capital to fund Don Bugito's ongoing development and expansion," said ICA's Chief Investment Officer, John Gough. "When they receive the capital and coaching they need, small businesses like Monica's add new good jobs and create wealth for their owners and workers," he added.ICA's investment will allow Don Bugito to expand its farming operations and, eventually, to meet Monica's goal of complete vertical integration across the entire product portfolio. Under Monica's leadership Don Bugito was a first-mover in the fast-growing insect protein market. Vertical integration is the next step for Don Bugito, allowing the company to scale, while eliminating waste. The insect market is expanding rapidly due in large part to the sustainability of cultivating insect which can be grown with limited natural resources and a relatively small environmental footprint,Don Bugito's snacks are delicious, and healthy too the insects are rich in Omega-3 fatty acids, non-GMO, grain, oil and cholesterol-free, and have great taste and texture.Don Bugito is on track to double its workforce in 2021and currently employs a team that is majority people of color. Monica is committed to creating wealth-building opportunities in parallel with the company's growth."ICA's investment in Monica demonstrates our strategy to support under-capitalized entrepreneurs poised for growth," said John Gough. "As we raise a new investment fund, we're looking forward to continued growth for ICA and our portfolio of companies."You can find Don Bugito products in stores throughout the country, or shop online at donbugito.com. To read more about ICA, our investments, our programs, and our companies visit ica.fund.About Don BugitoDon Bugito, the Prehispanic Snackeria, is a San Francisco company focused on planet-friendly protein snacks, featuring delicious edible insects in savory and sweet flavors. Founded by Monica Martinez, Don Bugito focuses on treats inspired by Pre-Columbian Mexican cuisine and works toward re-inventing ancestral food for the modern health-conscious market.About ICAICAaccelerates great businesses through mentoring and investments to close the racial and gender wealth gaps. A 501(c)3 organization with a vision of creating an economy that works for all, ICA supports growth-stage small businesses, led by people of color and women in the Bay Area, by providing capital, coaching, and connections to help them grow the value of their businesses, add good jobs, and create wealth.Contact:John Gough, Chief Investment Officer[emailprotected](406) 607-0123SOURCE ICA Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> ICA invests $200,000 to Accelerate Insect Snack Maker. Oakland-based nonprofit venture capital fund, ICA, invests $200K of patient capital in sustainable insect snack maker, Don Bugito.<|eot_id|>

edtsum854

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Industrial Refrigeration Systems Market Research Report: By Equipment Type, Refrigerant Type, Application - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The major factors driving the growth of the industrial refrigeration systems market are the expansion of the food and beverage processing sector in emerging economies, the advance of the cold chain industry, and the rise in the demand for refrigeration solutions among pharmaceutical and chemical companies. As a result of all these factors, the industry is expected to grow from $26.8 billion in 2019 to $41.1 billion in 2030, witnessing a CAGR of 5.0% between 2020 and 2030 (forecast period). Condensers, controls, evaporators, and compressors are the various categories under the equipment type segment. Among these, the compressor category led the industrial refrigeration systems market during the historical period (2014-2019). Being the component that actually provides the cooling, compressors account for anywhere between 25% and 35% of the cost of a complete refrigeration unit designed for industries. In the coming years, the controls category would grow the fastest, as the demand for energy efficiency and operational cost savings is driving the installation of control systems. The divisions under the refrigerant type segment of the industrial refrigeration systems market are hydrofluorocarbon (HFC), ammonia (NH3), and carbon dioxide (CO2). During the forecast period, the highest CAGR is projected to be witnessed by the CO2 category, as the gas is non-flammable, as well as less toxic. Termed as a natural refrigerant, the gas causes extremely little harm to the environment, if it is accidentally released from the refrigeration system. The adoption of eco-friendly refrigerants, such as CO2, is one of the key trends in the market presently. Owing to the high rate of ozone depletion, several laws have been implemented around the world to replace conventional refrigerants with natural and environment-friendly variants. For instance, the F-Gas Regulation of the European Union, which came into force in 2015, seeks to do away with the use of high-global-warming-potential (GWP) gases as refrigerants. The growth of the food and beverage processing industry in emerging economies is a significant reason for the industrial refrigeration systems market growth. With the increasing demand for processed and ready-to-eat products, food processing firms are seeing brisk business in developing countries. For instance, the food and beverage processing industry of India, which is the fifth-largest in the world, is receiving government support under the Make in India initiative. Under its 11th and 12th five-year plans, the central government has sanctioned the development of 40 mega food parks. Another reason the market for industrial refrigeration systems is expanding is the increasing demand for such systems in the pharmaceutical and chemical sectors. Refrigeration is quite important in the pharma, refining, and petrochemical sectors, as the products here need to be stored at specific temperatures to prevent spoilage. For instance, biologics, drugs, and certain medical devices need to be stored at low temperatures. With the increasing prevalence of various diseases, the demand for drugs is rising, thereby driving the demand for refrigeration solutions in the pharma industry. During the historical period, Asia-Pacific (APAC) was the largest industrial refrigeration system market, and it will also advance the fastest during the forecast period. This is attributed to the growth of the cold chain, where refrigeration is everything. For long-distance transportation of medical, chemical, and agricultural goods, it is imperative they remain refrigerated. The Indian government announced plans to execute 27 new integrated cold chain projects, worth $67.1 million (INR 743 crore), in September 2020. Market Dynamics Trends Drivers Restraints Opportunities Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/yj9d9c Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Global Industrial Refrigeration Systems Market (2020 to 2030) - by Equipment Type, Refrigerant Type, and Application - ResearchAndMarkets.com.

DUBLIN--(BUSINESS WIRE)--The "Industrial Refrigeration Systems Market Research Report: By Equipment Type, Refrigerant Type, Application - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The major factors driving the growth of the industrial refrigeration systems market are the expansion of the food and beverage processing sector in emerging economies, the advance of the cold chain industry, and the rise in the demand for refrigeration solutions among pharmaceutical and chemical companies. As a result of all these factors, the industry is expected to grow from $26.8 billion in 2019 to $41.1 billion in 2030, witnessing a CAGR of 5.0% between 2020 and 2030 (forecast period). Condensers, controls, evaporators, and compressors are the various categories under the equipment type segment. Among these, the compressor category led the industrial refrigeration systems market during the historical period (2014-2019). Being the component that actually provides the cooling, compressors account for anywhere between 25% and 35% of the cost of a complete refrigeration unit designed for industries. In the coming years, the controls category would grow the fastest, as the demand for energy efficiency and operational cost savings is driving the installation of control systems. The divisions under the refrigerant type segment of the industrial refrigeration systems market are hydrofluorocarbon (HFC), ammonia (NH3), and carbon dioxide (CO2). During the forecast period, the highest CAGR is projected to be witnessed by the CO2 category, as the gas is non-flammable, as well as less toxic. Termed as a natural refrigerant, the gas causes extremely little harm to the environment, if it is accidentally released from the refrigeration system. The adoption of eco-friendly refrigerants, such as CO2, is one of the key trends in the market presently. Owing to the high rate of ozone depletion, several laws have been implemented around the world to replace conventional refrigerants with natural and environment-friendly variants. For instance, the F-Gas Regulation of the European Union, which came into force in 2015, seeks to do away with the use of high-global-warming-potential (GWP) gases as refrigerants. The growth of the food and beverage processing industry in emerging economies is a significant reason for the industrial refrigeration systems market growth. With the increasing demand for processed and ready-to-eat products, food processing firms are seeing brisk business in developing countries. For instance, the food and beverage processing industry of India, which is the fifth-largest in the world, is receiving government support under the Make in India initiative. Under its 11th and 12th five-year plans, the central government has sanctioned the development of 40 mega food parks. Another reason the market for industrial refrigeration systems is expanding is the increasing demand for such systems in the pharmaceutical and chemical sectors. Refrigeration is quite important in the pharma, refining, and petrochemical sectors, as the products here need to be stored at specific temperatures to prevent spoilage. For instance, biologics, drugs, and certain medical devices need to be stored at low temperatures. With the increasing prevalence of various diseases, the demand for drugs is rising, thereby driving the demand for refrigeration solutions in the pharma industry. During the historical period, Asia-Pacific (APAC) was the largest industrial refrigeration system market, and it will also advance the fastest during the forecast period. This is attributed to the growth of the cold chain, where refrigeration is everything. For long-distance transportation of medical, chemical, and agricultural goods, it is imperative they remain refrigerated. The Indian government announced plans to execute 27 new integrated cold chain projects, worth $67.1 million (INR 743 crore), in September 2020. Market Dynamics Trends Drivers Restraints Opportunities Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/yj9d9c

Global Industrial Refrigeration Systems Market(2020 to 2030) - by Equipment Type, Refrigerant Type and Application - ResearchAndMarkets.com

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Industrial Refrigeration Systems Market Research Report: By Equipment Type, Refrigerant Type, Application - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The major factors driving the growth of the industrial refrigeration systems market are the expansion of the food and beverage processing sector in emerging economies, the advance of the cold chain industry, and the rise in the demand for refrigeration solutions among pharmaceutical and chemical companies. As a result of all these factors, the industry is expected to grow from $26.8 billion in 2019 to $41.1 billion in 2030, witnessing a CAGR of 5.0% between 2020 and 2030 (forecast period). Condensers, controls, evaporators, and compressors are the various categories under the equipment type segment. Among these, the compressor category led the industrial refrigeration systems market during the historical period (2014-2019). Being the component that actually provides the cooling, compressors account for anywhere between 25% and 35% of the cost of a complete refrigeration unit designed for industries. In the coming years, the controls category would grow the fastest, as the demand for energy efficiency and operational cost savings is driving the installation of control systems. The divisions under the refrigerant type segment of the industrial refrigeration systems market are hydrofluorocarbon (HFC), ammonia (NH3), and carbon dioxide (CO2). During the forecast period, the highest CAGR is projected to be witnessed by the CO2 category, as the gas is non-flammable, as well as less toxic. Termed as a natural refrigerant, the gas causes extremely little harm to the environment, if it is accidentally released from the refrigeration system. The adoption of eco-friendly refrigerants, such as CO2, is one of the key trends in the market presently. Owing to the high rate of ozone depletion, several laws have been implemented around the world to replace conventional refrigerants with natural and environment-friendly variants. For instance, the F-Gas Regulation of the European Union, which came into force in 2015, seeks to do away with the use of high-global-warming-potential (GWP) gases as refrigerants. The growth of the food and beverage processing industry in emerging economies is a significant reason for the industrial refrigeration systems market growth. With the increasing demand for processed and ready-to-eat products, food processing firms are seeing brisk business in developing countries. For instance, the food and beverage processing industry of India, which is the fifth-largest in the world, is receiving government support under the Make in India initiative. Under its 11th and 12th five-year plans, the central government has sanctioned the development of 40 mega food parks. Another reason the market for industrial refrigeration systems is expanding is the increasing demand for such systems in the pharmaceutical and chemical sectors. Refrigeration is quite important in the pharma, refining, and petrochemical sectors, as the products here need to be stored at specific temperatures to prevent spoilage. For instance, biologics, drugs, and certain medical devices need to be stored at low temperatures. With the increasing prevalence of various diseases, the demand for drugs is rising, thereby driving the demand for refrigeration solutions in the pharma industry. During the historical period, Asia-Pacific (APAC) was the largest industrial refrigeration system market, and it will also advance the fastest during the forecast period. This is attributed to the growth of the cold chain, where refrigeration is everything. For long-distance transportation of medical, chemical, and agricultural goods, it is imperative they remain refrigerated. The Indian government announced plans to execute 27 new integrated cold chain projects, worth $67.1 million (INR 743 crore), in September 2020. Market Dynamics Trends Drivers Restraints Opportunities Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/yj9d9c Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Global Industrial Refrigeration Systems Market (2020 to 2030) - by Equipment Type, Refrigerant Type, and Application - ResearchAndMarkets.com.<|eot_id|>

edtsum855

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin), Route of Administration (Oral, Injectable, Inhalation), Distribution Channel, End-Users, Application and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The Psychedelic Drugs Market size is projected to reach USD 10.75 Bn by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027. The Psychedelic Drugs Market research report provides an in-depth overview of the industry including market segmentation by drugs, route of administration, distribution channel, end-users, application and geography. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as product launches and acquisitions. The objective of this study is to identify the market opportunities and estimate market size by segments and countries for last few years and to forecast the values to the next five years. The report incorporates both the qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. The report also covers qualitative analysis on the market, by incorporating complete pricing and cost analysis of components & products, Porter's analysis and PEST (Political, Economic, Social & Technological factor) analysis of the market. The report also profiles all major companies active in this field. Psychedelic Drugs Market Scope and Market Size Psychedelic Drugs market is segmented by region and further by countries, drugs, route of administration, distribution channel, end-users, and application. Players, stakeholders, and other participants in the Global Psychedelic Drugs Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue and forecast for the period 2015-2026. The research covers the current and historic psychedelic drugs market size and its growth trend with company outline of key players/manufacturers: The Emmes Company, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V. , Merck & Co., Inc, Alkermes, and ALLERGAN among others. Report further studies the market development status and future of psychedelic drugs market trend across the world. Also, it splits Psychedelic Drugs Market Segmentation by drugs, route of administration, distribution channel, end-users, application and region to deep dive research and reveals market profile and prospects. Key Topics Covered: 1. EXECUTIVE SUMMARY 2. INTRODUCTION 2.1. Key Takeaways 2.2. Report Description 2.3. Market Scope & Definition 2.4. Stakeholders 2.5. Research Methodology 3. MARKET OVERVIEW 3.1. Industry Segmentation 3.2. Market Trends Analysis 3.3. Major Funding & Investments 3.4. Market Dynamics 3.4.1. Drivers 3.4.2. Restraints 3.4.3. Opportunities 3.5. Value Chain Analysis 3.6. Pricing Analysis 4. IMPACT OF COVID-19 ON PSYCHEDELIC DRUGS MARKET 4.1. Impact Of COVID-19 On Psychedelic Drugs Market By Drugs 4.2. Impact Of COVID-19 On Psychedelic Drugs Market By Route of Administration 4.3. Impact Of COVID-19 On Psychedelic Drugs Market By Distribution Channel 4.4. Impact Of COVID-19 On Psychedelic Drugs Market By End-Users 4.5. Impact Of COVID-19 On Psychedelic Drugs Market By Application 4.6. Impact Of COVID-19 On Psychedelic Drugs Market By Region 5. PSYCHEDELIC DRUGS MARKET, BY DRUGS 5.1. Introduction 5.2. Lysergic Acid Diethylamide (LSD) 5.3. 3,4-MethylEnedioxyMethamphetamine (Ecstasy) 5.4. Phencyclidine 5.5. Gamma Hydroxybutyric Acid (GHB) 5.6. Ketamine 5.7. Ayahuasca 5.8. Salvia 5.9. Psilocybin 5.10. Others 6. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION 6.1. Oral 6.2. Injectable 6.3. Inhalation 7. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL 7.1. Direct Retailers 7.2. Online Pharmacies 7.3. Others 8. PSYCHEDELIC DRUGS MARKET, BY END-USERS 8.1. Hospitals 8.2. Homecare 8.3. Specialty Clinics 8.4. Others 9. PSYCHEDELIC DRUGS MARKET, BY APPLICATION 9.1. Major Depressive Disorder 9.2. Resistant depression 9.3. Panic disorder 9.4. Post-traumatic stress disorder 9.5. Opiate Addiction 9.6. Others 10. PSYCHEDELIC DRUGS MARKET, BY GEOGRAPHY 10.1. North America 10.1.1. U.S. 10.1.2. Canada 10.2. Europe 10.2.1. Germany 10.2.2. U.K. 10.2.3. France 10.2.4. Rest of Europe 10.3. Asia Pacific 10.3.1. China 10.3.2. Japan 10.3.3. India 10.3.4. Rest Of Asia Pacific 10.4. Rest of the World 10.4.1. Middle East 10.4.2. Africa 11. COMPETITIVE ANALYSIS 11.1. Introduction 11.2. Top Companies Ranking 11.3. Market Share Analysis 11.4. Recent Developments 11.4.1. New Product Launch 11.4.2. Mergers & Acquisitions 11.4.3. Collaborations, Partnerships & Agreements 11.4.4. Rewards & Recognition 12. COMPANY PROFILES For more information about this report visit https://www.researchandmarkets.com/r/gu17yl Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Global Psychedelic Drugs Market Report 2020: Focus on LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin - ResearchAndMarkets.com.

DUBLIN--(BUSINESS WIRE)--The "Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin), Route of Administration (Oral, Injectable, Inhalation), Distribution Channel, End-Users, Application and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The Psychedelic Drugs Market size is projected to reach USD 10.75 Bn by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027. The Psychedelic Drugs Market research report provides an in-depth overview of the industry including market segmentation by drugs, route of administration, distribution channel, end-users, application and geography. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as product launches and acquisitions. The objective of this study is to identify the market opportunities and estimate market size by segments and countries for last few years and to forecast the values to the next five years. The report incorporates both the qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. The report also covers qualitative analysis on the market, by incorporating complete pricing and cost analysis of components & products, Porter's analysis and PEST (Political, Economic, Social & Technological factor) analysis of the market. The report also profiles all major companies active in this field. Psychedelic Drugs Market Scope and Market Size Psychedelic Drugs market is segmented by region and further by countries, drugs, route of administration, distribution channel, end-users, and application. Players, stakeholders, and other participants in the Global Psychedelic Drugs Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue and forecast for the period 2015-2026. The research covers the current and historic psychedelic drugs market size and its growth trend with company outline of key players/manufacturers: The Emmes Company, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V. , Merck & Co., Inc, Alkermes, and ALLERGAN among others. Report further studies the market development status and future of psychedelic drugs market trend across the world. Also, it splits Psychedelic Drugs Market Segmentation by drugs, route of administration, distribution channel, end-users, application and region to deep dive research and reveals market profile and prospects. Key Topics Covered: 1. EXECUTIVE SUMMARY 2. INTRODUCTION 2.1. Key Takeaways 2.2. Report Description 2.3. Market Scope & Definition 2.4. Stakeholders 2.5. Research Methodology 3. MARKET OVERVIEW 3.1. Industry Segmentation 3.2. Market Trends Analysis 3.3. Major Funding & Investments 3.4. Market Dynamics 3.4.1. Drivers 3.4.2. Restraints 3.4.3. Opportunities 3.5. Value Chain Analysis 3.6. Pricing Analysis 4. IMPACT OF COVID-19 ON PSYCHEDELIC DRUGS MARKET 4.1. Impact Of COVID-19 On Psychedelic Drugs Market By Drugs 4.2. Impact Of COVID-19 On Psychedelic Drugs Market By Route of Administration 4.3. Impact Of COVID-19 On Psychedelic Drugs Market By Distribution Channel 4.4. Impact Of COVID-19 On Psychedelic Drugs Market By End-Users 4.5. Impact Of COVID-19 On Psychedelic Drugs Market By Application 4.6. Impact Of COVID-19 On Psychedelic Drugs Market By Region 5. PSYCHEDELIC DRUGS MARKET, BY DRUGS 5.1. Introduction 5.2. Lysergic Acid Diethylamide (LSD) 5.3. 3,4-MethylEnedioxyMethamphetamine (Ecstasy) 5.4. Phencyclidine 5.5. Gamma Hydroxybutyric Acid (GHB) 5.6. Ketamine 5.7. Ayahuasca 5.8. Salvia 5.9. Psilocybin 5.10. Others 6. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION 6.1. Oral 6.2. Injectable 6.3. Inhalation 7. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL 7.1. Direct Retailers 7.2. Online Pharmacies 7.3. Others 8. PSYCHEDELIC DRUGS MARKET, BY END-USERS 8.1. Hospitals 8.2. Homecare 8.3. Specialty Clinics 8.4. Others 9. PSYCHEDELIC DRUGS MARKET, BY APPLICATION 9.1. Major Depressive Disorder 9.2. Resistant depression 9.3. Panic disorder 9.4. Post-traumatic stress disorder 9.5. Opiate Addiction 9.6. Others 10. PSYCHEDELIC DRUGS MARKET, BY GEOGRAPHY 10.1. North America 10.1.1. U.S. 10.1.2. Canada 10.2. Europe 10.2.1. Germany 10.2.2. U.K. 10.2.3. France 10.2.4. Rest of Europe 10.3. Asia Pacific 10.3.1. China 10.3.2. Japan 10.3.3. India 10.3.4. Rest Of Asia Pacific 10.4. Rest of the World 10.4.1. Middle East 10.4.2. Africa 11. COMPETITIVE ANALYSIS 11.1. Introduction 11.2. Top Companies Ranking 11.3. Market Share Analysis 11.4. Recent Developments 11.4.1. New Product Launch 11.4.2. Mergers & Acquisitions 11.4.3. Collaborations, Partnerships & Agreements 11.4.4. Rewards & Recognition 12. COMPANY PROFILES For more information about this report visit https://www.researchandmarkets.com/r/gu17yl

Global Psychedelic Drugs Market Report 2020: Focus on LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin - ResearchAndMarkets.com

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin), Route of Administration (Oral, Injectable, Inhalation), Distribution Channel, End-Users, Application and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The Psychedelic Drugs Market size is projected to reach USD 10.75 Bn by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027. The Psychedelic Drugs Market research report provides an in-depth overview of the industry including market segmentation by drugs, route of administration, distribution channel, end-users, application and geography. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as product launches and acquisitions. The objective of this study is to identify the market opportunities and estimate market size by segments and countries for last few years and to forecast the values to the next five years. The report incorporates both the qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. The report also covers qualitative analysis on the market, by incorporating complete pricing and cost analysis of components & products, Porter's analysis and PEST (Political, Economic, Social & Technological factor) analysis of the market. The report also profiles all major companies active in this field. Psychedelic Drugs Market Scope and Market Size Psychedelic Drugs market is segmented by region and further by countries, drugs, route of administration, distribution channel, end-users, and application. Players, stakeholders, and other participants in the Global Psychedelic Drugs Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue and forecast for the period 2015-2026. The research covers the current and historic psychedelic drugs market size and its growth trend with company outline of key players/manufacturers: The Emmes Company, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V. , Merck & Co., Inc, Alkermes, and ALLERGAN among others. Report further studies the market development status and future of psychedelic drugs market trend across the world. Also, it splits Psychedelic Drugs Market Segmentation by drugs, route of administration, distribution channel, end-users, application and region to deep dive research and reveals market profile and prospects. Key Topics Covered: 1. EXECUTIVE SUMMARY 2. INTRODUCTION 2.1. Key Takeaways 2.2. Report Description 2.3. Market Scope & Definition 2.4. Stakeholders 2.5. Research Methodology 3. MARKET OVERVIEW 3.1. Industry Segmentation 3.2. Market Trends Analysis 3.3. Major Funding & Investments 3.4. Market Dynamics 3.4.1. Drivers 3.4.2. Restraints 3.4.3. Opportunities 3.5. Value Chain Analysis 3.6. Pricing Analysis 4. IMPACT OF COVID-19 ON PSYCHEDELIC DRUGS MARKET 4.1. Impact Of COVID-19 On Psychedelic Drugs Market By Drugs 4.2. Impact Of COVID-19 On Psychedelic Drugs Market By Route of Administration 4.3. Impact Of COVID-19 On Psychedelic Drugs Market By Distribution Channel 4.4. Impact Of COVID-19 On Psychedelic Drugs Market By End-Users 4.5. Impact Of COVID-19 On Psychedelic Drugs Market By Application 4.6. Impact Of COVID-19 On Psychedelic Drugs Market By Region 5. PSYCHEDELIC DRUGS MARKET, BY DRUGS 5.1. Introduction 5.2. Lysergic Acid Diethylamide (LSD) 5.3. 3,4-MethylEnedioxyMethamphetamine (Ecstasy) 5.4. Phencyclidine 5.5. Gamma Hydroxybutyric Acid (GHB) 5.6. Ketamine 5.7. Ayahuasca 5.8. Salvia 5.9. Psilocybin 5.10. Others 6. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION 6.1. Oral 6.2. Injectable 6.3. Inhalation 7. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL 7.1. Direct Retailers 7.2. Online Pharmacies 7.3. Others 8. PSYCHEDELIC DRUGS MARKET, BY END-USERS 8.1. Hospitals 8.2. Homecare 8.3. Specialty Clinics 8.4. Others 9. PSYCHEDELIC DRUGS MARKET, BY APPLICATION 9.1. Major Depressive Disorder 9.2. Resistant depression 9.3. Panic disorder 9.4. Post-traumatic stress disorder 9.5. Opiate Addiction 9.6. Others 10. PSYCHEDELIC DRUGS MARKET, BY GEOGRAPHY 10.1. North America 10.1.1. U.S. 10.1.2. Canada 10.2. Europe 10.2.1. Germany 10.2.2. U.K. 10.2.3. France 10.2.4. Rest of Europe 10.3. Asia Pacific 10.3.1. China 10.3.2. Japan 10.3.3. India 10.3.4. Rest Of Asia Pacific 10.4. Rest of the World 10.4.1. Middle East 10.4.2. Africa 11. COMPETITIVE ANALYSIS 11.1. Introduction 11.2. Top Companies Ranking 11.3. Market Share Analysis 11.4. Recent Developments 11.4.1. New Product Launch 11.4.2. Mergers & Acquisitions 11.4.3. Collaborations, Partnerships & Agreements 11.4.4. Rewards & Recognition 12. COMPANY PROFILES For more information about this report visit https://www.researchandmarkets.com/r/gu17yl Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Global Psychedelic Drugs Market Report 2020: Focus on LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin - ResearchAndMarkets.com.<|eot_id|>

edtsum856

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN JUAN, Puerto Rico, April 27, 2020 /PRNewswire/ --Today, nic.PR(the .PR registry operator) and Afilias(its technology partner) announce the release of 64,000 prime dotPR names beginning at 0900 EDT. Internet addresses ending in ".PR" are the best names for public relations professionals. Many great .PR names have been on reserve at the registry for years, until today!These newly released names include hundreds of great category-relevant terms. In addition to ILOVE.PR, the list features: 420.PR GIG.PR ICON.PR AGENCY.PR GLOBAL.PR IMAGE.PR BITCOIN.PR GHOSTWRITER.PR IMMEDIATE.PR FREELANCE.PR GUERRILLA.PR IMPACT.PR and 64,000 others, including many in Spanish! If you are in the public relations field, NOW is the time to get a domain that shows you are a PR professional and will set you apart from competitors. The full list of names is posted on the nic.PR site; all names are available at any authorized .PR domain name registrar. PR professionals, including large agencies, small agencies, event pros and freelancers, know that the right internet address can mean the difference between success and failure. Now, there are 64,000 new names available that are tailor made to promote YOU and your business. Pablo Rodriguez, Executive Vice Presidentof nic.PR, said: "We are extremely excited to make these names available. This is a one of a kind opportunity for PR pros to get some amazing names that we believe will be more memorable and evocative than any other names on the internet today." "We are proud to support such a popular and growing domain," said Roland LaPlante, Chief Marketing Officer of Afilias. "Savvy public relations firms know that a .PR name enables them to quickly differentiate themselves from the many other agency types on the internet." Originally launched in 1989 as the country code extension for Puerto Rico, the address has become known for enabling public relations firms to quickly communicate their specialty on the internet. Unlike some of the longer new extensions, names ending in .PR work everywhere. About nic.PR www.domains.pr nic.PR is owned by Gauss Research Laboratory, Inc., a company organized under the laws of the Commonwealth of Puerto Rico and headquartered in Ro Piedras, Puerto Rico. Company founder Dr. Oscar Moreno de Ayala embarked on the responsibility of managing .PR and building it from its early foundations to promote a solid registry providing Puerto Ricans with accessible services and tools and aiding in the development of a reliable IT community throughout the island while also serving as the perfect Top Level Domain for those in the Public Relations Industry. About AfiliasAfilias is the world's second largest domain registry, with over 20 million domain names under management in over 200 top level domains. Afilias powers a wide variety of top-level domains, including TLDs for countries, cities, brands, communities, and generic terms. Afilias' specialized technology makes Internet addresses more accessible and useful through a broad range of applications, including Internetdomain registry services,managed DNS, andmobile Web services. Afilias, Inc. is based near Philadelphia offices are also located in Dublin Ireland, Toronto Canada, New Delhi India, Melbourne Australia, Vista California, and Beijing China. Afilias holds a Guinness World Records title for the "Largest migration of an internet top-level domain in a single transition" for its migration of the .au top-level domain in 2018. For more information on Afilias services please visitwww.afilias.info. For More Information: AfiliasAlan Wallace, Director of Corporate Communications[emailprotected]+1.425.691.8757 cell SOURCE Afilias Related Links http://www.afilias.info Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

ILOVE.PR - Prime Domains Released for the PR Industry. English. USA - español. Historic Release of 64,000 Premium Names Ending in .PR.

SAN JUAN, Puerto Rico, April 27, 2020 /PRNewswire/ --Today, nic.PR(the .PR registry operator) and Afilias(its technology partner) announce the release of 64,000 prime dotPR names beginning at 0900 EDT. Internet addresses ending in ".PR" are the best names for public relations professionals. Many great .PR names have been on reserve at the registry for years, until today!These newly released names include hundreds of great category-relevant terms. In addition to ILOVE.PR, the list features: 420.PR GIG.PR ICON.PR AGENCY.PR GLOBAL.PR IMAGE.PR BITCOIN.PR GHOSTWRITER.PR IMMEDIATE.PR FREELANCE.PR GUERRILLA.PR IMPACT.PR and 64,000 others, including many in Spanish! If you are in the public relations field, NOW is the time to get a domain that shows you are a PR professional and will set you apart from competitors. The full list of names is posted on the nic.PR site; all names are available at any authorized .PR domain name registrar. PR professionals, including large agencies, small agencies, event pros and freelancers, know that the right internet address can mean the difference between success and failure. Now, there are 64,000 new names available that are tailor made to promote YOU and your business. Pablo Rodriguez, Executive Vice Presidentof nic.PR, said: "We are extremely excited to make these names available. This is a one of a kind opportunity for PR pros to get some amazing names that we believe will be more memorable and evocative than any other names on the internet today." "We are proud to support such a popular and growing domain," said Roland LaPlante, Chief Marketing Officer of Afilias. "Savvy public relations firms know that a .PR name enables them to quickly differentiate themselves from the many other agency types on the internet." Originally launched in 1989 as the country code extension for Puerto Rico, the address has become known for enabling public relations firms to quickly communicate their specialty on the internet. Unlike some of the longer new extensions, names ending in .PR work everywhere. About nic.PR www.domains.pr nic.PR is owned by Gauss Research Laboratory, Inc., a company organized under the laws of the Commonwealth of Puerto Rico and headquartered in Ro Piedras, Puerto Rico. Company founder Dr. Oscar Moreno de Ayala embarked on the responsibility of managing .PR and building it from its early foundations to promote a solid registry providing Puerto Ricans with accessible services and tools and aiding in the development of a reliable IT community throughout the island while also serving as the perfect Top Level Domain for those in the Public Relations Industry. About AfiliasAfilias is the world's second largest domain registry, with over 20 million domain names under management in over 200 top level domains. Afilias powers a wide variety of top-level domains, including TLDs for countries, cities, brands, communities, and generic terms. Afilias' specialized technology makes Internet addresses more accessible and useful through a broad range of applications, including Internetdomain registry services,managed DNS, andmobile Web services. Afilias, Inc. is based near Philadelphia offices are also located in Dublin Ireland, Toronto Canada, New Delhi India, Melbourne Australia, Vista California, and Beijing China. Afilias holds a Guinness World Records title for the "Largest migration of an internet top-level domain in a single transition" for its migration of the .au top-level domain in 2018. For more information on Afilias services please visitwww.afilias.info. For More Information: AfiliasAlan Wallace, Director of Corporate Communications[emailprotected]+1.425.691.8757 cell SOURCE Afilias Related Links http://www.afilias.info

ILOVE.PR - Prime Domains Released for the PR Industry English USA - espaol Historic Release of 64,000 Premium Names Ending in .PR

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN JUAN, Puerto Rico, April 27, 2020 /PRNewswire/ --Today, nic.PR(the .PR registry operator) and Afilias(its technology partner) announce the release of 64,000 prime dotPR names beginning at 0900 EDT. Internet addresses ending in ".PR" are the best names for public relations professionals. Many great .PR names have been on reserve at the registry for years, until today!These newly released names include hundreds of great category-relevant terms. In addition to ILOVE.PR, the list features: 420.PR GIG.PR ICON.PR AGENCY.PR GLOBAL.PR IMAGE.PR BITCOIN.PR GHOSTWRITER.PR IMMEDIATE.PR FREELANCE.PR GUERRILLA.PR IMPACT.PR and 64,000 others, including many in Spanish! If you are in the public relations field, NOW is the time to get a domain that shows you are a PR professional and will set you apart from competitors. The full list of names is posted on the nic.PR site; all names are available at any authorized .PR domain name registrar. PR professionals, including large agencies, small agencies, event pros and freelancers, know that the right internet address can mean the difference between success and failure. Now, there are 64,000 new names available that are tailor made to promote YOU and your business. Pablo Rodriguez, Executive Vice Presidentof nic.PR, said: "We are extremely excited to make these names available. This is a one of a kind opportunity for PR pros to get some amazing names that we believe will be more memorable and evocative than any other names on the internet today." "We are proud to support such a popular and growing domain," said Roland LaPlante, Chief Marketing Officer of Afilias. "Savvy public relations firms know that a .PR name enables them to quickly differentiate themselves from the many other agency types on the internet." Originally launched in 1989 as the country code extension for Puerto Rico, the address has become known for enabling public relations firms to quickly communicate their specialty on the internet. Unlike some of the longer new extensions, names ending in .PR work everywhere. About nic.PR www.domains.pr nic.PR is owned by Gauss Research Laboratory, Inc., a company organized under the laws of the Commonwealth of Puerto Rico and headquartered in Ro Piedras, Puerto Rico. Company founder Dr. Oscar Moreno de Ayala embarked on the responsibility of managing .PR and building it from its early foundations to promote a solid registry providing Puerto Ricans with accessible services and tools and aiding in the development of a reliable IT community throughout the island while also serving as the perfect Top Level Domain for those in the Public Relations Industry. About AfiliasAfilias is the world's second largest domain registry, with over 20 million domain names under management in over 200 top level domains. Afilias powers a wide variety of top-level domains, including TLDs for countries, cities, brands, communities, and generic terms. Afilias' specialized technology makes Internet addresses more accessible and useful through a broad range of applications, including Internetdomain registry services,managed DNS, andmobile Web services. Afilias, Inc. is based near Philadelphia offices are also located in Dublin Ireland, Toronto Canada, New Delhi India, Melbourne Australia, Vista California, and Beijing China. Afilias holds a Guinness World Records title for the "Largest migration of an internet top-level domain in a single transition" for its migration of the .au top-level domain in 2018. For more information on Afilias services please visitwww.afilias.info. For More Information: AfiliasAlan Wallace, Director of Corporate Communications[emailprotected]+1.425.691.8757 cell SOURCE Afilias Related Links http://www.afilias.info Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> ILOVE.PR - Prime Domains Released for the PR Industry. English. USA - español. Historic Release of 64,000 Premium Names Ending in .PR.<|eot_id|>

edtsum857

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc. (the Company or Coeur) (NYSE: CDE) today announced its intention to offer (the Offering), subject to market and other conditions, $350,000,000 of Senior Notes due 2029 (the Notes). The Notes will be fully and unconditionally guaranteed by certain of the Companys subsidiaries. The Company intends to use the net proceeds from the Offering to pay the purchase price and tender premium for up to all $230,000,000 aggregate principal amount of its 5.875% Senior Notes due 2024 (the 2024 Notes) that are validly tendered (and not validly withdrawn) by holders and accepted by the Company in connection with the cash tender offer that it commenced on February 22, 2021 (the Concurrent Tender Offer), to pay the redemption price to redeem any of the 2024 Notes that are not so tendered in the Concurrent Tender Offer and to pay the fees and expenses in connection with the Offering, the Concurrent Tender Offer and any redemption of the 2024 Notes. To the extent that the Company has excess proceeds from the Offering, the Company intends to use such excess amounts for general corporate purposes. The Notes will only be offered and sold to qualified institutional buyers in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S under the Securities Act of 1933, as amended (the Securities Act). The Company has not registered the Notes under the Securities Act or any state securities laws and will not register the Notes under the Securities Act or any state securities laws. The Notes will be subject to restrictions on transferability and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. This news release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes or any other securities, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This news release is being issued pursuant to and in accordance with Rule 135c under the Securities Act. About Coeur Coeur Mining, Inc. is a U.S.-based, well-diversified, growing precious metals producer with five wholly-owned operations: the Palmarejo gold-silver complex in Mexico, the Rochester silver-gold mine in Nevada, the Kensington gold mine in Alaska, the Wharf gold mine in South Dakota, and the Silvertip silver-zinc-lead mine in British Columbia. In addition, the Company has interests in several precious metals exploration projects throughout North America. Cautionary Note Regarding Forward-Looking Statements This news release contains forward-looking statements or information within the meaning of securities legislation in the United States and Canada, including, among others, (i) Coeurs intention to offer the Notes, subject to market and other conditions and (ii) Coeurs intention to use the proceeds of the Offering to repurchase the 2024 Notes that are validly tendered (and not validly withdrawn) by holders and accepted by the Company, to pay the redemption price to redeem any of the 2024 Notes that are not so tendered, to pay related fees and expenses in connection with the offering, and to the extent the Company has excess proceeds from the offering, for general corporate purposes. These forward-looking statements and information reflect Coeurs current views with respect to future events and are necessarily based upon a number of assumptions that, while considered reasonable, are inherently subject to significant operational, business, economic, market and regulatory uncertainties and contingencies. These assumptions include the timing and success of the Offering, the tender offer and the satisfaction of customary closing conditions in a timely manner or at all. The foregoing list of assumptions is not exhaustive. Such forward-looking statements and information also involve known and unknown risks, uncertainties and other factors which may cause actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information. Such factors include, among others, the uncertainties and risk factors set out in filings made from time to time with the United States Securities and Exchange Commission, and the Canadian Securities regulators, including, without limitation, Coeurs most recent report on Form 10-K. Actual results, developments and timetables could vary significantly from the estimates presented. Readers are cautioned not to put undue reliance on forward-looking statements or information. Coeur disclaims any intent or obligation to update publicly such forward-looking statements or information, whether as a result of new information, future events or otherwise. Additionally, Coeur undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of Coeur, its financial or operating results or its securities. This news release does not constitute an offer of any securities for sale. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Coeur Mining, Inc. to Offer Senior Notes.

CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc. (the Company or Coeur) (NYSE: CDE) today announced its intention to offer (the Offering), subject to market and other conditions, $350,000,000 of Senior Notes due 2029 (the Notes). The Notes will be fully and unconditionally guaranteed by certain of the Companys subsidiaries. The Company intends to use the net proceeds from the Offering to pay the purchase price and tender premium for up to all $230,000,000 aggregate principal amount of its 5.875% Senior Notes due 2024 (the 2024 Notes) that are validly tendered (and not validly withdrawn) by holders and accepted by the Company in connection with the cash tender offer that it commenced on February 22, 2021 (the Concurrent Tender Offer), to pay the redemption price to redeem any of the 2024 Notes that are not so tendered in the Concurrent Tender Offer and to pay the fees and expenses in connection with the Offering, the Concurrent Tender Offer and any redemption of the 2024 Notes. To the extent that the Company has excess proceeds from the Offering, the Company intends to use such excess amounts for general corporate purposes. The Notes will only be offered and sold to qualified institutional buyers in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S under the Securities Act of 1933, as amended (the Securities Act). The Company has not registered the Notes under the Securities Act or any state securities laws and will not register the Notes under the Securities Act or any state securities laws. The Notes will be subject to restrictions on transferability and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. This news release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes or any other securities, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This news release is being issued pursuant to and in accordance with Rule 135c under the Securities Act. About Coeur Coeur Mining, Inc. is a U.S.-based, well-diversified, growing precious metals producer with five wholly-owned operations: the Palmarejo gold-silver complex in Mexico, the Rochester silver-gold mine in Nevada, the Kensington gold mine in Alaska, the Wharf gold mine in South Dakota, and the Silvertip silver-zinc-lead mine in British Columbia. In addition, the Company has interests in several precious metals exploration projects throughout North America. Cautionary Note Regarding Forward-Looking Statements This news release contains forward-looking statements or information within the meaning of securities legislation in the United States and Canada, including, among others, (i) Coeurs intention to offer the Notes, subject to market and other conditions and (ii) Coeurs intention to use the proceeds of the Offering to repurchase the 2024 Notes that are validly tendered (and not validly withdrawn) by holders and accepted by the Company, to pay the redemption price to redeem any of the 2024 Notes that are not so tendered, to pay related fees and expenses in connection with the offering, and to the extent the Company has excess proceeds from the offering, for general corporate purposes. These forward-looking statements and information reflect Coeurs current views with respect to future events and are necessarily based upon a number of assumptions that, while considered reasonable, are inherently subject to significant operational, business, economic, market and regulatory uncertainties and contingencies. These assumptions include the timing and success of the Offering, the tender offer and the satisfaction of customary closing conditions in a timely manner or at all. The foregoing list of assumptions is not exhaustive. Such forward-looking statements and information also involve known and unknown risks, uncertainties and other factors which may cause actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information. Such factors include, among others, the uncertainties and risk factors set out in filings made from time to time with the United States Securities and Exchange Commission, and the Canadian Securities regulators, including, without limitation, Coeurs most recent report on Form 10-K. Actual results, developments and timetables could vary significantly from the estimates presented. Readers are cautioned not to put undue reliance on forward-looking statements or information. Coeur disclaims any intent or obligation to update publicly such forward-looking statements or information, whether as a result of new information, future events or otherwise. Additionally, Coeur undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of Coeur, its financial or operating results or its securities. This news release does not constitute an offer of any securities for sale.

Coeur Mining, Inc. to Offer Senior Notes

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc. (the Company or Coeur) (NYSE: CDE) today announced its intention to offer (the Offering), subject to market and other conditions, $350,000,000 of Senior Notes due 2029 (the Notes). The Notes will be fully and unconditionally guaranteed by certain of the Companys subsidiaries. The Company intends to use the net proceeds from the Offering to pay the purchase price and tender premium for up to all $230,000,000 aggregate principal amount of its 5.875% Senior Notes due 2024 (the 2024 Notes) that are validly tendered (and not validly withdrawn) by holders and accepted by the Company in connection with the cash tender offer that it commenced on February 22, 2021 (the Concurrent Tender Offer), to pay the redemption price to redeem any of the 2024 Notes that are not so tendered in the Concurrent Tender Offer and to pay the fees and expenses in connection with the Offering, the Concurrent Tender Offer and any redemption of the 2024 Notes. To the extent that the Company has excess proceeds from the Offering, the Company intends to use such excess amounts for general corporate purposes. The Notes will only be offered and sold to qualified institutional buyers in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S under the Securities Act of 1933, as amended (the Securities Act). The Company has not registered the Notes under the Securities Act or any state securities laws and will not register the Notes under the Securities Act or any state securities laws. The Notes will be subject to restrictions on transferability and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. This news release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes or any other securities, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This news release is being issued pursuant to and in accordance with Rule 135c under the Securities Act. About Coeur Coeur Mining, Inc. is a U.S.-based, well-diversified, growing precious metals producer with five wholly-owned operations: the Palmarejo gold-silver complex in Mexico, the Rochester silver-gold mine in Nevada, the Kensington gold mine in Alaska, the Wharf gold mine in South Dakota, and the Silvertip silver-zinc-lead mine in British Columbia. In addition, the Company has interests in several precious metals exploration projects throughout North America. Cautionary Note Regarding Forward-Looking Statements This news release contains forward-looking statements or information within the meaning of securities legislation in the United States and Canada, including, among others, (i) Coeurs intention to offer the Notes, subject to market and other conditions and (ii) Coeurs intention to use the proceeds of the Offering to repurchase the 2024 Notes that are validly tendered (and not validly withdrawn) by holders and accepted by the Company, to pay the redemption price to redeem any of the 2024 Notes that are not so tendered, to pay related fees and expenses in connection with the offering, and to the extent the Company has excess proceeds from the offering, for general corporate purposes. These forward-looking statements and information reflect Coeurs current views with respect to future events and are necessarily based upon a number of assumptions that, while considered reasonable, are inherently subject to significant operational, business, economic, market and regulatory uncertainties and contingencies. These assumptions include the timing and success of the Offering, the tender offer and the satisfaction of customary closing conditions in a timely manner or at all. The foregoing list of assumptions is not exhaustive. Such forward-looking statements and information also involve known and unknown risks, uncertainties and other factors which may cause actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information. Such factors include, among others, the uncertainties and risk factors set out in filings made from time to time with the United States Securities and Exchange Commission, and the Canadian Securities regulators, including, without limitation, Coeurs most recent report on Form 10-K. Actual results, developments and timetables could vary significantly from the estimates presented. Readers are cautioned not to put undue reliance on forward-looking statements or information. Coeur disclaims any intent or obligation to update publicly such forward-looking statements or information, whether as a result of new information, future events or otherwise. Additionally, Coeur undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of Coeur, its financial or operating results or its securities. This news release does not constitute an offer of any securities for sale. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Coeur Mining, Inc. to Offer Senior Notes.<|eot_id|>

edtsum858

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced that the company has initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study (Assessment of KAN-101 in Celiac Disease), a Phase 1 clinical trial evaluating KAN-101 for the treatment of individuals with celiac disease. Initiation of the MAD cohort enrollment follows completion of the first two single-ascending dose (SAD) cohorts in the trial, with the third SAD cohort actively dosing patients. KAN-101, Anokions lead antigen-specific drug product candidate, aims to re-educate immune cells to not respond to gluten antigens. The ACeD study is a randomized, double-blind, placebo-controlled Phase 1 trial that will enroll a total of up to 40 patients with celiac disease who are on a gluten free diet. The study is composed of two parts. In Part A, patients enrolled will receive a single dose of KAN-101 across four SAD cohorts. Upon completion of the second SAD cohort, the company initiated Part B, in which patients enrolled will each receive three doses of either KAN-101 or placebo across three MAD cohorts. Celiac disease is a serious autoimmune disorder that results in severe and life-altering symptoms in patients when not managed properly. With no approved treatments today, symptoms can only be managed through a burdensome, gluten-free diet, said Deborah Geraghty, Ph.D., president and chief executive officer of Anokion. We are excited to advance our Phase 1 trial to the MAD portion, which will provide important information on the potential effects of repeat dosing of KAN-101 in our target patient population. By restoring natural immune tolerance, we believe KAN-101 could significantly impact the treatment of patients with celiac disease, and we look forward to assessing initial data and advancing this program later this year. The primary endpoint of the ACeD trial is to assess the safety and tolerability of KAN-101 in patients, and the secondary endpoint is to assess serum concentrations and pharmacokinetics of KAN-101. Exploratory endpoints include assessing cytokines critical to both innate and adaptive immunity, T cell responses, as well as other serum cytokines and celiac disease symptoms in patients treated with KAN-101. Anokion anticipates reporting preliminary safety and pharmacokinetic data from the SAD cohorts of ACeD later this year. Additional information about the ACeD trial can be found at: www.ACeDtrial.com About KAN-101 KAN-101, an investigational medicine being developed for the treatment of celiac disease, is currently being evaluated in a Phase 1 clinical trial (ACeD study). KAN-101 encompasses a well-described gluten antigen implicated in driving the onset of celiac disease and is designed to re-educate the immune system by targeting the bodys own natural immune pathways in the liver. Anokion has generated preclinical data demonstrating potentially durable, disease-modifying benefit with its immune tolerance platform in multiple animal models of disease. About Celiac Disease Celiac disease is a genetically driven, serious autoimmune disease where inappropriate immune responses to gluten peptides lead to damage of the small intestine.1 The prevalence of celiac disease in adults is approximately 0.40.95% in the United States and 12% in Europe.2 Celiac disease can cause severe symptoms including abdominal pain, diarrhea, nausea and vomiting.3 Long-term complications of celiac disease may include weight loss, osteoporosis, neurological problems and reproductive issues.4 The only treatment available for patients is maintaining a strict, lifelong gluten-free diet and limiting exposure to gluten proteins from wheat, barley and rye, which is oftentimes ineffective.5 About Anokion Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokions distinct approach leverages the companys immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease. For more information, please visit http://www.anokion.com/. ____________________________ 1 www.celiac.org 2 Dub, C. et al. Gastroenterology 128 (Suppl. 1), S57-S67 (2005) 3 www.nationalceliac.org 4 https://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease/symptoms-causes (accessed February 9, 2020) 5 www.celiac.org Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Anokion Announces Initiation of Multiple-Ascending Dose Portion of its Phase 1 Clinical Trial with KAN-101 for the Treatment of Celiac Disease. Preliminary Data from Single-Ascending Dose Cohorts Expected Later this Year.

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced that the company has initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study (Assessment of KAN-101 in Celiac Disease), a Phase 1 clinical trial evaluating KAN-101 for the treatment of individuals with celiac disease. Initiation of the MAD cohort enrollment follows completion of the first two single-ascending dose (SAD) cohorts in the trial, with the third SAD cohort actively dosing patients. KAN-101, Anokions lead antigen-specific drug product candidate, aims to re-educate immune cells to not respond to gluten antigens. The ACeD study is a randomized, double-blind, placebo-controlled Phase 1 trial that will enroll a total of up to 40 patients with celiac disease who are on a gluten free diet. The study is composed of two parts. In Part A, patients enrolled will receive a single dose of KAN-101 across four SAD cohorts. Upon completion of the second SAD cohort, the company initiated Part B, in which patients enrolled will each receive three doses of either KAN-101 or placebo across three MAD cohorts. Celiac disease is a serious autoimmune disorder that results in severe and life-altering symptoms in patients when not managed properly. With no approved treatments today, symptoms can only be managed through a burdensome, gluten-free diet, said Deborah Geraghty, Ph.D., president and chief executive officer of Anokion. We are excited to advance our Phase 1 trial to the MAD portion, which will provide important information on the potential effects of repeat dosing of KAN-101 in our target patient population. By restoring natural immune tolerance, we believe KAN-101 could significantly impact the treatment of patients with celiac disease, and we look forward to assessing initial data and advancing this program later this year. The primary endpoint of the ACeD trial is to assess the safety and tolerability of KAN-101 in patients, and the secondary endpoint is to assess serum concentrations and pharmacokinetics of KAN-101. Exploratory endpoints include assessing cytokines critical to both innate and adaptive immunity, T cell responses, as well as other serum cytokines and celiac disease symptoms in patients treated with KAN-101. Anokion anticipates reporting preliminary safety and pharmacokinetic data from the SAD cohorts of ACeD later this year. Additional information about the ACeD trial can be found at: www.ACeDtrial.com About KAN-101 KAN-101, an investigational medicine being developed for the treatment of celiac disease, is currently being evaluated in a Phase 1 clinical trial (ACeD study). KAN-101 encompasses a well-described gluten antigen implicated in driving the onset of celiac disease and is designed to re-educate the immune system by targeting the bodys own natural immune pathways in the liver. Anokion has generated preclinical data demonstrating potentially durable, disease-modifying benefit with its immune tolerance platform in multiple animal models of disease. About Celiac Disease Celiac disease is a genetically driven, serious autoimmune disease where inappropriate immune responses to gluten peptides lead to damage of the small intestine.1 The prevalence of celiac disease in adults is approximately 0.40.95% in the United States and 12% in Europe.2 Celiac disease can cause severe symptoms including abdominal pain, diarrhea, nausea and vomiting.3 Long-term complications of celiac disease may include weight loss, osteoporosis, neurological problems and reproductive issues.4 The only treatment available for patients is maintaining a strict, lifelong gluten-free diet and limiting exposure to gluten proteins from wheat, barley and rye, which is oftentimes ineffective.5 About Anokion Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokions distinct approach leverages the companys immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease. For more information, please visit http://www.anokion.com/. ____________________________ 1 www.celiac.org 2 Dub, C. et al. Gastroenterology 128 (Suppl. 1), S57-S67 (2005) 3 www.nationalceliac.org 4 https://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease/symptoms-causes (accessed February 9, 2020) 5 www.celiac.org

Anokion Announces Initiation of Multiple-Ascending Dose Portion of its Phase 1 Clinical Trial with KAN-101 for the Treatment of Celiac Disease Preliminary Data from Single-Ascending Dose Cohorts Expected Later this Year

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced that the company has initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study (Assessment of KAN-101 in Celiac Disease), a Phase 1 clinical trial evaluating KAN-101 for the treatment of individuals with celiac disease. Initiation of the MAD cohort enrollment follows completion of the first two single-ascending dose (SAD) cohorts in the trial, with the third SAD cohort actively dosing patients. KAN-101, Anokions lead antigen-specific drug product candidate, aims to re-educate immune cells to not respond to gluten antigens. The ACeD study is a randomized, double-blind, placebo-controlled Phase 1 trial that will enroll a total of up to 40 patients with celiac disease who are on a gluten free diet. The study is composed of two parts. In Part A, patients enrolled will receive a single dose of KAN-101 across four SAD cohorts. Upon completion of the second SAD cohort, the company initiated Part B, in which patients enrolled will each receive three doses of either KAN-101 or placebo across three MAD cohorts. Celiac disease is a serious autoimmune disorder that results in severe and life-altering symptoms in patients when not managed properly. With no approved treatments today, symptoms can only be managed through a burdensome, gluten-free diet, said Deborah Geraghty, Ph.D., president and chief executive officer of Anokion. We are excited to advance our Phase 1 trial to the MAD portion, which will provide important information on the potential effects of repeat dosing of KAN-101 in our target patient population. By restoring natural immune tolerance, we believe KAN-101 could significantly impact the treatment of patients with celiac disease, and we look forward to assessing initial data and advancing this program later this year. The primary endpoint of the ACeD trial is to assess the safety and tolerability of KAN-101 in patients, and the secondary endpoint is to assess serum concentrations and pharmacokinetics of KAN-101. Exploratory endpoints include assessing cytokines critical to both innate and adaptive immunity, T cell responses, as well as other serum cytokines and celiac disease symptoms in patients treated with KAN-101. Anokion anticipates reporting preliminary safety and pharmacokinetic data from the SAD cohorts of ACeD later this year. Additional information about the ACeD trial can be found at: www.ACeDtrial.com About KAN-101 KAN-101, an investigational medicine being developed for the treatment of celiac disease, is currently being evaluated in a Phase 1 clinical trial (ACeD study). KAN-101 encompasses a well-described gluten antigen implicated in driving the onset of celiac disease and is designed to re-educate the immune system by targeting the bodys own natural immune pathways in the liver. Anokion has generated preclinical data demonstrating potentially durable, disease-modifying benefit with its immune tolerance platform in multiple animal models of disease. About Celiac Disease Celiac disease is a genetically driven, serious autoimmune disease where inappropriate immune responses to gluten peptides lead to damage of the small intestine.1 The prevalence of celiac disease in adults is approximately 0.40.95% in the United States and 12% in Europe.2 Celiac disease can cause severe symptoms including abdominal pain, diarrhea, nausea and vomiting.3 Long-term complications of celiac disease may include weight loss, osteoporosis, neurological problems and reproductive issues.4 The only treatment available for patients is maintaining a strict, lifelong gluten-free diet and limiting exposure to gluten proteins from wheat, barley and rye, which is oftentimes ineffective.5 About Anokion Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokions distinct approach leverages the companys immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease. For more information, please visit http://www.anokion.com/. ____________________________ 1 www.celiac.org 2 Dub, C. et al. Gastroenterology 128 (Suppl. 1), S57-S67 (2005) 3 www.nationalceliac.org 4 https://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease/symptoms-causes (accessed February 9, 2020) 5 www.celiac.org Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Anokion Announces Initiation of Multiple-Ascending Dose Portion of its Phase 1 Clinical Trial with KAN-101 for the Treatment of Celiac Disease. Preliminary Data from Single-Ascending Dose Cohorts Expected Later this Year.<|eot_id|>

edtsum859

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CALGARY, Alberta--(BUSINESS WIRE)--(TSE:IMO, NYSE American: IMO) Brad Corson, chairman, president and chief executive officer, and Dave Hughes, vice-president investor relations, Imperial Oil Limited, will host a 2020 Fourth Quarter Earnings Call on Tuesday, February 2, following the companys fourth quarter earnings release that morning. The event begins at 9 a.m. MT and will be accessible by webcast. During the call, Mr. Corson will offer brief remarks prior to taking questions from Imperials covering analysts. Please click here [https://edge.media-server.com/mmc/p/95hwd8dj] to register for the live webcast. The webcast will be available for one year on the companys website at www.imperialoil.ca/en-ca/company/investors. After more than a century, Imperial continues to be an industry leader in applying technology and innovation to responsibly develop Canadas energy resources. As Canadas largest petroleum refiner, a major producer of crude oil, a key petrochemical producer and a leading fuels marketer from coast to coast, our company remains committed to high standards across all areas of our business. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Imperial to hold 2020 Fourth Quarter Earnings Call.

CALGARY, Alberta--(BUSINESS WIRE)--(TSE:IMO, NYSE American: IMO) Brad Corson, chairman, president and chief executive officer, and Dave Hughes, vice-president investor relations, Imperial Oil Limited, will host a 2020 Fourth Quarter Earnings Call on Tuesday, February 2, following the companys fourth quarter earnings release that morning. The event begins at 9 a.m. MT and will be accessible by webcast. During the call, Mr. Corson will offer brief remarks prior to taking questions from Imperials covering analysts. Please click here [https://edge.media-server.com/mmc/p/95hwd8dj] to register for the live webcast. The webcast will be available for one year on the companys website at www.imperialoil.ca/en-ca/company/investors. After more than a century, Imperial continues to be an industry leader in applying technology and innovation to responsibly develop Canadas energy resources. As Canadas largest petroleum refiner, a major producer of crude oil, a key petrochemical producer and a leading fuels marketer from coast to coast, our company remains committed to high standards across all areas of our business.

Imperial to hold 2020 Fourth Quarter Earnings Call

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CALGARY, Alberta--(BUSINESS WIRE)--(TSE:IMO, NYSE American: IMO) Brad Corson, chairman, president and chief executive officer, and Dave Hughes, vice-president investor relations, Imperial Oil Limited, will host a 2020 Fourth Quarter Earnings Call on Tuesday, February 2, following the companys fourth quarter earnings release that morning. The event begins at 9 a.m. MT and will be accessible by webcast. During the call, Mr. Corson will offer brief remarks prior to taking questions from Imperials covering analysts. Please click here [https://edge.media-server.com/mmc/p/95hwd8dj] to register for the live webcast. The webcast will be available for one year on the companys website at www.imperialoil.ca/en-ca/company/investors. After more than a century, Imperial continues to be an industry leader in applying technology and innovation to responsibly develop Canadas energy resources. As Canadas largest petroleum refiner, a major producer of crude oil, a key petrochemical producer and a leading fuels marketer from coast to coast, our company remains committed to high standards across all areas of our business. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Imperial to hold 2020 Fourth Quarter Earnings Call.<|eot_id|>

edtsum860

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (MedAvail), a technology-enabled retail pharmacy company driving best in class medication adherence by embedding its pharmacy services directly into Medicare-focused clinics using its proprietary MedCenter solution, today announced that it has opened its hub pharmacy in Detroit and its first SpotRx locations in Michigan. In-clinic SpotRx kiosks and courier home delivery are available to patients at two Oak Street Health clinic locations in the Detroit area. SpotRx Pharmacy is the retail pharmacy brand owned and operated by MedAvail in the United States, which deploys and operates the MedAvail MedCenters. "Our goal is to transform the $300 billion U.S. pharmacy market with a technology-enabled solution utilizing robotics and telemedicine, backed up with localized home delivery," said Ed Kilroy, Chief Executive Officer of MedAvail. "We are thrilled to be bringing our SpotRx technology and concierge services to the Medicare population in Michigan, our third target state. We have a total annual market opportunity of over $2 billion in Michigan with more than 700 potential clinics for our SpotRx solution. MedAvail now has SpotRx pharmacies in Arizona, California, and Michigan. MedAvails SpotRx Pharmacy business is primarily focused on the Medicare (65+ year old) market and the medical clinics where they receive care. The SpotRx MedCenter allows patients to virtually consult with a pharmacist and fill their medications within clinics, eliminating the need to visit a pharmacy. SpotRx also provides patients the option to have their medications delivered to their homes free of charge. The embedded nature of the SpotRx business model allows MedAvail to be a member of the care team improving adherence and health outcomes. MedAvails first fill adherence rates are typically over 85%, which is significantly higher than the average. Medication adherence, in turn, has a significant impact on the Star Rating system used by CMS and the resulting impact on clinic reimbursement. In addition to delivering higher than average first fill adherence rates, MedAvails net promoter score (NPS) of 90+ across patients is indicative of their high level of satisfaction with its pharmacy service. About SpotRx SpotRx is transforming pharmacy by placing control of the pharmacy experience in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability. About MedAvail MedAvail (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com. SOURCE MedAvail Holdings Inc. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

MedAvail Enters Michigan Market. Innovative self-serve pharmacy kiosks now embedded in two clinics.

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (MedAvail), a technology-enabled retail pharmacy company driving best in class medication adherence by embedding its pharmacy services directly into Medicare-focused clinics using its proprietary MedCenter solution, today announced that it has opened its hub pharmacy in Detroit and its first SpotRx locations in Michigan. In-clinic SpotRx kiosks and courier home delivery are available to patients at two Oak Street Health clinic locations in the Detroit area. SpotRx Pharmacy is the retail pharmacy brand owned and operated by MedAvail in the United States, which deploys and operates the MedAvail MedCenters. "Our goal is to transform the $300 billion U.S. pharmacy market with a technology-enabled solution utilizing robotics and telemedicine, backed up with localized home delivery," said Ed Kilroy, Chief Executive Officer of MedAvail. "We are thrilled to be bringing our SpotRx technology and concierge services to the Medicare population in Michigan, our third target state. We have a total annual market opportunity of over $2 billion in Michigan with more than 700 potential clinics for our SpotRx solution. MedAvail now has SpotRx pharmacies in Arizona, California, and Michigan. MedAvails SpotRx Pharmacy business is primarily focused on the Medicare (65+ year old) market and the medical clinics where they receive care. The SpotRx MedCenter allows patients to virtually consult with a pharmacist and fill their medications within clinics, eliminating the need to visit a pharmacy. SpotRx also provides patients the option to have their medications delivered to their homes free of charge. The embedded nature of the SpotRx business model allows MedAvail to be a member of the care team improving adherence and health outcomes. MedAvails first fill adherence rates are typically over 85%, which is significantly higher than the average. Medication adherence, in turn, has a significant impact on the Star Rating system used by CMS and the resulting impact on clinic reimbursement. In addition to delivering higher than average first fill adherence rates, MedAvails net promoter score (NPS) of 90+ across patients is indicative of their high level of satisfaction with its pharmacy service. About SpotRx SpotRx is transforming pharmacy by placing control of the pharmacy experience in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability. About MedAvail MedAvail (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com. SOURCE MedAvail Holdings Inc.

MedAvail Enters Michigan Market Innovative self-serve pharmacy kiosks now embedded in two clinics

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (MedAvail), a technology-enabled retail pharmacy company driving best in class medication adherence by embedding its pharmacy services directly into Medicare-focused clinics using its proprietary MedCenter solution, today announced that it has opened its hub pharmacy in Detroit and its first SpotRx locations in Michigan. In-clinic SpotRx kiosks and courier home delivery are available to patients at two Oak Street Health clinic locations in the Detroit area. SpotRx Pharmacy is the retail pharmacy brand owned and operated by MedAvail in the United States, which deploys and operates the MedAvail MedCenters. "Our goal is to transform the $300 billion U.S. pharmacy market with a technology-enabled solution utilizing robotics and telemedicine, backed up with localized home delivery," said Ed Kilroy, Chief Executive Officer of MedAvail. "We are thrilled to be bringing our SpotRx technology and concierge services to the Medicare population in Michigan, our third target state. We have a total annual market opportunity of over $2 billion in Michigan with more than 700 potential clinics for our SpotRx solution. MedAvail now has SpotRx pharmacies in Arizona, California, and Michigan. MedAvails SpotRx Pharmacy business is primarily focused on the Medicare (65+ year old) market and the medical clinics where they receive care. The SpotRx MedCenter allows patients to virtually consult with a pharmacist and fill their medications within clinics, eliminating the need to visit a pharmacy. SpotRx also provides patients the option to have their medications delivered to their homes free of charge. The embedded nature of the SpotRx business model allows MedAvail to be a member of the care team improving adherence and health outcomes. MedAvails first fill adherence rates are typically over 85%, which is significantly higher than the average. Medication adherence, in turn, has a significant impact on the Star Rating system used by CMS and the resulting impact on clinic reimbursement. In addition to delivering higher than average first fill adherence rates, MedAvails net promoter score (NPS) of 90+ across patients is indicative of their high level of satisfaction with its pharmacy service. About SpotRx SpotRx is transforming pharmacy by placing control of the pharmacy experience in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability. About MedAvail MedAvail (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com. SOURCE MedAvail Holdings Inc. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> MedAvail Enters Michigan Market. Innovative self-serve pharmacy kiosks now embedded in two clinics.<|eot_id|>

edtsum861

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SUZHOU, China, and ROCKVILLE, Md., June 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase II clinical study of the company's novel inhibitor of apoptosis proteins (IAP) antagonist APG-1387 in combination with entecavir for the treatment of patients with CHB has dosed its first patient in China. This global multi-center, open-label Phase II study is designed to evaluate the safety and efficacy of APG-1387 in combination with entecavir in patients with CHB who are treatment-naive or -experienced. The study is designed to enroll 104 patients with CHB globally. According to the 2017 Global Hepatitis Report by the World Health Organization[1], there were around 257 million patients with HBV (hepatitis B virus) infections globally, with approximately 650,000 deaths annually from HBV infection-induced hepatic failure, cirrhosis, and hepatocellular carcinoma. Standard of care treatments for HBV infection recommended by major international guidelines include entecavir, tenofovir disoproxil fumarate, tenofovir alafenamide, and long-acting interferon. However, the current available drugs can achieve clearance of hepatitis B surface antigen (HBsAg) and sustained post-treatment immune response only in a small proportion of patients, while most patients require long-term or even life-long treatments. As a result, there remains a significant unmet medical need for therapies that can effectively treat CHB and minimize the risk of disease progression within a limited duration of treatment. APG-1387 is a novel and highly specific IAP antagonist being developed by Ascentage Pharma. APG-1387 degrades IAPs by mimicking the endogenous second mitochondria-derived activator of caspases (SMAC) molecule to induce programmed cell death or apoptosis. In the course of HBV infection, the virus and inflammatory factors can facilitate molecular expression of cellular inhibitor of apoptosis proteins (cIAPs) in hepatocytes, inhibit cellular immune-mediated apoptosis, and promote the survival of infected hepatocytes, leading to persistent infections[2]. In addition, APG-1387 has demonstrated its ability to suppress and clear HBV infections in various in vivo and in vitro models. APG-1387 is the first IAP antagonist entering clinical stage in China. "Current treatment options for HBV infection are effective in suppressing viral replication, but much less effective in achieving clinical cure (clearance of HBsAg), necessitating long-term, and possibly life-time use of antiviral therapies," said Jinlin Hou, M.D., former President of the Society of Infectious Diseases of Chinese Medical Association (CMA), Director of Nanfang Hospital Liver Cancer of Southern Medical University (Guangzhou, China). "APG-1387 has the potential of clearing HBV infection in patients, and its unique mechanism has suggested a promising new approach to the treatment of CHB. Based on the favorable activity and safety observed in an earlier clinical study of single-agent APG-1387, we are initiating this global Phase II study of APG-1387 in combination with entecavir to further evaluate the therapeutic potential of this combination therapy." "At present, CHB still presents considerable unmet medical needs. As the first IAP antagonist entering clinical stage in China, APG-1387's unique mechanisms in inducing apoptosis and host immune modulations has the potential in delivering a cure to patients with HBV infections," said Dr. Yifan Zhai, Chief Medical Officer of Ascentage Pharma. "We hope our investigation of this combinational therapy will bring new approach to patients with CHB worldwide who are in urgent need for more effective therapies." References [1] WHO, Global Hepatitis Report 2017. [2] Ebert G., et al., Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proc Natl Acad Sci, 2015.112(18): p. 5797-5802 About APG-1387 APG-1387 is a novel small molecule IAP (Inhibitor of Apoptosis Protein) antagonist, that was discovered and is being developed by Ascentage Pharma. APG-1387 degrades IAPs by mimicking endogenous SMAC molecule to induce programmed cell death or apoptosis. Ascentage Pharma is developing APG-1387 globally, and has completed Phase I dose-escalation trials in patients with solid tumors in China and Australia, and a Phase Ib/II clinical trial of APG-1387 and pembrolizumab combination is currently ongoing in the US. In addition, APG-1387 is also being investigated in a Phase Ib trial for the treatment of patients with Chronic Hepatitis B (CHB) in China. In February 2020, Ascentage Pharma was cleared to initiate a Phase Ib/II study of APG-1387 in combination with nab-paclitaxel plus gemcitabine for the treatment of advanced pancreatic cancer. In April 2020, the company received clearance for a Phase II study of APG-1387 in combination with entecavir for the treatment of CHB. About Ascentage Pharma Ascentage Pharma (6855.HK) is a globally, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and age-related diseases. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 6855.HK. Ascentage Pharma focuses on developing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company has built a pipeline of eight clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. Ascentage Pharma is also the only company in the world with active clinical programs targeting all three known classes of key apoptosis regulators. The company is conducting more than 30 Phase I/II clinical trials in the US, Australia, and China. The company's core drug candidate HQP1351 is in pivotal Phase II studies in China for the treatment of drug-resistant chronic myeloid leukemia, and recently granted orphan drug and fast-track designations by the US Food and Drug Administration (FDA). Forward-Looking Statements The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. SOURCE Ascentage Pharma Related Links www.healthquearma.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Ascentage Pharma announces first patient dosed in the Phase II clinical study of IAP antagonist APG-1387 in combination with entecavir for the treatment of patients with chronic hepatitis B.

SUZHOU, China, and ROCKVILLE, Md., June 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase II clinical study of the company's novel inhibitor of apoptosis proteins (IAP) antagonist APG-1387 in combination with entecavir for the treatment of patients with CHB has dosed its first patient in China. This global multi-center, open-label Phase II study is designed to evaluate the safety and efficacy of APG-1387 in combination with entecavir in patients with CHB who are treatment-naive or -experienced. The study is designed to enroll 104 patients with CHB globally. According to the 2017 Global Hepatitis Report by the World Health Organization[1], there were around 257 million patients with HBV (hepatitis B virus) infections globally, with approximately 650,000 deaths annually from HBV infection-induced hepatic failure, cirrhosis, and hepatocellular carcinoma. Standard of care treatments for HBV infection recommended by major international guidelines include entecavir, tenofovir disoproxil fumarate, tenofovir alafenamide, and long-acting interferon. However, the current available drugs can achieve clearance of hepatitis B surface antigen (HBsAg) and sustained post-treatment immune response only in a small proportion of patients, while most patients require long-term or even life-long treatments. As a result, there remains a significant unmet medical need for therapies that can effectively treat CHB and minimize the risk of disease progression within a limited duration of treatment. APG-1387 is a novel and highly specific IAP antagonist being developed by Ascentage Pharma. APG-1387 degrades IAPs by mimicking the endogenous second mitochondria-derived activator of caspases (SMAC) molecule to induce programmed cell death or apoptosis. In the course of HBV infection, the virus and inflammatory factors can facilitate molecular expression of cellular inhibitor of apoptosis proteins (cIAPs) in hepatocytes, inhibit cellular immune-mediated apoptosis, and promote the survival of infected hepatocytes, leading to persistent infections[2]. In addition, APG-1387 has demonstrated its ability to suppress and clear HBV infections in various in vivo and in vitro models. APG-1387 is the first IAP antagonist entering clinical stage in China. "Current treatment options for HBV infection are effective in suppressing viral replication, but much less effective in achieving clinical cure (clearance of HBsAg), necessitating long-term, and possibly life-time use of antiviral therapies," said Jinlin Hou, M.D., former President of the Society of Infectious Diseases of Chinese Medical Association (CMA), Director of Nanfang Hospital Liver Cancer of Southern Medical University (Guangzhou, China). "APG-1387 has the potential of clearing HBV infection in patients, and its unique mechanism has suggested a promising new approach to the treatment of CHB. Based on the favorable activity and safety observed in an earlier clinical study of single-agent APG-1387, we are initiating this global Phase II study of APG-1387 in combination with entecavir to further evaluate the therapeutic potential of this combination therapy." "At present, CHB still presents considerable unmet medical needs. As the first IAP antagonist entering clinical stage in China, APG-1387's unique mechanisms in inducing apoptosis and host immune modulations has the potential in delivering a cure to patients with HBV infections," said Dr. Yifan Zhai, Chief Medical Officer of Ascentage Pharma. "We hope our investigation of this combinational therapy will bring new approach to patients with CHB worldwide who are in urgent need for more effective therapies." References [1] WHO, Global Hepatitis Report 2017. [2] Ebert G., et al., Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proc Natl Acad Sci, 2015.112(18): p. 5797-5802 About APG-1387 APG-1387 is a novel small molecule IAP (Inhibitor of Apoptosis Protein) antagonist, that was discovered and is being developed by Ascentage Pharma. APG-1387 degrades IAPs by mimicking endogenous SMAC molecule to induce programmed cell death or apoptosis. Ascentage Pharma is developing APG-1387 globally, and has completed Phase I dose-escalation trials in patients with solid tumors in China and Australia, and a Phase Ib/II clinical trial of APG-1387 and pembrolizumab combination is currently ongoing in the US. In addition, APG-1387 is also being investigated in a Phase Ib trial for the treatment of patients with Chronic Hepatitis B (CHB) in China. In February 2020, Ascentage Pharma was cleared to initiate a Phase Ib/II study of APG-1387 in combination with nab-paclitaxel plus gemcitabine for the treatment of advanced pancreatic cancer. In April 2020, the company received clearance for a Phase II study of APG-1387 in combination with entecavir for the treatment of CHB. About Ascentage Pharma Ascentage Pharma (6855.HK) is a globally, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and age-related diseases. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 6855.HK. Ascentage Pharma focuses on developing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company has built a pipeline of eight clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. Ascentage Pharma is also the only company in the world with active clinical programs targeting all three known classes of key apoptosis regulators. The company is conducting more than 30 Phase I/II clinical trials in the US, Australia, and China. The company's core drug candidate HQP1351 is in pivotal Phase II studies in China for the treatment of drug-resistant chronic myeloid leukemia, and recently granted orphan drug and fast-track designations by the US Food and Drug Administration (FDA). Forward-Looking Statements The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. SOURCE Ascentage Pharma Related Links www.healthquearma.com

Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SUZHOU, China, and ROCKVILLE, Md., June 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase II clinical study of the company's novel inhibitor of apoptosis proteins (IAP) antagonist APG-1387 in combination with entecavir for the treatment of patients with CHB has dosed its first patient in China. This global multi-center, open-label Phase II study is designed to evaluate the safety and efficacy of APG-1387 in combination with entecavir in patients with CHB who are treatment-naive or -experienced. The study is designed to enroll 104 patients with CHB globally. According to the 2017 Global Hepatitis Report by the World Health Organization[1], there were around 257 million patients with HBV (hepatitis B virus) infections globally, with approximately 650,000 deaths annually from HBV infection-induced hepatic failure, cirrhosis, and hepatocellular carcinoma. Standard of care treatments for HBV infection recommended by major international guidelines include entecavir, tenofovir disoproxil fumarate, tenofovir alafenamide, and long-acting interferon. However, the current available drugs can achieve clearance of hepatitis B surface antigen (HBsAg) and sustained post-treatment immune response only in a small proportion of patients, while most patients require long-term or even life-long treatments. As a result, there remains a significant unmet medical need for therapies that can effectively treat CHB and minimize the risk of disease progression within a limited duration of treatment. APG-1387 is a novel and highly specific IAP antagonist being developed by Ascentage Pharma. APG-1387 degrades IAPs by mimicking the endogenous second mitochondria-derived activator of caspases (SMAC) molecule to induce programmed cell death or apoptosis. In the course of HBV infection, the virus and inflammatory factors can facilitate molecular expression of cellular inhibitor of apoptosis proteins (cIAPs) in hepatocytes, inhibit cellular immune-mediated apoptosis, and promote the survival of infected hepatocytes, leading to persistent infections[2]. In addition, APG-1387 has demonstrated its ability to suppress and clear HBV infections in various in vivo and in vitro models. APG-1387 is the first IAP antagonist entering clinical stage in China. "Current treatment options for HBV infection are effective in suppressing viral replication, but much less effective in achieving clinical cure (clearance of HBsAg), necessitating long-term, and possibly life-time use of antiviral therapies," said Jinlin Hou, M.D., former President of the Society of Infectious Diseases of Chinese Medical Association (CMA), Director of Nanfang Hospital Liver Cancer of Southern Medical University (Guangzhou, China). "APG-1387 has the potential of clearing HBV infection in patients, and its unique mechanism has suggested a promising new approach to the treatment of CHB. Based on the favorable activity and safety observed in an earlier clinical study of single-agent APG-1387, we are initiating this global Phase II study of APG-1387 in combination with entecavir to further evaluate the therapeutic potential of this combination therapy." "At present, CHB still presents considerable unmet medical needs. As the first IAP antagonist entering clinical stage in China, APG-1387's unique mechanisms in inducing apoptosis and host immune modulations has the potential in delivering a cure to patients with HBV infections," said Dr. Yifan Zhai, Chief Medical Officer of Ascentage Pharma. "We hope our investigation of this combinational therapy will bring new approach to patients with CHB worldwide who are in urgent need for more effective therapies." References [1] WHO, Global Hepatitis Report 2017. [2] Ebert G., et al., Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proc Natl Acad Sci, 2015.112(18): p. 5797-5802 About APG-1387 APG-1387 is a novel small molecule IAP (Inhibitor of Apoptosis Protein) antagonist, that was discovered and is being developed by Ascentage Pharma. APG-1387 degrades IAPs by mimicking endogenous SMAC molecule to induce programmed cell death or apoptosis. Ascentage Pharma is developing APG-1387 globally, and has completed Phase I dose-escalation trials in patients with solid tumors in China and Australia, and a Phase Ib/II clinical trial of APG-1387 and pembrolizumab combination is currently ongoing in the US. In addition, APG-1387 is also being investigated in a Phase Ib trial for the treatment of patients with Chronic Hepatitis B (CHB) in China. In February 2020, Ascentage Pharma was cleared to initiate a Phase Ib/II study of APG-1387 in combination with nab-paclitaxel plus gemcitabine for the treatment of advanced pancreatic cancer. In April 2020, the company received clearance for a Phase II study of APG-1387 in combination with entecavir for the treatment of CHB. About Ascentage Pharma Ascentage Pharma (6855.HK) is a globally, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and age-related diseases. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 6855.HK. Ascentage Pharma focuses on developing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company has built a pipeline of eight clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. Ascentage Pharma is also the only company in the world with active clinical programs targeting all three known classes of key apoptosis regulators. The company is conducting more than 30 Phase I/II clinical trials in the US, Australia, and China. The company's core drug candidate HQP1351 is in pivotal Phase II studies in China for the treatment of drug-resistant chronic myeloid leukemia, and recently granted orphan drug and fast-track designations by the US Food and Drug Administration (FDA). Forward-Looking Statements The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. SOURCE Ascentage Pharma Related Links www.healthquearma.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Ascentage Pharma announces first patient dosed in the Phase II clinical study of IAP antagonist APG-1387 in combination with entecavir for the treatment of patients with chronic hepatitis B.<|eot_id|>

edtsum862

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: OSLO, Norway, Feb. 15, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immune-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that its lead clinical candidate ONCOS-102 has received Fast-Track designation in malignant pleural mesothelioma from the US FDA. The US FDA granted Fast-Track designation to ONCOS-102 based on encouraging pre-clinical and clinical efficacy associated with broad immune activation observed to date. Receiving this designation is an endorsement by the US FDA of the strength of the ONCOS-102 data package. The FDA Fast Track-designation is awarded to therapies with potential to address unmet medical needs in serious medical conditions and allows for more frequent interactions with the FDA to expedite clinical development, as well as the regulatory review processes. Fast-Track products have improved likelihood of receiving Priority Review for a future Biologics License Application (BLA) and may be allowed to submit parts of the application early to shorten review time. The Fast-Track approval comes in addition to ONCOS-102's existing Orphan Drug Designation (ODD) with both the US FDA and European EMA in the mesothelioma indication, which provides ONCOS-102 market exclusivity for 7 and 10 years in the USA and EU, respectively, from the date of BLA grant. Dr. Ingunn Munch Lindvig, VP Regulatory Affairs, said:"Securing this Fast-Track designation is a very important milestone for the ONCOS-102 program. Most importantly Fast-Track validates the strong potential of ONCOS-102 as a future treatment option for solid tumors with high unmet medical need". For further information, please contact:Renate Birkeli, Investor RelationsPhone: +47 922 61 624Email: [emailprotected] Media enquires:Andreas Tinglum - Corporate Communications (Norway)Phone: +47 9300 1773Email: [emailprotected] IR enquires:Kim Sutton Golodetz - LHA Investor Relations (US)Email: [emailprotected]Phone: +1 212-838-3777 This information was brought to you by Cision http://news.cision.com https://news.cision.com/targovax/r/targovax-receives-fast-track-designation-for-oncos-102,c3286718 SOURCE Targovax Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Targovax receives Fast-Track designation for ONCOS-102.

OSLO, Norway, Feb. 15, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immune-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that its lead clinical candidate ONCOS-102 has received Fast-Track designation in malignant pleural mesothelioma from the US FDA. The US FDA granted Fast-Track designation to ONCOS-102 based on encouraging pre-clinical and clinical efficacy associated with broad immune activation observed to date. Receiving this designation is an endorsement by the US FDA of the strength of the ONCOS-102 data package. The FDA Fast Track-designation is awarded to therapies with potential to address unmet medical needs in serious medical conditions and allows for more frequent interactions with the FDA to expedite clinical development, as well as the regulatory review processes. Fast-Track products have improved likelihood of receiving Priority Review for a future Biologics License Application (BLA) and may be allowed to submit parts of the application early to shorten review time. The Fast-Track approval comes in addition to ONCOS-102's existing Orphan Drug Designation (ODD) with both the US FDA and European EMA in the mesothelioma indication, which provides ONCOS-102 market exclusivity for 7 and 10 years in the USA and EU, respectively, from the date of BLA grant. Dr. Ingunn Munch Lindvig, VP Regulatory Affairs, said:"Securing this Fast-Track designation is a very important milestone for the ONCOS-102 program. Most importantly Fast-Track validates the strong potential of ONCOS-102 as a future treatment option for solid tumors with high unmet medical need". For further information, please contact:Renate Birkeli, Investor RelationsPhone: +47 922 61 624Email: [emailprotected] Media enquires:Andreas Tinglum - Corporate Communications (Norway)Phone: +47 9300 1773Email: [emailprotected] IR enquires:Kim Sutton Golodetz - LHA Investor Relations (US)Email: [emailprotected]Phone: +1 212-838-3777 This information was brought to you by Cision http://news.cision.com https://news.cision.com/targovax/r/targovax-receives-fast-track-designation-for-oncos-102,c3286718 SOURCE Targovax

Targovax receives Fast-Track designation for ONCOS-102

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: OSLO, Norway, Feb. 15, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immune-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that its lead clinical candidate ONCOS-102 has received Fast-Track designation in malignant pleural mesothelioma from the US FDA. The US FDA granted Fast-Track designation to ONCOS-102 based on encouraging pre-clinical and clinical efficacy associated with broad immune activation observed to date. Receiving this designation is an endorsement by the US FDA of the strength of the ONCOS-102 data package. The FDA Fast Track-designation is awarded to therapies with potential to address unmet medical needs in serious medical conditions and allows for more frequent interactions with the FDA to expedite clinical development, as well as the regulatory review processes. Fast-Track products have improved likelihood of receiving Priority Review for a future Biologics License Application (BLA) and may be allowed to submit parts of the application early to shorten review time. The Fast-Track approval comes in addition to ONCOS-102's existing Orphan Drug Designation (ODD) with both the US FDA and European EMA in the mesothelioma indication, which provides ONCOS-102 market exclusivity for 7 and 10 years in the USA and EU, respectively, from the date of BLA grant. Dr. Ingunn Munch Lindvig, VP Regulatory Affairs, said:"Securing this Fast-Track designation is a very important milestone for the ONCOS-102 program. Most importantly Fast-Track validates the strong potential of ONCOS-102 as a future treatment option for solid tumors with high unmet medical need". For further information, please contact:Renate Birkeli, Investor RelationsPhone: +47 922 61 624Email: [emailprotected] Media enquires:Andreas Tinglum - Corporate Communications (Norway)Phone: +47 9300 1773Email: [emailprotected] IR enquires:Kim Sutton Golodetz - LHA Investor Relations (US)Email: [emailprotected]Phone: +1 212-838-3777 This information was brought to you by Cision http://news.cision.com https://news.cision.com/targovax/r/targovax-receives-fast-track-designation-for-oncos-102,c3286718 SOURCE Targovax Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Targovax receives Fast-Track designation for ONCOS-102.<|eot_id|>

edtsum863

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, April 14, 2021 /PRNewswire/ --MediaMath, a leading global independent advertising technology company for brands and agencies, today announced the addition of several industry veterans to its leadership team, as the company continues on its journey toward delivering the most responsive and accountable advertising technology for brands and agencies to buy addressable media. MediaMath welcomes Ingrid Hackett as General Counsel, Ashish Shukla as Chief Technology Officer and Laurent Cordier as Chief Partnerships Officer. MediaMath "I am thrilled to welcome Ingrid, Ashish and Laurent to our leadership team. They bring broad experience across the advertising, digital media and technology space, as well as deep expertise in their specific focus areas," said Konrad Gerszke, President, MediaMath. "We continue to invest in and attract top-tier talent that helps us execute against the areas that are top of mind for our clients: A future-proofed platform with a flexible identity core, modernized workflows, updated intelligence and CTV solutions that is connected to SOURCE, a curated ecosystem that delivers better signals and improves outcomes for our clients." Ingrid Hackett, General Counsel Ingrid Hackett is a seasoned corporate attorney with extensive leadership experience in Fortune 100 companies. As General Counsel for MediaMath, she will provide guidance to management and the senior leadership team to help the company navigate the constantly evolving regulatory and privacy environment. She will partner with the leadership team to determine the right strategic outcomes for MediaMath and build out legal processes supporting our growth. She will also work closely with our Client Success and Partnerships teams to facilitate client and partnership deals. Hackett will oversee MediaMath's combined Legal and Data Policy & Governanceteams. "Over the last years, the ad-tech industry has faced new challenges with the impending demise of third-party cookies, the accelerating shift from linear to connected TV, and the proliferation of misinformation. MediaMath has a clear vision for the future of the digital advertising industry that is rooted in accountability and transparency," said Ingrid Hackett, General Counsel, MediaMath. "That vision is what drew me to MediaMath. I am thrilled to be joining the team at this exciting point in the company's journey, and to help guide the company as it continues to grow and scale." Ashish Shukla, Chief Technology OfficerAshish Shukla joins MediaMath with more than 20 years of experience leading global engineering organizations, including his most recent role as Head of Architecture at PayPal, where he led the global architecture team and was responsible for the technical vision and architecture of AI based Global Fraud & Risk platforms. Previously, Shukla held leadership positions at Yahoo!, Verisign, Cisco, and HP, leading engineering teams and delivering product innovation to customers. Shukla's experience in overseeing global development, management, and utilization of large-scale advertising architectures, data platforms and AI systems will be vital to his new role at MediaMath. As Chief Technology Officer, Shukla will provide the technical vision for our roadmap, lead the alignment of our engineering culture towards business objectives for product development, act as the technical liaison for key client relationships and develop a people strategy that will enhance MediaMath as a world-class technology organization."Throughout my career, I've developed deep experience in data-centric product innovation and cultivated a strong knowledge of the ad-tech space," said Ashish Shukla, Chief Technology Officer of MediaMath. "MediaMath's mission to connect a future-proofed omnichannel platform to an accountable, addressable and aligned media supply chain and digital media ecosystem is something I am passionate about being a part of. I am honored to join a company with an ambitious transformation agenda, a client centric vision and a world-class, talented team."Laurent Cordier, Chief Partnerships OfficerLaurent Cordier brings a wealth of industry expertise and knowledge to the role of Chief Partnerships Officer for MediaMath, including strong global operating experience, and running P&Ls at high-growth digital companies for over 20 years. Prior to MediaMath, Cordier served as Managing Director for Google's Partners Solutions Business in North America and globally, working extensively with key players across the programmatic ecosystem. Cordier also served in various sales and business development roles at KPMG and Dell, and most recently was CRO for HeadSpin, a digital experience platform. As MediaMath's Chief Partnerships Officer, Cordier will help shape, build, and evolve our partnership strategy across the digital media ecosystem and will be responsible for the development and execution of global media, data, and technology partnerships in support of our clients' marketers and agencies alike digital marketing strategies."MediaMath strives to deliver better outcomes for marketers and publishers and is modernizing the technical and commercial connections and integrations along the digital advertising supply chain. This delivers better signals and improves supply path optimization, algorithm decisioning, and helps our clients improve their return on ad spend. Deep partnerships will continue to be paramount for achieving better outcomes," Laurent Cordier said. "I am driven by MediaMath's strategic vision and its commitment to a modernized partner ecosystem. I very much look forward to being a part of the company's journey and to work closely with MediaMath's partners around the globe to bring this vision to life." About MediaMathMediaMath is a leading global independent advertising technology company, helping brands deliver personalized advertising across all digital touchpoints. We offer our clients a smart marketing platform which is truly omnichannel, provides the user with intelligent recommendations, and allows for creating turnkey verticalized solutions enabling measurable marketing outcomes in a privacy-first, cookie-less world. Over 9,500 marketers in 42 countries use our demand-side platform every day to plan, execute, analyze, and optimize their digital advertising campaigns across display, native, mobile, video, audio, digital out-of-home, and connected TV formats. MediaMath has offices in 15 cities worldwide and is headquartered in New York City. To learn more follow us Twitter, on LinkedIn or visit www.mediamath.com. CONTACT: Masha Krylova, [emailprotected]SOURCE MediaMath Related Links http://www.mediamath.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

MediaMath bolsters leadership team with appointment of industry veterans Ingrid Hackett as General Counsel, Ashish Shukla as Chief Technology Officer, and Laurent Cordier as Chief Partnerships Officer.

NEW YORK, April 14, 2021 /PRNewswire/ --MediaMath, a leading global independent advertising technology company for brands and agencies, today announced the addition of several industry veterans to its leadership team, as the company continues on its journey toward delivering the most responsive and accountable advertising technology for brands and agencies to buy addressable media. MediaMath welcomes Ingrid Hackett as General Counsel, Ashish Shukla as Chief Technology Officer and Laurent Cordier as Chief Partnerships Officer. MediaMath "I am thrilled to welcome Ingrid, Ashish and Laurent to our leadership team. They bring broad experience across the advertising, digital media and technology space, as well as deep expertise in their specific focus areas," said Konrad Gerszke, President, MediaMath. "We continue to invest in and attract top-tier talent that helps us execute against the areas that are top of mind for our clients: A future-proofed platform with a flexible identity core, modernized workflows, updated intelligence and CTV solutions that is connected to SOURCE, a curated ecosystem that delivers better signals and improves outcomes for our clients." Ingrid Hackett, General Counsel Ingrid Hackett is a seasoned corporate attorney with extensive leadership experience in Fortune 100 companies. As General Counsel for MediaMath, she will provide guidance to management and the senior leadership team to help the company navigate the constantly evolving regulatory and privacy environment. She will partner with the leadership team to determine the right strategic outcomes for MediaMath and build out legal processes supporting our growth. She will also work closely with our Client Success and Partnerships teams to facilitate client and partnership deals. Hackett will oversee MediaMath's combined Legal and Data Policy & Governanceteams. "Over the last years, the ad-tech industry has faced new challenges with the impending demise of third-party cookies, the accelerating shift from linear to connected TV, and the proliferation of misinformation. MediaMath has a clear vision for the future of the digital advertising industry that is rooted in accountability and transparency," said Ingrid Hackett, General Counsel, MediaMath. "That vision is what drew me to MediaMath. I am thrilled to be joining the team at this exciting point in the company's journey, and to help guide the company as it continues to grow and scale." Ashish Shukla, Chief Technology OfficerAshish Shukla joins MediaMath with more than 20 years of experience leading global engineering organizations, including his most recent role as Head of Architecture at PayPal, where he led the global architecture team and was responsible for the technical vision and architecture of AI based Global Fraud & Risk platforms. Previously, Shukla held leadership positions at Yahoo!, Verisign, Cisco, and HP, leading engineering teams and delivering product innovation to customers. Shukla's experience in overseeing global development, management, and utilization of large-scale advertising architectures, data platforms and AI systems will be vital to his new role at MediaMath. As Chief Technology Officer, Shukla will provide the technical vision for our roadmap, lead the alignment of our engineering culture towards business objectives for product development, act as the technical liaison for key client relationships and develop a people strategy that will enhance MediaMath as a world-class technology organization."Throughout my career, I've developed deep experience in data-centric product innovation and cultivated a strong knowledge of the ad-tech space," said Ashish Shukla, Chief Technology Officer of MediaMath. "MediaMath's mission to connect a future-proofed omnichannel platform to an accountable, addressable and aligned media supply chain and digital media ecosystem is something I am passionate about being a part of. I am honored to join a company with an ambitious transformation agenda, a client centric vision and a world-class, talented team."Laurent Cordier, Chief Partnerships OfficerLaurent Cordier brings a wealth of industry expertise and knowledge to the role of Chief Partnerships Officer for MediaMath, including strong global operating experience, and running P&Ls at high-growth digital companies for over 20 years. Prior to MediaMath, Cordier served as Managing Director for Google's Partners Solutions Business in North America and globally, working extensively with key players across the programmatic ecosystem. Cordier also served in various sales and business development roles at KPMG and Dell, and most recently was CRO for HeadSpin, a digital experience platform. As MediaMath's Chief Partnerships Officer, Cordier will help shape, build, and evolve our partnership strategy across the digital media ecosystem and will be responsible for the development and execution of global media, data, and technology partnerships in support of our clients' marketers and agencies alike digital marketing strategies."MediaMath strives to deliver better outcomes for marketers and publishers and is modernizing the technical and commercial connections and integrations along the digital advertising supply chain. This delivers better signals and improves supply path optimization, algorithm decisioning, and helps our clients improve their return on ad spend. Deep partnerships will continue to be paramount for achieving better outcomes," Laurent Cordier said. "I am driven by MediaMath's strategic vision and its commitment to a modernized partner ecosystem. I very much look forward to being a part of the company's journey and to work closely with MediaMath's partners around the globe to bring this vision to life." About MediaMathMediaMath is a leading global independent advertising technology company, helping brands deliver personalized advertising across all digital touchpoints. We offer our clients a smart marketing platform which is truly omnichannel, provides the user with intelligent recommendations, and allows for creating turnkey verticalized solutions enabling measurable marketing outcomes in a privacy-first, cookie-less world. Over 9,500 marketers in 42 countries use our demand-side platform every day to plan, execute, analyze, and optimize their digital advertising campaigns across display, native, mobile, video, audio, digital out-of-home, and connected TV formats. MediaMath has offices in 15 cities worldwide and is headquartered in New York City. To learn more follow us Twitter, on LinkedIn or visit www.mediamath.com. CONTACT: Masha Krylova, [emailprotected]SOURCE MediaMath Related Links http://www.mediamath.com

MediaMath Bolsters Leadership Team with Appointment of Industry Veterans Ingrid Hackett as General Counsel, Ashish Shukla as Chief Technology Officer and Laurent Cordier as Chief Partnerships Officer

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, April 14, 2021 /PRNewswire/ --MediaMath, a leading global independent advertising technology company for brands and agencies, today announced the addition of several industry veterans to its leadership team, as the company continues on its journey toward delivering the most responsive and accountable advertising technology for brands and agencies to buy addressable media. MediaMath welcomes Ingrid Hackett as General Counsel, Ashish Shukla as Chief Technology Officer and Laurent Cordier as Chief Partnerships Officer. MediaMath "I am thrilled to welcome Ingrid, Ashish and Laurent to our leadership team. They bring broad experience across the advertising, digital media and technology space, as well as deep expertise in their specific focus areas," said Konrad Gerszke, President, MediaMath. "We continue to invest in and attract top-tier talent that helps us execute against the areas that are top of mind for our clients: A future-proofed platform with a flexible identity core, modernized workflows, updated intelligence and CTV solutions that is connected to SOURCE, a curated ecosystem that delivers better signals and improves outcomes for our clients." Ingrid Hackett, General Counsel Ingrid Hackett is a seasoned corporate attorney with extensive leadership experience in Fortune 100 companies. As General Counsel for MediaMath, she will provide guidance to management and the senior leadership team to help the company navigate the constantly evolving regulatory and privacy environment. She will partner with the leadership team to determine the right strategic outcomes for MediaMath and build out legal processes supporting our growth. She will also work closely with our Client Success and Partnerships teams to facilitate client and partnership deals. Hackett will oversee MediaMath's combined Legal and Data Policy & Governanceteams. "Over the last years, the ad-tech industry has faced new challenges with the impending demise of third-party cookies, the accelerating shift from linear to connected TV, and the proliferation of misinformation. MediaMath has a clear vision for the future of the digital advertising industry that is rooted in accountability and transparency," said Ingrid Hackett, General Counsel, MediaMath. "That vision is what drew me to MediaMath. I am thrilled to be joining the team at this exciting point in the company's journey, and to help guide the company as it continues to grow and scale." Ashish Shukla, Chief Technology OfficerAshish Shukla joins MediaMath with more than 20 years of experience leading global engineering organizations, including his most recent role as Head of Architecture at PayPal, where he led the global architecture team and was responsible for the technical vision and architecture of AI based Global Fraud & Risk platforms. Previously, Shukla held leadership positions at Yahoo!, Verisign, Cisco, and HP, leading engineering teams and delivering product innovation to customers. Shukla's experience in overseeing global development, management, and utilization of large-scale advertising architectures, data platforms and AI systems will be vital to his new role at MediaMath. As Chief Technology Officer, Shukla will provide the technical vision for our roadmap, lead the alignment of our engineering culture towards business objectives for product development, act as the technical liaison for key client relationships and develop a people strategy that will enhance MediaMath as a world-class technology organization."Throughout my career, I've developed deep experience in data-centric product innovation and cultivated a strong knowledge of the ad-tech space," said Ashish Shukla, Chief Technology Officer of MediaMath. "MediaMath's mission to connect a future-proofed omnichannel platform to an accountable, addressable and aligned media supply chain and digital media ecosystem is something I am passionate about being a part of. I am honored to join a company with an ambitious transformation agenda, a client centric vision and a world-class, talented team."Laurent Cordier, Chief Partnerships OfficerLaurent Cordier brings a wealth of industry expertise and knowledge to the role of Chief Partnerships Officer for MediaMath, including strong global operating experience, and running P&Ls at high-growth digital companies for over 20 years. Prior to MediaMath, Cordier served as Managing Director for Google's Partners Solutions Business in North America and globally, working extensively with key players across the programmatic ecosystem. Cordier also served in various sales and business development roles at KPMG and Dell, and most recently was CRO for HeadSpin, a digital experience platform. As MediaMath's Chief Partnerships Officer, Cordier will help shape, build, and evolve our partnership strategy across the digital media ecosystem and will be responsible for the development and execution of global media, data, and technology partnerships in support of our clients' marketers and agencies alike digital marketing strategies."MediaMath strives to deliver better outcomes for marketers and publishers and is modernizing the technical and commercial connections and integrations along the digital advertising supply chain. This delivers better signals and improves supply path optimization, algorithm decisioning, and helps our clients improve their return on ad spend. Deep partnerships will continue to be paramount for achieving better outcomes," Laurent Cordier said. "I am driven by MediaMath's strategic vision and its commitment to a modernized partner ecosystem. I very much look forward to being a part of the company's journey and to work closely with MediaMath's partners around the globe to bring this vision to life." About MediaMathMediaMath is a leading global independent advertising technology company, helping brands deliver personalized advertising across all digital touchpoints. We offer our clients a smart marketing platform which is truly omnichannel, provides the user with intelligent recommendations, and allows for creating turnkey verticalized solutions enabling measurable marketing outcomes in a privacy-first, cookie-less world. Over 9,500 marketers in 42 countries use our demand-side platform every day to plan, execute, analyze, and optimize their digital advertising campaigns across display, native, mobile, video, audio, digital out-of-home, and connected TV formats. MediaMath has offices in 15 cities worldwide and is headquartered in New York City. To learn more follow us Twitter, on LinkedIn or visit www.mediamath.com. CONTACT: Masha Krylova, [emailprotected]SOURCE MediaMath Related Links http://www.mediamath.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> MediaMath bolsters leadership team with appointment of industry veterans Ingrid Hackett as General Counsel, Ashish Shukla as Chief Technology Officer, and Laurent Cordier as Chief Partnerships Officer.<|eot_id|>

edtsum864

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: PITTSBURGH, Oct. 12, 2020 /PRNewswire/ -- "I wanted to create a more convenient way for parents to control the warmth of their child while traveling," said an inventor, from Bronx, N.Y., "so I invented the THERMAL COMFORT." The patent-pending invention provides an effective way to keep a baby or child warm while seated in a car seat or stroller. In doing so, it offers an alternative to traditional blankets or heavy coats. As a result, it enhances comfort and warmth and it could provide added protection and peace of mind. The invention features a user-friendly design that is convenient and easy to use so it is ideal for parents with infants, toddlers and young children. Additionally, it is producible in design variations for adults. The inventor described the invention design. "My design enables a child or baby to stay warm and safe in their seat without having to wear a heavy coat or bulky snowsuit." The original design was submitted to the Manhattan sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-MTN-3492, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

InventHelp Inventor Develops Convenient and Comfortable Warming Accessory (MTN-3492).

PITTSBURGH, Oct. 12, 2020 /PRNewswire/ -- "I wanted to create a more convenient way for parents to control the warmth of their child while traveling," said an inventor, from Bronx, N.Y., "so I invented the THERMAL COMFORT." The patent-pending invention provides an effective way to keep a baby or child warm while seated in a car seat or stroller. In doing so, it offers an alternative to traditional blankets or heavy coats. As a result, it enhances comfort and warmth and it could provide added protection and peace of mind. The invention features a user-friendly design that is convenient and easy to use so it is ideal for parents with infants, toddlers and young children. Additionally, it is producible in design variations for adults. The inventor described the invention design. "My design enables a child or baby to stay warm and safe in their seat without having to wear a heavy coat or bulky snowsuit." The original design was submitted to the Manhattan sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-MTN-3492, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com

InventHelp Inventor Develops Convenient and Comfortable Warming Accessory (MTN-3492)

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: PITTSBURGH, Oct. 12, 2020 /PRNewswire/ -- "I wanted to create a more convenient way for parents to control the warmth of their child while traveling," said an inventor, from Bronx, N.Y., "so I invented the THERMAL COMFORT." The patent-pending invention provides an effective way to keep a baby or child warm while seated in a car seat or stroller. In doing so, it offers an alternative to traditional blankets or heavy coats. As a result, it enhances comfort and warmth and it could provide added protection and peace of mind. The invention features a user-friendly design that is convenient and easy to use so it is ideal for parents with infants, toddlers and young children. Additionally, it is producible in design variations for adults. The inventor described the invention design. "My design enables a child or baby to stay warm and safe in their seat without having to wear a heavy coat or bulky snowsuit." The original design was submitted to the Manhattan sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-MTN-3492, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> InventHelp Inventor Develops Convenient and Comfortable Warming Accessory (MTN-3492).<|eot_id|>

edtsum865

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CHICAGO, Aug. 26, 2020 /PRNewswire/ -- According to the new market research report "Commercial Touch Display Marketby Product (Monitors, Signage Displays, POS Terminals, Open Frame Touchscreen Displays, and Medical Displays), Touch Technology, Resolution, Application, Size, Aspect Ratio, Industry, and Geography - Global Forecast to 2025", published by MarketsandMarkets, the Commercial Touch Display Marketsize was valued at USD 4.3 billion in 2020 and is projected to reach USD 7.6 billion by 2025. It is expected to grow at a CAGR of 12.1% during the forecast period. High adoption of touchscreen displays in retail, hospitality, healthcare, and transportation verticals, dynamic nature of touchscreen displays leads to enhanced customer experience, and rapid adoption of technologically advanced, energy-efficient, attractive, and high-end-specification display products are the key driving factors for the commercial touch display market. Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=459 Open frame touchscreen to account for the largest share of the commercial touch display market Open frame touchscreen displays accounted for the largest share of the commercial touch display market in 2019, and a similar trendis likely to be observed in the coming years owing to the high demand for these products to install at several places, such as retail stores, airports, hospitals, school campuses, government offices, and entertainment places. These displays are used for various functions, such as ticketing,food vending, cash dispensing, and check-in. Due to rapid advancements in technology, companies focus on developing innovative products with a variety of additional features. Researchers associated with different companies are focusing on integrating new technologies in conventional open frame touchscreen displays to make them user-friendly and interactive. Artificial intelligence (AI) is one such technology that provides huge opportunities for the market to grow. Infrared touch technology to witness a higher CAGR during the forecast period. Infrared (IR) technology based touch screens are expected to witness the highest growth rates during forecast period owing to their highest image clarity, as well as light transmission capability, exceptional level of strength and durability. These displays can also be used with a bare finger, gloved finger, and stylus. Infrared touch screen devices are protected against scratches, finger prints, and other forms of minor damage. This makes it particularly beneficial when used to produce large touchscreen displays, along with medium-sized displays of size ranging from 3265 inches. Browsein-depth TOC on"Commercial Touch Display Market" 60 Tables 74 Figures 194 Pages Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=459 North America to account for the largest share of the commercial touch display market by 2025 The North American commercial touch display market has witnessed significant advancements in the past few years. The commercial touch market in North America is driven by various Factors, such as the increased need for quick, high-accuracy services, better standard of living compared to other regions, and high efficiency in retail services. The retail sector in the region is moving toward a more solution-oriented approach. This has motivated manufacturers to come up with highly automated products. The favorable economic conditions prevailing in North America and the high demand for touch displays among customers have encouraged various end-user industries, involved in main stream automated operations, to carry out easy and quick point-of-sale (POS) services. The US accounts for the largest demand for commercial touch display-based products including monitors, signage displays, open frame touchscreen displays, and medical displays used in industries such as corporate, retail, BFSI, sports & entertainment, and education for advertisement, way-finding, and displaying information. A few of the key players in the commercial touch display market are Samsung Electronics (South Korea), Leyard Optoelectronics (Planar) (China), LG Electronics (South Korea), Innolux Corporation (Taiwan), BOE Technology (China), Sharp (Foxconn) (Japan), NEC Corporation (Japan), Qisda Corp. (Taiwan), AU Optronics (Taiwan), and Panasonic (Japan). Related Reports: Interactive Kiosk Marketby Offering (Hardware and Software & Services), Type (Bank Kiosks, Self-service Kiosks, and Vending Kiosks), Location (Indoor and Outdoor), Panel Size (17"-32" and Above 32"), Vertical, and Region - Global Forecast to 2025 About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish MehraMarketsandMarkets INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [emailprotected] Visit Our Web Site: https://www.marketsandmarkets.com Research Insight : https://www.marketsandmarkets.com/ResearchInsight/multi-touch-nui-technology-market.asp Content Source : https://www.marketsandmarkets.com/PressReleases/multi-touch.asp SOURCE MarketsandMarkets Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Commercial Touch Display Market worth $7.6 billion by 2025 - Exclusive Report by MarketsandMarkets.

CHICAGO, Aug. 26, 2020 /PRNewswire/ -- According to the new market research report "Commercial Touch Display Marketby Product (Monitors, Signage Displays, POS Terminals, Open Frame Touchscreen Displays, and Medical Displays), Touch Technology, Resolution, Application, Size, Aspect Ratio, Industry, and Geography - Global Forecast to 2025", published by MarketsandMarkets, the Commercial Touch Display Marketsize was valued at USD 4.3 billion in 2020 and is projected to reach USD 7.6 billion by 2025. It is expected to grow at a CAGR of 12.1% during the forecast period. High adoption of touchscreen displays in retail, hospitality, healthcare, and transportation verticals, dynamic nature of touchscreen displays leads to enhanced customer experience, and rapid adoption of technologically advanced, energy-efficient, attractive, and high-end-specification display products are the key driving factors for the commercial touch display market. Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=459 Open frame touchscreen to account for the largest share of the commercial touch display market Open frame touchscreen displays accounted for the largest share of the commercial touch display market in 2019, and a similar trendis likely to be observed in the coming years owing to the high demand for these products to install at several places, such as retail stores, airports, hospitals, school campuses, government offices, and entertainment places. These displays are used for various functions, such as ticketing,food vending, cash dispensing, and check-in. Due to rapid advancements in technology, companies focus on developing innovative products with a variety of additional features. Researchers associated with different companies are focusing on integrating new technologies in conventional open frame touchscreen displays to make them user-friendly and interactive. Artificial intelligence (AI) is one such technology that provides huge opportunities for the market to grow. Infrared touch technology to witness a higher CAGR during the forecast period. Infrared (IR) technology based touch screens are expected to witness the highest growth rates during forecast period owing to their highest image clarity, as well as light transmission capability, exceptional level of strength and durability. These displays can also be used with a bare finger, gloved finger, and stylus. Infrared touch screen devices are protected against scratches, finger prints, and other forms of minor damage. This makes it particularly beneficial when used to produce large touchscreen displays, along with medium-sized displays of size ranging from 3265 inches. Browsein-depth TOC on"Commercial Touch Display Market" 60 Tables 74 Figures 194 Pages Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=459 North America to account for the largest share of the commercial touch display market by 2025 The North American commercial touch display market has witnessed significant advancements in the past few years. The commercial touch market in North America is driven by various Factors, such as the increased need for quick, high-accuracy services, better standard of living compared to other regions, and high efficiency in retail services. The retail sector in the region is moving toward a more solution-oriented approach. This has motivated manufacturers to come up with highly automated products. The favorable economic conditions prevailing in North America and the high demand for touch displays among customers have encouraged various end-user industries, involved in main stream automated operations, to carry out easy and quick point-of-sale (POS) services. The US accounts for the largest demand for commercial touch display-based products including monitors, signage displays, open frame touchscreen displays, and medical displays used in industries such as corporate, retail, BFSI, sports & entertainment, and education for advertisement, way-finding, and displaying information. A few of the key players in the commercial touch display market are Samsung Electronics (South Korea), Leyard Optoelectronics (Planar) (China), LG Electronics (South Korea), Innolux Corporation (Taiwan), BOE Technology (China), Sharp (Foxconn) (Japan), NEC Corporation (Japan), Qisda Corp. (Taiwan), AU Optronics (Taiwan), and Panasonic (Japan). Related Reports: Interactive Kiosk Marketby Offering (Hardware and Software & Services), Type (Bank Kiosks, Self-service Kiosks, and Vending Kiosks), Location (Indoor and Outdoor), Panel Size (17"-32" and Above 32"), Vertical, and Region - Global Forecast to 2025 About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish MehraMarketsandMarkets INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [emailprotected] Visit Our Web Site: https://www.marketsandmarkets.com Research Insight : https://www.marketsandmarkets.com/ResearchInsight/multi-touch-nui-technology-market.asp Content Source : https://www.marketsandmarkets.com/PressReleases/multi-touch.asp SOURCE MarketsandMarkets

Commercial Touch Display Market worth $7.6 billion by 2025 - Exclusive Report by MarketsandMarkets

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CHICAGO, Aug. 26, 2020 /PRNewswire/ -- According to the new market research report "Commercial Touch Display Marketby Product (Monitors, Signage Displays, POS Terminals, Open Frame Touchscreen Displays, and Medical Displays), Touch Technology, Resolution, Application, Size, Aspect Ratio, Industry, and Geography - Global Forecast to 2025", published by MarketsandMarkets, the Commercial Touch Display Marketsize was valued at USD 4.3 billion in 2020 and is projected to reach USD 7.6 billion by 2025. It is expected to grow at a CAGR of 12.1% during the forecast period. High adoption of touchscreen displays in retail, hospitality, healthcare, and transportation verticals, dynamic nature of touchscreen displays leads to enhanced customer experience, and rapid adoption of technologically advanced, energy-efficient, attractive, and high-end-specification display products are the key driving factors for the commercial touch display market. Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=459 Open frame touchscreen to account for the largest share of the commercial touch display market Open frame touchscreen displays accounted for the largest share of the commercial touch display market in 2019, and a similar trendis likely to be observed in the coming years owing to the high demand for these products to install at several places, such as retail stores, airports, hospitals, school campuses, government offices, and entertainment places. These displays are used for various functions, such as ticketing,food vending, cash dispensing, and check-in. Due to rapid advancements in technology, companies focus on developing innovative products with a variety of additional features. Researchers associated with different companies are focusing on integrating new technologies in conventional open frame touchscreen displays to make them user-friendly and interactive. Artificial intelligence (AI) is one such technology that provides huge opportunities for the market to grow. Infrared touch technology to witness a higher CAGR during the forecast period. Infrared (IR) technology based touch screens are expected to witness the highest growth rates during forecast period owing to their highest image clarity, as well as light transmission capability, exceptional level of strength and durability. These displays can also be used with a bare finger, gloved finger, and stylus. Infrared touch screen devices are protected against scratches, finger prints, and other forms of minor damage. This makes it particularly beneficial when used to produce large touchscreen displays, along with medium-sized displays of size ranging from 3265 inches. Browsein-depth TOC on"Commercial Touch Display Market" 60 Tables 74 Figures 194 Pages Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=459 North America to account for the largest share of the commercial touch display market by 2025 The North American commercial touch display market has witnessed significant advancements in the past few years. The commercial touch market in North America is driven by various Factors, such as the increased need for quick, high-accuracy services, better standard of living compared to other regions, and high efficiency in retail services. The retail sector in the region is moving toward a more solution-oriented approach. This has motivated manufacturers to come up with highly automated products. The favorable economic conditions prevailing in North America and the high demand for touch displays among customers have encouraged various end-user industries, involved in main stream automated operations, to carry out easy and quick point-of-sale (POS) services. The US accounts for the largest demand for commercial touch display-based products including monitors, signage displays, open frame touchscreen displays, and medical displays used in industries such as corporate, retail, BFSI, sports & entertainment, and education for advertisement, way-finding, and displaying information. A few of the key players in the commercial touch display market are Samsung Electronics (South Korea), Leyard Optoelectronics (Planar) (China), LG Electronics (South Korea), Innolux Corporation (Taiwan), BOE Technology (China), Sharp (Foxconn) (Japan), NEC Corporation (Japan), Qisda Corp. (Taiwan), AU Optronics (Taiwan), and Panasonic (Japan). Related Reports: Interactive Kiosk Marketby Offering (Hardware and Software & Services), Type (Bank Kiosks, Self-service Kiosks, and Vending Kiosks), Location (Indoor and Outdoor), Panel Size (17"-32" and Above 32"), Vertical, and Region - Global Forecast to 2025 About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish MehraMarketsandMarkets INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [emailprotected] Visit Our Web Site: https://www.marketsandmarkets.com Research Insight : https://www.marketsandmarkets.com/ResearchInsight/multi-touch-nui-technology-market.asp Content Source : https://www.marketsandmarkets.com/PressReleases/multi-touch.asp SOURCE MarketsandMarkets Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Commercial Touch Display Market worth $7.6 billion by 2025 - Exclusive Report by MarketsandMarkets.<|eot_id|>

edtsum866

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN JOSE, Calif., Feb. 2, 2021 /PRNewswire/ -- Events to be Webcast at: http://investors.sunpower.com/events.cfm SunPower Corp. (NASDAQ:SPWR) will discuss its fourth-quarter and fiscal year 2020 financial results on a conference call, Wednesday, Feb. 17th at 1:30 p.m. Pacific Time. The call-in number is (877) 371-5747 passcode: SunPower,or the webcast can be accessed from SunPower's website at http://investors.sunpower.com/events.cfm. The earnings press release and supplemental financial information will be available on SunPower's website at http://investors.sunpower.com/events.cfm at 1:05 p.m. Pacific Time on Feb. 17, 2021. About SunPowerHeadquartered in California's Silicon Valley, SunPower (NASDAQ:SPWR) is a leading Distributed Generation Storage and Energy Services provider in North America. SunPower offers the only solar + storage solution designed and warranted by one company that gives customers control over electricity consumptionandresiliency during power outages while providing cost savings to homeowners, businesses, governments, schools and utilities. For more information, visit www.sunpower.com. 2021 SunPower Corporation. All Rights Reserved. SUNPOWER and the SUNPOWER logo are registered trademarks of SunPower Corporation in the U.S. # # # # SOURCE SunPower Corp. Related Links https://www.sunpower.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

SunPower to Announce Fourth-Quarter and Fiscal Year 2020 Results on Feb. 17, 2021.

SAN JOSE, Calif., Feb. 2, 2021 /PRNewswire/ -- Events to be Webcast at: http://investors.sunpower.com/events.cfm SunPower Corp. (NASDAQ:SPWR) will discuss its fourth-quarter and fiscal year 2020 financial results on a conference call, Wednesday, Feb. 17th at 1:30 p.m. Pacific Time. The call-in number is (877) 371-5747 passcode: SunPower,or the webcast can be accessed from SunPower's website at http://investors.sunpower.com/events.cfm. The earnings press release and supplemental financial information will be available on SunPower's website at http://investors.sunpower.com/events.cfm at 1:05 p.m. Pacific Time on Feb. 17, 2021. About SunPowerHeadquartered in California's Silicon Valley, SunPower (NASDAQ:SPWR) is a leading Distributed Generation Storage and Energy Services provider in North America. SunPower offers the only solar + storage solution designed and warranted by one company that gives customers control over electricity consumptionandresiliency during power outages while providing cost savings to homeowners, businesses, governments, schools and utilities. For more information, visit www.sunpower.com. 2021 SunPower Corporation. All Rights Reserved. SUNPOWER and the SUNPOWER logo are registered trademarks of SunPower Corporation in the U.S. # # # # SOURCE SunPower Corp. Related Links https://www.sunpower.com

SunPower to Announce Fourth-Quarter and Fiscal Year 2020 Results on Feb. 17, 2021

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN JOSE, Calif., Feb. 2, 2021 /PRNewswire/ -- Events to be Webcast at: http://investors.sunpower.com/events.cfm SunPower Corp. (NASDAQ:SPWR) will discuss its fourth-quarter and fiscal year 2020 financial results on a conference call, Wednesday, Feb. 17th at 1:30 p.m. Pacific Time. The call-in number is (877) 371-5747 passcode: SunPower,or the webcast can be accessed from SunPower's website at http://investors.sunpower.com/events.cfm. The earnings press release and supplemental financial information will be available on SunPower's website at http://investors.sunpower.com/events.cfm at 1:05 p.m. Pacific Time on Feb. 17, 2021. About SunPowerHeadquartered in California's Silicon Valley, SunPower (NASDAQ:SPWR) is a leading Distributed Generation Storage and Energy Services provider in North America. SunPower offers the only solar + storage solution designed and warranted by one company that gives customers control over electricity consumptionandresiliency during power outages while providing cost savings to homeowners, businesses, governments, schools and utilities. For more information, visit www.sunpower.com. 2021 SunPower Corporation. All Rights Reserved. SUNPOWER and the SUNPOWER logo are registered trademarks of SunPower Corporation in the U.S. # # # # SOURCE SunPower Corp. Related Links https://www.sunpower.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> SunPower to Announce Fourth-Quarter and Fiscal Year 2020 Results on Feb. 17, 2021.<|eot_id|>

edtsum867

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: PITTSBURGH, Aug. 6, 2020 /PRNewswire/ --DICK'S Sporting Goods (NYSE: DKS), the largest U.S.-based, omni-channel sporting goods retailer, will expand its nationwide footprint with the opening of four DICK'S Sporting Goods stores, one combination DICK'S and Golf Galaxy location, five DICK'S Sporting Goods Warehouse Sale stores and one OVERTIME by DICK'S Sporting Goods location in August. These new stores will bring approximately 300 collective jobs to communities through the hiring of full-time, part-time and temporary associates for the stores. DICK'S Sporting Goods and Golf Galaxy locations will offer top-of-the-line in-store services and exclusive offerings in apparel, footwear and equipment from the Company's own private brands, such as DSG, Tommy Armour, CALIA by Carrie Underwood, Field & Stream and Fitness Gear, as well as popular national vendors like Nike, adidas, YETI, The North Face, Callaway and TaylorMade. The DICK'S Sporting Goods store locations will host a ribbon cutting ceremony to kick off their opening weekend celebrations. Visit dicks.com/CapeCod, dicks.com/Brockton, dicks.com/Deptford, dicks.com/Midland and dicks.com/Cumberland for full details on the Grand Openings. DICK'S Sporting Goods City/State Store Location Grand Opening Dates Hyannis, MA Cape Cod Mall 793 Iyannough Road, Suite XHC Hyannis, MA 02601 August 7 August 9 Brockton, MA Westgate Mall 200 Westgate Drive, N132 Brockton, MA 02301 August 8 August 9 Deptford, NJ Deptford Mall 1750 Deptford Center Road Deptford, NJ 08096 August 15 August 16 Midland, TX Midland Park Mall 4511 N. Midkiff Road, Suite 0P Midland, TX 79705 August 28 August 30 DICK'S Sporting Goods and Golf Galaxy City/State Store Location Grand Opening Dates Cumberland, GA Cumberland Mall 2860 Cumberland Mall SE., Suite 1520 Atlanta, GA 30339 August 21 August 23 In addition, the Company will also open new clearance and outlet locations to provide access to some of the nation's most-popular athletic brands at great prices in more communities across the country with five DICK'S Sporting Goods Warehouse Sale store locations and one OVERTIME by DICK'S Sporting Goods location. DICK'S Sporting Goods WarehouseSale store clearance locations will offer deep discounts between 30 90% off original prices on customer-favorite footwear and apparel brands. These stores will provide a temporary pop-up-style experience for customers in these communities. Visit dicks.com/Warehouse for additional details and information. DICK'S Sporting Goods Warehouse Sale City/State Store Location Grand Opening Dates Orland Park, IL Lake View Plaza 15852 S La Grange Road Orland Park, IL 60462 August 5 Englewood, CO Centennial Promenade 9637 E County Line Road Englewood, CO 80112 August 5 Fairfax, VA Fair City Mall 9652 Main Street Fairfax, VA 22031 August 5 Amherst, NY Burlington Plaza 1551 Niagara Falls Blvd. Amherst, NY 14226 August 7 Brockton, MA 435 Westgate Drive Brockton, MA 02301 August 26 The new OVERTIME by DICK'S Sporting Goods outlet location will offer an expansive assortment of apparel, footwear and equipment at up to 90% off the brands customers have enjoyed shopping for at DICK'S locations for many years. New markdowns will be added throughout the year, keeping inventory levels at these outlet centers fresh for shoppers. Customers can visit dicks.com/Overtime for additional details and information. OVERTIME by DICK'S Sporting Goods City/State Store Location Grand Opening Date Tempe, AZ Arizona Mills Mall 5000 S. Arizona Mills Circle, Suite 135 Tempe, AZ 85282 August 26 Following the store openings, DICK'S will have 729 DICK'S Sporting Goods stores, 96 Golf Galaxy stores, 10 Warehouse Sale locations and four OVERTIME by DICK'S Sporting Goods locations nationwide in 47 states. About DICK'S Sporting Goods, Inc. Founded in 1948, DICK'S Sporting Goods, Inc. is a leading omni-channel sporting goods retailer offering an extensive assortment of authentic, high-quality sports equipment, apparel, footwear and accessories. As of August 1, 2020, the Company operated 726 DICK'S Sporting Goods locations across the United States, serving and inspiring athletes and outdoor enthusiasts to achieve their personal best through a blend of dedicated teammates, in-store services and unique specialty shop-in-shops dedicated to Team Sports, Athletic Apparel, Golf, Lodge/Outdoor, Fitness and Footwear. Headquartered in Pittsburgh, PA, DICK'S also owns and operates Golf Galaxy and Field & Stream specialty stores, as well asGameChanger, a youth sports mobile app for scheduling, communications and live scorekeeping. DICK'S offers its products through a content-rich eCommerce platform that is integrated with its store network and provides customers with the convenience and expertise of a 24-hour storefront.For more information, visit the Investor Relations page at dicks.com. CONTACTS: DICK'S Sporting Goods, 724-273-5552, [emailprotected] Category: Company SOURCE DICK'S Sporting Goods Related Links http://www.dickssportinggoods.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

DICK'S Sporting Goods Announces Grand Opening of 11 Stores in Nine States in August.

PITTSBURGH, Aug. 6, 2020 /PRNewswire/ --DICK'S Sporting Goods (NYSE: DKS), the largest U.S.-based, omni-channel sporting goods retailer, will expand its nationwide footprint with the opening of four DICK'S Sporting Goods stores, one combination DICK'S and Golf Galaxy location, five DICK'S Sporting Goods Warehouse Sale stores and one OVERTIME by DICK'S Sporting Goods location in August. These new stores will bring approximately 300 collective jobs to communities through the hiring of full-time, part-time and temporary associates for the stores. DICK'S Sporting Goods and Golf Galaxy locations will offer top-of-the-line in-store services and exclusive offerings in apparel, footwear and equipment from the Company's own private brands, such as DSG, Tommy Armour, CALIA by Carrie Underwood, Field & Stream and Fitness Gear, as well as popular national vendors like Nike, adidas, YETI, The North Face, Callaway and TaylorMade. The DICK'S Sporting Goods store locations will host a ribbon cutting ceremony to kick off their opening weekend celebrations. Visit dicks.com/CapeCod, dicks.com/Brockton, dicks.com/Deptford, dicks.com/Midland and dicks.com/Cumberland for full details on the Grand Openings. DICK'S Sporting Goods City/State Store Location Grand Opening Dates Hyannis, MA Cape Cod Mall 793 Iyannough Road, Suite XHC Hyannis, MA 02601 August 7 August 9 Brockton, MA Westgate Mall 200 Westgate Drive, N132 Brockton, MA 02301 August 8 August 9 Deptford, NJ Deptford Mall 1750 Deptford Center Road Deptford, NJ 08096 August 15 August 16 Midland, TX Midland Park Mall 4511 N. Midkiff Road, Suite 0P Midland, TX 79705 August 28 August 30 DICK'S Sporting Goods and Golf Galaxy City/State Store Location Grand Opening Dates Cumberland, GA Cumberland Mall 2860 Cumberland Mall SE., Suite 1520 Atlanta, GA 30339 August 21 August 23 In addition, the Company will also open new clearance and outlet locations to provide access to some of the nation's most-popular athletic brands at great prices in more communities across the country with five DICK'S Sporting Goods Warehouse Sale store locations and one OVERTIME by DICK'S Sporting Goods location. DICK'S Sporting Goods WarehouseSale store clearance locations will offer deep discounts between 30 90% off original prices on customer-favorite footwear and apparel brands. These stores will provide a temporary pop-up-style experience for customers in these communities. Visit dicks.com/Warehouse for additional details and information. DICK'S Sporting Goods Warehouse Sale City/State Store Location Grand Opening Dates Orland Park, IL Lake View Plaza 15852 S La Grange Road Orland Park, IL 60462 August 5 Englewood, CO Centennial Promenade 9637 E County Line Road Englewood, CO 80112 August 5 Fairfax, VA Fair City Mall 9652 Main Street Fairfax, VA 22031 August 5 Amherst, NY Burlington Plaza 1551 Niagara Falls Blvd. Amherst, NY 14226 August 7 Brockton, MA 435 Westgate Drive Brockton, MA 02301 August 26 The new OVERTIME by DICK'S Sporting Goods outlet location will offer an expansive assortment of apparel, footwear and equipment at up to 90% off the brands customers have enjoyed shopping for at DICK'S locations for many years. New markdowns will be added throughout the year, keeping inventory levels at these outlet centers fresh for shoppers. Customers can visit dicks.com/Overtime for additional details and information. OVERTIME by DICK'S Sporting Goods City/State Store Location Grand Opening Date Tempe, AZ Arizona Mills Mall 5000 S. Arizona Mills Circle, Suite 135 Tempe, AZ 85282 August 26 Following the store openings, DICK'S will have 729 DICK'S Sporting Goods stores, 96 Golf Galaxy stores, 10 Warehouse Sale locations and four OVERTIME by DICK'S Sporting Goods locations nationwide in 47 states. About DICK'S Sporting Goods, Inc. Founded in 1948, DICK'S Sporting Goods, Inc. is a leading omni-channel sporting goods retailer offering an extensive assortment of authentic, high-quality sports equipment, apparel, footwear and accessories. As of August 1, 2020, the Company operated 726 DICK'S Sporting Goods locations across the United States, serving and inspiring athletes and outdoor enthusiasts to achieve their personal best through a blend of dedicated teammates, in-store services and unique specialty shop-in-shops dedicated to Team Sports, Athletic Apparel, Golf, Lodge/Outdoor, Fitness and Footwear. Headquartered in Pittsburgh, PA, DICK'S also owns and operates Golf Galaxy and Field & Stream specialty stores, as well asGameChanger, a youth sports mobile app for scheduling, communications and live scorekeeping. DICK'S offers its products through a content-rich eCommerce platform that is integrated with its store network and provides customers with the convenience and expertise of a 24-hour storefront.For more information, visit the Investor Relations page at dicks.com. CONTACTS: DICK'S Sporting Goods, 724-273-5552, [emailprotected] Category: Company SOURCE DICK'S Sporting Goods Related Links http://www.dickssportinggoods.com

DICK'S Sporting Goods Announces Grand Opening of 11 Stores in Nine States in August

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: PITTSBURGH, Aug. 6, 2020 /PRNewswire/ --DICK'S Sporting Goods (NYSE: DKS), the largest U.S.-based, omni-channel sporting goods retailer, will expand its nationwide footprint with the opening of four DICK'S Sporting Goods stores, one combination DICK'S and Golf Galaxy location, five DICK'S Sporting Goods Warehouse Sale stores and one OVERTIME by DICK'S Sporting Goods location in August. These new stores will bring approximately 300 collective jobs to communities through the hiring of full-time, part-time and temporary associates for the stores. DICK'S Sporting Goods and Golf Galaxy locations will offer top-of-the-line in-store services and exclusive offerings in apparel, footwear and equipment from the Company's own private brands, such as DSG, Tommy Armour, CALIA by Carrie Underwood, Field & Stream and Fitness Gear, as well as popular national vendors like Nike, adidas, YETI, The North Face, Callaway and TaylorMade. The DICK'S Sporting Goods store locations will host a ribbon cutting ceremony to kick off their opening weekend celebrations. Visit dicks.com/CapeCod, dicks.com/Brockton, dicks.com/Deptford, dicks.com/Midland and dicks.com/Cumberland for full details on the Grand Openings. DICK'S Sporting Goods City/State Store Location Grand Opening Dates Hyannis, MA Cape Cod Mall 793 Iyannough Road, Suite XHC Hyannis, MA 02601 August 7 August 9 Brockton, MA Westgate Mall 200 Westgate Drive, N132 Brockton, MA 02301 August 8 August 9 Deptford, NJ Deptford Mall 1750 Deptford Center Road Deptford, NJ 08096 August 15 August 16 Midland, TX Midland Park Mall 4511 N. Midkiff Road, Suite 0P Midland, TX 79705 August 28 August 30 DICK'S Sporting Goods and Golf Galaxy City/State Store Location Grand Opening Dates Cumberland, GA Cumberland Mall 2860 Cumberland Mall SE., Suite 1520 Atlanta, GA 30339 August 21 August 23 In addition, the Company will also open new clearance and outlet locations to provide access to some of the nation's most-popular athletic brands at great prices in more communities across the country with five DICK'S Sporting Goods Warehouse Sale store locations and one OVERTIME by DICK'S Sporting Goods location. DICK'S Sporting Goods WarehouseSale store clearance locations will offer deep discounts between 30 90% off original prices on customer-favorite footwear and apparel brands. These stores will provide a temporary pop-up-style experience for customers in these communities. Visit dicks.com/Warehouse for additional details and information. DICK'S Sporting Goods Warehouse Sale City/State Store Location Grand Opening Dates Orland Park, IL Lake View Plaza 15852 S La Grange Road Orland Park, IL 60462 August 5 Englewood, CO Centennial Promenade 9637 E County Line Road Englewood, CO 80112 August 5 Fairfax, VA Fair City Mall 9652 Main Street Fairfax, VA 22031 August 5 Amherst, NY Burlington Plaza 1551 Niagara Falls Blvd. Amherst, NY 14226 August 7 Brockton, MA 435 Westgate Drive Brockton, MA 02301 August 26 The new OVERTIME by DICK'S Sporting Goods outlet location will offer an expansive assortment of apparel, footwear and equipment at up to 90% off the brands customers have enjoyed shopping for at DICK'S locations for many years. New markdowns will be added throughout the year, keeping inventory levels at these outlet centers fresh for shoppers. Customers can visit dicks.com/Overtime for additional details and information. OVERTIME by DICK'S Sporting Goods City/State Store Location Grand Opening Date Tempe, AZ Arizona Mills Mall 5000 S. Arizona Mills Circle, Suite 135 Tempe, AZ 85282 August 26 Following the store openings, DICK'S will have 729 DICK'S Sporting Goods stores, 96 Golf Galaxy stores, 10 Warehouse Sale locations and four OVERTIME by DICK'S Sporting Goods locations nationwide in 47 states. About DICK'S Sporting Goods, Inc. Founded in 1948, DICK'S Sporting Goods, Inc. is a leading omni-channel sporting goods retailer offering an extensive assortment of authentic, high-quality sports equipment, apparel, footwear and accessories. As of August 1, 2020, the Company operated 726 DICK'S Sporting Goods locations across the United States, serving and inspiring athletes and outdoor enthusiasts to achieve their personal best through a blend of dedicated teammates, in-store services and unique specialty shop-in-shops dedicated to Team Sports, Athletic Apparel, Golf, Lodge/Outdoor, Fitness and Footwear. Headquartered in Pittsburgh, PA, DICK'S also owns and operates Golf Galaxy and Field & Stream specialty stores, as well asGameChanger, a youth sports mobile app for scheduling, communications and live scorekeeping. DICK'S offers its products through a content-rich eCommerce platform that is integrated with its store network and provides customers with the convenience and expertise of a 24-hour storefront.For more information, visit the Investor Relations page at dicks.com. CONTACTS: DICK'S Sporting Goods, 724-273-5552, [emailprotected] Category: Company SOURCE DICK'S Sporting Goods Related Links http://www.dickssportinggoods.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> DICK'S Sporting Goods Announces Grand Opening of 11 Stores in Nine States in August.<|eot_id|>

edtsum868

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: HALL COUNTY, Ga., April 21, 2021 /PRNewswire/ -- Makita U.S.A., Inc. held a ceremonial groundbreaking yesterday to launch construction of a new 600,000 sq.ft. state-of-the-art facility northeast of Atlanta in Hall County, GA. The new facility will be constructed on 80 acres of land and is part of Makita's planned future development to address continuing growth in the United States. "Today Makita begins a new phase of expansion with the construction of another new facility," said Joe Blackwell, senior vice president operations, Makita U.S.A. "This is part of our continuing growth here in the U.S.A., and this new facility will further increase our operations, service, and training capabilities. This means expanded service and support for our customers, while creating more jobs in the region." The new state-of-the-art facility will serve as a distribution center, and will also include a sales and training center, customer service resources, and a Factory Service Center. The location has adjacent space for future expansion up to 800,000 sq.ft. The groundbreaking marks another milestone in Makita's significant investment in the U.S.A. Construction of the Atlanta-area facility follows the August 2020 opening of a new distribution, training and service facility in Reno, NV, and the 2017 opening of a similar facility in Wilmer, TX. Makita's distribution chain also includes operations in Mt. Prospect, IL, Buford, GA, and La Mirada, CA. Additionally, the manufacturing and assembly plant in Buford is one of ten Makita manufacturing facilities worldwide.Makita representatives at yesterday's groundbreaking were joined by the project's construction and development executives, as well as the Mayor. Attendees included Ian MacDonald, Scannell Properties; Liz O'Connor, Evans General Contractors; Mike Dimond, Evans General Contractors; Mike Miller, Mayor; Sandra Silva, Makita U.S.A.; Joe Blackwell, Makita U.S.A. Jeff Couch, Makita U.S.A.; Don Tuttle, Scannell Properties; Chris Hilgeman, Evans General Contractors; Jason Dooley, Ware Malcomb.About MakitaMakita is a worldwide manufacturer of industrial power tools, power equipment, pneumatics, and janitorial-sanitation products, and offers a wide range of industrial accessories. Makita U.S.A., Inc. is located in La Mirada, California, and operates an extensive distribution network throughout the U.S.A. With 50 years in the United States and over 100 years worldwide, Makita utilizes experience and expertise to manufacture best-in-class solutions. For more information about Makita U.S.A. call (800)4-MAKITA or visit makitatools.com. Find Makita on Instagram, YouTube, Facebook, and Twitter @makitatoolsMEDIA CONTACTSWayne Hart(714) 522-8088 x4410[emailprotected] Jennifer Morse(714) 522-8088 x 4401[emailprotected] Consumer Inquiries: (800) 4-MAKITAmakitatools.com@makitatoolsSOURCE Makita U.S.A., Inc. Related Links https://www.makitatools.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Makita U.S.A. Breaks Ground On Major Expansion In Atlanta Region. Ceremonial groundbreaking marks the beginning of construction of new state-of-the-art facility.

HALL COUNTY, Ga., April 21, 2021 /PRNewswire/ -- Makita U.S.A., Inc. held a ceremonial groundbreaking yesterday to launch construction of a new 600,000 sq.ft. state-of-the-art facility northeast of Atlanta in Hall County, GA. The new facility will be constructed on 80 acres of land and is part of Makita's planned future development to address continuing growth in the United States. "Today Makita begins a new phase of expansion with the construction of another new facility," said Joe Blackwell, senior vice president operations, Makita U.S.A. "This is part of our continuing growth here in the U.S.A., and this new facility will further increase our operations, service, and training capabilities. This means expanded service and support for our customers, while creating more jobs in the region." The new state-of-the-art facility will serve as a distribution center, and will also include a sales and training center, customer service resources, and a Factory Service Center. The location has adjacent space for future expansion up to 800,000 sq.ft. The groundbreaking marks another milestone in Makita's significant investment in the U.S.A. Construction of the Atlanta-area facility follows the August 2020 opening of a new distribution, training and service facility in Reno, NV, and the 2017 opening of a similar facility in Wilmer, TX. Makita's distribution chain also includes operations in Mt. Prospect, IL, Buford, GA, and La Mirada, CA. Additionally, the manufacturing and assembly plant in Buford is one of ten Makita manufacturing facilities worldwide.Makita representatives at yesterday's groundbreaking were joined by the project's construction and development executives, as well as the Mayor. Attendees included Ian MacDonald, Scannell Properties; Liz O'Connor, Evans General Contractors; Mike Dimond, Evans General Contractors; Mike Miller, Mayor; Sandra Silva, Makita U.S.A.; Joe Blackwell, Makita U.S.A. Jeff Couch, Makita U.S.A.; Don Tuttle, Scannell Properties; Chris Hilgeman, Evans General Contractors; Jason Dooley, Ware Malcomb.About MakitaMakita is a worldwide manufacturer of industrial power tools, power equipment, pneumatics, and janitorial-sanitation products, and offers a wide range of industrial accessories. Makita U.S.A., Inc. is located in La Mirada, California, and operates an extensive distribution network throughout the U.S.A. With 50 years in the United States and over 100 years worldwide, Makita utilizes experience and expertise to manufacture best-in-class solutions. For more information about Makita U.S.A. call (800)4-MAKITA or visit makitatools.com. Find Makita on Instagram, YouTube, Facebook, and Twitter @makitatoolsMEDIA CONTACTSWayne Hart(714) 522-8088 x4410[emailprotected] Jennifer Morse(714) 522-8088 x 4401[emailprotected] Consumer Inquiries: (800) 4-MAKITAmakitatools.com@makitatoolsSOURCE Makita U.S.A., Inc. Related Links https://www.makitatools.com

Makita U.S.A. Breaks Ground On Major Expansion In Atlanta Region Ceremonial groundbreaking marks the beginning of construction of new state-of-the-art facility

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: HALL COUNTY, Ga., April 21, 2021 /PRNewswire/ -- Makita U.S.A., Inc. held a ceremonial groundbreaking yesterday to launch construction of a new 600,000 sq.ft. state-of-the-art facility northeast of Atlanta in Hall County, GA. The new facility will be constructed on 80 acres of land and is part of Makita's planned future development to address continuing growth in the United States. "Today Makita begins a new phase of expansion with the construction of another new facility," said Joe Blackwell, senior vice president operations, Makita U.S.A. "This is part of our continuing growth here in the U.S.A., and this new facility will further increase our operations, service, and training capabilities. This means expanded service and support for our customers, while creating more jobs in the region." The new state-of-the-art facility will serve as a distribution center, and will also include a sales and training center, customer service resources, and a Factory Service Center. The location has adjacent space for future expansion up to 800,000 sq.ft. The groundbreaking marks another milestone in Makita's significant investment in the U.S.A. Construction of the Atlanta-area facility follows the August 2020 opening of a new distribution, training and service facility in Reno, NV, and the 2017 opening of a similar facility in Wilmer, TX. Makita's distribution chain also includes operations in Mt. Prospect, IL, Buford, GA, and La Mirada, CA. Additionally, the manufacturing and assembly plant in Buford is one of ten Makita manufacturing facilities worldwide.Makita representatives at yesterday's groundbreaking were joined by the project's construction and development executives, as well as the Mayor. Attendees included Ian MacDonald, Scannell Properties; Liz O'Connor, Evans General Contractors; Mike Dimond, Evans General Contractors; Mike Miller, Mayor; Sandra Silva, Makita U.S.A.; Joe Blackwell, Makita U.S.A. Jeff Couch, Makita U.S.A.; Don Tuttle, Scannell Properties; Chris Hilgeman, Evans General Contractors; Jason Dooley, Ware Malcomb.About MakitaMakita is a worldwide manufacturer of industrial power tools, power equipment, pneumatics, and janitorial-sanitation products, and offers a wide range of industrial accessories. Makita U.S.A., Inc. is located in La Mirada, California, and operates an extensive distribution network throughout the U.S.A. With 50 years in the United States and over 100 years worldwide, Makita utilizes experience and expertise to manufacture best-in-class solutions. For more information about Makita U.S.A. call (800)4-MAKITA or visit makitatools.com. Find Makita on Instagram, YouTube, Facebook, and Twitter @makitatoolsMEDIA CONTACTSWayne Hart(714) 522-8088 x4410[emailprotected] Jennifer Morse(714) 522-8088 x 4401[emailprotected] Consumer Inquiries: (800) 4-MAKITAmakitatools.com@makitatoolsSOURCE Makita U.S.A., Inc. Related Links https://www.makitatools.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Makita U.S.A. Breaks Ground On Major Expansion In Atlanta Region. Ceremonial groundbreaking marks the beginning of construction of new state-of-the-art facility.<|eot_id|>

edtsum869

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Oct. 27, 2020 /PRNewswire/ --Val Kleyman, Esq., a New York City divorce lawyer with the Kleyman Law Firm, announced that artificial intelligence will not replace lawyers who practice divorce and family law. Continue Reading Val Kleyman, Esq. "This is because the legal system is set up so that a lawyer who practices family and divorce law must informally practice far more than just law: the nature of the controversies involved, and the emotional states of the parties, require that a lawyer be also a therapist, a teacher, a diary, a parent, and a friend all while applying the law and keeping an appropriate, professional distance. It is a complicated and emotionally draining balancing act that no computer could ever replicate," Kleyman said. First, this area of law relies more heavily on the discretion of judges than other areas of law, due to the nature of the issues presented to the court. For example, any decisions involving children, such as custody or parenting time, require an analysis of the situation, the child, and the parties to determine what is in "the best interests of the child" an incredibly subjective standard that incorporates all the factors you would expect, and more. Second, there are too many emotions involved. The parties to a divorce can be angry, depressed, mistrustful, vengeful, or worse. Even when extreme emotions are not involved, parties seeking divorce have just made the extremely difficult and painful decision to end a relationship that was likely emotionally damaging to both of them. Some people in emotional distress are less likely to tell the truth; others are more likely to spill every detail of their lives. Some people in such states are more likely to try to manipulate situations; others are so defeated they willingly submit to unfavorable agreements. "Divorce lawyers must be able to read people well enough to sense the truth behind what is being said, and to get to the heart of what the party truly wants and needs. This involves far more than asking the right questions in the right order and is also not something a computer can solve by analyzing data," according to the New York divorce attorney Kleyman, who engages in practice of high conflict divorce.However, Kleyman agreed that practicing divorce law is emotionally and intellectually taxing and that assistance in any form can help attorneys to remain healthy, and to streamline the practice of law so that focus can be directed where it is most needed. "Though a computer may not be able to understand a person's emotional state or weigh the complicated inner workings of unique families against the function and application of the law, a computer can: speed up the preparation and submission of documents; perform legal research; analyze financial documents; perform calculations to determine the value of assets; and many other important functions," said Kleyman.About:Val Kleymanis the founder of The Kleyman Law Firm, a matrimonial law firm inNew Yorkand is rated as one of the top divorce lawyers in New York City. Mr. Kleyman and his firm work with many complex, contested, and high conflict divorces. The Kleyman Law Firm is located at 45 Broadway, 15th Floor,New York, NY. For more info go to www.NYC-DivorceLawyer.com, email:[emailprotected]or call 212-401-1977.SOURCE Val Kleyman, Esq. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Will Artificial Intelligence Take Over Divorce Law? Not Really.

NEW YORK, Oct. 27, 2020 /PRNewswire/ --Val Kleyman, Esq., a New York City divorce lawyer with the Kleyman Law Firm, announced that artificial intelligence will not replace lawyers who practice divorce and family law. Continue Reading Val Kleyman, Esq. "This is because the legal system is set up so that a lawyer who practices family and divorce law must informally practice far more than just law: the nature of the controversies involved, and the emotional states of the parties, require that a lawyer be also a therapist, a teacher, a diary, a parent, and a friend all while applying the law and keeping an appropriate, professional distance. It is a complicated and emotionally draining balancing act that no computer could ever replicate," Kleyman said. First, this area of law relies more heavily on the discretion of judges than other areas of law, due to the nature of the issues presented to the court. For example, any decisions involving children, such as custody or parenting time, require an analysis of the situation, the child, and the parties to determine what is in "the best interests of the child" an incredibly subjective standard that incorporates all the factors you would expect, and more. Second, there are too many emotions involved. The parties to a divorce can be angry, depressed, mistrustful, vengeful, or worse. Even when extreme emotions are not involved, parties seeking divorce have just made the extremely difficult and painful decision to end a relationship that was likely emotionally damaging to both of them. Some people in emotional distress are less likely to tell the truth; others are more likely to spill every detail of their lives. Some people in such states are more likely to try to manipulate situations; others are so defeated they willingly submit to unfavorable agreements. "Divorce lawyers must be able to read people well enough to sense the truth behind what is being said, and to get to the heart of what the party truly wants and needs. This involves far more than asking the right questions in the right order and is also not something a computer can solve by analyzing data," according to the New York divorce attorney Kleyman, who engages in practice of high conflict divorce.However, Kleyman agreed that practicing divorce law is emotionally and intellectually taxing and that assistance in any form can help attorneys to remain healthy, and to streamline the practice of law so that focus can be directed where it is most needed. "Though a computer may not be able to understand a person's emotional state or weigh the complicated inner workings of unique families against the function and application of the law, a computer can: speed up the preparation and submission of documents; perform legal research; analyze financial documents; perform calculations to determine the value of assets; and many other important functions," said Kleyman.About:Val Kleymanis the founder of The Kleyman Law Firm, a matrimonial law firm inNew Yorkand is rated as one of the top divorce lawyers in New York City. Mr. Kleyman and his firm work with many complex, contested, and high conflict divorces. The Kleyman Law Firm is located at 45 Broadway, 15th Floor,New York, NY. For more info go to www.NYC-DivorceLawyer.com, email:[emailprotected]or call 212-401-1977.SOURCE Val Kleyman, Esq.

Will Artificial Intelligence Take Over Divorce Law? Not Really

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Oct. 27, 2020 /PRNewswire/ --Val Kleyman, Esq., a New York City divorce lawyer with the Kleyman Law Firm, announced that artificial intelligence will not replace lawyers who practice divorce and family law. Continue Reading Val Kleyman, Esq. "This is because the legal system is set up so that a lawyer who practices family and divorce law must informally practice far more than just law: the nature of the controversies involved, and the emotional states of the parties, require that a lawyer be also a therapist, a teacher, a diary, a parent, and a friend all while applying the law and keeping an appropriate, professional distance. It is a complicated and emotionally draining balancing act that no computer could ever replicate," Kleyman said. First, this area of law relies more heavily on the discretion of judges than other areas of law, due to the nature of the issues presented to the court. For example, any decisions involving children, such as custody or parenting time, require an analysis of the situation, the child, and the parties to determine what is in "the best interests of the child" an incredibly subjective standard that incorporates all the factors you would expect, and more. Second, there are too many emotions involved. The parties to a divorce can be angry, depressed, mistrustful, vengeful, or worse. Even when extreme emotions are not involved, parties seeking divorce have just made the extremely difficult and painful decision to end a relationship that was likely emotionally damaging to both of them. Some people in emotional distress are less likely to tell the truth; others are more likely to spill every detail of their lives. Some people in such states are more likely to try to manipulate situations; others are so defeated they willingly submit to unfavorable agreements. "Divorce lawyers must be able to read people well enough to sense the truth behind what is being said, and to get to the heart of what the party truly wants and needs. This involves far more than asking the right questions in the right order and is also not something a computer can solve by analyzing data," according to the New York divorce attorney Kleyman, who engages in practice of high conflict divorce.However, Kleyman agreed that practicing divorce law is emotionally and intellectually taxing and that assistance in any form can help attorneys to remain healthy, and to streamline the practice of law so that focus can be directed where it is most needed. "Though a computer may not be able to understand a person's emotional state or weigh the complicated inner workings of unique families against the function and application of the law, a computer can: speed up the preparation and submission of documents; perform legal research; analyze financial documents; perform calculations to determine the value of assets; and many other important functions," said Kleyman.About:Val Kleymanis the founder of The Kleyman Law Firm, a matrimonial law firm inNew Yorkand is rated as one of the top divorce lawyers in New York City. Mr. Kleyman and his firm work with many complex, contested, and high conflict divorces. The Kleyman Law Firm is located at 45 Broadway, 15th Floor,New York, NY. For more info go to www.NYC-DivorceLawyer.com, email:[emailprotected]or call 212-401-1977.SOURCE Val Kleyman, Esq. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Will Artificial Intelligence Take Over Divorce Law? Not Really.<|eot_id|>

edtsum870

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Feb. 16, 2021 /PRNewswire/ --Class Action Settlements, a company that helps businesses search, claim and receive money from class action settlements, today announced the launch of its new website, ClassAction-Settlements.com. Designed to simplify a previously arduous process, ClassAction-Settlements.com helps business owners receive payment from class action settlements through a single, centralized website with no upfront costs. Stats have shown that the current class action claims filing rate is roughly 10-30%, a range that Class Action Settlements is dedicated to help increase to 80% or higher. To date, the professionals at Class Action Settlements have worked with over 100,000 small- to medium-sized businesses, helping them receive money they are due from class action settlements. The team understands that the traditional process can be time-consuming and cumbersome for business owners, resulting in large sums of money going unclaimed each year. As many businesses struggle to cope with the financial impact of the COVID-19 restrictions and shutdowns, they are looking for hidden assets. By submitting a claim for a class action settlement, business owners can receive additional money that is due to them. Recognizing that many business owners are not aware of current settlements, and in many cases do not have the time or wherewithal to submit a claim, ClassAction-Settlements.com assists with the entire process from start to finish. "At Class Action Settlements, we recognize that small businesses are the backbone of the United States. Our new website will provide our valued clients with the most transparent and simplified claims process available," said Neil Montesano, chief operating officer for Class Action Settlements. "Not only does the website empower business owners to receive money due to them, but it also streamlines the entire claims process. Launching ClassAction-Settlements.com will provide our clients with the best platform in the industry and encourage business owners to submit claims." Class Action Settlements strives to help ease the cash flow challenges faced by business owners today, particularly amidst the pandemic. Recognizing that business owners often wait months or even years to receive their share of funds from a class action claim, Class Action Settlements also offers to buy clients' claims at an agreed upon, negotiated price which will result in an immediate payment to the client. To check if you're eligible for a settlement, please visit https://classaction-settlements.com/. ABOUT CLASS ACTION SETTLEMENTS Class Action Settlements is comprised of a group of professionals who are dedicated to helping business owners search, claim and receive money back from class action settlements. Our team members have helped more than 100,000 small- to medium-sized businesses receive money from antitrust class action settlements. Through our centralized website, we help business owners identify settlements and submit claims. Our mission is to increase the class action claims rate from its current position at less than 30% to 80% or higher. Learn more at https://classaction-settlements.com/. SOURCE Class Action Settlements Related Links http://ClassAction-Settlements.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

New Website, ClassAction-Settlements.com, Launches to Help Businesses Streamline the Process for Receiving Payment from Class Action Settlements. Website will simplify the process for businesses to receive money from class action settlements, providing users with the most effective, easy-to-use service available.

NEW YORK, Feb. 16, 2021 /PRNewswire/ --Class Action Settlements, a company that helps businesses search, claim and receive money from class action settlements, today announced the launch of its new website, ClassAction-Settlements.com. Designed to simplify a previously arduous process, ClassAction-Settlements.com helps business owners receive payment from class action settlements through a single, centralized website with no upfront costs. Stats have shown that the current class action claims filing rate is roughly 10-30%, a range that Class Action Settlements is dedicated to help increase to 80% or higher. To date, the professionals at Class Action Settlements have worked with over 100,000 small- to medium-sized businesses, helping them receive money they are due from class action settlements. The team understands that the traditional process can be time-consuming and cumbersome for business owners, resulting in large sums of money going unclaimed each year. As many businesses struggle to cope with the financial impact of the COVID-19 restrictions and shutdowns, they are looking for hidden assets. By submitting a claim for a class action settlement, business owners can receive additional money that is due to them. Recognizing that many business owners are not aware of current settlements, and in many cases do not have the time or wherewithal to submit a claim, ClassAction-Settlements.com assists with the entire process from start to finish. "At Class Action Settlements, we recognize that small businesses are the backbone of the United States. Our new website will provide our valued clients with the most transparent and simplified claims process available," said Neil Montesano, chief operating officer for Class Action Settlements. "Not only does the website empower business owners to receive money due to them, but it also streamlines the entire claims process. Launching ClassAction-Settlements.com will provide our clients with the best platform in the industry and encourage business owners to submit claims." Class Action Settlements strives to help ease the cash flow challenges faced by business owners today, particularly amidst the pandemic. Recognizing that business owners often wait months or even years to receive their share of funds from a class action claim, Class Action Settlements also offers to buy clients' claims at an agreed upon, negotiated price which will result in an immediate payment to the client. To check if you're eligible for a settlement, please visit https://classaction-settlements.com/. ABOUT CLASS ACTION SETTLEMENTS Class Action Settlements is comprised of a group of professionals who are dedicated to helping business owners search, claim and receive money back from class action settlements. Our team members have helped more than 100,000 small- to medium-sized businesses receive money from antitrust class action settlements. Through our centralized website, we help business owners identify settlements and submit claims. Our mission is to increase the class action claims rate from its current position at less than 30% to 80% or higher. Learn more at https://classaction-settlements.com/. SOURCE Class Action Settlements Related Links http://ClassAction-Settlements.com

New Website, ClassAction-Settlements.com, Launches to Help Businesses Streamline the Process for Receiving Payment from Class Action Settlements Website will simplify the process for businesses to receive money from class action settlements, providing users with the most effective, easy-to-use service available

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Feb. 16, 2021 /PRNewswire/ --Class Action Settlements, a company that helps businesses search, claim and receive money from class action settlements, today announced the launch of its new website, ClassAction-Settlements.com. Designed to simplify a previously arduous process, ClassAction-Settlements.com helps business owners receive payment from class action settlements through a single, centralized website with no upfront costs. Stats have shown that the current class action claims filing rate is roughly 10-30%, a range that Class Action Settlements is dedicated to help increase to 80% or higher. To date, the professionals at Class Action Settlements have worked with over 100,000 small- to medium-sized businesses, helping them receive money they are due from class action settlements. The team understands that the traditional process can be time-consuming and cumbersome for business owners, resulting in large sums of money going unclaimed each year. As many businesses struggle to cope with the financial impact of the COVID-19 restrictions and shutdowns, they are looking for hidden assets. By submitting a claim for a class action settlement, business owners can receive additional money that is due to them. Recognizing that many business owners are not aware of current settlements, and in many cases do not have the time or wherewithal to submit a claim, ClassAction-Settlements.com assists with the entire process from start to finish. "At Class Action Settlements, we recognize that small businesses are the backbone of the United States. Our new website will provide our valued clients with the most transparent and simplified claims process available," said Neil Montesano, chief operating officer for Class Action Settlements. "Not only does the website empower business owners to receive money due to them, but it also streamlines the entire claims process. Launching ClassAction-Settlements.com will provide our clients with the best platform in the industry and encourage business owners to submit claims." Class Action Settlements strives to help ease the cash flow challenges faced by business owners today, particularly amidst the pandemic. Recognizing that business owners often wait months or even years to receive their share of funds from a class action claim, Class Action Settlements also offers to buy clients' claims at an agreed upon, negotiated price which will result in an immediate payment to the client. To check if you're eligible for a settlement, please visit https://classaction-settlements.com/. ABOUT CLASS ACTION SETTLEMENTS Class Action Settlements is comprised of a group of professionals who are dedicated to helping business owners search, claim and receive money back from class action settlements. Our team members have helped more than 100,000 small- to medium-sized businesses receive money from antitrust class action settlements. Through our centralized website, we help business owners identify settlements and submit claims. Our mission is to increase the class action claims rate from its current position at less than 30% to 80% or higher. Learn more at https://classaction-settlements.com/. SOURCE Class Action Settlements Related Links http://ClassAction-Settlements.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> New Website, ClassAction-Settlements.com, Launches to Help Businesses Streamline the Process for Receiving Payment from Class Action Settlements. Website will simplify the process for businesses to receive money from class action settlements, providing users with the most effective, easy-to-use service available.<|eot_id|>

edtsum871

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Steel Stockholders (GLOBAL) - Industry Report" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed overview of the global steel stockholders market and delivers a comprehensive individual analysis on the top 310 companies, including ARCELOR MITTAL C.L.N. DISTRIBUZIONE ITALIA S.R.L., BARRETT STEEL LIMITED and AMARI METALL DEUTSCHLAND GMBH & CO. KG. This report includes a wealth of information on the financial trends over the past four years. The author's latest analysis is ideal for anyone wanting to: Using the author's exclusive methodology, a quick glance of this report will tell you that 36 companies have a declining financial rating, while 82 have shown good sales growth. Each of the largest 310 companies is meticulously scrutinised in an individual assessment and analysed using the most up-to-date and current financial data. Every business is examined on the following features: Subsequently, you will receive a thorough 100-page market analysis highlighting the latest changes in the market. This section includes: For more information about this report visit https://www.researchandmarkets.com/r/4yol1o Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Outlook on the 2020 Global Steel Stockholders Market - Comprehensive Individual Analysis on the Top 310 Companies - ResearchAndMarkets.com.

DUBLIN--(BUSINESS WIRE)--The "Steel Stockholders (GLOBAL) - Industry Report" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed overview of the global steel stockholders market and delivers a comprehensive individual analysis on the top 310 companies, including ARCELOR MITTAL C.L.N. DISTRIBUZIONE ITALIA S.R.L., BARRETT STEEL LIMITED and AMARI METALL DEUTSCHLAND GMBH & CO. KG. This report includes a wealth of information on the financial trends over the past four years. The author's latest analysis is ideal for anyone wanting to: Using the author's exclusive methodology, a quick glance of this report will tell you that 36 companies have a declining financial rating, while 82 have shown good sales growth. Each of the largest 310 companies is meticulously scrutinised in an individual assessment and analysed using the most up-to-date and current financial data. Every business is examined on the following features: Subsequently, you will receive a thorough 100-page market analysis highlighting the latest changes in the market. This section includes: For more information about this report visit https://www.researchandmarkets.com/r/4yol1o

Outlook on the 2020 Global Steel Stockholders Market - Comprehensive Individual Analysis on the Top 310 Companies - ResearchAndMarkets.com

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Steel Stockholders (GLOBAL) - Industry Report" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed overview of the global steel stockholders market and delivers a comprehensive individual analysis on the top 310 companies, including ARCELOR MITTAL C.L.N. DISTRIBUZIONE ITALIA S.R.L., BARRETT STEEL LIMITED and AMARI METALL DEUTSCHLAND GMBH & CO. KG. This report includes a wealth of information on the financial trends over the past four years. The author's latest analysis is ideal for anyone wanting to: Using the author's exclusive methodology, a quick glance of this report will tell you that 36 companies have a declining financial rating, while 82 have shown good sales growth. Each of the largest 310 companies is meticulously scrutinised in an individual assessment and analysed using the most up-to-date and current financial data. Every business is examined on the following features: Subsequently, you will receive a thorough 100-page market analysis highlighting the latest changes in the market. This section includes: For more information about this report visit https://www.researchandmarkets.com/r/4yol1o Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Outlook on the 2020 Global Steel Stockholders Market - Comprehensive Individual Analysis on the Top 310 Companies - ResearchAndMarkets.com.<|eot_id|>

edtsum872

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CHARLESTON, S.C., March 23, 2021 /PRNewswire/ -- Canyon Partners Real Estate LLC ("Canyon") today announced it has provided a $25.2 million loan to a joint venture between Opterra Capital ("Opterra") and The Montford Group ("TMG") for the construction of a 7-story select-service Moxy hotel located in Charleston, South Carolina. Featuring 131 guest rooms, the hotel construction is expected to commence immediately, and is scheduled to open in late 2022. The transaction was facilitated by Hodges Ward Elliott. The Charleston Moxy hotel is located in the Upper Peninsula District, a rapidly evolving submarket, less than a mile north of the renowned Historic District, and easily accessible to Charleston International Airport. The Moxy will be an attractive destination for tourists and Charleston residents alike, featuring a rooftop bar and restaurant, first-floor caf, large meeting space, and lobby bar and lounge. "Charleston is one of the most desired tourist destinations in the country given its accessibility, renowned restaurant scene, and plethora of sights and entertainment," said Sunju Patel of The Montford Group. "We see the opportunity to bring lifestyle hospitality to urban areas in secondary markets. There is a need and we want to satisfy that." "We are excited to partner with Canyon and continue to service the growing hospitality sector in this bustling city," said Glenn Alba of Opterra Capital. "Commencing construction now will position us well for the expected recovery in leisure and business travel in the next 18 months."Moxy Hotels are affiliated with Marriott International and the Charleston Moxy will benefit from Marriott's world-class reservation system and guest loyalty program, Bonvoy, with over 130 million rewards members. This investment brings Canyon's real estate portfolio to approximately $6.1 billion of project capitalization.About Canyon Partners Real Estate LLCFounded in 1991, Canyon Partners Real Estate LLC ("Canyon") is the real estate direct investing arm of Canyon Partners, LLC, a global alternative asset manager with over $26 billion in assets under management. Over the last ten years, Canyon has invested approximately $5.5 billion of debt and equity capital across over 200 transactions capitalizing approximately $14.9 billion of real estate assets, focusing on debt, value add, and opportunistic strategies. With 29 years of experience, Canyon has established a broad menu of investment capabilities spanning property types, US regions, and project stages (including development, transitional, and distressed/workouts). For more information visit: www.canyonpartners.com About the Sponsors/Developers:The Montford Group.is a hotel development company connecting brands with lifestyle destinations. We are visionaries thatacquire, design and developdynamic real estate. Taking form in 2017 from the creative minds of seasoned entrepreneur duo Sunju Patel and Jessica Reid, The Montford Group. set off to curate anunrivaled collection of unique properties and remarkable experiencesfor people who believe thathome and hospitalityshouldn't be rare finds, but thecommon ground that unites us. In partnership withOpterra Capitalis real estate investment sponsor and operatingpartner, capital markets advisor, and asset manager with significantexperience in all sectors of commercial real estate. Founded by Glenn Alba, a former Managing Director at Blackstonefor 23 years, Opterra Capital consists of four industry-professional principals with more than 80 years of experiencethat encompasses more than $10 billion worth of hotel transactions; the asset management of over 280 hotels, with a total of more than46,000 rooms; the oversight of 20 hotel development and renovation projects worth in excess of $3 billion; and the investment analysis of more than $120 billion of primarily hotel real estate. Opterra Capital seeks to leverage this expertise towardsvalue-add acquisitionandproactive investmentmanagement to deliverattractive, risk-adjusted returns.Together we are oneCurrently withover $500 Millionunder ownership and hotel developmentand more than 110 years of combined experience,we recognize the value of bringinglifestyle hotelstourban neighborhoods bypartnering withunique brands and experienced management companies always keeping in mind the number one goal:create value for people. www.montfordgroup.comwww.opterracapital.comMedia contacts:Kris ColeProsek Partners310.614.9208[emailprotected] SOURCE Canyon Partners LLC Related Links http://www.canyonpartners.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Canyon Partners Invests $25.2 Million in Charleston Moxy Hotel.

CHARLESTON, S.C., March 23, 2021 /PRNewswire/ -- Canyon Partners Real Estate LLC ("Canyon") today announced it has provided a $25.2 million loan to a joint venture between Opterra Capital ("Opterra") and The Montford Group ("TMG") for the construction of a 7-story select-service Moxy hotel located in Charleston, South Carolina. Featuring 131 guest rooms, the hotel construction is expected to commence immediately, and is scheduled to open in late 2022. The transaction was facilitated by Hodges Ward Elliott. The Charleston Moxy hotel is located in the Upper Peninsula District, a rapidly evolving submarket, less than a mile north of the renowned Historic District, and easily accessible to Charleston International Airport. The Moxy will be an attractive destination for tourists and Charleston residents alike, featuring a rooftop bar and restaurant, first-floor caf, large meeting space, and lobby bar and lounge. "Charleston is one of the most desired tourist destinations in the country given its accessibility, renowned restaurant scene, and plethora of sights and entertainment," said Sunju Patel of The Montford Group. "We see the opportunity to bring lifestyle hospitality to urban areas in secondary markets. There is a need and we want to satisfy that." "We are excited to partner with Canyon and continue to service the growing hospitality sector in this bustling city," said Glenn Alba of Opterra Capital. "Commencing construction now will position us well for the expected recovery in leisure and business travel in the next 18 months."Moxy Hotels are affiliated with Marriott International and the Charleston Moxy will benefit from Marriott's world-class reservation system and guest loyalty program, Bonvoy, with over 130 million rewards members. This investment brings Canyon's real estate portfolio to approximately $6.1 billion of project capitalization.About Canyon Partners Real Estate LLCFounded in 1991, Canyon Partners Real Estate LLC ("Canyon") is the real estate direct investing arm of Canyon Partners, LLC, a global alternative asset manager with over $26 billion in assets under management. Over the last ten years, Canyon has invested approximately $5.5 billion of debt and equity capital across over 200 transactions capitalizing approximately $14.9 billion of real estate assets, focusing on debt, value add, and opportunistic strategies. With 29 years of experience, Canyon has established a broad menu of investment capabilities spanning property types, US regions, and project stages (including development, transitional, and distressed/workouts). For more information visit: www.canyonpartners.com About the Sponsors/Developers:The Montford Group.is a hotel development company connecting brands with lifestyle destinations. We are visionaries thatacquire, design and developdynamic real estate. Taking form in 2017 from the creative minds of seasoned entrepreneur duo Sunju Patel and Jessica Reid, The Montford Group. set off to curate anunrivaled collection of unique properties and remarkable experiencesfor people who believe thathome and hospitalityshouldn't be rare finds, but thecommon ground that unites us. In partnership withOpterra Capitalis real estate investment sponsor and operatingpartner, capital markets advisor, and asset manager with significantexperience in all sectors of commercial real estate. Founded by Glenn Alba, a former Managing Director at Blackstonefor 23 years, Opterra Capital consists of four industry-professional principals with more than 80 years of experiencethat encompasses more than $10 billion worth of hotel transactions; the asset management of over 280 hotels, with a total of more than46,000 rooms; the oversight of 20 hotel development and renovation projects worth in excess of $3 billion; and the investment analysis of more than $120 billion of primarily hotel real estate. Opterra Capital seeks to leverage this expertise towardsvalue-add acquisitionandproactive investmentmanagement to deliverattractive, risk-adjusted returns.Together we are oneCurrently withover $500 Millionunder ownership and hotel developmentand more than 110 years of combined experience,we recognize the value of bringinglifestyle hotelstourban neighborhoods bypartnering withunique brands and experienced management companies always keeping in mind the number one goal:create value for people. www.montfordgroup.comwww.opterracapital.comMedia contacts:Kris ColeProsek Partners310.614.9208[emailprotected] SOURCE Canyon Partners LLC Related Links http://www.canyonpartners.com

Canyon Partners Invests $25.2 Million in Charleston Moxy Hotel

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CHARLESTON, S.C., March 23, 2021 /PRNewswire/ -- Canyon Partners Real Estate LLC ("Canyon") today announced it has provided a $25.2 million loan to a joint venture between Opterra Capital ("Opterra") and The Montford Group ("TMG") for the construction of a 7-story select-service Moxy hotel located in Charleston, South Carolina. Featuring 131 guest rooms, the hotel construction is expected to commence immediately, and is scheduled to open in late 2022. The transaction was facilitated by Hodges Ward Elliott. The Charleston Moxy hotel is located in the Upper Peninsula District, a rapidly evolving submarket, less than a mile north of the renowned Historic District, and easily accessible to Charleston International Airport. The Moxy will be an attractive destination for tourists and Charleston residents alike, featuring a rooftop bar and restaurant, first-floor caf, large meeting space, and lobby bar and lounge. "Charleston is one of the most desired tourist destinations in the country given its accessibility, renowned restaurant scene, and plethora of sights and entertainment," said Sunju Patel of The Montford Group. "We see the opportunity to bring lifestyle hospitality to urban areas in secondary markets. There is a need and we want to satisfy that." "We are excited to partner with Canyon and continue to service the growing hospitality sector in this bustling city," said Glenn Alba of Opterra Capital. "Commencing construction now will position us well for the expected recovery in leisure and business travel in the next 18 months."Moxy Hotels are affiliated with Marriott International and the Charleston Moxy will benefit from Marriott's world-class reservation system and guest loyalty program, Bonvoy, with over 130 million rewards members. This investment brings Canyon's real estate portfolio to approximately $6.1 billion of project capitalization.About Canyon Partners Real Estate LLCFounded in 1991, Canyon Partners Real Estate LLC ("Canyon") is the real estate direct investing arm of Canyon Partners, LLC, a global alternative asset manager with over $26 billion in assets under management. Over the last ten years, Canyon has invested approximately $5.5 billion of debt and equity capital across over 200 transactions capitalizing approximately $14.9 billion of real estate assets, focusing on debt, value add, and opportunistic strategies. With 29 years of experience, Canyon has established a broad menu of investment capabilities spanning property types, US regions, and project stages (including development, transitional, and distressed/workouts). For more information visit: www.canyonpartners.com About the Sponsors/Developers:The Montford Group.is a hotel development company connecting brands with lifestyle destinations. We are visionaries thatacquire, design and developdynamic real estate. Taking form in 2017 from the creative minds of seasoned entrepreneur duo Sunju Patel and Jessica Reid, The Montford Group. set off to curate anunrivaled collection of unique properties and remarkable experiencesfor people who believe thathome and hospitalityshouldn't be rare finds, but thecommon ground that unites us. In partnership withOpterra Capitalis real estate investment sponsor and operatingpartner, capital markets advisor, and asset manager with significantexperience in all sectors of commercial real estate. Founded by Glenn Alba, a former Managing Director at Blackstonefor 23 years, Opterra Capital consists of four industry-professional principals with more than 80 years of experiencethat encompasses more than $10 billion worth of hotel transactions; the asset management of over 280 hotels, with a total of more than46,000 rooms; the oversight of 20 hotel development and renovation projects worth in excess of $3 billion; and the investment analysis of more than $120 billion of primarily hotel real estate. Opterra Capital seeks to leverage this expertise towardsvalue-add acquisitionandproactive investmentmanagement to deliverattractive, risk-adjusted returns.Together we are oneCurrently withover $500 Millionunder ownership and hotel developmentand more than 110 years of combined experience,we recognize the value of bringinglifestyle hotelstourban neighborhoods bypartnering withunique brands and experienced management companies always keeping in mind the number one goal:create value for people. www.montfordgroup.comwww.opterracapital.comMedia contacts:Kris ColeProsek Partners310.614.9208[emailprotected] SOURCE Canyon Partners LLC Related Links http://www.canyonpartners.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Canyon Partners Invests $25.2 Million in Charleston Moxy Hotel.<|eot_id|>

edtsum873

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE:STT) announced today that its President & Chief Executive Officer, Ron OHanley, and Chief Financial Officer, Eric Aboaf, will participate in the Barclays Global Financial Services Conference on Monday, September 14, 2020 at 11:15 AM EDT. The webcast of the event will be accessible on State Streets investor relations home page at investors.statestreet.com. A recorded replay of the event will be available on the Investor Relations website later in the day and will be available for approximately two weeks. About State Street Corporation State Street Corporation (NYSE: STT) is one of the world's leading providers of financial services to institutional investors including investment servicing, investment management and investment research and trading. With $33.52 trillion in assets under custody and/or administration and $3.05 trillion* in assets under management as of June 30, 2020, State Street operates globally in more than 100 geographic markets and employs approximately 39,000 worldwide. For more information, visit State Street's website at www.statestreet.com. * Assets under management as of June 30, 2020 includes approximately $67 billion of assets with respect to which State Street Global Advisors Funds Distributors, LLC (SSGA FD) serves as marketing agent; SSGA FD and State Street Global Advisors are affiliated. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

President & Chief Executive Officer Ron OHanley and Chief Financial Officer Eric Aboaf to Participate in the Barclays Financial Services Conference.

BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE:STT) announced today that its President & Chief Executive Officer, Ron OHanley, and Chief Financial Officer, Eric Aboaf, will participate in the Barclays Global Financial Services Conference on Monday, September 14, 2020 at 11:15 AM EDT. The webcast of the event will be accessible on State Streets investor relations home page at investors.statestreet.com. A recorded replay of the event will be available on the Investor Relations website later in the day and will be available for approximately two weeks. About State Street Corporation State Street Corporation (NYSE: STT) is one of the world's leading providers of financial services to institutional investors including investment servicing, investment management and investment research and trading. With $33.52 trillion in assets under custody and/or administration and $3.05 trillion* in assets under management as of June 30, 2020, State Street operates globally in more than 100 geographic markets and employs approximately 39,000 worldwide. For more information, visit State Street's website at www.statestreet.com. * Assets under management as of June 30, 2020 includes approximately $67 billion of assets with respect to which State Street Global Advisors Funds Distributors, LLC (SSGA FD) serves as marketing agent; SSGA FD and State Street Global Advisors are affiliated.

President & Chief Executive Officer Ron OHanley and Chief Financial Officer Eric Aboaf to Participate in the Barclays Financial Services Conference

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE:STT) announced today that its President & Chief Executive Officer, Ron OHanley, and Chief Financial Officer, Eric Aboaf, will participate in the Barclays Global Financial Services Conference on Monday, September 14, 2020 at 11:15 AM EDT. The webcast of the event will be accessible on State Streets investor relations home page at investors.statestreet.com. A recorded replay of the event will be available on the Investor Relations website later in the day and will be available for approximately two weeks. About State Street Corporation State Street Corporation (NYSE: STT) is one of the world's leading providers of financial services to institutional investors including investment servicing, investment management and investment research and trading. With $33.52 trillion in assets under custody and/or administration and $3.05 trillion* in assets under management as of June 30, 2020, State Street operates globally in more than 100 geographic markets and employs approximately 39,000 worldwide. For more information, visit State Street's website at www.statestreet.com. * Assets under management as of June 30, 2020 includes approximately $67 billion of assets with respect to which State Street Global Advisors Funds Distributors, LLC (SSGA FD) serves as marketing agent; SSGA FD and State Street Global Advisors are affiliated. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> President & Chief Executive Officer Ron OHanley and Chief Financial Officer Eric Aboaf to Participate in the Barclays Financial Services Conference.<|eot_id|>

edtsum874

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Global Lubricant Anti-wear Agents Market by Type (ZDDP, Phosphate, Phosphite, Phosphonate), Application (Engine Oil, Automotive Gear Oil, Automotive Transmission Fluid, Hydraulic Oil, Metalworking Fluid, Grease) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global lubricant anti-wear agents market size is projected to grow from USD 698 million in 2020 to USD 784 million by 2025, at a CAGR of 2.4% from 2020 to 2025. The growing demand for high-passenger and commercial vehicles in the automotive industry is driving the lubricant anti-wear agents industry growth as well as the rising GDP in the Asia-Pacific. The increasing inclination toward electric vehicles and environmental concerns is restraining the growth of the market. The zinc dialkldithiophosphate (ZDDP) lubricant anti-wear agents segment, by type, is projected to have the largest market share Zinc dialkldithiophosphate (ZDDP) is a family of uncharged compounds composed of phosphorus, zinc, and sulfur traces, primarily used as anti-wear additives in lubricants such as gear oil, grease, and motor oil. Zinc dialkldithiophosphate has high thermal and hydrolytic stability and forms protective chemical films on metal surfaces which prevents corrosive damage to valve train and bearings. ZDDPs are multifunctional because they provide wear, oxidation, and corrosion protection. Their antioxidant properties prevent soot deposits and formation of sludge on engine components. This additive provides oxidation, copper-lead bearing corrosion, and wear control majorly in diesel and gasoline engines. It is particularly effective under severe temperature and load. Thus, zinc dialkldithiophosphate enhances the properties of lubricants and is used in various applications such as engine oil, hydraulic oil, and compressor oil. The engine oil application segment is projected to lead the global lubricant anti-wear agents market during the forecast period Based on the application, the engine oil application segment led the lubricant anti-wear agents market in 2019. The growth of this segment can be attributed to the growth of the automotive sector mainly related to passenger cars and commercial vehicles in the developing regions of the world, and the increasing population in APAC is driving the growth of the automotive oil application segment. Asia-Pacific is projected to lead the global lubricant anti-wear agents market during the forecast period The Asia-Pacific is expected to lead the lubricant anti-wear agents industry from 2020 to 2025 in terms of both value and volume. The demand for lubricant anti-wear agents is increasing in Asia-Pacific owing to the growing automotive industry in the region. Also, the increasing GDP in the area is expected to fuel the demand for automobiles; thus, driving the lubricant anti-wear agents market growth. The market in this region is also projected to continue its market dominance in terms of both value and volume, from 2020 to 2025, owing to the and rising industrial activities in the developing countries of the Asia-Pacific region. Market Dynamics Drivers Restraints Opportunities Challenges Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/vzm1c5 Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Global Lubricant Anti-wear Agents Market (2020 to 2025) - Increasing Demand for Renewable Energy Presents Opportunities - ResearchAndMarkets.com.

DUBLIN--(BUSINESS WIRE)--The "Global Lubricant Anti-wear Agents Market by Type (ZDDP, Phosphate, Phosphite, Phosphonate), Application (Engine Oil, Automotive Gear Oil, Automotive Transmission Fluid, Hydraulic Oil, Metalworking Fluid, Grease) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global lubricant anti-wear agents market size is projected to grow from USD 698 million in 2020 to USD 784 million by 2025, at a CAGR of 2.4% from 2020 to 2025. The growing demand for high-passenger and commercial vehicles in the automotive industry is driving the lubricant anti-wear agents industry growth as well as the rising GDP in the Asia-Pacific. The increasing inclination toward electric vehicles and environmental concerns is restraining the growth of the market. The zinc dialkldithiophosphate (ZDDP) lubricant anti-wear agents segment, by type, is projected to have the largest market share Zinc dialkldithiophosphate (ZDDP) is a family of uncharged compounds composed of phosphorus, zinc, and sulfur traces, primarily used as anti-wear additives in lubricants such as gear oil, grease, and motor oil. Zinc dialkldithiophosphate has high thermal and hydrolytic stability and forms protective chemical films on metal surfaces which prevents corrosive damage to valve train and bearings. ZDDPs are multifunctional because they provide wear, oxidation, and corrosion protection. Their antioxidant properties prevent soot deposits and formation of sludge on engine components. This additive provides oxidation, copper-lead bearing corrosion, and wear control majorly in diesel and gasoline engines. It is particularly effective under severe temperature and load. Thus, zinc dialkldithiophosphate enhances the properties of lubricants and is used in various applications such as engine oil, hydraulic oil, and compressor oil. The engine oil application segment is projected to lead the global lubricant anti-wear agents market during the forecast period Based on the application, the engine oil application segment led the lubricant anti-wear agents market in 2019. The growth of this segment can be attributed to the growth of the automotive sector mainly related to passenger cars and commercial vehicles in the developing regions of the world, and the increasing population in APAC is driving the growth of the automotive oil application segment. Asia-Pacific is projected to lead the global lubricant anti-wear agents market during the forecast period The Asia-Pacific is expected to lead the lubricant anti-wear agents industry from 2020 to 2025 in terms of both value and volume. The demand for lubricant anti-wear agents is increasing in Asia-Pacific owing to the growing automotive industry in the region. Also, the increasing GDP in the area is expected to fuel the demand for automobiles; thus, driving the lubricant anti-wear agents market growth. The market in this region is also projected to continue its market dominance in terms of both value and volume, from 2020 to 2025, owing to the and rising industrial activities in the developing countries of the Asia-Pacific region. Market Dynamics Drivers Restraints Opportunities Challenges Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/vzm1c5

Global Lubricant Anti-wear Agents Market (2020 to 2025) - Increasing Demand for Renewable Energy Presents Opportunities - ResearchAndMarkets.com

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Global Lubricant Anti-wear Agents Market by Type (ZDDP, Phosphate, Phosphite, Phosphonate), Application (Engine Oil, Automotive Gear Oil, Automotive Transmission Fluid, Hydraulic Oil, Metalworking Fluid, Grease) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global lubricant anti-wear agents market size is projected to grow from USD 698 million in 2020 to USD 784 million by 2025, at a CAGR of 2.4% from 2020 to 2025. The growing demand for high-passenger and commercial vehicles in the automotive industry is driving the lubricant anti-wear agents industry growth as well as the rising GDP in the Asia-Pacific. The increasing inclination toward electric vehicles and environmental concerns is restraining the growth of the market. The zinc dialkldithiophosphate (ZDDP) lubricant anti-wear agents segment, by type, is projected to have the largest market share Zinc dialkldithiophosphate (ZDDP) is a family of uncharged compounds composed of phosphorus, zinc, and sulfur traces, primarily used as anti-wear additives in lubricants such as gear oil, grease, and motor oil. Zinc dialkldithiophosphate has high thermal and hydrolytic stability and forms protective chemical films on metal surfaces which prevents corrosive damage to valve train and bearings. ZDDPs are multifunctional because they provide wear, oxidation, and corrosion protection. Their antioxidant properties prevent soot deposits and formation of sludge on engine components. This additive provides oxidation, copper-lead bearing corrosion, and wear control majorly in diesel and gasoline engines. It is particularly effective under severe temperature and load. Thus, zinc dialkldithiophosphate enhances the properties of lubricants and is used in various applications such as engine oil, hydraulic oil, and compressor oil. The engine oil application segment is projected to lead the global lubricant anti-wear agents market during the forecast period Based on the application, the engine oil application segment led the lubricant anti-wear agents market in 2019. The growth of this segment can be attributed to the growth of the automotive sector mainly related to passenger cars and commercial vehicles in the developing regions of the world, and the increasing population in APAC is driving the growth of the automotive oil application segment. Asia-Pacific is projected to lead the global lubricant anti-wear agents market during the forecast period The Asia-Pacific is expected to lead the lubricant anti-wear agents industry from 2020 to 2025 in terms of both value and volume. The demand for lubricant anti-wear agents is increasing in Asia-Pacific owing to the growing automotive industry in the region. Also, the increasing GDP in the area is expected to fuel the demand for automobiles; thus, driving the lubricant anti-wear agents market growth. The market in this region is also projected to continue its market dominance in terms of both value and volume, from 2020 to 2025, owing to the and rising industrial activities in the developing countries of the Asia-Pacific region. Market Dynamics Drivers Restraints Opportunities Challenges Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/vzm1c5 Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Global Lubricant Anti-wear Agents Market (2020 to 2025) - Increasing Demand for Renewable Energy Presents Opportunities - ResearchAndMarkets.com.<|eot_id|>

edtsum875

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SCHAUMBURG, Ill., May 21, 2020 /PRNewswire/ --Zurich North America, a leading provider of insurance products and services to businesses and individuals, is expanding its professional apprenticeship program from its Chicagoland headquarters to its downtown New York City office this fall, with the Borough of Manhattan Community College as the education provider. Zurich's earn-while-you-learn apprenticeship program, launched at its Schaumburg headquarters in 2016, is designed to attract diverse talent to the insurance industry while providing a debt-free path to a professional career. Zurich apprentices include high school graduates or those with an equivalent certification, veterans of the armed forces, people wanting to move from a job to a career, those returning to the workforce after a hiatus for family reasons, and others attracted by the prospect of a guaranteed job and promotion upon successful completion of the two-year program. The New York expansion will contribute to Zurich's largest cohort of apprentices yet. "We're proud to bring the Zurich Apprenticeship Program to New York, particularly at a time when many people are looking for new opportunities and signs of a brighter future," said Paul Horgan, Zurich's Head of U.S. Commercial Insurance. "Even with the challenges brought by COVID-19, we found a way to move forward with this expansion because Zurich's apprenticeship program has proven its value to our business and our industry." In August, the inaugural New York cohort of Zurich apprentices will begin orientation and onboarding. From there, they will work on the job three days a week and take BMCC courses two days a week. Apprentices earn a full-time salary and benefits, including health insurance and 401(k) matching, and they pay no tuition. "We welcome the opportunity to collaborate with Zurich to offer this terrific opportunity for the college, our faculty, and most important, our students," said BMCC Acting Provost Erwin Wong. "We are continuously looking for means to partner with the global business community to offer our students preparation for and access to in-demand 21st century positions, particularly opportunities in the tri-state area. The apprenticeship program that Zurich offers will be of immense value to our students in terms of their marketability." New York apprentices will be working toward certifications in General Insurance and an Associate in Applied Science in Business Management. In 2020 Zurich is adding an Information Technology apprenticeship at its Schaumburg headquarters for the first time, alongside the General Insurance and Cyber apprenticeships. Zurich's was the first insurance apprenticeship program to be certified by the Department of Labor, and Zurich was a founding member of the Chicago Apprentice Network with Aon and Accenture. Zurich's New York extension of apprenticeship also establishes the first new site under the Insurance Apprenticeship USA (IAUSA) banner, an industry collaboration to expand apprenticeships, led by the American Property Casualty Insurance Association. Earlier this year, Zurich's New York office participated in the city's first-ever Career Discovery Week, hosting students from the Laboratory School of Finance and Technology in the Bronx. Zurich also has a summer leadership program for students from Leadership & Public Service High School, near Zurich's Manhattan office. For more details or to apply for the Zurich Apprenticeship Program, please visit zurichna.com/en/careers/apprentices About Zurich North AmericaZurich North America is one of the largest providers of insurance solutions and services to businesses and individuals. Our customers represent industries ranging from agriculture to technology and include more than 90 percent of the Fortune 500. We've backed the building of some of the most recognizable structures in North America. Our North American, LEED Platinum headquarters is located in the Chicago area. We employ approximately 9,000 people in North America and have offices throughout the U.S. and Canada. Further information is available at www.zurichna.com. Zurich North America is part of Zurich Insurance Group, a leading multi-line insurer that serves its customers in global and local markets. With approximately 54,000 employees, Zurich provides a wide range of property and casualty, and life insurance products and services in more than 210 countries and territories. Zurich's customers include individuals, small businesses, and mid-sized and large companies, as well as multinational corporations. The Group is headquartered in Zurich, Switzerland, where it was founded in 1872. The holding company, Zurich Insurance Group Ltd (ZURN), is listed on the SIX Swiss Exchange and has a level I American Depositary Receipt (ZURVY) program, which is traded over-the-counter on OTCQX. Further information is available at www.zurich.com. Visit us on social media: LinkedIn and Twitter SOURCE Zurich North America Related Links www.zurichna.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Zurich North America brings Apprenticeship Program to NYC. Expansion of earn-while-you-learn program is a collaboration with Borough of Manhattan Community College.

SCHAUMBURG, Ill., May 21, 2020 /PRNewswire/ --Zurich North America, a leading provider of insurance products and services to businesses and individuals, is expanding its professional apprenticeship program from its Chicagoland headquarters to its downtown New York City office this fall, with the Borough of Manhattan Community College as the education provider. Zurich's earn-while-you-learn apprenticeship program, launched at its Schaumburg headquarters in 2016, is designed to attract diverse talent to the insurance industry while providing a debt-free path to a professional career. Zurich apprentices include high school graduates or those with an equivalent certification, veterans of the armed forces, people wanting to move from a job to a career, those returning to the workforce after a hiatus for family reasons, and others attracted by the prospect of a guaranteed job and promotion upon successful completion of the two-year program. The New York expansion will contribute to Zurich's largest cohort of apprentices yet. "We're proud to bring the Zurich Apprenticeship Program to New York, particularly at a time when many people are looking for new opportunities and signs of a brighter future," said Paul Horgan, Zurich's Head of U.S. Commercial Insurance. "Even with the challenges brought by COVID-19, we found a way to move forward with this expansion because Zurich's apprenticeship program has proven its value to our business and our industry." In August, the inaugural New York cohort of Zurich apprentices will begin orientation and onboarding. From there, they will work on the job three days a week and take BMCC courses two days a week. Apprentices earn a full-time salary and benefits, including health insurance and 401(k) matching, and they pay no tuition. "We welcome the opportunity to collaborate with Zurich to offer this terrific opportunity for the college, our faculty, and most important, our students," said BMCC Acting Provost Erwin Wong. "We are continuously looking for means to partner with the global business community to offer our students preparation for and access to in-demand 21st century positions, particularly opportunities in the tri-state area. The apprenticeship program that Zurich offers will be of immense value to our students in terms of their marketability." New York apprentices will be working toward certifications in General Insurance and an Associate in Applied Science in Business Management. In 2020 Zurich is adding an Information Technology apprenticeship at its Schaumburg headquarters for the first time, alongside the General Insurance and Cyber apprenticeships. Zurich's was the first insurance apprenticeship program to be certified by the Department of Labor, and Zurich was a founding member of the Chicago Apprentice Network with Aon and Accenture. Zurich's New York extension of apprenticeship also establishes the first new site under the Insurance Apprenticeship USA (IAUSA) banner, an industry collaboration to expand apprenticeships, led by the American Property Casualty Insurance Association. Earlier this year, Zurich's New York office participated in the city's first-ever Career Discovery Week, hosting students from the Laboratory School of Finance and Technology in the Bronx. Zurich also has a summer leadership program for students from Leadership & Public Service High School, near Zurich's Manhattan office. For more details or to apply for the Zurich Apprenticeship Program, please visit zurichna.com/en/careers/apprentices About Zurich North AmericaZurich North America is one of the largest providers of insurance solutions and services to businesses and individuals. Our customers represent industries ranging from agriculture to technology and include more than 90 percent of the Fortune 500. We've backed the building of some of the most recognizable structures in North America. Our North American, LEED Platinum headquarters is located in the Chicago area. We employ approximately 9,000 people in North America and have offices throughout the U.S. and Canada. Further information is available at www.zurichna.com. Zurich North America is part of Zurich Insurance Group, a leading multi-line insurer that serves its customers in global and local markets. With approximately 54,000 employees, Zurich provides a wide range of property and casualty, and life insurance products and services in more than 210 countries and territories. Zurich's customers include individuals, small businesses, and mid-sized and large companies, as well as multinational corporations. The Group is headquartered in Zurich, Switzerland, where it was founded in 1872. The holding company, Zurich Insurance Group Ltd (ZURN), is listed on the SIX Swiss Exchange and has a level I American Depositary Receipt (ZURVY) program, which is traded over-the-counter on OTCQX. Further information is available at www.zurich.com. Visit us on social media: LinkedIn and Twitter SOURCE Zurich North America Related Links www.zurichna.com

Zurich North America brings Apprenticeship Program to NYC Expansion of earn-while-you-learn program is a collaboration with Borough of Manhattan Community College

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SCHAUMBURG, Ill., May 21, 2020 /PRNewswire/ --Zurich North America, a leading provider of insurance products and services to businesses and individuals, is expanding its professional apprenticeship program from its Chicagoland headquarters to its downtown New York City office this fall, with the Borough of Manhattan Community College as the education provider. Zurich's earn-while-you-learn apprenticeship program, launched at its Schaumburg headquarters in 2016, is designed to attract diverse talent to the insurance industry while providing a debt-free path to a professional career. Zurich apprentices include high school graduates or those with an equivalent certification, veterans of the armed forces, people wanting to move from a job to a career, those returning to the workforce after a hiatus for family reasons, and others attracted by the prospect of a guaranteed job and promotion upon successful completion of the two-year program. The New York expansion will contribute to Zurich's largest cohort of apprentices yet. "We're proud to bring the Zurich Apprenticeship Program to New York, particularly at a time when many people are looking for new opportunities and signs of a brighter future," said Paul Horgan, Zurich's Head of U.S. Commercial Insurance. "Even with the challenges brought by COVID-19, we found a way to move forward with this expansion because Zurich's apprenticeship program has proven its value to our business and our industry." In August, the inaugural New York cohort of Zurich apprentices will begin orientation and onboarding. From there, they will work on the job three days a week and take BMCC courses two days a week. Apprentices earn a full-time salary and benefits, including health insurance and 401(k) matching, and they pay no tuition. "We welcome the opportunity to collaborate with Zurich to offer this terrific opportunity for the college, our faculty, and most important, our students," said BMCC Acting Provost Erwin Wong. "We are continuously looking for means to partner with the global business community to offer our students preparation for and access to in-demand 21st century positions, particularly opportunities in the tri-state area. The apprenticeship program that Zurich offers will be of immense value to our students in terms of their marketability." New York apprentices will be working toward certifications in General Insurance and an Associate in Applied Science in Business Management. In 2020 Zurich is adding an Information Technology apprenticeship at its Schaumburg headquarters for the first time, alongside the General Insurance and Cyber apprenticeships. Zurich's was the first insurance apprenticeship program to be certified by the Department of Labor, and Zurich was a founding member of the Chicago Apprentice Network with Aon and Accenture. Zurich's New York extension of apprenticeship also establishes the first new site under the Insurance Apprenticeship USA (IAUSA) banner, an industry collaboration to expand apprenticeships, led by the American Property Casualty Insurance Association. Earlier this year, Zurich's New York office participated in the city's first-ever Career Discovery Week, hosting students from the Laboratory School of Finance and Technology in the Bronx. Zurich also has a summer leadership program for students from Leadership & Public Service High School, near Zurich's Manhattan office. For more details or to apply for the Zurich Apprenticeship Program, please visit zurichna.com/en/careers/apprentices About Zurich North AmericaZurich North America is one of the largest providers of insurance solutions and services to businesses and individuals. Our customers represent industries ranging from agriculture to technology and include more than 90 percent of the Fortune 500. We've backed the building of some of the most recognizable structures in North America. Our North American, LEED Platinum headquarters is located in the Chicago area. We employ approximately 9,000 people in North America and have offices throughout the U.S. and Canada. Further information is available at www.zurichna.com. Zurich North America is part of Zurich Insurance Group, a leading multi-line insurer that serves its customers in global and local markets. With approximately 54,000 employees, Zurich provides a wide range of property and casualty, and life insurance products and services in more than 210 countries and territories. Zurich's customers include individuals, small businesses, and mid-sized and large companies, as well as multinational corporations. The Group is headquartered in Zurich, Switzerland, where it was founded in 1872. The holding company, Zurich Insurance Group Ltd (ZURN), is listed on the SIX Swiss Exchange and has a level I American Depositary Receipt (ZURVY) program, which is traded over-the-counter on OTCQX. Further information is available at www.zurich.com. Visit us on social media: LinkedIn and Twitter SOURCE Zurich North America Related Links www.zurichna.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Zurich North America brings Apprenticeship Program to NYC. Expansion of earn-while-you-learn program is a collaboration with Borough of Manhattan Community College.<|eot_id|>

edtsum876

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN, June 17, 2020 /PRNewswire/ -- The "Infection Prevention & Control - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Infection Prevention & Control market accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period. Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.By products & services equipment, the personal protective equipment segment is anticipated to grow at a significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment's. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment's market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.Some of the key players in infection prevention & control market include Danaher Corporation, Johnson & Johnson, Becton, Dickinson, and Company, 3M Company, Baxter International, Ansell Limited, Belimed AG, Aquionics, Bemis Company Incorporated, Abbott, Braun (B.) Melsungen AG, Cantel Medical Corporation, Cardinal Health Incorporated, Covidien, Henkel, Simens, Getinge Group, Hollister, Medtronics, and CCP Industries.What our report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc. Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling with detailed strategies, financials, and recent developments Supply chain trends mapping the latest technological advancements Key Topics Covered: 1 Executive Summary 2 Preface2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining2.4.2 Data Analysis2.4.3 Data Validation2.4.4 Research Approach2.5 Research Sources 2.5.1 Primary Research Sources2.5.2 Secondary Research Sources2.5.3 Assumptions3 Market Trend Analysis3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 End User Analysis 3.7 Emerging Markets 3.8 Impact of Covid-194 Porters Five Force Analysis4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Infection Prevention & Control Market, By Antimicrobial Drugs5.1 Introduction 5.2 Anti-Fungal Drugs 5.3 Vaccines 5.4 Anti-Bacterial Drugs 5.5 Anti-Viral Drugs 6 Global Infection Prevention & Control Market, By Infection Type6.1 Introduction 6.2 Healthcare Associated Infections 6.2.1 Community Acquired Infection6.2.1.1 Community Acquired Pneumonia (CAP) 6.2.1.2 Methicillin Resistant Staphylococcus Aureus (MRSA) Infection 6.2.2 Hospital Acquired Infection6.2.2.1 Surgical Site Infection6.2.2.2 Ventilator Associated Pneumonia (VAP) Infection 6.2.2.3 Central Line Associated Bloodstream Infection (CLABSI) 6.2.2.4 Catheter Associated Urinary Tract Infection 6.3 Microbial infections 6.3.1 Fungal Infections6.3.1.1 Cryptococcus Gatti 6.3.1.2 Aspergillis 6.3.1.3 Pneumocystis Pneumonia (PCP) 6.3.1.4 Dermatophytes 6.3.1.5 Gungal Keratitis 6.3.1.6 Exserohilum 6.3.1.7 Cladosporium 6.3.2 Viral Infections6.3.2.1 Herpes Simplex Virus 6.3.2.2 Yellow Fever 6.3.2.3 Dengue Viruses 6.3.2.4 Ebola Virus 6.3.2.5 Junin Virus 6.3.2.6 KFD (Kyasanur Forest Virus) 6.3.2.7 Machupo Virus 6.3.2.8 Human Immunodeficiency Virus (HIV) 6.3.3 Clostridium Difficile Infections6.3.3.1 Escherichia Coli Infections 6.3.3.2 Helicobacter Pylori 6.3.3.3 Salmonella 6.3.4 Exserohilum6.3.5 Bacterial Infections6.3.5.1 Mycobacterium Tuberculosis 7 Global Infection Prevention & Control Market, By Products & Services Equipment7.1 Introduction 7.2 Infection Prevention Supplies 7.2.1 Disinfectants7.2.1.1 Surgical Disinfectants 7.2.1.2 Environmental Disinfectants 7.2.1.3 Surface Disinfectants 7.2.1.4 Instrument Disinfectants 7.2.1.5 Skin Disinfectants 7.2.1.6 Hand Sanitizers 7.2.1.7 Disinfectants Wipes 7.2.2 Autoclave7.2.2.1 Horizontal Autoclave 7.2.2.2 Portable Autoclave 7.2.2.3 Vertical Autoclave 7.2.3 Personal Protective Equipment7.2.3.1 Medical & Laboratory Gloves 7.2.3.1.1 Examination Gloves 7.2.3.1.2 Surgical Gloves 7.2.3.1.3 Laboratory Gloves 7.2.3.2 Surgical Masks & Respirators 7.2.3.3 Surgical Foot Covers7.2.3.4 Surgical Drapes 7.2.3.4.1 Nonwoven Drapes 7.2.3.4.2 Plastic Drapes 7.2.3.4.3 Woven Drapes 7.2.3.5 Surgical Gowns 7.2.3.6 Patient Gowns 7.2.3.7 Surgical & Staff Face Masks 7.2.3.8 Other Personal Protective Equipment 7.2.3.8.1 Disposable Staff Apparel 7.2.3.8.2 Disposable Towels & Bedding 7.2.4 Safety-Enhanced Medical Devices7.2.4.1 Safety-Enhanced Syringes 7.2.4.1.1 Prefillable Syringes 7.2.4.1.2 Safety-Enhanced Clinical Syringes 7.2.4.2 Safety-Enhanced Catheters 7.2.4.2.1 IV Catheters 7.2.4.2.2 Urinary Catheters 7.2.4.3 Safety-Enhanced Blood Collection Tubes 7.2.5 Sterilization Supplies7.2.5.1 Sterile Containers 7.2.5.2 Sterilization Wrap 7.2.5.3 Sterilization Indicators 7.2.6 Medical Waste Disposal Supplies7.2.6.1 Medical Waste Disposal Containers 7.2.6.2 Medical Waste Disposal Accessories 7.3 Infection Prevention Equipment 7.3.1 Sterilization Equipment7.3.1.1 Sterilization Technologies 7.3.1.1.1 Filtration Sterilization 7.3.1.1.2 Radiation Sterilization 7.3.1.1.3 Low Temperature Sterilization 7.3.1.1.3.1 In-House Steam Sterilization7.3.1.1.3.2 Ethylene Oxide (EO) Sterilization7.3.1.1.3.3 Gamma and e-Beam Sterilization7.3.1.1.4 Wet/Stream Sterilization 7.3.1.1.5 Dry Heat Sterilization 7.3.1.1.6 Contract Sterilization Services 7.3.2 Washing/Disinfecting Equipment7.3.3 Endoscope Reprocessors7.3.4 Other Infection Prevention Equipment7.3.4.1 Infectious Waste Receptacles 7.3.4.2 Infectious Waste Processing Units 8 Global Infection Prevention & Control Market, By End User8.1 Introduction 8.2 Drug Usage 8.2.1 Individuals & Patients8.2.2 Nursing & Senior care Centers8.3 Equipment Usage 8.3.1 Medical Laboratories8.3.2 Manufacturing Units8.3.2.1 Pharmaceuticals 8.3.2.2 Medical Devices 8.3.2.3 Food & Beverages Industry 8.3.3 Hospitals & Clinics8.3.4 Life Science Industry9 Global Infection Prevention & Control Market, By Geography9.1 Introduction 9.2 North America 9.2.1 US9.2.2 Canada9.2.3 Mexico9.3 Europe 9.3.1 Germany9.3.2 UK9.3.3 Italy9.3.4 France9.3.5 Spain9.3.6 Rest of Europe9.4 Asia Pacific 9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 New Zealand9.4.6 South Korea9.4.7 Rest of Asia Pacific9.5 South America 9.5.1 Argentina9.5.2 Brazil9.5.3 Chile9.5.4 Rest of South America9.6 Middle East & Africa 9.6.1 Saudi Arabia9.6.2 UAE9.6.3 Qatar9.6.4 South Africa9.6.5 Rest of Middle East & Africa10 Key Developments10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling11.1 Danaher Corporation 11.2 Johnson & Johnson 11.3 Becton, Dickinson, and Company 11.4 3M Company 11.5 Baxter International 11.6 Ansell Limited 11.7 Belimed AG 11.8 Aquionics 11.9 Bemis Company Incorporated 11.10 Abbott 11.11 Braun (B.) Melsungen AG 11.12 Cantel Medical Corporation 11.13 Cardinal Health Incorporated 11.14 Covidien 11.15 Henkel 11.16 Simens 11.17 Getinge Group 11.18 Hollister 11.19 Medtronics 11.20 CCP Industries For more information about this report visit https://www.researchandmarkets.com/r/aulmz9 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

$200+ Billion Worldwide Infection Prevention & Control Market to 20207 - Impact of COVID-19.

DUBLIN, June 17, 2020 /PRNewswire/ -- The "Infection Prevention & Control - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Infection Prevention & Control market accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period. Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.By products & services equipment, the personal protective equipment segment is anticipated to grow at a significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment's. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment's market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.Some of the key players in infection prevention & control market include Danaher Corporation, Johnson & Johnson, Becton, Dickinson, and Company, 3M Company, Baxter International, Ansell Limited, Belimed AG, Aquionics, Bemis Company Incorporated, Abbott, Braun (B.) Melsungen AG, Cantel Medical Corporation, Cardinal Health Incorporated, Covidien, Henkel, Simens, Getinge Group, Hollister, Medtronics, and CCP Industries.What our report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc. Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling with detailed strategies, financials, and recent developments Supply chain trends mapping the latest technological advancements Key Topics Covered: 1 Executive Summary 2 Preface2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining2.4.2 Data Analysis2.4.3 Data Validation2.4.4 Research Approach2.5 Research Sources 2.5.1 Primary Research Sources2.5.2 Secondary Research Sources2.5.3 Assumptions3 Market Trend Analysis3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 End User Analysis 3.7 Emerging Markets 3.8 Impact of Covid-194 Porters Five Force Analysis4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Infection Prevention & Control Market, By Antimicrobial Drugs5.1 Introduction 5.2 Anti-Fungal Drugs 5.3 Vaccines 5.4 Anti-Bacterial Drugs 5.5 Anti-Viral Drugs 6 Global Infection Prevention & Control Market, By Infection Type6.1 Introduction 6.2 Healthcare Associated Infections 6.2.1 Community Acquired Infection6.2.1.1 Community Acquired Pneumonia (CAP) 6.2.1.2 Methicillin Resistant Staphylococcus Aureus (MRSA) Infection 6.2.2 Hospital Acquired Infection6.2.2.1 Surgical Site Infection6.2.2.2 Ventilator Associated Pneumonia (VAP) Infection 6.2.2.3 Central Line Associated Bloodstream Infection (CLABSI) 6.2.2.4 Catheter Associated Urinary Tract Infection 6.3 Microbial infections 6.3.1 Fungal Infections6.3.1.1 Cryptococcus Gatti 6.3.1.2 Aspergillis 6.3.1.3 Pneumocystis Pneumonia (PCP) 6.3.1.4 Dermatophytes 6.3.1.5 Gungal Keratitis 6.3.1.6 Exserohilum 6.3.1.7 Cladosporium 6.3.2 Viral Infections6.3.2.1 Herpes Simplex Virus 6.3.2.2 Yellow Fever 6.3.2.3 Dengue Viruses 6.3.2.4 Ebola Virus 6.3.2.5 Junin Virus 6.3.2.6 KFD (Kyasanur Forest Virus) 6.3.2.7 Machupo Virus 6.3.2.8 Human Immunodeficiency Virus (HIV) 6.3.3 Clostridium Difficile Infections6.3.3.1 Escherichia Coli Infections 6.3.3.2 Helicobacter Pylori 6.3.3.3 Salmonella 6.3.4 Exserohilum6.3.5 Bacterial Infections6.3.5.1 Mycobacterium Tuberculosis 7 Global Infection Prevention & Control Market, By Products & Services Equipment7.1 Introduction 7.2 Infection Prevention Supplies 7.2.1 Disinfectants7.2.1.1 Surgical Disinfectants 7.2.1.2 Environmental Disinfectants 7.2.1.3 Surface Disinfectants 7.2.1.4 Instrument Disinfectants 7.2.1.5 Skin Disinfectants 7.2.1.6 Hand Sanitizers 7.2.1.7 Disinfectants Wipes 7.2.2 Autoclave7.2.2.1 Horizontal Autoclave 7.2.2.2 Portable Autoclave 7.2.2.3 Vertical Autoclave 7.2.3 Personal Protective Equipment7.2.3.1 Medical & Laboratory Gloves 7.2.3.1.1 Examination Gloves 7.2.3.1.2 Surgical Gloves 7.2.3.1.3 Laboratory Gloves 7.2.3.2 Surgical Masks & Respirators 7.2.3.3 Surgical Foot Covers7.2.3.4 Surgical Drapes 7.2.3.4.1 Nonwoven Drapes 7.2.3.4.2 Plastic Drapes 7.2.3.4.3 Woven Drapes 7.2.3.5 Surgical Gowns 7.2.3.6 Patient Gowns 7.2.3.7 Surgical & Staff Face Masks 7.2.3.8 Other Personal Protective Equipment 7.2.3.8.1 Disposable Staff Apparel 7.2.3.8.2 Disposable Towels & Bedding 7.2.4 Safety-Enhanced Medical Devices7.2.4.1 Safety-Enhanced Syringes 7.2.4.1.1 Prefillable Syringes 7.2.4.1.2 Safety-Enhanced Clinical Syringes 7.2.4.2 Safety-Enhanced Catheters 7.2.4.2.1 IV Catheters 7.2.4.2.2 Urinary Catheters 7.2.4.3 Safety-Enhanced Blood Collection Tubes 7.2.5 Sterilization Supplies7.2.5.1 Sterile Containers 7.2.5.2 Sterilization Wrap 7.2.5.3 Sterilization Indicators 7.2.6 Medical Waste Disposal Supplies7.2.6.1 Medical Waste Disposal Containers 7.2.6.2 Medical Waste Disposal Accessories 7.3 Infection Prevention Equipment 7.3.1 Sterilization Equipment7.3.1.1 Sterilization Technologies 7.3.1.1.1 Filtration Sterilization 7.3.1.1.2 Radiation Sterilization 7.3.1.1.3 Low Temperature Sterilization 7.3.1.1.3.1 In-House Steam Sterilization7.3.1.1.3.2 Ethylene Oxide (EO) Sterilization7.3.1.1.3.3 Gamma and e-Beam Sterilization7.3.1.1.4 Wet/Stream Sterilization 7.3.1.1.5 Dry Heat Sterilization 7.3.1.1.6 Contract Sterilization Services 7.3.2 Washing/Disinfecting Equipment7.3.3 Endoscope Reprocessors7.3.4 Other Infection Prevention Equipment7.3.4.1 Infectious Waste Receptacles 7.3.4.2 Infectious Waste Processing Units 8 Global Infection Prevention & Control Market, By End User8.1 Introduction 8.2 Drug Usage 8.2.1 Individuals & Patients8.2.2 Nursing & Senior care Centers8.3 Equipment Usage 8.3.1 Medical Laboratories8.3.2 Manufacturing Units8.3.2.1 Pharmaceuticals 8.3.2.2 Medical Devices 8.3.2.3 Food & Beverages Industry 8.3.3 Hospitals & Clinics8.3.4 Life Science Industry9 Global Infection Prevention & Control Market, By Geography9.1 Introduction 9.2 North America 9.2.1 US9.2.2 Canada9.2.3 Mexico9.3 Europe 9.3.1 Germany9.3.2 UK9.3.3 Italy9.3.4 France9.3.5 Spain9.3.6 Rest of Europe9.4 Asia Pacific 9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 New Zealand9.4.6 South Korea9.4.7 Rest of Asia Pacific9.5 South America 9.5.1 Argentina9.5.2 Brazil9.5.3 Chile9.5.4 Rest of South America9.6 Middle East & Africa 9.6.1 Saudi Arabia9.6.2 UAE9.6.3 Qatar9.6.4 South Africa9.6.5 Rest of Middle East & Africa10 Key Developments10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling11.1 Danaher Corporation 11.2 Johnson & Johnson 11.3 Becton, Dickinson, and Company 11.4 3M Company 11.5 Baxter International 11.6 Ansell Limited 11.7 Belimed AG 11.8 Aquionics 11.9 Bemis Company Incorporated 11.10 Abbott 11.11 Braun (B.) Melsungen AG 11.12 Cantel Medical Corporation 11.13 Cardinal Health Incorporated 11.14 Covidien 11.15 Henkel 11.16 Simens 11.17 Getinge Group 11.18 Hollister 11.19 Medtronics 11.20 CCP Industries For more information about this report visit https://www.researchandmarkets.com/r/aulmz9 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

$200+ Billion Worldwide Infection Prevention & Control Market to 20207 - Impact of COVID-19

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN, June 17, 2020 /PRNewswire/ -- The "Infection Prevention & Control - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Infection Prevention & Control market accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period. Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.By products & services equipment, the personal protective equipment segment is anticipated to grow at a significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment's. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment's market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.Some of the key players in infection prevention & control market include Danaher Corporation, Johnson & Johnson, Becton, Dickinson, and Company, 3M Company, Baxter International, Ansell Limited, Belimed AG, Aquionics, Bemis Company Incorporated, Abbott, Braun (B.) Melsungen AG, Cantel Medical Corporation, Cardinal Health Incorporated, Covidien, Henkel, Simens, Getinge Group, Hollister, Medtronics, and CCP Industries.What our report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc. Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling with detailed strategies, financials, and recent developments Supply chain trends mapping the latest technological advancements Key Topics Covered: 1 Executive Summary 2 Preface2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining2.4.2 Data Analysis2.4.3 Data Validation2.4.4 Research Approach2.5 Research Sources 2.5.1 Primary Research Sources2.5.2 Secondary Research Sources2.5.3 Assumptions3 Market Trend Analysis3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 End User Analysis 3.7 Emerging Markets 3.8 Impact of Covid-194 Porters Five Force Analysis4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Infection Prevention & Control Market, By Antimicrobial Drugs5.1 Introduction 5.2 Anti-Fungal Drugs 5.3 Vaccines 5.4 Anti-Bacterial Drugs 5.5 Anti-Viral Drugs 6 Global Infection Prevention & Control Market, By Infection Type6.1 Introduction 6.2 Healthcare Associated Infections 6.2.1 Community Acquired Infection6.2.1.1 Community Acquired Pneumonia (CAP) 6.2.1.2 Methicillin Resistant Staphylococcus Aureus (MRSA) Infection 6.2.2 Hospital Acquired Infection6.2.2.1 Surgical Site Infection6.2.2.2 Ventilator Associated Pneumonia (VAP) Infection 6.2.2.3 Central Line Associated Bloodstream Infection (CLABSI) 6.2.2.4 Catheter Associated Urinary Tract Infection 6.3 Microbial infections 6.3.1 Fungal Infections6.3.1.1 Cryptococcus Gatti 6.3.1.2 Aspergillis 6.3.1.3 Pneumocystis Pneumonia (PCP) 6.3.1.4 Dermatophytes 6.3.1.5 Gungal Keratitis 6.3.1.6 Exserohilum 6.3.1.7 Cladosporium 6.3.2 Viral Infections6.3.2.1 Herpes Simplex Virus 6.3.2.2 Yellow Fever 6.3.2.3 Dengue Viruses 6.3.2.4 Ebola Virus 6.3.2.5 Junin Virus 6.3.2.6 KFD (Kyasanur Forest Virus) 6.3.2.7 Machupo Virus 6.3.2.8 Human Immunodeficiency Virus (HIV) 6.3.3 Clostridium Difficile Infections6.3.3.1 Escherichia Coli Infections 6.3.3.2 Helicobacter Pylori 6.3.3.3 Salmonella 6.3.4 Exserohilum6.3.5 Bacterial Infections6.3.5.1 Mycobacterium Tuberculosis 7 Global Infection Prevention & Control Market, By Products & Services Equipment7.1 Introduction 7.2 Infection Prevention Supplies 7.2.1 Disinfectants7.2.1.1 Surgical Disinfectants 7.2.1.2 Environmental Disinfectants 7.2.1.3 Surface Disinfectants 7.2.1.4 Instrument Disinfectants 7.2.1.5 Skin Disinfectants 7.2.1.6 Hand Sanitizers 7.2.1.7 Disinfectants Wipes 7.2.2 Autoclave7.2.2.1 Horizontal Autoclave 7.2.2.2 Portable Autoclave 7.2.2.3 Vertical Autoclave 7.2.3 Personal Protective Equipment7.2.3.1 Medical & Laboratory Gloves 7.2.3.1.1 Examination Gloves 7.2.3.1.2 Surgical Gloves 7.2.3.1.3 Laboratory Gloves 7.2.3.2 Surgical Masks & Respirators 7.2.3.3 Surgical Foot Covers7.2.3.4 Surgical Drapes 7.2.3.4.1 Nonwoven Drapes 7.2.3.4.2 Plastic Drapes 7.2.3.4.3 Woven Drapes 7.2.3.5 Surgical Gowns 7.2.3.6 Patient Gowns 7.2.3.7 Surgical & Staff Face Masks 7.2.3.8 Other Personal Protective Equipment 7.2.3.8.1 Disposable Staff Apparel 7.2.3.8.2 Disposable Towels & Bedding 7.2.4 Safety-Enhanced Medical Devices7.2.4.1 Safety-Enhanced Syringes 7.2.4.1.1 Prefillable Syringes 7.2.4.1.2 Safety-Enhanced Clinical Syringes 7.2.4.2 Safety-Enhanced Catheters 7.2.4.2.1 IV Catheters 7.2.4.2.2 Urinary Catheters 7.2.4.3 Safety-Enhanced Blood Collection Tubes 7.2.5 Sterilization Supplies7.2.5.1 Sterile Containers 7.2.5.2 Sterilization Wrap 7.2.5.3 Sterilization Indicators 7.2.6 Medical Waste Disposal Supplies7.2.6.1 Medical Waste Disposal Containers 7.2.6.2 Medical Waste Disposal Accessories 7.3 Infection Prevention Equipment 7.3.1 Sterilization Equipment7.3.1.1 Sterilization Technologies 7.3.1.1.1 Filtration Sterilization 7.3.1.1.2 Radiation Sterilization 7.3.1.1.3 Low Temperature Sterilization 7.3.1.1.3.1 In-House Steam Sterilization7.3.1.1.3.2 Ethylene Oxide (EO) Sterilization7.3.1.1.3.3 Gamma and e-Beam Sterilization7.3.1.1.4 Wet/Stream Sterilization 7.3.1.1.5 Dry Heat Sterilization 7.3.1.1.6 Contract Sterilization Services 7.3.2 Washing/Disinfecting Equipment7.3.3 Endoscope Reprocessors7.3.4 Other Infection Prevention Equipment7.3.4.1 Infectious Waste Receptacles 7.3.4.2 Infectious Waste Processing Units 8 Global Infection Prevention & Control Market, By End User8.1 Introduction 8.2 Drug Usage 8.2.1 Individuals & Patients8.2.2 Nursing & Senior care Centers8.3 Equipment Usage 8.3.1 Medical Laboratories8.3.2 Manufacturing Units8.3.2.1 Pharmaceuticals 8.3.2.2 Medical Devices 8.3.2.3 Food & Beverages Industry 8.3.3 Hospitals & Clinics8.3.4 Life Science Industry9 Global Infection Prevention & Control Market, By Geography9.1 Introduction 9.2 North America 9.2.1 US9.2.2 Canada9.2.3 Mexico9.3 Europe 9.3.1 Germany9.3.2 UK9.3.3 Italy9.3.4 France9.3.5 Spain9.3.6 Rest of Europe9.4 Asia Pacific 9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 New Zealand9.4.6 South Korea9.4.7 Rest of Asia Pacific9.5 South America 9.5.1 Argentina9.5.2 Brazil9.5.3 Chile9.5.4 Rest of South America9.6 Middle East & Africa 9.6.1 Saudi Arabia9.6.2 UAE9.6.3 Qatar9.6.4 South Africa9.6.5 Rest of Middle East & Africa10 Key Developments10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling11.1 Danaher Corporation 11.2 Johnson & Johnson 11.3 Becton, Dickinson, and Company 11.4 3M Company 11.5 Baxter International 11.6 Ansell Limited 11.7 Belimed AG 11.8 Aquionics 11.9 Bemis Company Incorporated 11.10 Abbott 11.11 Braun (B.) Melsungen AG 11.12 Cantel Medical Corporation 11.13 Cardinal Health Incorporated 11.14 Covidien 11.15 Henkel 11.16 Simens 11.17 Getinge Group 11.18 Hollister 11.19 Medtronics 11.20 CCP Industries For more information about this report visit https://www.researchandmarkets.com/r/aulmz9 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> $200+ Billion Worldwide Infection Prevention & Control Market to 20207 - Impact of COVID-19.<|eot_id|>

edtsum877

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: More chances to see Glacier Bay and the only Cruise+Denali+Yukon experience make Holland America Line number-one for adventures in Alaska SEATTLE, Jan. 13, 2021 /PRNewswire/ -- In 2022 Holland America Line is celebrating 75 years of Alaska exploration longer than any other cruise line and bookings are now open for its award-winning cruises and Land+Sea Journeys. Throughout the decades, the premium brand has cultivated its knowledge to create perfectly crafted Alaska adventures that offer travelers preferred access, exclusive overland transportation and immersive onboard experiences which is why Holland America Line can say "We Are Alaska." From April through October 2022, guests can embark on Holland America Line's cruises to Alaska aboard Eurodam, Koningsdam, Nieuw Amsterdam, Noordam, Oosterdam and Zuiderdam. For explorers who want to travel farther into the Great Land, 16 different Land+Sea Journeys combine a three-, four- or seven-day Alaska cruise with an inland exploration of Denali National Park. Holland America Line is the only cruise line that extends land tour options up to the unspoiled reaches of Canada's Yukon Territory. "It's incredible to think that Holland America Line has been taking guests to Alaska longer than it's been a state, and because 2022 is our 75th year, we want to allow plenty of time for guests to plan ahead," said Gus Antorcha, Holland America Line's president. "Alaska is a destination where if you've never been, it's on your bucket list; and if you have been, you're eager to go back. There's a reason we've won several awards naming us number-one in Alaska, and it's because we are Alaska. Come celebrate our 75th Anniversary with us." Voted Number-One Cruise Line in Alaska by ManyHolland America Line was named the top pick for Alaska cruises in the 2020 AFAR Travelers' Awards for the third time in five years. In addition to the AFAR award, Holland America Line was named the top pick for Alaska in the 2020 Porthole Cruise Magazine Editor-in-Chief Awards,2019 Cruise Critic Cruisers' Choice Destination Awards and 2019 TravelAge West Wave Awards Editor's Pick, confirming its position as the number-one cruise line in Alaska by some of the world's most discerning travelers and cruise experts. Additionally, Koningsdam was voted the top mid-sized cruise ship in the 2020 USA Today 10Best Readers' Choice Awards. New and Notable for 2022 Cruises Special onboard celebrations to commemorate the 75th Anniversary. Every Alaska cruise includes a visit to one or more of Alaska's iconic glacier destinations: Glacier Bay National Park, College Fjord, Hubbard Glacier and the Twin Sawyer Glaciers of Tracy Arm; the company has more Glacier Bay permits than any other major cruise line. Seven-day "Glacier Discovery Northbound" and "Glacier Discovery Southbound" itineraries cruise between Whittier, Alaska, and Vancouver, Canada, aboard Nieuw Amsterdam and Noordam. Ports include Ketchikan, Juneau and Skagway, Alaska. Seven-day "Alaska Inside Passage" cruises sail roundtrip from Vancouver on Koningsdam, Nieuw Amsterdam, Noordam and Zuiderdam. Ports include Ketchikan, Juneau and Skagway. Seven-day "Alaskan Explorer" cruises sail roundtrip from Seattle aboard Eurodam and Oosterdam, and include calls at Victoria, British Columbia; and Ketchikan, Juneau and Sitka, Alaska. All ships cruising in Alaska feature expanded onboard programming: guests can engage with an Alaska naturalist, cruises with Glacier Bay take on a National Park Ranger and Huna native speaker, and special presentations explore local topics such as Alaska's bush pilots and the famous Iditarod race. Highlights for 2022 Denali Land+Sea Journeys: Koningsdam, Nieuw Amsterdam, Noordam and Zuiderdamwill offer Land+Sea Journeys ranging from nine to 18 days. All Denali Land+Sea Journeys include a seven-day Glacier Discovery cruise featuring Glacier Bay and the Inside Passage,as well as either Hubbard Glacier or College Fjord and up to three nights at the McKinley Chalet Resort at the entrance to Denali National Park. Exclusive to Holland America Line, all 2-night and 3-night Denali itineraries include the longer Tundra Wilderness Tour into Denali National Park which provides the best wildlife and mountain viewing opportunities. Holland America Line owns its motorcoaches, railcars and hotels, so schedules are preferential. Each Land+Sea Journey gets a scenic ride on the luxury-domed McKinley Explorer, including select itineraries that offer Direct-to-Denali service, taking guests from their ship to their Denali hotel room on the same day. Highlights for 2022 Yukon+Denali Land+Sea Journeys: Holland America Line is the ONLY cruise line to offer an Alaska cruise combined with an overland tour to both Denali and the Yukon. These highly-rated Yukon itineraries include all of the highlights of our Denali Land+Sea Journeys and more. Each Yukon+Denali Land+Sea Journey includes either a three- or four-day Inside Passage cruise on Koningsdam or Zuiderdam, or a seven-day Glacier Discovery cruise on Nieuw Amsterdam or Noordam. Every Yukon+Denali Land+Sea Journey includes the services of a professional Journey Host, who makes time on land easy, convenient and insightful. Every Yukon Journey includes a ride on the McKinley Explorer railcars, and select itineraries add on the White Pass & Yukon Route railroad from Skagway. Guests on everyYukon Journey will also enjoy two nights in Dawson City, for more time to relive Gold Rush history. A tour on the Klondike Spirit paddlewheeler takes guests along the Yukon River past stunning tall pines, historic towns and wildlife; all Yukon+Denali itineraries also include the Tundra Wilderness Tour. McKinley Chalet Resort and Denali SquareEvery Land+Sea Journey includes a stay at the McKinley Chalet Resort at the entrance to Denali National Park, a must-see destination for the interior of Alaska. The property is Holland America Line's magnificent 60-acre hotel on the Nenana River. The resort features dining facilities and guest rooms, including a 99-room addition featuring Denali Suites with balconies and larger living areas. Centrally located between the McKinley Chalet Resort and riverfront guest rooms, Denali Square is a gathering area with restaurants, an amphitheater, fire pits, outdoor seating, retail shops offering local goods, and an artist-in-residence cabin where Alaska native and local artists display and discuss their works. Save Now, Cruise Later: Have it All SaleFor a limited time, guests who book 2022 Alaska cruises and Land+Sea Journeys by Feb. 28, 2021, can receive up to $2,300 in amenities, including a free Signature Beverage Package, pre-paid gratuities, free Signature Dining Package and 50% reduced deposits, plus free WiFi for suites. Alaska cruise pricing starts at $899 per person, double occupancy, for a seven-day sailing. Land+Sea Journeys start at$1,199 per person, double occupancy, for an 11-day itinerary. Taxes, fees and port expenses are additional. For more information, contact a travel advisor, call 1-877-SAIL HAL (1-877-724-5425) or visit hollandamerica.com. Find Holland America Line on Twitter, Facebook and the Holland America Blog. Access all social media outlets via the home page at hollandamerica.com. About Holland America Line [a division of Carnival Corporation and plc (NYSE: CCL and CUK)]Holland America Line has been exploring the world since 1873 and was the first cruise line to offer adventures to Alaska and the Yukon more than 70 years ago. Its fleet of premium ships visits more than 470 ports in 98 countries around the world, offering an ideal mid-sized ship experience. A third Pinnacle-class ship, Rotterdam, is under construction and will join the fleet in July 2021. The leader in premium cruising, Holland America Line's ships feature innovative initiatives and a diverse range of enriching experiences focused on destination exploration and personalized travel. The best live music at sea fills each evening at Music Walk, and dining venues feature exclusive selections from Holland America Line's esteemed Culinary Council, comprising world-famous chefs. In light of COVID-19, Holland America Line is currently assessing enhanced health and safety protocols and how they may impact future cruises. Actual offerings may vary from what is displayed. Stay updated on current Travel Advisoriesand Health & Safetyprotocols. CONTACT: Erik Elvejord PHONE: 800-637-5029, 206-626-9890 EMAIL: [emailprotected] SOURCE Holland America Line Related Links http://www.hollandamerica.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Holland America Line Celebrates 75 Years in Alaska in 2022. Bookings Open for Award-Winning Alaska Cruises and Land+Sea Journeys to Denali and the Yukon.

More chances to see Glacier Bay and the only Cruise+Denali+Yukon experience make Holland America Line number-one for adventures in Alaska SEATTLE, Jan. 13, 2021 /PRNewswire/ -- In 2022 Holland America Line is celebrating 75 years of Alaska exploration longer than any other cruise line and bookings are now open for its award-winning cruises and Land+Sea Journeys. Throughout the decades, the premium brand has cultivated its knowledge to create perfectly crafted Alaska adventures that offer travelers preferred access, exclusive overland transportation and immersive onboard experiences which is why Holland America Line can say "We Are Alaska." From April through October 2022, guests can embark on Holland America Line's cruises to Alaska aboard Eurodam, Koningsdam, Nieuw Amsterdam, Noordam, Oosterdam and Zuiderdam. For explorers who want to travel farther into the Great Land, 16 different Land+Sea Journeys combine a three-, four- or seven-day Alaska cruise with an inland exploration of Denali National Park. Holland America Line is the only cruise line that extends land tour options up to the unspoiled reaches of Canada's Yukon Territory. "It's incredible to think that Holland America Line has been taking guests to Alaska longer than it's been a state, and because 2022 is our 75th year, we want to allow plenty of time for guests to plan ahead," said Gus Antorcha, Holland America Line's president. "Alaska is a destination where if you've never been, it's on your bucket list; and if you have been, you're eager to go back. There's a reason we've won several awards naming us number-one in Alaska, and it's because we are Alaska. Come celebrate our 75th Anniversary with us." Voted Number-One Cruise Line in Alaska by ManyHolland America Line was named the top pick for Alaska cruises in the 2020 AFAR Travelers' Awards for the third time in five years. In addition to the AFAR award, Holland America Line was named the top pick for Alaska in the 2020 Porthole Cruise Magazine Editor-in-Chief Awards,2019 Cruise Critic Cruisers' Choice Destination Awards and 2019 TravelAge West Wave Awards Editor's Pick, confirming its position as the number-one cruise line in Alaska by some of the world's most discerning travelers and cruise experts. Additionally, Koningsdam was voted the top mid-sized cruise ship in the 2020 USA Today 10Best Readers' Choice Awards. New and Notable for 2022 Cruises Special onboard celebrations to commemorate the 75th Anniversary. Every Alaska cruise includes a visit to one or more of Alaska's iconic glacier destinations: Glacier Bay National Park, College Fjord, Hubbard Glacier and the Twin Sawyer Glaciers of Tracy Arm; the company has more Glacier Bay permits than any other major cruise line. Seven-day "Glacier Discovery Northbound" and "Glacier Discovery Southbound" itineraries cruise between Whittier, Alaska, and Vancouver, Canada, aboard Nieuw Amsterdam and Noordam. Ports include Ketchikan, Juneau and Skagway, Alaska. Seven-day "Alaska Inside Passage" cruises sail roundtrip from Vancouver on Koningsdam, Nieuw Amsterdam, Noordam and Zuiderdam. Ports include Ketchikan, Juneau and Skagway. Seven-day "Alaskan Explorer" cruises sail roundtrip from Seattle aboard Eurodam and Oosterdam, and include calls at Victoria, British Columbia; and Ketchikan, Juneau and Sitka, Alaska. All ships cruising in Alaska feature expanded onboard programming: guests can engage with an Alaska naturalist, cruises with Glacier Bay take on a National Park Ranger and Huna native speaker, and special presentations explore local topics such as Alaska's bush pilots and the famous Iditarod race. Highlights for 2022 Denali Land+Sea Journeys: Koningsdam, Nieuw Amsterdam, Noordam and Zuiderdamwill offer Land+Sea Journeys ranging from nine to 18 days. All Denali Land+Sea Journeys include a seven-day Glacier Discovery cruise featuring Glacier Bay and the Inside Passage,as well as either Hubbard Glacier or College Fjord and up to three nights at the McKinley Chalet Resort at the entrance to Denali National Park. Exclusive to Holland America Line, all 2-night and 3-night Denali itineraries include the longer Tundra Wilderness Tour into Denali National Park which provides the best wildlife and mountain viewing opportunities. Holland America Line owns its motorcoaches, railcars and hotels, so schedules are preferential. Each Land+Sea Journey gets a scenic ride on the luxury-domed McKinley Explorer, including select itineraries that offer Direct-to-Denali service, taking guests from their ship to their Denali hotel room on the same day. Highlights for 2022 Yukon+Denali Land+Sea Journeys: Holland America Line is the ONLY cruise line to offer an Alaska cruise combined with an overland tour to both Denali and the Yukon. These highly-rated Yukon itineraries include all of the highlights of our Denali Land+Sea Journeys and more. Each Yukon+Denali Land+Sea Journey includes either a three- or four-day Inside Passage cruise on Koningsdam or Zuiderdam, or a seven-day Glacier Discovery cruise on Nieuw Amsterdam or Noordam. Every Yukon+Denali Land+Sea Journey includes the services of a professional Journey Host, who makes time on land easy, convenient and insightful. Every Yukon Journey includes a ride on the McKinley Explorer railcars, and select itineraries add on the White Pass & Yukon Route railroad from Skagway. Guests on everyYukon Journey will also enjoy two nights in Dawson City, for more time to relive Gold Rush history. A tour on the Klondike Spirit paddlewheeler takes guests along the Yukon River past stunning tall pines, historic towns and wildlife; all Yukon+Denali itineraries also include the Tundra Wilderness Tour. McKinley Chalet Resort and Denali SquareEvery Land+Sea Journey includes a stay at the McKinley Chalet Resort at the entrance to Denali National Park, a must-see destination for the interior of Alaska. The property is Holland America Line's magnificent 60-acre hotel on the Nenana River. The resort features dining facilities and guest rooms, including a 99-room addition featuring Denali Suites with balconies and larger living areas. Centrally located between the McKinley Chalet Resort and riverfront guest rooms, Denali Square is a gathering area with restaurants, an amphitheater, fire pits, outdoor seating, retail shops offering local goods, and an artist-in-residence cabin where Alaska native and local artists display and discuss their works. Save Now, Cruise Later: Have it All SaleFor a limited time, guests who book 2022 Alaska cruises and Land+Sea Journeys by Feb. 28, 2021, can receive up to $2,300 in amenities, including a free Signature Beverage Package, pre-paid gratuities, free Signature Dining Package and 50% reduced deposits, plus free WiFi for suites. Alaska cruise pricing starts at $899 per person, double occupancy, for a seven-day sailing. Land+Sea Journeys start at$1,199 per person, double occupancy, for an 11-day itinerary. Taxes, fees and port expenses are additional. For more information, contact a travel advisor, call 1-877-SAIL HAL (1-877-724-5425) or visit hollandamerica.com. Find Holland America Line on Twitter, Facebook and the Holland America Blog. Access all social media outlets via the home page at hollandamerica.com. About Holland America Line [a division of Carnival Corporation and plc (NYSE: CCL and CUK)]Holland America Line has been exploring the world since 1873 and was the first cruise line to offer adventures to Alaska and the Yukon more than 70 years ago. Its fleet of premium ships visits more than 470 ports in 98 countries around the world, offering an ideal mid-sized ship experience. A third Pinnacle-class ship, Rotterdam, is under construction and will join the fleet in July 2021. The leader in premium cruising, Holland America Line's ships feature innovative initiatives and a diverse range of enriching experiences focused on destination exploration and personalized travel. The best live music at sea fills each evening at Music Walk, and dining venues feature exclusive selections from Holland America Line's esteemed Culinary Council, comprising world-famous chefs. In light of COVID-19, Holland America Line is currently assessing enhanced health and safety protocols and how they may impact future cruises. Actual offerings may vary from what is displayed. Stay updated on current Travel Advisoriesand Health & Safetyprotocols. CONTACT: Erik Elvejord PHONE: 800-637-5029, 206-626-9890 EMAIL: [emailprotected] SOURCE Holland America Line Related Links http://www.hollandamerica.com

Holland America Line Celebrates 75 Years in Alaska in 2022 -- Bookings Open for Award-Winning Alaska Cruises and Land+Sea Journeys to Denali and the Yukon

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: More chances to see Glacier Bay and the only Cruise+Denali+Yukon experience make Holland America Line number-one for adventures in Alaska SEATTLE, Jan. 13, 2021 /PRNewswire/ -- In 2022 Holland America Line is celebrating 75 years of Alaska exploration longer than any other cruise line and bookings are now open for its award-winning cruises and Land+Sea Journeys. Throughout the decades, the premium brand has cultivated its knowledge to create perfectly crafted Alaska adventures that offer travelers preferred access, exclusive overland transportation and immersive onboard experiences which is why Holland America Line can say "We Are Alaska." From April through October 2022, guests can embark on Holland America Line's cruises to Alaska aboard Eurodam, Koningsdam, Nieuw Amsterdam, Noordam, Oosterdam and Zuiderdam. For explorers who want to travel farther into the Great Land, 16 different Land+Sea Journeys combine a three-, four- or seven-day Alaska cruise with an inland exploration of Denali National Park. Holland America Line is the only cruise line that extends land tour options up to the unspoiled reaches of Canada's Yukon Territory. "It's incredible to think that Holland America Line has been taking guests to Alaska longer than it's been a state, and because 2022 is our 75th year, we want to allow plenty of time for guests to plan ahead," said Gus Antorcha, Holland America Line's president. "Alaska is a destination where if you've never been, it's on your bucket list; and if you have been, you're eager to go back. There's a reason we've won several awards naming us number-one in Alaska, and it's because we are Alaska. Come celebrate our 75th Anniversary with us." Voted Number-One Cruise Line in Alaska by ManyHolland America Line was named the top pick for Alaska cruises in the 2020 AFAR Travelers' Awards for the third time in five years. In addition to the AFAR award, Holland America Line was named the top pick for Alaska in the 2020 Porthole Cruise Magazine Editor-in-Chief Awards,2019 Cruise Critic Cruisers' Choice Destination Awards and 2019 TravelAge West Wave Awards Editor's Pick, confirming its position as the number-one cruise line in Alaska by some of the world's most discerning travelers and cruise experts. Additionally, Koningsdam was voted the top mid-sized cruise ship in the 2020 USA Today 10Best Readers' Choice Awards. New and Notable for 2022 Cruises Special onboard celebrations to commemorate the 75th Anniversary. Every Alaska cruise includes a visit to one or more of Alaska's iconic glacier destinations: Glacier Bay National Park, College Fjord, Hubbard Glacier and the Twin Sawyer Glaciers of Tracy Arm; the company has more Glacier Bay permits than any other major cruise line. Seven-day "Glacier Discovery Northbound" and "Glacier Discovery Southbound" itineraries cruise between Whittier, Alaska, and Vancouver, Canada, aboard Nieuw Amsterdam and Noordam. Ports include Ketchikan, Juneau and Skagway, Alaska. Seven-day "Alaska Inside Passage" cruises sail roundtrip from Vancouver on Koningsdam, Nieuw Amsterdam, Noordam and Zuiderdam. Ports include Ketchikan, Juneau and Skagway. Seven-day "Alaskan Explorer" cruises sail roundtrip from Seattle aboard Eurodam and Oosterdam, and include calls at Victoria, British Columbia; and Ketchikan, Juneau and Sitka, Alaska. All ships cruising in Alaska feature expanded onboard programming: guests can engage with an Alaska naturalist, cruises with Glacier Bay take on a National Park Ranger and Huna native speaker, and special presentations explore local topics such as Alaska's bush pilots and the famous Iditarod race. Highlights for 2022 Denali Land+Sea Journeys: Koningsdam, Nieuw Amsterdam, Noordam and Zuiderdamwill offer Land+Sea Journeys ranging from nine to 18 days. All Denali Land+Sea Journeys include a seven-day Glacier Discovery cruise featuring Glacier Bay and the Inside Passage,as well as either Hubbard Glacier or College Fjord and up to three nights at the McKinley Chalet Resort at the entrance to Denali National Park. Exclusive to Holland America Line, all 2-night and 3-night Denali itineraries include the longer Tundra Wilderness Tour into Denali National Park which provides the best wildlife and mountain viewing opportunities. Holland America Line owns its motorcoaches, railcars and hotels, so schedules are preferential. Each Land+Sea Journey gets a scenic ride on the luxury-domed McKinley Explorer, including select itineraries that offer Direct-to-Denali service, taking guests from their ship to their Denali hotel room on the same day. Highlights for 2022 Yukon+Denali Land+Sea Journeys: Holland America Line is the ONLY cruise line to offer an Alaska cruise combined with an overland tour to both Denali and the Yukon. These highly-rated Yukon itineraries include all of the highlights of our Denali Land+Sea Journeys and more. Each Yukon+Denali Land+Sea Journey includes either a three- or four-day Inside Passage cruise on Koningsdam or Zuiderdam, or a seven-day Glacier Discovery cruise on Nieuw Amsterdam or Noordam. Every Yukon+Denali Land+Sea Journey includes the services of a professional Journey Host, who makes time on land easy, convenient and insightful. Every Yukon Journey includes a ride on the McKinley Explorer railcars, and select itineraries add on the White Pass & Yukon Route railroad from Skagway. Guests on everyYukon Journey will also enjoy two nights in Dawson City, for more time to relive Gold Rush history. A tour on the Klondike Spirit paddlewheeler takes guests along the Yukon River past stunning tall pines, historic towns and wildlife; all Yukon+Denali itineraries also include the Tundra Wilderness Tour. McKinley Chalet Resort and Denali SquareEvery Land+Sea Journey includes a stay at the McKinley Chalet Resort at the entrance to Denali National Park, a must-see destination for the interior of Alaska. The property is Holland America Line's magnificent 60-acre hotel on the Nenana River. The resort features dining facilities and guest rooms, including a 99-room addition featuring Denali Suites with balconies and larger living areas. Centrally located between the McKinley Chalet Resort and riverfront guest rooms, Denali Square is a gathering area with restaurants, an amphitheater, fire pits, outdoor seating, retail shops offering local goods, and an artist-in-residence cabin where Alaska native and local artists display and discuss their works. Save Now, Cruise Later: Have it All SaleFor a limited time, guests who book 2022 Alaska cruises and Land+Sea Journeys by Feb. 28, 2021, can receive up to $2,300 in amenities, including a free Signature Beverage Package, pre-paid gratuities, free Signature Dining Package and 50% reduced deposits, plus free WiFi for suites. Alaska cruise pricing starts at $899 per person, double occupancy, for a seven-day sailing. Land+Sea Journeys start at$1,199 per person, double occupancy, for an 11-day itinerary. Taxes, fees and port expenses are additional. For more information, contact a travel advisor, call 1-877-SAIL HAL (1-877-724-5425) or visit hollandamerica.com. Find Holland America Line on Twitter, Facebook and the Holland America Blog. Access all social media outlets via the home page at hollandamerica.com. About Holland America Line [a division of Carnival Corporation and plc (NYSE: CCL and CUK)]Holland America Line has been exploring the world since 1873 and was the first cruise line to offer adventures to Alaska and the Yukon more than 70 years ago. Its fleet of premium ships visits more than 470 ports in 98 countries around the world, offering an ideal mid-sized ship experience. A third Pinnacle-class ship, Rotterdam, is under construction and will join the fleet in July 2021. The leader in premium cruising, Holland America Line's ships feature innovative initiatives and a diverse range of enriching experiences focused on destination exploration and personalized travel. The best live music at sea fills each evening at Music Walk, and dining venues feature exclusive selections from Holland America Line's esteemed Culinary Council, comprising world-famous chefs. In light of COVID-19, Holland America Line is currently assessing enhanced health and safety protocols and how they may impact future cruises. Actual offerings may vary from what is displayed. Stay updated on current Travel Advisoriesand Health & Safetyprotocols. CONTACT: Erik Elvejord PHONE: 800-637-5029, 206-626-9890 EMAIL: [emailprotected] SOURCE Holland America Line Related Links http://www.hollandamerica.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Holland America Line Celebrates 75 Years in Alaska in 2022. Bookings Open for Award-Winning Alaska Cruises and Land+Sea Journeys to Denali and the Yukon.<|eot_id|>

edtsum878

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN DIEGO, Aug. 13, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by OneSpan Inc.("OneSpanor the "Company") (NASDAQ: OSPN). On August 4, 2020, OneSpan disclosed that it had identified errors related to specific contracts with customers involving software licenses. Then, on August 11, 2020, OneSpan revealed that it could not timely file its quarterly report for the period ended June 30, 2020. OneSpan acknowledged that revenue had been overstated by $2.2 million from the first quarter in the year ended December 31, 2018, to the quarter ended March 31, 2020. Following this news, OneSpan shares plummeted nearly 40%, to close at $18.84 per share on August 12, 2020. If you have information that could assist in this investigation, including past employees and others, or if you are an OneSpan shareholder and are interested in learning more about the investigation, please contact Jim Baker ([emailprotected])by email or phone at 619-814-4471. If emailing, please include a phone number. Additionally, you can [click here to join this action]. There is no cost or obligation to you. About Johnson Fistel, LLP:Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes. Contact:Johnson Fistel, LLPJim Baker, 619-814-4471[emailprotected] [click here to join this action]. SOURCE Johnson Fistel, LLP Related Links http://www.johnsonfistel.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

(OSPN) Alert: Johnson Fistel Investigates OneSpan; Investors Suffering Losses Encouraged to Contact Firm.

SAN DIEGO, Aug. 13, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by OneSpan Inc.("OneSpanor the "Company") (NASDAQ: OSPN). On August 4, 2020, OneSpan disclosed that it had identified errors related to specific contracts with customers involving software licenses. Then, on August 11, 2020, OneSpan revealed that it could not timely file its quarterly report for the period ended June 30, 2020. OneSpan acknowledged that revenue had been overstated by $2.2 million from the first quarter in the year ended December 31, 2018, to the quarter ended March 31, 2020. Following this news, OneSpan shares plummeted nearly 40%, to close at $18.84 per share on August 12, 2020. If you have information that could assist in this investigation, including past employees and others, or if you are an OneSpan shareholder and are interested in learning more about the investigation, please contact Jim Baker ([emailprotected])by email or phone at 619-814-4471. If emailing, please include a phone number. Additionally, you can [click here to join this action]. There is no cost or obligation to you. About Johnson Fistel, LLP:Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes. Contact:Johnson Fistel, LLPJim Baker, 619-814-4471[emailprotected] [click here to join this action]. SOURCE Johnson Fistel, LLP Related Links http://www.johnsonfistel.com

(OSPN) Alert: Johnson Fistel Investigates OneSpan; Investors Suffering Losses Encouraged to Contact Firm

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN DIEGO, Aug. 13, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by OneSpan Inc.("OneSpanor the "Company") (NASDAQ: OSPN). On August 4, 2020, OneSpan disclosed that it had identified errors related to specific contracts with customers involving software licenses. Then, on August 11, 2020, OneSpan revealed that it could not timely file its quarterly report for the period ended June 30, 2020. OneSpan acknowledged that revenue had been overstated by $2.2 million from the first quarter in the year ended December 31, 2018, to the quarter ended March 31, 2020. Following this news, OneSpan shares plummeted nearly 40%, to close at $18.84 per share on August 12, 2020. If you have information that could assist in this investigation, including past employees and others, or if you are an OneSpan shareholder and are interested in learning more about the investigation, please contact Jim Baker ([emailprotected])by email or phone at 619-814-4471. If emailing, please include a phone number. Additionally, you can [click here to join this action]. There is no cost or obligation to you. About Johnson Fistel, LLP:Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes. Contact:Johnson Fistel, LLPJim Baker, 619-814-4471[emailprotected] [click here to join this action]. SOURCE Johnson Fistel, LLP Related Links http://www.johnsonfistel.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> (OSPN) Alert: Johnson Fistel Investigates OneSpan; Investors Suffering Losses Encouraged to Contact Firm.<|eot_id|>

edtsum879

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LONDON--(BUSINESS WIRE)--SpendEdge forecast the global Industrial Lighting market is expected to grow by USD 1 billion as we reach 2024. This is due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 2.13%. For the Right Perspective & Competitive Insights- Request Free Sample Report on Pandemic Recovery Analysis Read the 120-page research report with TOC and LOE on "Global Industrial Lighting market Procurement Intelligence Report, Pricing Outlook in Geographies that include APAC, North America, South America, and MEA, and insights into best practices to optimize procurement spend." Our Industrial Lighting market procurement intelligence report offers actionable procurement intelligence insights, sourcing strategies, and action plans to mitigate risks arising out of the current pandemic situation. The insights offered by our reports will help procurement professionals streamline supply chain operations and gain insights into the best procurement practices to mitigate losses. Major Five Industrial Lighting Companies: To get instant access to over 1000 market-ready procurement intelligence reports without any additional costs or commitment, Subscribe Now for Free. Industrial Lighting 2020-2024: Scope SpendEdge presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The Industrial Lighting market report covers the following areas: Industrial Lighting Market Geographic Landscape Outlook SpendEdge suggests various forecast scenarios considering the impact of COVID-19. SpendEdges in-depth research has direct and indirect COVID-19 impacted market research reports. SpendEdge's SUBSCRIPTION platform Industrial Lighting Market 2020-2024: Key Highlights Related Reports on Information Technology Include: Get access to regular sourcing and procurement insights to our digital procurement platform- Contact Us. Table of Content Executive Summary Market Insights Category Pricing Insights Cost-saving Opportunities Best Practices Category Ecosystem Category Management Strategy Category Management Enablers Suppliers Selection Suppliers under Coverage US Market Insights Category scope Appendix About SpendEdge: SpendEdge shares your passion for driving sourcing and procurement excellence. We are the preferred procurement market intelligence partner for 120+ Fortune 500 firms and other leading companies across numerous industries. Our strength lies in delivering robust, real-time procurement market intelligence reports and solutions. To know more https://www.spendedge.com/request-for-demo Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Industrial Lighting Market: Impact and Recovery Report. | Evolving Opportunities and New Market Possibilities Post Pandemic. | SpendEdge.

LONDON--(BUSINESS WIRE)--SpendEdge forecast the global Industrial Lighting market is expected to grow by USD 1 billion as we reach 2024. This is due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 2.13%. For the Right Perspective & Competitive Insights- Request Free Sample Report on Pandemic Recovery Analysis Read the 120-page research report with TOC and LOE on "Global Industrial Lighting market Procurement Intelligence Report, Pricing Outlook in Geographies that include APAC, North America, South America, and MEA, and insights into best practices to optimize procurement spend." Our Industrial Lighting market procurement intelligence report offers actionable procurement intelligence insights, sourcing strategies, and action plans to mitigate risks arising out of the current pandemic situation. The insights offered by our reports will help procurement professionals streamline supply chain operations and gain insights into the best procurement practices to mitigate losses. Major Five Industrial Lighting Companies: To get instant access to over 1000 market-ready procurement intelligence reports without any additional costs or commitment, Subscribe Now for Free. Industrial Lighting 2020-2024: Scope SpendEdge presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The Industrial Lighting market report covers the following areas: Industrial Lighting Market Geographic Landscape Outlook SpendEdge suggests various forecast scenarios considering the impact of COVID-19. SpendEdges in-depth research has direct and indirect COVID-19 impacted market research reports. SpendEdge's SUBSCRIPTION platform Industrial Lighting Market 2020-2024: Key Highlights Related Reports on Information Technology Include: Get access to regular sourcing and procurement insights to our digital procurement platform- Contact Us. Table of Content Executive Summary Market Insights Category Pricing Insights Cost-saving Opportunities Best Practices Category Ecosystem Category Management Strategy Category Management Enablers Suppliers Selection Suppliers under Coverage US Market Insights Category scope Appendix About SpendEdge: SpendEdge shares your passion for driving sourcing and procurement excellence. We are the preferred procurement market intelligence partner for 120+ Fortune 500 firms and other leading companies across numerous industries. Our strength lies in delivering robust, real-time procurement market intelligence reports and solutions. To know more https://www.spendedge.com/request-for-demo

Industrial Lighting Market: Impact and Recovery Report | Evolving Opportunities and New Market Possibilities Post Pandemic | SpendEdge

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LONDON--(BUSINESS WIRE)--SpendEdge forecast the global Industrial Lighting market is expected to grow by USD 1 billion as we reach 2024. This is due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 2.13%. For the Right Perspective & Competitive Insights- Request Free Sample Report on Pandemic Recovery Analysis Read the 120-page research report with TOC and LOE on "Global Industrial Lighting market Procurement Intelligence Report, Pricing Outlook in Geographies that include APAC, North America, South America, and MEA, and insights into best practices to optimize procurement spend." Our Industrial Lighting market procurement intelligence report offers actionable procurement intelligence insights, sourcing strategies, and action plans to mitigate risks arising out of the current pandemic situation. The insights offered by our reports will help procurement professionals streamline supply chain operations and gain insights into the best procurement practices to mitigate losses. Major Five Industrial Lighting Companies: To get instant access to over 1000 market-ready procurement intelligence reports without any additional costs or commitment, Subscribe Now for Free. Industrial Lighting 2020-2024: Scope SpendEdge presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The Industrial Lighting market report covers the following areas: Industrial Lighting Market Geographic Landscape Outlook SpendEdge suggests various forecast scenarios considering the impact of COVID-19. SpendEdges in-depth research has direct and indirect COVID-19 impacted market research reports. SpendEdge's SUBSCRIPTION platform Industrial Lighting Market 2020-2024: Key Highlights Related Reports on Information Technology Include: Get access to regular sourcing and procurement insights to our digital procurement platform- Contact Us. Table of Content Executive Summary Market Insights Category Pricing Insights Cost-saving Opportunities Best Practices Category Ecosystem Category Management Strategy Category Management Enablers Suppliers Selection Suppliers under Coverage US Market Insights Category scope Appendix About SpendEdge: SpendEdge shares your passion for driving sourcing and procurement excellence. We are the preferred procurement market intelligence partner for 120+ Fortune 500 firms and other leading companies across numerous industries. Our strength lies in delivering robust, real-time procurement market intelligence reports and solutions. To know more https://www.spendedge.com/request-for-demo Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Industrial Lighting Market: Impact and Recovery Report. | Evolving Opportunities and New Market Possibilities Post Pandemic. | SpendEdge.<|eot_id|>

edtsum880

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN FRANCISCO, Oct. 7, 2020 /PRNewswire/ -- Redaptive Inc., a leading provider of Efficiency-as-a-Service solutions for commercial and industrial customers, announced today it has closed $156.5 million in funding led by CarVal Investors. Existing investors CBRE, Engie New Ventures, EvergyVentures and Linse Capital also invested in the company alongside CarVal. Redaptive will leverage this operating capital to expand its energy efficiency offerings to meet growing demand from existing and new customers. More companies are seeing the benefit of running their operations smarter, more efficiently, and more sustainably. Tweet this Redaptive enables energy efficiency retrofit programs without upfront capital and guarantees results using directly measured building data. This allows companies to reduce their costs while continuing to scale their operations. Redaptive has partnered with a growing number of companies around the world, including Iron Mountain, McKesson, Saint-Gobain, SRS Distribution, Avantor, Swedish Health Services and more. "Achieving our sustainability commitments and optimizing our capital allocation are key components to our business strategy and are important to our employees and customers around the world," said Dan Anninos, Iron Mountain's VP of Global Facility Management. "Redaptive has played a fundamental role in helping us achieve broad emission and energy reductions, through our energy efficiency programs, while all along preserving internal capital for our core business in North America and across Europe." These strong partnerships have been pivotal to the company's continued growth and demand. Redaptive's guaranteed energy and cost savings, risk management, and program funding have resulted in reduced energy emissions for scores of customers, as sustainable infrastructure rises as a global imperative. Thus far, Redaptive has enabled over $380 million in sustainability projects and a total energy reduction of 1.1 billion kilowatt-hours, which is equivalent to approximately 778,000 metric tons of CO2 or 1.8 million barrels of oil consumed."More companies are seeing the benefit of running their operations smarter, more efficiently, and more sustainably," said Jerry Keefe, a Principal at CarVal Investors. "Providing companies with a way to reduce their energy and carbon footprint and save on costs without having to spend any capital is the perfect innovation for times like these and we see a bright and bankable future for Redaptive and their model."Redaptive's ability to lower facility maintenance costs, reduce grid reliance and perform data-driven energy efficiency retrofits is accelerating their customers' ability toexceed their sustainability goals while maintaining their bottom line. Current offerings include energy-efficient lighting and heating, ventilation and air conditioning (HVAC) systems, including boilers, chillers and rooftop units. With this funding, the company will be able to expand its offerings and deploy over $1 billion in new projects."We've achieved record sales this year, despite the global pandemic. By reducing costs for our customers we're seeing an increase in commitments from companies to make their facilities more efficient, resilient and sustainable," said Redaptive CEO Arvin Vohra. Redaptive's Executive Chairman, John Rhow, added, "We thank CarVal, and our existing investors, for their support as we expand our offerings to meet the broader global need."About RedaptiveRedaptive enables large-scale rapid deployment of building efficiency technologies that reduce operational expenses and deliver immediate returns and long-term value across our customers' real estate portfolios. Our Efficiency-as-a-Service solution provides turnkey efficiency upgrades that include materials, installation and maintenance. Customers realize immediate utility bill savings and actual kWh savings verified through Redaptive's metering and building intelligence platform. Redaptive manages a global portfolio of efficiency programs for commercial and industrial customers, including Iron Mountain, Swedish Health Services, Sutter Home, Bentley Mills, SRS Distribution, New Senior, Avantor, Saint-Gobain, Aramark, McKesson, and more. Redaptive has headquarters in San Francisco and offices in Denver and Pune, India. For more information, please visithttp://www.redaptiveinc.com.About CarVal InvestorsCarVal Investors is a leading global alternative investment fund manager focused on credit-intensive assets and market inefficiencies. Over the past four years, CarVal has invested more than $1.5 billion in assets and companies within clean energy and sustainability. Since 1987, CarVal's experienced team has navigated through ever-changing credit market cycles, opportunistically investing $123 billion in 5,480 transactions across 82 countries. Today, CarVal Investors has approximately $9 billion in assets under management in corporate securities, loan portfolios, structured credit and hard assets. For more information, visit http://www.carvalinvestors.com/.Media ContactRedaptiveMission Control Communications (mc) for Redaptive[emailprotected]SOURCE Redaptive Related Links https://redaptiveinc.com/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Energy Efficiency Leader Redaptive Secures $156.5 Million In Funding Led By CarVal Investors. Growing need to meet sustainability targets, reduce energy costs, and scale portfolio-wide resiliency drives demand for Redaptive's Efficiency-as-a-Service solutions in North America and worldwide.

SAN FRANCISCO, Oct. 7, 2020 /PRNewswire/ -- Redaptive Inc., a leading provider of Efficiency-as-a-Service solutions for commercial and industrial customers, announced today it has closed $156.5 million in funding led by CarVal Investors. Existing investors CBRE, Engie New Ventures, EvergyVentures and Linse Capital also invested in the company alongside CarVal. Redaptive will leverage this operating capital to expand its energy efficiency offerings to meet growing demand from existing and new customers. More companies are seeing the benefit of running their operations smarter, more efficiently, and more sustainably. Tweet this Redaptive enables energy efficiency retrofit programs without upfront capital and guarantees results using directly measured building data. This allows companies to reduce their costs while continuing to scale their operations. Redaptive has partnered with a growing number of companies around the world, including Iron Mountain, McKesson, Saint-Gobain, SRS Distribution, Avantor, Swedish Health Services and more. "Achieving our sustainability commitments and optimizing our capital allocation are key components to our business strategy and are important to our employees and customers around the world," said Dan Anninos, Iron Mountain's VP of Global Facility Management. "Redaptive has played a fundamental role in helping us achieve broad emission and energy reductions, through our energy efficiency programs, while all along preserving internal capital for our core business in North America and across Europe." These strong partnerships have been pivotal to the company's continued growth and demand. Redaptive's guaranteed energy and cost savings, risk management, and program funding have resulted in reduced energy emissions for scores of customers, as sustainable infrastructure rises as a global imperative. Thus far, Redaptive has enabled over $380 million in sustainability projects and a total energy reduction of 1.1 billion kilowatt-hours, which is equivalent to approximately 778,000 metric tons of CO2 or 1.8 million barrels of oil consumed."More companies are seeing the benefit of running their operations smarter, more efficiently, and more sustainably," said Jerry Keefe, a Principal at CarVal Investors. "Providing companies with a way to reduce their energy and carbon footprint and save on costs without having to spend any capital is the perfect innovation for times like these and we see a bright and bankable future for Redaptive and their model."Redaptive's ability to lower facility maintenance costs, reduce grid reliance and perform data-driven energy efficiency retrofits is accelerating their customers' ability toexceed their sustainability goals while maintaining their bottom line. Current offerings include energy-efficient lighting and heating, ventilation and air conditioning (HVAC) systems, including boilers, chillers and rooftop units. With this funding, the company will be able to expand its offerings and deploy over $1 billion in new projects."We've achieved record sales this year, despite the global pandemic. By reducing costs for our customers we're seeing an increase in commitments from companies to make their facilities more efficient, resilient and sustainable," said Redaptive CEO Arvin Vohra. Redaptive's Executive Chairman, John Rhow, added, "We thank CarVal, and our existing investors, for their support as we expand our offerings to meet the broader global need."About RedaptiveRedaptive enables large-scale rapid deployment of building efficiency technologies that reduce operational expenses and deliver immediate returns and long-term value across our customers' real estate portfolios. Our Efficiency-as-a-Service solution provides turnkey efficiency upgrades that include materials, installation and maintenance. Customers realize immediate utility bill savings and actual kWh savings verified through Redaptive's metering and building intelligence platform. Redaptive manages a global portfolio of efficiency programs for commercial and industrial customers, including Iron Mountain, Swedish Health Services, Sutter Home, Bentley Mills, SRS Distribution, New Senior, Avantor, Saint-Gobain, Aramark, McKesson, and more. Redaptive has headquarters in San Francisco and offices in Denver and Pune, India. For more information, please visithttp://www.redaptiveinc.com.About CarVal InvestorsCarVal Investors is a leading global alternative investment fund manager focused on credit-intensive assets and market inefficiencies. Over the past four years, CarVal has invested more than $1.5 billion in assets and companies within clean energy and sustainability. Since 1987, CarVal's experienced team has navigated through ever-changing credit market cycles, opportunistically investing $123 billion in 5,480 transactions across 82 countries. Today, CarVal Investors has approximately $9 billion in assets under management in corporate securities, loan portfolios, structured credit and hard assets. For more information, visit http://www.carvalinvestors.com/.Media ContactRedaptiveMission Control Communications (mc) for Redaptive[emailprotected]SOURCE Redaptive Related Links https://redaptiveinc.com/

Energy Efficiency Leader Redaptive Secures $156.5 Million In Funding Led By CarVal Investors Growing need to meet sustainability targets, reduce energy costs and scale portfolio-wide resiliency drives demand for Redaptive's Efficiency-as-a-Service solutions in North America and worldwide

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN FRANCISCO, Oct. 7, 2020 /PRNewswire/ -- Redaptive Inc., a leading provider of Efficiency-as-a-Service solutions for commercial and industrial customers, announced today it has closed $156.5 million in funding led by CarVal Investors. Existing investors CBRE, Engie New Ventures, EvergyVentures and Linse Capital also invested in the company alongside CarVal. Redaptive will leverage this operating capital to expand its energy efficiency offerings to meet growing demand from existing and new customers. More companies are seeing the benefit of running their operations smarter, more efficiently, and more sustainably. Tweet this Redaptive enables energy efficiency retrofit programs without upfront capital and guarantees results using directly measured building data. This allows companies to reduce their costs while continuing to scale their operations. Redaptive has partnered with a growing number of companies around the world, including Iron Mountain, McKesson, Saint-Gobain, SRS Distribution, Avantor, Swedish Health Services and more. "Achieving our sustainability commitments and optimizing our capital allocation are key components to our business strategy and are important to our employees and customers around the world," said Dan Anninos, Iron Mountain's VP of Global Facility Management. "Redaptive has played a fundamental role in helping us achieve broad emission and energy reductions, through our energy efficiency programs, while all along preserving internal capital for our core business in North America and across Europe." These strong partnerships have been pivotal to the company's continued growth and demand. Redaptive's guaranteed energy and cost savings, risk management, and program funding have resulted in reduced energy emissions for scores of customers, as sustainable infrastructure rises as a global imperative. Thus far, Redaptive has enabled over $380 million in sustainability projects and a total energy reduction of 1.1 billion kilowatt-hours, which is equivalent to approximately 778,000 metric tons of CO2 or 1.8 million barrels of oil consumed."More companies are seeing the benefit of running their operations smarter, more efficiently, and more sustainably," said Jerry Keefe, a Principal at CarVal Investors. "Providing companies with a way to reduce their energy and carbon footprint and save on costs without having to spend any capital is the perfect innovation for times like these and we see a bright and bankable future for Redaptive and their model."Redaptive's ability to lower facility maintenance costs, reduce grid reliance and perform data-driven energy efficiency retrofits is accelerating their customers' ability toexceed their sustainability goals while maintaining their bottom line. Current offerings include energy-efficient lighting and heating, ventilation and air conditioning (HVAC) systems, including boilers, chillers and rooftop units. With this funding, the company will be able to expand its offerings and deploy over $1 billion in new projects."We've achieved record sales this year, despite the global pandemic. By reducing costs for our customers we're seeing an increase in commitments from companies to make their facilities more efficient, resilient and sustainable," said Redaptive CEO Arvin Vohra. Redaptive's Executive Chairman, John Rhow, added, "We thank CarVal, and our existing investors, for their support as we expand our offerings to meet the broader global need."About RedaptiveRedaptive enables large-scale rapid deployment of building efficiency technologies that reduce operational expenses and deliver immediate returns and long-term value across our customers' real estate portfolios. Our Efficiency-as-a-Service solution provides turnkey efficiency upgrades that include materials, installation and maintenance. Customers realize immediate utility bill savings and actual kWh savings verified through Redaptive's metering and building intelligence platform. Redaptive manages a global portfolio of efficiency programs for commercial and industrial customers, including Iron Mountain, Swedish Health Services, Sutter Home, Bentley Mills, SRS Distribution, New Senior, Avantor, Saint-Gobain, Aramark, McKesson, and more. Redaptive has headquarters in San Francisco and offices in Denver and Pune, India. For more information, please visithttp://www.redaptiveinc.com.About CarVal InvestorsCarVal Investors is a leading global alternative investment fund manager focused on credit-intensive assets and market inefficiencies. Over the past four years, CarVal has invested more than $1.5 billion in assets and companies within clean energy and sustainability. Since 1987, CarVal's experienced team has navigated through ever-changing credit market cycles, opportunistically investing $123 billion in 5,480 transactions across 82 countries. Today, CarVal Investors has approximately $9 billion in assets under management in corporate securities, loan portfolios, structured credit and hard assets. For more information, visit http://www.carvalinvestors.com/.Media ContactRedaptiveMission Control Communications (mc) for Redaptive[emailprotected]SOURCE Redaptive Related Links https://redaptiveinc.com/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Energy Efficiency Leader Redaptive Secures $156.5 Million In Funding Led By CarVal Investors. Growing need to meet sustainability targets, reduce energy costs, and scale portfolio-wide resiliency drives demand for Redaptive's Efficiency-as-a-Service solutions in North America and worldwide.<|eot_id|>

edtsum881

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SHANGHAI, Nov. 3, 2020 /PRNewswire/ -- CooTek (Cayman) Inc. (NYSE: CTK) ("CooTek" or the "Company"), a fast-growing global mobile internet company, today announced that the Company will present and meet with institutional investors at the following virtual investor conferences. For more information on CooTek presentations, please visit investor relations website https://ir.cootek.com. BofA Securities 2020 China ConferencePanel or one-on-one Discussion on November 2 - November 13, 2020; Citi China Investor Conference 2020 Panel or one-on-one Discussion on November 4 - November 6, 2020; dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor ConferencePresentation on Wednesday, November 18, 2020 at 10:30 a.m. HKT. The Company's management will participate in virtual meetings with institutional investors throughout these events. For additional information, please contact your respective institutional sales representative at each sponsoring bank. About CooTek (Cayman) Inc. CooTek is a fast-growing mobile internet company with a global vision, offering mobile applications. Our mission is to empower everyone to enjoy relevant content seamlessly. The Company's user-centric and data-driven approach has enabled it to release appealing products to capture mobile internet users' ever-evolving content needs and helps it rapidly attract targeted users. CooTek has developed and brought to market content-rich mobile applications, focusing on three categories: online literature, scenario-based content apps and casual games. For more information on CooTek, please visit https://ir.cootek.com. For more information, please contact: CooTek (Cayman) Inc. Mr. Robert Cui[emailprotected] Christensen In ChinaMr. Rene VanguestainePhone: +86-10-5900-1548E-mail: [emailprotected]In U.S.Ms. Linda BergkampPhone: +1-480-614-3004Email: [emailprotected] SOURCE CooTek Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

CooTek to Participate in November Investor Conferences.

SHANGHAI, Nov. 3, 2020 /PRNewswire/ -- CooTek (Cayman) Inc. (NYSE: CTK) ("CooTek" or the "Company"), a fast-growing global mobile internet company, today announced that the Company will present and meet with institutional investors at the following virtual investor conferences. For more information on CooTek presentations, please visit investor relations website https://ir.cootek.com. BofA Securities 2020 China ConferencePanel or one-on-one Discussion on November 2 - November 13, 2020; Citi China Investor Conference 2020 Panel or one-on-one Discussion on November 4 - November 6, 2020; dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor ConferencePresentation on Wednesday, November 18, 2020 at 10:30 a.m. HKT. The Company's management will participate in virtual meetings with institutional investors throughout these events. For additional information, please contact your respective institutional sales representative at each sponsoring bank. About CooTek (Cayman) Inc. CooTek is a fast-growing mobile internet company with a global vision, offering mobile applications. Our mission is to empower everyone to enjoy relevant content seamlessly. The Company's user-centric and data-driven approach has enabled it to release appealing products to capture mobile internet users' ever-evolving content needs and helps it rapidly attract targeted users. CooTek has developed and brought to market content-rich mobile applications, focusing on three categories: online literature, scenario-based content apps and casual games. For more information on CooTek, please visit https://ir.cootek.com. For more information, please contact: CooTek (Cayman) Inc. Mr. Robert Cui[emailprotected] Christensen In ChinaMr. Rene VanguestainePhone: +86-10-5900-1548E-mail: [emailprotected]In U.S.Ms. Linda BergkampPhone: +1-480-614-3004Email: [emailprotected] SOURCE CooTek

CooTek to Participate in November Investor Conferences

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SHANGHAI, Nov. 3, 2020 /PRNewswire/ -- CooTek (Cayman) Inc. (NYSE: CTK) ("CooTek" or the "Company"), a fast-growing global mobile internet company, today announced that the Company will present and meet with institutional investors at the following virtual investor conferences. For more information on CooTek presentations, please visit investor relations website https://ir.cootek.com. BofA Securities 2020 China ConferencePanel or one-on-one Discussion on November 2 - November 13, 2020; Citi China Investor Conference 2020 Panel or one-on-one Discussion on November 4 - November 6, 2020; dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor ConferencePresentation on Wednesday, November 18, 2020 at 10:30 a.m. HKT. The Company's management will participate in virtual meetings with institutional investors throughout these events. For additional information, please contact your respective institutional sales representative at each sponsoring bank. About CooTek (Cayman) Inc. CooTek is a fast-growing mobile internet company with a global vision, offering mobile applications. Our mission is to empower everyone to enjoy relevant content seamlessly. The Company's user-centric and data-driven approach has enabled it to release appealing products to capture mobile internet users' ever-evolving content needs and helps it rapidly attract targeted users. CooTek has developed and brought to market content-rich mobile applications, focusing on three categories: online literature, scenario-based content apps and casual games. For more information on CooTek, please visit https://ir.cootek.com. For more information, please contact: CooTek (Cayman) Inc. Mr. Robert Cui[emailprotected] Christensen In ChinaMr. Rene VanguestainePhone: +86-10-5900-1548E-mail: [emailprotected]In U.S.Ms. Linda BergkampPhone: +1-480-614-3004Email: [emailprotected] SOURCE CooTek Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> CooTek to Participate in November Investor Conferences.<|eot_id|>

edtsum882

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: REDWOOD CITY, Calif., Feb. 8, 2021 /PRNewswire/ --Area 1 Security, the only preemptive cloud email security provider, announced that CRN, a brand ofThe Channel Company, has named Steve Pataky, Chief Revenue Officer, and Dawn Ringstaff, Director of Global Channel Sales, to its 2021 list of Channel Chiefs. Pataky has also been named to CRN's exclusive list of the 50 Most Influential Channel Chiefs for 2021. The CRN Channel Chiefs award recognizes leading IT channel vendor executives who continually demonstrate outstanding leadership, influence, innovation, and growth. The Channel Company names Area 1 Securitys Steve Pataky, Dawn Ringstaff to the 2021 CRN Channel Chiefs. Pataky is also named to CRNs exclusive list of the 50 Most Influential Channel Chiefs for 2021. Under their leadership, Area 1 has successfully pivoted to a 100% partner-centric go-to-market model. Tweet this Pataky and Ringstaff both joined Area 1 Security in 2020 to help expand the company's partnership initiatives and accelerate opportunities with VAR/Solution Providers, distributors, MSSPs, consultants, and technology alliances. Under their leadership, Area 1 has successfully pivoted to a 100% partner-centric go-to-market model and launched a new, two-tiered partner program; within the first quarter of the program's launch, Area 1 recruited over 40 partners and achieved over 80 percent channel revenue growth in 2H 2020. "As businesses have moved to the cloud, so have hackers: millions of phish evade traditional email gateways and cloud email suites each year. Organizations fed up with ineffective legacy defenses are now turning to their partners for a better solution," said Pataky. "This challenge represents a multibillion-dollar opportunity for partners to transition customers to Area 1 the only cloud email security solution that stops phishing attacks before they breach. I'm incredibly energized to play a role in this market shift, and to be recognized for our channel investments." Ringstaff added, "It's an honor to be included in the Channel Chiefs list this year. After having 25 years of channel sales experience under my belt, I truly believe this accolade demonstrates the perfect confluence of working with the best-possible product, team and partners, in the right market at the right time. I look forward to building on this momentum in 2021 and beyond."Each of the 2021 Channel Chiefs are prominent leaders who have influenced the IT channel with cutting-edge strategies, programs and partnerships. All honorees are selected by CRN's editorial staff based on their dedication, industry prestige, and exceptional accomplishments as channel advocates. The 50 Most Influential Channel Chiefs were chosen by the CRN editorial staff as the individuals who stand at the very top of this elite group."Having worked with both Steve and Dawn at prior organizations I had complete faith that they would drive an amazing expansion strategy for Area 1. I couldn't be more excited and proud of their accomplishments. In just six months, they have successfully led us to a new channel-centric sales model," said Patrick Sweeney, CEO and President of Area 1 Security. "This CRN recognition is yet another testament to their unmatched expertise in building innovative, scalable partner programs and ecosystems."Before joining Area 1, Pataky led partner sales as an Advisor for Ubiq Security, and previously served as Chief Revenue Officer for SonicWall and VP of Worldwide Channels and Alliances at FireEye). Pataky's notable leadership record includes being a key part of divesting SonicWall out of Dell and rebuilding SonicWall's independent channel of more than 17,000 partners worldwide. Pataky has been previously recognized as a CRN Channel Chief, including being named to the 50 Most Influential Channel Chiefs in 2014, 2015, 2017 and 2018. He also earned the Channel Innovation Awards Security Channel Chief of the Year in 2017.Ringstaff has a successful track record for developing channel programs that not only grow partner revenue but also partner sales and technical capabilities. Her experience prior to Area 1 includes Regional VP of Sales for Talari SD-WAN (acquired by Oracle), over a decade with SonicWall as a regional director and Channel leader, preceded by channel experience at Kaspersky Labs. Dawn was a recipient of CRN's Women of the Channel in 2017 and 2018."CRN's 2021 Channel Chiefs list includes the industry's biggest channel evangelists, a group of individuals who work tirelessly on behalf of their partners and drive growth through the development of strong partner programs and innovative business strategies that help bring business-critical solutions to market," said Blaine Raddon, CEO of The Channel Company. "The Channel Company is proud to recognize these channel influencers and looks forward to following their continued success."CRN's 2021 Channel Chiefs list, including the 50 Most Influential Channel Chiefs, will be featured in the February 2021 issue of CRN Magazine and online atwww.CRN.com/ChannelChiefs.About Area 1 SecurityArea 1 Security is the only company that preemptively stops Business Email Compromise, malware, ransomware and targeted phishing attacks. By focusing on the earliest stages of an attack, Area 1 stops phish the root cause of 95 percent of breaches 24 days (on average) before they launch. Area 1 also offers the cybersecurity industry's first and only performance-based pricing model, Pay-per-Phish.Area 1 is trusted by Fortune 500 enterprises across financial services, healthcare, critical infrastructure and other industries, to preempt targeted phishing attacks, improve their cybersecurity posture, and change outcomes.Area 1 is a Certified Microsoft Partner, and Google Cloud Technology Partner of the Year for Security. To learn more, visitwww.area1security.com, follow us onLinkedIn, or subscribe to thePhish of the Weeknewsletter.About The Channel CompanyThe Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers and end users. Backed by more than 30 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace.www.thechannelcompany.com Follow The Channel Company:Twitter,LinkedIn, andFacebook. 2021. CRN is a registered trademark of The Channel Company, LLC. All rights reserved.Contacts:Elaine DzubaArea 1 Security[emailprotected] Jennifer HoganThe Channel Company[emailprotected]SOURCE Area 1 Security Related Links https://www.area1security.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Area 1 Security's Steve Pataky and Dawn Ringstaff Recognized as 2021 CRN Channel Chiefs. Pataky Also Named to Elite List of CRN's 50 Most Influential Channel Chiefs of 2021.

REDWOOD CITY, Calif., Feb. 8, 2021 /PRNewswire/ --Area 1 Security, the only preemptive cloud email security provider, announced that CRN, a brand ofThe Channel Company, has named Steve Pataky, Chief Revenue Officer, and Dawn Ringstaff, Director of Global Channel Sales, to its 2021 list of Channel Chiefs. Pataky has also been named to CRN's exclusive list of the 50 Most Influential Channel Chiefs for 2021. The CRN Channel Chiefs award recognizes leading IT channel vendor executives who continually demonstrate outstanding leadership, influence, innovation, and growth. The Channel Company names Area 1 Securitys Steve Pataky, Dawn Ringstaff to the 2021 CRN Channel Chiefs. Pataky is also named to CRNs exclusive list of the 50 Most Influential Channel Chiefs for 2021. Under their leadership, Area 1 has successfully pivoted to a 100% partner-centric go-to-market model. Tweet this Pataky and Ringstaff both joined Area 1 Security in 2020 to help expand the company's partnership initiatives and accelerate opportunities with VAR/Solution Providers, distributors, MSSPs, consultants, and technology alliances. Under their leadership, Area 1 has successfully pivoted to a 100% partner-centric go-to-market model and launched a new, two-tiered partner program; within the first quarter of the program's launch, Area 1 recruited over 40 partners and achieved over 80 percent channel revenue growth in 2H 2020. "As businesses have moved to the cloud, so have hackers: millions of phish evade traditional email gateways and cloud email suites each year. Organizations fed up with ineffective legacy defenses are now turning to their partners for a better solution," said Pataky. "This challenge represents a multibillion-dollar opportunity for partners to transition customers to Area 1 the only cloud email security solution that stops phishing attacks before they breach. I'm incredibly energized to play a role in this market shift, and to be recognized for our channel investments." Ringstaff added, "It's an honor to be included in the Channel Chiefs list this year. After having 25 years of channel sales experience under my belt, I truly believe this accolade demonstrates the perfect confluence of working with the best-possible product, team and partners, in the right market at the right time. I look forward to building on this momentum in 2021 and beyond."Each of the 2021 Channel Chiefs are prominent leaders who have influenced the IT channel with cutting-edge strategies, programs and partnerships. All honorees are selected by CRN's editorial staff based on their dedication, industry prestige, and exceptional accomplishments as channel advocates. The 50 Most Influential Channel Chiefs were chosen by the CRN editorial staff as the individuals who stand at the very top of this elite group."Having worked with both Steve and Dawn at prior organizations I had complete faith that they would drive an amazing expansion strategy for Area 1. I couldn't be more excited and proud of their accomplishments. In just six months, they have successfully led us to a new channel-centric sales model," said Patrick Sweeney, CEO and President of Area 1 Security. "This CRN recognition is yet another testament to their unmatched expertise in building innovative, scalable partner programs and ecosystems."Before joining Area 1, Pataky led partner sales as an Advisor for Ubiq Security, and previously served as Chief Revenue Officer for SonicWall and VP of Worldwide Channels and Alliances at FireEye). Pataky's notable leadership record includes being a key part of divesting SonicWall out of Dell and rebuilding SonicWall's independent channel of more than 17,000 partners worldwide. Pataky has been previously recognized as a CRN Channel Chief, including being named to the 50 Most Influential Channel Chiefs in 2014, 2015, 2017 and 2018. He also earned the Channel Innovation Awards Security Channel Chief of the Year in 2017.Ringstaff has a successful track record for developing channel programs that not only grow partner revenue but also partner sales and technical capabilities. Her experience prior to Area 1 includes Regional VP of Sales for Talari SD-WAN (acquired by Oracle), over a decade with SonicWall as a regional director and Channel leader, preceded by channel experience at Kaspersky Labs. Dawn was a recipient of CRN's Women of the Channel in 2017 and 2018."CRN's 2021 Channel Chiefs list includes the industry's biggest channel evangelists, a group of individuals who work tirelessly on behalf of their partners and drive growth through the development of strong partner programs and innovative business strategies that help bring business-critical solutions to market," said Blaine Raddon, CEO of The Channel Company. "The Channel Company is proud to recognize these channel influencers and looks forward to following their continued success."CRN's 2021 Channel Chiefs list, including the 50 Most Influential Channel Chiefs, will be featured in the February 2021 issue of CRN Magazine and online atwww.CRN.com/ChannelChiefs.About Area 1 SecurityArea 1 Security is the only company that preemptively stops Business Email Compromise, malware, ransomware and targeted phishing attacks. By focusing on the earliest stages of an attack, Area 1 stops phish the root cause of 95 percent of breaches 24 days (on average) before they launch. Area 1 also offers the cybersecurity industry's first and only performance-based pricing model, Pay-per-Phish.Area 1 is trusted by Fortune 500 enterprises across financial services, healthcare, critical infrastructure and other industries, to preempt targeted phishing attacks, improve their cybersecurity posture, and change outcomes.Area 1 is a Certified Microsoft Partner, and Google Cloud Technology Partner of the Year for Security. To learn more, visitwww.area1security.com, follow us onLinkedIn, or subscribe to thePhish of the Weeknewsletter.About The Channel CompanyThe Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers and end users. Backed by more than 30 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace.www.thechannelcompany.com Follow The Channel Company:Twitter,LinkedIn, andFacebook. 2021. CRN is a registered trademark of The Channel Company, LLC. All rights reserved.Contacts:Elaine DzubaArea 1 Security[emailprotected] Jennifer HoganThe Channel Company[emailprotected]SOURCE Area 1 Security Related Links https://www.area1security.com

Area 1 Security's Steve Pataky and Dawn Ringstaff Recognized as 2021 CRN Channel Chiefs Pataky Also Named to Elite List of CRN's 50 Most Influential Channel Chiefs of 2021

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: REDWOOD CITY, Calif., Feb. 8, 2021 /PRNewswire/ --Area 1 Security, the only preemptive cloud email security provider, announced that CRN, a brand ofThe Channel Company, has named Steve Pataky, Chief Revenue Officer, and Dawn Ringstaff, Director of Global Channel Sales, to its 2021 list of Channel Chiefs. Pataky has also been named to CRN's exclusive list of the 50 Most Influential Channel Chiefs for 2021. The CRN Channel Chiefs award recognizes leading IT channel vendor executives who continually demonstrate outstanding leadership, influence, innovation, and growth. The Channel Company names Area 1 Securitys Steve Pataky, Dawn Ringstaff to the 2021 CRN Channel Chiefs. Pataky is also named to CRNs exclusive list of the 50 Most Influential Channel Chiefs for 2021. Under their leadership, Area 1 has successfully pivoted to a 100% partner-centric go-to-market model. Tweet this Pataky and Ringstaff both joined Area 1 Security in 2020 to help expand the company's partnership initiatives and accelerate opportunities with VAR/Solution Providers, distributors, MSSPs, consultants, and technology alliances. Under their leadership, Area 1 has successfully pivoted to a 100% partner-centric go-to-market model and launched a new, two-tiered partner program; within the first quarter of the program's launch, Area 1 recruited over 40 partners and achieved over 80 percent channel revenue growth in 2H 2020. "As businesses have moved to the cloud, so have hackers: millions of phish evade traditional email gateways and cloud email suites each year. Organizations fed up with ineffective legacy defenses are now turning to their partners for a better solution," said Pataky. "This challenge represents a multibillion-dollar opportunity for partners to transition customers to Area 1 the only cloud email security solution that stops phishing attacks before they breach. I'm incredibly energized to play a role in this market shift, and to be recognized for our channel investments." Ringstaff added, "It's an honor to be included in the Channel Chiefs list this year. After having 25 years of channel sales experience under my belt, I truly believe this accolade demonstrates the perfect confluence of working with the best-possible product, team and partners, in the right market at the right time. I look forward to building on this momentum in 2021 and beyond."Each of the 2021 Channel Chiefs are prominent leaders who have influenced the IT channel with cutting-edge strategies, programs and partnerships. All honorees are selected by CRN's editorial staff based on their dedication, industry prestige, and exceptional accomplishments as channel advocates. The 50 Most Influential Channel Chiefs were chosen by the CRN editorial staff as the individuals who stand at the very top of this elite group."Having worked with both Steve and Dawn at prior organizations I had complete faith that they would drive an amazing expansion strategy for Area 1. I couldn't be more excited and proud of their accomplishments. In just six months, they have successfully led us to a new channel-centric sales model," said Patrick Sweeney, CEO and President of Area 1 Security. "This CRN recognition is yet another testament to their unmatched expertise in building innovative, scalable partner programs and ecosystems."Before joining Area 1, Pataky led partner sales as an Advisor for Ubiq Security, and previously served as Chief Revenue Officer for SonicWall and VP of Worldwide Channels and Alliances at FireEye). Pataky's notable leadership record includes being a key part of divesting SonicWall out of Dell and rebuilding SonicWall's independent channel of more than 17,000 partners worldwide. Pataky has been previously recognized as a CRN Channel Chief, including being named to the 50 Most Influential Channel Chiefs in 2014, 2015, 2017 and 2018. He also earned the Channel Innovation Awards Security Channel Chief of the Year in 2017.Ringstaff has a successful track record for developing channel programs that not only grow partner revenue but also partner sales and technical capabilities. Her experience prior to Area 1 includes Regional VP of Sales for Talari SD-WAN (acquired by Oracle), over a decade with SonicWall as a regional director and Channel leader, preceded by channel experience at Kaspersky Labs. Dawn was a recipient of CRN's Women of the Channel in 2017 and 2018."CRN's 2021 Channel Chiefs list includes the industry's biggest channel evangelists, a group of individuals who work tirelessly on behalf of their partners and drive growth through the development of strong partner programs and innovative business strategies that help bring business-critical solutions to market," said Blaine Raddon, CEO of The Channel Company. "The Channel Company is proud to recognize these channel influencers and looks forward to following their continued success."CRN's 2021 Channel Chiefs list, including the 50 Most Influential Channel Chiefs, will be featured in the February 2021 issue of CRN Magazine and online atwww.CRN.com/ChannelChiefs.About Area 1 SecurityArea 1 Security is the only company that preemptively stops Business Email Compromise, malware, ransomware and targeted phishing attacks. By focusing on the earliest stages of an attack, Area 1 stops phish the root cause of 95 percent of breaches 24 days (on average) before they launch. Area 1 also offers the cybersecurity industry's first and only performance-based pricing model, Pay-per-Phish.Area 1 is trusted by Fortune 500 enterprises across financial services, healthcare, critical infrastructure and other industries, to preempt targeted phishing attacks, improve their cybersecurity posture, and change outcomes.Area 1 is a Certified Microsoft Partner, and Google Cloud Technology Partner of the Year for Security. To learn more, visitwww.area1security.com, follow us onLinkedIn, or subscribe to thePhish of the Weeknewsletter.About The Channel CompanyThe Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers and end users. Backed by more than 30 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace.www.thechannelcompany.com Follow The Channel Company:Twitter,LinkedIn, andFacebook. 2021. CRN is a registered trademark of The Channel Company, LLC. All rights reserved.Contacts:Elaine DzubaArea 1 Security[emailprotected] Jennifer HoganThe Channel Company[emailprotected]SOURCE Area 1 Security Related Links https://www.area1security.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Area 1 Security's Steve Pataky and Dawn Ringstaff Recognized as 2021 CRN Channel Chiefs. Pataky Also Named to Elite List of CRN's 50 Most Influential Channel Chiefs of 2021.<|eot_id|>

edtsum883

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Jan. 12, 2021 /PRNewswire/ --Spruce, the proptech company powering online real estate transactions through technology, today announced SprucePowered, a new white-label title and closing services solution that enables proptech companies to form their own title agencies and control the entire transaction experience end-to-end. SprucePowered partners benefit from offering a superior customer experience, while activating an added revenue stream. (PRNewsfoto/Spruce) Proptech companies are seeking increasingly diverse and robust services to offer their customers, but can't always scale these offerings to their high standards. SprucePowered offers a win-win solution, enabling partners to retain complete control of their customers' experiences while benefiting from Spruce's proprietary solution and industry expertise. The end result is a full-service model, and an entirely cohesive brand presentation for the customer. SprucePowered Benefits Higher revenues: Partners create a wholly-owned, licensed agencyearning the title and closing revenue as the Title Agent and Settlement Agentwithout the backend hassle. White-labeled: With Spruce working completely behind the scenes, there is no brand dilution, resulting in a fully owned experience and higher customer satisfaction. Simple onboarding: Implementing SprucePowered is easy, with all back-end services powered by Spruce's proprietary technology and workflows. Low barrier: Partners receive expert guidance and operational supportfrom onboarding to everyday execution. Scalability: SprucePowered enables ambitious growth and expansion by providing nationwide expertise and a flexible resourcing model. Predictable outcomes: Partners define and control their desired customer experience, with consistent speed, transparency, and reporting. "Spruce has the operational expertise, tech capabilities, and deep client understanding required to achieve a seamless end-to-end experience for our partners' customers," said Patrick Burns, CEO and co-founder of Spruce. "Offering SprucePowered as a white-label solution enables equal access to scalable title expertise for the many real estate technology companies looking to insource customer coordination and offer a frictionless customer experience."Spruce has powered tens of thousands of transactions to date for proptech companies, lenders, and real estate investors, and is growing 450% annually. SprucePowered is available nationwide.ABOUT SPRUCESpruce is digitizing real estate transactions for forward-thinking real estate companies and mortgage lenders. By leveraging proprietary technology and best-in-class operations, Spruce provides a seamless, affordable solution. Spruce was founded by Andrew Weisgall and Patrick Burns in 2016, and is headquartered in New York with hubs across the U.S. Learn more about how Spruce can bring your business digital: www.spruce.co.CONTACTHadley SteckerDirector of Communications[emailprotected]978.473.1754SOURCE Spruce Related Links https://spruce.co/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Spruce Launches New White-Label Title and Closing Solution. SprucePowered Offers End-to-End Customer Experience; Enables New Revenue Stream.

NEW YORK, Jan. 12, 2021 /PRNewswire/ --Spruce, the proptech company powering online real estate transactions through technology, today announced SprucePowered, a new white-label title and closing services solution that enables proptech companies to form their own title agencies and control the entire transaction experience end-to-end. SprucePowered partners benefit from offering a superior customer experience, while activating an added revenue stream. (PRNewsfoto/Spruce) Proptech companies are seeking increasingly diverse and robust services to offer their customers, but can't always scale these offerings to their high standards. SprucePowered offers a win-win solution, enabling partners to retain complete control of their customers' experiences while benefiting from Spruce's proprietary solution and industry expertise. The end result is a full-service model, and an entirely cohesive brand presentation for the customer. SprucePowered Benefits Higher revenues: Partners create a wholly-owned, licensed agencyearning the title and closing revenue as the Title Agent and Settlement Agentwithout the backend hassle. White-labeled: With Spruce working completely behind the scenes, there is no brand dilution, resulting in a fully owned experience and higher customer satisfaction. Simple onboarding: Implementing SprucePowered is easy, with all back-end services powered by Spruce's proprietary technology and workflows. Low barrier: Partners receive expert guidance and operational supportfrom onboarding to everyday execution. Scalability: SprucePowered enables ambitious growth and expansion by providing nationwide expertise and a flexible resourcing model. Predictable outcomes: Partners define and control their desired customer experience, with consistent speed, transparency, and reporting. "Spruce has the operational expertise, tech capabilities, and deep client understanding required to achieve a seamless end-to-end experience for our partners' customers," said Patrick Burns, CEO and co-founder of Spruce. "Offering SprucePowered as a white-label solution enables equal access to scalable title expertise for the many real estate technology companies looking to insource customer coordination and offer a frictionless customer experience."Spruce has powered tens of thousands of transactions to date for proptech companies, lenders, and real estate investors, and is growing 450% annually. SprucePowered is available nationwide.ABOUT SPRUCESpruce is digitizing real estate transactions for forward-thinking real estate companies and mortgage lenders. By leveraging proprietary technology and best-in-class operations, Spruce provides a seamless, affordable solution. Spruce was founded by Andrew Weisgall and Patrick Burns in 2016, and is headquartered in New York with hubs across the U.S. Learn more about how Spruce can bring your business digital: www.spruce.co.CONTACTHadley SteckerDirector of Communications[emailprotected]978.473.1754SOURCE Spruce Related Links https://spruce.co/

Spruce Launches New White-Label Title and Closing Solution SprucePowered Offers End-to-End Customer Experience; Enables New Revenue Stream

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Jan. 12, 2021 /PRNewswire/ --Spruce, the proptech company powering online real estate transactions through technology, today announced SprucePowered, a new white-label title and closing services solution that enables proptech companies to form their own title agencies and control the entire transaction experience end-to-end. SprucePowered partners benefit from offering a superior customer experience, while activating an added revenue stream. (PRNewsfoto/Spruce) Proptech companies are seeking increasingly diverse and robust services to offer their customers, but can't always scale these offerings to their high standards. SprucePowered offers a win-win solution, enabling partners to retain complete control of their customers' experiences while benefiting from Spruce's proprietary solution and industry expertise. The end result is a full-service model, and an entirely cohesive brand presentation for the customer. SprucePowered Benefits Higher revenues: Partners create a wholly-owned, licensed agencyearning the title and closing revenue as the Title Agent and Settlement Agentwithout the backend hassle. White-labeled: With Spruce working completely behind the scenes, there is no brand dilution, resulting in a fully owned experience and higher customer satisfaction. Simple onboarding: Implementing SprucePowered is easy, with all back-end services powered by Spruce's proprietary technology and workflows. Low barrier: Partners receive expert guidance and operational supportfrom onboarding to everyday execution. Scalability: SprucePowered enables ambitious growth and expansion by providing nationwide expertise and a flexible resourcing model. Predictable outcomes: Partners define and control their desired customer experience, with consistent speed, transparency, and reporting. "Spruce has the operational expertise, tech capabilities, and deep client understanding required to achieve a seamless end-to-end experience for our partners' customers," said Patrick Burns, CEO and co-founder of Spruce. "Offering SprucePowered as a white-label solution enables equal access to scalable title expertise for the many real estate technology companies looking to insource customer coordination and offer a frictionless customer experience."Spruce has powered tens of thousands of transactions to date for proptech companies, lenders, and real estate investors, and is growing 450% annually. SprucePowered is available nationwide.ABOUT SPRUCESpruce is digitizing real estate transactions for forward-thinking real estate companies and mortgage lenders. By leveraging proprietary technology and best-in-class operations, Spruce provides a seamless, affordable solution. Spruce was founded by Andrew Weisgall and Patrick Burns in 2016, and is headquartered in New York with hubs across the U.S. Learn more about how Spruce can bring your business digital: www.spruce.co.CONTACTHadley SteckerDirector of Communications[emailprotected]978.473.1754SOURCE Spruce Related Links https://spruce.co/ Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Spruce Launches New White-Label Title and Closing Solution. SprucePowered Offers End-to-End Customer Experience; Enables New Revenue Stream.<|eot_id|>

edtsum884

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MODESTO, Calif., Jan. 5, 2021 /PRNewswire/ --E. & J. Gallo Winery (Gallo) today announced that it has completed the acquisition of more than 30 wine brands from Constellation Brands, Inc. The closing of the agreement between Gallo and Constellation was approved by the Federal Trade Commission on December 23, 2020. (PRNewsfoto/E. & J. Gallo Winery) The acquisition includes well known wine brands such as Arbor Mist, Black Box, Clos du Bois, Estancia, Franciscan, Hogue, Manischewitz, Mark West, Ravenswood, Taylor, Vendange, and Wild Horse that will join the Gallo portfolio. With this acquisition, Gallo will expand its operational footprint with the addition of five wineries located in California, Washington, and New York, along with Constellation's Polyphenolics business. Gallo will also acquire the Nobilo New Zealand Sauvignon Blanc brand in a separate transaction with Constellation. "The closing of this transaction represents our company's long-term commitment to the wine industry," said Chief Executive Officer, Ernest J. Gallo. He added, "We are pleased to welcome the new employees joining the Gallo family." The acquisition was first announced by Gallo and Constellation on April 3, 2019. Pursuant to the FTC consent order, Gallo will also divest two of its legacy dessert brands, Fairbanks and Sheffield, to Precept Brands LLC. Terms of the transaction between Gallo and Precept were not disclosed. About E. & J. Gallo Winery Founded by brothers Ernest and Julio Gallo in 1933 in Modesto, California,E. & J. Gallo Winery is a family-owned winery with more than 7,000 global employees and is the acclaimed producer of award-winning wines and spirits featured in more than 110 countries around the globe. A pioneer in the art of grape growing, winemaking, sustainable practices, marketing and worldwide distribution, Gallo crafts and imports wines and spirits to suit a diverse range of tastes and occasions, from everyday offerings to boutique, luxury bottlings.The Gallo portfolio is comprised of more than 100 unique brands, including Barefoot Cellars, Dark Horse, and Gallo Family Vineyards, as well as premium box wines The Naked Grape and Vin Vault. Premium offerings include Apothic, Carnivor, Chateau Souverain, Columbia Winery, Ecco Domani, Edna Valley Vineyard, J Vineyards & Winery, Louis M. Martini, MacMurray Estate Vineyards, Mirassou, Orin Swift, Talbott Vineyards, and William Hill Estate, along with highly acclaimed imports, such as Alamos, Brancaia, La Marca, Las Rocas, Martn Cdax, Whitehaven, and LUX Wines, importers of Allegrini, Argiano, Jermann, Pieropan and Renato Ratti. Gallo Spirits currently offers New Amsterdam Vodka and Gin, Familia Camarena Tequila, RumHaven, Lo-Fi Aperitifs, E&J Brandy, Argonaut Brandy, Germain-Robin Brandy, Diplomtico Rum, as well as imported Scotch whiskies from Whyte & Mackay, including The Dalmore, Jura and John Barr. Contact:Natalie HendersonE. & J. Gallo Winery (209) 341-6479[emailprotected]SOURCE E. & J. Gallo Winery Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

E. & J. Gallo Winery Completes Acquisition Of More Than 30 Brands From Constellation. Purchase Accelerates Growth for Gallo and Expands Portfolio of Offerings at Every Price Point.

MODESTO, Calif., Jan. 5, 2021 /PRNewswire/ --E. & J. Gallo Winery (Gallo) today announced that it has completed the acquisition of more than 30 wine brands from Constellation Brands, Inc. The closing of the agreement between Gallo and Constellation was approved by the Federal Trade Commission on December 23, 2020. (PRNewsfoto/E. & J. Gallo Winery) The acquisition includes well known wine brands such as Arbor Mist, Black Box, Clos du Bois, Estancia, Franciscan, Hogue, Manischewitz, Mark West, Ravenswood, Taylor, Vendange, and Wild Horse that will join the Gallo portfolio. With this acquisition, Gallo will expand its operational footprint with the addition of five wineries located in California, Washington, and New York, along with Constellation's Polyphenolics business. Gallo will also acquire the Nobilo New Zealand Sauvignon Blanc brand in a separate transaction with Constellation. "The closing of this transaction represents our company's long-term commitment to the wine industry," said Chief Executive Officer, Ernest J. Gallo. He added, "We are pleased to welcome the new employees joining the Gallo family." The acquisition was first announced by Gallo and Constellation on April 3, 2019. Pursuant to the FTC consent order, Gallo will also divest two of its legacy dessert brands, Fairbanks and Sheffield, to Precept Brands LLC. Terms of the transaction between Gallo and Precept were not disclosed. About E. & J. Gallo Winery Founded by brothers Ernest and Julio Gallo in 1933 in Modesto, California,E. & J. Gallo Winery is a family-owned winery with more than 7,000 global employees and is the acclaimed producer of award-winning wines and spirits featured in more than 110 countries around the globe. A pioneer in the art of grape growing, winemaking, sustainable practices, marketing and worldwide distribution, Gallo crafts and imports wines and spirits to suit a diverse range of tastes and occasions, from everyday offerings to boutique, luxury bottlings.The Gallo portfolio is comprised of more than 100 unique brands, including Barefoot Cellars, Dark Horse, and Gallo Family Vineyards, as well as premium box wines The Naked Grape and Vin Vault. Premium offerings include Apothic, Carnivor, Chateau Souverain, Columbia Winery, Ecco Domani, Edna Valley Vineyard, J Vineyards & Winery, Louis M. Martini, MacMurray Estate Vineyards, Mirassou, Orin Swift, Talbott Vineyards, and William Hill Estate, along with highly acclaimed imports, such as Alamos, Brancaia, La Marca, Las Rocas, Martn Cdax, Whitehaven, and LUX Wines, importers of Allegrini, Argiano, Jermann, Pieropan and Renato Ratti. Gallo Spirits currently offers New Amsterdam Vodka and Gin, Familia Camarena Tequila, RumHaven, Lo-Fi Aperitifs, E&J Brandy, Argonaut Brandy, Germain-Robin Brandy, Diplomtico Rum, as well as imported Scotch whiskies from Whyte & Mackay, including The Dalmore, Jura and John Barr. Contact:Natalie HendersonE. & J. Gallo Winery (209) 341-6479[emailprotected]SOURCE E. & J. Gallo Winery

E. & J. Gallo Winery Completes Acquisition Of More Than 30 Brands From Constellation Purchase Accelerates Growth for Gallo and Expands Portfolio of Offerings at Every Price Point

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MODESTO, Calif., Jan. 5, 2021 /PRNewswire/ --E. & J. Gallo Winery (Gallo) today announced that it has completed the acquisition of more than 30 wine brands from Constellation Brands, Inc. The closing of the agreement between Gallo and Constellation was approved by the Federal Trade Commission on December 23, 2020. (PRNewsfoto/E. & J. Gallo Winery) The acquisition includes well known wine brands such as Arbor Mist, Black Box, Clos du Bois, Estancia, Franciscan, Hogue, Manischewitz, Mark West, Ravenswood, Taylor, Vendange, and Wild Horse that will join the Gallo portfolio. With this acquisition, Gallo will expand its operational footprint with the addition of five wineries located in California, Washington, and New York, along with Constellation's Polyphenolics business. Gallo will also acquire the Nobilo New Zealand Sauvignon Blanc brand in a separate transaction with Constellation. "The closing of this transaction represents our company's long-term commitment to the wine industry," said Chief Executive Officer, Ernest J. Gallo. He added, "We are pleased to welcome the new employees joining the Gallo family." The acquisition was first announced by Gallo and Constellation on April 3, 2019. Pursuant to the FTC consent order, Gallo will also divest two of its legacy dessert brands, Fairbanks and Sheffield, to Precept Brands LLC. Terms of the transaction between Gallo and Precept were not disclosed. About E. & J. Gallo Winery Founded by brothers Ernest and Julio Gallo in 1933 in Modesto, California,E. & J. Gallo Winery is a family-owned winery with more than 7,000 global employees and is the acclaimed producer of award-winning wines and spirits featured in more than 110 countries around the globe. A pioneer in the art of grape growing, winemaking, sustainable practices, marketing and worldwide distribution, Gallo crafts and imports wines and spirits to suit a diverse range of tastes and occasions, from everyday offerings to boutique, luxury bottlings.The Gallo portfolio is comprised of more than 100 unique brands, including Barefoot Cellars, Dark Horse, and Gallo Family Vineyards, as well as premium box wines The Naked Grape and Vin Vault. Premium offerings include Apothic, Carnivor, Chateau Souverain, Columbia Winery, Ecco Domani, Edna Valley Vineyard, J Vineyards & Winery, Louis M. Martini, MacMurray Estate Vineyards, Mirassou, Orin Swift, Talbott Vineyards, and William Hill Estate, along with highly acclaimed imports, such as Alamos, Brancaia, La Marca, Las Rocas, Martn Cdax, Whitehaven, and LUX Wines, importers of Allegrini, Argiano, Jermann, Pieropan and Renato Ratti. Gallo Spirits currently offers New Amsterdam Vodka and Gin, Familia Camarena Tequila, RumHaven, Lo-Fi Aperitifs, E&J Brandy, Argonaut Brandy, Germain-Robin Brandy, Diplomtico Rum, as well as imported Scotch whiskies from Whyte & Mackay, including The Dalmore, Jura and John Barr. Contact:Natalie HendersonE. & J. Gallo Winery (209) 341-6479[emailprotected]SOURCE E. & J. Gallo Winery Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> E. & J. Gallo Winery Completes Acquisition Of More Than 30 Brands From Constellation. Purchase Accelerates Growth for Gallo and Expands Portfolio of Offerings at Every Price Point.<|eot_id|>

edtsum885

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: GARDENA, Calif.--(BUSINESS WIRE)--VAIO is the first company in the world to successfully mass produce a 3-D molded, carbon fiber laptop using Uni-direction carbon fiber which is a type of carbon fiber material that is non-woven and all fibers running in a single direction. Using technology only previously available to the car racing industry, molded carbon fiber makes the new VAIO Z lighter at just under 2.3 lbs. Moreover, with all around carbon fiber protection, the VAIO Z offers exceptional toughness, and its turbo charged with unprecedented speed. In fact, the new VAIO Z features VAIO TruePerformance, that offers the powerful processing speed previously only found in the desktop PCs of the most demanding fields. Although previously gaining popularity, mobile computing has never been more essential. With more professionals and students having to work and collaborate remotely these days, their mobile computing needs have increased. Of course, there are inherent risks with mobility as seen with mobile phone usage, for example. Everyone is well acquainted with the challenge of keeping mobile devices from getting damaged and now, more so with laptops. Both have become indispensable investments that make work, learning and connecting socially possible. So, when they are damaged, it can disrupt users needs. The new VAIO Z was designed for todays mobile computing needs. The VAIO Zs lighter yet more durable design makes mobility less cumbersome, more practical, and safer for work and learning needs. No more having to carry a heavy laptop from place to place or even room to room. No more worrying that this valued work partner and learning tool will get damaged, and no more worrying about securing your privacy. The VAIO Z offers incredible power through 11th Gen Intel Core processors and new Intel integrated graphics on its 14-inch, high-def 4k LCD panel. Additional features include crystal clear sound with Dolby Audio speakers. No more struggling to hear teammates or teachers on video conferencing calls. There are also camera shutter and mic mute shortcuts for privacy, 180-degree open/close screen for easy collaboration and increased battery life to keep you connected for hours. Plus, the VAIO Z will get to know you. Its VAIO User Sensing engineering combines human sensing technology and biometrics to make the VAIO Z a truly personal experience. The VAIO Z uses face authentication to log you in when you are seated before it, and it keeps you logged in while you are seated in front of it. No more having to remember your password or worrying someone will use it. When you are away, it locks automatically to secure your privacy. Kaoru Hayashi, Director, Vice President and Head of PC Business at VAIO Corporation, proudly states, It is with great pleasure that we introduce VAIO Z to the world. With over a decade of relentless carbon fiber research, VAIO has succeeded in creating and mass producing the world's first 3-D molded full carbon chassis for laptop PCs. VAIO has developed a unique process of working with carbon fiber to achieve beautifully contoured lines and the flexible molding of carbon fiber, that was previously difficult to mass produce. The achievement of harnessing carbon fiber's full potential of lightness and durability is both revolutionary and evolutionary as we continue looking ahead. With this evolution, the new VAIO Z offers exceptional performance, lightness, endurance, now with true ruggedness, and without compromise, all converging into one elegant design. With VAIO Z as our flagship model, we hope it is the start of VAIOs future array of laptop PC developments. We also want to use this proud moment to share VAIOs redefined mission. Like VAIO Z, we have reshaped our mission statement to show our commitment to our technical ingenuity that is deeply engrained in our DNA. Therefore, our renewed mission statement is Illuminate your spirit with VAIO. Accelerating innovation through design and technology.' Our vision is to make VAIO PCs a valued partner to customers who, like VAIO, are the worlds innovators, creators, and relentless leaders in their fields. It is our hope that our VAIO PCs become an enduring presence that inspires our customers as they forge ahead to meet and exceed their goals no matter the challenge. Pricing for the VAIO Z starts at $3,579. The VAIO Z is sold directly through https://us.vaio.com/. Starting in March, the VAIO Z will be on display at select b8ta retail store locations for everyone to touch and try in person: NY, Boston, Palo Alto, Denver, and Houston. For more information, click here. About VAIO VAIOs HQ and factory are in Azumino, Nagano Prefecture, Japan, surrounded by beautiful forest and mountains known as the Japanese Alps. VAIO Z innovations were born here, and all VAIO Zs are shipped directly to the world from here. VAIO will continue to strive in delivering cutting-edge computing experiences, so that, Made by VAIO in Azumino, Nagano, Japan is equated with innovation. VAIO Corporation, which inherited the VAIO PC business from Sony Corporation, was established on July 1, 2014, headquartered in Azumino, Nagano Prefecture, Japan. VAIO Corporation is dedicated to planning, design, development, manufacturing and sale of PCs and related products labeled with the VAIO trademark. *Made with the material that has been three-dimensionally molded on all sides of a laptop PC housing. Confirmed by Stella Associa, January 6, 2021 Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

VAIO built the world's first* contoured carbon fiber laptop. Japan's VAIO, a leader in innovative technology, unleashes the first 3-D molded, carbon fiber laptop in the world. The new VAIO Z has a lighter, yet durable design and is engineered to make mobile computing effortless.

GARDENA, Calif.--(BUSINESS WIRE)--VAIO is the first company in the world to successfully mass produce a 3-D molded, carbon fiber laptop using Uni-direction carbon fiber which is a type of carbon fiber material that is non-woven and all fibers running in a single direction. Using technology only previously available to the car racing industry, molded carbon fiber makes the new VAIO Z lighter at just under 2.3 lbs. Moreover, with all around carbon fiber protection, the VAIO Z offers exceptional toughness, and its turbo charged with unprecedented speed. In fact, the new VAIO Z features VAIO TruePerformance, that offers the powerful processing speed previously only found in the desktop PCs of the most demanding fields. Although previously gaining popularity, mobile computing has never been more essential. With more professionals and students having to work and collaborate remotely these days, their mobile computing needs have increased. Of course, there are inherent risks with mobility as seen with mobile phone usage, for example. Everyone is well acquainted with the challenge of keeping mobile devices from getting damaged and now, more so with laptops. Both have become indispensable investments that make work, learning and connecting socially possible. So, when they are damaged, it can disrupt users needs. The new VAIO Z was designed for todays mobile computing needs. The VAIO Zs lighter yet more durable design makes mobility less cumbersome, more practical, and safer for work and learning needs. No more having to carry a heavy laptop from place to place or even room to room. No more worrying that this valued work partner and learning tool will get damaged, and no more worrying about securing your privacy. The VAIO Z offers incredible power through 11th Gen Intel Core processors and new Intel integrated graphics on its 14-inch, high-def 4k LCD panel. Additional features include crystal clear sound with Dolby Audio speakers. No more struggling to hear teammates or teachers on video conferencing calls. There are also camera shutter and mic mute shortcuts for privacy, 180-degree open/close screen for easy collaboration and increased battery life to keep you connected for hours. Plus, the VAIO Z will get to know you. Its VAIO User Sensing engineering combines human sensing technology and biometrics to make the VAIO Z a truly personal experience. The VAIO Z uses face authentication to log you in when you are seated before it, and it keeps you logged in while you are seated in front of it. No more having to remember your password or worrying someone will use it. When you are away, it locks automatically to secure your privacy. Kaoru Hayashi, Director, Vice President and Head of PC Business at VAIO Corporation, proudly states, It is with great pleasure that we introduce VAIO Z to the world. With over a decade of relentless carbon fiber research, VAIO has succeeded in creating and mass producing the world's first 3-D molded full carbon chassis for laptop PCs. VAIO has developed a unique process of working with carbon fiber to achieve beautifully contoured lines and the flexible molding of carbon fiber, that was previously difficult to mass produce. The achievement of harnessing carbon fiber's full potential of lightness and durability is both revolutionary and evolutionary as we continue looking ahead. With this evolution, the new VAIO Z offers exceptional performance, lightness, endurance, now with true ruggedness, and without compromise, all converging into one elegant design. With VAIO Z as our flagship model, we hope it is the start of VAIOs future array of laptop PC developments. We also want to use this proud moment to share VAIOs redefined mission. Like VAIO Z, we have reshaped our mission statement to show our commitment to our technical ingenuity that is deeply engrained in our DNA. Therefore, our renewed mission statement is Illuminate your spirit with VAIO. Accelerating innovation through design and technology.' Our vision is to make VAIO PCs a valued partner to customers who, like VAIO, are the worlds innovators, creators, and relentless leaders in their fields. It is our hope that our VAIO PCs become an enduring presence that inspires our customers as they forge ahead to meet and exceed their goals no matter the challenge. Pricing for the VAIO Z starts at $3,579. The VAIO Z is sold directly through https://us.vaio.com/. Starting in March, the VAIO Z will be on display at select b8ta retail store locations for everyone to touch and try in person: NY, Boston, Palo Alto, Denver, and Houston. For more information, click here. About VAIO VAIOs HQ and factory are in Azumino, Nagano Prefecture, Japan, surrounded by beautiful forest and mountains known as the Japanese Alps. VAIO Z innovations were born here, and all VAIO Zs are shipped directly to the world from here. VAIO will continue to strive in delivering cutting-edge computing experiences, so that, Made by VAIO in Azumino, Nagano, Japan is equated with innovation. VAIO Corporation, which inherited the VAIO PC business from Sony Corporation, was established on July 1, 2014, headquartered in Azumino, Nagano Prefecture, Japan. VAIO Corporation is dedicated to planning, design, development, manufacturing and sale of PCs and related products labeled with the VAIO trademark. *Made with the material that has been three-dimensionally molded on all sides of a laptop PC housing. Confirmed by Stella Associa, January 6, 2021

VAIO Built the Worlds First* Contoured Carbon Fiber Laptop Japans VAIO, a leader in innovative technology, unleashes the first 3-D molded, carbon fiber laptop in the world. The new VAIO Z has a lighter, yet durable design and is engineered to make mobile computing effortless.

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: GARDENA, Calif.--(BUSINESS WIRE)--VAIO is the first company in the world to successfully mass produce a 3-D molded, carbon fiber laptop using Uni-direction carbon fiber which is a type of carbon fiber material that is non-woven and all fibers running in a single direction. Using technology only previously available to the car racing industry, molded carbon fiber makes the new VAIO Z lighter at just under 2.3 lbs. Moreover, with all around carbon fiber protection, the VAIO Z offers exceptional toughness, and its turbo charged with unprecedented speed. In fact, the new VAIO Z features VAIO TruePerformance, that offers the powerful processing speed previously only found in the desktop PCs of the most demanding fields. Although previously gaining popularity, mobile computing has never been more essential. With more professionals and students having to work and collaborate remotely these days, their mobile computing needs have increased. Of course, there are inherent risks with mobility as seen with mobile phone usage, for example. Everyone is well acquainted with the challenge of keeping mobile devices from getting damaged and now, more so with laptops. Both have become indispensable investments that make work, learning and connecting socially possible. So, when they are damaged, it can disrupt users needs. The new VAIO Z was designed for todays mobile computing needs. The VAIO Zs lighter yet more durable design makes mobility less cumbersome, more practical, and safer for work and learning needs. No more having to carry a heavy laptop from place to place or even room to room. No more worrying that this valued work partner and learning tool will get damaged, and no more worrying about securing your privacy. The VAIO Z offers incredible power through 11th Gen Intel Core processors and new Intel integrated graphics on its 14-inch, high-def 4k LCD panel. Additional features include crystal clear sound with Dolby Audio speakers. No more struggling to hear teammates or teachers on video conferencing calls. There are also camera shutter and mic mute shortcuts for privacy, 180-degree open/close screen for easy collaboration and increased battery life to keep you connected for hours. Plus, the VAIO Z will get to know you. Its VAIO User Sensing engineering combines human sensing technology and biometrics to make the VAIO Z a truly personal experience. The VAIO Z uses face authentication to log you in when you are seated before it, and it keeps you logged in while you are seated in front of it. No more having to remember your password or worrying someone will use it. When you are away, it locks automatically to secure your privacy. Kaoru Hayashi, Director, Vice President and Head of PC Business at VAIO Corporation, proudly states, It is with great pleasure that we introduce VAIO Z to the world. With over a decade of relentless carbon fiber research, VAIO has succeeded in creating and mass producing the world's first 3-D molded full carbon chassis for laptop PCs. VAIO has developed a unique process of working with carbon fiber to achieve beautifully contoured lines and the flexible molding of carbon fiber, that was previously difficult to mass produce. The achievement of harnessing carbon fiber's full potential of lightness and durability is both revolutionary and evolutionary as we continue looking ahead. With this evolution, the new VAIO Z offers exceptional performance, lightness, endurance, now with true ruggedness, and without compromise, all converging into one elegant design. With VAIO Z as our flagship model, we hope it is the start of VAIOs future array of laptop PC developments. We also want to use this proud moment to share VAIOs redefined mission. Like VAIO Z, we have reshaped our mission statement to show our commitment to our technical ingenuity that is deeply engrained in our DNA. Therefore, our renewed mission statement is Illuminate your spirit with VAIO. Accelerating innovation through design and technology.' Our vision is to make VAIO PCs a valued partner to customers who, like VAIO, are the worlds innovators, creators, and relentless leaders in their fields. It is our hope that our VAIO PCs become an enduring presence that inspires our customers as they forge ahead to meet and exceed their goals no matter the challenge. Pricing for the VAIO Z starts at $3,579. The VAIO Z is sold directly through https://us.vaio.com/. Starting in March, the VAIO Z will be on display at select b8ta retail store locations for everyone to touch and try in person: NY, Boston, Palo Alto, Denver, and Houston. For more information, click here. About VAIO VAIOs HQ and factory are in Azumino, Nagano Prefecture, Japan, surrounded by beautiful forest and mountains known as the Japanese Alps. VAIO Z innovations were born here, and all VAIO Zs are shipped directly to the world from here. VAIO will continue to strive in delivering cutting-edge computing experiences, so that, Made by VAIO in Azumino, Nagano, Japan is equated with innovation. VAIO Corporation, which inherited the VAIO PC business from Sony Corporation, was established on July 1, 2014, headquartered in Azumino, Nagano Prefecture, Japan. VAIO Corporation is dedicated to planning, design, development, manufacturing and sale of PCs and related products labeled with the VAIO trademark. *Made with the material that has been three-dimensionally molded on all sides of a laptop PC housing. Confirmed by Stella Associa, January 6, 2021 Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> VAIO built the world's first* contoured carbon fiber laptop. Japan's VAIO, a leader in innovative technology, unleashes the first 3-D molded, carbon fiber laptop in the world. The new VAIO Z has a lighter, yet durable design and is engineered to make mobile computing effortless.<|eot_id|>

edtsum886

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN JOSE, Calif., Feb. 3, 2021 /PRNewswire/ --Extreme Networks, Inc. (Nasdaq: EXTR), a cloud-driven networking company, today announced the schedule for its Virtual Investor Day event to be held February 23, 2021, as well as its conference schedule for March: Extreme Networks Virtual Investor Day Tuesday, February 23, 2021Beginning at 11:00 AM ETExtreme Networks Virtual Investor Day Registration Link Morgan Stanley Virtual Technology, Media and Telecom ConferenceEd Meyercord, President & CEOWednesday, March 3, 20211:15 PM ET presentation and available for virtual 1x1 meetings throughout the day Enterprises are rapidly embracing cloud-based networking and the world is entering the 5G era. Attendees at Extreme's Virtual Investor Day event will receive an update on the company's differentiated market position, long-term vision and strategy, and multi-year business outlook. Registration and access to the live webcast and presentations for the Virtual Investor Day event will be available at:https://investor.extremenetworks.com/events-presentations A live webcast from the conference presentation will be accessible under Events & Presentations on the Investor Relations section of theExtreme Networks'website athttp://investor.extremenetworks.comand will be archived for at least 30 days following the live presentation. About Extreme Networks:Extreme Networks, Inc.(EXTR) creates effortless networking experiences that enable all of us to advance. We push the boundaries of technology leveraging the powers of machine learning, artificial intelligence, analytics, and automation. Over 50,000 customers globally trust our end-to-end, cloud-driven networking solutions and rely on our top-rated services and support to accelerate their digital transformation efforts and deliver progress like never before. For more information, visit Extreme'swebsiteor or follow us on Twitter, LinkedIn, and Facebook. Extreme Networks, and theExtreme Networkslogo are either trademarks or registered trademarks ofExtreme Networks, Inc.inthe United Statesand/or other countries. SOURCE Extreme Networks, Inc. Related Links http://www.extremenetworks.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Extreme Networks Announces Virtual Investor Day Conference Schedule.

SAN JOSE, Calif., Feb. 3, 2021 /PRNewswire/ --Extreme Networks, Inc. (Nasdaq: EXTR), a cloud-driven networking company, today announced the schedule for its Virtual Investor Day event to be held February 23, 2021, as well as its conference schedule for March: Extreme Networks Virtual Investor Day Tuesday, February 23, 2021Beginning at 11:00 AM ETExtreme Networks Virtual Investor Day Registration Link Morgan Stanley Virtual Technology, Media and Telecom ConferenceEd Meyercord, President & CEOWednesday, March 3, 20211:15 PM ET presentation and available for virtual 1x1 meetings throughout the day Enterprises are rapidly embracing cloud-based networking and the world is entering the 5G era. Attendees at Extreme's Virtual Investor Day event will receive an update on the company's differentiated market position, long-term vision and strategy, and multi-year business outlook. Registration and access to the live webcast and presentations for the Virtual Investor Day event will be available at:https://investor.extremenetworks.com/events-presentations A live webcast from the conference presentation will be accessible under Events & Presentations on the Investor Relations section of theExtreme Networks'website athttp://investor.extremenetworks.comand will be archived for at least 30 days following the live presentation. About Extreme Networks:Extreme Networks, Inc.(EXTR) creates effortless networking experiences that enable all of us to advance. We push the boundaries of technology leveraging the powers of machine learning, artificial intelligence, analytics, and automation. Over 50,000 customers globally trust our end-to-end, cloud-driven networking solutions and rely on our top-rated services and support to accelerate their digital transformation efforts and deliver progress like never before. For more information, visit Extreme'swebsiteor or follow us on Twitter, LinkedIn, and Facebook. Extreme Networks, and theExtreme Networkslogo are either trademarks or registered trademarks ofExtreme Networks, Inc.inthe United Statesand/or other countries. SOURCE Extreme Networks, Inc. Related Links http://www.extremenetworks.com

Extreme Networks Announces Virtual Investor Day Conference Schedule

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN JOSE, Calif., Feb. 3, 2021 /PRNewswire/ --Extreme Networks, Inc. (Nasdaq: EXTR), a cloud-driven networking company, today announced the schedule for its Virtual Investor Day event to be held February 23, 2021, as well as its conference schedule for March: Extreme Networks Virtual Investor Day Tuesday, February 23, 2021Beginning at 11:00 AM ETExtreme Networks Virtual Investor Day Registration Link Morgan Stanley Virtual Technology, Media and Telecom ConferenceEd Meyercord, President & CEOWednesday, March 3, 20211:15 PM ET presentation and available for virtual 1x1 meetings throughout the day Enterprises are rapidly embracing cloud-based networking and the world is entering the 5G era. Attendees at Extreme's Virtual Investor Day event will receive an update on the company's differentiated market position, long-term vision and strategy, and multi-year business outlook. Registration and access to the live webcast and presentations for the Virtual Investor Day event will be available at:https://investor.extremenetworks.com/events-presentations A live webcast from the conference presentation will be accessible under Events & Presentations on the Investor Relations section of theExtreme Networks'website athttp://investor.extremenetworks.comand will be archived for at least 30 days following the live presentation. About Extreme Networks:Extreme Networks, Inc.(EXTR) creates effortless networking experiences that enable all of us to advance. We push the boundaries of technology leveraging the powers of machine learning, artificial intelligence, analytics, and automation. Over 50,000 customers globally trust our end-to-end, cloud-driven networking solutions and rely on our top-rated services and support to accelerate their digital transformation efforts and deliver progress like never before. For more information, visit Extreme'swebsiteor or follow us on Twitter, LinkedIn, and Facebook. Extreme Networks, and theExtreme Networkslogo are either trademarks or registered trademarks ofExtreme Networks, Inc.inthe United Statesand/or other countries. SOURCE Extreme Networks, Inc. Related Links http://www.extremenetworks.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Extreme Networks Announces Virtual Investor Day Conference Schedule.<|eot_id|>

edtsum888

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CAMBRIDGE, Mass., April 2, 2020 /PRNewswire/ --Rgenta Therapeutics, a new biotechnology company focusing on developing RNA-targeting medicines for historically undruggable disease-relevant targets, announced today that it closed a $20 Million seed investment, co-led by Boehringer Ingelheim Venture Fund and Matrix Partners China. Rounding out the series seed syndicate are two additional investors, Kaitai Capital and Legend Star Fund. The company has assembled a world-class team of small-molecule drug developers and an exceptional Scientific Advisory Board in the fields of genomics and RNA biology. "We are delighted to have an outstanding syndicate of investors in this seed round," said Dr. Simon Xi, co-founder and CEO of Rgenta. "With their support, we will be able to rapidly advance our lead RNA-targeting programs into preclinical studies and expand our portfolio to pursue high-value RNA targets in a range of therapeutic areas." "Rgenta's RNA-targeting platform delivers an innovative approach that gives us access to historically undruggable, highly disease-relevant targets," said Dr. Travis Wager, co-founder and CSO of Rgenta. "The key to our platform's success is that we can analyze massive amounts of genomics data and identify regulatory sites in RNAs amenable for potent and selective modulation by small molecules.Our unique discovery engine can rapidly screen for drug-like small molecules to target RNAs and thereby regulate protein production or alter protein function." Rgenta builds on the groundbreaking work of its scientific co-founder, Dr. Zhiping Weng, an endowed professor at the University of Massachusetts Medical School in Worcester, Mass., who has decades of experience studying gene regulation and RNA biology and co-leads the data analysis centers of the ENCODE and psychENCODE consortia. The Rgenta scientific advisory board includes: Dr. Phillip Zamore, Chair of RNA Therapeutics Institute and Gretchen Stone Cook Professor of Biomedical Sciences at the University of Massachusetts Medical School and a co-founder of two biotechnology companies, Alnylam Pharmaceuticals and Voyager Therapeutics; Dr. Charles DeLisi, Metcalf Professor of Science and Engineering at Boston University, a transformative visionary, widely recognized as the father of the human genome project; and Dr. Friedrich Metzger, CEO of Versameb AG and previously Head of Roche Discovery Rare Diseases, and a leader of the discovery of Risdiplam, a small molecule RNA splicing modifier for treatment of spinal muscular atrophy. Rgenta's initial focus is on developing small molecules targeting the RNA regulation and splicing of disease-causing genes in oncology and neurological disorders that are 'undruggable' by traditional approaches. These target genes reside in the crux of regulatory programs and signaling pathways essential to disease development and represent ideal targets for pharmaceutical intervention. Martin Heidecker, Head of the Boehringer Ingelheim Venture fund USA and chairman of the board of directors of Rgenta, commented, "We are very excited about Rgenta's novel and integrative platform for RNA-targeting. With the unique expertise and experiences of the Rgenta team in genomics, computation, disease biology, screening, and medicinal chemistry, we are confident that Rgenta will unlock the therapeutic potentials for a new class of targets and develop innovative therapies for patients." About Rgenta TherapeuticsRgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. Learn more at http://www.rgentatx.com Rgenta contact: [emailprotected] SOURCE Rgenta Therapeutics Related Links rgentatx.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Rgenta Therapeutics Launches with $20 Million Seed Investment.

CAMBRIDGE, Mass., April 2, 2020 /PRNewswire/ --Rgenta Therapeutics, a new biotechnology company focusing on developing RNA-targeting medicines for historically undruggable disease-relevant targets, announced today that it closed a $20 Million seed investment, co-led by Boehringer Ingelheim Venture Fund and Matrix Partners China. Rounding out the series seed syndicate are two additional investors, Kaitai Capital and Legend Star Fund. The company has assembled a world-class team of small-molecule drug developers and an exceptional Scientific Advisory Board in the fields of genomics and RNA biology. "We are delighted to have an outstanding syndicate of investors in this seed round," said Dr. Simon Xi, co-founder and CEO of Rgenta. "With their support, we will be able to rapidly advance our lead RNA-targeting programs into preclinical studies and expand our portfolio to pursue high-value RNA targets in a range of therapeutic areas." "Rgenta's RNA-targeting platform delivers an innovative approach that gives us access to historically undruggable, highly disease-relevant targets," said Dr. Travis Wager, co-founder and CSO of Rgenta. "The key to our platform's success is that we can analyze massive amounts of genomics data and identify regulatory sites in RNAs amenable for potent and selective modulation by small molecules.Our unique discovery engine can rapidly screen for drug-like small molecules to target RNAs and thereby regulate protein production or alter protein function." Rgenta builds on the groundbreaking work of its scientific co-founder, Dr. Zhiping Weng, an endowed professor at the University of Massachusetts Medical School in Worcester, Mass., who has decades of experience studying gene regulation and RNA biology and co-leads the data analysis centers of the ENCODE and psychENCODE consortia. The Rgenta scientific advisory board includes: Dr. Phillip Zamore, Chair of RNA Therapeutics Institute and Gretchen Stone Cook Professor of Biomedical Sciences at the University of Massachusetts Medical School and a co-founder of two biotechnology companies, Alnylam Pharmaceuticals and Voyager Therapeutics; Dr. Charles DeLisi, Metcalf Professor of Science and Engineering at Boston University, a transformative visionary, widely recognized as the father of the human genome project; and Dr. Friedrich Metzger, CEO of Versameb AG and previously Head of Roche Discovery Rare Diseases, and a leader of the discovery of Risdiplam, a small molecule RNA splicing modifier for treatment of spinal muscular atrophy. Rgenta's initial focus is on developing small molecules targeting the RNA regulation and splicing of disease-causing genes in oncology and neurological disorders that are 'undruggable' by traditional approaches. These target genes reside in the crux of regulatory programs and signaling pathways essential to disease development and represent ideal targets for pharmaceutical intervention. Martin Heidecker, Head of the Boehringer Ingelheim Venture fund USA and chairman of the board of directors of Rgenta, commented, "We are very excited about Rgenta's novel and integrative platform for RNA-targeting. With the unique expertise and experiences of the Rgenta team in genomics, computation, disease biology, screening, and medicinal chemistry, we are confident that Rgenta will unlock the therapeutic potentials for a new class of targets and develop innovative therapies for patients." About Rgenta TherapeuticsRgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. Learn more at http://www.rgentatx.com Rgenta contact: [emailprotected] SOURCE Rgenta Therapeutics Related Links rgentatx.com

Rgenta Therapeutics Launches with $20 Million Seed Investment

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CAMBRIDGE, Mass., April 2, 2020 /PRNewswire/ --Rgenta Therapeutics, a new biotechnology company focusing on developing RNA-targeting medicines for historically undruggable disease-relevant targets, announced today that it closed a $20 Million seed investment, co-led by Boehringer Ingelheim Venture Fund and Matrix Partners China. Rounding out the series seed syndicate are two additional investors, Kaitai Capital and Legend Star Fund. The company has assembled a world-class team of small-molecule drug developers and an exceptional Scientific Advisory Board in the fields of genomics and RNA biology. "We are delighted to have an outstanding syndicate of investors in this seed round," said Dr. Simon Xi, co-founder and CEO of Rgenta. "With their support, we will be able to rapidly advance our lead RNA-targeting programs into preclinical studies and expand our portfolio to pursue high-value RNA targets in a range of therapeutic areas." "Rgenta's RNA-targeting platform delivers an innovative approach that gives us access to historically undruggable, highly disease-relevant targets," said Dr. Travis Wager, co-founder and CSO of Rgenta. "The key to our platform's success is that we can analyze massive amounts of genomics data and identify regulatory sites in RNAs amenable for potent and selective modulation by small molecules.Our unique discovery engine can rapidly screen for drug-like small molecules to target RNAs and thereby regulate protein production or alter protein function." Rgenta builds on the groundbreaking work of its scientific co-founder, Dr. Zhiping Weng, an endowed professor at the University of Massachusetts Medical School in Worcester, Mass., who has decades of experience studying gene regulation and RNA biology and co-leads the data analysis centers of the ENCODE and psychENCODE consortia. The Rgenta scientific advisory board includes: Dr. Phillip Zamore, Chair of RNA Therapeutics Institute and Gretchen Stone Cook Professor of Biomedical Sciences at the University of Massachusetts Medical School and a co-founder of two biotechnology companies, Alnylam Pharmaceuticals and Voyager Therapeutics; Dr. Charles DeLisi, Metcalf Professor of Science and Engineering at Boston University, a transformative visionary, widely recognized as the father of the human genome project; and Dr. Friedrich Metzger, CEO of Versameb AG and previously Head of Roche Discovery Rare Diseases, and a leader of the discovery of Risdiplam, a small molecule RNA splicing modifier for treatment of spinal muscular atrophy. Rgenta's initial focus is on developing small molecules targeting the RNA regulation and splicing of disease-causing genes in oncology and neurological disorders that are 'undruggable' by traditional approaches. These target genes reside in the crux of regulatory programs and signaling pathways essential to disease development and represent ideal targets for pharmaceutical intervention. Martin Heidecker, Head of the Boehringer Ingelheim Venture fund USA and chairman of the board of directors of Rgenta, commented, "We are very excited about Rgenta's novel and integrative platform for RNA-targeting. With the unique expertise and experiences of the Rgenta team in genomics, computation, disease biology, screening, and medicinal chemistry, we are confident that Rgenta will unlock the therapeutic potentials for a new class of targets and develop innovative therapies for patients." About Rgenta TherapeuticsRgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. Learn more at http://www.rgentatx.com Rgenta contact: [emailprotected] SOURCE Rgenta Therapeutics Related Links rgentatx.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Rgenta Therapeutics Launches with $20 Million Seed Investment.<|eot_id|>

edtsum889

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: ROLLING MEADOWS, Ill., March 23, 2021 /PRNewswire/ --Arthur J. Gallagher & Co.(NYSE: AJG) today announced the acquisition of South Bend, Indiana-based R&R Benefits/Risk Management, LLC. Terms of the transaction were not disclosed. Founded in 2000, R&R Benefits is an independent insurance agency offering employee benefit program solutions, as well as property/casualty risk placements, in the traditional and alternative risk financing market. Robert Frick, Troy Scott and their associates will continue operating from their current location under the direction of Tom Lannen, head of Gallagher's Great Lakes Region employee benefits consulting and brokerage operations, and Cindy LaMantia, head of Gallagher's Great Lakes Region retail property/casualty brokerage operations. "R&R offers creative approaches to helping clients manage healthcare costs, and the team's public entity expertise and strong relationships across Northern Indiana will further enhance Gallagher's capabilities in that market," said J. Patrick Gallagher, Jr., Chairman, President and CEO. "We are very pleased to welcome Bob, Troy and their associates to our growing global team." Arthur J. Gallagher & Co., a global insurance brokerage, risk management and consulting services firm, is headquartered inRolling Meadows,Illinois. The company has operations in 49 countries and offers client-service capabilities in more than 150 countries around the world through a network of correspondent brokers and consultants. Investors: Ray Iardella Media: Linda J. Collins VP Investor Relations VP Corporate Communications 630-285-3661/[emailprotected] 630-285-4009/[emailprotected] SOURCE Arthur J. Gallagher & Co. Related Links http://www.ajg.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Arthur J. Gallagher & Co. acquires R&R Benefits/Risk Management, LLC.

ROLLING MEADOWS, Ill., March 23, 2021 /PRNewswire/ --Arthur J. Gallagher & Co.(NYSE: AJG) today announced the acquisition of South Bend, Indiana-based R&R Benefits/Risk Management, LLC. Terms of the transaction were not disclosed. Founded in 2000, R&R Benefits is an independent insurance agency offering employee benefit program solutions, as well as property/casualty risk placements, in the traditional and alternative risk financing market. Robert Frick, Troy Scott and their associates will continue operating from their current location under the direction of Tom Lannen, head of Gallagher's Great Lakes Region employee benefits consulting and brokerage operations, and Cindy LaMantia, head of Gallagher's Great Lakes Region retail property/casualty brokerage operations. "R&R offers creative approaches to helping clients manage healthcare costs, and the team's public entity expertise and strong relationships across Northern Indiana will further enhance Gallagher's capabilities in that market," said J. Patrick Gallagher, Jr., Chairman, President and CEO. "We are very pleased to welcome Bob, Troy and their associates to our growing global team." Arthur J. Gallagher & Co., a global insurance brokerage, risk management and consulting services firm, is headquartered inRolling Meadows,Illinois. The company has operations in 49 countries and offers client-service capabilities in more than 150 countries around the world through a network of correspondent brokers and consultants. Investors: Ray Iardella Media: Linda J. Collins VP Investor Relations VP Corporate Communications 630-285-3661/[emailprotected] 630-285-4009/[emailprotected] SOURCE Arthur J. Gallagher & Co. Related Links http://www.ajg.com

Arthur J. Gallagher & Co. Acquires R&R Benefits/Risk Management, LLC

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: ROLLING MEADOWS, Ill., March 23, 2021 /PRNewswire/ --Arthur J. Gallagher & Co.(NYSE: AJG) today announced the acquisition of South Bend, Indiana-based R&R Benefits/Risk Management, LLC. Terms of the transaction were not disclosed. Founded in 2000, R&R Benefits is an independent insurance agency offering employee benefit program solutions, as well as property/casualty risk placements, in the traditional and alternative risk financing market. Robert Frick, Troy Scott and their associates will continue operating from their current location under the direction of Tom Lannen, head of Gallagher's Great Lakes Region employee benefits consulting and brokerage operations, and Cindy LaMantia, head of Gallagher's Great Lakes Region retail property/casualty brokerage operations. "R&R offers creative approaches to helping clients manage healthcare costs, and the team's public entity expertise and strong relationships across Northern Indiana will further enhance Gallagher's capabilities in that market," said J. Patrick Gallagher, Jr., Chairman, President and CEO. "We are very pleased to welcome Bob, Troy and their associates to our growing global team." Arthur J. Gallagher & Co., a global insurance brokerage, risk management and consulting services firm, is headquartered inRolling Meadows,Illinois. The company has operations in 49 countries and offers client-service capabilities in more than 150 countries around the world through a network of correspondent brokers and consultants. Investors: Ray Iardella Media: Linda J. Collins VP Investor Relations VP Corporate Communications 630-285-3661/[emailprotected] 630-285-4009/[emailprotected] SOURCE Arthur J. Gallagher & Co. Related Links http://www.ajg.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Arthur J. Gallagher & Co. acquires R&R Benefits/Risk Management, LLC.<|eot_id|>

edtsum890

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: ALBANY, N.Y, Dec. 3, 2020 /PRNewswire/ --A wide range of industry verticals including healthcare, hospitality, automotive, retail, e-Commerce, BFSI, and food and beverages are harnessing the capabilities of demand planning solutions for various stages of product development and supply chain. The gains that accrue include improved synchronization, reduce inventory investment, better cash flow, and boost customer satisfaction. The growing role of predictive analytics in understanding resource management and planning revenue targets is key to the increasing penetration of demand planning solutions market. The supply chain disruptions caused by novel COVID-19 pandemic has up the ante for stakeholders to have access to cutting-edge solutions, opine analysts at TMR. This is because the pandemic has severely constrained the supply and logistic chain of companies across industries. The analysts at TMR project the demand planning solutions market to clock impressive CAGR of ~16% from 2020 to 2030, and surpass a valuation of US$ 14.5 Bn by the period-end. Download PDF Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79575 Key Findings of Demand Planning Solutions Market Report Opportunities in North America have been rising at promising pace Europe is also a promising market and is expected to rise at impressive growth rate Asia Pacific is expected to remain at the key focus for consumers and solution providers In 2019 the demand planning solutions market stood at ~US$ 3 Bn Trade promotion planning, and product portfolio management are promising application areas Explore 238 pages of top-notch research, incisive insights, and detailed country-level projections on Demand Planning Solutions Market (Component: Software/Platform and Services [Professional and Managed]; Deployment: On-premise and Cloud-based; Enterprise Size: Small & Medium Enterprises and Large Enterprises; and Industry: BFSI, IT & Telecom, Healthcare, Retail & e-Commerce, Automotive, Food & Beverages, Manufacturing, Hospitality, and Others) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 at https://www.transparencymarketresearch.com/demand-planning-solutions-market.html Demand Planning Solutions Market: Key Driving Factors and Promising Avenues The relevance of planning and forecasting platforms is steadily growing across companies of different industries for maintaining the production and supply of products. The demand for product portfolio management is boosting the business propositions in the demand planning solutions market. The benefits of managing product lifecycle stages in real-time during seasonal demand is made possible by the array of demand forecasting solutions. The growing adoption of flexible promotional modeling is boosting the market. In this dynamically changing business landscape, consumer behavior has to be closely tracked before product development. This is boosting the prospects in the demand planning solutions market. The forecasting methods help understand the demand for new features. Over the years, the capabilities of solutions have increased as machine learning technologies, and automated technique are integrated. Demand Planning Solutions Market: Key Impediments Despite the high capabilities of real-time demand forecasting, small and medium-scale enterprises lack budget to gain access to contemporary solutions, impeding the expansion of the demand planning solutions market. Also, when not all features of the platforms are used, this sometimes give wrong or incomplete results, creating negative criticism among prospective buyers. This is mainly due to the lack of awareness and lack of expertise. Analyze global demand planning solutions market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sampleof the study Demand Planning Solutions Market: Regional Landscape North America has been a prominent market. The presence of numerous top players and the early adopters are key to growth avenues in the regional market. Asia Pacific is a promising regional market and will continue to present lucrative revenue streams in the coming years as well. The regional market is expected to clock at a higher CAGR during 2020 2030. Key Participants in Demand Planning Solutions Market Providers are increasingly leaning on aiming at better customer experience and satisfactions to stay ahead of their peers and competitors in the demand planning solutions market. Some of the key participants are SAP SE, RELEX Oy, International Business Machines Corporation, GAINSystems, Inc., Demand Works Company, Blue Ridge Solutions Inc., Aspire Systems, and Cognizant Technology Solutions Corp. Request the Covid19 Impact Analysis at https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79575 Global Demand Planning Solutions Market: Segmentation Demand Planning Solutions Market, by Component Software/Platform Services Professional Integration & Consulting Support & Maintenance Managed Demand Planning Solutions Market, by Deployment On-premise Cloud-based Demand Planning Solutions Market, by Enterprise Size Small & Medium Enterprises Large Enterprises Demand Planning Solutions Market, by Industry BFSI IT & Telecom Healthcare Retail & e-Commerce Automotive Food & Beverages Manufacturing Hospitality Others (Education, Media & Entertainment, etc.) Demand Planning Solutions Market, by Region North America U.S. Canada Mexico Europe Germany U.K. France Spain Italy Rest of Europe Asia Pacific (APAC) China Japan India ASEAN Rest of Asia Pacific Middle East & Africa (MEA) UAE South Africa Rest of Middle East & Africa South America Brazil Argentina Rest of South America Explore Transparency Market Research's award-winning coverage of the Global IT & Telecom Industry: Contact Center Solution Market The contact center solution market is expected to grow at an astonishing CAGR of ~19% during the forecast period. However, challenges such as poor audio quality and lack of communication at centers can affect services provided to customers. Hence, companies in the contact center solution market are implementing proactive monitoring and testing of phone lines to move toward better services. Conducting bi-weekly or monthly meetings at the center is another solution to avoid lack of communication. Extended Reality [XR] Market The global extended reality (XR) market is expected to grow at a staggering CAGR of 45% during the assessment period. The market growth is driven by a range of factors, including increasing smartphone penetration, rising demand for digital environments, growing popularity of augmented reality and virtual reality technologies, and its applicability across various end-use industries. Market players are anticipated to focus on the development of extended reality solutions in collaboration with a number of startups that have entered the market, particularly in developed regions such as North America and Europe. Machine Learning Market The machine learning market is expected to advance at an explosive CAGR of ~27% during the forecast period. However, the implementation of ML models is emerging as a challenge for companies. For instance, computations with Big Data can lead to issues in processing performance of ML models, thus making even trivial operations expensive. Companies in the machine learning market should provide proper training for algorithms in order to improve computational feasibility on very large datasets. About Transparency Market Research Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyse information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. ContactMr Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: [emailprotected] Website: https://www.transparencymarketresearch.com Press Release Source: https://www.transparencymarketresearch.com/pressrelease/demand-planning-solutions-market.htm SOURCE Transparency Market Research Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Manufacturing Industries Pin Hopes on Demand Planning Solutions Market to Boost Performance of Supply Chains. Market to Cross Mark of US$ 14.5 Bn by 2030-End: TMR.

ALBANY, N.Y, Dec. 3, 2020 /PRNewswire/ --A wide range of industry verticals including healthcare, hospitality, automotive, retail, e-Commerce, BFSI, and food and beverages are harnessing the capabilities of demand planning solutions for various stages of product development and supply chain. The gains that accrue include improved synchronization, reduce inventory investment, better cash flow, and boost customer satisfaction. The growing role of predictive analytics in understanding resource management and planning revenue targets is key to the increasing penetration of demand planning solutions market. The supply chain disruptions caused by novel COVID-19 pandemic has up the ante for stakeholders to have access to cutting-edge solutions, opine analysts at TMR. This is because the pandemic has severely constrained the supply and logistic chain of companies across industries. The analysts at TMR project the demand planning solutions market to clock impressive CAGR of ~16% from 2020 to 2030, and surpass a valuation of US$ 14.5 Bn by the period-end. Download PDF Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79575 Key Findings of Demand Planning Solutions Market Report Opportunities in North America have been rising at promising pace Europe is also a promising market and is expected to rise at impressive growth rate Asia Pacific is expected to remain at the key focus for consumers and solution providers In 2019 the demand planning solutions market stood at ~US$ 3 Bn Trade promotion planning, and product portfolio management are promising application areas Explore 238 pages of top-notch research, incisive insights, and detailed country-level projections on Demand Planning Solutions Market (Component: Software/Platform and Services [Professional and Managed]; Deployment: On-premise and Cloud-based; Enterprise Size: Small & Medium Enterprises and Large Enterprises; and Industry: BFSI, IT & Telecom, Healthcare, Retail & e-Commerce, Automotive, Food & Beverages, Manufacturing, Hospitality, and Others) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 at https://www.transparencymarketresearch.com/demand-planning-solutions-market.html Demand Planning Solutions Market: Key Driving Factors and Promising Avenues The relevance of planning and forecasting platforms is steadily growing across companies of different industries for maintaining the production and supply of products. The demand for product portfolio management is boosting the business propositions in the demand planning solutions market. The benefits of managing product lifecycle stages in real-time during seasonal demand is made possible by the array of demand forecasting solutions. The growing adoption of flexible promotional modeling is boosting the market. In this dynamically changing business landscape, consumer behavior has to be closely tracked before product development. This is boosting the prospects in the demand planning solutions market. The forecasting methods help understand the demand for new features. Over the years, the capabilities of solutions have increased as machine learning technologies, and automated technique are integrated. Demand Planning Solutions Market: Key Impediments Despite the high capabilities of real-time demand forecasting, small and medium-scale enterprises lack budget to gain access to contemporary solutions, impeding the expansion of the demand planning solutions market. Also, when not all features of the platforms are used, this sometimes give wrong or incomplete results, creating negative criticism among prospective buyers. This is mainly due to the lack of awareness and lack of expertise. Analyze global demand planning solutions market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sampleof the study Demand Planning Solutions Market: Regional Landscape North America has been a prominent market. The presence of numerous top players and the early adopters are key to growth avenues in the regional market. Asia Pacific is a promising regional market and will continue to present lucrative revenue streams in the coming years as well. The regional market is expected to clock at a higher CAGR during 2020 2030. Key Participants in Demand Planning Solutions Market Providers are increasingly leaning on aiming at better customer experience and satisfactions to stay ahead of their peers and competitors in the demand planning solutions market. Some of the key participants are SAP SE, RELEX Oy, International Business Machines Corporation, GAINSystems, Inc., Demand Works Company, Blue Ridge Solutions Inc., Aspire Systems, and Cognizant Technology Solutions Corp. Request the Covid19 Impact Analysis at https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79575 Global Demand Planning Solutions Market: Segmentation Demand Planning Solutions Market, by Component Software/Platform Services Professional Integration & Consulting Support & Maintenance Managed Demand Planning Solutions Market, by Deployment On-premise Cloud-based Demand Planning Solutions Market, by Enterprise Size Small & Medium Enterprises Large Enterprises Demand Planning Solutions Market, by Industry BFSI IT & Telecom Healthcare Retail & e-Commerce Automotive Food & Beverages Manufacturing Hospitality Others (Education, Media & Entertainment, etc.) Demand Planning Solutions Market, by Region North America U.S. Canada Mexico Europe Germany U.K. France Spain Italy Rest of Europe Asia Pacific (APAC) China Japan India ASEAN Rest of Asia Pacific Middle East & Africa (MEA) UAE South Africa Rest of Middle East & Africa South America Brazil Argentina Rest of South America Explore Transparency Market Research's award-winning coverage of the Global IT & Telecom Industry: Contact Center Solution Market The contact center solution market is expected to grow at an astonishing CAGR of ~19% during the forecast period. However, challenges such as poor audio quality and lack of communication at centers can affect services provided to customers. Hence, companies in the contact center solution market are implementing proactive monitoring and testing of phone lines to move toward better services. Conducting bi-weekly or monthly meetings at the center is another solution to avoid lack of communication. Extended Reality [XR] Market The global extended reality (XR) market is expected to grow at a staggering CAGR of 45% during the assessment period. The market growth is driven by a range of factors, including increasing smartphone penetration, rising demand for digital environments, growing popularity of augmented reality and virtual reality technologies, and its applicability across various end-use industries. Market players are anticipated to focus on the development of extended reality solutions in collaboration with a number of startups that have entered the market, particularly in developed regions such as North America and Europe. Machine Learning Market The machine learning market is expected to advance at an explosive CAGR of ~27% during the forecast period. However, the implementation of ML models is emerging as a challenge for companies. For instance, computations with Big Data can lead to issues in processing performance of ML models, thus making even trivial operations expensive. Companies in the machine learning market should provide proper training for algorithms in order to improve computational feasibility on very large datasets. About Transparency Market Research Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyse information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. ContactMr Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: [emailprotected] Website: https://www.transparencymarketresearch.com Press Release Source: https://www.transparencymarketresearch.com/pressrelease/demand-planning-solutions-market.htm SOURCE Transparency Market Research

Manufacturing Industries Pin Hopes on Demand Planning Solutions Market to Boost Performance of Supply Chains, Market to Cross Mark of US$ 14.5 Bn by 2030-End: TMR

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: ALBANY, N.Y, Dec. 3, 2020 /PRNewswire/ --A wide range of industry verticals including healthcare, hospitality, automotive, retail, e-Commerce, BFSI, and food and beverages are harnessing the capabilities of demand planning solutions for various stages of product development and supply chain. The gains that accrue include improved synchronization, reduce inventory investment, better cash flow, and boost customer satisfaction. The growing role of predictive analytics in understanding resource management and planning revenue targets is key to the increasing penetration of demand planning solutions market. The supply chain disruptions caused by novel COVID-19 pandemic has up the ante for stakeholders to have access to cutting-edge solutions, opine analysts at TMR. This is because the pandemic has severely constrained the supply and logistic chain of companies across industries. The analysts at TMR project the demand planning solutions market to clock impressive CAGR of ~16% from 2020 to 2030, and surpass a valuation of US$ 14.5 Bn by the period-end. Download PDF Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79575 Key Findings of Demand Planning Solutions Market Report Opportunities in North America have been rising at promising pace Europe is also a promising market and is expected to rise at impressive growth rate Asia Pacific is expected to remain at the key focus for consumers and solution providers In 2019 the demand planning solutions market stood at ~US$ 3 Bn Trade promotion planning, and product portfolio management are promising application areas Explore 238 pages of top-notch research, incisive insights, and detailed country-level projections on Demand Planning Solutions Market (Component: Software/Platform and Services [Professional and Managed]; Deployment: On-premise and Cloud-based; Enterprise Size: Small & Medium Enterprises and Large Enterprises; and Industry: BFSI, IT & Telecom, Healthcare, Retail & e-Commerce, Automotive, Food & Beverages, Manufacturing, Hospitality, and Others) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 at https://www.transparencymarketresearch.com/demand-planning-solutions-market.html Demand Planning Solutions Market: Key Driving Factors and Promising Avenues The relevance of planning and forecasting platforms is steadily growing across companies of different industries for maintaining the production and supply of products. The demand for product portfolio management is boosting the business propositions in the demand planning solutions market. The benefits of managing product lifecycle stages in real-time during seasonal demand is made possible by the array of demand forecasting solutions. The growing adoption of flexible promotional modeling is boosting the market. In this dynamically changing business landscape, consumer behavior has to be closely tracked before product development. This is boosting the prospects in the demand planning solutions market. The forecasting methods help understand the demand for new features. Over the years, the capabilities of solutions have increased as machine learning technologies, and automated technique are integrated. Demand Planning Solutions Market: Key Impediments Despite the high capabilities of real-time demand forecasting, small and medium-scale enterprises lack budget to gain access to contemporary solutions, impeding the expansion of the demand planning solutions market. Also, when not all features of the platforms are used, this sometimes give wrong or incomplete results, creating negative criticism among prospective buyers. This is mainly due to the lack of awareness and lack of expertise. Analyze global demand planning solutions market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sampleof the study Demand Planning Solutions Market: Regional Landscape North America has been a prominent market. The presence of numerous top players and the early adopters are key to growth avenues in the regional market. Asia Pacific is a promising regional market and will continue to present lucrative revenue streams in the coming years as well. The regional market is expected to clock at a higher CAGR during 2020 2030. Key Participants in Demand Planning Solutions Market Providers are increasingly leaning on aiming at better customer experience and satisfactions to stay ahead of their peers and competitors in the demand planning solutions market. Some of the key participants are SAP SE, RELEX Oy, International Business Machines Corporation, GAINSystems, Inc., Demand Works Company, Blue Ridge Solutions Inc., Aspire Systems, and Cognizant Technology Solutions Corp. Request the Covid19 Impact Analysis at https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79575 Global Demand Planning Solutions Market: Segmentation Demand Planning Solutions Market, by Component Software/Platform Services Professional Integration & Consulting Support & Maintenance Managed Demand Planning Solutions Market, by Deployment On-premise Cloud-based Demand Planning Solutions Market, by Enterprise Size Small & Medium Enterprises Large Enterprises Demand Planning Solutions Market, by Industry BFSI IT & Telecom Healthcare Retail & e-Commerce Automotive Food & Beverages Manufacturing Hospitality Others (Education, Media & Entertainment, etc.) Demand Planning Solutions Market, by Region North America U.S. Canada Mexico Europe Germany U.K. France Spain Italy Rest of Europe Asia Pacific (APAC) China Japan India ASEAN Rest of Asia Pacific Middle East & Africa (MEA) UAE South Africa Rest of Middle East & Africa South America Brazil Argentina Rest of South America Explore Transparency Market Research's award-winning coverage of the Global IT & Telecom Industry: Contact Center Solution Market The contact center solution market is expected to grow at an astonishing CAGR of ~19% during the forecast period. However, challenges such as poor audio quality and lack of communication at centers can affect services provided to customers. Hence, companies in the contact center solution market are implementing proactive monitoring and testing of phone lines to move toward better services. Conducting bi-weekly or monthly meetings at the center is another solution to avoid lack of communication. Extended Reality [XR] Market The global extended reality (XR) market is expected to grow at a staggering CAGR of 45% during the assessment period. The market growth is driven by a range of factors, including increasing smartphone penetration, rising demand for digital environments, growing popularity of augmented reality and virtual reality technologies, and its applicability across various end-use industries. Market players are anticipated to focus on the development of extended reality solutions in collaboration with a number of startups that have entered the market, particularly in developed regions such as North America and Europe. Machine Learning Market The machine learning market is expected to advance at an explosive CAGR of ~27% during the forecast period. However, the implementation of ML models is emerging as a challenge for companies. For instance, computations with Big Data can lead to issues in processing performance of ML models, thus making even trivial operations expensive. Companies in the machine learning market should provide proper training for algorithms in order to improve computational feasibility on very large datasets. About Transparency Market Research Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyse information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. ContactMr Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: [emailprotected] Website: https://www.transparencymarketresearch.com Press Release Source: https://www.transparencymarketresearch.com/pressrelease/demand-planning-solutions-market.htm SOURCE Transparency Market Research Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Manufacturing Industries Pin Hopes on Demand Planning Solutions Market to Boost Performance of Supply Chains. Market to Cross Mark of US$ 14.5 Bn by 2030-End: TMR.<|eot_id|>

edtsum891

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MENLO PARK, Calif., June 24, 2020 /PRNewswire/ --Quantifind announced today that it is joining the Snowflake Data Marketplace, enabling financial services customers of Snowflake's cloud data platform to seamlessly run customer and counterparty risk assessments in a private, secure, and efficient manner. Quantifind's proprietary cloud-enabled technology uses a combination of public-domain data sources, best-in-class entity resolution, and predictive risk typology models to build accurate risk profiles on the fly for individuals and organizations alike. In this integration, mutual customers will have direct access to Quantifind's Batch Search API from within the Snowflake platform, allowing them to build new secure and automated Customer Due Diligence (CDD) workflows. "We're thrilled to be partnering with Quantifind to help our financial services customers mitigate risks in their operations," says Justin Langseth, Vice President of Snowflake Data Marketplace. "The combination of Snowflake's world-class data platform capabilities with Quantifind's innovative technology in the anti-financial crimes space can provide a valuable service to our joint customers." "As financial services firms continue their migration of data storage and back-office services to the cloud, we believe there is a great opportunity to meet them where they are and help them reap the benefits of this transformative change," says Ari Tuchman, CEO and Co-Founder of Quantifind. "With this integration, Snowflake and Quantifind mutual customers will be able to stand up new, more efficient and secure anti-money laundering and fraud risk mitigation processes without ever transferring any data or executing a costly implementation program." About Quantifind: Quantifindis a technology company whose AI platform uncovers risk signals across disparate and unstructured text sources. In financial crimes risk management, Quantifind provides an AI solution for anti-money laundering and fraud detection that uniquely discovers risk by combining internal financial institution data with public domain data. At a time when false positive transaction-based Alerts are pushing compliance costs higher and further straining investigative workforces, a Quantifind implementation can help realize a 30% efficiency gain. SOURCE Quantifind Related Links https://www.quantifind.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Quantifind Joins the Snowflake Data Marketplace.

MENLO PARK, Calif., June 24, 2020 /PRNewswire/ --Quantifind announced today that it is joining the Snowflake Data Marketplace, enabling financial services customers of Snowflake's cloud data platform to seamlessly run customer and counterparty risk assessments in a private, secure, and efficient manner. Quantifind's proprietary cloud-enabled technology uses a combination of public-domain data sources, best-in-class entity resolution, and predictive risk typology models to build accurate risk profiles on the fly for individuals and organizations alike. In this integration, mutual customers will have direct access to Quantifind's Batch Search API from within the Snowflake platform, allowing them to build new secure and automated Customer Due Diligence (CDD) workflows. "We're thrilled to be partnering with Quantifind to help our financial services customers mitigate risks in their operations," says Justin Langseth, Vice President of Snowflake Data Marketplace. "The combination of Snowflake's world-class data platform capabilities with Quantifind's innovative technology in the anti-financial crimes space can provide a valuable service to our joint customers." "As financial services firms continue their migration of data storage and back-office services to the cloud, we believe there is a great opportunity to meet them where they are and help them reap the benefits of this transformative change," says Ari Tuchman, CEO and Co-Founder of Quantifind. "With this integration, Snowflake and Quantifind mutual customers will be able to stand up new, more efficient and secure anti-money laundering and fraud risk mitigation processes without ever transferring any data or executing a costly implementation program." About Quantifind: Quantifindis a technology company whose AI platform uncovers risk signals across disparate and unstructured text sources. In financial crimes risk management, Quantifind provides an AI solution for anti-money laundering and fraud detection that uniquely discovers risk by combining internal financial institution data with public domain data. At a time when false positive transaction-based Alerts are pushing compliance costs higher and further straining investigative workforces, a Quantifind implementation can help realize a 30% efficiency gain. SOURCE Quantifind Related Links https://www.quantifind.com

Quantifind Joins the Snowflake Data Marketplace

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MENLO PARK, Calif., June 24, 2020 /PRNewswire/ --Quantifind announced today that it is joining the Snowflake Data Marketplace, enabling financial services customers of Snowflake's cloud data platform to seamlessly run customer and counterparty risk assessments in a private, secure, and efficient manner. Quantifind's proprietary cloud-enabled technology uses a combination of public-domain data sources, best-in-class entity resolution, and predictive risk typology models to build accurate risk profiles on the fly for individuals and organizations alike. In this integration, mutual customers will have direct access to Quantifind's Batch Search API from within the Snowflake platform, allowing them to build new secure and automated Customer Due Diligence (CDD) workflows. "We're thrilled to be partnering with Quantifind to help our financial services customers mitigate risks in their operations," says Justin Langseth, Vice President of Snowflake Data Marketplace. "The combination of Snowflake's world-class data platform capabilities with Quantifind's innovative technology in the anti-financial crimes space can provide a valuable service to our joint customers." "As financial services firms continue their migration of data storage and back-office services to the cloud, we believe there is a great opportunity to meet them where they are and help them reap the benefits of this transformative change," says Ari Tuchman, CEO and Co-Founder of Quantifind. "With this integration, Snowflake and Quantifind mutual customers will be able to stand up new, more efficient and secure anti-money laundering and fraud risk mitigation processes without ever transferring any data or executing a costly implementation program." About Quantifind: Quantifindis a technology company whose AI platform uncovers risk signals across disparate and unstructured text sources. In financial crimes risk management, Quantifind provides an AI solution for anti-money laundering and fraud detection that uniquely discovers risk by combining internal financial institution data with public domain data. At a time when false positive transaction-based Alerts are pushing compliance costs higher and further straining investigative workforces, a Quantifind implementation can help realize a 30% efficiency gain. SOURCE Quantifind Related Links https://www.quantifind.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Quantifind Joins the Snowflake Data Marketplace.<|eot_id|>

edtsum892

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: ARLINGTON, Va., Nov. 23, 2020 /PRNewswire/ --American Trucking Associations and ATA's Share the Road highway safety program have provided safe driving tips for those who will be traveling this week during the Thanksgiving holiday. This Thanksgiving, the trucking industry will safely deliver 46 million turkeys (an estimated 1.4 billion pounds) along with all of the sides 214 million pounds of potatoes, 50 million pounds of sweet potatoes, 19 million pumpkin pies, and 80 million pounds of cranberries, to ensure Thanksgiving dinner is complete. "It is important to put safety first while driving on the highways to ensure everyone can make it to the dinner table," said ATA Share the Road professional truck driver Gary Martin of FedEx Ground. "As a family man and a professional truck driver, I am one of the last drivers on the road, delivering all the trimmings necessary for Thanksgiving. I hope my fellow motorists will consider safety as they travel to their Thanksgiving destinations." While AAA projects less than 50 million Americans will travel this Thanksgiving holiday, 10% less than previous years, a majority of those will be hitting the highways and sharing the road with professional truck drivers. ATA's Share the Road's Instructional Video, featuring million mile accident free professional truck drivers, gives an eight-minute recap of critical safe-driving habits. "Thanksgiving offers several other driving challenges beyond traffic congestion, said Share the Road professional truck driver Todd Wilemon of Ravenwood Transport. Winter driving presents unique problems for motorists, including high wind and blowing snow, which contributes to reduced visibility in many regions throughout North America. Similarly, freezing temperatures can have a profound impact on vehicles and the roadways. A thorough pre-trip inspection and understanding of driving conditions can play a significant role in driving success this holiday season." ATA's Share the Road is committed to spreading the message of safety. Share the Road professional drivers recommend planning and coordinating travel plans ahead of time, as well as following the below safety tips. This safe driving guidance applies to all motorists, and is crucial when operating small passenger vehicles near large tractor-trailers: Buckle Up: A seat belt will not prevent a collision, but it will save a life. Remove ice and snow from your vehicle: Clear your windows and roof of snow to ensure you have maximum visibility and avoid creating a hazard for the vehicle behind you. Don't allow ice and snow to create additional blind spots on your vehicle. Slow Down: Chances of a crash nearly triples when driving faster than surrounding traffic. Do not drive impaired: Driving is a great responsibility, and your fellow travelers are relying on safe, attentive drivers to respectfully share the road and make good decisions. Be aware of truck blind spots: Trucks deliver your favorite Thanksgiving traditions turkeys, cranberries, mashed potatoes and all kinds of tasty pies so make it easy on them by staying out of blind spots. Pass on the left where the truck's blind spot is much smaller. Keep your eyes on the road: Distracted driving is a major cause of traffic accidents and one of the leading causes of death amongst teenagers. Even just two seconds of distraction time doubles the chances of an accident. Use your cell phone when stopped and never text while driving. Do not cut in front of large trucks: Remember trucks are heavier and take longer to make a complete stop, so avoid cutting quickly in front of them. Fully loaded tractor-trailers can take the length of a football field plus both end zones to make a complete stop. Ask your favorite quarterback how far that is. Hint: it's far. Prepare your vehicle for long distance travel: Before you head out to your aunts, uncles and cousins, check your wipers and fluids and have your radiator and cooling system serviced. Simple maintenance before you leave your home can prevent many of the problems that strand motorists on the side of the road. Prepare yourself for long distance travel: The vehicle needs maintenance, and the driver needs plenty of rest and hydration to function at his or her best. If the turkey is making you feel drowsy, pull over and wait until you are more alert. Leave early and avoid risks: Leave early to reduce anxiety about arriving late. Road conditions may change due to inclement weather or traffic congestion. Be aware of the vehicle in front of you: Leave extra room between you and the vehicle ahead. A reminder to those who are considering travel that staying home and avoiding large-group gatherings is the best way to prevent COVID-19 from spreading. In addition, ATA and Share the Road encourage Americans to make smart decisions regarding travel during the COVID-19 pandemic. With experts discouraging travel this year, keeping off the roads to allow essential workers like truck drivers and medical personnel can help everyone be safe this holiday season. **Professional drivers are available for media interviews through the ATA Office of Public Affairs** Share the Roadis a highway safety outreach program of the American Trucking Associations that educates all drivers about sharing the roads safely with large trucks. An elite team of professional truck drivers with millions of accident-free miles deliver life-saving messages to millions of motorists annually. Follow Share the Road onTwitterand Facebook. American Trucking Associations is the largest national trade association for the trucking industry. Through a federation of 50 affiliated state trucking associations and industry-related conferences and councils, ATA is the voice of the industry America depends on most to move our nation's freight. Follow ATA onTwitter, Facebook, or atTrucking Moves America Forward. SOURCE American Trucking Associations Related Links www.trucking.org Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

ATA Shares Message of Safety, Trucking's Essentiality This Holiday Season.

ARLINGTON, Va., Nov. 23, 2020 /PRNewswire/ --American Trucking Associations and ATA's Share the Road highway safety program have provided safe driving tips for those who will be traveling this week during the Thanksgiving holiday. This Thanksgiving, the trucking industry will safely deliver 46 million turkeys (an estimated 1.4 billion pounds) along with all of the sides 214 million pounds of potatoes, 50 million pounds of sweet potatoes, 19 million pumpkin pies, and 80 million pounds of cranberries, to ensure Thanksgiving dinner is complete. "It is important to put safety first while driving on the highways to ensure everyone can make it to the dinner table," said ATA Share the Road professional truck driver Gary Martin of FedEx Ground. "As a family man and a professional truck driver, I am one of the last drivers on the road, delivering all the trimmings necessary for Thanksgiving. I hope my fellow motorists will consider safety as they travel to their Thanksgiving destinations." While AAA projects less than 50 million Americans will travel this Thanksgiving holiday, 10% less than previous years, a majority of those will be hitting the highways and sharing the road with professional truck drivers. ATA's Share the Road's Instructional Video, featuring million mile accident free professional truck drivers, gives an eight-minute recap of critical safe-driving habits. "Thanksgiving offers several other driving challenges beyond traffic congestion, said Share the Road professional truck driver Todd Wilemon of Ravenwood Transport. Winter driving presents unique problems for motorists, including high wind and blowing snow, which contributes to reduced visibility in many regions throughout North America. Similarly, freezing temperatures can have a profound impact on vehicles and the roadways. A thorough pre-trip inspection and understanding of driving conditions can play a significant role in driving success this holiday season." ATA's Share the Road is committed to spreading the message of safety. Share the Road professional drivers recommend planning and coordinating travel plans ahead of time, as well as following the below safety tips. This safe driving guidance applies to all motorists, and is crucial when operating small passenger vehicles near large tractor-trailers: Buckle Up: A seat belt will not prevent a collision, but it will save a life. Remove ice and snow from your vehicle: Clear your windows and roof of snow to ensure you have maximum visibility and avoid creating a hazard for the vehicle behind you. Don't allow ice and snow to create additional blind spots on your vehicle. Slow Down: Chances of a crash nearly triples when driving faster than surrounding traffic. Do not drive impaired: Driving is a great responsibility, and your fellow travelers are relying on safe, attentive drivers to respectfully share the road and make good decisions. Be aware of truck blind spots: Trucks deliver your favorite Thanksgiving traditions turkeys, cranberries, mashed potatoes and all kinds of tasty pies so make it easy on them by staying out of blind spots. Pass on the left where the truck's blind spot is much smaller. Keep your eyes on the road: Distracted driving is a major cause of traffic accidents and one of the leading causes of death amongst teenagers. Even just two seconds of distraction time doubles the chances of an accident. Use your cell phone when stopped and never text while driving. Do not cut in front of large trucks: Remember trucks are heavier and take longer to make a complete stop, so avoid cutting quickly in front of them. Fully loaded tractor-trailers can take the length of a football field plus both end zones to make a complete stop. Ask your favorite quarterback how far that is. Hint: it's far. Prepare your vehicle for long distance travel: Before you head out to your aunts, uncles and cousins, check your wipers and fluids and have your radiator and cooling system serviced. Simple maintenance before you leave your home can prevent many of the problems that strand motorists on the side of the road. Prepare yourself for long distance travel: The vehicle needs maintenance, and the driver needs plenty of rest and hydration to function at his or her best. If the turkey is making you feel drowsy, pull over and wait until you are more alert. Leave early and avoid risks: Leave early to reduce anxiety about arriving late. Road conditions may change due to inclement weather or traffic congestion. Be aware of the vehicle in front of you: Leave extra room between you and the vehicle ahead. A reminder to those who are considering travel that staying home and avoiding large-group gatherings is the best way to prevent COVID-19 from spreading. In addition, ATA and Share the Road encourage Americans to make smart decisions regarding travel during the COVID-19 pandemic. With experts discouraging travel this year, keeping off the roads to allow essential workers like truck drivers and medical personnel can help everyone be safe this holiday season. **Professional drivers are available for media interviews through the ATA Office of Public Affairs** Share the Roadis a highway safety outreach program of the American Trucking Associations that educates all drivers about sharing the roads safely with large trucks. An elite team of professional truck drivers with millions of accident-free miles deliver life-saving messages to millions of motorists annually. Follow Share the Road onTwitterand Facebook. American Trucking Associations is the largest national trade association for the trucking industry. Through a federation of 50 affiliated state trucking associations and industry-related conferences and councils, ATA is the voice of the industry America depends on most to move our nation's freight. Follow ATA onTwitter, Facebook, or atTrucking Moves America Forward. SOURCE American Trucking Associations Related Links www.trucking.org

ATA Shares Message of Safety, Trucking's Essentiality This Holiday Season

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: ARLINGTON, Va., Nov. 23, 2020 /PRNewswire/ --American Trucking Associations and ATA's Share the Road highway safety program have provided safe driving tips for those who will be traveling this week during the Thanksgiving holiday. This Thanksgiving, the trucking industry will safely deliver 46 million turkeys (an estimated 1.4 billion pounds) along with all of the sides 214 million pounds of potatoes, 50 million pounds of sweet potatoes, 19 million pumpkin pies, and 80 million pounds of cranberries, to ensure Thanksgiving dinner is complete. "It is important to put safety first while driving on the highways to ensure everyone can make it to the dinner table," said ATA Share the Road professional truck driver Gary Martin of FedEx Ground. "As a family man and a professional truck driver, I am one of the last drivers on the road, delivering all the trimmings necessary for Thanksgiving. I hope my fellow motorists will consider safety as they travel to their Thanksgiving destinations." While AAA projects less than 50 million Americans will travel this Thanksgiving holiday, 10% less than previous years, a majority of those will be hitting the highways and sharing the road with professional truck drivers. ATA's Share the Road's Instructional Video, featuring million mile accident free professional truck drivers, gives an eight-minute recap of critical safe-driving habits. "Thanksgiving offers several other driving challenges beyond traffic congestion, said Share the Road professional truck driver Todd Wilemon of Ravenwood Transport. Winter driving presents unique problems for motorists, including high wind and blowing snow, which contributes to reduced visibility in many regions throughout North America. Similarly, freezing temperatures can have a profound impact on vehicles and the roadways. A thorough pre-trip inspection and understanding of driving conditions can play a significant role in driving success this holiday season." ATA's Share the Road is committed to spreading the message of safety. Share the Road professional drivers recommend planning and coordinating travel plans ahead of time, as well as following the below safety tips. This safe driving guidance applies to all motorists, and is crucial when operating small passenger vehicles near large tractor-trailers: Buckle Up: A seat belt will not prevent a collision, but it will save a life. Remove ice and snow from your vehicle: Clear your windows and roof of snow to ensure you have maximum visibility and avoid creating a hazard for the vehicle behind you. Don't allow ice and snow to create additional blind spots on your vehicle. Slow Down: Chances of a crash nearly triples when driving faster than surrounding traffic. Do not drive impaired: Driving is a great responsibility, and your fellow travelers are relying on safe, attentive drivers to respectfully share the road and make good decisions. Be aware of truck blind spots: Trucks deliver your favorite Thanksgiving traditions turkeys, cranberries, mashed potatoes and all kinds of tasty pies so make it easy on them by staying out of blind spots. Pass on the left where the truck's blind spot is much smaller. Keep your eyes on the road: Distracted driving is a major cause of traffic accidents and one of the leading causes of death amongst teenagers. Even just two seconds of distraction time doubles the chances of an accident. Use your cell phone when stopped and never text while driving. Do not cut in front of large trucks: Remember trucks are heavier and take longer to make a complete stop, so avoid cutting quickly in front of them. Fully loaded tractor-trailers can take the length of a football field plus both end zones to make a complete stop. Ask your favorite quarterback how far that is. Hint: it's far. Prepare your vehicle for long distance travel: Before you head out to your aunts, uncles and cousins, check your wipers and fluids and have your radiator and cooling system serviced. Simple maintenance before you leave your home can prevent many of the problems that strand motorists on the side of the road. Prepare yourself for long distance travel: The vehicle needs maintenance, and the driver needs plenty of rest and hydration to function at his or her best. If the turkey is making you feel drowsy, pull over and wait until you are more alert. Leave early and avoid risks: Leave early to reduce anxiety about arriving late. Road conditions may change due to inclement weather or traffic congestion. Be aware of the vehicle in front of you: Leave extra room between you and the vehicle ahead. A reminder to those who are considering travel that staying home and avoiding large-group gatherings is the best way to prevent COVID-19 from spreading. In addition, ATA and Share the Road encourage Americans to make smart decisions regarding travel during the COVID-19 pandemic. With experts discouraging travel this year, keeping off the roads to allow essential workers like truck drivers and medical personnel can help everyone be safe this holiday season. **Professional drivers are available for media interviews through the ATA Office of Public Affairs** Share the Roadis a highway safety outreach program of the American Trucking Associations that educates all drivers about sharing the roads safely with large trucks. An elite team of professional truck drivers with millions of accident-free miles deliver life-saving messages to millions of motorists annually. Follow Share the Road onTwitterand Facebook. American Trucking Associations is the largest national trade association for the trucking industry. Through a federation of 50 affiliated state trucking associations and industry-related conferences and councils, ATA is the voice of the industry America depends on most to move our nation's freight. Follow ATA onTwitter, Facebook, or atTrucking Moves America Forward. SOURCE American Trucking Associations Related Links www.trucking.org Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> ATA Shares Message of Safety, Trucking's Essentiality This Holiday Season.<|eot_id|>

edtsum893

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LAND O' LAKES, Fla., Feb. 24, 2021 /PRNewswire/ --Pasco Middle School welcomed more than 50 school and district leaders from across the United States in January, 2021 as part of a virtual showcase of the Cambridge International program, which Pasco Middle has offered since 2014. Superintendent Kurt Browning opened the showcase and welcomed the attendees to learn about Cambridge implementation at his district. Pasco Middle was selected as one of the first Cambridge International School Demonstration Centers in the United States in February 2020. As a School Demonstration Center, Pasco Middle hosts two showcase events annually, at which administrators, teachers, and students will promote and explain to newly authorized Cambridge schools and districts how they implemented the Cambridge program. The Cambridge program is an international curriculum and examination system that emphasizes the value of broad and balanced study and provides high-quality education accessible to all students. Alongside in-depth understanding of a variety of subjects, students master a broader range of critical skills that will equip them for a world that is changing, both technologically and economically, at an unprecedented pace. The curriculum is designed to develop learners who are confident in working with information and ideas, equipped for new and future challenges, and engaged intellectually and socially.Cambridge Assessment International Education, a part of the University of Cambridge, has schools in over 35 states and the District of Columbia. Over the past decade, the number of U.S. students participating in the Cambridge program has increased by a compound annual rate of 45%; the largest growth has occurred at the high school level where the number of schools offering Cambridge AS- and A-level exams has grown by 220%. "Our investment in Cambridge has strengthened our efforts to create a culture of high expectations at Pasco Middle School through the delivery of a relevant curriculum full of meaningful experiences and inspiring opportunities for our students. This partnership serves as a lever to open doors as well as provide a life changing experience," stated Vanessa Hilton, Chief Academic Officer, Pasco County Schools. "We love having the Cambridge program at Pasco Middle School, because it aligns with our belief in having high expectations for all students. We believe in providing every opportunity for our students as we play a role in preparing them to be college, career, and life ready. Through the Cambridge program, our students are immersed in taking ownership of their learning and reflecting on what they learn," says Danielle Johnson, Principal of Pasco Middle School. Each year, Cambridge International authorizes a very small number of Demonstration Centers following a rigorous application process. Schools must describe how they meet the criteria in five key areas, such as educational values, inclusive teaching and learning, and exemplary leadership and management. Pasco County currently has two elementary, three middle, and fourteen high schools offering Cambridge programs. In 2018, Cambridge International named Pasco County Schools a District of the Year award recipient, which recognizes districts that have consistently strong Cambridge student performance in their schools. Each year, nearly 1 million students participate in Cambridge International programs worldwide, making more than 1.75 million exam entries. Colleges and universities all over the U.S. and the world, including all members of the Ivy League, all Florida public higher education institutions, Massachusetts Institute of Technology (MIT), Duke University, New York University, and University of Washington recognize Cambridge coursework and assessments, and provide credit and placement opportunities for students. Outside the U.S., Cambridge programs are offered at more than 10,000 schools in over 160 countries. About Pasco County Schools Pasco County Schools is the largest employer in Pasco County, Florida, with approximately 10,000 employees who serve more than 77,000 students. The district is the 10th largest in Florida and 49th largest in the United States. The operating budget is approximately $664.5 million, and the overall budget is $1.39 billion, which funds the operation and maintenance of 96 schools and construction of new schools and additions. Programs include traditional pre-k through 12th grade standards instruction, virtual instruction, career academies, adult education, magnet themes, and charter schools. The district is the largest in the United States with an elected superintendent who governs the district along with five elected school board members. About Cambridge Assessment International Education Cambridge Assessment International Education prepares school students for life, helping them develop an informed curiosity and a lasting passion for learning. We are part of the University of Cambridge. Our Cambridge Pathway gives students a clear path for educational success from age 5 to 19. Schools can shape the curriculum around how they want students to learn with a wide range of subjects and flexible ways to offer them. It helps students discover new abilities and a wider world, and gives them the skills they need for life, so they can achieve at school, university and work. Cambridge International is the short name of Cambridge Assessment International Education. Learn more! Visit www.cambridgeinternational.org SOURCE Cambridge International Related Links https://www.cambridgeinternational.org Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Pasco Middle School Hosts School and District Leaders from Across the U.S. to Showcase Cambridge International Program.

LAND O' LAKES, Fla., Feb. 24, 2021 /PRNewswire/ --Pasco Middle School welcomed more than 50 school and district leaders from across the United States in January, 2021 as part of a virtual showcase of the Cambridge International program, which Pasco Middle has offered since 2014. Superintendent Kurt Browning opened the showcase and welcomed the attendees to learn about Cambridge implementation at his district. Pasco Middle was selected as one of the first Cambridge International School Demonstration Centers in the United States in February 2020. As a School Demonstration Center, Pasco Middle hosts two showcase events annually, at which administrators, teachers, and students will promote and explain to newly authorized Cambridge schools and districts how they implemented the Cambridge program. The Cambridge program is an international curriculum and examination system that emphasizes the value of broad and balanced study and provides high-quality education accessible to all students. Alongside in-depth understanding of a variety of subjects, students master a broader range of critical skills that will equip them for a world that is changing, both technologically and economically, at an unprecedented pace. The curriculum is designed to develop learners who are confident in working with information and ideas, equipped for new and future challenges, and engaged intellectually and socially.Cambridge Assessment International Education, a part of the University of Cambridge, has schools in over 35 states and the District of Columbia. Over the past decade, the number of U.S. students participating in the Cambridge program has increased by a compound annual rate of 45%; the largest growth has occurred at the high school level where the number of schools offering Cambridge AS- and A-level exams has grown by 220%. "Our investment in Cambridge has strengthened our efforts to create a culture of high expectations at Pasco Middle School through the delivery of a relevant curriculum full of meaningful experiences and inspiring opportunities for our students. This partnership serves as a lever to open doors as well as provide a life changing experience," stated Vanessa Hilton, Chief Academic Officer, Pasco County Schools. "We love having the Cambridge program at Pasco Middle School, because it aligns with our belief in having high expectations for all students. We believe in providing every opportunity for our students as we play a role in preparing them to be college, career, and life ready. Through the Cambridge program, our students are immersed in taking ownership of their learning and reflecting on what they learn," says Danielle Johnson, Principal of Pasco Middle School. Each year, Cambridge International authorizes a very small number of Demonstration Centers following a rigorous application process. Schools must describe how they meet the criteria in five key areas, such as educational values, inclusive teaching and learning, and exemplary leadership and management. Pasco County currently has two elementary, three middle, and fourteen high schools offering Cambridge programs. In 2018, Cambridge International named Pasco County Schools a District of the Year award recipient, which recognizes districts that have consistently strong Cambridge student performance in their schools. Each year, nearly 1 million students participate in Cambridge International programs worldwide, making more than 1.75 million exam entries. Colleges and universities all over the U.S. and the world, including all members of the Ivy League, all Florida public higher education institutions, Massachusetts Institute of Technology (MIT), Duke University, New York University, and University of Washington recognize Cambridge coursework and assessments, and provide credit and placement opportunities for students. Outside the U.S., Cambridge programs are offered at more than 10,000 schools in over 160 countries. About Pasco County Schools Pasco County Schools is the largest employer in Pasco County, Florida, with approximately 10,000 employees who serve more than 77,000 students. The district is the 10th largest in Florida and 49th largest in the United States. The operating budget is approximately $664.5 million, and the overall budget is $1.39 billion, which funds the operation and maintenance of 96 schools and construction of new schools and additions. Programs include traditional pre-k through 12th grade standards instruction, virtual instruction, career academies, adult education, magnet themes, and charter schools. The district is the largest in the United States with an elected superintendent who governs the district along with five elected school board members. About Cambridge Assessment International Education Cambridge Assessment International Education prepares school students for life, helping them develop an informed curiosity and a lasting passion for learning. We are part of the University of Cambridge. Our Cambridge Pathway gives students a clear path for educational success from age 5 to 19. Schools can shape the curriculum around how they want students to learn with a wide range of subjects and flexible ways to offer them. It helps students discover new abilities and a wider world, and gives them the skills they need for life, so they can achieve at school, university and work. Cambridge International is the short name of Cambridge Assessment International Education. Learn more! Visit www.cambridgeinternational.org SOURCE Cambridge International Related Links https://www.cambridgeinternational.org

Pasco Middle School Hosts School and District Leaders from Across the U.S. to Showcase Cambridge International Program

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LAND O' LAKES, Fla., Feb. 24, 2021 /PRNewswire/ --Pasco Middle School welcomed more than 50 school and district leaders from across the United States in January, 2021 as part of a virtual showcase of the Cambridge International program, which Pasco Middle has offered since 2014. Superintendent Kurt Browning opened the showcase and welcomed the attendees to learn about Cambridge implementation at his district. Pasco Middle was selected as one of the first Cambridge International School Demonstration Centers in the United States in February 2020. As a School Demonstration Center, Pasco Middle hosts two showcase events annually, at which administrators, teachers, and students will promote and explain to newly authorized Cambridge schools and districts how they implemented the Cambridge program. The Cambridge program is an international curriculum and examination system that emphasizes the value of broad and balanced study and provides high-quality education accessible to all students. Alongside in-depth understanding of a variety of subjects, students master a broader range of critical skills that will equip them for a world that is changing, both technologically and economically, at an unprecedented pace. The curriculum is designed to develop learners who are confident in working with information and ideas, equipped for new and future challenges, and engaged intellectually and socially.Cambridge Assessment International Education, a part of the University of Cambridge, has schools in over 35 states and the District of Columbia. Over the past decade, the number of U.S. students participating in the Cambridge program has increased by a compound annual rate of 45%; the largest growth has occurred at the high school level where the number of schools offering Cambridge AS- and A-level exams has grown by 220%. "Our investment in Cambridge has strengthened our efforts to create a culture of high expectations at Pasco Middle School through the delivery of a relevant curriculum full of meaningful experiences and inspiring opportunities for our students. This partnership serves as a lever to open doors as well as provide a life changing experience," stated Vanessa Hilton, Chief Academic Officer, Pasco County Schools. "We love having the Cambridge program at Pasco Middle School, because it aligns with our belief in having high expectations for all students. We believe in providing every opportunity for our students as we play a role in preparing them to be college, career, and life ready. Through the Cambridge program, our students are immersed in taking ownership of their learning and reflecting on what they learn," says Danielle Johnson, Principal of Pasco Middle School. Each year, Cambridge International authorizes a very small number of Demonstration Centers following a rigorous application process. Schools must describe how they meet the criteria in five key areas, such as educational values, inclusive teaching and learning, and exemplary leadership and management. Pasco County currently has two elementary, three middle, and fourteen high schools offering Cambridge programs. In 2018, Cambridge International named Pasco County Schools a District of the Year award recipient, which recognizes districts that have consistently strong Cambridge student performance in their schools. Each year, nearly 1 million students participate in Cambridge International programs worldwide, making more than 1.75 million exam entries. Colleges and universities all over the U.S. and the world, including all members of the Ivy League, all Florida public higher education institutions, Massachusetts Institute of Technology (MIT), Duke University, New York University, and University of Washington recognize Cambridge coursework and assessments, and provide credit and placement opportunities for students. Outside the U.S., Cambridge programs are offered at more than 10,000 schools in over 160 countries. About Pasco County Schools Pasco County Schools is the largest employer in Pasco County, Florida, with approximately 10,000 employees who serve more than 77,000 students. The district is the 10th largest in Florida and 49th largest in the United States. The operating budget is approximately $664.5 million, and the overall budget is $1.39 billion, which funds the operation and maintenance of 96 schools and construction of new schools and additions. Programs include traditional pre-k through 12th grade standards instruction, virtual instruction, career academies, adult education, magnet themes, and charter schools. The district is the largest in the United States with an elected superintendent who governs the district along with five elected school board members. About Cambridge Assessment International Education Cambridge Assessment International Education prepares school students for life, helping them develop an informed curiosity and a lasting passion for learning. We are part of the University of Cambridge. Our Cambridge Pathway gives students a clear path for educational success from age 5 to 19. Schools can shape the curriculum around how they want students to learn with a wide range of subjects and flexible ways to offer them. It helps students discover new abilities and a wider world, and gives them the skills they need for life, so they can achieve at school, university and work. Cambridge International is the short name of Cambridge Assessment International Education. Learn more! Visit www.cambridgeinternational.org SOURCE Cambridge International Related Links https://www.cambridgeinternational.org Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Pasco Middle School Hosts School and District Leaders from Across the U.S. to Showcase Cambridge International Program.<|eot_id|>

edtsum894

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LAKE BUENA VISTA, Fla., March 9, 2021 /PRNewswire/ -- During today's virtual annual meeting of shareholders of The Walt Disney Company, Disney CEO Bob Chapek announced the grand opening of Remy's Ratatouille Adventure at EPCOT will be Oct. 1, 2021. This new family-friendly attraction will officially debut as part of the kickoff for "The World's Most Magical Celebration" honoring Walt Disney World Resort's 50th anniversary. The grand opening for Remys Ratatouille Adventure is set for Oct. 1, 2021, at EPCOT at Walt Disney World Resort in Lake Buena Vista, Fla. The family-friendly attraction makes guests feel as if they shrink to the size of Chef Remy as they scurry through Gusteaus restaurant. It will open in an expanded section of the parks France pavilion and will open as part of the 50th anniversary celebration for Walt Disney World. (Matt Stroshane, photographer) Remy's Ratatouille Adventure invites guests into the flavorful world of Disney and Pixar's Academy Award-winning "Ratatouille," where they will feel as if they shrink to the size of Chef Remy and scurry through Gusteau's famous restaurant. Guests will find Remy's Ratatouille Adventure in a newly expanded area of the park's France pavilion, where the real is made fantastic in a reimagining of Paris inspired by the film. Also debuting Oct. 1 in this section of the pavilion will be a delicious new restaurant, La Crperie de Paris, offering both table- and quick-service options. The menu will feature sweet crepes, savory buckwheat galettes (naturally gluten friendly) and authentic French hard cider. The attraction, restaurant and pavilion expansion are all part of the historic transformation of EPCOT currently underway, bringing a breadth of new experiences to the park in a celebration of curiosity, discovery and the magic of possibility. "The World's Most Magical Celebration" begins Oct. 1 on the 50th anniversary of Walt Disney World. This 18-month event will feature new experiences at the resort's four theme parks and beyond, where shimmering EARidescent dcor will appearas if by magic. Remy's Ratatouille Adventure and La Crperie de Paris will now join in the festivities for this landmark occasion; more details about the celebration will be announced in the future. For more on the transformation of EPCOT and "The World's Most Magical Celebration," visit WDWNews.com and DisneyParksBlog.com. SOURCE Walt Disney World Resort Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Grand Opening of Remy's Ratatouille Adventure at EPCOT Set for Oct. 1, 2021, in Honor of Walt Disney World Resort's 50th Anniversary. 'The World's Most Magical Celebration' will also include opening of La Crêperie de Paris as part of newly expanded France pavilion.

LAKE BUENA VISTA, Fla., March 9, 2021 /PRNewswire/ -- During today's virtual annual meeting of shareholders of The Walt Disney Company, Disney CEO Bob Chapek announced the grand opening of Remy's Ratatouille Adventure at EPCOT will be Oct. 1, 2021. This new family-friendly attraction will officially debut as part of the kickoff for "The World's Most Magical Celebration" honoring Walt Disney World Resort's 50th anniversary. The grand opening for Remys Ratatouille Adventure is set for Oct. 1, 2021, at EPCOT at Walt Disney World Resort in Lake Buena Vista, Fla. The family-friendly attraction makes guests feel as if they shrink to the size of Chef Remy as they scurry through Gusteaus restaurant. It will open in an expanded section of the parks France pavilion and will open as part of the 50th anniversary celebration for Walt Disney World. (Matt Stroshane, photographer) Remy's Ratatouille Adventure invites guests into the flavorful world of Disney and Pixar's Academy Award-winning "Ratatouille," where they will feel as if they shrink to the size of Chef Remy and scurry through Gusteau's famous restaurant. Guests will find Remy's Ratatouille Adventure in a newly expanded area of the park's France pavilion, where the real is made fantastic in a reimagining of Paris inspired by the film. Also debuting Oct. 1 in this section of the pavilion will be a delicious new restaurant, La Crperie de Paris, offering both table- and quick-service options. The menu will feature sweet crepes, savory buckwheat galettes (naturally gluten friendly) and authentic French hard cider. The attraction, restaurant and pavilion expansion are all part of the historic transformation of EPCOT currently underway, bringing a breadth of new experiences to the park in a celebration of curiosity, discovery and the magic of possibility. "The World's Most Magical Celebration" begins Oct. 1 on the 50th anniversary of Walt Disney World. This 18-month event will feature new experiences at the resort's four theme parks and beyond, where shimmering EARidescent dcor will appearas if by magic. Remy's Ratatouille Adventure and La Crperie de Paris will now join in the festivities for this landmark occasion; more details about the celebration will be announced in the future. For more on the transformation of EPCOT and "The World's Most Magical Celebration," visit WDWNews.com and DisneyParksBlog.com. SOURCE Walt Disney World Resort

Grand Opening of Remy's Ratatouille Adventure at EPCOT Set for Oct. 1, 2021, in Honor of Walt Disney World Resort's 50th Anniversary 'The World's Most Magical Celebration' will also include opening of La Crperie de Paris as part of newly expanded France pavilion

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LAKE BUENA VISTA, Fla., March 9, 2021 /PRNewswire/ -- During today's virtual annual meeting of shareholders of The Walt Disney Company, Disney CEO Bob Chapek announced the grand opening of Remy's Ratatouille Adventure at EPCOT will be Oct. 1, 2021. This new family-friendly attraction will officially debut as part of the kickoff for "The World's Most Magical Celebration" honoring Walt Disney World Resort's 50th anniversary. The grand opening for Remys Ratatouille Adventure is set for Oct. 1, 2021, at EPCOT at Walt Disney World Resort in Lake Buena Vista, Fla. The family-friendly attraction makes guests feel as if they shrink to the size of Chef Remy as they scurry through Gusteaus restaurant. It will open in an expanded section of the parks France pavilion and will open as part of the 50th anniversary celebration for Walt Disney World. (Matt Stroshane, photographer) Remy's Ratatouille Adventure invites guests into the flavorful world of Disney and Pixar's Academy Award-winning "Ratatouille," where they will feel as if they shrink to the size of Chef Remy and scurry through Gusteau's famous restaurant. Guests will find Remy's Ratatouille Adventure in a newly expanded area of the park's France pavilion, where the real is made fantastic in a reimagining of Paris inspired by the film. Also debuting Oct. 1 in this section of the pavilion will be a delicious new restaurant, La Crperie de Paris, offering both table- and quick-service options. The menu will feature sweet crepes, savory buckwheat galettes (naturally gluten friendly) and authentic French hard cider. The attraction, restaurant and pavilion expansion are all part of the historic transformation of EPCOT currently underway, bringing a breadth of new experiences to the park in a celebration of curiosity, discovery and the magic of possibility. "The World's Most Magical Celebration" begins Oct. 1 on the 50th anniversary of Walt Disney World. This 18-month event will feature new experiences at the resort's four theme parks and beyond, where shimmering EARidescent dcor will appearas if by magic. Remy's Ratatouille Adventure and La Crperie de Paris will now join in the festivities for this landmark occasion; more details about the celebration will be announced in the future. For more on the transformation of EPCOT and "The World's Most Magical Celebration," visit WDWNews.com and DisneyParksBlog.com. SOURCE Walt Disney World Resort Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Grand Opening of Remy's Ratatouille Adventure at EPCOT Set for Oct. 1, 2021, in Honor of Walt Disney World Resort's 50th Anniversary. 'The World's Most Magical Celebration' will also include opening of La Crêperie de Paris as part of newly expanded France pavilion.<|eot_id|>

edtsum895

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: --(BUSINESS WIRE)-- -- IC Power Integrations (Nasdaq: POWI) LinkSwitch-TN2 AC-DC LNK3207 IC 360 mA 575 mA Power Integrations Silvestro Fimiani LinkSwitch-TN2 IC 1 LNK3207 AC-DC IC 80% 30 mW 60% LinkSwitch-TN2 IC 725 V MOSFET ON/OFF () LinkSwitch-TN2 IC IoT IC PDIP-8CSMD-8C SO-8C 3 SMD-8C 85/105 C LNK3207 AC-DC IC 0.60 RDR-912 85 VAC 265 VAC 12 V550 mA 6.6 W Power Integrations Digi-KeyFarnell Mouser Power Integrations Power Integrations, Inc.Power Integrations www.power.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Power Integrations LinkSwitch AC-DC IC, 60% LNK3207 IC.

--(BUSINESS WIRE)-- -- IC Power Integrations (Nasdaq: POWI) LinkSwitch-TN2 AC-DC LNK3207 IC 360 mA 575 mA Power Integrations Silvestro Fimiani LinkSwitch-TN2 IC 1 LNK3207 AC-DC IC 80% 30 mW 60% LinkSwitch-TN2 IC 725 V MOSFET ON/OFF () LinkSwitch-TN2 IC IoT IC PDIP-8CSMD-8C SO-8C 3 SMD-8C 85/105 C LNK3207 AC-DC IC 0.60 RDR-912 85 VAC 265 VAC 12 V550 mA 6.6 W Power Integrations Digi-KeyFarnell Mouser Power Integrations Power Integrations, Inc.Power Integrations www.power.com

Power Integrations LinkSwitch AC-DC IC 60% LNK3207 IC

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: --(BUSINESS WIRE)-- -- IC Power Integrations (Nasdaq: POWI) LinkSwitch-TN2 AC-DC LNK3207 IC 360 mA 575 mA Power Integrations Silvestro Fimiani LinkSwitch-TN2 IC 1 LNK3207 AC-DC IC 80% 30 mW 60% LinkSwitch-TN2 IC 725 V MOSFET ON/OFF () LinkSwitch-TN2 IC IoT IC PDIP-8CSMD-8C SO-8C 3 SMD-8C 85/105 C LNK3207 AC-DC IC 0.60 RDR-912 85 VAC 265 VAC 12 V550 mA 6.6 W Power Integrations Digi-KeyFarnell Mouser Power Integrations Power Integrations, Inc.Power Integrations www.power.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Power Integrations LinkSwitch AC-DC IC, 60% LNK3207 IC.<|eot_id|>

edtsum896

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: COSTA MESA, Calif., Oct. 22, 2020 /PRNewswire/ -- Studio Chateau is the national leader when it comes to software that assists homeowners when personalizing their new home. As Zoom and Face Time continue as the preferred way of doing business, Studio Chateau remains steadfast in providing the tools needed to design spaces that homeowners desire. How does Studio Chateau assist designers during virtual appointments? This technology allows designers the ability to design in real time with a virtual room designer so that clients can see the options they've chosen as it's dropped into their actual space. Online catalogs, surface diagrams and flooring estimators are also paired with the system along with DocuSign capabilities. "We are constantly improving the Studio Chateau software so that we can remain competitive and deliver the features that our clients require," stated Carolyn Little, President of Studio Chateau. "We have to be nimble and evolve as the needs of our customers shift so we can continue to be of service to our marketplace." Studio Chateau is an Internet-based options selection program designed to ease the process of selecting home upgrades for design professionals, homebuilders and homebuyers. The program also includes: a visual, lot-specific options catalog for each community, drag and drop placement diagrams for each floorplan, construction cut-off date notification and management, purchase order generation and subcontractor notification, flooring entry and installation date management, accounting management and customer service follow-up and survey. The creation of this innovative program stems from the 35-year history of parent company Chateau Interiors, a full-service interior design center focused on meeting the needs of the builder options program. As the housing industry continues to excel at a rapid pace in these unprecedented times, clients have seized the opportunity to pair Studio Chateau with their builder options program. This technology offers a web-based program that improves communications during the new home purchase coupled with the interior options selection process. The system connects the homebuyer, sales, design center, purchasing, accounting, construction, trade partners, subcontractors and escrow by providing them all with accurate real-time information. For more information, visit online at www.studiochateau.com or call Vice President of Client Services Lynn Ellis at (619) 916-7959. SOURCE Studio Chateau Related Links http://www.studiochateau.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Studio Chateau introduces new tools for virtual interior design appointments.

COSTA MESA, Calif., Oct. 22, 2020 /PRNewswire/ -- Studio Chateau is the national leader when it comes to software that assists homeowners when personalizing their new home. As Zoom and Face Time continue as the preferred way of doing business, Studio Chateau remains steadfast in providing the tools needed to design spaces that homeowners desire. How does Studio Chateau assist designers during virtual appointments? This technology allows designers the ability to design in real time with a virtual room designer so that clients can see the options they've chosen as it's dropped into their actual space. Online catalogs, surface diagrams and flooring estimators are also paired with the system along with DocuSign capabilities. "We are constantly improving the Studio Chateau software so that we can remain competitive and deliver the features that our clients require," stated Carolyn Little, President of Studio Chateau. "We have to be nimble and evolve as the needs of our customers shift so we can continue to be of service to our marketplace." Studio Chateau is an Internet-based options selection program designed to ease the process of selecting home upgrades for design professionals, homebuilders and homebuyers. The program also includes: a visual, lot-specific options catalog for each community, drag and drop placement diagrams for each floorplan, construction cut-off date notification and management, purchase order generation and subcontractor notification, flooring entry and installation date management, accounting management and customer service follow-up and survey. The creation of this innovative program stems from the 35-year history of parent company Chateau Interiors, a full-service interior design center focused on meeting the needs of the builder options program. As the housing industry continues to excel at a rapid pace in these unprecedented times, clients have seized the opportunity to pair Studio Chateau with their builder options program. This technology offers a web-based program that improves communications during the new home purchase coupled with the interior options selection process. The system connects the homebuyer, sales, design center, purchasing, accounting, construction, trade partners, subcontractors and escrow by providing them all with accurate real-time information. For more information, visit online at www.studiochateau.com or call Vice President of Client Services Lynn Ellis at (619) 916-7959. SOURCE Studio Chateau Related Links http://www.studiochateau.com

Studio Chateau Introduces New Tools For Virtual Interior Design Appointments

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: COSTA MESA, Calif., Oct. 22, 2020 /PRNewswire/ -- Studio Chateau is the national leader when it comes to software that assists homeowners when personalizing their new home. As Zoom and Face Time continue as the preferred way of doing business, Studio Chateau remains steadfast in providing the tools needed to design spaces that homeowners desire. How does Studio Chateau assist designers during virtual appointments? This technology allows designers the ability to design in real time with a virtual room designer so that clients can see the options they've chosen as it's dropped into their actual space. Online catalogs, surface diagrams and flooring estimators are also paired with the system along with DocuSign capabilities. "We are constantly improving the Studio Chateau software so that we can remain competitive and deliver the features that our clients require," stated Carolyn Little, President of Studio Chateau. "We have to be nimble and evolve as the needs of our customers shift so we can continue to be of service to our marketplace." Studio Chateau is an Internet-based options selection program designed to ease the process of selecting home upgrades for design professionals, homebuilders and homebuyers. The program also includes: a visual, lot-specific options catalog for each community, drag and drop placement diagrams for each floorplan, construction cut-off date notification and management, purchase order generation and subcontractor notification, flooring entry and installation date management, accounting management and customer service follow-up and survey. The creation of this innovative program stems from the 35-year history of parent company Chateau Interiors, a full-service interior design center focused on meeting the needs of the builder options program. As the housing industry continues to excel at a rapid pace in these unprecedented times, clients have seized the opportunity to pair Studio Chateau with their builder options program. This technology offers a web-based program that improves communications during the new home purchase coupled with the interior options selection process. The system connects the homebuyer, sales, design center, purchasing, accounting, construction, trade partners, subcontractors and escrow by providing them all with accurate real-time information. For more information, visit online at www.studiochateau.com or call Vice President of Client Services Lynn Ellis at (619) 916-7959. SOURCE Studio Chateau Related Links http://www.studiochateau.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Studio Chateau introduces new tools for virtual interior design appointments.<|eot_id|>

edtsum897

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: ENGLEWOOD, Colo.--(BUSINESS WIRE)--Liberty Media Corporation (Liberty Media or Liberty) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, BATRA, BATRK) today announced the payment of a quarterly interest payment to the holders as of December 15, 2020 of its 2.25% Exchangeable Senior Debentures due 2046 (the Debentures). The amount of the quarterly interest payment is $5.625 per $1,000 original principal amount of Debentures. As of December 31, 2020, the aggregate adjusted principal amount outstanding is approximately $203 million, after giving effect to todays quarterly interest payment. Under the Indenture for the Debentures, the original principal amount of the Debentures is reduced in an amount equal to each Extraordinary Additional Distribution that is made to holders of the Debentures. Thereafter, the adjusted principal amount is further reduced on each successive quarterly interest payment date to the extent necessary to cause the quarterly interest payment to represent the payment of an annualized yield of 2.25% of the adjusted principal amount. This latter adjustment, to the extent it is made by reason of a particular Extraordinary Additional Distribution that results in a reduction to the principal amount of the Debentures, takes effect on the second succeeding interest payment date after the payment of that Extraordinary Additional Distribution. To date, Liberty has made one Extraordinary Additional Distribution to holders of the Debentures. On June 22, 2018, Liberty made an Extraordinary Additional Distribution of $514.1295 per $1,000 original principal amount of Debentures (a Debenture), which was attributable to the cash consideration of $53.75 per share paid to former holders of common stock of Time Warner Inc. (TWX) on June 15, 2018 in connection with AT&T Inc.s (AT&T) acquisition of TWX (AT&T/TWX Acquisition). Reductions to the principal amount of the Debentures do not affect the amount of the quarterly interest payments received by holders of the Debentures, which will continue to be a rate equal to 2.25% per annum of the original principal amount of the Debentures. Below is a detail of the amount of the quarterly interest payment being made on the Debentures, its allocation between payment of interest and repayment of principal and the revised adjusted principal amount of the Debentures resulting from such payment, per $1,000 original principal amount of the Debentures: December 31, 2020 Beginning Adjusted Principal Payment Interest Payment of Principal December 31, 2020 Ending Adjusted Principal $459.2493 $5.625 $2.5833 $3.0417 $456.2076 Liberty also announced the payment today, to holders of the Debentures as of December 15, 2020, of an excess regular cash dividend amount distribution of $3.2975 per Debenture, which is attributable to the regular quarterly dividends paid by AT&T of $0.52 on November 2, 2020. Payments of additional distributions attributable to regular cash dividends do not result in a reduction to the principal amount of the Debentures. As a result of the AT&T/TWX Acquisition, the reference shares attributable to each $1,000 original principal of Debentures consist of 13.7452 shares of common stock of AT&T (NYSE: T). About Liberty Media Corporation Liberty Media Corporation operates and owns interests in a broad range of media, communications and entertainment businesses. Those businesses are attributed to three tracking stock groups: the Liberty SiriusXM Group, the Braves Group and the Formula One Group. The businesses and assets attributed to the Liberty SiriusXM Group (NASDAQ: LSXMA, LSXMB, LSXMK) include Liberty Media Corporations interests in SiriusXM and Live Nation Entertainment. The businesses and assets attributed to the Braves Group (NASDAQ: BATRA, BATRK) include Liberty Media Corporations subsidiary Braves Holdings, LLC. The businesses and assets attributed to the Formula One Group (NASDAQ: FWONA, FWONK) consist of all of Liberty Media Corporations businesses and assets other than those attributed to the Liberty SiriusXM Group and the Braves Group, including its subsidiary Formula 1 and minority equity investment in AT&T Inc. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Liberty Media Corporation Announces Quarterly Interest Payment and Excess Regular Cash Dividend Amount on 2.25% Exchangeable Senior Debentures Due 2046.

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Liberty Media Corporation (Liberty Media or Liberty) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, BATRA, BATRK) today announced the payment of a quarterly interest payment to the holders as of December 15, 2020 of its 2.25% Exchangeable Senior Debentures due 2046 (the Debentures). The amount of the quarterly interest payment is $5.625 per $1,000 original principal amount of Debentures. As of December 31, 2020, the aggregate adjusted principal amount outstanding is approximately $203 million, after giving effect to todays quarterly interest payment. Under the Indenture for the Debentures, the original principal amount of the Debentures is reduced in an amount equal to each Extraordinary Additional Distribution that is made to holders of the Debentures. Thereafter, the adjusted principal amount is further reduced on each successive quarterly interest payment date to the extent necessary to cause the quarterly interest payment to represent the payment of an annualized yield of 2.25% of the adjusted principal amount. This latter adjustment, to the extent it is made by reason of a particular Extraordinary Additional Distribution that results in a reduction to the principal amount of the Debentures, takes effect on the second succeeding interest payment date after the payment of that Extraordinary Additional Distribution. To date, Liberty has made one Extraordinary Additional Distribution to holders of the Debentures. On June 22, 2018, Liberty made an Extraordinary Additional Distribution of $514.1295 per $1,000 original principal amount of Debentures (a Debenture), which was attributable to the cash consideration of $53.75 per share paid to former holders of common stock of Time Warner Inc. (TWX) on June 15, 2018 in connection with AT&T Inc.s (AT&T) acquisition of TWX (AT&T/TWX Acquisition). Reductions to the principal amount of the Debentures do not affect the amount of the quarterly interest payments received by holders of the Debentures, which will continue to be a rate equal to 2.25% per annum of the original principal amount of the Debentures. Below is a detail of the amount of the quarterly interest payment being made on the Debentures, its allocation between payment of interest and repayment of principal and the revised adjusted principal amount of the Debentures resulting from such payment, per $1,000 original principal amount of the Debentures: December 31, 2020 Beginning Adjusted Principal Payment Interest Payment of Principal December 31, 2020 Ending Adjusted Principal $459.2493 $5.625 $2.5833 $3.0417 $456.2076 Liberty also announced the payment today, to holders of the Debentures as of December 15, 2020, of an excess regular cash dividend amount distribution of $3.2975 per Debenture, which is attributable to the regular quarterly dividends paid by AT&T of $0.52 on November 2, 2020. Payments of additional distributions attributable to regular cash dividends do not result in a reduction to the principal amount of the Debentures. As a result of the AT&T/TWX Acquisition, the reference shares attributable to each $1,000 original principal of Debentures consist of 13.7452 shares of common stock of AT&T (NYSE: T). About Liberty Media Corporation Liberty Media Corporation operates and owns interests in a broad range of media, communications and entertainment businesses. Those businesses are attributed to three tracking stock groups: the Liberty SiriusXM Group, the Braves Group and the Formula One Group. The businesses and assets attributed to the Liberty SiriusXM Group (NASDAQ: LSXMA, LSXMB, LSXMK) include Liberty Media Corporations interests in SiriusXM and Live Nation Entertainment. The businesses and assets attributed to the Braves Group (NASDAQ: BATRA, BATRK) include Liberty Media Corporations subsidiary Braves Holdings, LLC. The businesses and assets attributed to the Formula One Group (NASDAQ: FWONA, FWONK) consist of all of Liberty Media Corporations businesses and assets other than those attributed to the Liberty SiriusXM Group and the Braves Group, including its subsidiary Formula 1 and minority equity investment in AT&T Inc.

Liberty Media Corporation Announces Quarterly Interest Payment and Excess Regular Cash Dividend Amount on 2.25% Exchangeable Senior Debentures Due 2046

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: ENGLEWOOD, Colo.--(BUSINESS WIRE)--Liberty Media Corporation (Liberty Media or Liberty) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, BATRA, BATRK) today announced the payment of a quarterly interest payment to the holders as of December 15, 2020 of its 2.25% Exchangeable Senior Debentures due 2046 (the Debentures). The amount of the quarterly interest payment is $5.625 per $1,000 original principal amount of Debentures. As of December 31, 2020, the aggregate adjusted principal amount outstanding is approximately $203 million, after giving effect to todays quarterly interest payment. Under the Indenture for the Debentures, the original principal amount of the Debentures is reduced in an amount equal to each Extraordinary Additional Distribution that is made to holders of the Debentures. Thereafter, the adjusted principal amount is further reduced on each successive quarterly interest payment date to the extent necessary to cause the quarterly interest payment to represent the payment of an annualized yield of 2.25% of the adjusted principal amount. This latter adjustment, to the extent it is made by reason of a particular Extraordinary Additional Distribution that results in a reduction to the principal amount of the Debentures, takes effect on the second succeeding interest payment date after the payment of that Extraordinary Additional Distribution. To date, Liberty has made one Extraordinary Additional Distribution to holders of the Debentures. On June 22, 2018, Liberty made an Extraordinary Additional Distribution of $514.1295 per $1,000 original principal amount of Debentures (a Debenture), which was attributable to the cash consideration of $53.75 per share paid to former holders of common stock of Time Warner Inc. (TWX) on June 15, 2018 in connection with AT&T Inc.s (AT&T) acquisition of TWX (AT&T/TWX Acquisition). Reductions to the principal amount of the Debentures do not affect the amount of the quarterly interest payments received by holders of the Debentures, which will continue to be a rate equal to 2.25% per annum of the original principal amount of the Debentures. Below is a detail of the amount of the quarterly interest payment being made on the Debentures, its allocation between payment of interest and repayment of principal and the revised adjusted principal amount of the Debentures resulting from such payment, per $1,000 original principal amount of the Debentures: December 31, 2020 Beginning Adjusted Principal Payment Interest Payment of Principal December 31, 2020 Ending Adjusted Principal $459.2493 $5.625 $2.5833 $3.0417 $456.2076 Liberty also announced the payment today, to holders of the Debentures as of December 15, 2020, of an excess regular cash dividend amount distribution of $3.2975 per Debenture, which is attributable to the regular quarterly dividends paid by AT&T of $0.52 on November 2, 2020. Payments of additional distributions attributable to regular cash dividends do not result in a reduction to the principal amount of the Debentures. As a result of the AT&T/TWX Acquisition, the reference shares attributable to each $1,000 original principal of Debentures consist of 13.7452 shares of common stock of AT&T (NYSE: T). About Liberty Media Corporation Liberty Media Corporation operates and owns interests in a broad range of media, communications and entertainment businesses. Those businesses are attributed to three tracking stock groups: the Liberty SiriusXM Group, the Braves Group and the Formula One Group. The businesses and assets attributed to the Liberty SiriusXM Group (NASDAQ: LSXMA, LSXMB, LSXMK) include Liberty Media Corporations interests in SiriusXM and Live Nation Entertainment. The businesses and assets attributed to the Braves Group (NASDAQ: BATRA, BATRK) include Liberty Media Corporations subsidiary Braves Holdings, LLC. The businesses and assets attributed to the Formula One Group (NASDAQ: FWONA, FWONK) consist of all of Liberty Media Corporations businesses and assets other than those attributed to the Liberty SiriusXM Group and the Braves Group, including its subsidiary Formula 1 and minority equity investment in AT&T Inc. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Liberty Media Corporation Announces Quarterly Interest Payment and Excess Regular Cash Dividend Amount on 2.25% Exchangeable Senior Debentures Due 2046.<|eot_id|>

edtsum898

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: GREEN BAY, Wis., April20, 2021 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced first quarter 2021 net income of $18.2 million and earnings per diluted common share of $1.75, compared to $18.0 million and $1.74 for fourth quarter 2020, and $10.6 million and $0.98 for first quarter 2020, respectively. Annualized quarterly return on average assets was 1.64%, 1.58% and 1.19%, for first quarter 2021, fourth quarter 2020 and first quarter 2020, respectively. "We are very pleased with the exceptional start to 2021," said Mike Daniels, President and CEO of Nicolet National Bank. "The main themes from late 2020 continue to drive our earnings - strong mortgage income, improved asset quality, Paycheck Protection Program ("PPP") loan activity, and expense control - producing $18 million of net income for the third consecutive quarter." "Our commercial customer base as a whole has proven to be resilient, entrepreneurial, and focused on being great operators of their businesses. Our bankers have worked hard to build solid relationships, not just for a transaction, but to become a true asset to our customers and to be a partner in finding solutions," Daniels said. "This combination of great customers and great bankers has led to pristine asset quality metrics, allowing us to lower our loan loss provision to $0.5 million this quarter." "In the mortgage and wealth business, our bankers and advisors continue to build on their outstanding reputation because of their willingness to lead proactive, real conversations, especially as the pandemic continues to affect our communities," Daniels said. "Word-of-mouth referrals determine success in these businesses. We continue to grow because of the trust we earn every day, with every customer." Secondary mortgage income was $7.2 million for first quarter (compared to $7.8 million and $2.3 million for fourth and first quarters of 2020, respectively), and wealth revenues were $4.6 million (3% and 17% more than fourth and first quarters of 2020, respectively). "All areas of the bank are performing well because we remain focused on executing a simple yet important purpose: serve our customers, communities, and each other," said Bob Atwell, Chairman and CEO of Nicolet. "The results of this execution are what shows in the first quarter numbers." The timing of Nicolet's acquisition of Advantage Community Bancshares, Inc. ("Advantage") on August 21, 2020, at 4% of then pre-merger assets, impacts financial comparisons. At consummation, Advantage added $172 million in assets, $88 million in loans, $1 million in core deposit intangible, $12 million in goodwill, $141 million in deposits and four branches. Balance Sheet ReviewAtMarch 31, 2021, period end assets were$4.5 billion, unchanged from December 31, 2020, with a slight shift in composition. The shift in assets included a $57million increase in loans (including $43million from net activity in PPP loans, and $14 million increase in all other loans, mainly commercial) and a $19million increase in investment securities, offset by a reduction in cash and cash equivalents (down $67million to $736million). Total deposits of$3.9 billion at March 31, 2021, were also minimally changed from December 31, 2020, with a decrease of $64 million in brokered deposits (as brokered deposits mature without renewal given our liquid position) substantially offset by a $54 million increase in customer core deposits (aided in part by additional stimulus checks and new PPP funds on deposit). Total capital was $550 million at March 31, 2021, an increase of $11million since December 31, 2020, mostly due to solid earnings, partly offset by share repurchase activity and unfavorable net fair value investment changes. Nicolet repurchased 56,886 shares at a total cost of $4.1million, or an average per share cost of $72.10 during first quarter 2021. During 2020, we originated 2,725 PPP loans totaling $351 million, bearing a 1% contractual rate, and earned a $12.3 million fee. During first quarter 2021, under the latest round of the SBA's program, Nicolet originated 1,928 PPP loans totaling $145 million and earned a $7.2 million fee. Of the total fees, $5.7 million was accreted into interest in 2020 and $3.4 million was accreted in first quarter 2021. At March 31, 2021, the net carrying value of all PPP loans was $229 million, or 8% of total loans, for a net $43 million increase over year-end 2020. SBA loan forgiveness that started in November 2020 has boosted overall borrower equity in their businesses, meaningfully improving the credit quality of many commercial relationships. Asset QualityNonperforming assets were $13 million at March 31, consisting of $9 million of nonaccrual loans and $4 million of other real estate owned (primarily closed bank branch properties yet to be sold), and representing 0.28% of total assets, unchanged from $13 million or 0.29% at December31 and down from $16 million or 0.42% at March 31, 2020. Since the prior quarter, the allowance for credit losses-loans increased to $33 million, due to the $0.5 million provision for credit losses recognized and negligible net charge-offs (0.01% of average loans, annualized). At March 31, 2021, the allowance represented 1.15% of total loans, and represented 1.25% of total loans excluding the net carrying value of PPP loans. Income Statement ReviewNet income for first quarter 2021 was $18.2 million, consistent with net income of $18.0 million for fourth quarter 2020 and 73% stronger than net income of $10.6 million for first quarter 2020. Net interest income was $33.6 million for first quarter 2021, $0.4 million (1%) lower than $34.0 million for fourth quarter 2020, comprised of $1.2 million lower interest income offset by $0.8 million lower interest expense. Higher net interest income from positive rate changes (up $0.6 million) between the sequential quarters was more than offset by lower net interest income from two fewer days (down $0.6 million) and unfavorable volumes (down $0.4 million). Average interest-earning assets of $4.1 billion were minimally changed from fourth quarter 2020, with lower average loans (down $43 million, mostly from forgiveness on PPP loans outpacing new PPP and other loan growth), offset by growth in investments (up $7 million) and other interest-earning assets (up $34 million, mostly cash). Average interest-bearing liabilities of $2.8 billion increased $20 million (1%) over fourth quarter 2020, comprised of higher core interest-bearing deposits (up $110 million), and lower brokered deposits and other interest-bearing liabilities (down $90 million combined). The mix of average interest-earning assets continues to impact the margin trend most, at 69% loans (comprised of 5% PPP loans earning 7.65% and 64% all other loans earning 4.57%), 13% investments and 18% other interest-earning assets (mostly low-earning cash), compared to fourth quarter 2020 with 70% loans (7% in PPP loans earning 5.26% and 63% all other loans earning 4.71%), 13% investments and 17% other interest-earning assets. The mix of interest-bearing liabilities for first quarter was 98% deposits costing 44bps and 2% all other borrowings costing 2.42%, compared to fourth quarter 2020 with 95% deposits costing 53bps and 5% all other borrowings costing 1.63% (of which over half was very low-cost funding directly related to PPP). The net interest margin for first quarter 2021 was 3.31%, up 2bps from 3.29% for fourth quarter 2020, as the yield on interest-earning assets declined 5bps (to 3.63%), the cost of funds favorably declined 11bps (to 0.47%), and the contribution from net free funds fell 4bps. Loans yielded 4.80% for first quarter 2021, up 4bps from fourth quarter 2020, with total PPP loans yielding 7.65% (up 239bps over fourth quarter, aided mostly by accelerating fee accretion in line with loan forgiveness), while all other loans earned 4.57% (down 14bps from the prior quarter, pressured by new or renewed loans in the lower rate environment). Investments yielded 1.96%, 19bps lower than fourth quarter 2020, as new funds are invested in the lower rate environment. The cost of funds of 0.47% for first quarter 2021 declined 11bps on a sequential quarter basis, attributable mainly to the timing of prudent pricing actions on core interest-bearing deposits (down 8bps to 0.31% for first quarter 2021). Noninterest income was $17.1 million for first quarter 2021, up $0.2 million (1%) compared to fourth quarter 2020. Excluding net asset gains (losses), noninterest income was $16.4 million, down $1.1 million (6%) from fourth quarter 2020. Net mortgage income of $7.2 million remains strong, though down from the record levels experienced in 2020, on lower sale gains and capitalized gains combined (down $0.4 million or 5%) and net unfavorable fair value marks (down $0.2 million). Trust services fee income and brokerage fee income combined increased $0.1 million (3%) over fourth quarter 2020. Net asset gains were $0.7 million (comprised primarily of market gains on equity securities), compared to net asset losses of $0.6 million in fourth quarter 2020 (mostly from $1.0 million of net losses on branch other real estate owned write-downs, partly offset by $0.4 million of market gains on equity securities). All remaining noninterest income categories combined decreased $0.6 million from fourth quarter 2020 largely due to $0.4 million lower BOLI income. Noninterest expense of $26.1 million increased $0.7 million (3%) from fourth quarter 2020. Personnel expense decreased slightly ($0.1 million or 1%) from fourth quarter 2020, with a 3% overall increase in base salaries for the new year more than offset by lower non-salary personnel costs combined given timing and pace changes in the new year. All non-personnel expenses combined increased $0.8 million (8%) over fourth quarter 2020, largely due to $0.5 million higher professional costs related to the recently announced acquisition and $0.2 million higher FDIC expense from the larger assessment base. On April 12, 2021, we entered into a definitive merger agreement with Mackinac Financial Corporation ("Mackinac" (NASDAQ: MFNC)) pursuant to which Mackinac will merge with and into Nicolet, expanding Nicolet prominently into Northern Michigan and the Upper Peninsula of Michigan. Mackinac shareholders will receive fixed consideration of 0.22 shares of Nicolet and $4.64 in cash for each share owned (approximating a 20% cash and 80% stock split), subject to provisions provided for in the merger agreement. At December 31, 2020, Mackinac had total assets of $1.5 billion, loans of $1.1 billion, deposits of $1.3 billion and equity of $168 million. The merger is expected to close in the third quarter of 2021, subject to customary closing conditions, including approval by regulators and shareholders of both Mackinac and Nicolet. "We are committed to realizing the promise of the acquisition of Mackinac Financial Corporation, which is to come together as a strong, people-driven, local community bank," said Daniels. "Our team is assembled and using their experience to help create a seamless integration. We understand that, at this point, we will be judged by our actions, not our words. It's time to deliver, and I am confident that our team will do exactly that," concluded Daniels. About Nicolet Bankshares, Inc. Nicolet Bankshares, Inc. is the bank holding company of Nicolet National Bank, a growing, full-service, community bank providing services ranging from commercial and consumer banking to wealth management and retirement plan services. Founded in Green Bay in 2000, Nicolet National Bank operates branches in Northeast and Central Wisconsin and the upper peninsula of Michigan. More information can be found at www.nicoletbank.com. Forward Looking Statements "Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995Certain statements contained in this communication, which are not statements of historical fact, constitute forward-looking statements within the meaning of the federal securities law. Such statements include, but are not limited to, statements about Nicolet's business plans, objectives, expectations and intentions, as well as certain plans, expectations, goals, projections and benefits relating to the proposed merger between Nicolet and Mackinac, all of which are subject to numerous assumptions, risks and uncertainties. Words or phrases such as "anticipate," "believe," "aim," "can," "conclude," "continue," "could," "estimate," "expect," "foresee," "goal," "intend," "may," "might," "outlook," "possible," "plan," "predict," "project," "potential," "seek," "should," "target," "will," "will likely," "would," or the negative of these terms or other comparable terminology, as well as similar expressions, are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements are not historical facts but instead express only management's beliefs regarding future results or events, many of which, by their nature, are inherently uncertain and outside of management's control. It is possible that actual results and outcomes may differ, possibly materially, from the anticipated results or outcomes indicated in these forward-looking statements. In addition to factors disclosed in reports filed by Nicolet with the SEC, risks and uncertainties, including but not limited to risks and uncertainties for Nicolet, Mackinac and the combined company with respect to the proposed merger, that may cause actual results or outcomes to differ materially from those anticipated include, but are not limited to: (1) the possibility that any of the anticipated benefits of the proposed merger will not be realized or will not be realized within the expected time period; (2) the risk that integration of Mackinac's operations with those of Nicolet will be materially delayed or will be more costly or difficult than expected; (3) the parties' inability to meet expectations regarding the timing of the proposed merger; (4) changes to tax legislation and their potential effects on the accounting for the merger; (5) the inability to complete the proposed merger due to the failure of Nicolet's or Mackinac's shareholders to adopt the Merger Agreement; (6) the failure to satisfy other conditions to completion of the proposed merger, including receipt of required regulatory and other approvals; (7) the failure of the proposed merger to close for any other reason; (8) diversion of management's attention from ongoing business operations and opportunities due to the proposed merger; (9) the challenges of integrating and retaining key employees; (10) the effect of the announcement of the proposed merger on Nicolet's, Mackinac's or the combined company's respective customer and employee relationships and operating results; (11) the possibility that the proposed merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; (12) dilution caused by Nicolet's issuance of additional shares of Nicolet common stock in connection with the merger; (13) the magnitude and duration of the COVID pandemic and its impact on the global economy and financial market conditions and the business, results of operations and financial condition of Nicolet, Mackinac and the combined company; (14) changes in consumer demand for financial services; and (15) general competitive, economic, political and market conditions and fluctuations. Please refer to Nicolet's Annual Report on Form 10-K for the year ended December 31, 2020, as well as its other filings with the SEC, for a more detailed discussion of risks, uncertainties and factors that could cause actual results to differ from those discussed in the forward-looking statements. The COVID pandemic is adversely affecting us, our customers, counterparties, employees, and third-party service providers, and the ultimate extent of the impacts on our business, financial position, results of operations, liquidity, and prospects is uncertain. Continued deterioration in general business and economic conditions or turbulence in domestic financial markets could adversely affect Nicolet's revenues and the values of its assets and liabilities, lead to a tightening of credit, and increase stock price volatility. In addition, the COVID pandemic may result in changes to statutes, regulations, or regulatory policies or practices that could affect Nicolet in substantial and unpredictable ways. All forward-looking statements included in this communication are made as of the date hereof and are based on information available to management at that time. Except as required by law, Nicolet does not assume any obligation to update any forward-looking statement to reflect events or circumstances that occur after the date the forward-looking statements were made. Important Information and Where to Find ItThis communication relates to the proposed merger transaction involving Nicolet and Mackinac. In connection with the proposed merger, Nicolet and Mackinac will file a joint proxy statement/prospectus on Form S-4 and other relevant documents concerning the merger with the Securities and Exchange Commission (the "SEC"). BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND ANY OTHER DOCUMENTS TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED MERGER OR INCORPORATED BY REFERENCE IN THE JOINT PROXY STATEMENT/PROSPECTUS BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NICOLET, MACKINAC AND THE PROPOSED MERGER. When available, the joint proxy statement/prospectus will be delivered to shareholders of Nicolet and Mackinac. Investors may obtain copies of the joint proxy statement/prospectus and other relevant documents (as they become available) free of charge at the SEC's website (www.sec.gov). Copies of the documents filed with the SEC by Nicolet will be available free of charge on Nicolet's website at www.nicoletbank.com. Copies of the documents filed with the SEC by Mackinac will be available free of charge on Mackinac's website at www.bankmbank.com. Nicolet, Mackinac and certain of their directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies from the shareholders of Nicolet and the shareholders of Mackinac in connection with the proposed merger. Information about the directors and executive officers of Nicolet and Mackinac will be included in the joint proxy statement/prospectus for the proposed transaction filed with the SEC. Information about the directors and executive officers of Nicolet is also included in the proxy statement for its 2021 annual meeting of shareholders, which was filed with the SEC on March 2, 2021. Information about the directors and executive officers of Mackinac is also included in the proxy statement for its 2020 annual meeting of shareholders, which was filed with the SEC on April 22, 2020. Additional information regarding the interests of such participants and other persons who may be deemed participants in the transaction will be included in the joint proxy statement/prospectus and the other relevant documents filed with the SEC when they become available. No Offer or SolicitationThis communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Nicolet Bankshares, Inc. Consolidated Financial Summary (Unaudited) At or for the Three Months Ended (In thousands, except per share data) 03/31/2021 12/31/2020 09/30/2020 06/30/2020 03/31/2020 Results of operations: Interest income $ 36,876 $ 38,037 $ 37,270 $ 36,892 $ 37,003 Interest expense 3,235 4,019 4,710 5,395 5,740 Net interest income 33,641 34,018 32,560 31,497 31,263 Provision for credit losses 500 1,300 3,000 3,000 3,000 Net interest income after provision for credit losses 33,141 32,718 29,560 28,497 28,263 Noninterest income 17,126 16,879 18,691 17,471 9,585 Noninterest expense 26,081 25,367 23,685 27,813 23,854 Income before income tax expense 24,186 24,230 24,566 18,155 13,994 Income tax expense 5,947 6,145 6,434 4,576 3,321 Net income 18,239 18,085 18,132 13,579 10,673 Net income attributable to noncontrolling interest 98 30 101 118 Net income attributable to Nicolet Bankshares, Inc. $ 18,239 $ 17,987 $ 18,102 $ 13,478 $ 10,555 Earnings per common share: Basic $ 1.82 $ 1.79 $ 1.75 $ 1.29 $ 1.00 Diluted $ 1.75 $ 1.74 $ 1.72 $ 1.28 $ 0.98 Common Shares: Basic weighted average 9,998 10,074 10,349 10,417 10,516 Diluted weighted average 10,403 10,350 10,499 10,520 10,801 Outstanding 9,988 10,011 10,196 10,424 10,408 Noninterest Income: Trust services fee income $ 1,775 $ 1,746 $ 1,628 $ 1,510 $ 1,579 Brokerage fee income 2,793 2,673 2,489 2,269 2,322 Mortgage income, net 7,230 7,842 9,675 9,963 2,327 Service charges on deposit accounts 1,091 1,133 1,037 813 1,225 Card interchange income 1,927 1,922 1,877 1,637 1,562 BOLI income 527 936 531 540 703 Other noninterest income 1,072 1,247 1,237 1,487 521 Noninterest income without net gains 16,415 17,499 18,474 18,219 10,239 Asset gains (losses), net 711 (620) 217 (748) (654) Total noninterest income $ 17,126 $ 16,879 $ 18,691 $ 17,471 $ 9,585 Noninterest Expense: Personnel expense $ 15,116 $ 15,244 $ 14,072 $ 14,482 $ 13,323 Occupancy, equipment and office 4,137 4,102 4,051 4,361 4,204 Business development and marketing 989 713 810 2,514 1,359 Data processing 2,658 3,074 2,658 2,399 2,563 Intangibles amortization 852 860 834 880 993 Other noninterest expense 2,329 1,374 1,260 3,177 1,412 Total noninterest expense $ 26,081 $ 25,367 $ 23,685 $ 27,813 $ 23,854 Period-End Balances: Total loans $ 2,846,351 $ 2,789,101 $ 2,908,793 $ 2,821,501 $ 2,607,424 PPP loans 229,403 186,016 335,236 329,157 Total loans, ex. PPP loans 2,616,948 2,603,085 2,573,557 2,492,344 2,607,424 Allowance for credit losses - loans 32,626 32,173 31,388 29,130 26,202 Securities available for sale, at fair value 558,229 539,337 535,351 510,809 511,860 Cash and cash equivalents 735,854 802,859 853,564 822,684 241,960 Goodwill and other intangibles, net 174,501 175,353 176,213 164,094 164,974 Total assets 4,543,804 4,551,789 4,706,375 4,541,228 3,732,554 Deposits 3,900,594 3,910,399 3,712,808 3,537,805 3,023,466 Stockholders' equity 550,046 539,189 538,068 532,033 510,971 Book value per common share 55.07 53.86 52.77 51.04 49.09 Tangible book value per common share (1) 37.60 36.34 35.49 35.30 33.24 Nicolet Bankshares, Inc. Consolidated Financial Summary (Unaudited) - Continued At or for the Three Months Ended (In thousands, except per share data) 03/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 Average Balances: Loans $ 2,825,664 $ 2,868,827 $ 2,871,256 $ 2,823,866 $ 2,584,584 Investment securities 528,342 520,867 496,153 489,597 453,820 Interest-earning assets 4,089,603 4,091,460 4,216,106 3,917,499 3,167,505 Cash and cash equivalents 750,075 714,031 864,295 614,034 139,768 Goodwill and other intangibles, net 174,825 175,678 169,353 164,564 165,532 Total assets 4,514,927 4,515,226 4,633,359 4,310,088 3,555,144 Deposits 3,875,205 3,793,430 3,636,260 3,403,188 2,920,071 Interest-bearing liabilities 2,764,232 2,744,578 2,933,737 2,741,199 2,218,592 Stockholders' equity 544,541 537,920 537,826 520,177 513,558 Selected Financial Ratios: (2) Return on average assets 1.64 % 1.58 % 1.55 % 1.26 % 1.19 % Return on average common equity 13.58 13.30 13.39 10.42 8.27 Return on average tangible common equity (1) 20.01 19.75 19.54 15.24 12.20 Average equity to average assets 12.06 11.91 11.61 12.07 14.45 Stockholders' equity to assets 12.11 11.85 11.43 11.72 13.69 Tangible common equity to tangible assets (1) 8.60 8.31 7.99 8.41 9.70 Net interest margin 3.31 3.29 3.06 3.21 3.94 Efficiency ratio 51.84 48.99 46.18 55.69 57.16 Effective tax rate 24.59 25.36 26.19 25.21 23.73 Selected Asset Quality Information: Nonaccrual loans $ 8,965 $ 9,455 10,997 $ 11,998 $ 14,769 Other real estate owned 3,797 3,608 1,000 1,000 1,000 Nonperforming assets $ 12,762 $ 13,063 $ 11,997 $ 12,998 $ 15,769 Net loan charge-offs (recoveries) $ 47 $ 515 $ 743 $ 71 $ 55 Allowance for credit losses-loans to loans 1.15 % 1.15 % 1.08 % 1.03 % 1.00 % Net loan charge-offs to average loans (2) 0.01 0.07 0.10 0.01 0.01 Nonperforming loans to total loans 0.31 0.34 0.38 0.43 0.57 Nonperforming assets to total assets 0.28 0.29 0.25 0.29 0.42 Selected Other Information: Tax-equivalent adjustment net interest income $ 252 $ 260 $ 249 $ 229 $ 231 Tax benefit on stock-based compensation $ (234) $ (77) $ (14) $ (24) $ (323) Common stock repurchased (dollars) (3) $ 4,102 $ 12,909 $ 13,732 $ $ 13,903 Common stock repurchased (full shares) (3) 56,886 205,001 234,914 206,833 1 The ratios of tangible book value per common share, return on average tangible common equity, and tangible common equity to tangible assets exclude goodwill and other intangibles, net. These financial ratios have been included as they are considered to be critical metrics with which to analyze and evaluate financial condition and capital strength. 2 Income statement-related ratios for partial-year periods are annualized. 3 Reflects common stock repurchased under board of director authorizations for the common stock repurchase program. Nicolet Bankshares, Inc. Net Interest Income and Net Interest Margin Analysis (Unaudited) At or for the Three Months Ended March 31, 2021 December 31, 2020 March 31, 2020 Average Average Average Average Average Average (In thousands) Balance Interest Rate Balance Interest Rate Balance Interest Rate ASSETS PPP loans $ 206,498 $ 3,951 7.65 % $ 282,736 $ 3,799 5.26 % $ $ % Total loans ex PPP 2,619,166 29,934 4.57 % 2,586,091 31,005 4.71 % 2,584,584 33,808 5.19 % Total loans (1) (2) 2,825,664 33,885 4.80 % 2,868,827 34,804 4.76 % 2,584,584 33,808 5.19 % Investment securities (2) 528,342 2,588 1.96 % 520,867 2,799 2.15 % 453,820 2,764 2.44 % Other interest-earning assets 735,597 655 0.36 % 701,766 694 0.39 % 129,101 662 2.04 % Total interest-earning assets 4,089,603 $ 37,128 3.63 % 4,091,460 $ 38,297 3.68 % 3,167,505 $ 37,234 4.66 % Other assets, net 425,324 423,766 387,639 Total assets $ 4,514,927 $ 4,515,226 $ 3,555,144 LIABILITIES AND STOCKHOLDERS' EQUITY Interest-bearing core deposits $ 2,395,948 $ 1,841 0.31 % $ 2,285,858 $ 2,269 0.39 % $ 1,975,145 $ 4,182 0.85 % Brokered deposits 316,589 1,081 1.38 % 320,237 1,176 1.46 % 158,068 775 1.97 % Total interest-bearing deposits 2,712,537 2,922 0.44 % 2,606,095 3,445 0.53 % 2,133,213 4,957 0.93 % PPPLF 0.00 % 72,582 64 0.35 % 0.00 % Other interest-bearing liabilities 51,695 313 2.42 % 65,901 510 3.04 % 85,379 783 3.64 % Total interest-bearing liabilities 2,764,232 $ 3,235 0.47 % 2,744,578 $ 4,019 0.58 % 2,218,592 $ 5,740 1.04 % Noninterest-bearing demand deposits 1,162,668 1,187,335 786,858 Other liabilities 43,486 45,393 36,136 Stockholders' equity 544,541 537,920 513,558 Total liabilities and stockholders' equity $ 4,514,927 $ 4,515,226 $ 3,555,144 Net interest income and rate spread $ 33,893 3.16 % $ 34,278 3.10 % $ 31,494 3.62 % Net interest margin 3.31 % 3.29 % 3.94 % (1) Nonaccrual loans and loans held for sale are included in the daily average loan balances outstanding. (2) The yield on tax-exempt loans and tax-exempt investment securities is computed on a tax-equivalent basis using a federal tax rate of 21%, and adjusted for the disallowance of interest expense. SOURCE Nicolet Bankshares, Inc. Related Links https://www.nicoletbank.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Nicolet Bankshares, Inc. Announces First Quarter 2021 Earnings.

GREEN BAY, Wis., April20, 2021 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced first quarter 2021 net income of $18.2 million and earnings per diluted common share of $1.75, compared to $18.0 million and $1.74 for fourth quarter 2020, and $10.6 million and $0.98 for first quarter 2020, respectively. Annualized quarterly return on average assets was 1.64%, 1.58% and 1.19%, for first quarter 2021, fourth quarter 2020 and first quarter 2020, respectively. "We are very pleased with the exceptional start to 2021," said Mike Daniels, President and CEO of Nicolet National Bank. "The main themes from late 2020 continue to drive our earnings - strong mortgage income, improved asset quality, Paycheck Protection Program ("PPP") loan activity, and expense control - producing $18 million of net income for the third consecutive quarter." "Our commercial customer base as a whole has proven to be resilient, entrepreneurial, and focused on being great operators of their businesses. Our bankers have worked hard to build solid relationships, not just for a transaction, but to become a true asset to our customers and to be a partner in finding solutions," Daniels said. "This combination of great customers and great bankers has led to pristine asset quality metrics, allowing us to lower our loan loss provision to $0.5 million this quarter." "In the mortgage and wealth business, our bankers and advisors continue to build on their outstanding reputation because of their willingness to lead proactive, real conversations, especially as the pandemic continues to affect our communities," Daniels said. "Word-of-mouth referrals determine success in these businesses. We continue to grow because of the trust we earn every day, with every customer." Secondary mortgage income was $7.2 million for first quarter (compared to $7.8 million and $2.3 million for fourth and first quarters of 2020, respectively), and wealth revenues were $4.6 million (3% and 17% more than fourth and first quarters of 2020, respectively). "All areas of the bank are performing well because we remain focused on executing a simple yet important purpose: serve our customers, communities, and each other," said Bob Atwell, Chairman and CEO of Nicolet. "The results of this execution are what shows in the first quarter numbers." The timing of Nicolet's acquisition of Advantage Community Bancshares, Inc. ("Advantage") on August 21, 2020, at 4% of then pre-merger assets, impacts financial comparisons. At consummation, Advantage added $172 million in assets, $88 million in loans, $1 million in core deposit intangible, $12 million in goodwill, $141 million in deposits and four branches. Balance Sheet ReviewAtMarch 31, 2021, period end assets were$4.5 billion, unchanged from December 31, 2020, with a slight shift in composition. The shift in assets included a $57million increase in loans (including $43million from net activity in PPP loans, and $14 million increase in all other loans, mainly commercial) and a $19million increase in investment securities, offset by a reduction in cash and cash equivalents (down $67million to $736million). Total deposits of$3.9 billion at March 31, 2021, were also minimally changed from December 31, 2020, with a decrease of $64 million in brokered deposits (as brokered deposits mature without renewal given our liquid position) substantially offset by a $54 million increase in customer core deposits (aided in part by additional stimulus checks and new PPP funds on deposit). Total capital was $550 million at March 31, 2021, an increase of $11million since December 31, 2020, mostly due to solid earnings, partly offset by share repurchase activity and unfavorable net fair value investment changes. Nicolet repurchased 56,886 shares at a total cost of $4.1million, or an average per share cost of $72.10 during first quarter 2021. During 2020, we originated 2,725 PPP loans totaling $351 million, bearing a 1% contractual rate, and earned a $12.3 million fee. During first quarter 2021, under the latest round of the SBA's program, Nicolet originated 1,928 PPP loans totaling $145 million and earned a $7.2 million fee. Of the total fees, $5.7 million was accreted into interest in 2020 and $3.4 million was accreted in first quarter 2021. At March 31, 2021, the net carrying value of all PPP loans was $229 million, or 8% of total loans, for a net $43 million increase over year-end 2020. SBA loan forgiveness that started in November 2020 has boosted overall borrower equity in their businesses, meaningfully improving the credit quality of many commercial relationships. Asset QualityNonperforming assets were $13 million at March 31, consisting of $9 million of nonaccrual loans and $4 million of other real estate owned (primarily closed bank branch properties yet to be sold), and representing 0.28% of total assets, unchanged from $13 million or 0.29% at December31 and down from $16 million or 0.42% at March 31, 2020. Since the prior quarter, the allowance for credit losses-loans increased to $33 million, due to the $0.5 million provision for credit losses recognized and negligible net charge-offs (0.01% of average loans, annualized). At March 31, 2021, the allowance represented 1.15% of total loans, and represented 1.25% of total loans excluding the net carrying value of PPP loans. Income Statement ReviewNet income for first quarter 2021 was $18.2 million, consistent with net income of $18.0 million for fourth quarter 2020 and 73% stronger than net income of $10.6 million for first quarter 2020. Net interest income was $33.6 million for first quarter 2021, $0.4 million (1%) lower than $34.0 million for fourth quarter 2020, comprised of $1.2 million lower interest income offset by $0.8 million lower interest expense. Higher net interest income from positive rate changes (up $0.6 million) between the sequential quarters was more than offset by lower net interest income from two fewer days (down $0.6 million) and unfavorable volumes (down $0.4 million). Average interest-earning assets of $4.1 billion were minimally changed from fourth quarter 2020, with lower average loans (down $43 million, mostly from forgiveness on PPP loans outpacing new PPP and other loan growth), offset by growth in investments (up $7 million) and other interest-earning assets (up $34 million, mostly cash). Average interest-bearing liabilities of $2.8 billion increased $20 million (1%) over fourth quarter 2020, comprised of higher core interest-bearing deposits (up $110 million), and lower brokered deposits and other interest-bearing liabilities (down $90 million combined). The mix of average interest-earning assets continues to impact the margin trend most, at 69% loans (comprised of 5% PPP loans earning 7.65% and 64% all other loans earning 4.57%), 13% investments and 18% other interest-earning assets (mostly low-earning cash), compared to fourth quarter 2020 with 70% loans (7% in PPP loans earning 5.26% and 63% all other loans earning 4.71%), 13% investments and 17% other interest-earning assets. The mix of interest-bearing liabilities for first quarter was 98% deposits costing 44bps and 2% all other borrowings costing 2.42%, compared to fourth quarter 2020 with 95% deposits costing 53bps and 5% all other borrowings costing 1.63% (of which over half was very low-cost funding directly related to PPP). The net interest margin for first quarter 2021 was 3.31%, up 2bps from 3.29% for fourth quarter 2020, as the yield on interest-earning assets declined 5bps (to 3.63%), the cost of funds favorably declined 11bps (to 0.47%), and the contribution from net free funds fell 4bps. Loans yielded 4.80% for first quarter 2021, up 4bps from fourth quarter 2020, with total PPP loans yielding 7.65% (up 239bps over fourth quarter, aided mostly by accelerating fee accretion in line with loan forgiveness), while all other loans earned 4.57% (down 14bps from the prior quarter, pressured by new or renewed loans in the lower rate environment). Investments yielded 1.96%, 19bps lower than fourth quarter 2020, as new funds are invested in the lower rate environment. The cost of funds of 0.47% for first quarter 2021 declined 11bps on a sequential quarter basis, attributable mainly to the timing of prudent pricing actions on core interest-bearing deposits (down 8bps to 0.31% for first quarter 2021). Noninterest income was $17.1 million for first quarter 2021, up $0.2 million (1%) compared to fourth quarter 2020. Excluding net asset gains (losses), noninterest income was $16.4 million, down $1.1 million (6%) from fourth quarter 2020. Net mortgage income of $7.2 million remains strong, though down from the record levels experienced in 2020, on lower sale gains and capitalized gains combined (down $0.4 million or 5%) and net unfavorable fair value marks (down $0.2 million). Trust services fee income and brokerage fee income combined increased $0.1 million (3%) over fourth quarter 2020. Net asset gains were $0.7 million (comprised primarily of market gains on equity securities), compared to net asset losses of $0.6 million in fourth quarter 2020 (mostly from $1.0 million of net losses on branch other real estate owned write-downs, partly offset by $0.4 million of market gains on equity securities). All remaining noninterest income categories combined decreased $0.6 million from fourth quarter 2020 largely due to $0.4 million lower BOLI income. Noninterest expense of $26.1 million increased $0.7 million (3%) from fourth quarter 2020. Personnel expense decreased slightly ($0.1 million or 1%) from fourth quarter 2020, with a 3% overall increase in base salaries for the new year more than offset by lower non-salary personnel costs combined given timing and pace changes in the new year. All non-personnel expenses combined increased $0.8 million (8%) over fourth quarter 2020, largely due to $0.5 million higher professional costs related to the recently announced acquisition and $0.2 million higher FDIC expense from the larger assessment base. On April 12, 2021, we entered into a definitive merger agreement with Mackinac Financial Corporation ("Mackinac" (NASDAQ: MFNC)) pursuant to which Mackinac will merge with and into Nicolet, expanding Nicolet prominently into Northern Michigan and the Upper Peninsula of Michigan. Mackinac shareholders will receive fixed consideration of 0.22 shares of Nicolet and $4.64 in cash for each share owned (approximating a 20% cash and 80% stock split), subject to provisions provided for in the merger agreement. At December 31, 2020, Mackinac had total assets of $1.5 billion, loans of $1.1 billion, deposits of $1.3 billion and equity of $168 million. The merger is expected to close in the third quarter of 2021, subject to customary closing conditions, including approval by regulators and shareholders of both Mackinac and Nicolet. "We are committed to realizing the promise of the acquisition of Mackinac Financial Corporation, which is to come together as a strong, people-driven, local community bank," said Daniels. "Our team is assembled and using their experience to help create a seamless integration. We understand that, at this point, we will be judged by our actions, not our words. It's time to deliver, and I am confident that our team will do exactly that," concluded Daniels. About Nicolet Bankshares, Inc. Nicolet Bankshares, Inc. is the bank holding company of Nicolet National Bank, a growing, full-service, community bank providing services ranging from commercial and consumer banking to wealth management and retirement plan services. Founded in Green Bay in 2000, Nicolet National Bank operates branches in Northeast and Central Wisconsin and the upper peninsula of Michigan. More information can be found at www.nicoletbank.com. Forward Looking Statements "Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995Certain statements contained in this communication, which are not statements of historical fact, constitute forward-looking statements within the meaning of the federal securities law. Such statements include, but are not limited to, statements about Nicolet's business plans, objectives, expectations and intentions, as well as certain plans, expectations, goals, projections and benefits relating to the proposed merger between Nicolet and Mackinac, all of which are subject to numerous assumptions, risks and uncertainties. Words or phrases such as "anticipate," "believe," "aim," "can," "conclude," "continue," "could," "estimate," "expect," "foresee," "goal," "intend," "may," "might," "outlook," "possible," "plan," "predict," "project," "potential," "seek," "should," "target," "will," "will likely," "would," or the negative of these terms or other comparable terminology, as well as similar expressions, are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements are not historical facts but instead express only management's beliefs regarding future results or events, many of which, by their nature, are inherently uncertain and outside of management's control. It is possible that actual results and outcomes may differ, possibly materially, from the anticipated results or outcomes indicated in these forward-looking statements. In addition to factors disclosed in reports filed by Nicolet with the SEC, risks and uncertainties, including but not limited to risks and uncertainties for Nicolet, Mackinac and the combined company with respect to the proposed merger, that may cause actual results or outcomes to differ materially from those anticipated include, but are not limited to: (1) the possibility that any of the anticipated benefits of the proposed merger will not be realized or will not be realized within the expected time period; (2) the risk that integration of Mackinac's operations with those of Nicolet will be materially delayed or will be more costly or difficult than expected; (3) the parties' inability to meet expectations regarding the timing of the proposed merger; (4) changes to tax legislation and their potential effects on the accounting for the merger; (5) the inability to complete the proposed merger due to the failure of Nicolet's or Mackinac's shareholders to adopt the Merger Agreement; (6) the failure to satisfy other conditions to completion of the proposed merger, including receipt of required regulatory and other approvals; (7) the failure of the proposed merger to close for any other reason; (8) diversion of management's attention from ongoing business operations and opportunities due to the proposed merger; (9) the challenges of integrating and retaining key employees; (10) the effect of the announcement of the proposed merger on Nicolet's, Mackinac's or the combined company's respective customer and employee relationships and operating results; (11) the possibility that the proposed merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; (12) dilution caused by Nicolet's issuance of additional shares of Nicolet common stock in connection with the merger; (13) the magnitude and duration of the COVID pandemic and its impact on the global economy and financial market conditions and the business, results of operations and financial condition of Nicolet, Mackinac and the combined company; (14) changes in consumer demand for financial services; and (15) general competitive, economic, political and market conditions and fluctuations. Please refer to Nicolet's Annual Report on Form 10-K for the year ended December 31, 2020, as well as its other filings with the SEC, for a more detailed discussion of risks, uncertainties and factors that could cause actual results to differ from those discussed in the forward-looking statements. The COVID pandemic is adversely affecting us, our customers, counterparties, employees, and third-party service providers, and the ultimate extent of the impacts on our business, financial position, results of operations, liquidity, and prospects is uncertain. Continued deterioration in general business and economic conditions or turbulence in domestic financial markets could adversely affect Nicolet's revenues and the values of its assets and liabilities, lead to a tightening of credit, and increase stock price volatility. In addition, the COVID pandemic may result in changes to statutes, regulations, or regulatory policies or practices that could affect Nicolet in substantial and unpredictable ways. All forward-looking statements included in this communication are made as of the date hereof and are based on information available to management at that time. Except as required by law, Nicolet does not assume any obligation to update any forward-looking statement to reflect events or circumstances that occur after the date the forward-looking statements were made. Important Information and Where to Find ItThis communication relates to the proposed merger transaction involving Nicolet and Mackinac. In connection with the proposed merger, Nicolet and Mackinac will file a joint proxy statement/prospectus on Form S-4 and other relevant documents concerning the merger with the Securities and Exchange Commission (the "SEC"). BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND ANY OTHER DOCUMENTS TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED MERGER OR INCORPORATED BY REFERENCE IN THE JOINT PROXY STATEMENT/PROSPECTUS BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NICOLET, MACKINAC AND THE PROPOSED MERGER. When available, the joint proxy statement/prospectus will be delivered to shareholders of Nicolet and Mackinac. Investors may obtain copies of the joint proxy statement/prospectus and other relevant documents (as they become available) free of charge at the SEC's website (www.sec.gov). Copies of the documents filed with the SEC by Nicolet will be available free of charge on Nicolet's website at www.nicoletbank.com. Copies of the documents filed with the SEC by Mackinac will be available free of charge on Mackinac's website at www.bankmbank.com. Nicolet, Mackinac and certain of their directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies from the shareholders of Nicolet and the shareholders of Mackinac in connection with the proposed merger. Information about the directors and executive officers of Nicolet and Mackinac will be included in the joint proxy statement/prospectus for the proposed transaction filed with the SEC. Information about the directors and executive officers of Nicolet is also included in the proxy statement for its 2021 annual meeting of shareholders, which was filed with the SEC on March 2, 2021. Information about the directors and executive officers of Mackinac is also included in the proxy statement for its 2020 annual meeting of shareholders, which was filed with the SEC on April 22, 2020. Additional information regarding the interests of such participants and other persons who may be deemed participants in the transaction will be included in the joint proxy statement/prospectus and the other relevant documents filed with the SEC when they become available. No Offer or SolicitationThis communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Nicolet Bankshares, Inc. Consolidated Financial Summary (Unaudited) At or for the Three Months Ended (In thousands, except per share data) 03/31/2021 12/31/2020 09/30/2020 06/30/2020 03/31/2020 Results of operations: Interest income $ 36,876 $ 38,037 $ 37,270 $ 36,892 $ 37,003 Interest expense 3,235 4,019 4,710 5,395 5,740 Net interest income 33,641 34,018 32,560 31,497 31,263 Provision for credit losses 500 1,300 3,000 3,000 3,000 Net interest income after provision for credit losses 33,141 32,718 29,560 28,497 28,263 Noninterest income 17,126 16,879 18,691 17,471 9,585 Noninterest expense 26,081 25,367 23,685 27,813 23,854 Income before income tax expense 24,186 24,230 24,566 18,155 13,994 Income tax expense 5,947 6,145 6,434 4,576 3,321 Net income 18,239 18,085 18,132 13,579 10,673 Net income attributable to noncontrolling interest 98 30 101 118 Net income attributable to Nicolet Bankshares, Inc. $ 18,239 $ 17,987 $ 18,102 $ 13,478 $ 10,555 Earnings per common share: Basic $ 1.82 $ 1.79 $ 1.75 $ 1.29 $ 1.00 Diluted $ 1.75 $ 1.74 $ 1.72 $ 1.28 $ 0.98 Common Shares: Basic weighted average 9,998 10,074 10,349 10,417 10,516 Diluted weighted average 10,403 10,350 10,499 10,520 10,801 Outstanding 9,988 10,011 10,196 10,424 10,408 Noninterest Income: Trust services fee income $ 1,775 $ 1,746 $ 1,628 $ 1,510 $ 1,579 Brokerage fee income 2,793 2,673 2,489 2,269 2,322 Mortgage income, net 7,230 7,842 9,675 9,963 2,327 Service charges on deposit accounts 1,091 1,133 1,037 813 1,225 Card interchange income 1,927 1,922 1,877 1,637 1,562 BOLI income 527 936 531 540 703 Other noninterest income 1,072 1,247 1,237 1,487 521 Noninterest income without net gains 16,415 17,499 18,474 18,219 10,239 Asset gains (losses), net 711 (620) 217 (748) (654) Total noninterest income $ 17,126 $ 16,879 $ 18,691 $ 17,471 $ 9,585 Noninterest Expense: Personnel expense $ 15,116 $ 15,244 $ 14,072 $ 14,482 $ 13,323 Occupancy, equipment and office 4,137 4,102 4,051 4,361 4,204 Business development and marketing 989 713 810 2,514 1,359 Data processing 2,658 3,074 2,658 2,399 2,563 Intangibles amortization 852 860 834 880 993 Other noninterest expense 2,329 1,374 1,260 3,177 1,412 Total noninterest expense $ 26,081 $ 25,367 $ 23,685 $ 27,813 $ 23,854 Period-End Balances: Total loans $ 2,846,351 $ 2,789,101 $ 2,908,793 $ 2,821,501 $ 2,607,424 PPP loans 229,403 186,016 335,236 329,157 Total loans, ex. PPP loans 2,616,948 2,603,085 2,573,557 2,492,344 2,607,424 Allowance for credit losses - loans 32,626 32,173 31,388 29,130 26,202 Securities available for sale, at fair value 558,229 539,337 535,351 510,809 511,860 Cash and cash equivalents 735,854 802,859 853,564 822,684 241,960 Goodwill and other intangibles, net 174,501 175,353 176,213 164,094 164,974 Total assets 4,543,804 4,551,789 4,706,375 4,541,228 3,732,554 Deposits 3,900,594 3,910,399 3,712,808 3,537,805 3,023,466 Stockholders' equity 550,046 539,189 538,068 532,033 510,971 Book value per common share 55.07 53.86 52.77 51.04 49.09 Tangible book value per common share (1) 37.60 36.34 35.49 35.30 33.24 Nicolet Bankshares, Inc. Consolidated Financial Summary (Unaudited) - Continued At or for the Three Months Ended (In thousands, except per share data) 03/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 Average Balances: Loans $ 2,825,664 $ 2,868,827 $ 2,871,256 $ 2,823,866 $ 2,584,584 Investment securities 528,342 520,867 496,153 489,597 453,820 Interest-earning assets 4,089,603 4,091,460 4,216,106 3,917,499 3,167,505 Cash and cash equivalents 750,075 714,031 864,295 614,034 139,768 Goodwill and other intangibles, net 174,825 175,678 169,353 164,564 165,532 Total assets 4,514,927 4,515,226 4,633,359 4,310,088 3,555,144 Deposits 3,875,205 3,793,430 3,636,260 3,403,188 2,920,071 Interest-bearing liabilities 2,764,232 2,744,578 2,933,737 2,741,199 2,218,592 Stockholders' equity 544,541 537,920 537,826 520,177 513,558 Selected Financial Ratios: (2) Return on average assets 1.64 % 1.58 % 1.55 % 1.26 % 1.19 % Return on average common equity 13.58 13.30 13.39 10.42 8.27 Return on average tangible common equity (1) 20.01 19.75 19.54 15.24 12.20 Average equity to average assets 12.06 11.91 11.61 12.07 14.45 Stockholders' equity to assets 12.11 11.85 11.43 11.72 13.69 Tangible common equity to tangible assets (1) 8.60 8.31 7.99 8.41 9.70 Net interest margin 3.31 3.29 3.06 3.21 3.94 Efficiency ratio 51.84 48.99 46.18 55.69 57.16 Effective tax rate 24.59 25.36 26.19 25.21 23.73 Selected Asset Quality Information: Nonaccrual loans $ 8,965 $ 9,455 10,997 $ 11,998 $ 14,769 Other real estate owned 3,797 3,608 1,000 1,000 1,000 Nonperforming assets $ 12,762 $ 13,063 $ 11,997 $ 12,998 $ 15,769 Net loan charge-offs (recoveries) $ 47 $ 515 $ 743 $ 71 $ 55 Allowance for credit losses-loans to loans 1.15 % 1.15 % 1.08 % 1.03 % 1.00 % Net loan charge-offs to average loans (2) 0.01 0.07 0.10 0.01 0.01 Nonperforming loans to total loans 0.31 0.34 0.38 0.43 0.57 Nonperforming assets to total assets 0.28 0.29 0.25 0.29 0.42 Selected Other Information: Tax-equivalent adjustment net interest income $ 252 $ 260 $ 249 $ 229 $ 231 Tax benefit on stock-based compensation $ (234) $ (77) $ (14) $ (24) $ (323) Common stock repurchased (dollars) (3) $ 4,102 $ 12,909 $ 13,732 $ $ 13,903 Common stock repurchased (full shares) (3) 56,886 205,001 234,914 206,833 1 The ratios of tangible book value per common share, return on average tangible common equity, and tangible common equity to tangible assets exclude goodwill and other intangibles, net. These financial ratios have been included as they are considered to be critical metrics with which to analyze and evaluate financial condition and capital strength. 2 Income statement-related ratios for partial-year periods are annualized. 3 Reflects common stock repurchased under board of director authorizations for the common stock repurchase program. Nicolet Bankshares, Inc. Net Interest Income and Net Interest Margin Analysis (Unaudited) At or for the Three Months Ended March 31, 2021 December 31, 2020 March 31, 2020 Average Average Average Average Average Average (In thousands) Balance Interest Rate Balance Interest Rate Balance Interest Rate ASSETS PPP loans $ 206,498 $ 3,951 7.65 % $ 282,736 $ 3,799 5.26 % $ $ % Total loans ex PPP 2,619,166 29,934 4.57 % 2,586,091 31,005 4.71 % 2,584,584 33,808 5.19 % Total loans (1) (2) 2,825,664 33,885 4.80 % 2,868,827 34,804 4.76 % 2,584,584 33,808 5.19 % Investment securities (2) 528,342 2,588 1.96 % 520,867 2,799 2.15 % 453,820 2,764 2.44 % Other interest-earning assets 735,597 655 0.36 % 701,766 694 0.39 % 129,101 662 2.04 % Total interest-earning assets 4,089,603 $ 37,128 3.63 % 4,091,460 $ 38,297 3.68 % 3,167,505 $ 37,234 4.66 % Other assets, net 425,324 423,766 387,639 Total assets $ 4,514,927 $ 4,515,226 $ 3,555,144 LIABILITIES AND STOCKHOLDERS' EQUITY Interest-bearing core deposits $ 2,395,948 $ 1,841 0.31 % $ 2,285,858 $ 2,269 0.39 % $ 1,975,145 $ 4,182 0.85 % Brokered deposits 316,589 1,081 1.38 % 320,237 1,176 1.46 % 158,068 775 1.97 % Total interest-bearing deposits 2,712,537 2,922 0.44 % 2,606,095 3,445 0.53 % 2,133,213 4,957 0.93 % PPPLF 0.00 % 72,582 64 0.35 % 0.00 % Other interest-bearing liabilities 51,695 313 2.42 % 65,901 510 3.04 % 85,379 783 3.64 % Total interest-bearing liabilities 2,764,232 $ 3,235 0.47 % 2,744,578 $ 4,019 0.58 % 2,218,592 $ 5,740 1.04 % Noninterest-bearing demand deposits 1,162,668 1,187,335 786,858 Other liabilities 43,486 45,393 36,136 Stockholders' equity 544,541 537,920 513,558 Total liabilities and stockholders' equity $ 4,514,927 $ 4,515,226 $ 3,555,144 Net interest income and rate spread $ 33,893 3.16 % $ 34,278 3.10 % $ 31,494 3.62 % Net interest margin 3.31 % 3.29 % 3.94 % (1) Nonaccrual loans and loans held for sale are included in the daily average loan balances outstanding. (2) The yield on tax-exempt loans and tax-exempt investment securities is computed on a tax-equivalent basis using a federal tax rate of 21%, and adjusted for the disallowance of interest expense. SOURCE Nicolet Bankshares, Inc. Related Links https://www.nicoletbank.com

Nicolet Bankshares, Inc. Announces First Quarter 2021 Earnings

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: GREEN BAY, Wis., April20, 2021 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced first quarter 2021 net income of $18.2 million and earnings per diluted common share of $1.75, compared to $18.0 million and $1.74 for fourth quarter 2020, and $10.6 million and $0.98 for first quarter 2020, respectively. Annualized quarterly return on average assets was 1.64%, 1.58% and 1.19%, for first quarter 2021, fourth quarter 2020 and first quarter 2020, respectively. "We are very pleased with the exceptional start to 2021," said Mike Daniels, President and CEO of Nicolet National Bank. "The main themes from late 2020 continue to drive our earnings - strong mortgage income, improved asset quality, Paycheck Protection Program ("PPP") loan activity, and expense control - producing $18 million of net income for the third consecutive quarter." "Our commercial customer base as a whole has proven to be resilient, entrepreneurial, and focused on being great operators of their businesses. Our bankers have worked hard to build solid relationships, not just for a transaction, but to become a true asset to our customers and to be a partner in finding solutions," Daniels said. "This combination of great customers and great bankers has led to pristine asset quality metrics, allowing us to lower our loan loss provision to $0.5 million this quarter." "In the mortgage and wealth business, our bankers and advisors continue to build on their outstanding reputation because of their willingness to lead proactive, real conversations, especially as the pandemic continues to affect our communities," Daniels said. "Word-of-mouth referrals determine success in these businesses. We continue to grow because of the trust we earn every day, with every customer." Secondary mortgage income was $7.2 million for first quarter (compared to $7.8 million and $2.3 million for fourth and first quarters of 2020, respectively), and wealth revenues were $4.6 million (3% and 17% more than fourth and first quarters of 2020, respectively). "All areas of the bank are performing well because we remain focused on executing a simple yet important purpose: serve our customers, communities, and each other," said Bob Atwell, Chairman and CEO of Nicolet. "The results of this execution are what shows in the first quarter numbers." The timing of Nicolet's acquisition of Advantage Community Bancshares, Inc. ("Advantage") on August 21, 2020, at 4% of then pre-merger assets, impacts financial comparisons. At consummation, Advantage added $172 million in assets, $88 million in loans, $1 million in core deposit intangible, $12 million in goodwill, $141 million in deposits and four branches. Balance Sheet ReviewAtMarch 31, 2021, period end assets were$4.5 billion, unchanged from December 31, 2020, with a slight shift in composition. The shift in assets included a $57million increase in loans (including $43million from net activity in PPP loans, and $14 million increase in all other loans, mainly commercial) and a $19million increase in investment securities, offset by a reduction in cash and cash equivalents (down $67million to $736million). Total deposits of$3.9 billion at March 31, 2021, were also minimally changed from December 31, 2020, with a decrease of $64 million in brokered deposits (as brokered deposits mature without renewal given our liquid position) substantially offset by a $54 million increase in customer core deposits (aided in part by additional stimulus checks and new PPP funds on deposit). Total capital was $550 million at March 31, 2021, an increase of $11million since December 31, 2020, mostly due to solid earnings, partly offset by share repurchase activity and unfavorable net fair value investment changes. Nicolet repurchased 56,886 shares at a total cost of $4.1million, or an average per share cost of $72.10 during first quarter 2021. During 2020, we originated 2,725 PPP loans totaling $351 million, bearing a 1% contractual rate, and earned a $12.3 million fee. During first quarter 2021, under the latest round of the SBA's program, Nicolet originated 1,928 PPP loans totaling $145 million and earned a $7.2 million fee. Of the total fees, $5.7 million was accreted into interest in 2020 and $3.4 million was accreted in first quarter 2021. At March 31, 2021, the net carrying value of all PPP loans was $229 million, or 8% of total loans, for a net $43 million increase over year-end 2020. SBA loan forgiveness that started in November 2020 has boosted overall borrower equity in their businesses, meaningfully improving the credit quality of many commercial relationships. Asset QualityNonperforming assets were $13 million at March 31, consisting of $9 million of nonaccrual loans and $4 million of other real estate owned (primarily closed bank branch properties yet to be sold), and representing 0.28% of total assets, unchanged from $13 million or 0.29% at December31 and down from $16 million or 0.42% at March 31, 2020. Since the prior quarter, the allowance for credit losses-loans increased to $33 million, due to the $0.5 million provision for credit losses recognized and negligible net charge-offs (0.01% of average loans, annualized). At March 31, 2021, the allowance represented 1.15% of total loans, and represented 1.25% of total loans excluding the net carrying value of PPP loans. Income Statement ReviewNet income for first quarter 2021 was $18.2 million, consistent with net income of $18.0 million for fourth quarter 2020 and 73% stronger than net income of $10.6 million for first quarter 2020. Net interest income was $33.6 million for first quarter 2021, $0.4 million (1%) lower than $34.0 million for fourth quarter 2020, comprised of $1.2 million lower interest income offset by $0.8 million lower interest expense. Higher net interest income from positive rate changes (up $0.6 million) between the sequential quarters was more than offset by lower net interest income from two fewer days (down $0.6 million) and unfavorable volumes (down $0.4 million). Average interest-earning assets of $4.1 billion were minimally changed from fourth quarter 2020, with lower average loans (down $43 million, mostly from forgiveness on PPP loans outpacing new PPP and other loan growth), offset by growth in investments (up $7 million) and other interest-earning assets (up $34 million, mostly cash). Average interest-bearing liabilities of $2.8 billion increased $20 million (1%) over fourth quarter 2020, comprised of higher core interest-bearing deposits (up $110 million), and lower brokered deposits and other interest-bearing liabilities (down $90 million combined). The mix of average interest-earning assets continues to impact the margin trend most, at 69% loans (comprised of 5% PPP loans earning 7.65% and 64% all other loans earning 4.57%), 13% investments and 18% other interest-earning assets (mostly low-earning cash), compared to fourth quarter 2020 with 70% loans (7% in PPP loans earning 5.26% and 63% all other loans earning 4.71%), 13% investments and 17% other interest-earning assets. The mix of interest-bearing liabilities for first quarter was 98% deposits costing 44bps and 2% all other borrowings costing 2.42%, compared to fourth quarter 2020 with 95% deposits costing 53bps and 5% all other borrowings costing 1.63% (of which over half was very low-cost funding directly related to PPP). The net interest margin for first quarter 2021 was 3.31%, up 2bps from 3.29% for fourth quarter 2020, as the yield on interest-earning assets declined 5bps (to 3.63%), the cost of funds favorably declined 11bps (to 0.47%), and the contribution from net free funds fell 4bps. Loans yielded 4.80% for first quarter 2021, up 4bps from fourth quarter 2020, with total PPP loans yielding 7.65% (up 239bps over fourth quarter, aided mostly by accelerating fee accretion in line with loan forgiveness), while all other loans earned 4.57% (down 14bps from the prior quarter, pressured by new or renewed loans in the lower rate environment). Investments yielded 1.96%, 19bps lower than fourth quarter 2020, as new funds are invested in the lower rate environment. The cost of funds of 0.47% for first quarter 2021 declined 11bps on a sequential quarter basis, attributable mainly to the timing of prudent pricing actions on core interest-bearing deposits (down 8bps to 0.31% for first quarter 2021). Noninterest income was $17.1 million for first quarter 2021, up $0.2 million (1%) compared to fourth quarter 2020. Excluding net asset gains (losses), noninterest income was $16.4 million, down $1.1 million (6%) from fourth quarter 2020. Net mortgage income of $7.2 million remains strong, though down from the record levels experienced in 2020, on lower sale gains and capitalized gains combined (down $0.4 million or 5%) and net unfavorable fair value marks (down $0.2 million). Trust services fee income and brokerage fee income combined increased $0.1 million (3%) over fourth quarter 2020. Net asset gains were $0.7 million (comprised primarily of market gains on equity securities), compared to net asset losses of $0.6 million in fourth quarter 2020 (mostly from $1.0 million of net losses on branch other real estate owned write-downs, partly offset by $0.4 million of market gains on equity securities). All remaining noninterest income categories combined decreased $0.6 million from fourth quarter 2020 largely due to $0.4 million lower BOLI income. Noninterest expense of $26.1 million increased $0.7 million (3%) from fourth quarter 2020. Personnel expense decreased slightly ($0.1 million or 1%) from fourth quarter 2020, with a 3% overall increase in base salaries for the new year more than offset by lower non-salary personnel costs combined given timing and pace changes in the new year. All non-personnel expenses combined increased $0.8 million (8%) over fourth quarter 2020, largely due to $0.5 million higher professional costs related to the recently announced acquisition and $0.2 million higher FDIC expense from the larger assessment base. On April 12, 2021, we entered into a definitive merger agreement with Mackinac Financial Corporation ("Mackinac" (NASDAQ: MFNC)) pursuant to which Mackinac will merge with and into Nicolet, expanding Nicolet prominently into Northern Michigan and the Upper Peninsula of Michigan. Mackinac shareholders will receive fixed consideration of 0.22 shares of Nicolet and $4.64 in cash for each share owned (approximating a 20% cash and 80% stock split), subject to provisions provided for in the merger agreement. At December 31, 2020, Mackinac had total assets of $1.5 billion, loans of $1.1 billion, deposits of $1.3 billion and equity of $168 million. The merger is expected to close in the third quarter of 2021, subject to customary closing conditions, including approval by regulators and shareholders of both Mackinac and Nicolet. "We are committed to realizing the promise of the acquisition of Mackinac Financial Corporation, which is to come together as a strong, people-driven, local community bank," said Daniels. "Our team is assembled and using their experience to help create a seamless integration. We understand that, at this point, we will be judged by our actions, not our words. It's time to deliver, and I am confident that our team will do exactly that," concluded Daniels. About Nicolet Bankshares, Inc. Nicolet Bankshares, Inc. is the bank holding company of Nicolet National Bank, a growing, full-service, community bank providing services ranging from commercial and consumer banking to wealth management and retirement plan services. Founded in Green Bay in 2000, Nicolet National Bank operates branches in Northeast and Central Wisconsin and the upper peninsula of Michigan. More information can be found at www.nicoletbank.com. Forward Looking Statements "Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995Certain statements contained in this communication, which are not statements of historical fact, constitute forward-looking statements within the meaning of the federal securities law. Such statements include, but are not limited to, statements about Nicolet's business plans, objectives, expectations and intentions, as well as certain plans, expectations, goals, projections and benefits relating to the proposed merger between Nicolet and Mackinac, all of which are subject to numerous assumptions, risks and uncertainties. Words or phrases such as "anticipate," "believe," "aim," "can," "conclude," "continue," "could," "estimate," "expect," "foresee," "goal," "intend," "may," "might," "outlook," "possible," "plan," "predict," "project," "potential," "seek," "should," "target," "will," "will likely," "would," or the negative of these terms or other comparable terminology, as well as similar expressions, are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements are not historical facts but instead express only management's beliefs regarding future results or events, many of which, by their nature, are inherently uncertain and outside of management's control. It is possible that actual results and outcomes may differ, possibly materially, from the anticipated results or outcomes indicated in these forward-looking statements. In addition to factors disclosed in reports filed by Nicolet with the SEC, risks and uncertainties, including but not limited to risks and uncertainties for Nicolet, Mackinac and the combined company with respect to the proposed merger, that may cause actual results or outcomes to differ materially from those anticipated include, but are not limited to: (1) the possibility that any of the anticipated benefits of the proposed merger will not be realized or will not be realized within the expected time period; (2) the risk that integration of Mackinac's operations with those of Nicolet will be materially delayed or will be more costly or difficult than expected; (3) the parties' inability to meet expectations regarding the timing of the proposed merger; (4) changes to tax legislation and their potential effects on the accounting for the merger; (5) the inability to complete the proposed merger due to the failure of Nicolet's or Mackinac's shareholders to adopt the Merger Agreement; (6) the failure to satisfy other conditions to completion of the proposed merger, including receipt of required regulatory and other approvals; (7) the failure of the proposed merger to close for any other reason; (8) diversion of management's attention from ongoing business operations and opportunities due to the proposed merger; (9) the challenges of integrating and retaining key employees; (10) the effect of the announcement of the proposed merger on Nicolet's, Mackinac's or the combined company's respective customer and employee relationships and operating results; (11) the possibility that the proposed merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; (12) dilution caused by Nicolet's issuance of additional shares of Nicolet common stock in connection with the merger; (13) the magnitude and duration of the COVID pandemic and its impact on the global economy and financial market conditions and the business, results of operations and financial condition of Nicolet, Mackinac and the combined company; (14) changes in consumer demand for financial services; and (15) general competitive, economic, political and market conditions and fluctuations. Please refer to Nicolet's Annual Report on Form 10-K for the year ended December 31, 2020, as well as its other filings with the SEC, for a more detailed discussion of risks, uncertainties and factors that could cause actual results to differ from those discussed in the forward-looking statements. The COVID pandemic is adversely affecting us, our customers, counterparties, employees, and third-party service providers, and the ultimate extent of the impacts on our business, financial position, results of operations, liquidity, and prospects is uncertain. Continued deterioration in general business and economic conditions or turbulence in domestic financial markets could adversely affect Nicolet's revenues and the values of its assets and liabilities, lead to a tightening of credit, and increase stock price volatility. In addition, the COVID pandemic may result in changes to statutes, regulations, or regulatory policies or practices that could affect Nicolet in substantial and unpredictable ways. All forward-looking statements included in this communication are made as of the date hereof and are based on information available to management at that time. Except as required by law, Nicolet does not assume any obligation to update any forward-looking statement to reflect events or circumstances that occur after the date the forward-looking statements were made. Important Information and Where to Find ItThis communication relates to the proposed merger transaction involving Nicolet and Mackinac. In connection with the proposed merger, Nicolet and Mackinac will file a joint proxy statement/prospectus on Form S-4 and other relevant documents concerning the merger with the Securities and Exchange Commission (the "SEC"). BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND ANY OTHER DOCUMENTS TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED MERGER OR INCORPORATED BY REFERENCE IN THE JOINT PROXY STATEMENT/PROSPECTUS BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NICOLET, MACKINAC AND THE PROPOSED MERGER. When available, the joint proxy statement/prospectus will be delivered to shareholders of Nicolet and Mackinac. Investors may obtain copies of the joint proxy statement/prospectus and other relevant documents (as they become available) free of charge at the SEC's website (www.sec.gov). Copies of the documents filed with the SEC by Nicolet will be available free of charge on Nicolet's website at www.nicoletbank.com. Copies of the documents filed with the SEC by Mackinac will be available free of charge on Mackinac's website at www.bankmbank.com. Nicolet, Mackinac and certain of their directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies from the shareholders of Nicolet and the shareholders of Mackinac in connection with the proposed merger. Information about the directors and executive officers of Nicolet and Mackinac will be included in the joint proxy statement/prospectus for the proposed transaction filed with the SEC. Information about the directors and executive officers of Nicolet is also included in the proxy statement for its 2021 annual meeting of shareholders, which was filed with the SEC on March 2, 2021. Information about the directors and executive officers of Mackinac is also included in the proxy statement for its 2020 annual meeting of shareholders, which was filed with the SEC on April 22, 2020. Additional information regarding the interests of such participants and other persons who may be deemed participants in the transaction will be included in the joint proxy statement/prospectus and the other relevant documents filed with the SEC when they become available. No Offer or SolicitationThis communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Nicolet Bankshares, Inc. Consolidated Financial Summary (Unaudited) At or for the Three Months Ended (In thousands, except per share data) 03/31/2021 12/31/2020 09/30/2020 06/30/2020 03/31/2020 Results of operations: Interest income $ 36,876 $ 38,037 $ 37,270 $ 36,892 $ 37,003 Interest expense 3,235 4,019 4,710 5,395 5,740 Net interest income 33,641 34,018 32,560 31,497 31,263 Provision for credit losses 500 1,300 3,000 3,000 3,000 Net interest income after provision for credit losses 33,141 32,718 29,560 28,497 28,263 Noninterest income 17,126 16,879 18,691 17,471 9,585 Noninterest expense 26,081 25,367 23,685 27,813 23,854 Income before income tax expense 24,186 24,230 24,566 18,155 13,994 Income tax expense 5,947 6,145 6,434 4,576 3,321 Net income 18,239 18,085 18,132 13,579 10,673 Net income attributable to noncontrolling interest 98 30 101 118 Net income attributable to Nicolet Bankshares, Inc. $ 18,239 $ 17,987 $ 18,102 $ 13,478 $ 10,555 Earnings per common share: Basic $ 1.82 $ 1.79 $ 1.75 $ 1.29 $ 1.00 Diluted $ 1.75 $ 1.74 $ 1.72 $ 1.28 $ 0.98 Common Shares: Basic weighted average 9,998 10,074 10,349 10,417 10,516 Diluted weighted average 10,403 10,350 10,499 10,520 10,801 Outstanding 9,988 10,011 10,196 10,424 10,408 Noninterest Income: Trust services fee income $ 1,775 $ 1,746 $ 1,628 $ 1,510 $ 1,579 Brokerage fee income 2,793 2,673 2,489 2,269 2,322 Mortgage income, net 7,230 7,842 9,675 9,963 2,327 Service charges on deposit accounts 1,091 1,133 1,037 813 1,225 Card interchange income 1,927 1,922 1,877 1,637 1,562 BOLI income 527 936 531 540 703 Other noninterest income 1,072 1,247 1,237 1,487 521 Noninterest income without net gains 16,415 17,499 18,474 18,219 10,239 Asset gains (losses), net 711 (620) 217 (748) (654) Total noninterest income $ 17,126 $ 16,879 $ 18,691 $ 17,471 $ 9,585 Noninterest Expense: Personnel expense $ 15,116 $ 15,244 $ 14,072 $ 14,482 $ 13,323 Occupancy, equipment and office 4,137 4,102 4,051 4,361 4,204 Business development and marketing 989 713 810 2,514 1,359 Data processing 2,658 3,074 2,658 2,399 2,563 Intangibles amortization 852 860 834 880 993 Other noninterest expense 2,329 1,374 1,260 3,177 1,412 Total noninterest expense $ 26,081 $ 25,367 $ 23,685 $ 27,813 $ 23,854 Period-End Balances: Total loans $ 2,846,351 $ 2,789,101 $ 2,908,793 $ 2,821,501 $ 2,607,424 PPP loans 229,403 186,016 335,236 329,157 Total loans, ex. PPP loans 2,616,948 2,603,085 2,573,557 2,492,344 2,607,424 Allowance for credit losses - loans 32,626 32,173 31,388 29,130 26,202 Securities available for sale, at fair value 558,229 539,337 535,351 510,809 511,860 Cash and cash equivalents 735,854 802,859 853,564 822,684 241,960 Goodwill and other intangibles, net 174,501 175,353 176,213 164,094 164,974 Total assets 4,543,804 4,551,789 4,706,375 4,541,228 3,732,554 Deposits 3,900,594 3,910,399 3,712,808 3,537,805 3,023,466 Stockholders' equity 550,046 539,189 538,068 532,033 510,971 Book value per common share 55.07 53.86 52.77 51.04 49.09 Tangible book value per common share (1) 37.60 36.34 35.49 35.30 33.24 Nicolet Bankshares, Inc. Consolidated Financial Summary (Unaudited) - Continued At or for the Three Months Ended (In thousands, except per share data) 03/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 Average Balances: Loans $ 2,825,664 $ 2,868,827 $ 2,871,256 $ 2,823,866 $ 2,584,584 Investment securities 528,342 520,867 496,153 489,597 453,820 Interest-earning assets 4,089,603 4,091,460 4,216,106 3,917,499 3,167,505 Cash and cash equivalents 750,075 714,031 864,295 614,034 139,768 Goodwill and other intangibles, net 174,825 175,678 169,353 164,564 165,532 Total assets 4,514,927 4,515,226 4,633,359 4,310,088 3,555,144 Deposits 3,875,205 3,793,430 3,636,260 3,403,188 2,920,071 Interest-bearing liabilities 2,764,232 2,744,578 2,933,737 2,741,199 2,218,592 Stockholders' equity 544,541 537,920 537,826 520,177 513,558 Selected Financial Ratios: (2) Return on average assets 1.64 % 1.58 % 1.55 % 1.26 % 1.19 % Return on average common equity 13.58 13.30 13.39 10.42 8.27 Return on average tangible common equity (1) 20.01 19.75 19.54 15.24 12.20 Average equity to average assets 12.06 11.91 11.61 12.07 14.45 Stockholders' equity to assets 12.11 11.85 11.43 11.72 13.69 Tangible common equity to tangible assets (1) 8.60 8.31 7.99 8.41 9.70 Net interest margin 3.31 3.29 3.06 3.21 3.94 Efficiency ratio 51.84 48.99 46.18 55.69 57.16 Effective tax rate 24.59 25.36 26.19 25.21 23.73 Selected Asset Quality Information: Nonaccrual loans $ 8,965 $ 9,455 10,997 $ 11,998 $ 14,769 Other real estate owned 3,797 3,608 1,000 1,000 1,000 Nonperforming assets $ 12,762 $ 13,063 $ 11,997 $ 12,998 $ 15,769 Net loan charge-offs (recoveries) $ 47 $ 515 $ 743 $ 71 $ 55 Allowance for credit losses-loans to loans 1.15 % 1.15 % 1.08 % 1.03 % 1.00 % Net loan charge-offs to average loans (2) 0.01 0.07 0.10 0.01 0.01 Nonperforming loans to total loans 0.31 0.34 0.38 0.43 0.57 Nonperforming assets to total assets 0.28 0.29 0.25 0.29 0.42 Selected Other Information: Tax-equivalent adjustment net interest income $ 252 $ 260 $ 249 $ 229 $ 231 Tax benefit on stock-based compensation $ (234) $ (77) $ (14) $ (24) $ (323) Common stock repurchased (dollars) (3) $ 4,102 $ 12,909 $ 13,732 $ $ 13,903 Common stock repurchased (full shares) (3) 56,886 205,001 234,914 206,833 1 The ratios of tangible book value per common share, return on average tangible common equity, and tangible common equity to tangible assets exclude goodwill and other intangibles, net. These financial ratios have been included as they are considered to be critical metrics with which to analyze and evaluate financial condition and capital strength. 2 Income statement-related ratios for partial-year periods are annualized. 3 Reflects common stock repurchased under board of director authorizations for the common stock repurchase program. Nicolet Bankshares, Inc. Net Interest Income and Net Interest Margin Analysis (Unaudited) At or for the Three Months Ended March 31, 2021 December 31, 2020 March 31, 2020 Average Average Average Average Average Average (In thousands) Balance Interest Rate Balance Interest Rate Balance Interest Rate ASSETS PPP loans $ 206,498 $ 3,951 7.65 % $ 282,736 $ 3,799 5.26 % $ $ % Total loans ex PPP 2,619,166 29,934 4.57 % 2,586,091 31,005 4.71 % 2,584,584 33,808 5.19 % Total loans (1) (2) 2,825,664 33,885 4.80 % 2,868,827 34,804 4.76 % 2,584,584 33,808 5.19 % Investment securities (2) 528,342 2,588 1.96 % 520,867 2,799 2.15 % 453,820 2,764 2.44 % Other interest-earning assets 735,597 655 0.36 % 701,766 694 0.39 % 129,101 662 2.04 % Total interest-earning assets 4,089,603 $ 37,128 3.63 % 4,091,460 $ 38,297 3.68 % 3,167,505 $ 37,234 4.66 % Other assets, net 425,324 423,766 387,639 Total assets $ 4,514,927 $ 4,515,226 $ 3,555,144 LIABILITIES AND STOCKHOLDERS' EQUITY Interest-bearing core deposits $ 2,395,948 $ 1,841 0.31 % $ 2,285,858 $ 2,269 0.39 % $ 1,975,145 $ 4,182 0.85 % Brokered deposits 316,589 1,081 1.38 % 320,237 1,176 1.46 % 158,068 775 1.97 % Total interest-bearing deposits 2,712,537 2,922 0.44 % 2,606,095 3,445 0.53 % 2,133,213 4,957 0.93 % PPPLF 0.00 % 72,582 64 0.35 % 0.00 % Other interest-bearing liabilities 51,695 313 2.42 % 65,901 510 3.04 % 85,379 783 3.64 % Total interest-bearing liabilities 2,764,232 $ 3,235 0.47 % 2,744,578 $ 4,019 0.58 % 2,218,592 $ 5,740 1.04 % Noninterest-bearing demand deposits 1,162,668 1,187,335 786,858 Other liabilities 43,486 45,393 36,136 Stockholders' equity 544,541 537,920 513,558 Total liabilities and stockholders' equity $ 4,514,927 $ 4,515,226 $ 3,555,144 Net interest income and rate spread $ 33,893 3.16 % $ 34,278 3.10 % $ 31,494 3.62 % Net interest margin 3.31 % 3.29 % 3.94 % (1) Nonaccrual loans and loans held for sale are included in the daily average loan balances outstanding. (2) The yield on tax-exempt loans and tax-exempt investment securities is computed on a tax-equivalent basis using a federal tax rate of 21%, and adjusted for the disallowance of interest expense. SOURCE Nicolet Bankshares, Inc. Related Links https://www.nicoletbank.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Nicolet Bankshares, Inc. Announces First Quarter 2021 Earnings.<|eot_id|>

edtsum899

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MINNEAPOLIS, March 25, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today shared news from clinical partners on the use of the ProteinSimple-branded EllaAutomated Immunoassay platform in the fight against COVID-19. In a March 23, 2020 press release, the Icahn School of Medicine, Mount Sinai announced that they are utilizing Bio-Techne's Ella Automated Immunoassay Platform to monitor individual immune responses to COVID-19. Specifically, the Ella Cytokine Storm Panel is being used to detect Cytokine Release Syndrome (CRS) in real-time. Cytokine Release Syndrome represents a critical point in individuals with severe COVID-19 disease where immune molecules, called cytokines, attack the patient's organs, representing a critical and potentially fatal point in disease management. As stated in its press release, "Mount Sinai clinical laboratories will use the ELLA Cytokine Storm Panel in COVID-19 patients who have been admitted to the hospital to monitor them and know, in real time, when they are experiencing cytokine storm. The test results are available in a few hours and can be repeated throughout the course of care to help guide hospital care and to measure the response to experimental drugs given in clinical trials for COVID-19 patients." (link) "Mount Sinai clinical laboratories will use the ELLA Cytokine Storm Panel in COVID-19 patients who have been admitted to the hospital to monitor them and know, in real time, when they are experiencing cytokine storm. The test results are available in a few hours and can be repeated throughout the course of care to help guide hospital care and to measure the response to experimental drugs given in clinical trials for COVID-19 patients." Mount Sinai joins hospitals in Italy and throughout Europe that have and are continuing to adopt the Ella platform for CRS testing during this crisis. Ella's sensitivity, simplified workflow, and fast time-to-results make the platform ideal for CRS testing and are the key factors driving this adoption. These developments follow the 2018 announcement that Micropoint Biotechnologies of China is developing clinical applications for the detection of CRS on the Ella platform. "Ella is a potentially important tool for monitoring and saving patients who are infected by COVID-19," commented Chuck Kummeth, President and Chief Executive Officer of Bio-Techne. "The Ella Cytokine Storm Panel has the potential to enable front line healthcare workers to triage high-risk COVID-19 patients in real-time, guide hospital care and to measure responses to experimental clinical trial drugs. Ella joins several other products Bio-Techne has deployed to combat COVID-19, including RNAscope for detection of coronavirus in tissue and antibodies for vaccine development. We are focused on leveraging our deep portfolio and developing new tools to enable solutions for this rapidly evolving pandemic." Bio-Techne aims to further enable customers to utilize the Ella platform for this and other clinical applications where time-to-results is critical. To that end, Bio-Techne is investing in both near-term and long-term efforts to enable broader clinical adoption of Ella and expand beyond its current Research Use Only (RUO) status. This includes partnering with clinical research customers to pursue Emergency Use Authorization (EUA) status for COVID-19 testing in key regions, as well as investing in manufacturing and quality control systems required for diagnostic products. About Bio-Techne Corporation(NASDAQ: TECH) Ella Automated Immunoassay platform, ProteinSimple, a Bio-Techne Brand Contact: David Clair, Senior Director, Business Development[emailprotected]612-656-4416 SOURCE Bio-Techne Corporation Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Bio-Techne's Ella On The Front Lines In Fight Against COVID-19.

MINNEAPOLIS, March 25, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today shared news from clinical partners on the use of the ProteinSimple-branded EllaAutomated Immunoassay platform in the fight against COVID-19. In a March 23, 2020 press release, the Icahn School of Medicine, Mount Sinai announced that they are utilizing Bio-Techne's Ella Automated Immunoassay Platform to monitor individual immune responses to COVID-19. Specifically, the Ella Cytokine Storm Panel is being used to detect Cytokine Release Syndrome (CRS) in real-time. Cytokine Release Syndrome represents a critical point in individuals with severe COVID-19 disease where immune molecules, called cytokines, attack the patient's organs, representing a critical and potentially fatal point in disease management. As stated in its press release, "Mount Sinai clinical laboratories will use the ELLA Cytokine Storm Panel in COVID-19 patients who have been admitted to the hospital to monitor them and know, in real time, when they are experiencing cytokine storm. The test results are available in a few hours and can be repeated throughout the course of care to help guide hospital care and to measure the response to experimental drugs given in clinical trials for COVID-19 patients." (link) "Mount Sinai clinical laboratories will use the ELLA Cytokine Storm Panel in COVID-19 patients who have been admitted to the hospital to monitor them and know, in real time, when they are experiencing cytokine storm. The test results are available in a few hours and can be repeated throughout the course of care to help guide hospital care and to measure the response to experimental drugs given in clinical trials for COVID-19 patients." Mount Sinai joins hospitals in Italy and throughout Europe that have and are continuing to adopt the Ella platform for CRS testing during this crisis. Ella's sensitivity, simplified workflow, and fast time-to-results make the platform ideal for CRS testing and are the key factors driving this adoption. These developments follow the 2018 announcement that Micropoint Biotechnologies of China is developing clinical applications for the detection of CRS on the Ella platform. "Ella is a potentially important tool for monitoring and saving patients who are infected by COVID-19," commented Chuck Kummeth, President and Chief Executive Officer of Bio-Techne. "The Ella Cytokine Storm Panel has the potential to enable front line healthcare workers to triage high-risk COVID-19 patients in real-time, guide hospital care and to measure responses to experimental clinical trial drugs. Ella joins several other products Bio-Techne has deployed to combat COVID-19, including RNAscope for detection of coronavirus in tissue and antibodies for vaccine development. We are focused on leveraging our deep portfolio and developing new tools to enable solutions for this rapidly evolving pandemic." Bio-Techne aims to further enable customers to utilize the Ella platform for this and other clinical applications where time-to-results is critical. To that end, Bio-Techne is investing in both near-term and long-term efforts to enable broader clinical adoption of Ella and expand beyond its current Research Use Only (RUO) status. This includes partnering with clinical research customers to pursue Emergency Use Authorization (EUA) status for COVID-19 testing in key regions, as well as investing in manufacturing and quality control systems required for diagnostic products. About Bio-Techne Corporation(NASDAQ: TECH) Ella Automated Immunoassay platform, ProteinSimple, a Bio-Techne Brand Contact: David Clair, Senior Director, Business Development[emailprotected]612-656-4416 SOURCE Bio-Techne Corporation

Bio-Techne's Ella On The Front Lines In Fight Against COVID-19

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MINNEAPOLIS, March 25, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today shared news from clinical partners on the use of the ProteinSimple-branded EllaAutomated Immunoassay platform in the fight against COVID-19. In a March 23, 2020 press release, the Icahn School of Medicine, Mount Sinai announced that they are utilizing Bio-Techne's Ella Automated Immunoassay Platform to monitor individual immune responses to COVID-19. Specifically, the Ella Cytokine Storm Panel is being used to detect Cytokine Release Syndrome (CRS) in real-time. Cytokine Release Syndrome represents a critical point in individuals with severe COVID-19 disease where immune molecules, called cytokines, attack the patient's organs, representing a critical and potentially fatal point in disease management. As stated in its press release, "Mount Sinai clinical laboratories will use the ELLA Cytokine Storm Panel in COVID-19 patients who have been admitted to the hospital to monitor them and know, in real time, when they are experiencing cytokine storm. The test results are available in a few hours and can be repeated throughout the course of care to help guide hospital care and to measure the response to experimental drugs given in clinical trials for COVID-19 patients." (link) "Mount Sinai clinical laboratories will use the ELLA Cytokine Storm Panel in COVID-19 patients who have been admitted to the hospital to monitor them and know, in real time, when they are experiencing cytokine storm. The test results are available in a few hours and can be repeated throughout the course of care to help guide hospital care and to measure the response to experimental drugs given in clinical trials for COVID-19 patients." Mount Sinai joins hospitals in Italy and throughout Europe that have and are continuing to adopt the Ella platform for CRS testing during this crisis. Ella's sensitivity, simplified workflow, and fast time-to-results make the platform ideal for CRS testing and are the key factors driving this adoption. These developments follow the 2018 announcement that Micropoint Biotechnologies of China is developing clinical applications for the detection of CRS on the Ella platform. "Ella is a potentially important tool for monitoring and saving patients who are infected by COVID-19," commented Chuck Kummeth, President and Chief Executive Officer of Bio-Techne. "The Ella Cytokine Storm Panel has the potential to enable front line healthcare workers to triage high-risk COVID-19 patients in real-time, guide hospital care and to measure responses to experimental clinical trial drugs. Ella joins several other products Bio-Techne has deployed to combat COVID-19, including RNAscope for detection of coronavirus in tissue and antibodies for vaccine development. We are focused on leveraging our deep portfolio and developing new tools to enable solutions for this rapidly evolving pandemic." Bio-Techne aims to further enable customers to utilize the Ella platform for this and other clinical applications where time-to-results is critical. To that end, Bio-Techne is investing in both near-term and long-term efforts to enable broader clinical adoption of Ella and expand beyond its current Research Use Only (RUO) status. This includes partnering with clinical research customers to pursue Emergency Use Authorization (EUA) status for COVID-19 testing in key regions, as well as investing in manufacturing and quality control systems required for diagnostic products. About Bio-Techne Corporation(NASDAQ: TECH) Ella Automated Immunoassay platform, ProteinSimple, a Bio-Techne Brand Contact: David Clair, Senior Director, Business Development[emailprotected]612-656-4416 SOURCE Bio-Techne Corporation Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Bio-Techne's Ella On The Front Lines In Fight Against COVID-19.<|eot_id|>

edtsum900

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SILVER SPRING, Md., April 18, 2020 /PRNewswire/ --Every step we have taken as part of our approach to COVID-19 testing has been a careful balancing of risks and benefits in order to meet the urgent public health needs as we combat this new pathogen. We have moved quickly and thoughtfully, and we are continuing to learn and adapt based on the real-world experience and data we're seeing. In the meantime, frontline health care workers who are making life-and-death decisions every day in their fight against this novel coronavirus need to have all the information possible to make educated decisions about which test to use to help identify individuals who have developed an immune response to the virus. We are committed to providing as up-to-date information as possible to support their heroic efforts. As the country starts to see positive signs that the mitigation efforts, like stay-at-home orders and social distancing, are working in our fight against the COVID-19 pandemic, the question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation. Antibody tests also known as serological tests may have the potential to play a role in this complex calculation. Results from these tests can help identify who has been infected and developed antibodies that may protect from future infection as well as identify those still at risk. Results can also help inform who may qualify to donate blood that can be used to manufacture convalescent plasma, an investigational product for use with those who are seriously ill from COVID-19. Today, given the active dialogue about serological tests that are currently on the market, and their significance in the nation's response efforts, we'd like to provide further details about our thinking on these tests and our approach to making accurate and reliable serology tests widely available, while also protecting Americans from tests marketed with false or unsubstantiated claims. FDA Approach to Expanding Access to Serology Tests First, we continue to provide the opportunity for interested developers to request FDA authorization through the emergency use authorization (EUA) process. To date, we have already issued four EUAs for serological tests, and we expect that number to continue to grow in the coming weeks. The FDA encourages developers to submit EUA requests for their tests, as an EUA will provide laboratories and providers with assurance that FDA has reviewed that test. We are working around-the-clock to review EUA submissions quickly and we continue to take steps to ensure the process is as streamlined and efficient as possible. For example, we are working on EUA Templates that laboratories and commercial manufacturers may use to facilitate the preparation and submission of an EUA request. We expect to make them available in the coming days. To enhance the U.S. Government's ability to identify well-performing tests and inform FDA recommendations and decision making, we are collaboratingwith the National Institutes of Health's National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Disease Control and Prevention (CDC) to establish a capability at NIH to evaluate serological tests for developers. This effort includes tests already available for use, as well as tests not yet on the market where additional validation data is needed to support an EUA. Performance assessments for serological tests will begin soon, and we expect to start seeing results shortly thereafter. We will review NIH's results expeditiously, and performance results from NIH's assessment may complement and inform the determination of whether FDA issues an EUA for a particular test. Recognizing that more flexibility was needed during a pandemic of this scale and speed, and incorporating feedback from the medical community, states and test developers, we have also provided regulatory flexibility for serological tests in an effort to provide laboratories and health care providers with early access to these tests with the understanding that the FDA had not reviewed or authorized (or "approved") them, at least not initially, and these tests should not be used for diagnosing or excluding active SARS-CoV-2 infection. Specifically, last month, as part of our broader strategy, the FDA issued a policy explaining that FDA does not intend to object when developers of serological tests market or use their tests without prior FDA review where: 1) the tests are validated by the developer to determine that they are accurate and reliable, 2) notification of the developer's validation is provided to FDA, and 3) the tests are labeled appropriately, including that they are not to be used as a sole basis for diagnosis. Our policy does not apply to at-home specimen collection or at-home testing because of the added challenges in assuring test accuracy that these pose. The policy does apply to tests that can be performed in patient care settings. Laboratories could validate tests they receive from commercial manufacturers and determine if they should be used in their facilities. Some laboratories have already done so or have developed their own serological tests. The bottom line is that FDA still expects tests to be validated even under our revised policy for tests. However, the EUA process or an evaluation by NIH supports greater confidence in test performance. How the Tests Work Unlike a test designed to diagnose an active COVID-19 infection (specifically from the SARS-CoV-2 virus), serological tests can help identify individuals who have developed an immune response to the virus, either as part of an active infection or a prior infection. The tests detect the presence of antibodies in the blood if antibodies are present, that indicates that the person has been exposed to the virus and developed antibodies against it, which may mean that person has at least some immunity to the coronavirus. In the early days of an infection when the body's immune response is still building, antibodies may not be detected, which is why serological tests should not be used as the sole basis to diagnose or exclude infection with the SARS-CoV-2 virus. There is still a great deal about COVID-19 immunity that we don't yet fully understand. For example, we don't yet know that just because someone has developed antibodies, that they are fully protected from reinfection, or how long any immunity lasts. We do expect that data from more widespread serological testing will help us track the spread of the virus nationwide and assess the impact of our public health efforts now, while also informing our COVID-19 response as we continue to move forward. Determining the next steps in our response to COVID-19 is partially dependent on an accurate assessment of our national efforts thus far, and the quality of data for making this decision is dependent on accurate testing products. Why Validation Data Are Needed All clinical tests should be validated prior to use, and this expectation is articulated in our March 16 policy. We have provided regulatory flexibility regarding the independent check by FDA for antibody tests that are limited in their clinical applications, but still expect all developers to validate their tests prior to offering them for limited clinical uses. To minimize the number of false positive results, serological tests must be well-designed to specifically identify antibodies against SARS-CoV-2 and must not "cross-react," or provide positive results when encountering antibodies against other respiratory viruses. Concerns and Education for Frontline Workers and States Currently, we are working on several fronts to provide more clarity about which tests have received FDA review and which have not. In addition, to facilitate awareness of these serological tests, the FDA has been posting on its website the tests for which it has received a notification under this policy since mid-March. We have also updated our website to better clarify which tests have been authorized by FDA and which have not been authorized. However, some test developers have misused the serology test kit notification list to falsely claim their serological tests are FDA approved or authorized. Others have falsely claimed that their tests can diagnose COVID-19. When we become aware of these issues, we have and will continue to take appropriate action against firms making or distributing unvalidated tests or those making false claims, such as issuing Warning Letters requesting that companies stop their unlawful promotion and detaining and refusing fraudulent test kits at the border. We are sharing educational materials with state governments, hospital systems, payors, and health care professional associations to ensure they understand the potential for false-positive results in tests that have not yet been reviewed by FDA, and can make educated decisions when considering purchasing, insuring and using these tests. We have been and will continue actively engaging with the testing development community to continue to gain input and provide clarity around our processes, policies and validation efforts. Additional Resources: FAQs on Diagnostic Testing for SARS-CoV-2 Important Information on the Use of Serological (Antibody) Tests for COVID-19 - Letter to Health Care Providers FDA Fact Sheet: Serological Testing for Antibodies to SARS-CoV-2 Infection Media Contact:Stephanie Caccomo, 301-348-1956 Consumer Inquiries: Email, 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts. The following is attributed to Commissioner of Food and Drugs - Food and Drug Administration, Stephen M. Hahn, M.D.

SILVER SPRING, Md., April 18, 2020 /PRNewswire/ --Every step we have taken as part of our approach to COVID-19 testing has been a careful balancing of risks and benefits in order to meet the urgent public health needs as we combat this new pathogen. We have moved quickly and thoughtfully, and we are continuing to learn and adapt based on the real-world experience and data we're seeing. In the meantime, frontline health care workers who are making life-and-death decisions every day in their fight against this novel coronavirus need to have all the information possible to make educated decisions about which test to use to help identify individuals who have developed an immune response to the virus. We are committed to providing as up-to-date information as possible to support their heroic efforts. As the country starts to see positive signs that the mitigation efforts, like stay-at-home orders and social distancing, are working in our fight against the COVID-19 pandemic, the question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation. Antibody tests also known as serological tests may have the potential to play a role in this complex calculation. Results from these tests can help identify who has been infected and developed antibodies that may protect from future infection as well as identify those still at risk. Results can also help inform who may qualify to donate blood that can be used to manufacture convalescent plasma, an investigational product for use with those who are seriously ill from COVID-19. Today, given the active dialogue about serological tests that are currently on the market, and their significance in the nation's response efforts, we'd like to provide further details about our thinking on these tests and our approach to making accurate and reliable serology tests widely available, while also protecting Americans from tests marketed with false or unsubstantiated claims. FDA Approach to Expanding Access to Serology Tests First, we continue to provide the opportunity for interested developers to request FDA authorization through the emergency use authorization (EUA) process. To date, we have already issued four EUAs for serological tests, and we expect that number to continue to grow in the coming weeks. The FDA encourages developers to submit EUA requests for their tests, as an EUA will provide laboratories and providers with assurance that FDA has reviewed that test. We are working around-the-clock to review EUA submissions quickly and we continue to take steps to ensure the process is as streamlined and efficient as possible. For example, we are working on EUA Templates that laboratories and commercial manufacturers may use to facilitate the preparation and submission of an EUA request. We expect to make them available in the coming days. To enhance the U.S. Government's ability to identify well-performing tests and inform FDA recommendations and decision making, we are collaboratingwith the National Institutes of Health's National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Disease Control and Prevention (CDC) to establish a capability at NIH to evaluate serological tests for developers. This effort includes tests already available for use, as well as tests not yet on the market where additional validation data is needed to support an EUA. Performance assessments for serological tests will begin soon, and we expect to start seeing results shortly thereafter. We will review NIH's results expeditiously, and performance results from NIH's assessment may complement and inform the determination of whether FDA issues an EUA for a particular test. Recognizing that more flexibility was needed during a pandemic of this scale and speed, and incorporating feedback from the medical community, states and test developers, we have also provided regulatory flexibility for serological tests in an effort to provide laboratories and health care providers with early access to these tests with the understanding that the FDA had not reviewed or authorized (or "approved") them, at least not initially, and these tests should not be used for diagnosing or excluding active SARS-CoV-2 infection. Specifically, last month, as part of our broader strategy, the FDA issued a policy explaining that FDA does not intend to object when developers of serological tests market or use their tests without prior FDA review where: 1) the tests are validated by the developer to determine that they are accurate and reliable, 2) notification of the developer's validation is provided to FDA, and 3) the tests are labeled appropriately, including that they are not to be used as a sole basis for diagnosis. Our policy does not apply to at-home specimen collection or at-home testing because of the added challenges in assuring test accuracy that these pose. The policy does apply to tests that can be performed in patient care settings. Laboratories could validate tests they receive from commercial manufacturers and determine if they should be used in their facilities. Some laboratories have already done so or have developed their own serological tests. The bottom line is that FDA still expects tests to be validated even under our revised policy for tests. However, the EUA process or an evaluation by NIH supports greater confidence in test performance. How the Tests Work Unlike a test designed to diagnose an active COVID-19 infection (specifically from the SARS-CoV-2 virus), serological tests can help identify individuals who have developed an immune response to the virus, either as part of an active infection or a prior infection. The tests detect the presence of antibodies in the blood if antibodies are present, that indicates that the person has been exposed to the virus and developed antibodies against it, which may mean that person has at least some immunity to the coronavirus. In the early days of an infection when the body's immune response is still building, antibodies may not be detected, which is why serological tests should not be used as the sole basis to diagnose or exclude infection with the SARS-CoV-2 virus. There is still a great deal about COVID-19 immunity that we don't yet fully understand. For example, we don't yet know that just because someone has developed antibodies, that they are fully protected from reinfection, or how long any immunity lasts. We do expect that data from more widespread serological testing will help us track the spread of the virus nationwide and assess the impact of our public health efforts now, while also informing our COVID-19 response as we continue to move forward. Determining the next steps in our response to COVID-19 is partially dependent on an accurate assessment of our national efforts thus far, and the quality of data for making this decision is dependent on accurate testing products. Why Validation Data Are Needed All clinical tests should be validated prior to use, and this expectation is articulated in our March 16 policy. We have provided regulatory flexibility regarding the independent check by FDA for antibody tests that are limited in their clinical applications, but still expect all developers to validate their tests prior to offering them for limited clinical uses. To minimize the number of false positive results, serological tests must be well-designed to specifically identify antibodies against SARS-CoV-2 and must not "cross-react," or provide positive results when encountering antibodies against other respiratory viruses. Concerns and Education for Frontline Workers and States Currently, we are working on several fronts to provide more clarity about which tests have received FDA review and which have not. In addition, to facilitate awareness of these serological tests, the FDA has been posting on its website the tests for which it has received a notification under this policy since mid-March. We have also updated our website to better clarify which tests have been authorized by FDA and which have not been authorized. However, some test developers have misused the serology test kit notification list to falsely claim their serological tests are FDA approved or authorized. Others have falsely claimed that their tests can diagnose COVID-19. When we become aware of these issues, we have and will continue to take appropriate action against firms making or distributing unvalidated tests or those making false claims, such as issuing Warning Letters requesting that companies stop their unlawful promotion and detaining and refusing fraudulent test kits at the border. We are sharing educational materials with state governments, hospital systems, payors, and health care professional associations to ensure they understand the potential for false-positive results in tests that have not yet been reviewed by FDA, and can make educated decisions when considering purchasing, insuring and using these tests. We have been and will continue actively engaging with the testing development community to continue to gain input and provide clarity around our processes, policies and validation efforts. Additional Resources: FAQs on Diagnostic Testing for SARS-CoV-2 Important Information on the Use of Serological (Antibody) Tests for COVID-19 - Letter to Health Care Providers FDA Fact Sheet: Serological Testing for Antibodies to SARS-CoV-2 Infection Media Contact:Stephanie Caccomo, 301-348-1956 Consumer Inquiries: Email, 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov

Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts The following is attributed to Commissioner of Food and Drugs - Food and Drug Administration, Stephen M. Hahn, M.D.

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SILVER SPRING, Md., April 18, 2020 /PRNewswire/ --Every step we have taken as part of our approach to COVID-19 testing has been a careful balancing of risks and benefits in order to meet the urgent public health needs as we combat this new pathogen. We have moved quickly and thoughtfully, and we are continuing to learn and adapt based on the real-world experience and data we're seeing. In the meantime, frontline health care workers who are making life-and-death decisions every day in their fight against this novel coronavirus need to have all the information possible to make educated decisions about which test to use to help identify individuals who have developed an immune response to the virus. We are committed to providing as up-to-date information as possible to support their heroic efforts. As the country starts to see positive signs that the mitigation efforts, like stay-at-home orders and social distancing, are working in our fight against the COVID-19 pandemic, the question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation. Antibody tests also known as serological tests may have the potential to play a role in this complex calculation. Results from these tests can help identify who has been infected and developed antibodies that may protect from future infection as well as identify those still at risk. Results can also help inform who may qualify to donate blood that can be used to manufacture convalescent plasma, an investigational product for use with those who are seriously ill from COVID-19. Today, given the active dialogue about serological tests that are currently on the market, and their significance in the nation's response efforts, we'd like to provide further details about our thinking on these tests and our approach to making accurate and reliable serology tests widely available, while also protecting Americans from tests marketed with false or unsubstantiated claims. FDA Approach to Expanding Access to Serology Tests First, we continue to provide the opportunity for interested developers to request FDA authorization through the emergency use authorization (EUA) process. To date, we have already issued four EUAs for serological tests, and we expect that number to continue to grow in the coming weeks. The FDA encourages developers to submit EUA requests for their tests, as an EUA will provide laboratories and providers with assurance that FDA has reviewed that test. We are working around-the-clock to review EUA submissions quickly and we continue to take steps to ensure the process is as streamlined and efficient as possible. For example, we are working on EUA Templates that laboratories and commercial manufacturers may use to facilitate the preparation and submission of an EUA request. We expect to make them available in the coming days. To enhance the U.S. Government's ability to identify well-performing tests and inform FDA recommendations and decision making, we are collaboratingwith the National Institutes of Health's National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Disease Control and Prevention (CDC) to establish a capability at NIH to evaluate serological tests for developers. This effort includes tests already available for use, as well as tests not yet on the market where additional validation data is needed to support an EUA. Performance assessments for serological tests will begin soon, and we expect to start seeing results shortly thereafter. We will review NIH's results expeditiously, and performance results from NIH's assessment may complement and inform the determination of whether FDA issues an EUA for a particular test. Recognizing that more flexibility was needed during a pandemic of this scale and speed, and incorporating feedback from the medical community, states and test developers, we have also provided regulatory flexibility for serological tests in an effort to provide laboratories and health care providers with early access to these tests with the understanding that the FDA had not reviewed or authorized (or "approved") them, at least not initially, and these tests should not be used for diagnosing or excluding active SARS-CoV-2 infection. Specifically, last month, as part of our broader strategy, the FDA issued a policy explaining that FDA does not intend to object when developers of serological tests market or use their tests without prior FDA review where: 1) the tests are validated by the developer to determine that they are accurate and reliable, 2) notification of the developer's validation is provided to FDA, and 3) the tests are labeled appropriately, including that they are not to be used as a sole basis for diagnosis. Our policy does not apply to at-home specimen collection or at-home testing because of the added challenges in assuring test accuracy that these pose. The policy does apply to tests that can be performed in patient care settings. Laboratories could validate tests they receive from commercial manufacturers and determine if they should be used in their facilities. Some laboratories have already done so or have developed their own serological tests. The bottom line is that FDA still expects tests to be validated even under our revised policy for tests. However, the EUA process or an evaluation by NIH supports greater confidence in test performance. How the Tests Work Unlike a test designed to diagnose an active COVID-19 infection (specifically from the SARS-CoV-2 virus), serological tests can help identify individuals who have developed an immune response to the virus, either as part of an active infection or a prior infection. The tests detect the presence of antibodies in the blood if antibodies are present, that indicates that the person has been exposed to the virus and developed antibodies against it, which may mean that person has at least some immunity to the coronavirus. In the early days of an infection when the body's immune response is still building, antibodies may not be detected, which is why serological tests should not be used as the sole basis to diagnose or exclude infection with the SARS-CoV-2 virus. There is still a great deal about COVID-19 immunity that we don't yet fully understand. For example, we don't yet know that just because someone has developed antibodies, that they are fully protected from reinfection, or how long any immunity lasts. We do expect that data from more widespread serological testing will help us track the spread of the virus nationwide and assess the impact of our public health efforts now, while also informing our COVID-19 response as we continue to move forward. Determining the next steps in our response to COVID-19 is partially dependent on an accurate assessment of our national efforts thus far, and the quality of data for making this decision is dependent on accurate testing products. Why Validation Data Are Needed All clinical tests should be validated prior to use, and this expectation is articulated in our March 16 policy. We have provided regulatory flexibility regarding the independent check by FDA for antibody tests that are limited in their clinical applications, but still expect all developers to validate their tests prior to offering them for limited clinical uses. To minimize the number of false positive results, serological tests must be well-designed to specifically identify antibodies against SARS-CoV-2 and must not "cross-react," or provide positive results when encountering antibodies against other respiratory viruses. Concerns and Education for Frontline Workers and States Currently, we are working on several fronts to provide more clarity about which tests have received FDA review and which have not. In addition, to facilitate awareness of these serological tests, the FDA has been posting on its website the tests for which it has received a notification under this policy since mid-March. We have also updated our website to better clarify which tests have been authorized by FDA and which have not been authorized. However, some test developers have misused the serology test kit notification list to falsely claim their serological tests are FDA approved or authorized. Others have falsely claimed that their tests can diagnose COVID-19. When we become aware of these issues, we have and will continue to take appropriate action against firms making or distributing unvalidated tests or those making false claims, such as issuing Warning Letters requesting that companies stop their unlawful promotion and detaining and refusing fraudulent test kits at the border. We are sharing educational materials with state governments, hospital systems, payors, and health care professional associations to ensure they understand the potential for false-positive results in tests that have not yet been reviewed by FDA, and can make educated decisions when considering purchasing, insuring and using these tests. We have been and will continue actively engaging with the testing development community to continue to gain input and provide clarity around our processes, policies and validation efforts. Additional Resources: FAQs on Diagnostic Testing for SARS-CoV-2 Important Information on the Use of Serological (Antibody) Tests for COVID-19 - Letter to Health Care Providers FDA Fact Sheet: Serological Testing for Antibodies to SARS-CoV-2 Infection Media Contact:Stephanie Caccomo, 301-348-1956 Consumer Inquiries: Email, 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts. The following is attributed to Commissioner of Food and Drugs - Food and Drug Administration, Stephen M. Hahn, M.D.<|eot_id|>

edtsum901

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MIAMI BEACH, Fla., June 17, 2020 /PRNewswire/ -- Last year the Miami Beach Chamber of Commerce (Chamber) began developing a Diversity, Equity & Inclusion Council that officially launched February 2020 and is Co-Chaired by Eva Dias and Andre Williams. The Chamber continues to strive to improve the quality of life for our diverse community and is looking forward to making significant contributions with this new Council. Diversity and inclusion are core values for the Chamber and it is critical that we incorporate these values into all aspects of our work including advocacy, communications, workplace environment, vendor selection, hiring, promotion and retention. In order to carry out the Chamber's core values, Committee will foster a shared culture at the Chamber that promotes the goals of accepting, respecting and valuing differences that include attributes such as age, race, gender, ethnicity, religion, sexual orientation, gender expression, sexual identity, ability, language, family circumstances and cultural backgrounds. "I appreciate the support from the Chamber, Board Chair Robin Jacobs and Chamber President & CEO Jerry Libbin for the DE&I Council," said Williams. "These goals can only be achieved by engaging leadership in mainstream organizations like the Chamber to promote diversity, equity and inclusion to its member businesses whose bottom line will grow because of it." "The world will be a better place when we recognize that diversity, equity and inclusion are no longer a necessary discussion," said Dias. "I look forward to the day that our mission is just part of our regular life and that we have completed our Council's goals through the Chamber." "I want to acknowledge Andre and Eva's leadership as co-chairs," said Chair of the Board Robin Jacobs. "A diverse workforce means having a greater variety of backgrounds, talents, and experiences." On June 30 at 4 PM, the Chamber will host a free webinar on how minority businesses can apply for and receive contracts with the City of Miami Beach. City officials will be present. To date the Council has done the following: In an effort to expand their multicultural efforts, the Council has developed partnerships with other organizations and government entities such asthe City's procurement department, the Brazilian Consulateand theGreater Miami Convention & Visitors Bureau. In the months ahead, this Council will focus on ways to create greater economic opportunities for minority owned businesses in and around Miami Beach. CONTACT: Daniel Diaz, 305-389-8986, [emailprotected] SOURCE Miami Beach Chamber of Commerce Related Links www.miamibeachchamber.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Miami Beach Chamber of Commerce's Diversity, Equity & Inclusion Council Makes Inroads in The Community.

MIAMI BEACH, Fla., June 17, 2020 /PRNewswire/ -- Last year the Miami Beach Chamber of Commerce (Chamber) began developing a Diversity, Equity & Inclusion Council that officially launched February 2020 and is Co-Chaired by Eva Dias and Andre Williams. The Chamber continues to strive to improve the quality of life for our diverse community and is looking forward to making significant contributions with this new Council. Diversity and inclusion are core values for the Chamber and it is critical that we incorporate these values into all aspects of our work including advocacy, communications, workplace environment, vendor selection, hiring, promotion and retention. In order to carry out the Chamber's core values, Committee will foster a shared culture at the Chamber that promotes the goals of accepting, respecting and valuing differences that include attributes such as age, race, gender, ethnicity, religion, sexual orientation, gender expression, sexual identity, ability, language, family circumstances and cultural backgrounds. "I appreciate the support from the Chamber, Board Chair Robin Jacobs and Chamber President & CEO Jerry Libbin for the DE&I Council," said Williams. "These goals can only be achieved by engaging leadership in mainstream organizations like the Chamber to promote diversity, equity and inclusion to its member businesses whose bottom line will grow because of it." "The world will be a better place when we recognize that diversity, equity and inclusion are no longer a necessary discussion," said Dias. "I look forward to the day that our mission is just part of our regular life and that we have completed our Council's goals through the Chamber." "I want to acknowledge Andre and Eva's leadership as co-chairs," said Chair of the Board Robin Jacobs. "A diverse workforce means having a greater variety of backgrounds, talents, and experiences." On June 30 at 4 PM, the Chamber will host a free webinar on how minority businesses can apply for and receive contracts with the City of Miami Beach. City officials will be present. To date the Council has done the following: In an effort to expand their multicultural efforts, the Council has developed partnerships with other organizations and government entities such asthe City's procurement department, the Brazilian Consulateand theGreater Miami Convention & Visitors Bureau. In the months ahead, this Council will focus on ways to create greater economic opportunities for minority owned businesses in and around Miami Beach. CONTACT: Daniel Diaz, 305-389-8986, [emailprotected] SOURCE Miami Beach Chamber of Commerce Related Links www.miamibeachchamber.com

Miami Beach Chamber of Commerce's Diversity, Equity & Inclusion Council Makes Inroads in The Community

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MIAMI BEACH, Fla., June 17, 2020 /PRNewswire/ -- Last year the Miami Beach Chamber of Commerce (Chamber) began developing a Diversity, Equity & Inclusion Council that officially launched February 2020 and is Co-Chaired by Eva Dias and Andre Williams. The Chamber continues to strive to improve the quality of life for our diverse community and is looking forward to making significant contributions with this new Council. Diversity and inclusion are core values for the Chamber and it is critical that we incorporate these values into all aspects of our work including advocacy, communications, workplace environment, vendor selection, hiring, promotion and retention. In order to carry out the Chamber's core values, Committee will foster a shared culture at the Chamber that promotes the goals of accepting, respecting and valuing differences that include attributes such as age, race, gender, ethnicity, religion, sexual orientation, gender expression, sexual identity, ability, language, family circumstances and cultural backgrounds. "I appreciate the support from the Chamber, Board Chair Robin Jacobs and Chamber President & CEO Jerry Libbin for the DE&I Council," said Williams. "These goals can only be achieved by engaging leadership in mainstream organizations like the Chamber to promote diversity, equity and inclusion to its member businesses whose bottom line will grow because of it." "The world will be a better place when we recognize that diversity, equity and inclusion are no longer a necessary discussion," said Dias. "I look forward to the day that our mission is just part of our regular life and that we have completed our Council's goals through the Chamber." "I want to acknowledge Andre and Eva's leadership as co-chairs," said Chair of the Board Robin Jacobs. "A diverse workforce means having a greater variety of backgrounds, talents, and experiences." On June 30 at 4 PM, the Chamber will host a free webinar on how minority businesses can apply for and receive contracts with the City of Miami Beach. City officials will be present. To date the Council has done the following: In an effort to expand their multicultural efforts, the Council has developed partnerships with other organizations and government entities such asthe City's procurement department, the Brazilian Consulateand theGreater Miami Convention & Visitors Bureau. In the months ahead, this Council will focus on ways to create greater economic opportunities for minority owned businesses in and around Miami Beach. CONTACT: Daniel Diaz, 305-389-8986, [emailprotected] SOURCE Miami Beach Chamber of Commerce Related Links www.miamibeachchamber.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Miami Beach Chamber of Commerce's Diversity, Equity & Inclusion Council Makes Inroads in The Community.<|eot_id|>

edtsum902

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: TINTON FALLS, N.J., March 30, 2020 /PRNewswire/ --Commvault (NASDAQ: CVLT), a recognized global enterprise software leader in the management of data across cloud and on-premises environments, today announced the availability of its latest product innovations, which include new cloud and on-premises data management capabilities. These capabilities extend the flexibility and simplicity of Commvault's cloud solutions, making it easier for customers to protect, control, manage, and use data across multiple clouds. This includes new support for the backup and recovery of AWS databases, migration of Oracle and MS SQL databases across multiple clouds such as AWS, Microsoft Azure, and the Alibaba Cloud Elastic Compute Service (ECS), and ServiceNow integration. "In these challenging times it is important that organizations have flexibility when it comes to managing their data, and the cloud is a critical part of that," said Commvault Vice President of Product Management Ranga Rajagopalan. "With these new capabilities we are making it easier for our customers to move more workloads into the cloud and offering greater simplicity and flexibility in managing and protecting their data, wherever it resides." More Flexibility in Shifting and Managing Workloads in the CloudAs customers shift more workloads into the cloud, they require the ability to move and manage data on a variety of cloud platforms. With today's announcement, Commvault has expanded its cloud capabilities by: Enabling customers to back up, recover, and migrate AWS DynamoDB, Redshift, and DocumentDB database solutions. Allowing customers to convert, back up, and migrate VMware workloads to the Alibaba Cloud ECS to increase the flexibility of their hybrid multi-cloud environments. Supporting the migration of Oracle and Microsoft SQL database applications to Microsoft Azure, expanding customers' ability to integrate Azure cloud services into hybrid environments. Further integrating with the ServiceNow platform to enable self-service. This deep integration allows Commvault customers to back up, recover, and migrate file systems, VMs, Microsoft SQL Server workloads and other ServiceNow catalog assets, all within the ServiceNow SaaS platform. Offering the ability to quickly convert Oracle Unix databases to Linux and vice versa. This new capability makes it easier for customers to migrate on-premises Unix Oracle databases to the cloud, or cloud Linux Oracle databases to on-premises infrastructure, all without needing an Oracle enterprise license. Simplifying Data Management with a Tightly Integrated User InterfaceTo simplify the customer experience across Commvault solutions, customers can now sign in once to manage Commvault across multiple deployments, all through a pull-down menu that enables quick navigation across Commvault regional, datacenter, client, or other deployments within the Commvault Command Center. Commvault has also further simplified the user experience for its Commvault Activate data insights and governance solution by allowing customers to schedule data collection and access reports on File Storage Optimization, Sensitive Data Governance, and eDiscovery from the Commvault Command Center. Commvault is making it easier for its customers to understand how to make the most of new capabilities by expanding its on-demand learning resources. This includes videos on new capabilities that can be viewed at Commvault's on-demand learning library. About CommvaultCommvault is the recognized leader in data backup and recovery. Commvault's converged data management solution redefines what backup means for the progressive enterprise through solutions that protect, manage and use their most critical asset their data. Commvault software, solutions and services are available from the company and through a global ecosystem of trusted partners. Commvault employs more than 2,300 highly-skilled individuals across markets worldwide, is publicly traded on NASDAQ (CVLT), and is headquartered in Tinton Falls, New Jersey in the United States. To learn more about Commvault visit www.commvault.com Safe Harbor StatementCustomers' results may differ materially from those stated herein; Commvault does not guarantee that all customers can achieve benefits similar to those stated above. This press release may contain forward-looking statements, including statements regarding financial projections, which are subject to risks and uncertainties, such as competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of software products and related services, general economic conditions and others. Statements regarding Commvault's beliefs, plans, expectations or intentions regarding the future are forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from anticipated results. Commvault does not undertake to update its forward-looking statements. The development and timing of any product release as well as any of its features or functionality remain at our sole discretion. 1999-2020 Commvault Systems, Inc. All rights reserved. Commvault, Commvault and logo, the "C hexagon" logo, Commvault Systems, Commvault HyperScale, ScaleProtect, Commvault OnePass, Unified Data Management, Quick Recovery, QR, CommNet, GridStor, Vault Tracker, InnerVault, Quick Snap, QSnap, IntelliSnap, Recovery Director, CommServe, CommCell, APSS, Commvault Edge, Commvault GO, Commvault Advantage, Commvault Complete, Commvault Activate, Commvault Orchestrate, Commvault Command Center, Hedvig, Universal Data Plane, the "Cube" logo, Metallic, the "M Wave" logo, and CommValue are trademarks or registered trademarks of Commvault Systems, Inc. All other third party brands, products, service names, trademarks, or registered service marks are the property of and used to identify the products or services of their respective owners. All specifications are subject to change without notice. SOURCE Commvault Related Links www.commvault.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Commvault's New Product Innovations Help Enterprises Accelerate Their Move to the Cloud. Latest release extends Commvault's cloud leadership, with new capabilities for AWS, Azure, and Alibaba that expand enterprises' ability to quickly and easily back up, recover, and migrate workloads across on-premises and multiple clouds.

TINTON FALLS, N.J., March 30, 2020 /PRNewswire/ --Commvault (NASDAQ: CVLT), a recognized global enterprise software leader in the management of data across cloud and on-premises environments, today announced the availability of its latest product innovations, which include new cloud and on-premises data management capabilities. These capabilities extend the flexibility and simplicity of Commvault's cloud solutions, making it easier for customers to protect, control, manage, and use data across multiple clouds. This includes new support for the backup and recovery of AWS databases, migration of Oracle and MS SQL databases across multiple clouds such as AWS, Microsoft Azure, and the Alibaba Cloud Elastic Compute Service (ECS), and ServiceNow integration. "In these challenging times it is important that organizations have flexibility when it comes to managing their data, and the cloud is a critical part of that," said Commvault Vice President of Product Management Ranga Rajagopalan. "With these new capabilities we are making it easier for our customers to move more workloads into the cloud and offering greater simplicity and flexibility in managing and protecting their data, wherever it resides." More Flexibility in Shifting and Managing Workloads in the CloudAs customers shift more workloads into the cloud, they require the ability to move and manage data on a variety of cloud platforms. With today's announcement, Commvault has expanded its cloud capabilities by: Enabling customers to back up, recover, and migrate AWS DynamoDB, Redshift, and DocumentDB database solutions. Allowing customers to convert, back up, and migrate VMware workloads to the Alibaba Cloud ECS to increase the flexibility of their hybrid multi-cloud environments. Supporting the migration of Oracle and Microsoft SQL database applications to Microsoft Azure, expanding customers' ability to integrate Azure cloud services into hybrid environments. Further integrating with the ServiceNow platform to enable self-service. This deep integration allows Commvault customers to back up, recover, and migrate file systems, VMs, Microsoft SQL Server workloads and other ServiceNow catalog assets, all within the ServiceNow SaaS platform. Offering the ability to quickly convert Oracle Unix databases to Linux and vice versa. This new capability makes it easier for customers to migrate on-premises Unix Oracle databases to the cloud, or cloud Linux Oracle databases to on-premises infrastructure, all without needing an Oracle enterprise license. Simplifying Data Management with a Tightly Integrated User InterfaceTo simplify the customer experience across Commvault solutions, customers can now sign in once to manage Commvault across multiple deployments, all through a pull-down menu that enables quick navigation across Commvault regional, datacenter, client, or other deployments within the Commvault Command Center. Commvault has also further simplified the user experience for its Commvault Activate data insights and governance solution by allowing customers to schedule data collection and access reports on File Storage Optimization, Sensitive Data Governance, and eDiscovery from the Commvault Command Center. Commvault is making it easier for its customers to understand how to make the most of new capabilities by expanding its on-demand learning resources. This includes videos on new capabilities that can be viewed at Commvault's on-demand learning library. About CommvaultCommvault is the recognized leader in data backup and recovery. Commvault's converged data management solution redefines what backup means for the progressive enterprise through solutions that protect, manage and use their most critical asset their data. Commvault software, solutions and services are available from the company and through a global ecosystem of trusted partners. Commvault employs more than 2,300 highly-skilled individuals across markets worldwide, is publicly traded on NASDAQ (CVLT), and is headquartered in Tinton Falls, New Jersey in the United States. To learn more about Commvault visit www.commvault.com Safe Harbor StatementCustomers' results may differ materially from those stated herein; Commvault does not guarantee that all customers can achieve benefits similar to those stated above. This press release may contain forward-looking statements, including statements regarding financial projections, which are subject to risks and uncertainties, such as competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of software products and related services, general economic conditions and others. Statements regarding Commvault's beliefs, plans, expectations or intentions regarding the future are forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from anticipated results. Commvault does not undertake to update its forward-looking statements. The development and timing of any product release as well as any of its features or functionality remain at our sole discretion. 1999-2020 Commvault Systems, Inc. All rights reserved. Commvault, Commvault and logo, the "C hexagon" logo, Commvault Systems, Commvault HyperScale, ScaleProtect, Commvault OnePass, Unified Data Management, Quick Recovery, QR, CommNet, GridStor, Vault Tracker, InnerVault, Quick Snap, QSnap, IntelliSnap, Recovery Director, CommServe, CommCell, APSS, Commvault Edge, Commvault GO, Commvault Advantage, Commvault Complete, Commvault Activate, Commvault Orchestrate, Commvault Command Center, Hedvig, Universal Data Plane, the "Cube" logo, Metallic, the "M Wave" logo, and CommValue are trademarks or registered trademarks of Commvault Systems, Inc. All other third party brands, products, service names, trademarks, or registered service marks are the property of and used to identify the products or services of their respective owners. All specifications are subject to change without notice. SOURCE Commvault Related Links www.commvault.com

Commvault's New Product Innovations Help Enterprises Accelerate Their Move to the Cloud -- Latest release extends Commvault's cloud leadership, with new capabilities for AWS, Azure, and Alibaba that expand enterprises' ability to quickly and easily back up, recover, and migrate workloads across on-premises and multiple clouds--

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: TINTON FALLS, N.J., March 30, 2020 /PRNewswire/ --Commvault (NASDAQ: CVLT), a recognized global enterprise software leader in the management of data across cloud and on-premises environments, today announced the availability of its latest product innovations, which include new cloud and on-premises data management capabilities. These capabilities extend the flexibility and simplicity of Commvault's cloud solutions, making it easier for customers to protect, control, manage, and use data across multiple clouds. This includes new support for the backup and recovery of AWS databases, migration of Oracle and MS SQL databases across multiple clouds such as AWS, Microsoft Azure, and the Alibaba Cloud Elastic Compute Service (ECS), and ServiceNow integration. "In these challenging times it is important that organizations have flexibility when it comes to managing their data, and the cloud is a critical part of that," said Commvault Vice President of Product Management Ranga Rajagopalan. "With these new capabilities we are making it easier for our customers to move more workloads into the cloud and offering greater simplicity and flexibility in managing and protecting their data, wherever it resides." More Flexibility in Shifting and Managing Workloads in the CloudAs customers shift more workloads into the cloud, they require the ability to move and manage data on a variety of cloud platforms. With today's announcement, Commvault has expanded its cloud capabilities by: Enabling customers to back up, recover, and migrate AWS DynamoDB, Redshift, and DocumentDB database solutions. Allowing customers to convert, back up, and migrate VMware workloads to the Alibaba Cloud ECS to increase the flexibility of their hybrid multi-cloud environments. Supporting the migration of Oracle and Microsoft SQL database applications to Microsoft Azure, expanding customers' ability to integrate Azure cloud services into hybrid environments. Further integrating with the ServiceNow platform to enable self-service. This deep integration allows Commvault customers to back up, recover, and migrate file systems, VMs, Microsoft SQL Server workloads and other ServiceNow catalog assets, all within the ServiceNow SaaS platform. Offering the ability to quickly convert Oracle Unix databases to Linux and vice versa. This new capability makes it easier for customers to migrate on-premises Unix Oracle databases to the cloud, or cloud Linux Oracle databases to on-premises infrastructure, all without needing an Oracle enterprise license. Simplifying Data Management with a Tightly Integrated User InterfaceTo simplify the customer experience across Commvault solutions, customers can now sign in once to manage Commvault across multiple deployments, all through a pull-down menu that enables quick navigation across Commvault regional, datacenter, client, or other deployments within the Commvault Command Center. Commvault has also further simplified the user experience for its Commvault Activate data insights and governance solution by allowing customers to schedule data collection and access reports on File Storage Optimization, Sensitive Data Governance, and eDiscovery from the Commvault Command Center. Commvault is making it easier for its customers to understand how to make the most of new capabilities by expanding its on-demand learning resources. This includes videos on new capabilities that can be viewed at Commvault's on-demand learning library. About CommvaultCommvault is the recognized leader in data backup and recovery. Commvault's converged data management solution redefines what backup means for the progressive enterprise through solutions that protect, manage and use their most critical asset their data. Commvault software, solutions and services are available from the company and through a global ecosystem of trusted partners. Commvault employs more than 2,300 highly-skilled individuals across markets worldwide, is publicly traded on NASDAQ (CVLT), and is headquartered in Tinton Falls, New Jersey in the United States. To learn more about Commvault visit www.commvault.com Safe Harbor StatementCustomers' results may differ materially from those stated herein; Commvault does not guarantee that all customers can achieve benefits similar to those stated above. This press release may contain forward-looking statements, including statements regarding financial projections, which are subject to risks and uncertainties, such as competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of software products and related services, general economic conditions and others. Statements regarding Commvault's beliefs, plans, expectations or intentions regarding the future are forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from anticipated results. Commvault does not undertake to update its forward-looking statements. The development and timing of any product release as well as any of its features or functionality remain at our sole discretion. 1999-2020 Commvault Systems, Inc. All rights reserved. Commvault, Commvault and logo, the "C hexagon" logo, Commvault Systems, Commvault HyperScale, ScaleProtect, Commvault OnePass, Unified Data Management, Quick Recovery, QR, CommNet, GridStor, Vault Tracker, InnerVault, Quick Snap, QSnap, IntelliSnap, Recovery Director, CommServe, CommCell, APSS, Commvault Edge, Commvault GO, Commvault Advantage, Commvault Complete, Commvault Activate, Commvault Orchestrate, Commvault Command Center, Hedvig, Universal Data Plane, the "Cube" logo, Metallic, the "M Wave" logo, and CommValue are trademarks or registered trademarks of Commvault Systems, Inc. All other third party brands, products, service names, trademarks, or registered service marks are the property of and used to identify the products or services of their respective owners. All specifications are subject to change without notice. SOURCE Commvault Related Links www.commvault.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Commvault's New Product Innovations Help Enterprises Accelerate Their Move to the Cloud. Latest release extends Commvault's cloud leadership, with new capabilities for AWS, Azure, and Alibaba that expand enterprises' ability to quickly and easily back up, recover, and migrate workloads across on-premises and multiple clouds.<|eot_id|>

edtsum903

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MARIETTA, Ga.--(BUSINESS WIRE)--Benevis, a leading dental practice management organization, today announced the appointment of Craig Albright as Chief Executive Officer. We are pleased to welcome Craig as our new CEO, he brings the right experience and skills to lead Benevis in the next stage of its growth, said Daniel D. Crowley, Executive Chairman. Our company has a great team supporting excellent dentists, and the organization is a robust platform on which to build; Craig is the right leader for Benevis as it continues to grow and serve the dental community. Mr. Albright has more than 25 years of experience leading successful growth and transformation strategies at healthcare organizations. Most recently he was CEO of InHealth Medical Alliance, Inc., one of the largest globally capitated primary care physician groups in Florida. Prior to that he was CEO of JSA Healthcare Corporation, then a division of DaVita Medical Group. He was also a CEO and/or board member for several portfolio companies of Three Arch Partners, including Free and Clear, Inc., a smoking cessation program provider; Gentiae Clinical Research, Inc.; and U. S. HealthWorks, the nations second-largest practice management organization for occupational medicine and urgent care physicians. As an organization dedicated to supporting high quality care and patient service and distinguished by the caliber of the dentists affiliated with it, Benevis is exceptionally well positioned for a leadership role in the dental industry in the months and years ahead, said Mr. Albright. I look forward to working with our team at Benevis to continue building an enduring organization that attracts and supports the nations best dental practitioners. This organization was founded with a mission to expand access to high quality care in underserved communities, especially for children, and I am proud to become part of that tradition. ABOUT BENEVIS DENTAL PRACTICE MANAGEMENT SERVICES Benevis is focused on improving access to dentistry by providing the highest quality non-clinical practice management services to dentists. With a strong focus on supporting oral healthcare opportunities for underserved communities, including for children, the Company affiliates with top dentists throughout the country, providing support services that help them better manage and grow their practices and focus on providing high-quality care to their patients. Benevis dental offices have more than 2 million patient visits per year in 17 states. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Benevis Announces the Appointment of Craig Albright as Chief Executive Officer.

MARIETTA, Ga.--(BUSINESS WIRE)--Benevis, a leading dental practice management organization, today announced the appointment of Craig Albright as Chief Executive Officer. We are pleased to welcome Craig as our new CEO, he brings the right experience and skills to lead Benevis in the next stage of its growth, said Daniel D. Crowley, Executive Chairman. Our company has a great team supporting excellent dentists, and the organization is a robust platform on which to build; Craig is the right leader for Benevis as it continues to grow and serve the dental community. Mr. Albright has more than 25 years of experience leading successful growth and transformation strategies at healthcare organizations. Most recently he was CEO of InHealth Medical Alliance, Inc., one of the largest globally capitated primary care physician groups in Florida. Prior to that he was CEO of JSA Healthcare Corporation, then a division of DaVita Medical Group. He was also a CEO and/or board member for several portfolio companies of Three Arch Partners, including Free and Clear, Inc., a smoking cessation program provider; Gentiae Clinical Research, Inc.; and U. S. HealthWorks, the nations second-largest practice management organization for occupational medicine and urgent care physicians. As an organization dedicated to supporting high quality care and patient service and distinguished by the caliber of the dentists affiliated with it, Benevis is exceptionally well positioned for a leadership role in the dental industry in the months and years ahead, said Mr. Albright. I look forward to working with our team at Benevis to continue building an enduring organization that attracts and supports the nations best dental practitioners. This organization was founded with a mission to expand access to high quality care in underserved communities, especially for children, and I am proud to become part of that tradition. ABOUT BENEVIS DENTAL PRACTICE MANAGEMENT SERVICES Benevis is focused on improving access to dentistry by providing the highest quality non-clinical practice management services to dentists. With a strong focus on supporting oral healthcare opportunities for underserved communities, including for children, the Company affiliates with top dentists throughout the country, providing support services that help them better manage and grow their practices and focus on providing high-quality care to their patients. Benevis dental offices have more than 2 million patient visits per year in 17 states.

Benevis Announces the Appointment of Craig Albright as Chief Executive Officer

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: MARIETTA, Ga.--(BUSINESS WIRE)--Benevis, a leading dental practice management organization, today announced the appointment of Craig Albright as Chief Executive Officer. We are pleased to welcome Craig as our new CEO, he brings the right experience and skills to lead Benevis in the next stage of its growth, said Daniel D. Crowley, Executive Chairman. Our company has a great team supporting excellent dentists, and the organization is a robust platform on which to build; Craig is the right leader for Benevis as it continues to grow and serve the dental community. Mr. Albright has more than 25 years of experience leading successful growth and transformation strategies at healthcare organizations. Most recently he was CEO of InHealth Medical Alliance, Inc., one of the largest globally capitated primary care physician groups in Florida. Prior to that he was CEO of JSA Healthcare Corporation, then a division of DaVita Medical Group. He was also a CEO and/or board member for several portfolio companies of Three Arch Partners, including Free and Clear, Inc., a smoking cessation program provider; Gentiae Clinical Research, Inc.; and U. S. HealthWorks, the nations second-largest practice management organization for occupational medicine and urgent care physicians. As an organization dedicated to supporting high quality care and patient service and distinguished by the caliber of the dentists affiliated with it, Benevis is exceptionally well positioned for a leadership role in the dental industry in the months and years ahead, said Mr. Albright. I look forward to working with our team at Benevis to continue building an enduring organization that attracts and supports the nations best dental practitioners. This organization was founded with a mission to expand access to high quality care in underserved communities, especially for children, and I am proud to become part of that tradition. ABOUT BENEVIS DENTAL PRACTICE MANAGEMENT SERVICES Benevis is focused on improving access to dentistry by providing the highest quality non-clinical practice management services to dentists. With a strong focus on supporting oral healthcare opportunities for underserved communities, including for children, the Company affiliates with top dentists throughout the country, providing support services that help them better manage and grow their practices and focus on providing high-quality care to their patients. Benevis dental offices have more than 2 million patient visits per year in 17 states. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Benevis Announces the Appointment of Craig Albright as Chief Executive Officer.<|eot_id|>

edtsum904

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates. Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity and the surprising impact of COVID-19 on what might seem to be an unrelated area. A revolution in cancer therapy is underway. New therapy based on using the body's natural immune defenses is having unprecedented success. But diagnostics, especially biomarkers are desperately needed to help select the right therapy. The technology is moving faster than the market. The impact on the health care industry is enormous. Tumor Mutational Burden? Checkpoint Inhibitors? Cytokines? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. Key Topics Covered: 1. Introduction and Market Definition 1.1 What are Immuno-Oncology Diagnostics? 1.2 Immuno-oncology - the looming cure 1.2.1 Immuno-oncology Diagnostics Takes a Leading Role 1.3 Market Definition 1.4 Methodology 1.5 U.S. Medical Market and laboratory Testing - Perspective 2. Immunotherapy - Guide to Immune Technologies 2.0 The Immune System 2.0.1 Innate immune system 2.0.1.1 Surface barriers 2.0.1.2 Inflammation 2.0.1.3 Complement system 2.0.1.4 Cellular barriers 2.0.1.5 Natural killer cells 2.0.2 Adaptive immune system 2.0.2.1 Lymphocytes 2.0.2.2 Killer T cells 2.0.2.3 Helper T cells 2.0.2.4 Gamma delta T cells 2.0.2.5 B lymphocytes and antibodies 2.0.3 Tumor immunology - the immune surveillance system 2.1 Immuno Oncology Diagnostics 2.1.1 Checkpoint Assays 2.1.2 Cytokine Assays 2.1.3 Genomic Germline 2.1.4 Genomic Tumour 2.1.5 Tumor Microenviroment 3. Industry Overview 3.1 Players in a Dynamic Market 3.1.1 Academic Research Lab 3.1.2 Diagnostic Test Developer 3.1.3 Genomic Instrumentation Supplier 3.1.3.1 Cell Separation and Viewing Instrumentation Supplier 3.1.4 Pharmaceutical/Reagent Supplier 3.1.5 Independent Testing Lab 3.1.6 Public National/regional lab 3.1.7 Hospital lab 3.1.8 Physician Lab 3.1.9 Audit Body 3.1.10 Certification Body 4. Market Trends 4.1 Factors Driving Growth 4.1.1 Outcome potential 4.1.2 Companion Diagnostics 4.1.3 Funding 4.1.4 Technology Environment 4.1.5 Target Solutions 4.2 Factors Limiting Growth 4.2.1 Complex Role of Diagnostics 4.2.2 Clinical Trials Role 4.2.3 Protocols 4.3 Diagnostic Technology Development 4.3.1 Combinations - Issues and Complexity 4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.5 The Race for Biomarkers 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section 6. Profiles of Key Immunotherapy Companies 7. The Global Market for Immuno-Oncology Diagnostics 7.1 Global Market Overview by Country 7.2 Global Market by Assay Type - Overview 8. Global Immuno-Oncology Diagnostic Markets - By Assay Type 8.1 Checkpoint 8.2 Cytokine 8.3 Germline Genetic 8.4 Genetic Tumor 8.5 Tumor Microenvironment 9. Appendices 9.1 FDA Cancer Drug Approvals by Year 9.2 Clinical Trials Started 2010 to 2016 9.3 Prevalence of Cancer Treatments For more information about this report visit https://www.researchandmarkets.com/r/3y5pyf Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Immuno-Oncology Diagnostics Market: Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, Q1 2021 Edition - ResearchAndMarkets.com.

DUBLIN--(BUSINESS WIRE)--The "Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates. Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity and the surprising impact of COVID-19 on what might seem to be an unrelated area. A revolution in cancer therapy is underway. New therapy based on using the body's natural immune defenses is having unprecedented success. But diagnostics, especially biomarkers are desperately needed to help select the right therapy. The technology is moving faster than the market. The impact on the health care industry is enormous. Tumor Mutational Burden? Checkpoint Inhibitors? Cytokines? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. Key Topics Covered: 1. Introduction and Market Definition 1.1 What are Immuno-Oncology Diagnostics? 1.2 Immuno-oncology - the looming cure 1.2.1 Immuno-oncology Diagnostics Takes a Leading Role 1.3 Market Definition 1.4 Methodology 1.5 U.S. Medical Market and laboratory Testing - Perspective 2. Immunotherapy - Guide to Immune Technologies 2.0 The Immune System 2.0.1 Innate immune system 2.0.1.1 Surface barriers 2.0.1.2 Inflammation 2.0.1.3 Complement system 2.0.1.4 Cellular barriers 2.0.1.5 Natural killer cells 2.0.2 Adaptive immune system 2.0.2.1 Lymphocytes 2.0.2.2 Killer T cells 2.0.2.3 Helper T cells 2.0.2.4 Gamma delta T cells 2.0.2.5 B lymphocytes and antibodies 2.0.3 Tumor immunology - the immune surveillance system 2.1 Immuno Oncology Diagnostics 2.1.1 Checkpoint Assays 2.1.2 Cytokine Assays 2.1.3 Genomic Germline 2.1.4 Genomic Tumour 2.1.5 Tumor Microenviroment 3. Industry Overview 3.1 Players in a Dynamic Market 3.1.1 Academic Research Lab 3.1.2 Diagnostic Test Developer 3.1.3 Genomic Instrumentation Supplier 3.1.3.1 Cell Separation and Viewing Instrumentation Supplier 3.1.4 Pharmaceutical/Reagent Supplier 3.1.5 Independent Testing Lab 3.1.6 Public National/regional lab 3.1.7 Hospital lab 3.1.8 Physician Lab 3.1.9 Audit Body 3.1.10 Certification Body 4. Market Trends 4.1 Factors Driving Growth 4.1.1 Outcome potential 4.1.2 Companion Diagnostics 4.1.3 Funding 4.1.4 Technology Environment 4.1.5 Target Solutions 4.2 Factors Limiting Growth 4.2.1 Complex Role of Diagnostics 4.2.2 Clinical Trials Role 4.2.3 Protocols 4.3 Diagnostic Technology Development 4.3.1 Combinations - Issues and Complexity 4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.5 The Race for Biomarkers 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section 6. Profiles of Key Immunotherapy Companies 7. The Global Market for Immuno-Oncology Diagnostics 7.1 Global Market Overview by Country 7.2 Global Market by Assay Type - Overview 8. Global Immuno-Oncology Diagnostic Markets - By Assay Type 8.1 Checkpoint 8.2 Cytokine 8.3 Germline Genetic 8.4 Genetic Tumor 8.5 Tumor Microenvironment 9. Appendices 9.1 FDA Cancer Drug Approvals by Year 9.2 Clinical Trials Started 2010 to 2016 9.3 Prevalence of Cancer Treatments For more information about this report visit https://www.researchandmarkets.com/r/3y5pyf

Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, Q1 2021 Edition - ResearchAndMarkets.com

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN--(BUSINESS WIRE)--The "Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates. Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity and the surprising impact of COVID-19 on what might seem to be an unrelated area. A revolution in cancer therapy is underway. New therapy based on using the body's natural immune defenses is having unprecedented success. But diagnostics, especially biomarkers are desperately needed to help select the right therapy. The technology is moving faster than the market. The impact on the health care industry is enormous. Tumor Mutational Burden? Checkpoint Inhibitors? Cytokines? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. Key Topics Covered: 1. Introduction and Market Definition 1.1 What are Immuno-Oncology Diagnostics? 1.2 Immuno-oncology - the looming cure 1.2.1 Immuno-oncology Diagnostics Takes a Leading Role 1.3 Market Definition 1.4 Methodology 1.5 U.S. Medical Market and laboratory Testing - Perspective 2. Immunotherapy - Guide to Immune Technologies 2.0 The Immune System 2.0.1 Innate immune system 2.0.1.1 Surface barriers 2.0.1.2 Inflammation 2.0.1.3 Complement system 2.0.1.4 Cellular barriers 2.0.1.5 Natural killer cells 2.0.2 Adaptive immune system 2.0.2.1 Lymphocytes 2.0.2.2 Killer T cells 2.0.2.3 Helper T cells 2.0.2.4 Gamma delta T cells 2.0.2.5 B lymphocytes and antibodies 2.0.3 Tumor immunology - the immune surveillance system 2.1 Immuno Oncology Diagnostics 2.1.1 Checkpoint Assays 2.1.2 Cytokine Assays 2.1.3 Genomic Germline 2.1.4 Genomic Tumour 2.1.5 Tumor Microenviroment 3. Industry Overview 3.1 Players in a Dynamic Market 3.1.1 Academic Research Lab 3.1.2 Diagnostic Test Developer 3.1.3 Genomic Instrumentation Supplier 3.1.3.1 Cell Separation and Viewing Instrumentation Supplier 3.1.4 Pharmaceutical/Reagent Supplier 3.1.5 Independent Testing Lab 3.1.6 Public National/regional lab 3.1.7 Hospital lab 3.1.8 Physician Lab 3.1.9 Audit Body 3.1.10 Certification Body 4. Market Trends 4.1 Factors Driving Growth 4.1.1 Outcome potential 4.1.2 Companion Diagnostics 4.1.3 Funding 4.1.4 Technology Environment 4.1.5 Target Solutions 4.2 Factors Limiting Growth 4.2.1 Complex Role of Diagnostics 4.2.2 Clinical Trials Role 4.2.3 Protocols 4.3 Diagnostic Technology Development 4.3.1 Combinations - Issues and Complexity 4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.5 The Race for Biomarkers 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section 6. Profiles of Key Immunotherapy Companies 7. The Global Market for Immuno-Oncology Diagnostics 7.1 Global Market Overview by Country 7.2 Global Market by Assay Type - Overview 8. Global Immuno-Oncology Diagnostic Markets - By Assay Type 8.1 Checkpoint 8.2 Cytokine 8.3 Germline Genetic 8.4 Genetic Tumor 8.5 Tumor Microenvironment 9. Appendices 9.1 FDA Cancer Drug Approvals by Year 9.2 Clinical Trials Started 2010 to 2016 9.3 Prevalence of Cancer Treatments For more information about this report visit https://www.researchandmarkets.com/r/3y5pyf Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Immuno-Oncology Diagnostics Market: Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, Q1 2021 Edition - ResearchAndMarkets.com.<|eot_id|>

edtsum905

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR), a leading supplier of single-plane illumination microscopy (SPIM) technology for research on live cells and cleared biological samples, today announced that two Luxendo MuVi and LCS SPIM light-sheet microscopes have been installed by Memorial Sloan Kettering Cancer Center (MSK). The funding for the two light-sheet fluorescence microscopes was supported by Cycle for Survival (https://www.cycleforsurvival.org). The new SPIM microscopes will help researchers visualize the cellular and tissue hallmarks of cancer and translate those findings into better cancer treatment methods. By understanding how cells mobilize to build organs, researchers can glean insights into why some cells become cancerous and lead to organ destruction, said Dr. Anna-Katerina Hadjantonakis, MSK Chair of the Developmental Biology Program. Instruments such as these are useful for imaging across differing length scales from subcellular to single cells to tissue-level processes allowing researchers to study cellular dynamics and cellular motion, processes that enable cells to metastasize. Light-sheet fluorescence microscopy has emerged as a uniquely powerful method for high-resolution, cleared-sample and dynamic biological imaging, added Dr. Lars Hufnagel, Vice President and General Manager of Brukers Luxendo light-sheet microscopy business. We couldnt be more pleased that our technology will be assisting the great MSK researchers and programs in such important work. About the MuVi and LCS SPIM Systems Brukers SPIM systems avoid sample phototoxicity by sequentially illuminating a stack of small slices of the organism, allowing scientists to observe living organisms for extended periods of time without photodamage. In particular, MuVi SPIM allows fast 3D imaging of live cells and living objects, such as spheroids and whole specimens, without the need of sample rotation. Despite the fact that sample rotation is not necessarily needed for a non-isotropic acquisition, the MuVi SPIM system provides this degree of freedom such that isotropic resolution can be achieved. The modular LCS SPIM for large, cleared samples has been designed to be compatible with a broad variety of clearing solutions and sample sizes. Its new sample mounting approach and innovative optical design enables unprecedented acquisition times and minimizes sample distortions while seamlessly integrating into existing clearing and sample preparation pipelines. To handle the vast amount of data produced by the light-sheet technique, Lux DATA comprehensive data processing and storage provides fast transfer and large-capacity storage and leverages multi-core- and multi-GPU-based processing. About Bruker Corporation (Nasdaq: BRKR) Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Brukers high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center. New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes.

NEW YORK--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR), a leading supplier of single-plane illumination microscopy (SPIM) technology for research on live cells and cleared biological samples, today announced that two Luxendo MuVi and LCS SPIM light-sheet microscopes have been installed by Memorial Sloan Kettering Cancer Center (MSK). The funding for the two light-sheet fluorescence microscopes was supported by Cycle for Survival (https://www.cycleforsurvival.org). The new SPIM microscopes will help researchers visualize the cellular and tissue hallmarks of cancer and translate those findings into better cancer treatment methods. By understanding how cells mobilize to build organs, researchers can glean insights into why some cells become cancerous and lead to organ destruction, said Dr. Anna-Katerina Hadjantonakis, MSK Chair of the Developmental Biology Program. Instruments such as these are useful for imaging across differing length scales from subcellular to single cells to tissue-level processes allowing researchers to study cellular dynamics and cellular motion, processes that enable cells to metastasize. Light-sheet fluorescence microscopy has emerged as a uniquely powerful method for high-resolution, cleared-sample and dynamic biological imaging, added Dr. Lars Hufnagel, Vice President and General Manager of Brukers Luxendo light-sheet microscopy business. We couldnt be more pleased that our technology will be assisting the great MSK researchers and programs in such important work. About the MuVi and LCS SPIM Systems Brukers SPIM systems avoid sample phototoxicity by sequentially illuminating a stack of small slices of the organism, allowing scientists to observe living organisms for extended periods of time without photodamage. In particular, MuVi SPIM allows fast 3D imaging of live cells and living objects, such as spheroids and whole specimens, without the need of sample rotation. Despite the fact that sample rotation is not necessarily needed for a non-isotropic acquisition, the MuVi SPIM system provides this degree of freedom such that isotropic resolution can be achieved. The modular LCS SPIM for large, cleared samples has been designed to be compatible with a broad variety of clearing solutions and sample sizes. Its new sample mounting approach and innovative optical design enables unprecedented acquisition times and minimizes sample distortions while seamlessly integrating into existing clearing and sample preparation pipelines. To handle the vast amount of data produced by the light-sheet technique, Lux DATA comprehensive data processing and storage provides fast transfer and large-capacity storage and leverages multi-core- and multi-GPU-based processing. About Bruker Corporation (Nasdaq: BRKR) Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Brukers high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR), a leading supplier of single-plane illumination microscopy (SPIM) technology for research on live cells and cleared biological samples, today announced that two Luxendo MuVi and LCS SPIM light-sheet microscopes have been installed by Memorial Sloan Kettering Cancer Center (MSK). The funding for the two light-sheet fluorescence microscopes was supported by Cycle for Survival (https://www.cycleforsurvival.org). The new SPIM microscopes will help researchers visualize the cellular and tissue hallmarks of cancer and translate those findings into better cancer treatment methods. By understanding how cells mobilize to build organs, researchers can glean insights into why some cells become cancerous and lead to organ destruction, said Dr. Anna-Katerina Hadjantonakis, MSK Chair of the Developmental Biology Program. Instruments such as these are useful for imaging across differing length scales from subcellular to single cells to tissue-level processes allowing researchers to study cellular dynamics and cellular motion, processes that enable cells to metastasize. Light-sheet fluorescence microscopy has emerged as a uniquely powerful method for high-resolution, cleared-sample and dynamic biological imaging, added Dr. Lars Hufnagel, Vice President and General Manager of Brukers Luxendo light-sheet microscopy business. We couldnt be more pleased that our technology will be assisting the great MSK researchers and programs in such important work. About the MuVi and LCS SPIM Systems Brukers SPIM systems avoid sample phototoxicity by sequentially illuminating a stack of small slices of the organism, allowing scientists to observe living organisms for extended periods of time without photodamage. In particular, MuVi SPIM allows fast 3D imaging of live cells and living objects, such as spheroids and whole specimens, without the need of sample rotation. Despite the fact that sample rotation is not necessarily needed for a non-isotropic acquisition, the MuVi SPIM system provides this degree of freedom such that isotropic resolution can be achieved. The modular LCS SPIM for large, cleared samples has been designed to be compatible with a broad variety of clearing solutions and sample sizes. Its new sample mounting approach and innovative optical design enables unprecedented acquisition times and minimizes sample distortions while seamlessly integrating into existing clearing and sample preparation pipelines. To handle the vast amount of data produced by the light-sheet technique, Lux DATA comprehensive data processing and storage provides fast transfer and large-capacity storage and leverages multi-core- and multi-GPU-based processing. About Bruker Corporation (Nasdaq: BRKR) Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Brukers high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center. New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes.<|eot_id|>

edtsum906

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: GREENSBORO, N.C., July 28, 2020 /PRNewswire/ --Sensory Analytics, the fast-growing supplier of highly precise and award-winning SpecMetrix coating thickness and film layer measurement systems, announced the issuance of the Company's latest patent, European Patent No. 2972070. This new patent covers methods and systems for the in-process thickness measurement of thinner coatings or layers on various substrates. The patent extends the Company's current intellectual property portfolio related to measuring thinner coatings and layers into the EU. "The addition of this EU patent reflects our ongoing focus on broadening the geography and application range of our SpecMetrix product line and our intellectual property portfolio" said Greg Frisby, Global Industry Manager for SpecMetrix Systems at Sensory Analytics. "We look forward to expanding the breadth of our exclusive SpecMetrix coating thickness solutions within the global coated metal, flexible packaging, automotive, electronics, glass, and industrial manufacturing industries while adding value for our global partners and shareholders." Built upon its expanding intellectual property portfolio, Sensory Analytics has launched a series of innovative measurement tools including its exclusive SpecMetrix coil coating measurement systems for primer, pretreatments, clear coats, back coats, and highly pigmented thicker topcoats directly on coil coating lines or in QA labs. All SpecMetrix systems give users accurate, objective, and real-time coating measurement data without any operator interpretation or involvement. With the capability of measuring a broad coating thickness range from 0.2 to 250 microns and a wide variety of materials from transparent to highly pigmented coatings, SpecMetrix systems help manufacturing customers in over 40 countries to reduce costs while streamlining plant QA processes. These patented and exclusive offerings are integrated with proprietary SpecMetrix software to automatically capture and deliver real-time coating and layer thickness data for improved process control and quality assurance. About Sensory AnalyticsSensory Analytics supplies award-winning SpecMetrix coating thickness and film layer measurement systems to manufacturing and coating leaders worldwide. The company's exclusive SpecMetrix offerings measure the absolute thickness of applied wet or dry coatings in real-time with nanometric precision during the coating process or in QA labs and R&D centers. SpecMetrix systems help global manufacturers to optimize coating usage, process control, and the quality of their coated end-products. For additional information, visit www.specmetrix.com. Photo(s):https://www.prlog.org/12831782 Press release distributed by PRLog SOURCE Sensory Analytics Related Links http://www.specmetrix.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Sensory Analytics Awarded European Patent for Coating Thickness Measurement. Sensory's latest patent will further expand its intellectual property portfolio for coating and layer thickness measurement into the European Union.

GREENSBORO, N.C., July 28, 2020 /PRNewswire/ --Sensory Analytics, the fast-growing supplier of highly precise and award-winning SpecMetrix coating thickness and film layer measurement systems, announced the issuance of the Company's latest patent, European Patent No. 2972070. This new patent covers methods and systems for the in-process thickness measurement of thinner coatings or layers on various substrates. The patent extends the Company's current intellectual property portfolio related to measuring thinner coatings and layers into the EU. "The addition of this EU patent reflects our ongoing focus on broadening the geography and application range of our SpecMetrix product line and our intellectual property portfolio" said Greg Frisby, Global Industry Manager for SpecMetrix Systems at Sensory Analytics. "We look forward to expanding the breadth of our exclusive SpecMetrix coating thickness solutions within the global coated metal, flexible packaging, automotive, electronics, glass, and industrial manufacturing industries while adding value for our global partners and shareholders." Built upon its expanding intellectual property portfolio, Sensory Analytics has launched a series of innovative measurement tools including its exclusive SpecMetrix coil coating measurement systems for primer, pretreatments, clear coats, back coats, and highly pigmented thicker topcoats directly on coil coating lines or in QA labs. All SpecMetrix systems give users accurate, objective, and real-time coating measurement data without any operator interpretation or involvement. With the capability of measuring a broad coating thickness range from 0.2 to 250 microns and a wide variety of materials from transparent to highly pigmented coatings, SpecMetrix systems help manufacturing customers in over 40 countries to reduce costs while streamlining plant QA processes. These patented and exclusive offerings are integrated with proprietary SpecMetrix software to automatically capture and deliver real-time coating and layer thickness data for improved process control and quality assurance. About Sensory AnalyticsSensory Analytics supplies award-winning SpecMetrix coating thickness and film layer measurement systems to manufacturing and coating leaders worldwide. The company's exclusive SpecMetrix offerings measure the absolute thickness of applied wet or dry coatings in real-time with nanometric precision during the coating process or in QA labs and R&D centers. SpecMetrix systems help global manufacturers to optimize coating usage, process control, and the quality of their coated end-products. For additional information, visit www.specmetrix.com. Photo(s):https://www.prlog.org/12831782 Press release distributed by PRLog SOURCE Sensory Analytics Related Links http://www.specmetrix.com

Sensory Analytics Awarded European Patent for Coating Thickness Measurement Sensory's latest patent will further expand its intellectual property portfolio for coating and layer thickness measurement into the European Union

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: GREENSBORO, N.C., July 28, 2020 /PRNewswire/ --Sensory Analytics, the fast-growing supplier of highly precise and award-winning SpecMetrix coating thickness and film layer measurement systems, announced the issuance of the Company's latest patent, European Patent No. 2972070. This new patent covers methods and systems for the in-process thickness measurement of thinner coatings or layers on various substrates. The patent extends the Company's current intellectual property portfolio related to measuring thinner coatings and layers into the EU. "The addition of this EU patent reflects our ongoing focus on broadening the geography and application range of our SpecMetrix product line and our intellectual property portfolio" said Greg Frisby, Global Industry Manager for SpecMetrix Systems at Sensory Analytics. "We look forward to expanding the breadth of our exclusive SpecMetrix coating thickness solutions within the global coated metal, flexible packaging, automotive, electronics, glass, and industrial manufacturing industries while adding value for our global partners and shareholders." Built upon its expanding intellectual property portfolio, Sensory Analytics has launched a series of innovative measurement tools including its exclusive SpecMetrix coil coating measurement systems for primer, pretreatments, clear coats, back coats, and highly pigmented thicker topcoats directly on coil coating lines or in QA labs. All SpecMetrix systems give users accurate, objective, and real-time coating measurement data without any operator interpretation or involvement. With the capability of measuring a broad coating thickness range from 0.2 to 250 microns and a wide variety of materials from transparent to highly pigmented coatings, SpecMetrix systems help manufacturing customers in over 40 countries to reduce costs while streamlining plant QA processes. These patented and exclusive offerings are integrated with proprietary SpecMetrix software to automatically capture and deliver real-time coating and layer thickness data for improved process control and quality assurance. About Sensory AnalyticsSensory Analytics supplies award-winning SpecMetrix coating thickness and film layer measurement systems to manufacturing and coating leaders worldwide. The company's exclusive SpecMetrix offerings measure the absolute thickness of applied wet or dry coatings in real-time with nanometric precision during the coating process or in QA labs and R&D centers. SpecMetrix systems help global manufacturers to optimize coating usage, process control, and the quality of their coated end-products. For additional information, visit www.specmetrix.com. Photo(s):https://www.prlog.org/12831782 Press release distributed by PRLog SOURCE Sensory Analytics Related Links http://www.specmetrix.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Sensory Analytics Awarded European Patent for Coating Thickness Measurement. Sensory's latest patent will further expand its intellectual property portfolio for coating and layer thickness measurement into the European Union.<|eot_id|>

edtsum908

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LONDON--(BUSINESS WIRE)-- Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) First Eagle Investment Management, LLC Company dealt in Willis Towers Watson plc Class of relevant security to which the dealings being disclosed relate (Note 2) NASDAQ: WLTW Date of dealing March 18, 2021 2. INTERESTS AND SHORT POSITIONS a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 2,205,626 (1.71%) - (2) Derivatives (other than options) - - (3) Options and agreements to purchase/sell - - Total 2,205,626 (1.71%) - b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities N/A N/A (2) Derivatives (other than options) N/A N/A (3) Options and agreements to purchase/sell N/A N/A Total N/A N/A Ap20 1. DEALINGS (Note 4) a. Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) Purchase 35,519 220.8476 USD b. Derivatives transactions (other than options transactions) Product name, e.g. CFD Nature of transaction (Note 6) Number of relevant securities (Note 7) Price per unit (Note 5) N/A N/A N/A N/A c. Options transactions in respect of existing relevant securities i. Writing, selling, purchasing or varying Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5) N/A N/A N/A N/A N/A N/A N/A ii. Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) N/A N/A N/A d. Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) N/A N/A N/A Ap21 2. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure March 19, 2021 Contact name Audrey Miller Telephone number +1 212-698-3300 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Form 8.3 - Willis Towers Watson plc.

LONDON--(BUSINESS WIRE)-- Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) First Eagle Investment Management, LLC Company dealt in Willis Towers Watson plc Class of relevant security to which the dealings being disclosed relate (Note 2) NASDAQ: WLTW Date of dealing March 18, 2021 2. INTERESTS AND SHORT POSITIONS a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 2,205,626 (1.71%) - (2) Derivatives (other than options) - - (3) Options and agreements to purchase/sell - - Total 2,205,626 (1.71%) - b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities N/A N/A (2) Derivatives (other than options) N/A N/A (3) Options and agreements to purchase/sell N/A N/A Total N/A N/A Ap20 1. DEALINGS (Note 4) a. Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) Purchase 35,519 220.8476 USD b. Derivatives transactions (other than options transactions) Product name, e.g. CFD Nature of transaction (Note 6) Number of relevant securities (Note 7) Price per unit (Note 5) N/A N/A N/A N/A c. Options transactions in respect of existing relevant securities i. Writing, selling, purchasing or varying Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5) N/A N/A N/A N/A N/A N/A N/A ii. Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) N/A N/A N/A d. Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) N/A N/A N/A Ap21 2. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure March 19, 2021 Contact name Audrey Miller Telephone number +1 212-698-3300 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10)

Form 8.3 - Willis Towers Watson plc

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: LONDON--(BUSINESS WIRE)-- Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) First Eagle Investment Management, LLC Company dealt in Willis Towers Watson plc Class of relevant security to which the dealings being disclosed relate (Note 2) NASDAQ: WLTW Date of dealing March 18, 2021 2. INTERESTS AND SHORT POSITIONS a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 2,205,626 (1.71%) - (2) Derivatives (other than options) - - (3) Options and agreements to purchase/sell - - Total 2,205,626 (1.71%) - b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities N/A N/A (2) Derivatives (other than options) N/A N/A (3) Options and agreements to purchase/sell N/A N/A Total N/A N/A Ap20 1. DEALINGS (Note 4) a. Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) Purchase 35,519 220.8476 USD b. Derivatives transactions (other than options transactions) Product name, e.g. CFD Nature of transaction (Note 6) Number of relevant securities (Note 7) Price per unit (Note 5) N/A N/A N/A N/A c. Options transactions in respect of existing relevant securities i. Writing, selling, purchasing or varying Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5) N/A N/A N/A N/A N/A N/A N/A ii. Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) N/A N/A N/A d. Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) N/A N/A N/A Ap21 2. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure March 19, 2021 Contact name Audrey Miller Telephone number +1 212-698-3300 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Form 8.3 - Willis Towers Watson plc.<|eot_id|>

edtsum909

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Dec.3, 2020 /PRNewswire/ --Kubient(NasdaqCM: KBNT, KBNTW), the cloud advertising marketplace that enables advertisers and publishers to reach, monetize and connect their audiences efficiently and effectively, today announced the identification of previously undetected fraudulent synthetic network (SynthNet) designed to present web based or computer generated traffic as legitimate mobile application traffic coming from premium app publishers. The SynthNet fraud was detected through Kubient's Artificial Intelligence (KAI), an in-stream ad-fraud prevention tool that uses pattern recognition and device scoring to catch and identify fraud before it happens. The result was a significant amount of fraudulent website and computer traffic being transmitted that claimed to come from mobile sources like The Washington Post, Weather Underground, and a mixture of apps in other categories such as gaming, entertainment, utilities, shopping, and food. SynthNet is a Central Control System (CCS) bot, meaning it doesn't infect devices or make calls from third party networks, but rather it is deployed directly by the fraudsters on their own systems. These bad actors use it to sell fraudulent traffic as a video ad placement which offers a higher payout to the publisher compared to traditional display advertising. To deploy SynthNet at large scale and have wide saturation across the United States, SynthNet used a Cloud Service Broker (CSB). The service enabled SynthNet to be deployed across multiple cloud providers such as AWS, Google and Azure without needing a direct account with the services and it allows them to continue to operate and deploy if they are disabled from any single provider. "Bad actors are getting smarter about finding ways to send false impressions," said Paul Roberts, Interim CEO and founder of Kubient. "We continue to urge advertisers to be cautious of the partners they allow into their tech stacks and remain skeptical about suspicious activity or CPMs that appear to be too good to be true. As ad budgets are still recovering due to COVID-19, it's important that media buyers are buying quality inventory and are catching fraud as soon as possible." The KAI algorithm is trained to analyze the behavior, consistency, and quality to determine audience credibility - accurately flagging fraud within the 300 milliseconds time frame of a programmatic advertising auction. In fact, Kubient's technology catches it in less than 10 milliseconds, which the company believes is faster than any other tool on the market. In the case of SynthNet, Kubient saw two things in a routine analysis of KAI: Fingerprint device information called "User Agents" that were being used in the auction requests which were many versions passed the current iterations of the web browsers they portrayed; and The same "User Agents" were in fact Mobile Web traffic, yet the criminals were attempting to sell the advertising impressions as Mobile App traffic. "Fraudsters have devised simplistic yet agile systems that allow them to do less work but achieve maximum impact while evading typical anti-fraud measures," stated Roberts. "KAI technology goes beyond the narrow scope our competitors are relying on and allows us to weed out this new crop of criminals quickly before our clients spend any money." Following the unveiling of the fraud, Kubient reached out to the three companies that had been impacted by the invalid traffic and is working to future proof their ad operations moving forward. This discovery comes on the heels of the Kubient Fraud Prevention Team also discovering Weasel Fraud in October. To learn more about Kubient and read the full white paper, view the Weasel Fraud White Paper. About KubientKubient is a technology company with a mission to transform the digital advertising industry to audience-based marketing. Kubient's next generation cloud-based infrastructure enables efficient marketplace liquidity for buyers and sellers of digital advertising. The Kubient Audience Cloud is a flexible open marketplace for advertisers and publishers to reach, monetize and connect their audiences. Kubient's platform provides a transparent programmatic environment with proprietary artificial intelligence-powered pre-bid ad fraud prevention, and proprietary real-time bidding (RTB) marketplace automation for the digital out of home industry. The Audience Cloud is the solution for brands and publishers that demand transparency and the ability to reach audiences across all channels and ad formats. For additional information, please visit www.kubient.com. Forward-Looking StatementsThe information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act. Kubient Public RelationsClarity PR Molly GagnonT: 1-646-934-6924[emailprotected] Kubient Investor RelationsGateway Investor RelationsMatt Glover and Tom ColtonT: 1-949-574-3860[emailprotected] SOURCE Kubient Related Links https://kubient.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Kubient's KAI Identifies SynthNet Ad Fraud, Impacting Mobile App Ad Ecosystem. Fraud scheme targeting the mobile app space and evading detection from traditional linear fraud systems identified by KAI platform.

NEW YORK, Dec.3, 2020 /PRNewswire/ --Kubient(NasdaqCM: KBNT, KBNTW), the cloud advertising marketplace that enables advertisers and publishers to reach, monetize and connect their audiences efficiently and effectively, today announced the identification of previously undetected fraudulent synthetic network (SynthNet) designed to present web based or computer generated traffic as legitimate mobile application traffic coming from premium app publishers. The SynthNet fraud was detected through Kubient's Artificial Intelligence (KAI), an in-stream ad-fraud prevention tool that uses pattern recognition and device scoring to catch and identify fraud before it happens. The result was a significant amount of fraudulent website and computer traffic being transmitted that claimed to come from mobile sources like The Washington Post, Weather Underground, and a mixture of apps in other categories such as gaming, entertainment, utilities, shopping, and food. SynthNet is a Central Control System (CCS) bot, meaning it doesn't infect devices or make calls from third party networks, but rather it is deployed directly by the fraudsters on their own systems. These bad actors use it to sell fraudulent traffic as a video ad placement which offers a higher payout to the publisher compared to traditional display advertising. To deploy SynthNet at large scale and have wide saturation across the United States, SynthNet used a Cloud Service Broker (CSB). The service enabled SynthNet to be deployed across multiple cloud providers such as AWS, Google and Azure without needing a direct account with the services and it allows them to continue to operate and deploy if they are disabled from any single provider. "Bad actors are getting smarter about finding ways to send false impressions," said Paul Roberts, Interim CEO and founder of Kubient. "We continue to urge advertisers to be cautious of the partners they allow into their tech stacks and remain skeptical about suspicious activity or CPMs that appear to be too good to be true. As ad budgets are still recovering due to COVID-19, it's important that media buyers are buying quality inventory and are catching fraud as soon as possible." The KAI algorithm is trained to analyze the behavior, consistency, and quality to determine audience credibility - accurately flagging fraud within the 300 milliseconds time frame of a programmatic advertising auction. In fact, Kubient's technology catches it in less than 10 milliseconds, which the company believes is faster than any other tool on the market. In the case of SynthNet, Kubient saw two things in a routine analysis of KAI: Fingerprint device information called "User Agents" that were being used in the auction requests which were many versions passed the current iterations of the web browsers they portrayed; and The same "User Agents" were in fact Mobile Web traffic, yet the criminals were attempting to sell the advertising impressions as Mobile App traffic. "Fraudsters have devised simplistic yet agile systems that allow them to do less work but achieve maximum impact while evading typical anti-fraud measures," stated Roberts. "KAI technology goes beyond the narrow scope our competitors are relying on and allows us to weed out this new crop of criminals quickly before our clients spend any money." Following the unveiling of the fraud, Kubient reached out to the three companies that had been impacted by the invalid traffic and is working to future proof their ad operations moving forward. This discovery comes on the heels of the Kubient Fraud Prevention Team also discovering Weasel Fraud in October. To learn more about Kubient and read the full white paper, view the Weasel Fraud White Paper. About KubientKubient is a technology company with a mission to transform the digital advertising industry to audience-based marketing. Kubient's next generation cloud-based infrastructure enables efficient marketplace liquidity for buyers and sellers of digital advertising. The Kubient Audience Cloud is a flexible open marketplace for advertisers and publishers to reach, monetize and connect their audiences. Kubient's platform provides a transparent programmatic environment with proprietary artificial intelligence-powered pre-bid ad fraud prevention, and proprietary real-time bidding (RTB) marketplace automation for the digital out of home industry. The Audience Cloud is the solution for brands and publishers that demand transparency and the ability to reach audiences across all channels and ad formats. For additional information, please visit www.kubient.com. Forward-Looking StatementsThe information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act. Kubient Public RelationsClarity PR Molly GagnonT: 1-646-934-6924[emailprotected] Kubient Investor RelationsGateway Investor RelationsMatt Glover and Tom ColtonT: 1-949-574-3860[emailprotected] SOURCE Kubient Related Links https://kubient.com

Kubient's KAI Identifies SynthNet Ad Fraud, Impacting Mobile App Ad Ecosystem Fraud scheme targeting the mobile app space and evading detection from traditional linear fraud systems identified by KAI platform

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Dec.3, 2020 /PRNewswire/ --Kubient(NasdaqCM: KBNT, KBNTW), the cloud advertising marketplace that enables advertisers and publishers to reach, monetize and connect their audiences efficiently and effectively, today announced the identification of previously undetected fraudulent synthetic network (SynthNet) designed to present web based or computer generated traffic as legitimate mobile application traffic coming from premium app publishers. The SynthNet fraud was detected through Kubient's Artificial Intelligence (KAI), an in-stream ad-fraud prevention tool that uses pattern recognition and device scoring to catch and identify fraud before it happens. The result was a significant amount of fraudulent website and computer traffic being transmitted that claimed to come from mobile sources like The Washington Post, Weather Underground, and a mixture of apps in other categories such as gaming, entertainment, utilities, shopping, and food. SynthNet is a Central Control System (CCS) bot, meaning it doesn't infect devices or make calls from third party networks, but rather it is deployed directly by the fraudsters on their own systems. These bad actors use it to sell fraudulent traffic as a video ad placement which offers a higher payout to the publisher compared to traditional display advertising. To deploy SynthNet at large scale and have wide saturation across the United States, SynthNet used a Cloud Service Broker (CSB). The service enabled SynthNet to be deployed across multiple cloud providers such as AWS, Google and Azure without needing a direct account with the services and it allows them to continue to operate and deploy if they are disabled from any single provider. "Bad actors are getting smarter about finding ways to send false impressions," said Paul Roberts, Interim CEO and founder of Kubient. "We continue to urge advertisers to be cautious of the partners they allow into their tech stacks and remain skeptical about suspicious activity or CPMs that appear to be too good to be true. As ad budgets are still recovering due to COVID-19, it's important that media buyers are buying quality inventory and are catching fraud as soon as possible." The KAI algorithm is trained to analyze the behavior, consistency, and quality to determine audience credibility - accurately flagging fraud within the 300 milliseconds time frame of a programmatic advertising auction. In fact, Kubient's technology catches it in less than 10 milliseconds, which the company believes is faster than any other tool on the market. In the case of SynthNet, Kubient saw two things in a routine analysis of KAI: Fingerprint device information called "User Agents" that were being used in the auction requests which were many versions passed the current iterations of the web browsers they portrayed; and The same "User Agents" were in fact Mobile Web traffic, yet the criminals were attempting to sell the advertising impressions as Mobile App traffic. "Fraudsters have devised simplistic yet agile systems that allow them to do less work but achieve maximum impact while evading typical anti-fraud measures," stated Roberts. "KAI technology goes beyond the narrow scope our competitors are relying on and allows us to weed out this new crop of criminals quickly before our clients spend any money." Following the unveiling of the fraud, Kubient reached out to the three companies that had been impacted by the invalid traffic and is working to future proof their ad operations moving forward. This discovery comes on the heels of the Kubient Fraud Prevention Team also discovering Weasel Fraud in October. To learn more about Kubient and read the full white paper, view the Weasel Fraud White Paper. About KubientKubient is a technology company with a mission to transform the digital advertising industry to audience-based marketing. Kubient's next generation cloud-based infrastructure enables efficient marketplace liquidity for buyers and sellers of digital advertising. The Kubient Audience Cloud is a flexible open marketplace for advertisers and publishers to reach, monetize and connect their audiences. Kubient's platform provides a transparent programmatic environment with proprietary artificial intelligence-powered pre-bid ad fraud prevention, and proprietary real-time bidding (RTB) marketplace automation for the digital out of home industry. The Audience Cloud is the solution for brands and publishers that demand transparency and the ability to reach audiences across all channels and ad formats. For additional information, please visit www.kubient.com. Forward-Looking StatementsThe information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act. Kubient Public RelationsClarity PR Molly GagnonT: 1-646-934-6924[emailprotected] Kubient Investor RelationsGateway Investor RelationsMatt Glover and Tom ColtonT: 1-949-574-3860[emailprotected] SOURCE Kubient Related Links https://kubient.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Kubient's KAI Identifies SynthNet Ad Fraud, Impacting Mobile App Ad Ecosystem. Fraud scheme targeting the mobile app space and evading detection from traditional linear fraud systems identified by KAI platform.<|eot_id|>

edtsum910

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NANJING, China, June 8, 2020 /PRNewswire/ -- China's eastern city Nanjing will hold 2020 Nanjing Tech Week on June 22-26, showcasing latest technologies, according to the event's organizing committee.Nanjing Tech Week centers around the theme of "Understanding City Innovation", with virtual exhibitions of over 460 latest technologies, landmark projects, solutions for local developments, as well as video displays and 25 webinars. Theme of Nanjing Tech Week "Understanding City Innovation" Activities of the week-long event go virtual, as conferences will be held remotely with scientists, entrepreneurs, investors, bankers participating via video link supported by 5G, VR and AR technologies, an online platform set up showcasing local progress in innovation, international exchanges and regional cooperation. Also on the website (https://www.nanjingtech.cn) are an entrepreneur contest and forums designed to increase interactivity. As of June 5, nearly 3,000 participants confirmed their attendance including Chinese and foreign academicians, high-ranking government officials, relevant government agencies, presidents of universities and research institutes, prominent entrepreneurs, and investors. As one of the signature activities of the 2020 Nanjing Tech Week, the entrepreneurship contest will conduct roadshows and recruitment, with over 100 preliminary selections, so far attracting hundreds of projects participating in the category of software information services, new energy vehicles, biomedicine, AI, and integrated circuits. The finals will be held on June 25 in Nanjing, with Hangzhou and a Russian city as two virtual venue. The number of online audiences is expected to exceed one million.Image Attachments Links:Link: http://asianetnews.net/view-attachment?attach-id=364866Caption: Theme of Nanjing Tech Week "Understanding City Innovation"SOURCE The Organizing Committee of Nanjing Tech Week Related Links https://www.nanjingtech.cn Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Nanjing to hold virtual tech week. English - P. France - Français. Deutschland - Deutsch.

NANJING, China, June 8, 2020 /PRNewswire/ -- China's eastern city Nanjing will hold 2020 Nanjing Tech Week on June 22-26, showcasing latest technologies, according to the event's organizing committee.Nanjing Tech Week centers around the theme of "Understanding City Innovation", with virtual exhibitions of over 460 latest technologies, landmark projects, solutions for local developments, as well as video displays and 25 webinars. Theme of Nanjing Tech Week "Understanding City Innovation" Activities of the week-long event go virtual, as conferences will be held remotely with scientists, entrepreneurs, investors, bankers participating via video link supported by 5G, VR and AR technologies, an online platform set up showcasing local progress in innovation, international exchanges and regional cooperation. Also on the website (https://www.nanjingtech.cn) are an entrepreneur contest and forums designed to increase interactivity. As of June 5, nearly 3,000 participants confirmed their attendance including Chinese and foreign academicians, high-ranking government officials, relevant government agencies, presidents of universities and research institutes, prominent entrepreneurs, and investors. As one of the signature activities of the 2020 Nanjing Tech Week, the entrepreneurship contest will conduct roadshows and recruitment, with over 100 preliminary selections, so far attracting hundreds of projects participating in the category of software information services, new energy vehicles, biomedicine, AI, and integrated circuits. The finals will be held on June 25 in Nanjing, with Hangzhou and a Russian city as two virtual venue. The number of online audiences is expected to exceed one million.Image Attachments Links:Link: http://asianetnews.net/view-attachment?attach-id=364866Caption: Theme of Nanjing Tech Week "Understanding City Innovation"SOURCE The Organizing Committee of Nanjing Tech Week Related Links https://www.nanjingtech.cn

Nanjing to hold virtual tech week English - P France - Franais Deutschland - Deutsch

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NANJING, China, June 8, 2020 /PRNewswire/ -- China's eastern city Nanjing will hold 2020 Nanjing Tech Week on June 22-26, showcasing latest technologies, according to the event's organizing committee.Nanjing Tech Week centers around the theme of "Understanding City Innovation", with virtual exhibitions of over 460 latest technologies, landmark projects, solutions for local developments, as well as video displays and 25 webinars. Theme of Nanjing Tech Week "Understanding City Innovation" Activities of the week-long event go virtual, as conferences will be held remotely with scientists, entrepreneurs, investors, bankers participating via video link supported by 5G, VR and AR technologies, an online platform set up showcasing local progress in innovation, international exchanges and regional cooperation. Also on the website (https://www.nanjingtech.cn) are an entrepreneur contest and forums designed to increase interactivity. As of June 5, nearly 3,000 participants confirmed their attendance including Chinese and foreign academicians, high-ranking government officials, relevant government agencies, presidents of universities and research institutes, prominent entrepreneurs, and investors. As one of the signature activities of the 2020 Nanjing Tech Week, the entrepreneurship contest will conduct roadshows and recruitment, with over 100 preliminary selections, so far attracting hundreds of projects participating in the category of software information services, new energy vehicles, biomedicine, AI, and integrated circuits. The finals will be held on June 25 in Nanjing, with Hangzhou and a Russian city as two virtual venue. The number of online audiences is expected to exceed one million.Image Attachments Links:Link: http://asianetnews.net/view-attachment?attach-id=364866Caption: Theme of Nanjing Tech Week "Understanding City Innovation"SOURCE The Organizing Committee of Nanjing Tech Week Related Links https://www.nanjingtech.cn Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Nanjing to hold virtual tech week. English - P. France - Français. Deutschland - Deutsch.<|eot_id|>

edtsum911

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN, Aug. 11, 2020 /PRNewswire/ -- The "Shale Gas Market Size, Share & Trends Analysis Report By Application (Industrial, Power Generation, Residential, Commercial, Transportation), By Region, And Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering. The global shale gas market size is expected to reach USD 131.1 billion by 2027, ascending at a CAGR of 8.5% over the forecast period. Rising demand for cleaner combustion energy sources in several end-use applications is likely to drive the market over the forecast period.Profitable production of shale gas, a natural gas trapped in shale formations, relies on accessible demand for it. It has technical characteristics that make it a very useful and flexible fuel, where the delivery infrastructure exists, and it has found uses in the building thermal sector, industrial thermal sector, and power generation. Recent macroeconomic shifts along with fuel supply competitive dynamics have caused the proportions to favor shale gas usage in power generation more and industrial usage less.Shale gas contributes substantial energy to electricity generation and second only to coal in terms of the share of energy supply in global electricity generation. This share is expected to grow over the next few decades in response to the economic and environmental limits of coal generation, at least where natural gas is a viable alternative. This end-use application is expected to drive the market over the forecast period.The shale gas supply chain includes production and processing, gas transmission and storage, and distribution to city gate, large volume customers, residential customers, and commercial customers. Development of hydraulic fracturing technology along with horizontal drilling technique is expected to boost economical production of shale gas, thereby strengthening the upstream segment of the supply chain.Shale Gas Market Report Highlights North America occupied the largest market revenue share in 2019, with U.S. being the major contributor to the regional market. Abundant shale gas reserves along with development of advanced drilling technology are among the key factors influencing industry growth Potential shale gas resources in China are attracting huge investments from major market players all over the world in order to extract and produce unconventional gas from the reserves The power generation segment occupied the largest market share of 36.1% in 2019 owing to growing demand of natural gas in coal-to-gas electricity generation plants The transportation sector is estimated to witness a significant CAGR owing to increasing number of Compressed Natural Gas (CNG) fueled vehicles across the automotive industry. Key Topics Covered: Chapter 1. Methodology and Scope1.1. Market segmentation & scope1.2. Information procurement1.2.1. Purchased database1.2.2. Internal database1.2.3. Secondary sources &third-party perspectives1.2.4. Primary research1.3. Information analysis1.3.1. Data analysis models1.4. Market formulation & data visualization1.5. Data validation & publishingChapter 2. Executive Shale gasChapter 3. Market DefinitionsChapter 4. Shale gas Market Variables, Trends & Scope4.1. Market Size and Growth Prospects4.2. Industry Value Chain Analysis4.3. Market Dynamics4.3.1. Market Driver Analysis4.3.1.1. Advancement in drilling technology4.3.1.2. Abundant reserves4.3.2. Market Restraint/ Challenges Analysis4.3.2.1. High production cost4.4. Penetration & Growth Prospect Mapping4.5. Business Environment Analysis Tools4.5.1. Industry Analysis - Porter's4.5.2. PEST Analysis4.6. Company Market Share Analysis, 2019Chapter 5. Shale gas Market Application Outlook5.1. Market Size Estimates & Forecasts and Trend Analysis, 2016 - 2027 (Bcf) (USD Billion)5.2. Industrial5.2.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.3. Power Generation5.3.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.4. Residential5.4.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.5. Commercial5.5.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.6. Transportation5.6.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)Chapter 6. Shale Gas Market Regional Outlook6.1. Shale gas Market, By Region, 2019 & 20276.2. North America6.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.2. U.S.6.2.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.3. Canada6.2.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.4. Mexico6.2.4.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3. ROW6.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.2. China6.3.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.3. Argentina6.3.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.4. Algeria6.3.4.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.5. South Africa6.3.5.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)Chapter 7. Competitive Landscape7.1. Royal Dutch Shell PLC7.1.1. Company overview7.1.2. Financial performance7.1.3. Product benchmarking7.1.4. Recent developments7.2. ConocoPhillips7.2.1. Company overview7.2.2. Financial performance7.2.3. Product benchmarking7.2.4. Recent developments7.3. PetroChina Company Limited7.3.1. Company overview7.3.2. Financial performance7.3.3. Product benchmarking7.3.4. Recent developments7.4. Exxon Mobil Corporation7.4.1. Company overview7.4.2. Financial performance7.4.3. Product benchmarking7.4.4. Recent developments7.5. Chevron Corporation7.5.1. Company overview7.5.2. Product benchmarking7.5.3. Product benchmarking7.5.4. Recent developments7.6. Chesapeake Energy Corporation7.6.1. Company overview7.6.2. Financial performance7.6.3. Product benchmarking7.6.4. Recent developments7.7. Equinor ASA7.7.1. Company overview7.7.2. Financial performance7.7.3. Product benchmarking7.7.4. Recent developments7.8. Repsol SA7.8.1. Company overview7.8.2. Financial performance7.8.3. Product benchmarking7.8.4. Recent developments7.9. Southwestern Energy Company7.9.1. Company overview7.9.2. Financial performance7.9.3. Product benchmarking7.9.4. Recent developments7.10. SINOPEC/Shs7.10.1. Company overview7.10.2. Financial performance7.10.3. Product benchmarking7.10.4. Recent developmentsFor more information about this report visit https://www.researchandmarkets.com/r/f5pstb Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

$131 Billion Worldwide Shale Gas Industry to 2027 - Advancement in Drilling Technology to Drive the Market.

DUBLIN, Aug. 11, 2020 /PRNewswire/ -- The "Shale Gas Market Size, Share & Trends Analysis Report By Application (Industrial, Power Generation, Residential, Commercial, Transportation), By Region, And Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering. The global shale gas market size is expected to reach USD 131.1 billion by 2027, ascending at a CAGR of 8.5% over the forecast period. Rising demand for cleaner combustion energy sources in several end-use applications is likely to drive the market over the forecast period.Profitable production of shale gas, a natural gas trapped in shale formations, relies on accessible demand for it. It has technical characteristics that make it a very useful and flexible fuel, where the delivery infrastructure exists, and it has found uses in the building thermal sector, industrial thermal sector, and power generation. Recent macroeconomic shifts along with fuel supply competitive dynamics have caused the proportions to favor shale gas usage in power generation more and industrial usage less.Shale gas contributes substantial energy to electricity generation and second only to coal in terms of the share of energy supply in global electricity generation. This share is expected to grow over the next few decades in response to the economic and environmental limits of coal generation, at least where natural gas is a viable alternative. This end-use application is expected to drive the market over the forecast period.The shale gas supply chain includes production and processing, gas transmission and storage, and distribution to city gate, large volume customers, residential customers, and commercial customers. Development of hydraulic fracturing technology along with horizontal drilling technique is expected to boost economical production of shale gas, thereby strengthening the upstream segment of the supply chain.Shale Gas Market Report Highlights North America occupied the largest market revenue share in 2019, with U.S. being the major contributor to the regional market. Abundant shale gas reserves along with development of advanced drilling technology are among the key factors influencing industry growth Potential shale gas resources in China are attracting huge investments from major market players all over the world in order to extract and produce unconventional gas from the reserves The power generation segment occupied the largest market share of 36.1% in 2019 owing to growing demand of natural gas in coal-to-gas electricity generation plants The transportation sector is estimated to witness a significant CAGR owing to increasing number of Compressed Natural Gas (CNG) fueled vehicles across the automotive industry. Key Topics Covered: Chapter 1. Methodology and Scope1.1. Market segmentation & scope1.2. Information procurement1.2.1. Purchased database1.2.2. Internal database1.2.3. Secondary sources &third-party perspectives1.2.4. Primary research1.3. Information analysis1.3.1. Data analysis models1.4. Market formulation & data visualization1.5. Data validation & publishingChapter 2. Executive Shale gasChapter 3. Market DefinitionsChapter 4. Shale gas Market Variables, Trends & Scope4.1. Market Size and Growth Prospects4.2. Industry Value Chain Analysis4.3. Market Dynamics4.3.1. Market Driver Analysis4.3.1.1. Advancement in drilling technology4.3.1.2. Abundant reserves4.3.2. Market Restraint/ Challenges Analysis4.3.2.1. High production cost4.4. Penetration & Growth Prospect Mapping4.5. Business Environment Analysis Tools4.5.1. Industry Analysis - Porter's4.5.2. PEST Analysis4.6. Company Market Share Analysis, 2019Chapter 5. Shale gas Market Application Outlook5.1. Market Size Estimates & Forecasts and Trend Analysis, 2016 - 2027 (Bcf) (USD Billion)5.2. Industrial5.2.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.3. Power Generation5.3.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.4. Residential5.4.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.5. Commercial5.5.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.6. Transportation5.6.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)Chapter 6. Shale Gas Market Regional Outlook6.1. Shale gas Market, By Region, 2019 & 20276.2. North America6.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.2. U.S.6.2.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.3. Canada6.2.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.4. Mexico6.2.4.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3. ROW6.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.2. China6.3.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.3. Argentina6.3.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.4. Algeria6.3.4.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.5. South Africa6.3.5.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)Chapter 7. Competitive Landscape7.1. Royal Dutch Shell PLC7.1.1. Company overview7.1.2. Financial performance7.1.3. Product benchmarking7.1.4. Recent developments7.2. ConocoPhillips7.2.1. Company overview7.2.2. Financial performance7.2.3. Product benchmarking7.2.4. Recent developments7.3. PetroChina Company Limited7.3.1. Company overview7.3.2. Financial performance7.3.3. Product benchmarking7.3.4. Recent developments7.4. Exxon Mobil Corporation7.4.1. Company overview7.4.2. Financial performance7.4.3. Product benchmarking7.4.4. Recent developments7.5. Chevron Corporation7.5.1. Company overview7.5.2. Product benchmarking7.5.3. Product benchmarking7.5.4. Recent developments7.6. Chesapeake Energy Corporation7.6.1. Company overview7.6.2. Financial performance7.6.3. Product benchmarking7.6.4. Recent developments7.7. Equinor ASA7.7.1. Company overview7.7.2. Financial performance7.7.3. Product benchmarking7.7.4. Recent developments7.8. Repsol SA7.8.1. Company overview7.8.2. Financial performance7.8.3. Product benchmarking7.8.4. Recent developments7.9. Southwestern Energy Company7.9.1. Company overview7.9.2. Financial performance7.9.3. Product benchmarking7.9.4. Recent developments7.10. SINOPEC/Shs7.10.1. Company overview7.10.2. Financial performance7.10.3. Product benchmarking7.10.4. Recent developmentsFor more information about this report visit https://www.researchandmarkets.com/r/f5pstb Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

$131 Billion Worldwide Shale Gas Industry to 2027 - Advancement in Drilling Technology to Drive the Market

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN, Aug. 11, 2020 /PRNewswire/ -- The "Shale Gas Market Size, Share & Trends Analysis Report By Application (Industrial, Power Generation, Residential, Commercial, Transportation), By Region, And Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering. The global shale gas market size is expected to reach USD 131.1 billion by 2027, ascending at a CAGR of 8.5% over the forecast period. Rising demand for cleaner combustion energy sources in several end-use applications is likely to drive the market over the forecast period.Profitable production of shale gas, a natural gas trapped in shale formations, relies on accessible demand for it. It has technical characteristics that make it a very useful and flexible fuel, where the delivery infrastructure exists, and it has found uses in the building thermal sector, industrial thermal sector, and power generation. Recent macroeconomic shifts along with fuel supply competitive dynamics have caused the proportions to favor shale gas usage in power generation more and industrial usage less.Shale gas contributes substantial energy to electricity generation and second only to coal in terms of the share of energy supply in global electricity generation. This share is expected to grow over the next few decades in response to the economic and environmental limits of coal generation, at least where natural gas is a viable alternative. This end-use application is expected to drive the market over the forecast period.The shale gas supply chain includes production and processing, gas transmission and storage, and distribution to city gate, large volume customers, residential customers, and commercial customers. Development of hydraulic fracturing technology along with horizontal drilling technique is expected to boost economical production of shale gas, thereby strengthening the upstream segment of the supply chain.Shale Gas Market Report Highlights North America occupied the largest market revenue share in 2019, with U.S. being the major contributor to the regional market. Abundant shale gas reserves along with development of advanced drilling technology are among the key factors influencing industry growth Potential shale gas resources in China are attracting huge investments from major market players all over the world in order to extract and produce unconventional gas from the reserves The power generation segment occupied the largest market share of 36.1% in 2019 owing to growing demand of natural gas in coal-to-gas electricity generation plants The transportation sector is estimated to witness a significant CAGR owing to increasing number of Compressed Natural Gas (CNG) fueled vehicles across the automotive industry. Key Topics Covered: Chapter 1. Methodology and Scope1.1. Market segmentation & scope1.2. Information procurement1.2.1. Purchased database1.2.2. Internal database1.2.3. Secondary sources &third-party perspectives1.2.4. Primary research1.3. Information analysis1.3.1. Data analysis models1.4. Market formulation & data visualization1.5. Data validation & publishingChapter 2. Executive Shale gasChapter 3. Market DefinitionsChapter 4. Shale gas Market Variables, Trends & Scope4.1. Market Size and Growth Prospects4.2. Industry Value Chain Analysis4.3. Market Dynamics4.3.1. Market Driver Analysis4.3.1.1. Advancement in drilling technology4.3.1.2. Abundant reserves4.3.2. Market Restraint/ Challenges Analysis4.3.2.1. High production cost4.4. Penetration & Growth Prospect Mapping4.5. Business Environment Analysis Tools4.5.1. Industry Analysis - Porter's4.5.2. PEST Analysis4.6. Company Market Share Analysis, 2019Chapter 5. Shale gas Market Application Outlook5.1. Market Size Estimates & Forecasts and Trend Analysis, 2016 - 2027 (Bcf) (USD Billion)5.2. Industrial5.2.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.3. Power Generation5.3.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.4. Residential5.4.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.5. Commercial5.5.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)5.6. Transportation5.6.1. Market Estimates and forecasts by region, 2016 - 2027 (Bcf) (USD Billion)Chapter 6. Shale Gas Market Regional Outlook6.1. Shale gas Market, By Region, 2019 & 20276.2. North America6.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.2. U.S.6.2.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.3. Canada6.2.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.2.4. Mexico6.2.4.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3. ROW6.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.2. China6.3.2.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.3. Argentina6.3.3.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.4. Algeria6.3.4.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)6.3.5. South Africa6.3.5.1. Market Estimates and forecasts by application, 2016 - 2027 (Bcf) (USD Billion)Chapter 7. Competitive Landscape7.1. Royal Dutch Shell PLC7.1.1. Company overview7.1.2. Financial performance7.1.3. Product benchmarking7.1.4. Recent developments7.2. ConocoPhillips7.2.1. Company overview7.2.2. Financial performance7.2.3. Product benchmarking7.2.4. Recent developments7.3. PetroChina Company Limited7.3.1. Company overview7.3.2. Financial performance7.3.3. Product benchmarking7.3.4. Recent developments7.4. Exxon Mobil Corporation7.4.1. Company overview7.4.2. Financial performance7.4.3. Product benchmarking7.4.4. Recent developments7.5. Chevron Corporation7.5.1. Company overview7.5.2. Product benchmarking7.5.3. Product benchmarking7.5.4. Recent developments7.6. Chesapeake Energy Corporation7.6.1. Company overview7.6.2. Financial performance7.6.3. Product benchmarking7.6.4. Recent developments7.7. Equinor ASA7.7.1. Company overview7.7.2. Financial performance7.7.3. Product benchmarking7.7.4. Recent developments7.8. Repsol SA7.8.1. Company overview7.8.2. Financial performance7.8.3. Product benchmarking7.8.4. Recent developments7.9. Southwestern Energy Company7.9.1. Company overview7.9.2. Financial performance7.9.3. Product benchmarking7.9.4. Recent developments7.10. SINOPEC/Shs7.10.1. Company overview7.10.2. Financial performance7.10.3. Product benchmarking7.10.4. Recent developmentsFor more information about this report visit https://www.researchandmarkets.com/r/f5pstb Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> $131 Billion Worldwide Shale Gas Industry to 2027 - Advancement in Drilling Technology to Drive the Market.<|eot_id|>

edtsum912

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BRONX, N.Y., July 29, 2020 /PRNewswire/ -- Britta Will, Ph.D., assistant professor of medicine and of cell biology at Albert Einstein College of Medicine, has won a 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research. Dr. Will is one of seven New York City area-based scientists to receive the prestigious award, which provides $600,000 over three years for innovative basic science cancer research. Dr. Will's award will help fund her studies on the mechanisms that create and sustain cancer stem cellsa unique and therapy-resistant population of cancer cells in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), two age-related and largely incurable blood cancers. Watch video of Dr. Britta Will describing her cancer research. "I'm very excited and honored that the Pershing Square Sohn Cancer Research Alliance selected me for this award," Dr. Will said. "The prize will boost my lab's efforts to make scientific advances that can help us better understand these cancers and work toward developing drugs that can benefit patients. With every publication, with every piece of data we put out there, we increase the knowledge and our ability to help patients. Being able to work on this every day is a real privilege." When people have AML or MDS, a small population of cancerous blood stem cells, called leukemic stem cells (LSCs), resists chemotherapy and causes the cancers to relapse. Dr. Will plans to investigate how iron influences LSCs. Specifically, she will study iron regulatory pathways, key processes that determine how cells acquire and use this essential nutrient. In research involving mouse models of myeloid leukemia and human LSCs, she willdetermine whether limiting the cells' access to iron can slow or prevent cancer growth. Results could lead to new drugs that could limit iron availability and make cancer stem cells more susceptible to chemotherapy. Dr. Will noted that the prize specifically supports early-stage research that is impossible to get funded through traditional grants. "The Pershing Square Sohn Alliance's mission stresses that no one should be afraid to start something new and out-of-the-box," said Dr. Will, whose lab includes four postdoctoral researchers, a Ph.D. student, and several technicians. "This award enables us to step out of our comfort zone. It's also a great encouragement that provides an ecosystem for younger trainees on these projects to develop their careers." "This is a well-deserved honor for Dr. Will," said Roman Perez-Soler,M.D.,chief of medical oncology at Einstein and chair of oncology at Montefiore Health System. "Her creative and bold research earned her this award and we look forward to her continued success and scientific discoveries." Dr. Will is the second Einstein faculty member to win the Pershing Square Sohn prize; in 2015, the Alliance awarded the honor to Evripidis Gavathiotis, Ph.D., professor of biochemistry and of medicine. About Albert Einstein College of MedicineAlbert Einstein College of Medicineis one of the nation's premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D.students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centersat Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, followus on Twitter, like us on Facebook,and view us on YouTube. SOURCE Albert Einstein College of Medicine Related Links www.einstein.yu.edu Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Britta Will, Ph.D., Wins Pershing Square Sohn Prize for Cancer Research.

BRONX, N.Y., July 29, 2020 /PRNewswire/ -- Britta Will, Ph.D., assistant professor of medicine and of cell biology at Albert Einstein College of Medicine, has won a 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research. Dr. Will is one of seven New York City area-based scientists to receive the prestigious award, which provides $600,000 over three years for innovative basic science cancer research. Dr. Will's award will help fund her studies on the mechanisms that create and sustain cancer stem cellsa unique and therapy-resistant population of cancer cells in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), two age-related and largely incurable blood cancers. Watch video of Dr. Britta Will describing her cancer research. "I'm very excited and honored that the Pershing Square Sohn Cancer Research Alliance selected me for this award," Dr. Will said. "The prize will boost my lab's efforts to make scientific advances that can help us better understand these cancers and work toward developing drugs that can benefit patients. With every publication, with every piece of data we put out there, we increase the knowledge and our ability to help patients. Being able to work on this every day is a real privilege." When people have AML or MDS, a small population of cancerous blood stem cells, called leukemic stem cells (LSCs), resists chemotherapy and causes the cancers to relapse. Dr. Will plans to investigate how iron influences LSCs. Specifically, she will study iron regulatory pathways, key processes that determine how cells acquire and use this essential nutrient. In research involving mouse models of myeloid leukemia and human LSCs, she willdetermine whether limiting the cells' access to iron can slow or prevent cancer growth. Results could lead to new drugs that could limit iron availability and make cancer stem cells more susceptible to chemotherapy. Dr. Will noted that the prize specifically supports early-stage research that is impossible to get funded through traditional grants. "The Pershing Square Sohn Alliance's mission stresses that no one should be afraid to start something new and out-of-the-box," said Dr. Will, whose lab includes four postdoctoral researchers, a Ph.D. student, and several technicians. "This award enables us to step out of our comfort zone. It's also a great encouragement that provides an ecosystem for younger trainees on these projects to develop their careers." "This is a well-deserved honor for Dr. Will," said Roman Perez-Soler,M.D.,chief of medical oncology at Einstein and chair of oncology at Montefiore Health System. "Her creative and bold research earned her this award and we look forward to her continued success and scientific discoveries." Dr. Will is the second Einstein faculty member to win the Pershing Square Sohn prize; in 2015, the Alliance awarded the honor to Evripidis Gavathiotis, Ph.D., professor of biochemistry and of medicine. About Albert Einstein College of MedicineAlbert Einstein College of Medicineis one of the nation's premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D.students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centersat Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, followus on Twitter, like us on Facebook,and view us on YouTube. SOURCE Albert Einstein College of Medicine Related Links www.einstein.yu.edu

Britta Will, Ph.D., Wins Pershing Square Sohn Prize for Cancer Research

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: BRONX, N.Y., July 29, 2020 /PRNewswire/ -- Britta Will, Ph.D., assistant professor of medicine and of cell biology at Albert Einstein College of Medicine, has won a 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research. Dr. Will is one of seven New York City area-based scientists to receive the prestigious award, which provides $600,000 over three years for innovative basic science cancer research. Dr. Will's award will help fund her studies on the mechanisms that create and sustain cancer stem cellsa unique and therapy-resistant population of cancer cells in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), two age-related and largely incurable blood cancers. Watch video of Dr. Britta Will describing her cancer research. "I'm very excited and honored that the Pershing Square Sohn Cancer Research Alliance selected me for this award," Dr. Will said. "The prize will boost my lab's efforts to make scientific advances that can help us better understand these cancers and work toward developing drugs that can benefit patients. With every publication, with every piece of data we put out there, we increase the knowledge and our ability to help patients. Being able to work on this every day is a real privilege." When people have AML or MDS, a small population of cancerous blood stem cells, called leukemic stem cells (LSCs), resists chemotherapy and causes the cancers to relapse. Dr. Will plans to investigate how iron influences LSCs. Specifically, she will study iron regulatory pathways, key processes that determine how cells acquire and use this essential nutrient. In research involving mouse models of myeloid leukemia and human LSCs, she willdetermine whether limiting the cells' access to iron can slow or prevent cancer growth. Results could lead to new drugs that could limit iron availability and make cancer stem cells more susceptible to chemotherapy. Dr. Will noted that the prize specifically supports early-stage research that is impossible to get funded through traditional grants. "The Pershing Square Sohn Alliance's mission stresses that no one should be afraid to start something new and out-of-the-box," said Dr. Will, whose lab includes four postdoctoral researchers, a Ph.D. student, and several technicians. "This award enables us to step out of our comfort zone. It's also a great encouragement that provides an ecosystem for younger trainees on these projects to develop their careers." "This is a well-deserved honor for Dr. Will," said Roman Perez-Soler,M.D.,chief of medical oncology at Einstein and chair of oncology at Montefiore Health System. "Her creative and bold research earned her this award and we look forward to her continued success and scientific discoveries." Dr. Will is the second Einstein faculty member to win the Pershing Square Sohn prize; in 2015, the Alliance awarded the honor to Evripidis Gavathiotis, Ph.D., professor of biochemistry and of medicine. About Albert Einstein College of MedicineAlbert Einstein College of Medicineis one of the nation's premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D.students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centersat Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, followus on Twitter, like us on Facebook,and view us on YouTube. SOURCE Albert Einstein College of Medicine Related Links www.einstein.yu.edu Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Britta Will, Ph.D., Wins Pershing Square Sohn Prize for Cancer Research.<|eot_id|>

edtsum913

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NASHVILLE, Tenn., March 9, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, today announced fourth quarter and full year 2020 financial results. Net Revenues for the fourth quarter were $10.3 million, up 10% over the prior year period. For the full year 2020, Net Revenues totaled $37.4 million, a 9% increase over 2019. The company also recorded an additional $3.2 million in revenue during the year associated with divested product rights for two brands it is no longer distributing. As of December31, 2020, the total assets of the Company were $96.5 million, including $24.8 million in cash and investments. Total Liabilities were $49.6 million, and Total Shareholder's Equity was $47 million. Cumberland also had approximately $44 million in tax net operating loss carryforwards, resulting from the prior exercise of stock options. 2020 Highlights: Implemented national launch of a Next Generation Caldolor product featuring a ready-to-use formulation in a pre-mixed bag Commenced several national initiatives during 2020 to help hospitals access Cumberland's acute care brands during the COVID-19 pandemic Announced a series of publications featuring important new data associated with the Company's Caldolor (ibuprofen) Injection, for the treatment of pain and fever and Vibativ (telavancin) Injection, for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections Introduced an FDA-approved RediTrex line of injectable methotrexate products, featuring an innovative delivery system for patients with arthritis "We are grateful that Cumberland was able to successfully manage through the pandemic during 2020, in spite of the significant market headwinds and other challenges we encountered," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "Our facilities remained open, our operations continued, and our organization remained intact." He continued, "I would like to acknowledge and thank my colleagues for their continued dedication during such trying times for many. Together, we remain focused on our mission of advancing patient care through the delivery of high-quality medicines." Caldolor Early in 2020, Cumberland implemented a national launch of its Next Generation Caldolorproduct featuring a ready-to-use formulation, offering time and cost savings associated with its administration. Caldolor is a non-steroidal anti-inflammatory drug (NSAID) and may be used as the sole method of treatment for mild-moderate pain or as part of a multimodal treatment for severe pain. Cumberland's new formulation of Caldolor comes in a pre-mixed bag that is ready for use. It is the first FDA-approved pre-mixed bag of ibuprofen. Caldolor was also the subject of several clinical studies published during the year. These studies demonstrated that patients given Caldolor experienced less postoperative pain and had decreased opioid use. Due to these studies, Caldolor was recommended for consideration in Enhanced Recovery After Surgery protocols for the management of postoperative pain - including that of traumatic origin. Vibativ Cumberland launched several national initiatives during 2020 to help hospitals access the Company's acute care brands during the healthcare emergency. Cumberland's Vibativ product was used to help COVID-19 patients who developed secondary-bacterial infections in their lungs. Vibativ is a potent antibiotic, FDA approved to treat hospital and ventilator acquired pneumonia that can result from a variety of infectious agents. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. Additionally, there were a series of clinical study manuscripts published during the year regarding Vibativ. One study suggested that Vibativ is a promising and viable option for patients with bacteremia or endocarditis, including those with MRSA or another S. aureus pathogen. Two other studies confirmed the continued in vitro potency of Vibativ and detailed the positive outcomes that resulted. RediTrex The Company implemented a soft launch of its newly FDA-approved RediTrex product line during the fourth quarter. Cumberland is now preparing for a full national launch during the second half of 2021, once product supplies are assured and market conditions return to normal. The Company believes that RediTrex will be a valuable addition to the portfolio and help further diversify and grow its business. RediTrex is approved for patients with severe, active rheumatoid arthritis and polyarticular juvenile idiopathic arthritis who have difficulty tolerating or responding to orally delivered methotrexate. It is also approved for symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy. Omeclamox-Pak Cumberland closely monitored its supply chain during the 2020 pandemic. This included monitoring the facilities that supply the raw materials along with those that manufacture the Company's products. Overall, the chain remained intact with batches of finished goods shipped to the warehouses that supply the country's hospital and retail pharmacies. However, there was one exception, as the facility packaging Omeclamox-Pak encountered financial difficulties due to the pandemic and suspended operations. Subsequently, Cumberland learned that this facility is reorganizing, and the Company awaits the resumption of its operations. Ifetroban Phase II Clinical Programs Cumberland's development pipeline includes a series of product candidates in Phase II development. Enrollment in the Company's studies significantly slowed during the pandemic, due to trial suspensions and the decrease in eligible patient admissions to medical centers across the country. While enrollment of new patients was limited most of the year, the Company ensured that patients already entered into a trial continued to receive their study drug. Cumberland looks forward to an improvement in study enrollment as the pandemic subsides and centers begin to reopen. The Company has Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy, Systemic Sclerosis, and Aspirin-Exacerbated Respiratory Disease. FINANCIAL RESULTS: Net Revenue: For the three months ended December31, 2020, net revenues were $10.3 million, up 10% from $9.3 million for the prior year period. The company also recorded an additional $900,000 in revenue during the fourth quarter associated with divested product rights. Net revenue by product for the three months ended December31, 2020, included $5.2 million for Kristalose, $2.3 million for Vibativ, $1.7 million for Caldolor, and $0.9million for the Company's newest brand, RediTrex. For the year ended December31, 2020, net revenues were $37.4million, an 8.9% increase compared to $34.4million for the year ended December31, 2019. Additionally, the company recorded a total of $3.2 million in revenue during 2020 associated with divested product rights. Net revenue by product for the year ended December31, 2020, included $15.6million for Kristalose, $10.9million for Vibativ, $5.3million for Caldolor, $1.9million for Acetadote (including the brand and Company's Authorized Generic), $1.1million for Vaprisol, $0.9million for RediTrex, and $0.3million for Omeclamox- Pak. Operating Expenses: Total operating expenses for the three months ended December31, 2020 were $12.0 million, down from $12.7 million for the prior year period. Total operating expenses for the year ended December31, 2020 were $43.8million, similar to $43.7million for 2019. Adjusted Earnings: Adjusted Earnings for the three months ended December31, 2020 were $0.2 million, or $0.01 per share, compared to a loss of $(1.9) million, or $(0.12) per share for the prior year period. Adjusted Earnings for the full year ended December31, 2020 were a loss of $(0.1)million, or $(0.01) per share, a significant turnaround over the loss of $(3.4) million, or $(0.22) per share in 2019. This performance measure represents net income attributable to common shareholders with adjustments for the impact of income taxes, depreciation, amortization, share based compensation expenses and expenses that are non-core to the operating performance of the period. The definition and the reconciliation of Adjusted Earnings are provided in this release. Cash Flow: Cash flow from operations for the year ended December31, 2020 was $5.4million, compared to $3.1million for the prior year. Balance Sheet: At December31, 2020, Cumberland had $24.8 million in cash and cash equivalents. Total assets at December31, 2020 were $96.5 million. Total Liabilities were $49.6 million, including $15.0 million outstanding on the Company's revolving line of credit and $8.2 million related to contingent liabilities related to the Vibativ acquisition, resulting in Total Shareholder's Equity of $47 million. Conference Call and Webcast A conference call and live Internet webcast will be held on Tuesday, March9, 2021 at 4:30 p.m. Eastern Time to discuss the Company's fourth quarter and annual 2020 financial results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 7005878. The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.cumberlandpharma.com/events-calendar. About Cumberland Pharmaceuticals Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the delivery of high quality prescription brands to improve patient care. The Company develops, acquires and commercializes brands for the hospital acute care, gastroenterology and rheumatology market segments. These medical specialties are categorized by moderately concentrated prescriber bases that the Company believes can be penetrated effectively by targeted sales forces. The Company's portfolio of FDA-approved brands includes: Caldolor (ibuprofen) Injection, for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation; Vibativ (telavancin) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; RediTrex (methotrexate) Injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Vaprisol (conivaptan) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Acetadote (acetylcysteine) Injection, for the treatment of acetaminophen poisoning. For more information on Cumberland's approved products, including full prescribing information, please visit links to the individual product websites, which can be found on the Company's website www.cumberlandpharma.com. The Company has Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy (DMD), Systemic Sclerosis (SSc), and Aspirin-Exacerbated Respiratory Disease (AERD). About Caldolor (ibuprofen) Injection Caldolor is indicated in adults and pediatric patients for the management of mild to moderate pain and management of moderate to severe pain as an adjunct to opioid analgesics, as well as the reduction of fever. It was the first FDA-approved intravenous therapy for fever. Caldolor is contraindicated in patients with known hypersensitivity to ibuprofen or other NSAIDs, patients with a history of asthma or other allergic type reactions after taking aspirin or other NSAIDs. Caldolor is contraindicated for use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery. For full prescribing and safety information, including boxed warning, visit www.caldolor.com. About Kristalose (lactulose) Oral Solution Kristalose is indicated for the treatment of acute and chronic constipation. It is a unique, proprietary, crystalline form of lactulose, with no restrictions on length of therapy or patient age. Kristalose is contraindicated in patients who require a low-galactose diet. Elderly, debilitated patients who receive lactulose for more than six months should have serum electrolytes (potassium, chloride, carbon dioxide) measured periodically. For full prescribing and safety information, visit www.kristalose.com. About Vibativ (telavancin) for Injection Vibativ is a patented, FDA approved injectable anti-infective for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia and complicated skin and skin structure infections. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. Intravenous unfractionated heparin sodium is contraindicated with Vibativ administration due to artificially prolonged activated partial thromboplastin time (aPTT) test results for up to 18 hours after Vibativ administration. Vibativ is contraindicated in patients with a known hypersensitivity to telavancin. For more information please visit www.vibativ.com. About RediTrex (methotrexate) Injection RediTrex is a single-dose prefilled syringe containing prescription methotrexate. RediTrex is used to treat adults with severe, active rheumatoid arthritis and children with active polyarticular juvenile idiopathic arthritis, after treatment with other medicines including non-steroidal anti-inflammatory drugs (NSAIDS) have been used and did not work well. Methotrexate can control the symptoms of severe, resistant, disabling psoriasis in adults when other types of treatment have failed. For full prescribing and safety information, visit www.reditrex.com. About Vaprisol (conivaptan hydrochloride) Injection Vaprisol is an intravenous treatment for hyponatremia used in the critical care setting. Hyponatremia is an electrolyte disturbance in which sodium ion concentration in blood plasma is lower than normal. This can be associated with a variety of critical care conditions including congestive heart failure, liver failure, kidney failure and pneumonia. The product is a vasopressin receptor antagonist that raises serum sodium levels and promotes free water secretion. Vaprisol is contraindicated in patients with hypovolemic hyponatremia. The coadministration of Vaprisol with potent CYP3A inhibitors, such as ketoconazole, itraconazole, clarithromycin, ritonavir, and indinavir, is contraindicated. For full prescribing and safety information, including boxed warning, visit www.vaprisol.com. About Omeclamox-Pak (omeprazole, clarithromycin, amoxicillin) Omeprazole is an antisecretory drug, which works by decreasing the amount of acid the stomach produces. Clarithromycin and amoxicillin are antibacterial drugs, which inhibit the growth of bacteria allowing the stomach lining to heal. Omeclamox-Pak is contraindicated in patients with a history of hypersensitivity to omeprazole, any macrolide antibiotic or penicillin. For full prescribing and safety information, visit www.omeclamox.com. About Acetadote (acetylcysteine) Injection Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury. Used in the emergency department, Acetadote is approved in the United States to treat overdose of acetaminophen, a common ingredient in many over-the-counter medications. Acetadote is contraindicated in patients with hypersensitivity or previous anaphylactoid reactions to acetylcysteine or any components of the preparation. For full prescribing and safety information, visit www.acetadote.com. About Cumberland Emerging Technologies (CET) Cumberland Emerging Technologies, Inc. (www.cet-fund.com) is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN, and WinHealth. The mission of CET is to advance biomedical technologies and products conceived at Vanderbilt University and other regional research centers towards the marketplace. CET helps manage the development and commercialization process for select projects, and provides expertise on intellectual property, regulatory, manufacturing and marketing issues that are critical to successful new biomedical products. CET's Life Sciences Center provides laboratory space, equipment and infrastructure for CET's activities and other early-stage life sciences ventures. Forward-Looking Statements This press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. As with any business, all phases of Cumberland's operations are subject to factors outside of its control, and any one or combination of these factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure, natural disasters, public health epidemics, and other events beyond our control as more fully discussed in the Company's most recent Form 10-K and subsequent 10-Qs as filed with the SEC. There can be no assurance that results anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof. CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Consolidated Balance Sheets December31, 2020 and 2019 (Unaudited) 2020 2019 ASSETS Current assets: Cash and cash equivalents $ 24,753,796 $ 28,212,635 Accounts receivable, net 12,377,713 7,859,006 Inventories, net 10,638,157 8,871,254 Prepaid and other current assets 2,199,926 2,757,456 Current assets associated with discontinued operations 2,462,724 Total current assets 49,969,592 50,163,075 Non-current inventory 11,656,742 15,554,992 Property and equipment, net 574,169 747,796 Intangible assets, net 28,118,316 30,920,324 Goodwill 882,000 882,000 Deferred tax assets, net 21,802 Operating lease right-of-use assets 2,028,148 2,960,569 Other assets 3,234,338 3,298,725 Total assets $ 96,463,305 $ 104,549,283 LIABILITIES AND EQUITY Current liabilities: Accounts payable $ 13,396,286 $ 9,993,578 Operating lease current liabilities 1,016,779 920,431 Other current liabilities 11,254,381 11,084,869 Current liabilities associated with discontinued operations 2,151,357 Total current liabilities 25,667,446 24,150,235 Revolving line of credit 15,000,000 18,500,000 Operating lease non-current liabilities 1,059,693 2,076,472 Other long-term liabilities 7,862,772 8,737,323 Total liabilities 49,589,911 53,464,030 Commitments and contingencies Equity: Shareholders' equity: Common stock no par value; 100,000,000 shares authorized; 14,988,429 and 15,263,555 shares issued and outstanding as of December31, 2020 and 2019, respectively 49,121,523 49,914,478 Retained earnings (deficit) (2,131,013) 1,208,395 Total shareholders' equity 46,990,510 51,122,873 Noncontrolling interests (117,116) (37,620) Total equity 46,873,394 51,085,253 Total liabilities and equity $ 96,463,305 $ 104,549,283 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Three months ended December 31, Years endedDecember 31, 2020 2019 2020 2019 Revenues: Net revenues $ 10,261,534 $ 9,305,553 $ 37,441,134 $ 34,388,295 Costs and expenses: Cost of products sold 2,266,018 2,389,584 8,653,020 7,421,316 Selling and marketing 3,604,541 4,045,962 14,765,465 15,277,740 Research and development 1,399,433 2,079,782 5,773,825 6,868,480 General and administrative 3,587,977 3,135,197 10,196,299 9,974,384 Amortization 1,149,511 1,049,418 4,434,120 4,134,557 Total costs and expenses 12,007,480 12,699,943 43,822,729 43,676,477 Operating income (loss) (1,745,946) (3,394,390) (6,381,595) (9,288,182) Interest income 4,792 47,449 75,345 243,364 Interest expense (35,897) (29,198) (263,627) (246,186) Income (loss) before income taxes (1,777,051) (3,376,139) (6,569,877) (9,291,004) Income tax expense (benefit) (10,479) 6,812 (55,902) 79,316 Net income (loss) from continuing operations (1,787,530) (3,369,327) (6,625,779) (9,211,688) Discontinued operations net of tax 872,064 2,396,983 3,206,875 5,665,177 Net income (loss) (915,466) (972,344) (3,418,904) (3,546,511) Net loss at subsidiary attributable to noncontrolling interests 31,690 11,640 79,496 8,752 Net income (loss) attributable to common shareholders $ (883,776) $ (960,704) $ (3,339,408) $ (3,537,759) Earnings (loss) per share attributable to common shareholders: -Continuing operations-basic $ (0.12) $ (0.22) $ (0.43) $ (0.60) -Discontinuing operations-basic 0.06 0.16 0.21 0.37 Basic $ (0.06) $ (0.06) $ (0.22) $ (0.23) -Continuing operations-diluted $ (0.12) $ (0.22) $ (0.43) $ (0.60) -Discontinuing operations-diluted 0.06 0.16 0.21 0.37 Diluted $ (0.06) $ (0.06) $ (0.22) $ (0.23) Weighted-average common shares outstanding: Basic 15,031,942 15,227,514 15,162,184 15,396,098 Diluted 15,031,942 15,227,514 15,162,184 15,396,098 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Condensed Consolidated Statements of Cash Flows Years ended December31, 2020 and 2019 (Unaudited) 2020 2019 Cash flows from operating activities: Net income (loss) $ (3,418,904) $ (3,546,511) Discontinued operations 3,206,875 5,665,177 Net income (loss) from continuing operations (6,625,779) (9,211,688) Adjustments to reconcile net income (loss) to net cash flows provided byoperating activities: Depreciation and amortization expense 4,748,565 4,404,175 Deferred tax expense 21,802 65,408 Share-based compensation 1,046,516 1,485,898 Decrease in non-cash contingent consideration (1,160,202) (804,167) Write-off of deferred offering costs 440,091 Increase in cash surrender value of life insurance policies over premiums paid (154,611) Noncash interest expense 47,636 47,525 Noncash investment gains (26,315) Net changes in assets and liabilities affecting operating activities: Accounts receivable (4,518,707) (1,399,012) Inventories 2,131,347 1,106,175 Other current assets and other assets 1,210,489 (615,199) Accounts payable and other current liabilities 6,569,002 3,221,780 Other long-term liabilities (1,859,330) (729,820) Net cash provided by (used in) operating activities from continuing operations 1,896,819 (2,455,240) Discontinued operations 3,518,242 5,511,596 Net cash provided by operating activities 5,415,061 3,056,356 Cash flows from investing activities: Additions to property and equipment (140,817) (246,202) Cash paid for acquisitions (5,000,000) Proceeds from surrender of life insurance policies 460,888 Increase in cash surrender value of life insurance policies (104,750) Additions to intangible assets (1,973,110) (772,944) Proceeds from sale of marketable securities 20,062,132 Purchases of marketable securities (11,745,138) Net cash (used in) provided by investing activities (1,757,789) 2,297,848 2020 2019 Cash flows from financing activities: Borrowings on line of credit 59,000,000 76,000,000 Payments on line of credit (62,500,000) (77,500,000) Sale of subsidiary shares to noncontrolling interest 1,000,000 Cash settlement of contingent consideration (819,180) (1,033,108) Repurchase of subsidiary shares from noncontrolling interest (800,000) Cash payments of financing costs (10,000) (52,500) Payments of deferred equity offering costs (135,405) Payments made in connection with repurchase of common shares (1,851,526) (3,494,921) Net cash used in financing activities (7,116,111) (5,080,529) Net increase (decrease) in cash and cash equivalents (3,458,839) 273,675 Cash and cash equivalents, beginning of year 28,212,635 27,938,960 Cash and cash equivalents, end of year $ 24,753,796 $ 28,212,635 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Reconciliation of Net Income (Loss) Attributable to Common Shareholders to Adjusted Earnings (Loss) and Adjusted Diluted Earnings Per Share (Unaudited) Three months ended December 31, Three months ended December 31, 2020 2020 2019 2019 Earningsimpact Earnings pershare impact Earningsimpact Earnings pershare impact Net income (loss) attributable to common shareholders $ (883,776) $ (0.06) $ (960,704) $ (0.06) Less: Net loss at subsidiary attributable to noncontrolling interests 31,690 11,640 Net income (loss) (915,466) (0.06) (972,344) (0.06) Discontinued operations 872,064 0.06 2,396,983 0.16 Net income (loss) from continuing operations $ (1,787,530) (0.12) (3,369,327) (0.22) Adjustments to net income (loss) from continuing operations Income tax expense (benefit) 10,479 (6,812) Depreciation and amortization 1,223,881 0.08 1,125,217 0.07 Share-based compensation (a) 241,178 0.02 378,081 0.02 Write-off of deferred offering costs expense (b) 440,091 0.03 Interest income (4,792) (47,449) Interest expense 35,897 29,198 Adjusted Earnings (loss) from continuing operations and Adjusted Diluted Earnings (loss) from continuing operations Per Share $ 159,204 $ 0.01 $ (1,891,092) $ (0.12) Diluted weighted-average common shares outstanding: 15,031,942 15,227,514 Twelve months ended December 31, Twelve months ended December 31, 2020 2020 2019 2019 Earningsimpact Earnings pershare impact Earningsimpact Earnings pershare impact Net income (loss) attributable to common shareholders $ (3,339,408) $ (0.22) $ (3,537,759) $ (0.23) Less: Net loss at subsidiary attributable to noncontrolling interests 79,496 8,752 Net income (loss) (3,418,904) (0.22) (3,546,511) (0.23) Discontinued operations 3,206,875 0.21 5,665,177 0.37 Net income (loss) from continuing operations $ (6,625,779) $ (0.43) $ (9,211,688) (0.60) Adjustments to net income (loss) from continuing operations Income tax expense (benefit) 55,902 (79,316) (0.01) Depreciation and amortization 4,748,565 0.31 4,404,175 0.29 Share-based compensation (a) 1,046,516 0.07 1,485,898 0.10 Write-off of deferred offering costs expense (b) 440,091 0.03 Interest income (75,345) (243,364) (0.02) Interest expense 263,627 0.02 246,186 0.02 Adjusted Earnings (loss) from continuing operations and Adjusted Diluted Earnings (loss) from continuing operations Per Share $ (146,423) $ (0.01) $ (3,398,109) $ (0.22) Diluted weighted-average common shares outstanding: 15,162,184 15,396,098 The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable Securities and Exchange Commission rules and regulations. These financial measures should be considered supplemental to, and not as a substitute for, financial information prepared in accordance with generally accepted accounting principles ("GAAP"). The definition of these supplemental measures may differ from similarly titled measures used by others. Because these supplemental financial measures exclude the effect of items that will increase or decrease the Company's reported results of operations, management strongly encourages investors to review the Company's consolidated financial statements and publicly filed reports in their entirety. A reconciliation of the supplemental financial measures to the most directly comparable GAAP financial measures is included in the tables accompanying this release. Cumberland's management believes these supplemental financial performance measures are important as they are used by management, along with financial measures in accordance with GAAP, to evaluate the Company's operating performance. In addition, Cumberland believes that they will be used by certain investors to measure the Company's operating results. Management believes that presenting these supplemental measures provides useful information about the Company's underlying performance across reporting periods on a consistent basis by excluding items that Cumberland does not believe are indicative of its core business performance or reflect long-term strategic activities. Certain of these items are not settled through cash payments and include: depreciation, amortization, share-based compensation expense and income taxes. Cumberland utilizes its net operating loss carryforwards to pay minimal income taxes. In addition, the use of these financial measures provides greater transparency to investors of supplemental information used by management in its financial and operational decision-making, including the evaluation of the Company's operating performance. The Company defines these supplemental financial measures as follows: Adjusted Earnings: net income (loss) adjusted for the impact of income taxes, depreciation and amortization expense, share-based compensation expense and other income and interest expense. (a) Represents the share-based compensation of Cumberland. (b) Represents the write-off of deferred offering costs associated with our previous S-3. Adjusted Diluted Earnings Per Share: Adjusted Earnings divided by diluted weighted-average common shares outstanding. SOURCE Cumberland Pharmaceuticals Inc. Related Links http://www.cumberlandpharma.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020.

NASHVILLE, Tenn., March 9, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, today announced fourth quarter and full year 2020 financial results. Net Revenues for the fourth quarter were $10.3 million, up 10% over the prior year period. For the full year 2020, Net Revenues totaled $37.4 million, a 9% increase over 2019. The company also recorded an additional $3.2 million in revenue during the year associated with divested product rights for two brands it is no longer distributing. As of December31, 2020, the total assets of the Company were $96.5 million, including $24.8 million in cash and investments. Total Liabilities were $49.6 million, and Total Shareholder's Equity was $47 million. Cumberland also had approximately $44 million in tax net operating loss carryforwards, resulting from the prior exercise of stock options. 2020 Highlights: Implemented national launch of a Next Generation Caldolor product featuring a ready-to-use formulation in a pre-mixed bag Commenced several national initiatives during 2020 to help hospitals access Cumberland's acute care brands during the COVID-19 pandemic Announced a series of publications featuring important new data associated with the Company's Caldolor (ibuprofen) Injection, for the treatment of pain and fever and Vibativ (telavancin) Injection, for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections Introduced an FDA-approved RediTrex line of injectable methotrexate products, featuring an innovative delivery system for patients with arthritis "We are grateful that Cumberland was able to successfully manage through the pandemic during 2020, in spite of the significant market headwinds and other challenges we encountered," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "Our facilities remained open, our operations continued, and our organization remained intact." He continued, "I would like to acknowledge and thank my colleagues for their continued dedication during such trying times for many. Together, we remain focused on our mission of advancing patient care through the delivery of high-quality medicines." Caldolor Early in 2020, Cumberland implemented a national launch of its Next Generation Caldolorproduct featuring a ready-to-use formulation, offering time and cost savings associated with its administration. Caldolor is a non-steroidal anti-inflammatory drug (NSAID) and may be used as the sole method of treatment for mild-moderate pain or as part of a multimodal treatment for severe pain. Cumberland's new formulation of Caldolor comes in a pre-mixed bag that is ready for use. It is the first FDA-approved pre-mixed bag of ibuprofen. Caldolor was also the subject of several clinical studies published during the year. These studies demonstrated that patients given Caldolor experienced less postoperative pain and had decreased opioid use. Due to these studies, Caldolor was recommended for consideration in Enhanced Recovery After Surgery protocols for the management of postoperative pain - including that of traumatic origin. Vibativ Cumberland launched several national initiatives during 2020 to help hospitals access the Company's acute care brands during the healthcare emergency. Cumberland's Vibativ product was used to help COVID-19 patients who developed secondary-bacterial infections in their lungs. Vibativ is a potent antibiotic, FDA approved to treat hospital and ventilator acquired pneumonia that can result from a variety of infectious agents. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. Additionally, there were a series of clinical study manuscripts published during the year regarding Vibativ. One study suggested that Vibativ is a promising and viable option for patients with bacteremia or endocarditis, including those with MRSA or another S. aureus pathogen. Two other studies confirmed the continued in vitro potency of Vibativ and detailed the positive outcomes that resulted. RediTrex The Company implemented a soft launch of its newly FDA-approved RediTrex product line during the fourth quarter. Cumberland is now preparing for a full national launch during the second half of 2021, once product supplies are assured and market conditions return to normal. The Company believes that RediTrex will be a valuable addition to the portfolio and help further diversify and grow its business. RediTrex is approved for patients with severe, active rheumatoid arthritis and polyarticular juvenile idiopathic arthritis who have difficulty tolerating or responding to orally delivered methotrexate. It is also approved for symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy. Omeclamox-Pak Cumberland closely monitored its supply chain during the 2020 pandemic. This included monitoring the facilities that supply the raw materials along with those that manufacture the Company's products. Overall, the chain remained intact with batches of finished goods shipped to the warehouses that supply the country's hospital and retail pharmacies. However, there was one exception, as the facility packaging Omeclamox-Pak encountered financial difficulties due to the pandemic and suspended operations. Subsequently, Cumberland learned that this facility is reorganizing, and the Company awaits the resumption of its operations. Ifetroban Phase II Clinical Programs Cumberland's development pipeline includes a series of product candidates in Phase II development. Enrollment in the Company's studies significantly slowed during the pandemic, due to trial suspensions and the decrease in eligible patient admissions to medical centers across the country. While enrollment of new patients was limited most of the year, the Company ensured that patients already entered into a trial continued to receive their study drug. Cumberland looks forward to an improvement in study enrollment as the pandemic subsides and centers begin to reopen. The Company has Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy, Systemic Sclerosis, and Aspirin-Exacerbated Respiratory Disease. FINANCIAL RESULTS: Net Revenue: For the three months ended December31, 2020, net revenues were $10.3 million, up 10% from $9.3 million for the prior year period. The company also recorded an additional $900,000 in revenue during the fourth quarter associated with divested product rights. Net revenue by product for the three months ended December31, 2020, included $5.2 million for Kristalose, $2.3 million for Vibativ, $1.7 million for Caldolor, and $0.9million for the Company's newest brand, RediTrex. For the year ended December31, 2020, net revenues were $37.4million, an 8.9% increase compared to $34.4million for the year ended December31, 2019. Additionally, the company recorded a total of $3.2 million in revenue during 2020 associated with divested product rights. Net revenue by product for the year ended December31, 2020, included $15.6million for Kristalose, $10.9million for Vibativ, $5.3million for Caldolor, $1.9million for Acetadote (including the brand and Company's Authorized Generic), $1.1million for Vaprisol, $0.9million for RediTrex, and $0.3million for Omeclamox- Pak. Operating Expenses: Total operating expenses for the three months ended December31, 2020 were $12.0 million, down from $12.7 million for the prior year period. Total operating expenses for the year ended December31, 2020 were $43.8million, similar to $43.7million for 2019. Adjusted Earnings: Adjusted Earnings for the three months ended December31, 2020 were $0.2 million, or $0.01 per share, compared to a loss of $(1.9) million, or $(0.12) per share for the prior year period. Adjusted Earnings for the full year ended December31, 2020 were a loss of $(0.1)million, or $(0.01) per share, a significant turnaround over the loss of $(3.4) million, or $(0.22) per share in 2019. This performance measure represents net income attributable to common shareholders with adjustments for the impact of income taxes, depreciation, amortization, share based compensation expenses and expenses that are non-core to the operating performance of the period. The definition and the reconciliation of Adjusted Earnings are provided in this release. Cash Flow: Cash flow from operations for the year ended December31, 2020 was $5.4million, compared to $3.1million for the prior year. Balance Sheet: At December31, 2020, Cumberland had $24.8 million in cash and cash equivalents. Total assets at December31, 2020 were $96.5 million. Total Liabilities were $49.6 million, including $15.0 million outstanding on the Company's revolving line of credit and $8.2 million related to contingent liabilities related to the Vibativ acquisition, resulting in Total Shareholder's Equity of $47 million. Conference Call and Webcast A conference call and live Internet webcast will be held on Tuesday, March9, 2021 at 4:30 p.m. Eastern Time to discuss the Company's fourth quarter and annual 2020 financial results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 7005878. The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.cumberlandpharma.com/events-calendar. About Cumberland Pharmaceuticals Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the delivery of high quality prescription brands to improve patient care. The Company develops, acquires and commercializes brands for the hospital acute care, gastroenterology and rheumatology market segments. These medical specialties are categorized by moderately concentrated prescriber bases that the Company believes can be penetrated effectively by targeted sales forces. The Company's portfolio of FDA-approved brands includes: Caldolor (ibuprofen) Injection, for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation; Vibativ (telavancin) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; RediTrex (methotrexate) Injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Vaprisol (conivaptan) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Acetadote (acetylcysteine) Injection, for the treatment of acetaminophen poisoning. For more information on Cumberland's approved products, including full prescribing information, please visit links to the individual product websites, which can be found on the Company's website www.cumberlandpharma.com. The Company has Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy (DMD), Systemic Sclerosis (SSc), and Aspirin-Exacerbated Respiratory Disease (AERD). About Caldolor (ibuprofen) Injection Caldolor is indicated in adults and pediatric patients for the management of mild to moderate pain and management of moderate to severe pain as an adjunct to opioid analgesics, as well as the reduction of fever. It was the first FDA-approved intravenous therapy for fever. Caldolor is contraindicated in patients with known hypersensitivity to ibuprofen or other NSAIDs, patients with a history of asthma or other allergic type reactions after taking aspirin or other NSAIDs. Caldolor is contraindicated for use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery. For full prescribing and safety information, including boxed warning, visit www.caldolor.com. About Kristalose (lactulose) Oral Solution Kristalose is indicated for the treatment of acute and chronic constipation. It is a unique, proprietary, crystalline form of lactulose, with no restrictions on length of therapy or patient age. Kristalose is contraindicated in patients who require a low-galactose diet. Elderly, debilitated patients who receive lactulose for more than six months should have serum electrolytes (potassium, chloride, carbon dioxide) measured periodically. For full prescribing and safety information, visit www.kristalose.com. About Vibativ (telavancin) for Injection Vibativ is a patented, FDA approved injectable anti-infective for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia and complicated skin and skin structure infections. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. Intravenous unfractionated heparin sodium is contraindicated with Vibativ administration due to artificially prolonged activated partial thromboplastin time (aPTT) test results for up to 18 hours after Vibativ administration. Vibativ is contraindicated in patients with a known hypersensitivity to telavancin. For more information please visit www.vibativ.com. About RediTrex (methotrexate) Injection RediTrex is a single-dose prefilled syringe containing prescription methotrexate. RediTrex is used to treat adults with severe, active rheumatoid arthritis and children with active polyarticular juvenile idiopathic arthritis, after treatment with other medicines including non-steroidal anti-inflammatory drugs (NSAIDS) have been used and did not work well. Methotrexate can control the symptoms of severe, resistant, disabling psoriasis in adults when other types of treatment have failed. For full prescribing and safety information, visit www.reditrex.com. About Vaprisol (conivaptan hydrochloride) Injection Vaprisol is an intravenous treatment for hyponatremia used in the critical care setting. Hyponatremia is an electrolyte disturbance in which sodium ion concentration in blood plasma is lower than normal. This can be associated with a variety of critical care conditions including congestive heart failure, liver failure, kidney failure and pneumonia. The product is a vasopressin receptor antagonist that raises serum sodium levels and promotes free water secretion. Vaprisol is contraindicated in patients with hypovolemic hyponatremia. The coadministration of Vaprisol with potent CYP3A inhibitors, such as ketoconazole, itraconazole, clarithromycin, ritonavir, and indinavir, is contraindicated. For full prescribing and safety information, including boxed warning, visit www.vaprisol.com. About Omeclamox-Pak (omeprazole, clarithromycin, amoxicillin) Omeprazole is an antisecretory drug, which works by decreasing the amount of acid the stomach produces. Clarithromycin and amoxicillin are antibacterial drugs, which inhibit the growth of bacteria allowing the stomach lining to heal. Omeclamox-Pak is contraindicated in patients with a history of hypersensitivity to omeprazole, any macrolide antibiotic or penicillin. For full prescribing and safety information, visit www.omeclamox.com. About Acetadote (acetylcysteine) Injection Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury. Used in the emergency department, Acetadote is approved in the United States to treat overdose of acetaminophen, a common ingredient in many over-the-counter medications. Acetadote is contraindicated in patients with hypersensitivity or previous anaphylactoid reactions to acetylcysteine or any components of the preparation. For full prescribing and safety information, visit www.acetadote.com. About Cumberland Emerging Technologies (CET) Cumberland Emerging Technologies, Inc. (www.cet-fund.com) is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN, and WinHealth. The mission of CET is to advance biomedical technologies and products conceived at Vanderbilt University and other regional research centers towards the marketplace. CET helps manage the development and commercialization process for select projects, and provides expertise on intellectual property, regulatory, manufacturing and marketing issues that are critical to successful new biomedical products. CET's Life Sciences Center provides laboratory space, equipment and infrastructure for CET's activities and other early-stage life sciences ventures. Forward-Looking Statements This press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. As with any business, all phases of Cumberland's operations are subject to factors outside of its control, and any one or combination of these factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure, natural disasters, public health epidemics, and other events beyond our control as more fully discussed in the Company's most recent Form 10-K and subsequent 10-Qs as filed with the SEC. There can be no assurance that results anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof. CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Consolidated Balance Sheets December31, 2020 and 2019 (Unaudited) 2020 2019 ASSETS Current assets: Cash and cash equivalents $ 24,753,796 $ 28,212,635 Accounts receivable, net 12,377,713 7,859,006 Inventories, net 10,638,157 8,871,254 Prepaid and other current assets 2,199,926 2,757,456 Current assets associated with discontinued operations 2,462,724 Total current assets 49,969,592 50,163,075 Non-current inventory 11,656,742 15,554,992 Property and equipment, net 574,169 747,796 Intangible assets, net 28,118,316 30,920,324 Goodwill 882,000 882,000 Deferred tax assets, net 21,802 Operating lease right-of-use assets 2,028,148 2,960,569 Other assets 3,234,338 3,298,725 Total assets $ 96,463,305 $ 104,549,283 LIABILITIES AND EQUITY Current liabilities: Accounts payable $ 13,396,286 $ 9,993,578 Operating lease current liabilities 1,016,779 920,431 Other current liabilities 11,254,381 11,084,869 Current liabilities associated with discontinued operations 2,151,357 Total current liabilities 25,667,446 24,150,235 Revolving line of credit 15,000,000 18,500,000 Operating lease non-current liabilities 1,059,693 2,076,472 Other long-term liabilities 7,862,772 8,737,323 Total liabilities 49,589,911 53,464,030 Commitments and contingencies Equity: Shareholders' equity: Common stock no par value; 100,000,000 shares authorized; 14,988,429 and 15,263,555 shares issued and outstanding as of December31, 2020 and 2019, respectively 49,121,523 49,914,478 Retained earnings (deficit) (2,131,013) 1,208,395 Total shareholders' equity 46,990,510 51,122,873 Noncontrolling interests (117,116) (37,620) Total equity 46,873,394 51,085,253 Total liabilities and equity $ 96,463,305 $ 104,549,283 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Three months ended December 31, Years endedDecember 31, 2020 2019 2020 2019 Revenues: Net revenues $ 10,261,534 $ 9,305,553 $ 37,441,134 $ 34,388,295 Costs and expenses: Cost of products sold 2,266,018 2,389,584 8,653,020 7,421,316 Selling and marketing 3,604,541 4,045,962 14,765,465 15,277,740 Research and development 1,399,433 2,079,782 5,773,825 6,868,480 General and administrative 3,587,977 3,135,197 10,196,299 9,974,384 Amortization 1,149,511 1,049,418 4,434,120 4,134,557 Total costs and expenses 12,007,480 12,699,943 43,822,729 43,676,477 Operating income (loss) (1,745,946) (3,394,390) (6,381,595) (9,288,182) Interest income 4,792 47,449 75,345 243,364 Interest expense (35,897) (29,198) (263,627) (246,186) Income (loss) before income taxes (1,777,051) (3,376,139) (6,569,877) (9,291,004) Income tax expense (benefit) (10,479) 6,812 (55,902) 79,316 Net income (loss) from continuing operations (1,787,530) (3,369,327) (6,625,779) (9,211,688) Discontinued operations net of tax 872,064 2,396,983 3,206,875 5,665,177 Net income (loss) (915,466) (972,344) (3,418,904) (3,546,511) Net loss at subsidiary attributable to noncontrolling interests 31,690 11,640 79,496 8,752 Net income (loss) attributable to common shareholders $ (883,776) $ (960,704) $ (3,339,408) $ (3,537,759) Earnings (loss) per share attributable to common shareholders: -Continuing operations-basic $ (0.12) $ (0.22) $ (0.43) $ (0.60) -Discontinuing operations-basic 0.06 0.16 0.21 0.37 Basic $ (0.06) $ (0.06) $ (0.22) $ (0.23) -Continuing operations-diluted $ (0.12) $ (0.22) $ (0.43) $ (0.60) -Discontinuing operations-diluted 0.06 0.16 0.21 0.37 Diluted $ (0.06) $ (0.06) $ (0.22) $ (0.23) Weighted-average common shares outstanding: Basic 15,031,942 15,227,514 15,162,184 15,396,098 Diluted 15,031,942 15,227,514 15,162,184 15,396,098 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Condensed Consolidated Statements of Cash Flows Years ended December31, 2020 and 2019 (Unaudited) 2020 2019 Cash flows from operating activities: Net income (loss) $ (3,418,904) $ (3,546,511) Discontinued operations 3,206,875 5,665,177 Net income (loss) from continuing operations (6,625,779) (9,211,688) Adjustments to reconcile net income (loss) to net cash flows provided byoperating activities: Depreciation and amortization expense 4,748,565 4,404,175 Deferred tax expense 21,802 65,408 Share-based compensation 1,046,516 1,485,898 Decrease in non-cash contingent consideration (1,160,202) (804,167) Write-off of deferred offering costs 440,091 Increase in cash surrender value of life insurance policies over premiums paid (154,611) Noncash interest expense 47,636 47,525 Noncash investment gains (26,315) Net changes in assets and liabilities affecting operating activities: Accounts receivable (4,518,707) (1,399,012) Inventories 2,131,347 1,106,175 Other current assets and other assets 1,210,489 (615,199) Accounts payable and other current liabilities 6,569,002 3,221,780 Other long-term liabilities (1,859,330) (729,820) Net cash provided by (used in) operating activities from continuing operations 1,896,819 (2,455,240) Discontinued operations 3,518,242 5,511,596 Net cash provided by operating activities 5,415,061 3,056,356 Cash flows from investing activities: Additions to property and equipment (140,817) (246,202) Cash paid for acquisitions (5,000,000) Proceeds from surrender of life insurance policies 460,888 Increase in cash surrender value of life insurance policies (104,750) Additions to intangible assets (1,973,110) (772,944) Proceeds from sale of marketable securities 20,062,132 Purchases of marketable securities (11,745,138) Net cash (used in) provided by investing activities (1,757,789) 2,297,848 2020 2019 Cash flows from financing activities: Borrowings on line of credit 59,000,000 76,000,000 Payments on line of credit (62,500,000) (77,500,000) Sale of subsidiary shares to noncontrolling interest 1,000,000 Cash settlement of contingent consideration (819,180) (1,033,108) Repurchase of subsidiary shares from noncontrolling interest (800,000) Cash payments of financing costs (10,000) (52,500) Payments of deferred equity offering costs (135,405) Payments made in connection with repurchase of common shares (1,851,526) (3,494,921) Net cash used in financing activities (7,116,111) (5,080,529) Net increase (decrease) in cash and cash equivalents (3,458,839) 273,675 Cash and cash equivalents, beginning of year 28,212,635 27,938,960 Cash and cash equivalents, end of year $ 24,753,796 $ 28,212,635 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Reconciliation of Net Income (Loss) Attributable to Common Shareholders to Adjusted Earnings (Loss) and Adjusted Diluted Earnings Per Share (Unaudited) Three months ended December 31, Three months ended December 31, 2020 2020 2019 2019 Earningsimpact Earnings pershare impact Earningsimpact Earnings pershare impact Net income (loss) attributable to common shareholders $ (883,776) $ (0.06) $ (960,704) $ (0.06) Less: Net loss at subsidiary attributable to noncontrolling interests 31,690 11,640 Net income (loss) (915,466) (0.06) (972,344) (0.06) Discontinued operations 872,064 0.06 2,396,983 0.16 Net income (loss) from continuing operations $ (1,787,530) (0.12) (3,369,327) (0.22) Adjustments to net income (loss) from continuing operations Income tax expense (benefit) 10,479 (6,812) Depreciation and amortization 1,223,881 0.08 1,125,217 0.07 Share-based compensation (a) 241,178 0.02 378,081 0.02 Write-off of deferred offering costs expense (b) 440,091 0.03 Interest income (4,792) (47,449) Interest expense 35,897 29,198 Adjusted Earnings (loss) from continuing operations and Adjusted Diluted Earnings (loss) from continuing operations Per Share $ 159,204 $ 0.01 $ (1,891,092) $ (0.12) Diluted weighted-average common shares outstanding: 15,031,942 15,227,514 Twelve months ended December 31, Twelve months ended December 31, 2020 2020 2019 2019 Earningsimpact Earnings pershare impact Earningsimpact Earnings pershare impact Net income (loss) attributable to common shareholders $ (3,339,408) $ (0.22) $ (3,537,759) $ (0.23) Less: Net loss at subsidiary attributable to noncontrolling interests 79,496 8,752 Net income (loss) (3,418,904) (0.22) (3,546,511) (0.23) Discontinued operations 3,206,875 0.21 5,665,177 0.37 Net income (loss) from continuing operations $ (6,625,779) $ (0.43) $ (9,211,688) (0.60) Adjustments to net income (loss) from continuing operations Income tax expense (benefit) 55,902 (79,316) (0.01) Depreciation and amortization 4,748,565 0.31 4,404,175 0.29 Share-based compensation (a) 1,046,516 0.07 1,485,898 0.10 Write-off of deferred offering costs expense (b) 440,091 0.03 Interest income (75,345) (243,364) (0.02) Interest expense 263,627 0.02 246,186 0.02 Adjusted Earnings (loss) from continuing operations and Adjusted Diluted Earnings (loss) from continuing operations Per Share $ (146,423) $ (0.01) $ (3,398,109) $ (0.22) Diluted weighted-average common shares outstanding: 15,162,184 15,396,098 The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable Securities and Exchange Commission rules and regulations. These financial measures should be considered supplemental to, and not as a substitute for, financial information prepared in accordance with generally accepted accounting principles ("GAAP"). The definition of these supplemental measures may differ from similarly titled measures used by others. Because these supplemental financial measures exclude the effect of items that will increase or decrease the Company's reported results of operations, management strongly encourages investors to review the Company's consolidated financial statements and publicly filed reports in their entirety. A reconciliation of the supplemental financial measures to the most directly comparable GAAP financial measures is included in the tables accompanying this release. Cumberland's management believes these supplemental financial performance measures are important as they are used by management, along with financial measures in accordance with GAAP, to evaluate the Company's operating performance. In addition, Cumberland believes that they will be used by certain investors to measure the Company's operating results. Management believes that presenting these supplemental measures provides useful information about the Company's underlying performance across reporting periods on a consistent basis by excluding items that Cumberland does not believe are indicative of its core business performance or reflect long-term strategic activities. Certain of these items are not settled through cash payments and include: depreciation, amortization, share-based compensation expense and income taxes. Cumberland utilizes its net operating loss carryforwards to pay minimal income taxes. In addition, the use of these financial measures provides greater transparency to investors of supplemental information used by management in its financial and operational decision-making, including the evaluation of the Company's operating performance. The Company defines these supplemental financial measures as follows: Adjusted Earnings: net income (loss) adjusted for the impact of income taxes, depreciation and amortization expense, share-based compensation expense and other income and interest expense. (a) Represents the share-based compensation of Cumberland. (b) Represents the write-off of deferred offering costs associated with our previous S-3. Adjusted Diluted Earnings Per Share: Adjusted Earnings divided by diluted weighted-average common shares outstanding. SOURCE Cumberland Pharmaceuticals Inc. Related Links http://www.cumberlandpharma.com

Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NASHVILLE, Tenn., March 9, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, today announced fourth quarter and full year 2020 financial results. Net Revenues for the fourth quarter were $10.3 million, up 10% over the prior year period. For the full year 2020, Net Revenues totaled $37.4 million, a 9% increase over 2019. The company also recorded an additional $3.2 million in revenue during the year associated with divested product rights for two brands it is no longer distributing. As of December31, 2020, the total assets of the Company were $96.5 million, including $24.8 million in cash and investments. Total Liabilities were $49.6 million, and Total Shareholder's Equity was $47 million. Cumberland also had approximately $44 million in tax net operating loss carryforwards, resulting from the prior exercise of stock options. 2020 Highlights: Implemented national launch of a Next Generation Caldolor product featuring a ready-to-use formulation in a pre-mixed bag Commenced several national initiatives during 2020 to help hospitals access Cumberland's acute care brands during the COVID-19 pandemic Announced a series of publications featuring important new data associated with the Company's Caldolor (ibuprofen) Injection, for the treatment of pain and fever and Vibativ (telavancin) Injection, for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections Introduced an FDA-approved RediTrex line of injectable methotrexate products, featuring an innovative delivery system for patients with arthritis "We are grateful that Cumberland was able to successfully manage through the pandemic during 2020, in spite of the significant market headwinds and other challenges we encountered," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "Our facilities remained open, our operations continued, and our organization remained intact." He continued, "I would like to acknowledge and thank my colleagues for their continued dedication during such trying times for many. Together, we remain focused on our mission of advancing patient care through the delivery of high-quality medicines." Caldolor Early in 2020, Cumberland implemented a national launch of its Next Generation Caldolorproduct featuring a ready-to-use formulation, offering time and cost savings associated with its administration. Caldolor is a non-steroidal anti-inflammatory drug (NSAID) and may be used as the sole method of treatment for mild-moderate pain or as part of a multimodal treatment for severe pain. Cumberland's new formulation of Caldolor comes in a pre-mixed bag that is ready for use. It is the first FDA-approved pre-mixed bag of ibuprofen. Caldolor was also the subject of several clinical studies published during the year. These studies demonstrated that patients given Caldolor experienced less postoperative pain and had decreased opioid use. Due to these studies, Caldolor was recommended for consideration in Enhanced Recovery After Surgery protocols for the management of postoperative pain - including that of traumatic origin. Vibativ Cumberland launched several national initiatives during 2020 to help hospitals access the Company's acute care brands during the healthcare emergency. Cumberland's Vibativ product was used to help COVID-19 patients who developed secondary-bacterial infections in their lungs. Vibativ is a potent antibiotic, FDA approved to treat hospital and ventilator acquired pneumonia that can result from a variety of infectious agents. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. Additionally, there were a series of clinical study manuscripts published during the year regarding Vibativ. One study suggested that Vibativ is a promising and viable option for patients with bacteremia or endocarditis, including those with MRSA or another S. aureus pathogen. Two other studies confirmed the continued in vitro potency of Vibativ and detailed the positive outcomes that resulted. RediTrex The Company implemented a soft launch of its newly FDA-approved RediTrex product line during the fourth quarter. Cumberland is now preparing for a full national launch during the second half of 2021, once product supplies are assured and market conditions return to normal. The Company believes that RediTrex will be a valuable addition to the portfolio and help further diversify and grow its business. RediTrex is approved for patients with severe, active rheumatoid arthritis and polyarticular juvenile idiopathic arthritis who have difficulty tolerating or responding to orally delivered methotrexate. It is also approved for symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy. Omeclamox-Pak Cumberland closely monitored its supply chain during the 2020 pandemic. This included monitoring the facilities that supply the raw materials along with those that manufacture the Company's products. Overall, the chain remained intact with batches of finished goods shipped to the warehouses that supply the country's hospital and retail pharmacies. However, there was one exception, as the facility packaging Omeclamox-Pak encountered financial difficulties due to the pandemic and suspended operations. Subsequently, Cumberland learned that this facility is reorganizing, and the Company awaits the resumption of its operations. Ifetroban Phase II Clinical Programs Cumberland's development pipeline includes a series of product candidates in Phase II development. Enrollment in the Company's studies significantly slowed during the pandemic, due to trial suspensions and the decrease in eligible patient admissions to medical centers across the country. While enrollment of new patients was limited most of the year, the Company ensured that patients already entered into a trial continued to receive their study drug. Cumberland looks forward to an improvement in study enrollment as the pandemic subsides and centers begin to reopen. The Company has Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy, Systemic Sclerosis, and Aspirin-Exacerbated Respiratory Disease. FINANCIAL RESULTS: Net Revenue: For the three months ended December31, 2020, net revenues were $10.3 million, up 10% from $9.3 million for the prior year period. The company also recorded an additional $900,000 in revenue during the fourth quarter associated with divested product rights. Net revenue by product for the three months ended December31, 2020, included $5.2 million for Kristalose, $2.3 million for Vibativ, $1.7 million for Caldolor, and $0.9million for the Company's newest brand, RediTrex. For the year ended December31, 2020, net revenues were $37.4million, an 8.9% increase compared to $34.4million for the year ended December31, 2019. Additionally, the company recorded a total of $3.2 million in revenue during 2020 associated with divested product rights. Net revenue by product for the year ended December31, 2020, included $15.6million for Kristalose, $10.9million for Vibativ, $5.3million for Caldolor, $1.9million for Acetadote (including the brand and Company's Authorized Generic), $1.1million for Vaprisol, $0.9million for RediTrex, and $0.3million for Omeclamox- Pak. Operating Expenses: Total operating expenses for the three months ended December31, 2020 were $12.0 million, down from $12.7 million for the prior year period. Total operating expenses for the year ended December31, 2020 were $43.8million, similar to $43.7million for 2019. Adjusted Earnings: Adjusted Earnings for the three months ended December31, 2020 were $0.2 million, or $0.01 per share, compared to a loss of $(1.9) million, or $(0.12) per share for the prior year period. Adjusted Earnings for the full year ended December31, 2020 were a loss of $(0.1)million, or $(0.01) per share, a significant turnaround over the loss of $(3.4) million, or $(0.22) per share in 2019. This performance measure represents net income attributable to common shareholders with adjustments for the impact of income taxes, depreciation, amortization, share based compensation expenses and expenses that are non-core to the operating performance of the period. The definition and the reconciliation of Adjusted Earnings are provided in this release. Cash Flow: Cash flow from operations for the year ended December31, 2020 was $5.4million, compared to $3.1million for the prior year. Balance Sheet: At December31, 2020, Cumberland had $24.8 million in cash and cash equivalents. Total assets at December31, 2020 were $96.5 million. Total Liabilities were $49.6 million, including $15.0 million outstanding on the Company's revolving line of credit and $8.2 million related to contingent liabilities related to the Vibativ acquisition, resulting in Total Shareholder's Equity of $47 million. Conference Call and Webcast A conference call and live Internet webcast will be held on Tuesday, March9, 2021 at 4:30 p.m. Eastern Time to discuss the Company's fourth quarter and annual 2020 financial results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 7005878. The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.cumberlandpharma.com/events-calendar. About Cumberland Pharmaceuticals Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the delivery of high quality prescription brands to improve patient care. The Company develops, acquires and commercializes brands for the hospital acute care, gastroenterology and rheumatology market segments. These medical specialties are categorized by moderately concentrated prescriber bases that the Company believes can be penetrated effectively by targeted sales forces. The Company's portfolio of FDA-approved brands includes: Caldolor (ibuprofen) Injection, for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation; Vibativ (telavancin) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; RediTrex (methotrexate) Injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Vaprisol (conivaptan) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Acetadote (acetylcysteine) Injection, for the treatment of acetaminophen poisoning. For more information on Cumberland's approved products, including full prescribing information, please visit links to the individual product websites, which can be found on the Company's website www.cumberlandpharma.com. The Company has Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy (DMD), Systemic Sclerosis (SSc), and Aspirin-Exacerbated Respiratory Disease (AERD). About Caldolor (ibuprofen) Injection Caldolor is indicated in adults and pediatric patients for the management of mild to moderate pain and management of moderate to severe pain as an adjunct to opioid analgesics, as well as the reduction of fever. It was the first FDA-approved intravenous therapy for fever. Caldolor is contraindicated in patients with known hypersensitivity to ibuprofen or other NSAIDs, patients with a history of asthma or other allergic type reactions after taking aspirin or other NSAIDs. Caldolor is contraindicated for use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery. For full prescribing and safety information, including boxed warning, visit www.caldolor.com. About Kristalose (lactulose) Oral Solution Kristalose is indicated for the treatment of acute and chronic constipation. It is a unique, proprietary, crystalline form of lactulose, with no restrictions on length of therapy or patient age. Kristalose is contraindicated in patients who require a low-galactose diet. Elderly, debilitated patients who receive lactulose for more than six months should have serum electrolytes (potassium, chloride, carbon dioxide) measured periodically. For full prescribing and safety information, visit www.kristalose.com. About Vibativ (telavancin) for Injection Vibativ is a patented, FDA approved injectable anti-infective for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia and complicated skin and skin structure infections. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. Intravenous unfractionated heparin sodium is contraindicated with Vibativ administration due to artificially prolonged activated partial thromboplastin time (aPTT) test results for up to 18 hours after Vibativ administration. Vibativ is contraindicated in patients with a known hypersensitivity to telavancin. For more information please visit www.vibativ.com. About RediTrex (methotrexate) Injection RediTrex is a single-dose prefilled syringe containing prescription methotrexate. RediTrex is used to treat adults with severe, active rheumatoid arthritis and children with active polyarticular juvenile idiopathic arthritis, after treatment with other medicines including non-steroidal anti-inflammatory drugs (NSAIDS) have been used and did not work well. Methotrexate can control the symptoms of severe, resistant, disabling psoriasis in adults when other types of treatment have failed. For full prescribing and safety information, visit www.reditrex.com. About Vaprisol (conivaptan hydrochloride) Injection Vaprisol is an intravenous treatment for hyponatremia used in the critical care setting. Hyponatremia is an electrolyte disturbance in which sodium ion concentration in blood plasma is lower than normal. This can be associated with a variety of critical care conditions including congestive heart failure, liver failure, kidney failure and pneumonia. The product is a vasopressin receptor antagonist that raises serum sodium levels and promotes free water secretion. Vaprisol is contraindicated in patients with hypovolemic hyponatremia. The coadministration of Vaprisol with potent CYP3A inhibitors, such as ketoconazole, itraconazole, clarithromycin, ritonavir, and indinavir, is contraindicated. For full prescribing and safety information, including boxed warning, visit www.vaprisol.com. About Omeclamox-Pak (omeprazole, clarithromycin, amoxicillin) Omeprazole is an antisecretory drug, which works by decreasing the amount of acid the stomach produces. Clarithromycin and amoxicillin are antibacterial drugs, which inhibit the growth of bacteria allowing the stomach lining to heal. Omeclamox-Pak is contraindicated in patients with a history of hypersensitivity to omeprazole, any macrolide antibiotic or penicillin. For full prescribing and safety information, visit www.omeclamox.com. About Acetadote (acetylcysteine) Injection Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury. Used in the emergency department, Acetadote is approved in the United States to treat overdose of acetaminophen, a common ingredient in many over-the-counter medications. Acetadote is contraindicated in patients with hypersensitivity or previous anaphylactoid reactions to acetylcysteine or any components of the preparation. For full prescribing and safety information, visit www.acetadote.com. About Cumberland Emerging Technologies (CET) Cumberland Emerging Technologies, Inc. (www.cet-fund.com) is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN, and WinHealth. The mission of CET is to advance biomedical technologies and products conceived at Vanderbilt University and other regional research centers towards the marketplace. CET helps manage the development and commercialization process for select projects, and provides expertise on intellectual property, regulatory, manufacturing and marketing issues that are critical to successful new biomedical products. CET's Life Sciences Center provides laboratory space, equipment and infrastructure for CET's activities and other early-stage life sciences ventures. Forward-Looking Statements This press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. As with any business, all phases of Cumberland's operations are subject to factors outside of its control, and any one or combination of these factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure, natural disasters, public health epidemics, and other events beyond our control as more fully discussed in the Company's most recent Form 10-K and subsequent 10-Qs as filed with the SEC. There can be no assurance that results anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof. CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Consolidated Balance Sheets December31, 2020 and 2019 (Unaudited) 2020 2019 ASSETS Current assets: Cash and cash equivalents $ 24,753,796 $ 28,212,635 Accounts receivable, net 12,377,713 7,859,006 Inventories, net 10,638,157 8,871,254 Prepaid and other current assets 2,199,926 2,757,456 Current assets associated with discontinued operations 2,462,724 Total current assets 49,969,592 50,163,075 Non-current inventory 11,656,742 15,554,992 Property and equipment, net 574,169 747,796 Intangible assets, net 28,118,316 30,920,324 Goodwill 882,000 882,000 Deferred tax assets, net 21,802 Operating lease right-of-use assets 2,028,148 2,960,569 Other assets 3,234,338 3,298,725 Total assets $ 96,463,305 $ 104,549,283 LIABILITIES AND EQUITY Current liabilities: Accounts payable $ 13,396,286 $ 9,993,578 Operating lease current liabilities 1,016,779 920,431 Other current liabilities 11,254,381 11,084,869 Current liabilities associated with discontinued operations 2,151,357 Total current liabilities 25,667,446 24,150,235 Revolving line of credit 15,000,000 18,500,000 Operating lease non-current liabilities 1,059,693 2,076,472 Other long-term liabilities 7,862,772 8,737,323 Total liabilities 49,589,911 53,464,030 Commitments and contingencies Equity: Shareholders' equity: Common stock no par value; 100,000,000 shares authorized; 14,988,429 and 15,263,555 shares issued and outstanding as of December31, 2020 and 2019, respectively 49,121,523 49,914,478 Retained earnings (deficit) (2,131,013) 1,208,395 Total shareholders' equity 46,990,510 51,122,873 Noncontrolling interests (117,116) (37,620) Total equity 46,873,394 51,085,253 Total liabilities and equity $ 96,463,305 $ 104,549,283 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Three months ended December 31, Years endedDecember 31, 2020 2019 2020 2019 Revenues: Net revenues $ 10,261,534 $ 9,305,553 $ 37,441,134 $ 34,388,295 Costs and expenses: Cost of products sold 2,266,018 2,389,584 8,653,020 7,421,316 Selling and marketing 3,604,541 4,045,962 14,765,465 15,277,740 Research and development 1,399,433 2,079,782 5,773,825 6,868,480 General and administrative 3,587,977 3,135,197 10,196,299 9,974,384 Amortization 1,149,511 1,049,418 4,434,120 4,134,557 Total costs and expenses 12,007,480 12,699,943 43,822,729 43,676,477 Operating income (loss) (1,745,946) (3,394,390) (6,381,595) (9,288,182) Interest income 4,792 47,449 75,345 243,364 Interest expense (35,897) (29,198) (263,627) (246,186) Income (loss) before income taxes (1,777,051) (3,376,139) (6,569,877) (9,291,004) Income tax expense (benefit) (10,479) 6,812 (55,902) 79,316 Net income (loss) from continuing operations (1,787,530) (3,369,327) (6,625,779) (9,211,688) Discontinued operations net of tax 872,064 2,396,983 3,206,875 5,665,177 Net income (loss) (915,466) (972,344) (3,418,904) (3,546,511) Net loss at subsidiary attributable to noncontrolling interests 31,690 11,640 79,496 8,752 Net income (loss) attributable to common shareholders $ (883,776) $ (960,704) $ (3,339,408) $ (3,537,759) Earnings (loss) per share attributable to common shareholders: -Continuing operations-basic $ (0.12) $ (0.22) $ (0.43) $ (0.60) -Discontinuing operations-basic 0.06 0.16 0.21 0.37 Basic $ (0.06) $ (0.06) $ (0.22) $ (0.23) -Continuing operations-diluted $ (0.12) $ (0.22) $ (0.43) $ (0.60) -Discontinuing operations-diluted 0.06 0.16 0.21 0.37 Diluted $ (0.06) $ (0.06) $ (0.22) $ (0.23) Weighted-average common shares outstanding: Basic 15,031,942 15,227,514 15,162,184 15,396,098 Diluted 15,031,942 15,227,514 15,162,184 15,396,098 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Condensed Consolidated Statements of Cash Flows Years ended December31, 2020 and 2019 (Unaudited) 2020 2019 Cash flows from operating activities: Net income (loss) $ (3,418,904) $ (3,546,511) Discontinued operations 3,206,875 5,665,177 Net income (loss) from continuing operations (6,625,779) (9,211,688) Adjustments to reconcile net income (loss) to net cash flows provided byoperating activities: Depreciation and amortization expense 4,748,565 4,404,175 Deferred tax expense 21,802 65,408 Share-based compensation 1,046,516 1,485,898 Decrease in non-cash contingent consideration (1,160,202) (804,167) Write-off of deferred offering costs 440,091 Increase in cash surrender value of life insurance policies over premiums paid (154,611) Noncash interest expense 47,636 47,525 Noncash investment gains (26,315) Net changes in assets and liabilities affecting operating activities: Accounts receivable (4,518,707) (1,399,012) Inventories 2,131,347 1,106,175 Other current assets and other assets 1,210,489 (615,199) Accounts payable and other current liabilities 6,569,002 3,221,780 Other long-term liabilities (1,859,330) (729,820) Net cash provided by (used in) operating activities from continuing operations 1,896,819 (2,455,240) Discontinued operations 3,518,242 5,511,596 Net cash provided by operating activities 5,415,061 3,056,356 Cash flows from investing activities: Additions to property and equipment (140,817) (246,202) Cash paid for acquisitions (5,000,000) Proceeds from surrender of life insurance policies 460,888 Increase in cash surrender value of life insurance policies (104,750) Additions to intangible assets (1,973,110) (772,944) Proceeds from sale of marketable securities 20,062,132 Purchases of marketable securities (11,745,138) Net cash (used in) provided by investing activities (1,757,789) 2,297,848 2020 2019 Cash flows from financing activities: Borrowings on line of credit 59,000,000 76,000,000 Payments on line of credit (62,500,000) (77,500,000) Sale of subsidiary shares to noncontrolling interest 1,000,000 Cash settlement of contingent consideration (819,180) (1,033,108) Repurchase of subsidiary shares from noncontrolling interest (800,000) Cash payments of financing costs (10,000) (52,500) Payments of deferred equity offering costs (135,405) Payments made in connection with repurchase of common shares (1,851,526) (3,494,921) Net cash used in financing activities (7,116,111) (5,080,529) Net increase (decrease) in cash and cash equivalents (3,458,839) 273,675 Cash and cash equivalents, beginning of year 28,212,635 27,938,960 Cash and cash equivalents, end of year $ 24,753,796 $ 28,212,635 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES Reconciliation of Net Income (Loss) Attributable to Common Shareholders to Adjusted Earnings (Loss) and Adjusted Diluted Earnings Per Share (Unaudited) Three months ended December 31, Three months ended December 31, 2020 2020 2019 2019 Earningsimpact Earnings pershare impact Earningsimpact Earnings pershare impact Net income (loss) attributable to common shareholders $ (883,776) $ (0.06) $ (960,704) $ (0.06) Less: Net loss at subsidiary attributable to noncontrolling interests 31,690 11,640 Net income (loss) (915,466) (0.06) (972,344) (0.06) Discontinued operations 872,064 0.06 2,396,983 0.16 Net income (loss) from continuing operations $ (1,787,530) (0.12) (3,369,327) (0.22) Adjustments to net income (loss) from continuing operations Income tax expense (benefit) 10,479 (6,812) Depreciation and amortization 1,223,881 0.08 1,125,217 0.07 Share-based compensation (a) 241,178 0.02 378,081 0.02 Write-off of deferred offering costs expense (b) 440,091 0.03 Interest income (4,792) (47,449) Interest expense 35,897 29,198 Adjusted Earnings (loss) from continuing operations and Adjusted Diluted Earnings (loss) from continuing operations Per Share $ 159,204 $ 0.01 $ (1,891,092) $ (0.12) Diluted weighted-average common shares outstanding: 15,031,942 15,227,514 Twelve months ended December 31, Twelve months ended December 31, 2020 2020 2019 2019 Earningsimpact Earnings pershare impact Earningsimpact Earnings pershare impact Net income (loss) attributable to common shareholders $ (3,339,408) $ (0.22) $ (3,537,759) $ (0.23) Less: Net loss at subsidiary attributable to noncontrolling interests 79,496 8,752 Net income (loss) (3,418,904) (0.22) (3,546,511) (0.23) Discontinued operations 3,206,875 0.21 5,665,177 0.37 Net income (loss) from continuing operations $ (6,625,779) $ (0.43) $ (9,211,688) (0.60) Adjustments to net income (loss) from continuing operations Income tax expense (benefit) 55,902 (79,316) (0.01) Depreciation and amortization 4,748,565 0.31 4,404,175 0.29 Share-based compensation (a) 1,046,516 0.07 1,485,898 0.10 Write-off of deferred offering costs expense (b) 440,091 0.03 Interest income (75,345) (243,364) (0.02) Interest expense 263,627 0.02 246,186 0.02 Adjusted Earnings (loss) from continuing operations and Adjusted Diluted Earnings (loss) from continuing operations Per Share $ (146,423) $ (0.01) $ (3,398,109) $ (0.22) Diluted weighted-average common shares outstanding: 15,162,184 15,396,098 The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable Securities and Exchange Commission rules and regulations. These financial measures should be considered supplemental to, and not as a substitute for, financial information prepared in accordance with generally accepted accounting principles ("GAAP"). The definition of these supplemental measures may differ from similarly titled measures used by others. Because these supplemental financial measures exclude the effect of items that will increase or decrease the Company's reported results of operations, management strongly encourages investors to review the Company's consolidated financial statements and publicly filed reports in their entirety. A reconciliation of the supplemental financial measures to the most directly comparable GAAP financial measures is included in the tables accompanying this release. Cumberland's management believes these supplemental financial performance measures are important as they are used by management, along with financial measures in accordance with GAAP, to evaluate the Company's operating performance. In addition, Cumberland believes that they will be used by certain investors to measure the Company's operating results. Management believes that presenting these supplemental measures provides useful information about the Company's underlying performance across reporting periods on a consistent basis by excluding items that Cumberland does not believe are indicative of its core business performance or reflect long-term strategic activities. Certain of these items are not settled through cash payments and include: depreciation, amortization, share-based compensation expense and income taxes. Cumberland utilizes its net operating loss carryforwards to pay minimal income taxes. In addition, the use of these financial measures provides greater transparency to investors of supplemental information used by management in its financial and operational decision-making, including the evaluation of the Company's operating performance. The Company defines these supplemental financial measures as follows: Adjusted Earnings: net income (loss) adjusted for the impact of income taxes, depreciation and amortization expense, share-based compensation expense and other income and interest expense. (a) Represents the share-based compensation of Cumberland. (b) Represents the write-off of deferred offering costs associated with our previous S-3. Adjusted Diluted Earnings Per Share: Adjusted Earnings divided by diluted weighted-average common shares outstanding. SOURCE Cumberland Pharmaceuticals Inc. Related Links http://www.cumberlandpharma.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020.<|eot_id|>

edtsum914

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN, Dec. 29, 2020 /PRNewswire/ -- The "Architectural LED Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 9th edition of this report. The 297-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Architectural LED Products Market to Reach $22.2 Billion by 2027 Amid the COVID-19 crisis, the global market for Architectural LED Products estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$22.2 Billion by 2027, growing at a CAGR of 16.2% over the analysis period 2020-2027. Wall Washing, one of the segments analyzed in the report, is projected to record a 16.1% CAGR and reach US$8.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the In Ground segment is readjusted to a revised 17% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 21% CAGRThe Architectural LED Products market in the U.S. is estimated at US$2.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.1 Billion by the year 2027 trailing a CAGR of 20.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 14.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.Cove Lighting Segment to Record 16.6% CAGRIn the global Cove Lighting segment, USA, Canada, Japan, China and Europe will drive the 15.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.4 Billion by the year 2027, while Latin America will expand at a 18.4% CAGR through the analysis period. Competitors identified in this market include, among others: Cree, Inc. Eaton Corporation PLC Epistar Corporation Galaxia Electronics Corporation GE Lighting Osram Licht AG Philips Lumileds Lighting Company Samsung Electronics Co., Ltd. Toshiba Lighting & Technology Corporation Verbatim GmbH Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Architectural LED Products Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 57 For more information about this report visit https://www.researchandmarkets.com/r/qchvuv Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Insights on the Architectural LED Products Global Market to 2027 - Featuring Cree, Eaton Corporation & Epistar Among Others.

DUBLIN, Dec. 29, 2020 /PRNewswire/ -- The "Architectural LED Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 9th edition of this report. The 297-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Architectural LED Products Market to Reach $22.2 Billion by 2027 Amid the COVID-19 crisis, the global market for Architectural LED Products estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$22.2 Billion by 2027, growing at a CAGR of 16.2% over the analysis period 2020-2027. Wall Washing, one of the segments analyzed in the report, is projected to record a 16.1% CAGR and reach US$8.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the In Ground segment is readjusted to a revised 17% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 21% CAGRThe Architectural LED Products market in the U.S. is estimated at US$2.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.1 Billion by the year 2027 trailing a CAGR of 20.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 14.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.Cove Lighting Segment to Record 16.6% CAGRIn the global Cove Lighting segment, USA, Canada, Japan, China and Europe will drive the 15.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.4 Billion by the year 2027, while Latin America will expand at a 18.4% CAGR through the analysis period. Competitors identified in this market include, among others: Cree, Inc. Eaton Corporation PLC Epistar Corporation Galaxia Electronics Corporation GE Lighting Osram Licht AG Philips Lumileds Lighting Company Samsung Electronics Co., Ltd. Toshiba Lighting & Technology Corporation Verbatim GmbH Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Architectural LED Products Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 57 For more information about this report visit https://www.researchandmarkets.com/r/qchvuv Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Insights on the Architectural LED Products Global Market to 2027 - Featuring Cree, Eaton Corporation & Epistar Among Others

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: DUBLIN, Dec. 29, 2020 /PRNewswire/ -- The "Architectural LED Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 9th edition of this report. The 297-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Architectural LED Products Market to Reach $22.2 Billion by 2027 Amid the COVID-19 crisis, the global market for Architectural LED Products estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$22.2 Billion by 2027, growing at a CAGR of 16.2% over the analysis period 2020-2027. Wall Washing, one of the segments analyzed in the report, is projected to record a 16.1% CAGR and reach US$8.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the In Ground segment is readjusted to a revised 17% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 21% CAGRThe Architectural LED Products market in the U.S. is estimated at US$2.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.1 Billion by the year 2027 trailing a CAGR of 20.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 14.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.Cove Lighting Segment to Record 16.6% CAGRIn the global Cove Lighting segment, USA, Canada, Japan, China and Europe will drive the 15.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.4 Billion by the year 2027, while Latin America will expand at a 18.4% CAGR through the analysis period. Competitors identified in this market include, among others: Cree, Inc. Eaton Corporation PLC Epistar Corporation Galaxia Electronics Corporation GE Lighting Osram Licht AG Philips Lumileds Lighting Company Samsung Electronics Co., Ltd. Toshiba Lighting & Technology Corporation Verbatim GmbH Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Architectural LED Products Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 57 For more information about this report visit https://www.researchandmarkets.com/r/qchvuv Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Insights on the Architectural LED Products Global Market to 2027 - Featuring Cree, Eaton Corporation & Epistar Among Others.<|eot_id|>

edtsum915

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN DIEGO, April 21, 2020 /PRNewswire/ --Truvian Sciences ("Truvian"), a healthcare company at the intersection of diagnostics and consumer technology, today announced that healthcare executive Jean-Pierre "JP" Millon has been named to the company's Board of Directors. With this appointment Millon joins board members Dr. Kim Kamdar of Domain Associates, Ashok Krishnamurthi of GreatPoint Ventures,PaulMeister whoserved in senior executive and board roles for high-growth and publicly traded companies including Chairman of the Board of Thermo Fisher Scientific, and Truvian President and CEO, Jeff Hawkins. (PRNewsfoto/Truvian Sciences) Millon brings a wealth of expertise and leadership in the healthcare and life science industries to Truvian's Board of Directors. He is currently a director at CVS Health, Inc., a role to which he was appointed in 2007, and also served as a director at Prometheus Labs from 2003 to 2011. Prior to that, he was president and chief executive officer of PCS from 1996 to 2000. Millon also held several global leadership positions over the span of two decades with Eli Lilly and Company. He is the co-founder of BLS LLC, a consulting and investing entity based in Indianapolis. "JP is one of the most trusted and respected voices in the healthcare industry," said Jeff Hawkins, President and Chief Executive Officer, Truvian. "His diverse and impressive background, experience and insights will be invaluable to the team at Truvian as we march towards regulatory submission and, ultimately, commercialization of our benchtop blood testing platform." Millon serves on a number of healthcare company boards, including InanoBio Inc., Curemetrix, Equality Health and Valenz, and he is also on the advisory boards of several companies, including Sky Republic, Kazuhm and Curematch. The latter two are incubated by Analytics Ventures, where he is also an advisor. "It is an honor to be appointed to Truvian's Board of Directors," said Millon. "I have been impressed by the quality of and potential for the company's diagnostics benchtop blood testing platform and believe it will be a game-changer for physicians, healthcare professionals and consumers in the quest for reliable and fast testing. I look forward to assisting the management team in delivering a disruptive platform that will improve healthcare for all." Millon earned a degree in mechanical engineering from Ecole Centrale de Lyon, France, and a degree in economics from the University of Lyon, France. He was awarded a Master's of Business Administration in finance from the Kellogg School of Management at Northwestern University. He is a trustee of Scottsdale Arts and a board member of ASU Biodesign Institute. For more information about Truvian, its automated benchtop blood testing system or its Board of Directors, please visit www.truviansciences.com. About Truvian SciencesTruvian is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop blood testing system is being developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian's system delivers a convenient and affordable alternative to off-site labs, providing immediate insights to inform healthcare decisions. Truvian was founded by individuals with deep domain experience in healthcare, diagnostics and consumer technology. Today, the team has expanded to include top scientists, engineers, and healthcare business leaders each bringing specialized expertise to drive Truvian's mission of making routine health testing convenient, affordable and actionable. For more information, visit www.truviansciences.com. SOURCE Truvian Sciences Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Truvian Sciences Names Jean-Pierre Millon to its Board of Directors. Decorated Healthcare Executive and Current CVS Health Director Brings Deep Expertise to Burgeoning Blood Testing Company.

SAN DIEGO, April 21, 2020 /PRNewswire/ --Truvian Sciences ("Truvian"), a healthcare company at the intersection of diagnostics and consumer technology, today announced that healthcare executive Jean-Pierre "JP" Millon has been named to the company's Board of Directors. With this appointment Millon joins board members Dr. Kim Kamdar of Domain Associates, Ashok Krishnamurthi of GreatPoint Ventures,PaulMeister whoserved in senior executive and board roles for high-growth and publicly traded companies including Chairman of the Board of Thermo Fisher Scientific, and Truvian President and CEO, Jeff Hawkins. (PRNewsfoto/Truvian Sciences) Millon brings a wealth of expertise and leadership in the healthcare and life science industries to Truvian's Board of Directors. He is currently a director at CVS Health, Inc., a role to which he was appointed in 2007, and also served as a director at Prometheus Labs from 2003 to 2011. Prior to that, he was president and chief executive officer of PCS from 1996 to 2000. Millon also held several global leadership positions over the span of two decades with Eli Lilly and Company. He is the co-founder of BLS LLC, a consulting and investing entity based in Indianapolis. "JP is one of the most trusted and respected voices in the healthcare industry," said Jeff Hawkins, President and Chief Executive Officer, Truvian. "His diverse and impressive background, experience and insights will be invaluable to the team at Truvian as we march towards regulatory submission and, ultimately, commercialization of our benchtop blood testing platform." Millon serves on a number of healthcare company boards, including InanoBio Inc., Curemetrix, Equality Health and Valenz, and he is also on the advisory boards of several companies, including Sky Republic, Kazuhm and Curematch. The latter two are incubated by Analytics Ventures, where he is also an advisor. "It is an honor to be appointed to Truvian's Board of Directors," said Millon. "I have been impressed by the quality of and potential for the company's diagnostics benchtop blood testing platform and believe it will be a game-changer for physicians, healthcare professionals and consumers in the quest for reliable and fast testing. I look forward to assisting the management team in delivering a disruptive platform that will improve healthcare for all." Millon earned a degree in mechanical engineering from Ecole Centrale de Lyon, France, and a degree in economics from the University of Lyon, France. He was awarded a Master's of Business Administration in finance from the Kellogg School of Management at Northwestern University. He is a trustee of Scottsdale Arts and a board member of ASU Biodesign Institute. For more information about Truvian, its automated benchtop blood testing system or its Board of Directors, please visit www.truviansciences.com. About Truvian SciencesTruvian is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop blood testing system is being developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian's system delivers a convenient and affordable alternative to off-site labs, providing immediate insights to inform healthcare decisions. Truvian was founded by individuals with deep domain experience in healthcare, diagnostics and consumer technology. Today, the team has expanded to include top scientists, engineers, and healthcare business leaders each bringing specialized expertise to drive Truvian's mission of making routine health testing convenient, affordable and actionable. For more information, visit www.truviansciences.com. SOURCE Truvian Sciences

Truvian Sciences Names Jean-Pierre Millon to its Board of Directors Decorated Healthcare Executive and Current CVS Health Director Brings Deep Expertise to Burgeoning Blood Testing Company

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SAN DIEGO, April 21, 2020 /PRNewswire/ --Truvian Sciences ("Truvian"), a healthcare company at the intersection of diagnostics and consumer technology, today announced that healthcare executive Jean-Pierre "JP" Millon has been named to the company's Board of Directors. With this appointment Millon joins board members Dr. Kim Kamdar of Domain Associates, Ashok Krishnamurthi of GreatPoint Ventures,PaulMeister whoserved in senior executive and board roles for high-growth and publicly traded companies including Chairman of the Board of Thermo Fisher Scientific, and Truvian President and CEO, Jeff Hawkins. (PRNewsfoto/Truvian Sciences) Millon brings a wealth of expertise and leadership in the healthcare and life science industries to Truvian's Board of Directors. He is currently a director at CVS Health, Inc., a role to which he was appointed in 2007, and also served as a director at Prometheus Labs from 2003 to 2011. Prior to that, he was president and chief executive officer of PCS from 1996 to 2000. Millon also held several global leadership positions over the span of two decades with Eli Lilly and Company. He is the co-founder of BLS LLC, a consulting and investing entity based in Indianapolis. "JP is one of the most trusted and respected voices in the healthcare industry," said Jeff Hawkins, President and Chief Executive Officer, Truvian. "His diverse and impressive background, experience and insights will be invaluable to the team at Truvian as we march towards regulatory submission and, ultimately, commercialization of our benchtop blood testing platform." Millon serves on a number of healthcare company boards, including InanoBio Inc., Curemetrix, Equality Health and Valenz, and he is also on the advisory boards of several companies, including Sky Republic, Kazuhm and Curematch. The latter two are incubated by Analytics Ventures, where he is also an advisor. "It is an honor to be appointed to Truvian's Board of Directors," said Millon. "I have been impressed by the quality of and potential for the company's diagnostics benchtop blood testing platform and believe it will be a game-changer for physicians, healthcare professionals and consumers in the quest for reliable and fast testing. I look forward to assisting the management team in delivering a disruptive platform that will improve healthcare for all." Millon earned a degree in mechanical engineering from Ecole Centrale de Lyon, France, and a degree in economics from the University of Lyon, France. He was awarded a Master's of Business Administration in finance from the Kellogg School of Management at Northwestern University. He is a trustee of Scottsdale Arts and a board member of ASU Biodesign Institute. For more information about Truvian, its automated benchtop blood testing system or its Board of Directors, please visit www.truviansciences.com. About Truvian SciencesTruvian is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop blood testing system is being developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian's system delivers a convenient and affordable alternative to off-site labs, providing immediate insights to inform healthcare decisions. Truvian was founded by individuals with deep domain experience in healthcare, diagnostics and consumer technology. Today, the team has expanded to include top scientists, engineers, and healthcare business leaders each bringing specialized expertise to drive Truvian's mission of making routine health testing convenient, affordable and actionable. For more information, visit www.truviansciences.com. SOURCE Truvian Sciences Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Truvian Sciences Names Jean-Pierre Millon to its Board of Directors. Decorated Healthcare Executive and Current CVS Health Director Brings Deep Expertise to Burgeoning Blood Testing Company.<|eot_id|>

edtsum916

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Feb. 19, 2021 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for MRNA, TSLA, PFE, PLUG, and NIO. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast. MRNA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=MRNA&prnumber=021920213 TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=TSLA&prnumber=021920213 PFE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PFE&prnumber=021920213 PLUG: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PLUG&prnumber=021920213 NIO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NIO&prnumber=021920213 (Note: You may have to copy this link into your browser then press the [ENTER] key.) SOURCE InvestorsObserver Related Links http://www.investorsobserver.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Thinking about trading options or stock in Moderna, Tesla, Pfizer, Plug Power, or Nio?

NEW YORK, Feb. 19, 2021 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for MRNA, TSLA, PFE, PLUG, and NIO. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast. MRNA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=MRNA&prnumber=021920213 TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=TSLA&prnumber=021920213 PFE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PFE&prnumber=021920213 PLUG: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PLUG&prnumber=021920213 NIO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NIO&prnumber=021920213 (Note: You may have to copy this link into your browser then press the [ENTER] key.) SOURCE InvestorsObserver Related Links http://www.investorsobserver.com

Thinking about trading options or stock in Moderna, Tesla, Pfizer, Plug Power, or Nio?

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, Feb. 19, 2021 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for MRNA, TSLA, PFE, PLUG, and NIO. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast. MRNA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=MRNA&prnumber=021920213 TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=TSLA&prnumber=021920213 PFE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PFE&prnumber=021920213 PLUG: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PLUG&prnumber=021920213 NIO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NIO&prnumber=021920213 (Note: You may have to copy this link into your browser then press the [ENTER] key.) SOURCE InvestorsObserver Related Links http://www.investorsobserver.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Thinking about trading options or stock in Moderna, Tesla, Pfizer, Plug Power, or Nio?<|eot_id|>

edtsum917

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, April 14, 2021 /PRNewswire/ --Hudson Executive Investment Corp. III (the "Company") announced today that holders of the units sold in the Company's initial public offering of 60,000,000 units completed on February 26, 2021 may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about April 16, 2021. Any units not separated will continue to trade on The Nasdaq Capital Market ("Nasdaq") under the symbol "HIIIU," and each of the shares of Class A common stock and warrants will separately trade on Nasdaq under the symbols "HIII" and "HIIIW," respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units are required to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent with respect to the units, Class A common stock and warrants, in order to separate the units into shares of Class A common stock and warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering was made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 800-831-9146; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 866-803- 9204, email: [emailprotected]; and Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: (888) 603-5847, email: [emailprotected]. About Hudson Executive Investment Corp. III Hudson Executive Investment Corp. III is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company was co-sponsored by Hudson Executive Capital LP, a value-oriented, event-driven investment firm with a focus on small and mid-cap companies, Douglas L. Braunstein, its founder and managing partner, and Douglas G. Bergeron, its managing partner. The Company intends to focus its search on technology-driven, disruptive companies with desirable growth-oriented characteristics as well as on more mature businesses with attractive cash flow characteristics and long-term, sustainable growth profiles. Hudson Executive Investment Corp., the first SPAC managed by Mr. Braunstein and Mr. Bergeron, went public and raised $414 million in June 2020 and in January 2021 announced a combination with digital and virtual behavioral healthcare company Talkspace. Hudson Executive Investment Corp. II, the second SPAC managed by Mr. Braunstein and Mr. Bergeron, went public and raised $250 million in January 2021. Cautionary Note Concerning Forward-Looking Statements This press release contains statements that constitute "forward-looking statements," including with respect to the Company's search for an initial business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement for the initial public offering filed with the SEC. Copies are available on the SEC's website,www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Investor Contact Hatcher Snead [emailprotected] 212-521-8495 Media Contact Gladstone Place Partners Steven Lipin/Max Dutcher 212-230-5930 SOURCE Hudson Executive Investment Corp. III Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Hudson Executive Investment Corp. III Announces Separate Trading of its Class A Common Stock and Warrants Commencing on or about April 16, 2021.

NEW YORK, April 14, 2021 /PRNewswire/ --Hudson Executive Investment Corp. III (the "Company") announced today that holders of the units sold in the Company's initial public offering of 60,000,000 units completed on February 26, 2021 may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about April 16, 2021. Any units not separated will continue to trade on The Nasdaq Capital Market ("Nasdaq") under the symbol "HIIIU," and each of the shares of Class A common stock and warrants will separately trade on Nasdaq under the symbols "HIII" and "HIIIW," respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units are required to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent with respect to the units, Class A common stock and warrants, in order to separate the units into shares of Class A common stock and warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering was made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 800-831-9146; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 866-803- 9204, email: [emailprotected]; and Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: (888) 603-5847, email: [emailprotected]. About Hudson Executive Investment Corp. III Hudson Executive Investment Corp. III is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company was co-sponsored by Hudson Executive Capital LP, a value-oriented, event-driven investment firm with a focus on small and mid-cap companies, Douglas L. Braunstein, its founder and managing partner, and Douglas G. Bergeron, its managing partner. The Company intends to focus its search on technology-driven, disruptive companies with desirable growth-oriented characteristics as well as on more mature businesses with attractive cash flow characteristics and long-term, sustainable growth profiles. Hudson Executive Investment Corp., the first SPAC managed by Mr. Braunstein and Mr. Bergeron, went public and raised $414 million in June 2020 and in January 2021 announced a combination with digital and virtual behavioral healthcare company Talkspace. Hudson Executive Investment Corp. II, the second SPAC managed by Mr. Braunstein and Mr. Bergeron, went public and raised $250 million in January 2021. Cautionary Note Concerning Forward-Looking Statements This press release contains statements that constitute "forward-looking statements," including with respect to the Company's search for an initial business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement for the initial public offering filed with the SEC. Copies are available on the SEC's website,www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Investor Contact Hatcher Snead [emailprotected] 212-521-8495 Media Contact Gladstone Place Partners Steven Lipin/Max Dutcher 212-230-5930 SOURCE Hudson Executive Investment Corp. III

Hudson Executive Investment Corp. III Announces Separate Trading of its Class A Common Stock and Warrants Commencing on or about April 16, 2021

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK, April 14, 2021 /PRNewswire/ --Hudson Executive Investment Corp. III (the "Company") announced today that holders of the units sold in the Company's initial public offering of 60,000,000 units completed on February 26, 2021 may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about April 16, 2021. Any units not separated will continue to trade on The Nasdaq Capital Market ("Nasdaq") under the symbol "HIIIU," and each of the shares of Class A common stock and warrants will separately trade on Nasdaq under the symbols "HIII" and "HIIIW," respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units are required to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent with respect to the units, Class A common stock and warrants, in order to separate the units into shares of Class A common stock and warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering was made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 800-831-9146; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 866-803- 9204, email: [emailprotected]; and Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: (888) 603-5847, email: [emailprotected]. About Hudson Executive Investment Corp. III Hudson Executive Investment Corp. III is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company was co-sponsored by Hudson Executive Capital LP, a value-oriented, event-driven investment firm with a focus on small and mid-cap companies, Douglas L. Braunstein, its founder and managing partner, and Douglas G. Bergeron, its managing partner. The Company intends to focus its search on technology-driven, disruptive companies with desirable growth-oriented characteristics as well as on more mature businesses with attractive cash flow characteristics and long-term, sustainable growth profiles. Hudson Executive Investment Corp., the first SPAC managed by Mr. Braunstein and Mr. Bergeron, went public and raised $414 million in June 2020 and in January 2021 announced a combination with digital and virtual behavioral healthcare company Talkspace. Hudson Executive Investment Corp. II, the second SPAC managed by Mr. Braunstein and Mr. Bergeron, went public and raised $250 million in January 2021. Cautionary Note Concerning Forward-Looking Statements This press release contains statements that constitute "forward-looking statements," including with respect to the Company's search for an initial business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement for the initial public offering filed with the SEC. Copies are available on the SEC's website,www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Investor Contact Hatcher Snead [emailprotected] 212-521-8495 Media Contact Gladstone Place Partners Steven Lipin/Max Dutcher 212-230-5930 SOURCE Hudson Executive Investment Corp. III Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Hudson Executive Investment Corp. III Announces Separate Trading of its Class A Common Stock and Warrants Commencing on or about April 16, 2021.<|eot_id|>

edtsum918

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against EHang Holdings Limited ("EH" or the "Company") (NASDAQ: EH) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired EH securities between December 12, 2019 and February 16, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/eh. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors material adverse information. Specifically, the complaint alleges that EH's approvals in North America and Europe for the EH216 were for use as a drone and not as a passenger vehicle and that the Company's purported relationship with its primary customer was in fact fraudulent. The complaint continues to allege that EH has only collected on a small fraction of its reported sales since December 2019, and that its manufacturing facilities appeared empty, lacking both advanced manufacturing equipment and employees. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/eh or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in EH you have until April 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

EH Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds EHang Holdings Limited Investors of Class Action and Encourages Shareholders to Contact the Firm.

NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against EHang Holdings Limited ("EH" or the "Company") (NASDAQ: EH) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired EH securities between December 12, 2019 and February 16, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/eh. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors material adverse information. Specifically, the complaint alleges that EH's approvals in North America and Europe for the EH216 were for use as a drone and not as a passenger vehicle and that the Company's purported relationship with its primary customer was in fact fraudulent. The complaint continues to allege that EH has only collected on a small fraction of its reported sales since December 2019, and that its manufacturing facilities appeared empty, lacking both advanced manufacturing equipment and employees. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/eh or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in EH you have until April 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

EH Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds EHang Holdings Limited Investors of Class Action and Encourages Shareholders to Contact the Firm

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against EHang Holdings Limited ("EH" or the "Company") (NASDAQ: EH) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired EH securities between December 12, 2019 and February 16, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/eh. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors material adverse information. Specifically, the complaint alleges that EH's approvals in North America and Europe for the EH216 were for use as a drone and not as a passenger vehicle and that the Company's purported relationship with its primary customer was in fact fraudulent. The complaint continues to allege that EH has only collected on a small fraction of its reported sales since December 2019, and that its manufacturing facilities appeared empty, lacking both advanced manufacturing equipment and employees. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/eh or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in EH you have until April 19, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> EH Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds EHang Holdings Limited Investors of Class Action and Encourages Shareholders to Contact the Firm.<|eot_id|>

edtsum919

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SHENZHEN, China, Aug. 2, 2020 /PRNewswire/ --realme, one of the leading smartphone brands globally has just released its H1 2020 figures and statistics. realme reported an 11% growth in Q2 2020, the only major brand to have registered a double-digit positive figure and has been named the fastest growing smartphone brand in the world for four consecutive quarters by Counterpoint. In Q1, Counterpoint also reported that realme was one of the only two brands to have registered positive growth with 157% YoY. Dear to Leap, realme H1 2020 Highlight Reel Based on the latest user numbers, realme has added 15M users in the first half of the year. realme reported that it is now a TOP 4 smartphone brand in Thailand, India, Cambodia and Egypt, and also achieved TOP 5 in Myanmar, Philippines, Ukraine, Indonesia and Vietnam, according the Counterpoint Research and IDC. realme has focused on promoting 5G products in its retail markets, beginning with the X50 Pro 5G. realme has launched the first 5G-capable flagship phone in India, as well as Thailand's first 5G phone. The company has also launched Cambodia's first 5G phone under USD1,000. In 2020, realme has implemented a 'Smartphone + AIoT' dual-driven strategy. In spite of a challenging economic environment, realme has successfully met targets laid out in this initiative. realme is on track to launch over 50 AIoT products in 2020 and over 100 the following year. In Q1 2020, despite realme being a new entrant into the smart personal audio market in India, it has secured a third place in terms of market share, according to a report by Canalys, a research firm.realme defines its AIoT strategy as a "1+4+N" initiative, which refers to one core product (smartphones), complemented by four major groups of lifestyle devices (speakers, earphones, TVs and watches) which is in turn supported by "N" types of smart accessories.realme's CEO, Mr Li Bingzhong, issued the following comments: Since 2018, realme has grown to 40M users, and this is due to the strong, youthful and international team here at realme. With an average age of only 29 years old, this team has shown that they dared to leap forward and proved the power of youth in a competitive market. As we continue to build upon a strong H1 performance, realme is aiming to sell 100m phones in 3 years. We plan to continue our international expansion plans, where we think there will be the most growth. For example, our AIoT products have been performing well in the Indian market, where we sold 15,000 TV sets within 10 mins and our smart personal audio devices have reached 3rd place in terms of market share within 3 months. realme has done well in expanding to nearly 60 different markets. As the world's fastest growing smartphone brand, this is a validation of our mission and strategy to empower youths to 'dare to leap' outside of their boundaries. realme's products have also made waves in the design world. In 2020, realme's Design Studio have collaborated with world-renowned designers NaotoFukasawaand Jose Levy, of Hermes fame to produce trendsetting realme products. In addition, realme has won the prestigious Red Dot Design Award for its X2 Pro Master, issuing a strong challenge to incumbent brands. realme has pioneered innovations not only in design but also in technology, most notably when it launched the world's first 125W fast charging technology.Milestones: realme grew by 157% in Q1 2020 realme is the fastest growing smartphone brand globally, according to Counterpoint realme has gained more than 15M users in H1 2020 realme is now active in 59 countries and regions across 5 continents realme has achieved at least TOP5 in 9 different markets About realme:realme is a technology brand that providessuperior quality and trendsetting smartphones and AIoT productsto the global market. realme users are young, ambitious and globally minded. realme products empower these people to 'Dare to Leap' using the latest in technology and design.realme is the seventh top smartphone brand in the world and was recognized as one ofthe mainstream smartphone brands according to Counterpoint'sstatistics of global smartphone shipments in Q3 2019. In 2019, realme's global smartphone shipments reached 25 million with a YoYgrowth rate of 808%, making realme the fastest-growing smartphone brand in the world. realme has entered 59 markets worldwide, including China, Southeast Asia, South Asia, Europe, Russia, Australia, Middle East, Africa with global user base of over 40 million.Media Contact Wen WU Head of Corporate Public Relations [emailprotected] (+86 158 1058 0696) or go to https://www.realme.com/global/SOURCE realme Related Links http://www.realme.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

World's fastest growing smartphone brand realme releases H1 2020 results.

SHENZHEN, China, Aug. 2, 2020 /PRNewswire/ --realme, one of the leading smartphone brands globally has just released its H1 2020 figures and statistics. realme reported an 11% growth in Q2 2020, the only major brand to have registered a double-digit positive figure and has been named the fastest growing smartphone brand in the world for four consecutive quarters by Counterpoint. In Q1, Counterpoint also reported that realme was one of the only two brands to have registered positive growth with 157% YoY. Dear to Leap, realme H1 2020 Highlight Reel Based on the latest user numbers, realme has added 15M users in the first half of the year. realme reported that it is now a TOP 4 smartphone brand in Thailand, India, Cambodia and Egypt, and also achieved TOP 5 in Myanmar, Philippines, Ukraine, Indonesia and Vietnam, according the Counterpoint Research and IDC. realme has focused on promoting 5G products in its retail markets, beginning with the X50 Pro 5G. realme has launched the first 5G-capable flagship phone in India, as well as Thailand's first 5G phone. The company has also launched Cambodia's first 5G phone under USD1,000. In 2020, realme has implemented a 'Smartphone + AIoT' dual-driven strategy. In spite of a challenging economic environment, realme has successfully met targets laid out in this initiative. realme is on track to launch over 50 AIoT products in 2020 and over 100 the following year. In Q1 2020, despite realme being a new entrant into the smart personal audio market in India, it has secured a third place in terms of market share, according to a report by Canalys, a research firm.realme defines its AIoT strategy as a "1+4+N" initiative, which refers to one core product (smartphones), complemented by four major groups of lifestyle devices (speakers, earphones, TVs and watches) which is in turn supported by "N" types of smart accessories.realme's CEO, Mr Li Bingzhong, issued the following comments: Since 2018, realme has grown to 40M users, and this is due to the strong, youthful and international team here at realme. With an average age of only 29 years old, this team has shown that they dared to leap forward and proved the power of youth in a competitive market. As we continue to build upon a strong H1 performance, realme is aiming to sell 100m phones in 3 years. We plan to continue our international expansion plans, where we think there will be the most growth. For example, our AIoT products have been performing well in the Indian market, where we sold 15,000 TV sets within 10 mins and our smart personal audio devices have reached 3rd place in terms of market share within 3 months. realme has done well in expanding to nearly 60 different markets. As the world's fastest growing smartphone brand, this is a validation of our mission and strategy to empower youths to 'dare to leap' outside of their boundaries. realme's products have also made waves in the design world. In 2020, realme's Design Studio have collaborated with world-renowned designers NaotoFukasawaand Jose Levy, of Hermes fame to produce trendsetting realme products. In addition, realme has won the prestigious Red Dot Design Award for its X2 Pro Master, issuing a strong challenge to incumbent brands. realme has pioneered innovations not only in design but also in technology, most notably when it launched the world's first 125W fast charging technology.Milestones: realme grew by 157% in Q1 2020 realme is the fastest growing smartphone brand globally, according to Counterpoint realme has gained more than 15M users in H1 2020 realme is now active in 59 countries and regions across 5 continents realme has achieved at least TOP5 in 9 different markets About realme:realme is a technology brand that providessuperior quality and trendsetting smartphones and AIoT productsto the global market. realme users are young, ambitious and globally minded. realme products empower these people to 'Dare to Leap' using the latest in technology and design.realme is the seventh top smartphone brand in the world and was recognized as one ofthe mainstream smartphone brands according to Counterpoint'sstatistics of global smartphone shipments in Q3 2019. In 2019, realme's global smartphone shipments reached 25 million with a YoYgrowth rate of 808%, making realme the fastest-growing smartphone brand in the world. realme has entered 59 markets worldwide, including China, Southeast Asia, South Asia, Europe, Russia, Australia, Middle East, Africa with global user base of over 40 million.Media Contact Wen WU Head of Corporate Public Relations [emailprotected] (+86 158 1058 0696) or go to https://www.realme.com/global/SOURCE realme Related Links http://www.realme.com

World's fastest growing smartphone brand realme releases H1 2020 results

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: SHENZHEN, China, Aug. 2, 2020 /PRNewswire/ --realme, one of the leading smartphone brands globally has just released its H1 2020 figures and statistics. realme reported an 11% growth in Q2 2020, the only major brand to have registered a double-digit positive figure and has been named the fastest growing smartphone brand in the world for four consecutive quarters by Counterpoint. In Q1, Counterpoint also reported that realme was one of the only two brands to have registered positive growth with 157% YoY. Dear to Leap, realme H1 2020 Highlight Reel Based on the latest user numbers, realme has added 15M users in the first half of the year. realme reported that it is now a TOP 4 smartphone brand in Thailand, India, Cambodia and Egypt, and also achieved TOP 5 in Myanmar, Philippines, Ukraine, Indonesia and Vietnam, according the Counterpoint Research and IDC. realme has focused on promoting 5G products in its retail markets, beginning with the X50 Pro 5G. realme has launched the first 5G-capable flagship phone in India, as well as Thailand's first 5G phone. The company has also launched Cambodia's first 5G phone under USD1,000. In 2020, realme has implemented a 'Smartphone + AIoT' dual-driven strategy. In spite of a challenging economic environment, realme has successfully met targets laid out in this initiative. realme is on track to launch over 50 AIoT products in 2020 and over 100 the following year. In Q1 2020, despite realme being a new entrant into the smart personal audio market in India, it has secured a third place in terms of market share, according to a report by Canalys, a research firm.realme defines its AIoT strategy as a "1+4+N" initiative, which refers to one core product (smartphones), complemented by four major groups of lifestyle devices (speakers, earphones, TVs and watches) which is in turn supported by "N" types of smart accessories.realme's CEO, Mr Li Bingzhong, issued the following comments: Since 2018, realme has grown to 40M users, and this is due to the strong, youthful and international team here at realme. With an average age of only 29 years old, this team has shown that they dared to leap forward and proved the power of youth in a competitive market. As we continue to build upon a strong H1 performance, realme is aiming to sell 100m phones in 3 years. We plan to continue our international expansion plans, where we think there will be the most growth. For example, our AIoT products have been performing well in the Indian market, where we sold 15,000 TV sets within 10 mins and our smart personal audio devices have reached 3rd place in terms of market share within 3 months. realme has done well in expanding to nearly 60 different markets. As the world's fastest growing smartphone brand, this is a validation of our mission and strategy to empower youths to 'dare to leap' outside of their boundaries. realme's products have also made waves in the design world. In 2020, realme's Design Studio have collaborated with world-renowned designers NaotoFukasawaand Jose Levy, of Hermes fame to produce trendsetting realme products. In addition, realme has won the prestigious Red Dot Design Award for its X2 Pro Master, issuing a strong challenge to incumbent brands. realme has pioneered innovations not only in design but also in technology, most notably when it launched the world's first 125W fast charging technology.Milestones: realme grew by 157% in Q1 2020 realme is the fastest growing smartphone brand globally, according to Counterpoint realme has gained more than 15M users in H1 2020 realme is now active in 59 countries and regions across 5 continents realme has achieved at least TOP5 in 9 different markets About realme:realme is a technology brand that providessuperior quality and trendsetting smartphones and AIoT productsto the global market. realme users are young, ambitious and globally minded. realme products empower these people to 'Dare to Leap' using the latest in technology and design.realme is the seventh top smartphone brand in the world and was recognized as one ofthe mainstream smartphone brands according to Counterpoint'sstatistics of global smartphone shipments in Q3 2019. In 2019, realme's global smartphone shipments reached 25 million with a YoYgrowth rate of 808%, making realme the fastest-growing smartphone brand in the world. realme has entered 59 markets worldwide, including China, Southeast Asia, South Asia, Europe, Russia, Australia, Middle East, Africa with global user base of over 40 million.Media Contact Wen WU Head of Corporate Public Relations [emailprotected] (+86 158 1058 0696) or go to https://www.realme.com/global/SOURCE realme Related Links http://www.realme.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> World's fastest growing smartphone brand realme releases H1 2020 results.<|eot_id|>

edtsum920

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CLEVELAND--(BUSINESS WIRE)--Applied Industrial Technologies (NYSE: AIT) today announced plans to release its fiscal 2021 first quarter financial results on Wednesday, October 28, 2020, before the market opens. The Companys fiscal 2021 first quarter ended September 30, 2020. The quarterly conference call for investors and analysts will begin at 10 a.m. ET on October 28. Neil A. Schrimsher President & CEO, and David K. Wells CFO will discuss the Companys performance. A supplemental investor deck detailing latest quarter results will be available for reference on the Investor Relations portion of the Companys website at www.applied.com. To join the call, dial 877-311-4351 (toll free) or 614-999-9139 (International callers) using conference ID 2164357. A live audio webcast can be accessed online through the investor relations portion of the Companys website at www.applied.com. To help ensure you do not miss any of the conference call, please dial-in or link to the call 15 minutes prior to the scheduled start. Replays of the call will be made available for two weeks via webcast or telephone by dialing 855-859-2056 or 800-585-8367 (both toll free), or 404-537-3406 (International) using conference ID 2164357. About Applied Applied Industrial Technologies is a leading value-added distributor and technical solutions provider of industrial motion, fluid power, flow control, automation technologies, and related maintenance supplies. Our leading brands, specialized services, and comprehensive knowledge serve MRO and OEM end users in virtually all industrial markets through our multi-channel capabilities that provide choice, convenience, and expertise. For more information, visit www.applied.com. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Applied Industrial Technologies to Report First Quarter Earnings and Conduct Investor Teleconference on October 28, 2020.

CLEVELAND--(BUSINESS WIRE)--Applied Industrial Technologies (NYSE: AIT) today announced plans to release its fiscal 2021 first quarter financial results on Wednesday, October 28, 2020, before the market opens. The Companys fiscal 2021 first quarter ended September 30, 2020. The quarterly conference call for investors and analysts will begin at 10 a.m. ET on October 28. Neil A. Schrimsher President & CEO, and David K. Wells CFO will discuss the Companys performance. A supplemental investor deck detailing latest quarter results will be available for reference on the Investor Relations portion of the Companys website at www.applied.com. To join the call, dial 877-311-4351 (toll free) or 614-999-9139 (International callers) using conference ID 2164357. A live audio webcast can be accessed online through the investor relations portion of the Companys website at www.applied.com. To help ensure you do not miss any of the conference call, please dial-in or link to the call 15 minutes prior to the scheduled start. Replays of the call will be made available for two weeks via webcast or telephone by dialing 855-859-2056 or 800-585-8367 (both toll free), or 404-537-3406 (International) using conference ID 2164357. About Applied Applied Industrial Technologies is a leading value-added distributor and technical solutions provider of industrial motion, fluid power, flow control, automation technologies, and related maintenance supplies. Our leading brands, specialized services, and comprehensive knowledge serve MRO and OEM end users in virtually all industrial markets through our multi-channel capabilities that provide choice, convenience, and expertise. For more information, visit www.applied.com.

Applied Industrial Technologies to Report First Quarter Earnings and Conduct Investor Teleconference on October 28, 2020

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CLEVELAND--(BUSINESS WIRE)--Applied Industrial Technologies (NYSE: AIT) today announced plans to release its fiscal 2021 first quarter financial results on Wednesday, October 28, 2020, before the market opens. The Companys fiscal 2021 first quarter ended September 30, 2020. The quarterly conference call for investors and analysts will begin at 10 a.m. ET on October 28. Neil A. Schrimsher President & CEO, and David K. Wells CFO will discuss the Companys performance. A supplemental investor deck detailing latest quarter results will be available for reference on the Investor Relations portion of the Companys website at www.applied.com. To join the call, dial 877-311-4351 (toll free) or 614-999-9139 (International callers) using conference ID 2164357. A live audio webcast can be accessed online through the investor relations portion of the Companys website at www.applied.com. To help ensure you do not miss any of the conference call, please dial-in or link to the call 15 minutes prior to the scheduled start. Replays of the call will be made available for two weeks via webcast or telephone by dialing 855-859-2056 or 800-585-8367 (both toll free), or 404-537-3406 (International) using conference ID 2164357. About Applied Applied Industrial Technologies is a leading value-added distributor and technical solutions provider of industrial motion, fluid power, flow control, automation technologies, and related maintenance supplies. Our leading brands, specialized services, and comprehensive knowledge serve MRO and OEM end users in virtually all industrial markets through our multi-channel capabilities that provide choice, convenience, and expertise. For more information, visit www.applied.com. Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Applied Industrial Technologies to Report First Quarter Earnings and Conduct Investor Teleconference on October 28, 2020.<|eot_id|>

edtsum921

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CAMBRIDGE, Mass., Aug. 4, 2020 /PRNewswire/ --Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on August 1, 2020, the Compensation Committee of Blueprint Medicines' Board of Directors granted non-qualified stock options to purchase an aggregate of 14,514 shares of its common stock and an aggregate of 7,255 restricted stock units (RSUs) to six new employees under Blueprint Medicines' 2020 Inducement Plan. The 2020 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Blueprint Medicines, as an inducement material to such individual's entering into employment with Blueprint Medicines, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. The options have an exercise price of $73.18 per share, which is equal to the closing price of Blueprint Medicines' common stock on July 31, 2020. Each option will vest as to 25% of the shares underlying such option on the first anniversary of the grant date and as to an additional 1/48th of the shares underlying the optionmonthly thereafter, in each case, subject to each such employee's continued employment on each vesting date. Each RSU will vest as to 25% of the shares underlying the RSU award on the first anniversary of the grant date and as to an additional 25% of the shares underlying the RSU award annually thereafter, subject to each such employee's continued employment on each vesting date. The options and RSUs are subject to the terms and conditions of Blueprint Medicines' 2020 Inducement Plan, and the terms and conditions of the stock option and RSU agreement covering the grant. About Blueprint Medicines Blueprint Medicinesis a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and development of new treatments and increases the likelihood of clinical success. We have one FDA-approved precision therapy and are currently advancing multiple investigational medicines in clinical development, along with a number of research programs. For more information, visit www.BlueprintMedicines.comand follow us on Twitter(@BlueprintMeds) andLinkedIn. SOURCE Blueprint Medicines Corporation Related Links http://www.blueprintmedicines.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).

CAMBRIDGE, Mass., Aug. 4, 2020 /PRNewswire/ --Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on August 1, 2020, the Compensation Committee of Blueprint Medicines' Board of Directors granted non-qualified stock options to purchase an aggregate of 14,514 shares of its common stock and an aggregate of 7,255 restricted stock units (RSUs) to six new employees under Blueprint Medicines' 2020 Inducement Plan. The 2020 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Blueprint Medicines, as an inducement material to such individual's entering into employment with Blueprint Medicines, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. The options have an exercise price of $73.18 per share, which is equal to the closing price of Blueprint Medicines' common stock on July 31, 2020. Each option will vest as to 25% of the shares underlying such option on the first anniversary of the grant date and as to an additional 1/48th of the shares underlying the optionmonthly thereafter, in each case, subject to each such employee's continued employment on each vesting date. Each RSU will vest as to 25% of the shares underlying the RSU award on the first anniversary of the grant date and as to an additional 25% of the shares underlying the RSU award annually thereafter, subject to each such employee's continued employment on each vesting date. The options and RSUs are subject to the terms and conditions of Blueprint Medicines' 2020 Inducement Plan, and the terms and conditions of the stock option and RSU agreement covering the grant. About Blueprint Medicines Blueprint Medicinesis a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and development of new treatments and increases the likelihood of clinical success. We have one FDA-approved precision therapy and are currently advancing multiple investigational medicines in clinical development, along with a number of research programs. For more information, visit www.BlueprintMedicines.comand follow us on Twitter(@BlueprintMeds) andLinkedIn. SOURCE Blueprint Medicines Corporation Related Links http://www.blueprintmedicines.com

Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: CAMBRIDGE, Mass., Aug. 4, 2020 /PRNewswire/ --Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on August 1, 2020, the Compensation Committee of Blueprint Medicines' Board of Directors granted non-qualified stock options to purchase an aggregate of 14,514 shares of its common stock and an aggregate of 7,255 restricted stock units (RSUs) to six new employees under Blueprint Medicines' 2020 Inducement Plan. The 2020 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Blueprint Medicines, as an inducement material to such individual's entering into employment with Blueprint Medicines, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. The options have an exercise price of $73.18 per share, which is equal to the closing price of Blueprint Medicines' common stock on July 31, 2020. Each option will vest as to 25% of the shares underlying such option on the first anniversary of the grant date and as to an additional 1/48th of the shares underlying the optionmonthly thereafter, in each case, subject to each such employee's continued employment on each vesting date. Each RSU will vest as to 25% of the shares underlying the RSU award on the first anniversary of the grant date and as to an additional 25% of the shares underlying the RSU award annually thereafter, subject to each such employee's continued employment on each vesting date. The options and RSUs are subject to the terms and conditions of Blueprint Medicines' 2020 Inducement Plan, and the terms and conditions of the stock option and RSU agreement covering the grant. About Blueprint Medicines Blueprint Medicinesis a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and development of new treatments and increases the likelihood of clinical success. We have one FDA-approved precision therapy and are currently advancing multiple investigational medicines in clinical development, along with a number of research programs. For more information, visit www.BlueprintMedicines.comand follow us on Twitter(@BlueprintMeds) andLinkedIn. SOURCE Blueprint Medicines Corporation Related Links http://www.blueprintmedicines.com Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).<|eot_id|>

edtsum922

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: WINONA, Minn.--(BUSINESS WIRE)--Fastenal Company (Nasdaq:FAST) announced the date and time for its conference call to review 2020 annual and fourth quarter results, as well as current operations. The conference call will be broadcast live over the Internet on Wednesday, January 20, 2021 at 9:00 a.m. central time. To access the call, please visit the following Web address: https://investor.fastenal.com/events.cfm Our conference call presentation (which includes information, supplemental to that contained in our earnings announcement, regarding results for the quarter) will be available at 6:00 a.m., central time, on the day of the conference call. To access the presentation, please visit the following Web address: https://investor.fastenal.com/releases.cfm An online archive of the webcast will be available within one hour of the conclusion of the call and will remain available until March 1, 2021. Participants must have a soundcard and speakers to listen to the online webcast. About Fastenal Fastenal helps customers simplify and realize product and process savings across their supply chain. We sell a broad offering of products spanning more than nine major product lines from fasteners and tools to safety and janitorial supplies. These products are efficiently distributed to manufacturing facilities, job sites, and other customer locations through local service teams and point-of-use inventory solutions, including industrial vending technology and bin stock programs (Fastenal Managed Inventory, or FMI). Our distribution system centers on over 3,200 in-market locations (a combination of public branches and customer-specific Onsite locations), primarily in North America but also in Asia, Europe, and Central and South America, each providing tailored inventory, flexible service, and custom solutions to drive the unique goals of local customers. These in-market servicing locations are supported by fifteen regional distribution centers, a captive logistics fleet, robust sourcing, quality and manufacturing resources, and multiple teams of industry specialists and support personnel all working toward Fastenals common goal of Growth Through Customer Service. Additional information regarding Fastenal is available on the Fastenal Company website at www.fastenal.com. FAST-G Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Fastenal Company Announces Conference Call to Review 2020 Annual and Fourth Quarter Earnings.

WINONA, Minn.--(BUSINESS WIRE)--Fastenal Company (Nasdaq:FAST) announced the date and time for its conference call to review 2020 annual and fourth quarter results, as well as current operations. The conference call will be broadcast live over the Internet on Wednesday, January 20, 2021 at 9:00 a.m. central time. To access the call, please visit the following Web address: https://investor.fastenal.com/events.cfm Our conference call presentation (which includes information, supplemental to that contained in our earnings announcement, regarding results for the quarter) will be available at 6:00 a.m., central time, on the day of the conference call. To access the presentation, please visit the following Web address: https://investor.fastenal.com/releases.cfm An online archive of the webcast will be available within one hour of the conclusion of the call and will remain available until March 1, 2021. Participants must have a soundcard and speakers to listen to the online webcast. About Fastenal Fastenal helps customers simplify and realize product and process savings across their supply chain. We sell a broad offering of products spanning more than nine major product lines from fasteners and tools to safety and janitorial supplies. These products are efficiently distributed to manufacturing facilities, job sites, and other customer locations through local service teams and point-of-use inventory solutions, including industrial vending technology and bin stock programs (Fastenal Managed Inventory, or FMI). Our distribution system centers on over 3,200 in-market locations (a combination of public branches and customer-specific Onsite locations), primarily in North America but also in Asia, Europe, and Central and South America, each providing tailored inventory, flexible service, and custom solutions to drive the unique goals of local customers. These in-market servicing locations are supported by fifteen regional distribution centers, a captive logistics fleet, robust sourcing, quality and manufacturing resources, and multiple teams of industry specialists and support personnel all working toward Fastenals common goal of Growth Through Customer Service. Additional information regarding Fastenal is available on the Fastenal Company website at www.fastenal.com. FAST-G

Fastenal Company Announces Conference Call to Review 2020 Annual and Fourth Quarter Earnings

<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a seasoned marketing PR professional brainstorming a captivating headline for a press release at BUSINESS WIRE and PRNewswire<|eot_id|><|start_header_id|>user<|end_header_id|> Write a headline with strong SEO potential. Article: WINONA, Minn.--(BUSINESS WIRE)--Fastenal Company (Nasdaq:FAST) announced the date and time for its conference call to review 2020 annual and fourth quarter results, as well as current operations. The conference call will be broadcast live over the Internet on Wednesday, January 20, 2021 at 9:00 a.m. central time. To access the call, please visit the following Web address: https://investor.fastenal.com/events.cfm Our conference call presentation (which includes information, supplemental to that contained in our earnings announcement, regarding results for the quarter) will be available at 6:00 a.m., central time, on the day of the conference call. To access the presentation, please visit the following Web address: https://investor.fastenal.com/releases.cfm An online archive of the webcast will be available within one hour of the conclusion of the call and will remain available until March 1, 2021. Participants must have a soundcard and speakers to listen to the online webcast. About Fastenal Fastenal helps customers simplify and realize product and process savings across their supply chain. We sell a broad offering of products spanning more than nine major product lines from fasteners and tools to safety and janitorial supplies. These products are efficiently distributed to manufacturing facilities, job sites, and other customer locations through local service teams and point-of-use inventory solutions, including industrial vending technology and bin stock programs (Fastenal Managed Inventory, or FMI). Our distribution system centers on over 3,200 in-market locations (a combination of public branches and customer-specific Onsite locations), primarily in North America but also in Asia, Europe, and Central and South America, each providing tailored inventory, flexible service, and custom solutions to drive the unique goals of local customers. These in-market servicing locations are supported by fifteen regional distribution centers, a captive logistics fleet, robust sourcing, quality and manufacturing resources, and multiple teams of industry specialists and support personnel all working toward Fastenals common goal of Growth Through Customer Service. Additional information regarding Fastenal is available on the Fastenal Company website at www.fastenal.com. FAST-G Just write a title.<|eot_id|><|start_header_id|>assistant<|end_header_id|> Fastenal Company Announces Conference Call to Review 2020 Annual and Fourth Quarter Earnings.<|eot_id|>